SB 643: Medical marijuana.
- Session Year: 2015-2016
- House: Senate
- Latest Version Date: 2015-10-09
(1)Existing law, the Compassionate Use Act of 1996, an initiative measure enacted by the approval of Proposition 215 at the November 6, 1996, statewide general election, authorizes the use of marijuana for medical purposes. Existing law enacted by the Legislature requires the establishment of a program for the issuance of identification cards to qualified patients so that they may lawfully use marijuana for medical purposes, and requires the establishment of guidelines for the lawful cultivation of marijuana grown for medical use. Existing law provides for the licensure of various professions by the Department of Consumer Affairs. Existing law, the Sherman Food, Drug, and Cosmetic Law, provides for the regulation of food, drugs, devices, and cosmetics, as specified. A violation of that law is a crime.
This bill would, among other things, set forth standards for a physician and surgeon prescribing medical cannabis and require the Medical Board of California to prioritize its investigative and prosecutorial resources to identify and discipline physicians and surgeons that have repeatedly recommended excessive cannabis to patients for medical purposes or repeatedly recommended cannabis to patients for medical purposes without a good faith examination, as specified. The bill would require the Bureau of Medical Marijuana to require an applicant to furnish a full set of fingerprints for the purposes of conducting criminal history record checks. The bill would prohibit a physician and surgeon who recommends cannabis to a patient for a medical purpose from accepting, soliciting, or offering any form of remuneration from a facility licensed under the Medical Marijuana Regulation and Safety Act. The bill would make a violation of this prohibition a misdemeanor, and by creating a new crime, this bill would impose a state-mandated local program.
This bill would require the Governor, under the Medical Marijuana Regulation and Safety Act, to appoint, subject to confirmation by the Senate, a chief of the Bureau of Medical Marijuana Regulation. The act would require the Department of Consumer Affairs to have the sole authority to create, issue, renew, discipline, suspend, or revoke licenses for the transportation and storage, unrelated to manufacturing, of medical marijuana, and would authorize the department to collect fees for its regulatory activities and impose specified duties on this department in this regard. The act would require the Department of Food and Agriculture to administer the provisions of the act related to, and associated with, the cultivation, and transportation of, medical cannabis and would impose specified duties on this department in this regard. The act would require the State Department of Public Health to administer the provisions of the act related to, and associated with, the manufacturing and testing of medical cannabis and would impose specified duties on this department in this regard.
This bill would authorize counties to impose a tax upon specified cannabis-related activity.
This bill would require an applicant for a state license pursuant to the act to provide a statement signed by the applicant under penalty of perjury, thereby changing the scope of a crime and imposing a state-mandated local program.
This bill would set forth standards for the licensed cultivation of medical cannabis, including, but not limited to, establishing duties relating to the environmental impact of cannabis and cannabis products. The bill would also establish state cultivator license types, as specified.
(2)This bill would provide that its provisions are severable.
(3)The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that with regard to certain mandates no reimbursement is required by this act for a specified reason.
With regard to any other mandates, this bill would provide that, if the Commission on State Mandates determines that the bill contains costs so mandated by the state, reimbursement for those costs shall be made pursuant to the statutory provisions noted above.
(4)Existing constitutional provisions require that a statute that limits the right of access to the meeting of public bodies or the writings of public bodies or the writings of public officials and agencies be adopted with finding demonstrating the interest protected by the limitation and the need for protecting that interest. The bill would make legislative findings to that effect.
(5)The bill would become operative only if AB 266 and AB 243 of the 201516 Regular Session are enacted and take effect on or before January 1, 2016.
(1)Existing law, the Compassionate Use Act of 1996, an initiative measure enacted by the approval of Proposition 215 at the November 6, 1996, statewide general election, authorizes the use of marijuana for medical purposes. Existing law enacted by the Legislature requires the establishment of a program for the issuance of identification cards to qualified patients so that they may lawfully use marijuana for medical purposes, and requires the establishment of guidelines for the lawful cultivation of marijuana grown for medical use. Existing law provides for the licensure of various professions by the Department of Consumer Affairs. Existing law, the Sherman Food, Drug, and Cosmetic Law, provides for the regulation of food, drugs, devices, and cosmetics, as specified. A violation of that law is a crime.
This bill would, among other things, set forth standards for a physician and surgeon prescribing medical cannabis and require the Medical Board of California to prioritize its investigative and prosecutorial resources to identify and discipline physicians and surgeons that have repeatedly recommended excessive cannabis to patients for medical purposes or repeatedly recommended cannabis to patients for medical purposes without a good faith examination, as specified. The bill would require the Bureau of Medical Marijuana to require an applicant to furnish a full set of fingerprints for the purposes of conducting criminal history record checks. The bill would prohibit a physician and surgeon who recommends cannabis to a patient for a medical purpose from accepting, soliciting, or offering any form of remuneration from a facility licensed under the Medical Marijuana Regulation and Safety Act. The bill would make a violation of this prohibition a misdemeanor, and by creating a new crime, this bill would impose a state-mandated local program.
This bill would require the Governor, under the Medical Marijuana Regulation and Safety Act, to appoint, subject to confirmation by the Senate, a chief of the Bureau of Medical Marijuana Regulation. The act would require the Department of Consumer Affairs to have the sole authority to create, issue, renew, discipline, suspend, or revoke licenses for the transportation and storage, unrelated to manufacturing, of medical marijuana, and would authorize the department to collect fees for its regulatory activities and impose specified duties on this department in this regard. The act would require the Department of Food and Agriculture to administer the provisions of the act related to, and associated with, the cultivation, and transportation of, medical cannabis and would impose specified duties on this department in this regard. The act would require the State Department of Public Health to administer the provisions of the act related to, and associated with, the manufacturing and testing of medical cannabis and would impose specified duties on this department in this regard.
This bill would authorize counties to impose a tax upon specified cannabis-related activity.
This bill would require an applicant for a state license pursuant to the act to provide a statement signed by the applicant under penalty of perjury, thereby changing the scope of a crime and imposing a state-mandated local program.
This bill would set forth standards for the licensed cultivation of medical cannabis, including, but not limited to, establishing duties relating to the environmental impact of cannabis and cannabis products. The bill would also establish state cultivator license types, as specified.
(2)This bill would provide that its provisions are severable.
(3)The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that with regard to certain mandates no reimbursement is required by this act for a specified reason.
With regard to any other mandates, this bill would provide that, if the Commission on State Mandates determines that the bill contains costs so mandated by the state, reimbursement for those costs shall be made pursuant to the statutory provisions noted above.
(4)Existing constitutional provisions require that a statute that limits the right of access to the meeting of public bodies or the writings of public bodies or the writings of public officials and agencies be adopted with finding demonstrating the interest protected by the limitation and the need for protecting that interest. The bill would make legislative findings to that effect.
(5)The bill would become operative only if AB 266 and AB 243 of the 201516 Regular Session are enacted and take effect on or before January 1, 2016.
Existing
(1)Existing law, the Compassionate Use Act of 1996, an initiative measure enacted by the approval of Proposition 215 at the November 6, 1996, statewide general election, authorizes the use of marijuana for medical purposes. Existing law enacted by the Legislature requires the establishment of a program for the issuance of identification cards to qualified patients so that they may lawfully use marijuana for medical purposes, and requires the establishment of guidelines for the lawful cultivation of marijuana grown for medical use. Existing law provides for the licensure of various professions by the Department of Consumer Affairs. Existing law, the Sherman Food, Drug, and Cosmetic Law, provides for the regulation of food, drugs, devices, and cosmetics, as specified. A violation of that law is a crime.
This bill would would, among other things, set forth standards for a physician and surgeon prescribing medical cannabis and require that the Medical Board of California to prioritize its investigative and prosecutorial resources to identify and discipline physicians and surgeons that have repeatedly recommended excessive cannabis to patients for medical purposes or repeatedly recommending cannabis to patients for medical purposes without a good faith examination, as specified. The bill would become operative only if AB 266 of the 201516 Regular Session is enacted and takes effect on or before January 1, 2016. The bill would require the Bureau of Medical Marijuana to require an applicant to furnish a full set of fingerprints for the purposes of conducting criminal history record checks. The bill would prohibit a physician and surgeon who recommends cannabis to a patient for a medical purpose from accepting, soliciting, or offering any form of remuneration from a facility licensed under the Medical Marijuana Regulation and Safety Act. The bill would make a violation of this prohibition a misdemeanor, and by creating a new crime, this bill would impose a state-mandated local program.
This bill would require the Governor, under the Medical Marijuana Regulation and Safety Act, to appoint, subject to confirmation by the Senate, a chief of the Bureau of Medical Marijuana Regulation. The act would require the Department of Consumer Affairs to have the sole authority to create, issue, renew, discipline, suspend, or revoke licenses for the transportation and storage, unrelated to manufacturing, of medical marijuana, and would authorize the department to collect fees for its regulatory activities and impose specified duties on this department in this regard. The act would require the Department of Food and Agriculture to administer the provisions of the act related to, and associated with, the cultivation, and transportation of, medical cannabis and would impose specified duties on this department in this regard. The act would require the State Department of Public Health to administer the provisions of the act related to, and associated with, the manufacturing and testing of medical cannabis and would impose specified duties on this department in this regard.
This bill would authorize counties to impose a tax upon specified cannabis-related activity.
This bill would require an applicant for a state license pursuant to the act to provide a statement signed by the applicant under penalty of perjury, thereby changing the scope of a crime and imposing a state-mandated local program.
This bill would set forth standards for the licensed cultivation of medical cannabis, including, but not limited to, establishing duties relating to the environmental impact of cannabis and cannabis products. The bill would also establish state cultivator license types, as specified.
(2)This bill would provide that its provisions are severable.
(3)The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that with regard to certain mandates no reimbursement is required by this act for a specified reason.
With regard to any other mandates, this bill would provide that, if the Commission on State Mandates determines that the bill contains costs so mandated by the state, reimbursement for those costs shall be made pursuant to the statutory provisions noted above.
(4)Existing constitutional provisions require that a statute that limits the right of access to the meeting of public bodies or the writings of public bodies or the writings of public officials and agencies be adopted with finding demonstrating the interest protected by the limitation and the need for protecting that interest. The bill would make legislative findings to that effect.
(5)The bill would become operative only if AB 266 and AB 243 of the 201516 Regular Session are enacted and take effect on or before January 1, 2016.
Existing law, the Compassionate Use Act of 1996, an initiative measure enacted by the approval of Proposition 215 at the November 6, 1996, statewide general election, authorizes the use of marijuana for medical purposes. Existing law enacted by the Legislature requires the establishment of a program for the issuance of identification cards to qualified patients so that they may lawfully use marijuana for medical purposes, and requires the establishment of guidelines for the lawful cultivation of marijuana grown for medical use. Existing law provides for the licensure of various professions by the Department of Consumer Affairs. Existing law, the Sherman Food, Drug, and Cosmetic Law, provides for the regulation of food, drugs, devices, and cosmetics, as specified. A violation of that law is a crime.
This bill would state the intent of the Legislature to enact a comprehensive regulatory framework for medical marijuana in the State of California. This bill would require that the Medical Board of California prioritize its investigative and prosecutorial resources to identify and discipline physicians and surgeons that have repeatedly recommended excessive cannabis to patients for medical purposes or repeatedly recommending cannabis to patients for medical purposes without a good faith examination, as specified. The bill would become operative only if AB 266 of the 201516 Regular Session is enacted and takes effect on or before January 1, 2016.
(1)Existing
Existing law, the Compassionate Use Act of 1996, an initiative measure enacted by the approval of Proposition 215 at the November 6, 1996, statewide general election, authorizes the use of marijuana for medical purposes. Existing law enacted by the Legislature requires the establishment of a program for the issuance of identification cards to qualified patients so that they may lawfully use marijuana for medical purposes, and requires the establishment of guidelines for the lawful cultivation of marijuana grown for medical use. Existing law provides for the licensure of various professions by the Department of Consumer Affairs. Existing law, the Sherman Food, Drug, and Cosmetic Law, provides for the regulation of food, drugs, devices, and cosmetics, as specified. A violation of that law is a crime.
This bill would establish within the Business, Consumer Services, and Housing Agency the Office of Medical Marijuana Regulation, under the supervision and control of the Chief of the Office of Medical Marijuana Regulation. The bill would authorize the office to issue licenses for commercial marijuana activity and would require the office to regulate dispensing facilities, cultivation sites, transporters, and manufacturers of medical marijuana and medical marijuana products, subject to local ordinances. The bill would require a background check of applicants for licensure, as defined, to be administered by the Department of Justice, and submission of a statement signed by an applicant, under penalty of perjury, that the information on his or her application is true, thereby creating a crime and imposing a state-mandated local program. Violation of the provisions related to applying for a license would be punishable by a civil fine of up to $35,000 for each individual violation, or as otherwise specified.
The bill would make licenses subject to the restrictions of the local jurisdiction in which the facility operates or proposes to operate. The bill would authorize a facility or entity that is operating in compliance with local zoning ordinances and other state and local requirements on January 1, 2016, to continue its operations until its application for licensure is approved or denied. The bill would set forth provisions related to the transportation, testing, and distribution of medical marijuana and medical marijuana products. The bill would prohibit the distribution of any form of advertising for physician recommendations for medical marijuana, unless the advertisement bears a specified notice and requires that the advertisement meet specified requirements and not be fraudulent, deceitful, or misleading.
The bill would establish the Medical Marijuana Regulation Fund and would require the deposit of specified fees collected pursuant to this act into the fund. The bill would make moneys from the fund available upon appropriation to the office for the purposes of administering this act. The bill would also establish the Special Account for Environmental Enforcement within the Medical Marijuana Regulation Fund. This account would contain money from fees assessed against licensed cultivation sites and would be available upon appropriation for the enforcement of environmental regulations relating to licensed cultivation sites. The bill would require the deposit of penalty moneys collected pursuant to this bill into the General Fund.
The bill would require, the Department of Food and Agriculture, in conjunction with the office, to make available a certified organic designation for medical marijuana by January 1, 2020, or, if the certified organic designation and organic certification program is not available by that date, to develop an equivalent program by January 1, 2022. The bill would also require that the office establish appellations of origin for marijuana grown in the state.
The bill would establish enforcement procedures and would authorize a city, county, or city and county to administer and enforce these provisions. The bill would further set forth provisions regulating edible medical marijuana products, as specified. By adding these provisions to the Sherman Food, Drug, and Cosmetic Law, a violation of which is a crime, the bill would impose a state-mandated local program.
(2)Existing law, the Medical Practice Act, provides for the licensure and regulation of physicians and surgeons by the Medical Board of California. Existing law requires the board to prioritize investigations and prosecutions of physicians and surgeons representing the greatest threat of harm, as specified. Existing law identifies the cases that are to be given priority, which include cases of repeated acts of excessively prescribing, furnishing, or administering controlled substances without a good faith prior examination of the patient. Existing law provides that a violation of the Medical Practice Act is a crime.
This bill would require the board to consult with the Center for Medicinal Cannabis Research on developing and adopting medical guidelines for the appropriate administration and use of marijuana.
The bill would also make it a misdemeanor for a physician and surgeon who recommends marijuana to a patient for a medical purpose to accept, solicit, or offer any remuneration from or to a licensed dispensing facility in which the physician and surgeon or his or her immediate family has a financial interest. By creating a new crime, the bill would impose a state-mandated local program.
The bill would provide that specified acts of recommending marijuana for medical purposes without a good faith examination are among the types of cases that should be given priority for investigation and prosecution by the board, as described above. The bill would further prohibit a physician and surgeon from recommending medical marijuana to a patient unless that person is the patients attending physician, as defined. Because a violation of that provision would be a crime, the bill would impose a state-mandated local program.
(3)Existing law authorizes the legislative body of a city or county to impose various taxes, including a transactions and use tax at a rate of 0.25%, or a multiple thereof, if approved by the required vote of the legislative body and the required vote of qualified voters, and limits the combined rate of transactions and use taxes within a city or county to 2%.
This bill would authorize a county by ordinance, to impose a tax on the privilege of cultivating, dispensing, producing, processing, preparing, storing, providing, donating, selling, or distributing medical marijuana by an entity issued a license. The bill would authorize the tax to be imposed for either general or specific governmental purposes. The bill would require a tax imposed pursuant to this authority to be subject to any applicable voter approval requirement.
(4)Existing law exempts qualified patients, persons with valid identification cards, and the designated primary caregivers of qualified patients and persons with identification cards from certain crimes, including possession of concentrated cannabis and marijuana, cultivation of marijuana, and possession of marijuana for sale.
This bill, after July 1, 2018, would also exempt from those crimes an employee, officer, or board member of a licensed cultivation site or a licensed dispensing facility, except as specified.
(5)Existing law establishes the Division of Apprenticeship Standards, which audits and regulates apprenticeship programs for various trades, including electricians.
This bill would require the division to investigate, approve, or reject applications for apprenticeship employees of a licensed cultivation site or a licensed dispensing facility, as defined.
(6)Existing law establishes the Department of Motor Vehicles and the Department of the California Highway Patrol. Existing law also prohibits and establishes standards for driving under the influence of alcohol.
This bill would require the Department of Motor Vehicles, in consultation with the Department of the California Highway Patrol, to establish protocols to determine whether a driver is operating a vehicle under the influence of cannabis, and to develop protocols setting forth best practices to assist law enforcement agencies. The bill would require the Department of Motor Vehicles to prepare and submit a report, by September 1, 2016, that identifies best practices for the identification, detection, and apprehension of drivers operating a vehicle unsafely due to medical cannabis impairment.
(7)Existing law imposes sales and use taxes, as specified, to be collected by the State Board of Equalization.
This bill would require the State Board of Equalization, on or before July 1, 2016, to compile a report that includes the actual tax collected on the sale of medical marijuana, using the most current data available, and the expected tax revenues, under the existing tax structure, for the years 2016 to 2021, inclusive, and to submit that report to the Legislature and Governors Office.
(8)This bill would provide that its provisions are severable.
(9)Existing constitutional provisions require that a statute that limits the right of access to the meetings of public bodies or the writings of public officials and agencies be adopted with findings demonstrating the interest protected by the limitation and the need for protecting that interest.
This bill would make legislative findings to that effect.
(10)The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
This bill would state the intent of the Legislature to enact a comprehensive regulatory framework for medical marijuana in the State of California. The bill would become operative only if AB 266 of the 201516 Regular Session is enacted and takes effect on or before January 1, 2016.
(1)Existing law, the Compassionate Use Act of 1996, an initiative measure enacted by the approval of Proposition 215 at the November 6, 1996, statewide general election, authorizes the use of marijuana for medical purposes. Existing law enacted by the Legislature requires the establishment of a program for the issuance of identification cards to qualified patients so that they may lawfully use marijuana for medical purposes, and requires the establishment of guidelines for the lawful cultivation of marijuana grown for medical use. Existing law provides for the licensure of various professions by the Department of Consumer Affairs. Existing law, the Sherman Food, Drug, and Cosmetic Law, provides for the regulation of food, drugs, devices, and cosmetics, as specified. A violation of that law is a crime.
This bill would establish within the Business, Consumer Services, and Housing Agency the Office of Medical Marijuana Regulation, under the supervision and control of the Chief of the Office of Medical Marijuana Regulation, and, beginning no later than July 1, 2018, would require the office to license and Regulation. The bill would authorize the office to issue licenses for commercial marijuana activity and would require the office to regulate dispensing facilities, cultivation sites, transporters, and manufacturers of medical marijuana and medical marijuana products, subject to local ordinances. The bill would require a background check of applicants for licensure, as defined, to be administered by the Department of Justice, and submission of a statement signed by an applicant, under penalty of perjury, that the information on his or her application is true, thereby creating a crime and imposing a state-mandated local program. Violation of the provisions related to applying for a conditional license would be punishable by a civil fine of up to $35,000 for each individual violation, or as otherwise specified.
The bill would make conditional licenses subject to the restrictions of the local jurisdiction in which the facility operates or proposes to operate. The bill would authorize a facility or entity that is operating in conformance compliance with local zoning ordinances and other state and local requirements on January 1, 2016, to continue its operations until its application for conditional licensure is approved or denied. The bill would set forth provisions related to the transportation, testing, and distribution of medical marijuana and medical marijuana products. The bill would prohibit the distribution of any form of advertising for physician recommendations for medical marijuana, unless the advertisement bears a specified notice and requires that the advertisement meet specified requirements and not be fraudulent, deceitful, or misleading.
The bill would establish the Medical Marijuana Regulation Fund and would require the deposit of specified fees collected pursuant to this act into the fund. The bill would make moneys from the fund available upon appropriation to the office for the purposes of administering this act. The bill would also establish the Special Account for Environmental Enforcement within the Medical Marijuana Regulation Fund. This account would contain money from fees assessed against licensed cultivation sites and would be available upon appropriation for the enforcement of environmental regulations relating to licensed cultivation sites. The bill would require the deposit of penalty moneys collected pursuant to this bill into the General Fund.
The bill would require, among other things, that all marijuana grown, produced, distributed, and sold in the state, by January 1, 2022, meet standards equivalent to those for certified organic crops and the Department of Food and Agriculture, in conjunction with the office, to make available a certified organic designation for medical marijuana by January 1, 2020, or, if the certified organic designation and organic certification program is not available by that date, to develop an equivalent program by January 1, 2022. The bill would also require that the office establish appellations of origin for marijuana grown in the state.
The bill would provide that it shall not supersede provisions of Measure D, as approved by the voters of the City of Los Angeles, or other similar measures, as specified.
The bill would establish enforcement procedures and would authorize a city, county, or city and county to administer and enforce these provisions. The bill, by July 1, 2017, would require the office to report to the Legislature on the feasibility of developing a program to certify laboratories for the testing of medical marijuana and related products and the feasibility of developing a labeling requirement for edible marijuana products, as specified. The bill would further set forth provisions regulating edible medical marijuana products, as specified. By adding these provisions to the Sherman Food, Drug, and Cosmetic Law, a violation of which is a crime, the bill would impose a state-mandated local program.
(2)Existing law, the Medical Practice Act, provides for the licensure and regulation of physicians and surgeons by the Medical Board of California. Existing law requires the board to prioritize investigations and prosecutions of physicians and surgeons representing the greatest threat of harm, as specified. Existing law identifies the cases that are to be given priority, which include cases of repeated acts of excessively prescribing, furnishing, or administering controlled substances without a good faith prior examination of the patient. Existing law provides that a violation of the Medical Practice Act is a crime.
This bill would require the board to consult with the Center for Medicinal Cannabis Research on developing and adopting medical guidelines for the appropriate administration and use of marijuana.
The bill would also make it a misdemeanor for a physician and surgeon who recommends marijuana to a patient for a medical purpose to accept, solicit, or offer any remuneration from or to a licensed dispensing facility in which the physician and surgeon or his or her immediate family has a financial interest. By creating a new crime, the bill would impose a state-mandated local program.
The bill would provide that specified acts of recommending marijuana for medical purposes without a good faith examination are among the types of cases that should be given priority for investigation and prosecution by the board, as described above. The bill would further prohibit a physician and surgeon from recommending medical marijuana to a patient unless that person is the patients attending physician, as defined. Because a violation of that provision would be a crime, the bill would impose a state-mandated local program.
(3)Existing law authorizes the legislative body of a city or county to impose various taxes, including a transactions and use tax at a rate of 0.25%, or a multiple thereof, if approved by the required vote of the legislative body and the required vote of qualified voters, and limits the combined rate of transactions and use taxes within a city or county to 2%.
This bill would authorize a county by ordinance, to impose a tax on the privilege of cultivating, dispensing, producing, processing, preparing, storing, providing, donating, selling, or distributing medical marijuana by an entity issued a conditional license. The bill would authorize the tax to be imposed for either general or specific governmental purposes. The bill would require a tax imposed pursuant to this authority to be subject to any applicable voter approval requirement.
(4)Existing law exempts qualified patients, persons with valid identification cards, and the designated primary caregivers of qualified patients and persons with identification cards from certain crimes, including possession of concentrated cannabis and marijuana, cultivation of marijuana, and possession of marijuana for sale.
This bill, after July 1, 2018, would also exempt from those crimes an employee, officer, or board member of a licensed cultivation site or a licensed dispensing facility, except as specified.
(5)Existing law establishes the Division of Apprenticeship Standards, which audits and regulates apprenticeship programs for various trades, including electricians.
This bill would require the division to investigate, approve, or reject applications for apprenticeship employees of a licensed cultivation site or a licensed dispensing facility, as defined.
(6)Existing law establishes the Department of Motor Vehicles and the Department of the California Highway Patrol. Existing law also prohibits and establishes standards for driving under the influence of alcohol.
This bill would require the Department of Motor Vehicles, in consultation with the Department of the California Highway Patrol, to establish protocols to determine whether a driver is operating a vehicle under the influence of cannabis, and to develop protocols setting forth best practices to assist law enforcement agencies. The bill would require the Department of Motor Vehicles to prepare and submit a report, by September 1, 2016, that identifies best practices for the identification, detection, and apprehension of drivers operating a vehicle unsafely due to medical cannabis impairment.
(5)
(7)Existing law imposes sales and use taxes, as specified, to be collected by the State Board of Equalization.
This bill would require the State Board of Equalization, on or before July 1, 2016, to compile a report that includes the actual tax collected on the sale of medical marijuana, using the most current data available, and the expected tax revenues, under the existing tax structure, for the years 2016 to 2021, inclusive, and to submit that report to the Legislature and Governors Office.
(6)
(8)This bill would provide that its provisions are severable.
(7)
(9)Existing constitutional provisions require that a statute that limits the right of access to the meetings of public bodies or the writings of public officials and agencies be adopted with findings demonstrating the interest protected by the limitation and the need for protecting that interest.
This bill would make legislative findings to that effect.
(8)
(10)The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
(1)Existing law, the Compassionate Use Act of 1996, an initiative measure enacted by the approval of Proposition 215 at the November 6, 1996, statewide general election, authorizes the use of marijuana for medical purposes. Existing law enacted by the Legislature requires the establishment of a program for the issuance of identification cards to qualified patients so that they may lawfully use marijuana for medical purposes, and requires the establishment of guidelines for the lawful cultivation of marijuana grown for medical use. Existing law provides for the licensure of various professions by the Department of Consumer Affairs. Existing law, the Sherman Food, Drug, and Cosmetic Law, provides for the regulation of food, drugs, devices, and cosmetics, as specified. A violation of that law is a crime.
This bill would establish within the Business, Consumer Services, and Housing Agency the Office of Medical Marijuana Regulation, under the supervision and control of the Chief of the Office of Medical Marijuana Regulation, and, beginning no later than July 1, 2018, would require the office to license and regulate dispensing facilities, cultivation sites, transporters, and manufacturers of medical marijuana and medical marijuana products, subject to local ordinances. The bill would require a background check of applicants for licensure, as defined, to be administered by the Department of Justice, and submission of a statement signed by an applicant, under penalty of perjury, that the information on his or her application is true, thereby creating a crime and imposing a state-mandated local program. Violation of the provisions related to applying for a conditional license would be punishable by a civil fine of up to $35,000 for each individual violation, or as otherwise specified.
The bill would make conditional licenses subject to the restrictions of the local jurisdiction in which the facility operates or proposes to operate. The bill would authorize a facility or entity that is operating in conformance with local zoning ordinances and other state and local requirements on January 1, 2016, to continue its operations until its application for conditional licensure is approved or denied. The bill would set forth provisions related to the transportation, testing, and distribution of medical marijuana and medical marijuana products. The bill would prohibit the distribution of any form of advertising for physician recommendations for medical marijuana, unless the advertisement bears a specified notice and requires that the advertisement meet specified requirements and not be fraudulent, deceitful, or misleading.
The bill would establish the Medical Marijuana Regulation Fund and would require the deposit of specified fees collected pursuant to this act into the fund. The bill would make moneys from the fund available upon appropriation to the office for the purposes of administering this act. The bill would also establish the Special Account for Environmental Enforcement within the Medical Marijuana Regulation Fund. This account would contain money from fees assessed against licensed cultivation sites and would be available upon appropriation for the enforcement of environmental regulations relating to licensed cultivation sites. The bill would require the deposit of penalty moneys collected pursuant to this bill into the General Fund.
The bill would require, among other things, that all marijuana grown, produced, distributed, and sold in the state meet the certified organic standards state, by January 1, 2022, meet standards equivalent to those for certified organic crops and that the bureau office establish appellations of origin for marijuana grown in the state.
The bill would provide that it shall not supersede provisions of Measure D, as approved by the voters of the City of Los Angeles, or other similar measures, as specified.
The bill would establish enforcement procedures and would authorize a city, county, or city and county to administer and enforce these provisions. The bill, by July 1, 2017, would require the office to report to the Legislature on the feasability feasibility of developing a program to certify laboratories for the testing of medical marijuana and related products and the feasability feasibility of developing a labeling requirement for edible marijuana products, as specified. The bill would further set forth provisions regulating edible medical marijuana products, as specified. By adding these provisions to the Sherman Food, Drug, and Cosmetic Law, a violation of which is a crime, the bill would impose a state-mandated local program.
(2)Existing law, the Medical Practice Act, provides for the licensure and regulation of physicians and surgeons by the Medical Board of California. Existing law requires the board to prioritize investigations and prosecutions of physicians and surgeons representing the greatest threat of harm, as specified. Existing law identifies the cases that are to be given priority, which include cases of repeated acts of excessively prescribing, furnishing, or administering controlled substances without a good faith prior examination of the patient. Existing law provides that a violation of the Medical Practice Act is a crime.
This bill would require the board to consult with the Center for Medicinal Cannabis Research on developing and adopting medical guidelines for the appropriate administration and use of marijuana.
The bill would also make it a misdemeanor for a physician and surgeon who recommends marijuana to a patient for a medical purpose to accept, solicit, or offer any remuneration from or to a licensed dispensing facility in which the physician and surgeon or his or her immediate family has a financial interest. By creating a new crime, the bill would impose a state-mandated local program.
The bill would provide that specified acts of recommending marijuana for medical purposes without a good faith examination are among the types of cases that should be given priority for investigation and prosecution by the board, as described above. The bill would further prohibit a physician and surgeon from recommending medical marijuana to a patient unless that person is the patients attending physician, as defined. Because a violation of that provision would be a crime, the bill would impose a state-mandated local program.
(3)Existing law authorizes the legislative body of a city or county to impose various taxes, including a transactions and use tax at a rate of 0.25%, or a multiple thereof, if approved by the required vote of the legislative body and the required vote of qualified voters, and limits the combined rate of transactions and use taxes within a city or county to 2%.
This bill would authorize a city, county, or city and county, county by ordinance, to impose a tax on the privilege of cultivating, dispensing, producing, processing, preparing, storing, providing, donating, selling, or distributing medical marijuana by an entity issued a conditional license. The bill would authorize the tax to be imposed for either general or specific governmental purposes. The bill would require a tax imposed pursuant to this authority to be subject to any applicable voter approval requirement.
(4)Existing law exempts qualified patients, persons with valid identification cards, and the designated primary caregivers of qualified patients and persons with identification cards from certain crimes, including possession of concentrated cannabis and marijuana, cultivation of marijuana, and possession of marijuana for sale.
This bill, after July 1, 2017, 2018, would also exempt from those crimes an employee, officer, or board member of a licensed cultivation site or a licensed dispensing facility, except as specified.
(5)Existing law imposes sales and use taxes, as specified, to be collected by the State Board of Equalization.
This bill would require the State Board of Equalization, on or before July 1, 2016, to compile a report that includes the actual tax collected on the sale of medical marijuana, using the most current data available, and the expected tax revenues, under the existing tax structure, for the years 2016 to 2021, inclusive, and to submit that report to the Legislature and Governors Office.
(6)This bill would provide that its provisions are severable.
(7)Existing constitutional provisions require that a statute that limits the right of access to the meetings of public bodies or the writings of public officials and agencies be adopted with findings demonstrating the interest protected by the limitation and the need for protecting that interest.
This bill would make legislative findings to that effect.
(8)The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
(1)Existing law, the Compassionate Use Act of 1996, an initiative measure enacted by the approval of Proposition 215 at the November 6, 1996, statewide general election, authorizes the use of marijuana for medical purposes. Existing law enacted by the Legislature requires the establishment of a program for the issuance of identification cards to qualified patients so that they may lawfully use marijuana for medical purposes, and requires the establishment of guidelines for the lawful cultivation of marijuana grown for medical use. Existing law provides for the licensure of various professions by the Department of Consumer Affairs. Existing law, the Sherman Food, Drug, and Cosmetic Law, provides for the regulation of food, drugs, devices, and cosmetics, as specified. A violation of that law is a crime.
This bill would establish within the Department of Consumer Affairs a Bureau Business, Consumer Services, and Housing Agency the Office of Medical Marijuana Regulation, under the supervision and control of the Chief of the Bureau Office of Medical Marijuana Regulation, and, beginning no later than July 1, 2018, would require the bureau office to license and regulate dispensing facilities, cultivation sites, transporters, and manufacturers of medical marijuana and medical marijuana products, subject to local ordinances. The bill would require a background check of applicants for licensure, as defined, to be administered by the Department of Justice, and submission of a statement signed by an applicant, under penalty of perjury, that the information on his or her application is true, thereby creating a crime and imposing a state-mandated local program. Violation of the provisions related to applying for a conditional license would be punishable by a civil fine of up to $35,000 for each individual violation, or as otherwise specified.
The bill would make conditional licenses subject to the restrictions of the local jurisdiction in which the facility operates or proposes to operate. The bill would authorize a facility or entity that is operating in conformance with local zoning ordinances and other state and local requirements on January 1, 2016, to continue its operations until its application for conditional licensure is approved or denied. The bill would set forth provisions related to the transportation, testing, and distribution of medical marijuana. The bill would prohibit the distribution of any form of advertising for physician recommendations for medical marijuana, unless the advertisement bears a specified notice and requires that the advertisement meet specified requirements and not be fraudulent, deceitful, or misleading.
The bill would establish the Medical Marijuana Regulation Fund and would require the deposit of specified fees collected pursuant to this act into the fund. The bill would continuously appropriate make moneys from the fund available upon appropriation to the bureau office for the purposes of administering this act, thereby making an appropriation. act. The bill would also establish the Special Account for Environmental Enforcement within the Medical Marijuana Fund. This account would contain money from fees assessed against licensed cultivation sites and would be continuously appropriated available upon appropriation for the enforcement of environmental regulations relating to licensed cultivation sites. The bill would require the deposit of penalty moneys collected pursuant to this bill into the General Fund.
The bill would ban cultivation sites in areas zoned residential and would require, among other things, that all marijuana grown, produced, distributed, and sold in the state meet the certified organic standards by January 1, 2022, and that the bureau establish appellations of origin for marijuana grown in the state.
The bill would provide that it shall not supersede provisions of Measure D, as approved by the voters of the City of Los Angeles, or other similar measures, as specified.
The bill would establish enforcement procedures and would authorize a city, county, or city and county to administer and enforce these provisions. The bill would require the bureau to establish quality assurance protocols by January 1, 2018, to ensure uniform testing standards of medical marijuana, and would require licensees to comply with these provisions. The bill, by July 1, 2017, would require the office to report to the Legislature on the feasability of developing a program to certify laboratories for the testing of medical marijuana and related products and the feasability of developing a labeling requirement for edible marijuana products, as specified. The bill would further set forth provisions regulating edible medical marijuana products, as specified. By adding these provisions to the Sherman Food, Drug, and Cosmetic Law, a violation of which is a crime, the bill would impose a state-mandated local program.
(2)Existing law, the Medical Practice Act, provides for the licensure and regulation of physicians and surgeons by the Medical Board of California. Existing law requires the board to prioritize investigations and prosecutions of physicians and surgeons representing the greatest threat of harm, as specified. Existing law identifies the cases that are to be given priority, which include cases of repeated acts of excessively prescribing, furnishing, or administering controlled substances without a good faith prior examination of the patient. Existing law provides that a violation of the Medical Practice Act is a crime.
This bill would require the board to consult with the Center for Medicinal Cannabis Research on developing and adopting medical guidelines for the appropriate administration and use of marijuana.
The bill would also make it a misdemeanor for a physician and surgeon who recommends marijuana to a patient for a medical purpose to accept, solicit, or offer any remuneration from or to a licensed dispensing facility in which the physician and surgeon or his or her immediate family has a financial interest. By creating a new crime, the bill would impose a state-mandated local program.
The bill would provide that specified acts of recommending marijuana for medical purposes without a good faith examination are among the types of cases that should be given priority for investigation and prosecution by the board, as described above. The bill would further prohibit a physician and surgeon from recommending medical marijuana to a patient unless that person is the patients attending physician, as defined. Because a violation of that provision would be a crime, the bill would impose a state-mandated local program.
(3)Existing law authorizes the legislative body of a city or county to impose various taxes, including a transactions and use tax at a rate of 0.25%, or a multiple thereof, if approved by the required vote of the legislative body and the required vote of qualified voters, and limits the combined rate of transactions and use taxes within a city or county to 2%.
This bill would authorize a city, county, or city and county, by ordinance, to impose a tax on the privilege of cultivating, dispensing, producing, processing, preparing, storing, providing, donating, selling, or distributing marijuana by an entity issued a conditional license. The bill would authorize the tax to be imposed for either general or specific governmental purposes. The bill would require a tax imposed pursuant to this authority to be subject to any applicable voter approval requirement.
(4)Existing law exempts qualified patients, persons with valid identification cards, and the designated primary caregivers of qualified patients and persons with identification cards from certain crimes, including possession of concentrated cannabis and marijuana, cultivation of marijuana, and possession of marijuana for sale.
This bill, after July 1, 2017, would also exempt from those crimes an employee, officer, or board member of a licensed cultivation site or a licensed dispensing facility, except as specified.
(5)Existing law imposes sales and use taxes, as specified, to be collected by the State Board of Equalization.
This bill would require the State Board of Equalization, on or before July 1, 2016, to compile a report that includes the actual tax collected on the sale of medical marijuana, using the most current data available, and the expected tax revenues, under the existing tax structure, for the years 2016 to 2021, inclusive, and to submit that report to the Legislature and Governors Office.
(6)This bill would provide that its provisions are severable.
(7)Existing constitutional provisions require that a statute that limits the right of access to the meetings of public bodies or the writings of public officials and agencies be adopted with findings demonstrating the interest protected by the limitation and the need for protecting that interest.
This bill would make legislative findings to that effect.
(8)The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
(1)Existing law, the Compassionate Use Act of 1996, an initiative measure enacted by the approval of Proposition 215 at the November 6, 1996, statewide general election, authorizes the use of marijuana for medical purposes. Existing law enacted by the Legislature requires the establishment of a program for the issuance of identification cards to qualified patients so that they may lawfully use marijuana for medical purposes, and requires the establishment of guidelines for the lawful cultivation of marijuana grown for medical use. Existing law provides for the licensure of various professions by the Department of Consumer Affairs. Existing law, the Sherman Food, Drug, and Cosmetic Law, provides for the regulation of food, drugs, devices, and cosmetics, as specified. A violation of that law is a crime.
This bill would establish within the Department of Consumer Affairs a Bureau of Medical Marijuana Regulation, under the supervision and control of the Chief of the Bureau of Medical Marijuana Regulation, and would require the bureau to license and regulate dispensing facilities, cultivation sites, transporters, and manufacturers of medical marijuana and medical marijuana products, subject to local ordinances. The bill would require a background check of applicants for licensure, as defined, to be administered by the Department of Justice, and submission of a statement signed by an applicant, under penalty of perjury, that the information on his or her application is true, thereby creating a crime and imposing a state-mandated local program. Violation of the provisions related to applying for a conditional license would be punishable by a civil fine of up to $35,000 for each individual violation, or as otherwise specified.
The bill would make conditional licenses subject to the restrictions of the local jurisdiction in which the facility operates or proposes to operate. The bill would authorize a facility or entity that is operating in conformance with local zoning ordinances and other state and local requirements on January 1, 2016, to continue its operations until its application for conditional licensure is approved or denied. The bill would set forth provisions related to the transportation, testing, and distribution of medical marijuana. The bill would prohibit the distribution of any form of advertising for physician recommendations for medical marijuana, unless the advertisement bears a specified notice and requires that the advertisement meet specified requirements and not be fraudulent, deceitful, or misleading.
The bill would establish the Medical Marijuana Regulation Fund and would require the deposit of specified fees collected pursuant to this act into the fund. The bill would continuously appropriate moneys from the fund to the bureau for the purposes of administering this act, thereby making an appropriation. The bill would also establish the Special Account for Environmental Enforcement within the Medical Marijuana Fund. This account would contain money from fees assessed against licensed cultivation sites and would be continuously appropriated for the enforcement of environmental regulations relating to licensed cultivation sites. The bill would require the deposit of penalty moneys collected pursuant to this bill into the General Fund.
The bill would ban cultivation sites in areas zoned residential and would require, among other things, that all marijuana grown, produced, distributed, and sold in the state meet the certified organic standards by January 1, 2022, and that the bureau establish appellations of origin for marijuana grown in the state.
The bill would provide that it shall not supersede provisions of Measure D, as approved by the voters of the City of Los Angeles, or other similar measures, as specified.
The bill would authorize a city, county, or city and county to administer and enforce these provisions. The bill would require the bureau to establish quality assurance protocols by January 1, 2018, to ensure uniform testing standards of medical marijuana, and would require licensees to comply with these provisions. The bill would further set forth provisions regulating edible medical marijuana products, as specified. By adding these provisions to the Sherman Food, Drug, and Cosmetic Law, a violation of which is a crime, the bill would impose a state-mandated local program.
(2)Existing law, the Medical Practice Act, provides for the licensure and regulation of physicians and surgeons by the Medical Board of California. Existing law requires the board to prioritize investigations and prosecutions of physicians and surgeons representing the greatest threat of harm, as specified. Existing law identifies the cases that are to be given priority, which include cases of repeated acts of excessively prescribing, furnishing, or administering controlled substances without a good faith prior examination of the patient. Existing law provides that a violation of the Medical Practice Act is a crime.
This bill would require the board to consult with the Center for Medicinal Cannabis Research on developing and adopting medical guidelines for the appropriate administration and use of marijuana.
The bill would also make it a misdemeanor for a physician and surgeon who recommends marijuana to a patient for a medical purpose to accept, solicit, or offer any remuneration from or to a licensed dispensing facility in which the physician and surgeon or his or her immediate family has a financial interest. By creating a new crime, the bill would impose a state-mandated local program.
The bill would provide that specified acts of recommending marijuana for medical purposes without a good faith examination are among the types of cases that should be given priority for investigation and prosecution by the board, as described above. The bill would further prohibit a physician and surgeon from recommending medical marijuana to a patient unless that person is the patients attending physician, as defined. Because a violation of that provision would be a crime, the bill would impose a state-mandated local program.
(3)Existing law authorizes the legislative body of a city or county to impose various taxes, including a transactions and use tax at a rate of 0.25%, or a multiple thereof, if approved by the required vote of the legislative body and the required vote of qualified voters, and limits the combined rate of transactions and use taxes within a city or county to 2%.
This bill would authorize the board of supervisors of a county or the city council of a city a city, county, or city and county, by ordinance, to impose a tax on the privilege of cultivating, dispensing, producing, processing, preparing, storing, providing, donating, selling, or distributing marijuana or products containing marijuana by an entity issued a conditional license. The bill would authorize the tax to be imposed for either general or specific governmental purposes. The bill would require a tax imposed pursuant to this authority to be subject to any applicable voter approval requirement.
(4)Existing law exempts qualified patients, persons with valid identification cards, and the designated primary caregivers of qualified patients and persons with identification cards from certain crimes, including possession of concentrated cannabis and marijuana, cultivation of marijuana, and possession of marijuana for sale.
This bill would also exempt from those crimes an employee, officer, or board member of a licensed cultivation site or a licensed dispensing facility, except as specified.
(5)Existing law imposes sales and use taxes, as specified, to be collected by the State Board of Equalization.
This bill would require the State Board of Equalization, on or before July 1, 2016, to compile a report that includes the actual tax collected on the sale of medical marijuana, using the most current data available, and the expected tax revenues, under the existing tax structure, for the years 2016 to 2021, inclusive, and to submit that report to the Legislature and Governors Office.
(6)This bill would provide that its provisions are severable.
(7)Existing constitutional provisions require that a statute that limits the right of access to the meetings of public bodies or the writings of public officials and agencies be adopted with findings demonstrating the interest protected by the limitation and the need for protecting that interest.
This bill would make legislative findings to that effect.
(8)The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
(1)Existing law, the Compassionate Use Act of 1996, an initiative measure enacted by the approval of Proposition 215 at the November 6, 1996, statewide general election, authorizes the use of marijuana for medical purposes. Existing law enacted by the Legislature requires the establishment of a program for the issuance of identification cards to qualified patients so that they may lawfully use marijuana for medical purposes, and requires the establishment of guidelines for the lawful cultivation of marijuana grown for medical use. Existing law provides for the licensure of various professions by the Department of Consumer Affairs. Existing law, the Sherman Food, Drug, and Cosmetic Law, provides for the regulation of food, drugs, devices, and cosmetics, as specified. A violation of that law is a crime.
This bill would establish within the Department of Consumer Affairs a Bureau of Medical Marijuana Regulation, under the supervision and control of the Chief of the Bureau of Medical Marijuana Regulation, and would require the bureau to license and regulate dispensing facilities, cultivation sites, transporters, and manufacturers of medical marijuana and medical marijuana products, subject to local ordinances. The bill would require a background check of applicants for licensure, as defined, to be administered by the Department of Justice, and submission of a statement signed by an applicant, under penalty of perjury, that the information on his or her application is true, thereby creating a crime and imposing a state-mandated local program. Violation of the provisions related to applying for a conditional license would be punishable by a civil fine of up to $35,000 for each individual violation, or as otherwise specified.
The bill would make conditional licenses subject to the restrictions of the local jurisdiction in which the facility operates or proposes to operate. The bill would authorize a facility or entity that is operating in conformance with local zoning ordinances and other state and local requirements on January 1, 2016, to continue its operations until its application for conditional licensure is approved or denied. The bill would set forth provisions related to the transportation, testing, and distribution of medical marijuana. The bill would prohibit the distribution of any form of advertising for physician recommendations for medical marijuana, unless the advertisement bears a specified notice and requires that the advertisement meet specified requirements and not be fraudulent, deceitful, or misleading.
The bill would establish the Medical Marijuana Regulation Fund and would require the deposit of specified fees collected pursuant to this act into the fund. The bill would continuously appropriate moneys from the fund to the bureau for the purposes of administering this act, thereby making an appropriation. The bill would also establish the Special Account for Environmental Enforcement within the Medical Marijuana Fund. This account would contain money from fees assessed against licensed cultivation sites and would be continuously appropriated for the enforcement of environmental regulations relating to licensed cultivation sites. The bill would require the deposit of penalty moneys collected pursuant to this bill into the General Fund.
The bill would ban cultivation sites in areas zoned residential and would require, among other things, that all marijuana grown, produced, distributed, and sold in the state meet the certified organic standards by January 1, 2022, and that the bureau establish appellations of origin for marijuana grown in the state.
The bill would provide that it shall not supersede provisions of Measure D, as approved by the voters of the City of Los Angeles, or other similar measures, as specified.
The bill would authorize a city, county, or city and county to administer and enforce these provisions. The bill would require the bureau to establish quality assurance protocols by January 1, 2018, to ensure uniform testing standards of medical marijuana, and would require licensees to comply with these provisions. The bill would further set forth provisions regulating edible medical marijuana products, as specified. By adding these provisions to the Sherman Food, Drug, and Cosmetic Law, a violation of which is a crime, the bill would impose a state-mandated local program.
(2)Existing law, the Medical Practice Act, provides for the licensure and regulation of physicians and surgeons by the Medical Board of California. Existing law requires the board to prioritize investigations and prosecutions of physicians and surgeons representing the greatest threat of harm, as specified. Existing law identifies the cases that are to be given priority, which include cases of repeated acts of excessively prescribing, furnishing, or administering controlled substances without a good faith prior examination of the patient. Existing law provides that a violation of the Medical Practice Act is a crime.
This bill would require the board to consult with the Center for Medicinal Cannabis Research on developing and adopting medical guidelines for the appropriate administration and use of marijuana.
The bill would also make it a misdemeanor for a physician and surgeon who recommends marijuana to a patient for a medical purpose to accept, solicit, or offer any remuneration from or to a licensed dispensing facility in which the physician and surgeon or his or her immediate family has a financial interest. By creating a new crime, the bill would impose a state-mandated local program.
The bill would provide that specified acts of recommending marijuana for medical purposes without a good faith examination are among the types of cases that should be given priority for investigation and prosecution by the board, as described above. The bill would further prohibit a physician and surgeon from recommending medical marijuana to a patient unless that person is the patients attending physician, as defined. Because a violation of that provision would be a crime, the bill would impose a state-mandated local program.
(3)Existing law authorizes the legislative body of a city or county to impose various taxes, including a transactions and use tax at a rate of 0.25%, or a multiple thereof, if approved by the required vote of the legislative body and the required vote of qualified voters, and limits the combined rate of transactions and use taxes within a city or county to 2%.
This bill would authorize the board of supervisors of a county or the city council of a city to impose a tax on the privilege of cultivating, dispensing, producing, processing, preparing, storing, providing, donating, selling, or distributing marijuana or products containing marijuana. The bill would authorize the tax to be imposed for either general or specific governmental purposes. The bill would require a tax imposed pursuant to this authority to be subject to any applicable voter approval requirement.
(4)Existing law exempts qualified patients, persons with valid identification cards, and the designated primary caregivers of qualified patients and persons with identification cards from certain crimes, including possession of concentrated cannabis and marijuana, cultivation of marijuana, and possession of marijuana for sale.
This bill would also exempt from those crimes an employee, officer, or board member of a licensed cultivation site or a licensed dispensing facility, except as specified.
(5)Existing law imposes sales and use taxes, as specified, to be collected by the State Board of Equalization.
This bill would require the State Board of Equalization, on or before July 1, 2016, to compile a report that includes the actual tax collected on the sale of medical marijuana, using the most current data available, and the expected tax revenues, under the existing tax structure, for the years 2016 to 2021, inclusive, and to submit that report to the Legislature and Governors Office.
(6)This bill would provide that its provisions are severable.
(7)Existing constitutional provisions require that a statute that limits the right of access to the meetings of public bodies or the writings of public officials and agencies be adopted with findings demonstrating the interest protected by the limitation and the need for protecting that interest.
This bill would make legislative findings to that effect.
(8)The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
Existing law, the Compassionate Use Act of 1996, an initiative measure enacted by the voters at the November 6, 1996, statewide general election, authorizes the use of marijuana for medical purposes. Existing law enacted by the Legislature, commonly referred to as the Medical Marijuana Program Act, requires the establishment of a program for the issuance of identification cards to qualified patients so that they may lawfully use marijuana for medical purposes, and requires the establishment of guidelines for the lawful cultivation of marijuana grown for medical use.
This bill would express the Legislatures intent to enact legislation that would, among other things, reaffirm and clarify aspects of the Medical Marijuana Program Act, regulate the cultivation of medical marijuana, and authorize and appropriate adequate funding for the Board of Equalization to undertake a study, as specified, in order to make recommendations on the best way to levy and collect fees to regulate the cultivation and sale of medical marijuana.
Existing law, the Compassionate Use Act of 1996, an initiative measure enacted by the voters at the November 6, 1996, statewide general election, authorizes the use of marijuana for medical purposes. Existing law enacted by the Legislature, commonly referred to as the Medical Marijuana Program Act, requires the establishment of a program for the issuance of identification cards to qualified patients so that they may lawfully use marijuana for medical purposes, and requires the establishment of guidelines for the lawful cultivation of marijuana grown for medical use.
This bill would express the Legislatures intent to enact legislation that would, among other things, reaffirm and clarify aspects of the Medical Marijuana Program Act, regulate the cultivation of medical marijuana, and authorize and appropriate adequate funding for the Board of Equalization to undertake a study, as specified, in order to make recommendations on the best way to levy and collect fees to regulate the cultivation and sale of medical marijuana.
(a)Notwithstanding any other provision of law, an agency designated in subdivision (b) shall require an applicant to furnish to the agency a full set of fingerprints for purposes of conducting criminal history record checks. Any agency designated in subdivision (b) may obtain and receive, at its discretion, criminal history information from the Department of Justice and the United States Federal Bureau of Investigation.
(b)Subdivision (a) applies to the following:
(1)California Board of Accountancy.
(2)State Athletic Commission.
(3)Board of Behavioral Sciences.
(4)Court Reporters Board of California.
(5)State Board of Guide Dogs for the Blind.
(6)California State Board of Pharmacy.
(7)Board of Registered Nursing.
(8)Veterinary Medical Board.
(9)Board of Vocational Nursing and Psychiatric Technicians.
(10)Respiratory Care Board of California.
(11)Physical Therapy Board of California.
(12)Physician Assistant Committee of the Medical Board of California.
(13)Speech-Language Pathology and Audiology and Hearing Aid Dispenser Board.
(14)Medical Board of California.
(15)State Board of Optometry.
(16)Acupuncture Board.
(17)Cemetery and Funeral Bureau.
(18)Bureau of Security and Investigative Services.
(19)Division of Investigation.
(20)Board of Psychology.
(21)California Board of Occupational Therapy.
(22)Structural Pest Control Board.
(23)Contractors State License Board.
(24)Naturopathic Medicine Committee.
(25)Professional Fiduciaries Bureau.
(26)Board for Professional Engineers, Land Surveyors, and Geologists.
(27)Bureau of Medical Marijuana Regulation.
(c)For purposes of paragraph (26) of subdivision (b), the term applicant shall be limited to an initial applicant who has never been registered or licensed by the board or to an applicant for a new licensure or registration category.
SEC. 2.Section 2220.05 of the Business and Professions Code is amended to read:2220.05.(a)In order to ensure that its resources are maximized for the protection of the public, the Medical Board of California shall prioritize its investigative and prosecutorial resources to ensure that physicians and surgeons representing the greatest threat of harm are identified and disciplined expeditiously. Cases involving any of the following allegations shall be handled on a priority basis, as follows, with the highest priority being given to cases in the first paragraph:
(1)Gross negligence, incompetence, or repeated negligent acts that involve death or serious bodily injury to one or more patients, such that the physician and surgeon represents a danger to the public.
(2)Drug or alcohol abuse by a physician and surgeon involving death or serious bodily injury to a patient.
(3)Repeated acts of clearly excessive prescribing, furnishing, or administering of controlled substances, or repeated acts of prescribing, dispensing, or furnishing of controlled substances without a good faith prior examination of the patient and medical reason therefor. However, in no event shall a physician and surgeon prescribing, furnishing, or administering controlled substances for intractable pain consistent with lawful prescribing, including, but not limited to, Sections 725, 2241.5, and 2241.6 of this code and Sections 11159.2 and 124961 of the Health and Safety Code, be prosecuted for excessive prescribing and prompt review of the applicability of these provisions shall be made in any complaint that may implicate these provisions.
(4)Repeated acts of clearly excessive recommending of cannabis to patients for medical purposes, or repeated acts of recommending cannabis to patients for medical purposes without a good faith prior examination of the patient and a medical reason for the recommendation.
(5)Sexual misconduct with one or more patients during a course of treatment or an examination.
(6)Practicing medicine while under the influence of drugs or alcohol.
(b)The board may by regulation prioritize cases involving an allegation of conduct that is not described in subdivision (a). Those cases prioritized by regulation shall not be assigned a priority equal to or higher than the priorities established in subdivision (a).
(c)The Medical Board of California shall indicate in its annual report mandated by Section 2312 the number of temporary restraining orders, interim suspension orders, and disciplinary actions that are taken in each priority category specified in subdivisions (a) and (b).
SEC. 3.Section 2241.5 of the Business and Professions Code is amended to read:2241.5.(a)A physician and surgeon may prescribe for, or dispense or administer to, a person under his or her treatment for a medical condition dangerous drugs or prescription controlled substances for the treatment of pain or a condition causing pain, including, but not limited to, intractable pain.
(b)No physician and surgeon shall be subject to disciplinary action for prescribing, dispensing, or administering dangerous drugs or prescription controlled substances in accordance with this section.
(c)This section shall not affect the power of the board to take any action described in Section 2227 against a physician and surgeon who does any of the following:
(1)Violates subdivision (b), (c), or (d) of Section 2234 regarding gross negligence, repeated negligent acts, or incompetence.
(2)Violates Section 2241 regarding treatment of an addict.
(3)Violates Section 2242 or 2525.3 regarding performing an appropriate prior examination and the existence of a medical indication for prescribing, dispensing, or furnishing dangerous drugs or recommending medical cannabis.
(4)Violates Section 2242.1 regarding prescribing on the Internet.
(5)Fails to keep complete and accurate records of purchases and disposals of substances listed in the California Uniform Controlled Substances Act (Division 10 (commencing with Section 11000) of the Health and Safety Code) or controlled substances scheduled in the federal Comprehensive Drug Abuse Prevention and Control Act of 1970 (21 U.S.C. Sec. 801 et seq.), or pursuant to the federal Comprehensive Drug Abuse Prevention and Control Act of 1970. A physician and surgeon shall keep records of his or her purchases and disposals of these controlled substances or dangerous drugs, including the date of purchase, the date and records of the sale or disposal of the drugs by the physician and surgeon, the name and address of the person receiving the drugs, and the reason for the disposal or the dispensing of the drugs to the person, and shall otherwise comply with all state recordkeeping requirements for controlled substances.
(6)Writes false or fictitious prescriptions for controlled substances listed in the California Uniform Controlled Substances Act or scheduled in the federal Comprehensive Drug Abuse Prevention and Control Act of 1970.
(7)Prescribes, administers, or dispenses in violation of this chapter, or in violation of Chapter 4 (commencing with Section 11150) or Chapter 5 (commencing with Section 11210) of Division 10 of the Health and Safety Code.
(d)A physician and surgeon shall exercise reasonable care in determining whether a particular patient or condition, or the complexity of a patients treatment, including, but not limited to, a current or recent pattern of drug abuse, requires consultation with, or referral to, a more qualified specialist.
(e)Nothing in this section shall prohibit the governing body of a hospital from taking disciplinary actions against a physician and surgeon pursuant to Sections 809.05, 809.4, and 809.5.
SEC. 4.Section 2242.1 of the Business and Professions Code is amended to read:2242.1.(a)No person or entity may prescribe, dispense, or furnish, or cause to be prescribed, dispensed, or furnished, dangerous drugs or dangerous devices, as defined in Section 4022, on the Internet for delivery to any person in this state, without an appropriate prior examination and medical indication, except as authorized by Section 2242.
(b)Notwithstanding any other provision of law, a violation of this section may subject the person or entity that has committed the violation to either a fine of up to twenty-five thousand dollars ($25,000) per occurrence pursuant to a citation issued by the board or a civil penalty of twenty-five thousand dollars ($25,000) per occurrence.
(c)The Attorney General may bring an action to enforce this section and to collect the fines or civil penalties authorized by subdivision (b).
(d)For notifications made on and after January 1, 2002, the Franchise Tax Board, upon notification by the Attorney General or the board of a final judgment in an action brought under this section, shall subtract the amount of the fine or awarded civil penalties from any tax refunds or lottery winnings due to the person who is a defendant in the action using the offset authority under Section 12419.5 of the Government Code, as delegated by the Controller, and the processes as established by the Franchise Tax Board for this purpose. That amount shall be forwarded to the board for deposit in the Contingent Fund of the Medical Board of California.
(e)If the person or entity that is the subject of an action brought pursuant to this section is not a resident of this state, a violation of this section shall, if applicable, be reported to the persons or entitys appropriate professional licensing authority.
(f)Nothing in this section shall prohibit the board from commencing a disciplinary action against a physician and surgeon pursuant to Section 2242 or 2525.3.
SEC. 5.Article 25 (commencing with Section 2525) is added to Chapter 5 of Division 2 of the Business and Professions Code, to read:25.Recommending Medical Cannabis2525.(a)It is unlawful for a physician and surgeon who recommends cannabis to a patient for a medical purpose to accept, solicit, or offer any form of remuneration from or to a facility issued a state license pursuant to Chapter 3.5 (commencing with Section 19300) of Division 8, if the physician and surgeon or his or her immediate family have a financial interest in that facility.
(b)For the purposes of this section, financial interest shall have the same meaning as in Section 650.01.
(c)A violation of this section shall be a misdemeanor punishable by up to one year in county jail and a fine of up to five thousand dollars ($5,000) or by civil penalties of up to five thousand dollars ($5,000) and shall constitute unprofessional conduct.
2525.1.The Medical Board of California shall consult with the California Marijuana Research Program, known as the Center for Medicinal Cannabis Research, authorized pursuant to Section 11362.9 of the Health and Safety Code, on developing and adopting medical guidelines for the appropriate administration and use of medical cannabis.
2525.2.An individual who possesses a license in good standing to practice medicine or osteopathy issued by the Medical Board of California or the Osteopathic Medical Board of California shall not recommend medical cannabis to a patient, unless that person is the patients attending physician, as defined by subdivision (a) of Section 11362.7 of the Health and Safety Code.
2525.3.Recommending medical cannabis to a patient for a medical purpose without an appropriate prior examination and a medical indication constitutes unprofessional conduct.
2525.4.It is unprofessional conduct for any attending physician recommending medical cannabis to be employed by, or enter into any other agreement with, any person or entity dispensing medical cannabis.
2525.5.(a)A person shall not distribute any form of advertising for physician recommendations for medical cannabis in California unless the advertisement bears the following notice to consumers:
NOTICE TO CONSUMERS: The Compassionate Use Act of 1996 ensures that seriously ill Californians have the right to obtain and use cannabis for medical purposes where medical use is deemed appropriate and has been recommended by a physician who has determined that the persons health would benefit from the use of medical cannabis. Recommendations must come from an attending physician as defined in Section 11362.7 of the Health and Safety Code. Cannabis is a Schedule I drug according to the federal Controlled Substances Act. Activity related to cannabis use is subject to federal prosecution, regardless of the protections provided by state law.
(b)Advertising for attending physician recommendations for medical cannabis shall meet all of the requirements in Section 651. Price advertising shall not be fraudulent, deceitful, or misleading, including statements or advertisements of bait, discounts, premiums, gifts, or statements of a similar nature.
SEC. 6.Section 19302.1 is added to the Business and Professions Code, to read:19302.1.(a)The Governor shall appoint a chief of the bureau, subject to confirmation by the Senate, at a salary to be fixed and determined by the director with the approval of the Director of Finance. The chief shall serve under the direction and supervision of the director and at the pleasure of the Governor.
(b)Every power granted to or duty imposed upon the director under this chapter may be exercised or performed in the name of the director by a deputy or assistant director or by the chief, subject to conditions and limitations that the director may prescribe. In addition to every power granted or duty imposed with this chapter, the director shall have all other powers and duties generally applicable in relation to bureaus that are part of the Department of Consumer Affairs.
(c)The director may employ and appoint all employees necessary to properly administer the work of the bureau, in accordance with civil service laws and regulations.
(d)The Department of Consumer Affairs shall have the sole authority to create, issue, renew, discipline, suspend, or revoke licenses for the transportation, storage unrelated to manufacturing activities, distribution, and sale of medical marijuana within the state and to collect fees in connection with activities the bureau regulates. The bureau may create licenses in addition to those identified in this chapter that the bureau deems necessary to effectuate its duties under this chapter.
(e)The Department of Food and Agriculture shall administer the provisions of this chapter related to and associated with the cultivation of medical cannabis. The Department of Food and Agriculture shall have the authority to create, issue, and suspend or revoke cultivation licenses for violations of this chapter. The State Department of Public Health shall administer the provisions of this chapter related to and associated with the manufacturing and testing of medical cannabis.
SEC. 7.Section 19319 is added to the Business and Professions Code, to read:19319.(a)A qualified patient, as defined in Section 11362.7 of the Health and Safety Code, who cultivates, possesses, stores, manufactures, or transports cannabis exclusively for his or her personal medical use but who does not provide, donate, sell, or distribute cannabis to any other person is not thereby engaged in commercial cannabis activity and is therefore exempt from the licensure requirements of this chapter.
(b)A primary caregiver who cultivates, possesses, stores, manufactures, transports, donates, or provides cannabis exclusively for the personal medical purposes of no more than five specified qualified patients for whom he or she is the primary caregiver within the meaning of Section 11362.7 of the Health and Safety Code, but who does not receive remuneration for these activities except for compensation in full compliance with subdivision (c) of Section 11362.765 of the Health and Safety Code, is exempt from the licensure requirements of this chapter.
SEC. 8.Section 19320 is added to the Business and Professions Code, to read:19320.(a)Licensing authorities administering this chapter may issue state licenses only to qualified applicants engaging in commercial cannabis activity pursuant to this chapter. Upon the date of implementation of regulations by the licensing authority, no person shall engage in commercial cannabis activity without possessing both a state license and a local permit, license, or other authorization. A licensee shall not commence activity under the authority of a state license until the applicant has obtained, in addition to the state license, a license or permit from the local jurisdiction in which he or she proposes to operate, following the requirements of the applicable local ordinance.
(b)Revocation of a local license, permit, or other authorization shall terminate the ability of a medical cannabis business to operate within that local jurisdiction until the local jurisdiction reinstates or reissues the local license, permit, or other required authorization. Local authorities shall notify the bureau upon revocation of a local license. The bureau shall inform relevant licensing authorities.
(c)Revocation of a state license shall terminate the ability of a medical cannabis licensee to operate within California until the licensing authority reinstates or reissues the state license. Each licensee shall obtain a separate license for each location where it engages in commercial medical cannabis activity. However, transporters only need to obtain licenses for each physical location where the licensee conducts business while not in transport, or any equipment that is not currently transporting medical cannabis or medical cannabis products, permanently resides.
(d)In addition to the provisions of this chapter, local jurisdictions retain the power to assess fees and taxes, as applicable, on facilities that are licensed pursuant to this chapter and the business activities of those licensees.
(e)Nothing in this chapter shall be construed to supersede or limit state agencies, including the State Water Resources Control Board and Department of Fish and Wildlife, from establishing fees to support their medical cannabis regulatory programs.
SEC. 9.Section 19322 is added to the Business and Professions Code, to read:19322.(a)A person or entity shall not submit an application for a state license issued by the department pursuant to this chapter unless that person or entity has received a license, permit, or authorization by a local jurisdiction. An applicant for any type of state license issued pursuant to this chapter shall do all of the following:
(1)Electronically submit to the Department of Justice fingerprint images and related information required by the Department of Justice for the purpose of obtaining information as to the existence and content of a record of state or federal convictions and arrests, and information as to the existence and content of a record of state or federal convictions and arrests for which the Department of Justice establishes that the person is free on bail or on his or her own recognizance, pending trial or appeal.
(A)The Department of Justice shall provide a response to the licensing authority pursuant to paragraph (1) of subdivision (p) of Section 11105 of the Penal Code.
(B)The licensing authority shall request from the Department of Justice subsequent notification service, as provided pursuant to Section 11105.2 of the Penal Code, for applicants.
(C)The Department of Justice shall charge the applicant a fee sufficient to cover the reasonable cost of processing the requests described in this paragraph.
(2)Provide documentation issued by the local jurisdiction in which the proposed business is operating certifying that the applicant is or will be in compliance with all local ordinances and regulations.
(3)Provide evidence of the legal right to occupy and use the proposed location. For an applicant seeking a cultivator, distributor, manufacturing, or dispensary license, provide a statement from the owner of real property or their agent where the cultivation, distribution, manufacturing, or dispensing commercial medical cannabis activities will occur, as proof to demonstrate the landowner has acknowledged and consented to permit cultivation, distribution, manufacturing, or dispensary activities to be conducted on the property by the tenant applicant.
(4)If the application is for a cultivator or a dispensary, provide evidence that the proposed location is located beyond at least a 600-foot radius from a school, as required by Section 11362.768 of the Health and Safety Code.
(5)Provide a statement, signed by the applicant under penalty of perjury, that the information provided is complete, true, and accurate.
(6)(A)For an applicant with 20 or more employees, provide a statement that the applicant will enter into, or demonstrate that it has already entered into, and abide by the terms of a labor peace agreement.
(B)For the purposes of this paragraph, employee does not include a supervisor.
(C)For purposes of this paragraph, supervisor means an individual having authority, in the interest of the licensee, to hire, transfer, suspend, lay off, recall, promote, discharge, assign, reward, or discipline other employees, or responsibility to direct them or to adjust their grievances, or effectively to recommend such action, if, in connection with the foregoing, the exercise of that authority is not of a merely routine or clerical nature, but requires the use of independent judgment.
(7)Provide the applicants sellers permit number issued pursuant to Part 1 (commencing with Section 6001) of Division 2 of the Revenue and Taxation Code or indicate that the applicant is currently applying for a sellers permit.
(8)Provide any other information required by the licensing authority.
(9)For an applicant seeking a cultivation license, provide a statement declaring the applicant is an agricultural employer, as defined in the Alatorre-Zenovich-Dunlap-Berman Agricultural Labor Relations Act of 1975 (Part 3.5 (commencing with Section 1140) of Division 2 of the Labor Code), to the extent not prohibited by law.
(10)For an applicant seeking licensure as a testing laboratory, register with the State Department of Public Health and provide any information required by the State Department of Public Health.
(11)Pay all applicable fees required for licensure by the licensing authority.
(b)For applicants seeking licensure to cultivate, distribute, or manufacture medical cannabis, the application shall also include a detailed description of the applicants operating procedures for all of the following, as required by the licensing authority:
(1)Cultivation.
(2)Extraction and infusion methods.
(3)The transportation process.
(4)Inventory procedures.
(5)Quality control procedures.
SEC. 10.Section 19323 is added to the Business and Professions Code, to read:19323.(a)The licensing authority shall deny an application if either the applicant or the premises for which a state license is applied do not qualify for licensure under this chapter.
(b)The licensing authority may deny the application for licensure or renewal of a state license if any of the following conditions apply:
(1)Failure to comply with the provisions of this chapter or any rule or regulation adopted pursuant to this chapter, including but not limited to, any requirement imposed to protect natural resources, instream flow, and water quality pursuant to subdivision (a) of Section 19332.
(2)Conduct that constitutes grounds for denial of licensure pursuant to Chapter 2 (commencing with Section 480) of Division 1.5.
(3)A local agency has notified the licensing authority that a licensee or applicant within its jurisdiction is in violation of state rules and regulation relating to commercial cannabis activities, and the licensing authority, through an investigation, has determined that the violation is grounds for termination or revocation of the license. The licensing authority shall have the authority to collect reasonable costs, as determined by the licensing authority, for investigation from the licensee or applicant.
(4)The applicant has failed to provide information required by the licensing authority.
(5)The applicant or licensee has been convicted of an offense that is substantially related to the qualifications, functions, or duties of the business or profession for which the application is made, except that if the licensing authority determines that the applicant or licensee is otherwise suitable to be issued a license and granting the license would not compromise public safety, the licensing authority shall conduct a thorough review of the nature of the crime, conviction, circumstances, and evidence of rehabilitation of the applicant, and shall evaluate the suitability of the applicant or licensee to be issued a license based on the evidence found through the review. In determining which offenses are substantially related to the qualifications, functions, or duties of the business or profession for which the application is made, the licensing authority shall include, but not be limited to, the following:
(A)A felony conviction for the illegal possession for sale, sale, manufacture, transportation, or cultivation of a controlled substance.
(B)A violent felony conviction, as specified in subdivision (c) of Section 667.5 of the Penal Code.
(C)A serious felony conviction, as specified in subdivision (c) of Section 1192.7 of the Penal Code.
(D)A felony conviction involving fraud, deceit, or embezzlement.
(6)The applicant, or any of its officers, directors, or owners, is a licensed physician making patient recommendations for medical cannabis pursuant to Section 11362.7 of the Health and Safety Code.
(7)The applicant or any of its officers, directors, or owners has been subject to fines or penalties for cultivation or production of a controlled substance on public or private lands pursuant to Section 12025 or 12025.1 of the Fish and Game Code.
(8)The applicant, or any of its officers, directors, or owners, has been sanctioned by a licensing authority or a city, county, or city and county for unlicensed commercial medical cannabis activities or has had a license revoked under this chapter in the three years immediately preceding the date the application is filed with the licensing authority.
(9)Failure to obtain and maintain a valid sellers permit required pursuant to Part 1 (commencing with Section 6001) of Division 2 of the Revenue and Taxation Code.
SEC. 11.Section 19324 is added to the Business and Professions Code, to read:19324.Upon the denial of any application for a license, the licensing authority shall notify the applicant in writing. Within 30 days of service of the notice, the applicant may file a written petition for a license with the licensing authority. Upon receipt of a timely filed petition, the licensing authority shall set the petition for hearing. The hearing shall be conducted in accordance with Chapter 5 (commencing with Section 11500) of Part 1 of Division 3 of Title 2 of the Government Code, and the director of each licensing authority shall have all the powers granted therein.
SEC. 12.Section 19325 is added to the Business and Professions Code, to read:19325.An applicant shall not be denied a state license if the denial is based solely on any of the following:
(a)A conviction or act that is substantially related to the qualifications, functions, or duties of the business or profession for which the application is made for which the applicant or licensee has obtained a certificate of rehabilitation pursuant to Chapter 3.5 (commencing with Section 4852.01) of Title 6 of Part 3 of the Penal Code.
(b)A conviction that was subsequently dismissed pursuant to Section 1203.4, 1203.4a, or 1203.41 of the Penal Code.
SEC. 13.Article 6 (commencing with Section 19331) is added to Chapter 3.5 of Division 8 of the Business and Professions Code, to read:6.Licensed Cultivation Sites19331.The Legislature finds and declares all of the following:
(a)The United States Environmental Protection Agency has not established appropriate pesticide tolerances for, or permitted the registration and lawful use of, pesticides on cannabis crops intended for human consumption pursuant to the Federal Insecticide, Fungicide, and Rodenticide Act (7 U.S.C. 136 et seq.).
(b)The use of pesticides is not adequately regulated due to the omissions in federal law, and cannabis cultivated in California for California patients can and often does contain pesticide residues.
(c)Lawful California medical cannabis growers and caregivers urge the Department of Pesticide Regulation to provide guidance, in absence of federal guidance, on whether the pesticides currently used at most cannabis cultivation sites are actually safe for use on cannabis intended for human consumption.
19332.(a)The Department of Food and Agriculture shall promulgate regulations governing the licensing of indoor and outdoor cultivation sites.
(b)The Department of Pesticide Regulation, in consultation with the Department of Food and Agriculture, shall develop standards for the use of pesticides in cultivation, and maximum tolerances for pesticides and other foreign object residue in harvested cannabis.
(c)The State Department of Public Health shall develop standards for the production and labeling of all edible medical cannabis products.
(d)The Department of Food and Agriculture, in consultation with the Department of Fish and Wildlife and the State Water Resources Control Board, shall ensure that individual and cumulative effects of water diversion and discharge associated with cultivation do not affect the instream flows needed for fish spawning, migration, and rearing, and the flows needed to maintain natural flow variability.
(e)The Department of Food and Agriculture shall have the authority necessary for the implementation of the regulations it adopts pursuant to this chapter. The regulations shall do all of the following:
(1)Provide that weighing or measuring devices used in connection with the sale or distribution of medical cannabis are required to meet standards equivalent to Division 5 (commencing with Section 12001).
(2)Require that cannabis cultivation by licensees is conducted in accordance with state and local laws related to land conversion, grading, electricity usage, water usage, agricultural discharges, and similar matters. Nothing in this chapter, and no regulation adopted by the department, shall be construed to supersede or limit the authority of the State Water Resources Control Board, regional water quality control boards, or the Department of Fish and Wildlife to implement and enforce their statutory obligations or to adopt regulations to protect water quality, water supply, and natural resources.
(3)Establish procedures for the issuance and revocation of unique identifiers for activities associated with a cannabis cultivation license, pursuant to Article 8 (commencing with Section 19337). All cannabis shall be labeled with the unique identifier issued by the Department of Food and Agriculture.
(4)Prescribe standards, in consultation with the bureau, for the reporting of information as necessary related to unique identifiers, pursuant to Article 8 (commencing with Section 19337).
(f)The Department of Pesticide Regulation, in consultation with the State Water Resources Control Board, shall promulgate regulations that require that the application of pesticides or other pest control in connection with the indoor or outdoor cultivation of medical cannabis meets standards equivalent to Division 6 (commencing with Section 11401) of the Food and Agricultural Code and its implementing regulations.
(g)State cultivator license types issued by the Department of Food and Agriculture include:
(1)Type 1, or specialty outdoor, for outdoor cultivation using no artificial lighting of less than or equal to 5,000 square feet of total canopy size on one premises, or up to 50 mature plants on noncontiguous plots.
(2)Type 1A, or specialty indoor, for indoor cultivation using exclusively artificial lighting of less than or equal to 5,000 square feet of total canopy size on one premises.
(3)Type 1B, or specialty mixed-light, for cultivation using a combination of natural and supplemental artificial lighting at a maximum threshold to be determined by the licensing authority, of less than or equal to 5,000 square feet of total canopy size on one premises.
(4)Type 2, or small outdoor, for outdoor cultivation using no artificial lighting between 5,001 and 10,000 square feet, inclusive, of total canopy size on one premises.
(5)Type 2A, or small indoor, for indoor cultivation using exclusively artificial lighting between 5,001 and 10,000 square feet, inclusive, of total canopy size on one premises.
(6)Type 2B, or small mixed-light, for cultivation using a combination of natural and supplemental artificial lighting at a maximum threshold to be determined by the licensing authority, between 5,001 and 10,000 square feet, inclusive, of total canopy size on one premises.
(7)Type 3, or outdoor, for outdoor cultivation using no artificial lighting from 10,001 square feet to one acre, inclusive, of total canopy size on one premises. The Department of Food and Agriculture shall limit the number of licenses allowed of this type.
(8)Type 3A, or indoor, for indoor cultivation using exclusively artificial lighting between 10,001 and 22,000 square feet, inclusive, of total canopy size on one premises. The Department of Food and Agriculture shall limit the number of licenses allowed of this type.
(9)Type 3B, or mixed-light, for cultivation using a combination of natural and supplemental artificial lighting at a maximum threshold to be determined by the licensing authority, between 10,001 and 22,000 square feet, inclusive, of total canopy size on one premises. The Department of Food and Agriculture shall limit the number of licenses allowed of this type.
(10)Type 4, or nursery, for cultivation of medical cannabis solely as a nursery. Type 4 licensees may transport live plants.
19332.5.(a)Not later than January 1, 2020, the Department of Food and Agriculture in conjunction with the bureau, shall make available a certified organic designation and organic certification program for medical marijuana, if permitted under federal law and the National Organic Program (Section 6517 of the federal Organic Foods Production Act of 1990 (7 U.S.C. Sec. 6501 et seq.)), and Article 7 (commencing with Section 110810) of Chapter 5 of Part 5 of Division 104 of the Health and Safety Code.
(b)The bureau may establish appellations of origin for marijuana grown in California.
(c)It is unlawful for medical marijuana to be marketed, labeled, or sold as grown in a California county when the medical marijuana was not grown in that county.
(d)It is unlawful to use the name of a California county in the labeling, marketing, or packaging of medical marijuana products unless the product was grown in that county.
19333.An employee engaged in commercial cannabis cultivation activity shall be subject to Wage Order 4-2001 of the Industrial Welfare Commission.
SEC. 14.Article 7.5 (commencing with Section 19335) is added to Chapter 3.5 of Division 8 of the Business and Professions Code, to read:7.5.Unique Identifier and Track and Trace Program19335.(a)The Department of Food and Agriculture, in consultation with the bureau, shall establish a track and trace program for reporting the movement of medical marijuana items throughout the distribution chain that utilizes a unique identifier pursuant to Section 11362.777 of the Health and Safety Code and secure packaging and is capable of providing information that captures, at a minimum, all of the following:
(1)The licensee receiving the product.
(2)The transaction date.
(3)The cultivator from which the product originates, including the associated unique identifier, pursuant to Section 11362.777 of the Health and Safety Code.
(b)(1)The Department of Food and Agriculture shall create an electronic database containing the electronic shipping manifests which shall include, but not be limited to, the following information:
(A)The quantity, or weight, and variety of products shipped.
(B)The estimated times of departure and arrival.
(C)The quantity, or weight, and variety of products received.
(D)The actual time of departure and arrival.
(E)A categorization of the product.
(F)The license number and the unique identifier pursuant to Section 11362.777 of the Health and Safety Code issued by the licensing authority for all licensees involved in the shipping process, including cultivators, transporters, distributors, and dispensaries.
(2)(A)The database shall be designed to flag irregularities for all licensing authorities in this chapter to investigate. All licensing authorities pursuant to this chapter may access the database and share information related to licensees under this chapter, including social security and individual taxpayer identifications notwithstanding Section 30.
(B)The Department of Food and Agriculture shall immediately inform the bureau upon the finding of an irregularity or suspicious finding related to a licensee, applicant, or commercial cannabis activity for investigatory purposes.
(3)Licensing authorities and state and local agencies may, at any time, inspect shipments and request documentation for current inventory.
(4)The bureau shall have 24-hour access to the electronic database administered by the Department of Food and Agriculture.
(5)The Department of Food and Agriculture shall be authorized to enter into memoranda of understandings with licensing authorities for data sharing purposes, as deemed necessary by the Department of Food and Agriculture.
(6)Information received and contained in records kept by the Department of Food and Agriculture or licensing authorities for the purposes of administering this section are confidential and shall not be disclosed pursuant to the California Public Records Act (Chapter 3.5 (commencing with Section 6250) of Division 7 of Title 1 of the Government Code), except as necessary for authorized employees of the State of California or any city, county, or city and county to perform official duties pursuant to this chapter or a local ordinance.
(7)Upon the request of a state or local law enforcement agency, licensing authorities shall allow access to or provide information contained within the database to assist law enforcement in their duties and responsibilities pursuant to this chapter.
19336.(a)Chapter 4 (commencing with Section 55121) of Part 30 of Division 2 of the Revenue and Taxation Code shall apply with respect to the bureaus collection of the fees, civil fines, and penalties imposed pursuant to this chapter.
(b)Chapter 8 (commencing with Section 55381) of Part 30 of Division 2 of the Revenue and Taxation Code shall apply with respect to the disclosure of information under this chapter.
SEC. 15.Article 8 (commencing with Section 19337) is added to Chapter 3.5 of Division 8 of the Business and Professions Code, to read:8.Licensed Transporters19337.(a)A licensee authorized to transport medical cannabis and medical cannabis products between licenses shall do so only as set forth in this chapter.
(b)Prior to transporting medical cannabis or medical cannabis products, a licensed transporter of medical cannabis or medical cannabis products shall do both of the following:
(1)Complete an electronic shipping manifest as prescribed by the licensing authority. The shipping manifest must include the unique identifier, pursuant to Section 11362.777 of the Health and Safety Code, issued by the Department of Food and Agriculture for the original cannabis product.
(2)Securely transmit the manifest to the bureau and the licensee that will receive the medical cannabis product. The bureau shall inform the Department of Food and Agriculture of information pertaining to commercial cannabis activity for the purpose of the track and trace program identified in Section 19335.
(c)During transportation, the licensed transporter shall maintain a physical copy of the shipping manifest and make it available upon request to agents of the Department of Consumer Affairs and law enforcement officers.
(d)The licensee receiving the shipment shall maintain each electronic shipping manifest and shall make it available upon request to the Department of Consumer Affairs and any law enforcement officers.
(e)Upon receipt of the transported shipment, the licensee receiving the shipment shall submit to the licensing agency a record verifying receipt of the shipment and the details of the shipment.
(f)Transporting, or arranging for or facilitating the transport of, medical cannabis or medical cannabis products in violation of this chapter is grounds for disciplinary action against the license.
19338.(a)This chapter shall not be construed to authorize or permit a licensee to transport or cause to be transported cannabis or cannabis products outside the state, unless authorized by federal law.
(b)A local jurisdiction shall not prevent transportation of medical cannabis or medical cannabis products on public roads by a licensee transporting medical cannabis or medical cannabis products in compliance with this chapter.
SEC. 16.Article 11 (commencing with Section 19348) is added to Chapter 3.5 of Division 8 of the Business and Professions Code, to read:11.Taxation19348.(a)(1)A county may impose a tax on the privilege of cultivating, dispensing, producing, processing, preparing, storing, providing, donating, selling, or distributing medical cannabis or medical cannabis products by a licensee operating pursuant to this chapter.
(2)The board of supervisors shall specify in the ordinance proposing the tax the activities subject to the tax, the applicable rate or rates, the method of apportionment, if necessary, and the manner of collection of the tax. The tax may be imposed for general governmental purposes or for purposes specified in the ordinance by the board of supervisors.
(3)In addition to any other method of collection authorized by law, the board of supervisors may provide for the collection of the tax imposed pursuant to this section in the same manner, and subject to the same penalties and priority of lien, as other charges and taxes fixed and collected by the county. A tax imposed pursuant to this section is a tax and not a fee or special assessment. The board of supervisors shall specify whether the tax applies throughout the entire county or within the unincorporated area of the county.
(4)The tax authorized by this section may be imposed upon any or all of the activities set forth in paragraph (1), as specified in the ordinance, regardless of whether the activity is undertaken individually, collectively, or cooperatively, and regardless of whether the activity is for compensation or gratuitous, as determined by the board of supervisors.
(b)A tax imposed pursuant to this section shall be subject to applicable voter approval requirements imposed by law.
(c)This section is declaratory of existing law and does not limit or prohibit the levy or collection of any other fee, charge, or tax, or a license or service fee or charge upon, or related to, the activities set forth in subdivision (a) as otherwise provided by law. This section shall not be construed as a limitation upon the taxing authority of a county as provided by law.
(d)This section shall not be construed to authorize a county to impose a sales or use tax in addition to the sales and use tax imposed under an ordinance conforming to the provisions of Sections 7202 and 7203 of the Revenue and Taxation Code.
SEC. 17.The provisions of this act are severable. If any provision of this act or its application is held invalid, that invalidity shall not affect other provisions or applications that can be given effect without the invalid provision or application.
SEC. 18.The Legislature finds and declares that Section 14 of this act, which adds Section 19335 to the Business and Professions Code, thereby imposes a limitation on the publics right of access to the meetings of public bodies or the writings of public officials and agencies within the meaning of Section 3 of Article I of the California Constitution. Pursuant to that constitutional provision, the Legislature makes the following findings to demonstrate the interest protected by this limitation and the need for protecting that interest:
The limitation imposed under this act is necessary for purposes of compliance with the federal Health Insurance Portability and Accountability Act of 1996 (42 U.S.C. Sec. 1320d et seq.), the Confidentiality of Medical Information Act (Part 2.6 (commencing with Section 56) of Division 1 of the Civil Code), and the Insurance Information and Privacy Protection Act (Article 6.6 (commencing with Section 791) of Part 2 of Division 1 of the Insurance Code).
SEC. 19.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution for certain costs that may be incurred by a local agency or school district because, in that regard, this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
However, if the Commission on State Mandates determines that this act contains other costs mandated by the state, reimbursement to local agencies and school districts for those costs shall be made pursuant to Part 7 (commencing with Section 17500) of Division 4 of Title 2 of the Government Code.
SEC. 20.This act shall become operative only if Assembly Bill 266 and Assembly Bill 243 of the 201516 Session are enacted and take effect on or before January 1, 2016.
(a)Notwithstanding any other provision of law, an agency designated in subdivision (b) shall require an applicant to furnish to the agency a full set of fingerprints for purposes of conducting criminal history record checks. Any agency designated in subdivision (b) may obtain and receive, at its discretion, criminal history information from the Department of Justice and the United States Federal Bureau of Investigation.
(b)Subdivision (a) applies to the following:
(1)California Board of Accountancy.
(2)State Athletic Commission.
(3)Board of Behavioral Sciences.
(4)Court Reporters Board of California.
(5)State Board of Guide Dogs for the Blind.
(6)California State Board of Pharmacy.
(7)Board of Registered Nursing.
(8)Veterinary Medical Board.
(9)Board of Vocational Nursing and Psychiatric Technicians.
(10)Respiratory Care Board of California.
(11)Physical Therapy Board of California.
(12)Physician Assistant Committee of the Medical Board of California.
(13)Speech-Language Pathology and Audiology and Hearing Aid Dispenser Board.
(14)Medical Board of California.
(15)State Board of Optometry.
(16)Acupuncture Board.
(17)Cemetery and Funeral Bureau.
(18)Bureau of Security and Investigative Services.
(19)Division of Investigation.
(20)Board of Psychology.
(21)California Board of Occupational Therapy.
(22)Structural Pest Control Board.
(23)Contractors State License Board.
(24)Naturopathic Medicine Committee.
(25)Professional Fiduciaries Bureau.
(26)Board for Professional Engineers, Land Surveyors, and Geologists.
(27)Bureau of Medical Marijuana Regulation.
(c)For purposes of paragraph (26) of subdivision (b), the term applicant shall be limited to an initial applicant who has never been registered or licensed by the board or to an applicant for a new licensure or registration category.
SEC. 2.Section 2220.05 of the Business and Professions Code is amended to read:2220.05.(a)In order to ensure that its resources are maximized for the protection of the public, the Medical Board of California shall prioritize its investigative and prosecutorial resources to ensure that physicians and surgeons representing the greatest threat of harm are identified and disciplined expeditiously. Cases involving any of the following allegations shall be handled on a priority basis, as follows, with the highest priority being given to cases in the first paragraph:
(1)Gross negligence, incompetence, or repeated negligent acts that involve death or serious bodily injury to one or more patients, such that the physician and surgeon represents a danger to the public.
(2)Drug or alcohol abuse by a physician and surgeon involving death or serious bodily injury to a patient.
(3)Repeated acts of clearly excessive prescribing, furnishing, or administering of controlled substances, or repeated acts of prescribing, dispensing, or furnishing of controlled substances without a good faith prior examination of the patient and medical reason therefor. However, in no event shall a physician and surgeon prescribing, furnishing, or administering controlled substances for intractable pain consistent with lawful prescribing, including, but not limited to, Sections 725, 2241.5, and 2241.6 of this code and Sections 11159.2 and 124961 of the Health and Safety Code, be prosecuted for excessive prescribing and prompt review of the applicability of these provisions shall be made in any complaint that may implicate these provisions.
(4)Repeated acts of clearly excessive recommending of cannabis to patients for medical purposes, or repeated acts of recommending cannabis to patients for medical purposes without a good faith prior examination of the patient and a medical reason for the recommendation.
(5)Sexual misconduct with one or more patients during a course of treatment or an examination.
(6)Practicing medicine while under the influence of drugs or alcohol.
(b)The board may by regulation prioritize cases involving an allegation of conduct that is not described in subdivision (a). Those cases prioritized by regulation shall not be assigned a priority equal to or higher than the priorities established in subdivision (a).
(c)The Medical Board of California shall indicate in its annual report mandated by Section 2312 the number of temporary restraining orders, interim suspension orders, and disciplinary actions that are taken in each priority category specified in subdivisions (a) and (b).
SEC. 3.Section 2241.5 of the Business and Professions Code is amended to read:2241.5.(a)A physician and surgeon may prescribe for, or dispense or administer to, a person under his or her treatment for a medical condition dangerous drugs or prescription controlled substances for the treatment of pain or a condition causing pain, including, but not limited to, intractable pain.
(b)No physician and surgeon shall be subject to disciplinary action for prescribing, dispensing, or administering dangerous drugs or prescription controlled substances in accordance with this section.
(c)This section shall not affect the power of the board to take any action described in Section 2227 against a physician and surgeon who does any of the following:
(1)Violates subdivision (b), (c), or (d) of Section 2234 regarding gross negligence, repeated negligent acts, or incompetence.
(2)Violates Section 2241 regarding treatment of an addict.
(3)Violates Section 2242 or 2525.3 regarding performing an appropriate prior examination and the existence of a medical indication for prescribing, dispensing, or furnishing dangerous drugs or recommending medical cannabis.
(4)Violates Section 2242.1 regarding prescribing on the Internet.
(5)Fails to keep complete and accurate records of purchases and disposals of substances listed in the California Uniform Controlled Substances Act (Division 10 (commencing with Section 11000) of the Health and Safety Code) or controlled substances scheduled in the federal Comprehensive Drug Abuse Prevention and Control Act of 1970 (21 U.S.C. Sec. 801 et seq.), or pursuant to the federal Comprehensive Drug Abuse Prevention and Control Act of 1970. A physician and surgeon shall keep records of his or her purchases and disposals of these controlled substances or dangerous drugs, including the date of purchase, the date and records of the sale or disposal of the drugs by the physician and surgeon, the name and address of the person receiving the drugs, and the reason for the disposal or the dispensing of the drugs to the person, and shall otherwise comply with all state recordkeeping requirements for controlled substances.
(6)Writes false or fictitious prescriptions for controlled substances listed in the California Uniform Controlled Substances Act or scheduled in the federal Comprehensive Drug Abuse Prevention and Control Act of 1970.
(7)Prescribes, administers, or dispenses in violation of this chapter, or in violation of Chapter 4 (commencing with Section 11150) or Chapter 5 (commencing with Section 11210) of Division 10 of the Health and Safety Code.
(d)A physician and surgeon shall exercise reasonable care in determining whether a particular patient or condition, or the complexity of a patients treatment, including, but not limited to, a current or recent pattern of drug abuse, requires consultation with, or referral to, a more qualified specialist.
(e)Nothing in this section shall prohibit the governing body of a hospital from taking disciplinary actions against a physician and surgeon pursuant to Sections 809.05, 809.4, and 809.5.
SEC. 4.Section 2242.1 of the Business and Professions Code is amended to read:2242.1.(a)No person or entity may prescribe, dispense, or furnish, or cause to be prescribed, dispensed, or furnished, dangerous drugs or dangerous devices, as defined in Section 4022, on the Internet for delivery to any person in this state, without an appropriate prior examination and medical indication, except as authorized by Section 2242.
(b)Notwithstanding any other provision of law, a violation of this section may subject the person or entity that has committed the violation to either a fine of up to twenty-five thousand dollars ($25,000) per occurrence pursuant to a citation issued by the board or a civil penalty of twenty-five thousand dollars ($25,000) per occurrence.
(c)The Attorney General may bring an action to enforce this section and to collect the fines or civil penalties authorized by subdivision (b).
(d)For notifications made on and after January 1, 2002, the Franchise Tax Board, upon notification by the Attorney General or the board of a final judgment in an action brought under this section, shall subtract the amount of the fine or awarded civil penalties from any tax refunds or lottery winnings due to the person who is a defendant in the action using the offset authority under Section 12419.5 of the Government Code, as delegated by the Controller, and the processes as established by the Franchise Tax Board for this purpose. That amount shall be forwarded to the board for deposit in the Contingent Fund of the Medical Board of California.
(e)If the person or entity that is the subject of an action brought pursuant to this section is not a resident of this state, a violation of this section shall, if applicable, be reported to the persons or entitys appropriate professional licensing authority.
(f)Nothing in this section shall prohibit the board from commencing a disciplinary action against a physician and surgeon pursuant to Section 2242 or 2525.3.
SEC. 5.Article 25 (commencing with Section 2525) is added to Chapter 5 of Division 2 of the Business and Professions Code, to read:25.Recommending Medical Cannabis2525.(a)It is unlawful for a physician and surgeon who recommends cannabis to a patient for a medical purpose to accept, solicit, or offer any form of remuneration from or to a facility issued a state license pursuant to Chapter 3.5 (commencing with Section 19300) of Division 8, if the physician and surgeon or his or her immediate family have a financial interest in that facility.
(b)For the purposes of this section, financial interest shall have the same meaning as in Section 650.01.
(c)A violation of this section shall be a misdemeanor punishable by up to one year in county jail and a fine of up to five thousand dollars ($5,000) or by civil penalties of up to five thousand dollars ($5,000) and shall constitute unprofessional conduct.
2525.1.The Medical Board of California shall consult with the California Marijuana Research Program, known as the Center for Medicinal Cannabis Research, authorized pursuant to Section 11362.9 of the Health and Safety Code, on developing and adopting medical guidelines for the appropriate administration and use of medical cannabis.
2525.2.An individual who possesses a license in good standing to practice medicine or osteopathy issued by the Medical Board of California or the Osteopathic Medical Board of California shall not recommend medical cannabis to a patient, unless that person is the patients attending physician, as defined by subdivision (a) of Section 11362.7 of the Health and Safety Code.
2525.3.Recommending medical cannabis to a patient for a medical purpose without an appropriate prior examination and a medical indication constitutes unprofessional conduct.
2525.4.It is unprofessional conduct for any attending physician recommending medical cannabis to be employed by, or enter into any other agreement with, any person or entity dispensing medical cannabis.
2525.5.(a)A person shall not distribute any form of advertising for physician recommendations for medical cannabis in California unless the advertisement bears the following notice to consumers:
NOTICE TO CONSUMERS: The Compassionate Use Act of 1996 ensures that seriously ill Californians have the right to obtain and use cannabis for medical purposes where medical use is deemed appropriate and has been recommended by a physician who has determined that the persons health would benefit from the use of medical cannabis. Recommendations must come from an attending physician as defined in Section 11362.7 of the Health and Safety Code. Cannabis is a Schedule I drug according to the federal Controlled Substances Act. Activity related to cannabis use is subject to federal prosecution, regardless of the protections provided by state law.
(b)Advertising for attending physician recommendations for medical cannabis shall meet all of the requirements in Section 651. Price advertising shall not be fraudulent, deceitful, or misleading, including statements or advertisements of bait, discounts, premiums, gifts, or statements of a similar nature.
SEC. 6.Section 19302.1 is added to the Business and Professions Code, to read:19302.1.(a)The Governor shall appoint a chief of the bureau, subject to confirmation by the Senate, at a salary to be fixed and determined by the director with the approval of the Director of Finance. The chief shall serve under the direction and supervision of the director and at the pleasure of the Governor.
(b)Every power granted to or duty imposed upon the director under this chapter may be exercised or performed in the name of the director by a deputy or assistant director or by the chief, subject to conditions and limitations that the director may prescribe. In addition to every power granted or duty imposed with this chapter, the director shall have all other powers and duties generally applicable in relation to bureaus that are part of the Department of Consumer Affairs.
(c)The director may employ and appoint all employees necessary to properly administer the work of the bureau, in accordance with civil service laws and regulations.
(d)The Department of Consumer Affairs shall have the sole authority to create, issue, renew, discipline, suspend, or revoke licenses for the transportation, storage unrelated to manufacturing activities, distribution, and sale of medical marijuana within the state and to collect fees in connection with activities the bureau regulates. The bureau may create licenses in addition to those identified in this chapter that the bureau deems necessary to effectuate its duties under this chapter.
(e)The Department of Food and Agriculture shall administer the provisions of this chapter related to and associated with the cultivation of medical cannabis. The Department of Food and Agriculture shall have the authority to create, issue, and suspend or revoke cultivation licenses for violations of this chapter. The State Department of Public Health shall administer the provisions of this chapter related to and associated with the manufacturing and testing of medical cannabis.
SEC. 7.Section 19319 is added to the Business and Professions Code, to read:19319.(a)A qualified patient, as defined in Section 11362.7 of the Health and Safety Code, who cultivates, possesses, stores, manufactures, or transports cannabis exclusively for his or her personal medical use but who does not provide, donate, sell, or distribute cannabis to any other person is not thereby engaged in commercial cannabis activity and is therefore exempt from the licensure requirements of this chapter.
(b)A primary caregiver who cultivates, possesses, stores, manufactures, transports, donates, or provides cannabis exclusively for the personal medical purposes of no more than five specified qualified patients for whom he or she is the primary caregiver within the meaning of Section 11362.7 of the Health and Safety Code, but who does not receive remuneration for these activities except for compensation in full compliance with subdivision (c) of Section 11362.765 of the Health and Safety Code, is exempt from the licensure requirements of this chapter.
SEC. 8.Section 19320 is added to the Business and Professions Code, to read:19320.(a)Licensing authorities administering this chapter may issue state licenses only to qualified applicants engaging in commercial cannabis activity pursuant to this chapter. Upon the date of implementation of regulations by the licensing authority, no person shall engage in commercial cannabis activity without possessing both a state license and a local permit, license, or other authorization. A licensee shall not commence activity under the authority of a state license until the applicant has obtained, in addition to the state license, a license or permit from the local jurisdiction in which he or she proposes to operate, following the requirements of the applicable local ordinance.
(b)Revocation of a local license, permit, or other authorization shall terminate the ability of a medical cannabis business to operate within that local jurisdiction until the local jurisdiction reinstates or reissues the local license, permit, or other required authorization. Local authorities shall notify the bureau upon revocation of a local license. The bureau shall inform relevant licensing authorities.
(c)Revocation of a state license shall terminate the ability of a medical cannabis licensee to operate within California until the licensing authority reinstates or reissues the state license. Each licensee shall obtain a separate license for each location where it engages in commercial medical cannabis activity. However, transporters only need to obtain licenses for each physical location where the licensee conducts business while not in transport, or any equipment that is not currently transporting medical cannabis or medical cannabis products, permanently resides.
(d)In addition to the provisions of this chapter, local jurisdictions retain the power to assess fees and taxes, as applicable, on facilities that are licensed pursuant to this chapter and the business activities of those licensees.
(e)Nothing in this chapter shall be construed to supersede or limit state agencies, including the State Water Resources Control Board and Department of Fish and Wildlife, from establishing fees to support their medical cannabis regulatory programs.
SEC. 9.Section 19322 is added to the Business and Professions Code, to read:19322.(a)A person or entity shall not submit an application for a state license issued by the department pursuant to this chapter unless that person or entity has received a license, permit, or authorization by a local jurisdiction. An applicant for any type of state license issued pursuant to this chapter shall do all of the following:
(1)Electronically submit to the Department of Justice fingerprint images and related information required by the Department of Justice for the purpose of obtaining information as to the existence and content of a record of state or federal convictions and arrests, and information as to the existence and content of a record of state or federal convictions and arrests for which the Department of Justice establishes that the person is free on bail or on his or her own recognizance, pending trial or appeal.
(A)The Department of Justice shall provide a response to the licensing authority pursuant to paragraph (1) of subdivision (p) of Section 11105 of the Penal Code.
(B)The licensing authority shall request from the Department of Justice subsequent notification service, as provided pursuant to Section 11105.2 of the Penal Code, for applicants.
(C)The Department of Justice shall charge the applicant a fee sufficient to cover the reasonable cost of processing the requests described in this paragraph.
(2)Provide documentation issued by the local jurisdiction in which the proposed business is operating certifying that the applicant is or will be in compliance with all local ordinances and regulations.
(3)Provide evidence of the legal right to occupy and use the proposed location. For an applicant seeking a cultivator, distributor, manufacturing, or dispensary license, provide a statement from the owner of real property or their agent where the cultivation, distribution, manufacturing, or dispensing commercial medical cannabis activities will occur, as proof to demonstrate the landowner has acknowledged and consented to permit cultivation, distribution, manufacturing, or dispensary activities to be conducted on the property by the tenant applicant.
(4)If the application is for a cultivator or a dispensary, provide evidence that the proposed location is located beyond at least a 600-foot radius from a school, as required by Section 11362.768 of the Health and Safety Code.
(5)Provide a statement, signed by the applicant under penalty of perjury, that the information provided is complete, true, and accurate.
(6)(A)For an applicant with 20 or more employees, provide a statement that the applicant will enter into, or demonstrate that it has already entered into, and abide by the terms of a labor peace agreement.
(B)For the purposes of this paragraph, employee does not include a supervisor.
(C)For purposes of this paragraph, supervisor means an individual having authority, in the interest of the licensee, to hire, transfer, suspend, lay off, recall, promote, discharge, assign, reward, or discipline other employees, or responsibility to direct them or to adjust their grievances, or effectively to recommend such action, if, in connection with the foregoing, the exercise of that authority is not of a merely routine or clerical nature, but requires the use of independent judgment.
(7)Provide the applicants sellers permit number issued pursuant to Part 1 (commencing with Section 6001) of Division 2 of the Revenue and Taxation Code or indicate that the applicant is currently applying for a sellers permit.
(8)Provide any other information required by the licensing authority.
(9)For an applicant seeking a cultivation license, provide a statement declaring the applicant is an agricultural employer, as defined in the Alatorre-Zenovich-Dunlap-Berman Agricultural Labor Relations Act of 1975 (Part 3.5 (commencing with Section 1140) of Division 2 of the Labor Code), to the extent not prohibited by law.
(10)For an applicant seeking licensure as a testing laboratory, register with the State Department of Public Health and provide any information required by the State Department of Public Health.
(11)Pay all applicable fees required for licensure by the licensing authority.
(b)For applicants seeking licensure to cultivate, distribute, or manufacture medical cannabis, the application shall also include a detailed description of the applicants operating procedures for all of the following, as required by the licensing authority:
(1)Cultivation.
(2)Extraction and infusion methods.
(3)The transportation process.
(4)Inventory procedures.
(5)Quality control procedures.
SEC. 10.Section 19323 is added to the Business and Professions Code, to read:19323.(a)The licensing authority shall deny an application if either the applicant or the premises for which a state license is applied do not qualify for licensure under this chapter.
(b)The licensing authority may deny the application for licensure or renewal of a state license if any of the following conditions apply:
(1)Failure to comply with the provisions of this chapter or any rule or regulation adopted pursuant to this chapter, including but not limited to, any requirement imposed to protect natural resources, instream flow, and water quality pursuant to subdivision (a) of Section 19332.
(2)Conduct that constitutes grounds for denial of licensure pursuant to Chapter 2 (commencing with Section 480) of Division 1.5.
(3)A local agency has notified the licensing authority that a licensee or applicant within its jurisdiction is in violation of state rules and regulation relating to commercial cannabis activities, and the licensing authority, through an investigation, has determined that the violation is grounds for termination or revocation of the license. The licensing authority shall have the authority to collect reasonable costs, as determined by the licensing authority, for investigation from the licensee or applicant.
(4)The applicant has failed to provide information required by the licensing authority.
(5)The applicant or licensee has been convicted of an offense that is substantially related to the qualifications, functions, or duties of the business or profession for which the application is made, except that if the licensing authority determines that the applicant or licensee is otherwise suitable to be issued a license and granting the license would not compromise public safety, the licensing authority shall conduct a thorough review of the nature of the crime, conviction, circumstances, and evidence of rehabilitation of the applicant, and shall evaluate the suitability of the applicant or licensee to be issued a license based on the evidence found through the review. In determining which offenses are substantially related to the qualifications, functions, or duties of the business or profession for which the application is made, the licensing authority shall include, but not be limited to, the following:
(A)A felony conviction for the illegal possession for sale, sale, manufacture, transportation, or cultivation of a controlled substance.
(B)A violent felony conviction, as specified in subdivision (c) of Section 667.5 of the Penal Code.
(C)A serious felony conviction, as specified in subdivision (c) of Section 1192.7 of the Penal Code.
(D)A felony conviction involving fraud, deceit, or embezzlement.
(6)The applicant, or any of its officers, directors, or owners, is a licensed physician making patient recommendations for medical cannabis pursuant to Section 11362.7 of the Health and Safety Code.
(7)The applicant or any of its officers, directors, or owners has been subject to fines or penalties for cultivation or production of a controlled substance on public or private lands pursuant to Section 12025 or 12025.1 of the Fish and Game Code.
(8)The applicant, or any of its officers, directors, or owners, has been sanctioned by a licensing authority or a city, county, or city and county for unlicensed commercial medical cannabis activities or has had a license revoked under this chapter in the three years immediately preceding the date the application is filed with the licensing authority.
(9)Failure to obtain and maintain a valid sellers permit required pursuant to Part 1 (commencing with Section 6001) of Division 2 of the Revenue and Taxation Code.
SEC. 11.Section 19324 is added to the Business and Professions Code, to read:19324.Upon the denial of any application for a license, the licensing authority shall notify the applicant in writing. Within 30 days of service of the notice, the applicant may file a written petition for a license with the licensing authority. Upon receipt of a timely filed petition, the licensing authority shall set the petition for hearing. The hearing shall be conducted in accordance with Chapter 5 (commencing with Section 11500) of Part 1 of Division 3 of Title 2 of the Government Code, and the director of each licensing authority shall have all the powers granted therein.
SEC. 12.Section 19325 is added to the Business and Professions Code, to read:19325.An applicant shall not be denied a state license if the denial is based solely on any of the following:
(a)A conviction or act that is substantially related to the qualifications, functions, or duties of the business or profession for which the application is made for which the applicant or licensee has obtained a certificate of rehabilitation pursuant to Chapter 3.5 (commencing with Section 4852.01) of Title 6 of Part 3 of the Penal Code.
(b)A conviction that was subsequently dismissed pursuant to Section 1203.4, 1203.4a, or 1203.41 of the Penal Code.
SEC. 13.Article 6 (commencing with Section 19331) is added to Chapter 3.5 of Division 8 of the Business and Professions Code, to read:6.Licensed Cultivation Sites19331.The Legislature finds and declares all of the following:
(a)The United States Environmental Protection Agency has not established appropriate pesticide tolerances for, or permitted the registration and lawful use of, pesticides on cannabis crops intended for human consumption pursuant to the Federal Insecticide, Fungicide, and Rodenticide Act (7 U.S.C. 136 et seq.).
(b)The use of pesticides is not adequately regulated due to the omissions in federal law, and cannabis cultivated in California for California patients can and often does contain pesticide residues.
(c)Lawful California medical cannabis growers and caregivers urge the Department of Pesticide Regulation to provide guidance, in absence of federal guidance, on whether the pesticides currently used at most cannabis cultivation sites are actually safe for use on cannabis intended for human consumption.
19332.(a)The Department of Food and Agriculture shall promulgate regulations governing the licensing of indoor and outdoor cultivation sites.
(b)The Department of Pesticide Regulation, in consultation with the Department of Food and Agriculture, shall develop standards for the use of pesticides in cultivation, and maximum tolerances for pesticides and other foreign object residue in harvested cannabis.
(c)The State Department of Public Health shall develop standards for the production and labeling of all edible medical cannabis products.
(d)The Department of Food and Agriculture, in consultation with the Department of Fish and Wildlife and the State Water Resources Control Board, shall ensure that individual and cumulative effects of water diversion and discharge associated with cultivation do not affect the instream flows needed for fish spawning, migration, and rearing, and the flows needed to maintain natural flow variability.
(e)The Department of Food and Agriculture shall have the authority necessary for the implementation of the regulations it adopts pursuant to this chapter. The regulations shall do all of the following:
(1)Provide that weighing or measuring devices used in connection with the sale or distribution of medical cannabis are required to meet standards equivalent to Division 5 (commencing with Section 12001).
(2)Require that cannabis cultivation by licensees is conducted in accordance with state and local laws related to land conversion, grading, electricity usage, water usage, agricultural discharges, and similar matters. Nothing in this chapter, and no regulation adopted by the department, shall be construed to supersede or limit the authority of the State Water Resources Control Board, regional water quality control boards, or the Department of Fish and Wildlife to implement and enforce their statutory obligations or to adopt regulations to protect water quality, water supply, and natural resources.
(3)Establish procedures for the issuance and revocation of unique identifiers for activities associated with a cannabis cultivation license, pursuant to Article 8 (commencing with Section 19337). All cannabis shall be labeled with the unique identifier issued by the Department of Food and Agriculture.
(4)Prescribe standards, in consultation with the bureau, for the reporting of information as necessary related to unique identifiers, pursuant to Article 8 (commencing with Section 19337).
(f)The Department of Pesticide Regulation, in consultation with the State Water Resources Control Board, shall promulgate regulations that require that the application of pesticides or other pest control in connection with the indoor or outdoor cultivation of medical cannabis meets standards equivalent to Division 6 (commencing with Section 11401) of the Food and Agricultural Code and its implementing regulations.
(g)State cultivator license types issued by the Department of Food and Agriculture include:
(1)Type 1, or specialty outdoor, for outdoor cultivation using no artificial lighting of less than or equal to 5,000 square feet of total canopy size on one premises, or up to 50 mature plants on noncontiguous plots.
(2)Type 1A, or specialty indoor, for indoor cultivation using exclusively artificial lighting of less than or equal to 5,000 square feet of total canopy size on one premises.
(3)Type 1B, or specialty mixed-light, for cultivation using a combination of natural and supplemental artificial lighting at a maximum threshold to be determined by the licensing authority, of less than or equal to 5,000 square feet of total canopy size on one premises.
(4)Type 2, or small outdoor, for outdoor cultivation using no artificial lighting between 5,001 and 10,000 square feet, inclusive, of total canopy size on one premises.
(5)Type 2A, or small indoor, for indoor cultivation using exclusively artificial lighting between 5,001 and 10,000 square feet, inclusive, of total canopy size on one premises.
(6)Type 2B, or small mixed-light, for cultivation using a combination of natural and supplemental artificial lighting at a maximum threshold to be determined by the licensing authority, between 5,001 and 10,000 square feet, inclusive, of total canopy size on one premises.
(7)Type 3, or outdoor, for outdoor cultivation using no artificial lighting from 10,001 square feet to one acre, inclusive, of total canopy size on one premises. The Department of Food and Agriculture shall limit the number of licenses allowed of this type.
(8)Type 3A, or indoor, for indoor cultivation using exclusively artificial lighting between 10,001 and 22,000 square feet, inclusive, of total canopy size on one premises. The Department of Food and Agriculture shall limit the number of licenses allowed of this type.
(9)Type 3B, or mixed-light, for cultivation using a combination of natural and supplemental artificial lighting at a maximum threshold to be determined by the licensing authority, between 10,001 and 22,000 square feet, inclusive, of total canopy size on one premises. The Department of Food and Agriculture shall limit the number of licenses allowed of this type.
(10)Type 4, or nursery, for cultivation of medical cannabis solely as a nursery. Type 4 licensees may transport live plants.
19332.5.(a)Not later than January 1, 2020, the Department of Food and Agriculture in conjunction with the bureau, shall make available a certified organic designation and organic certification program for medical marijuana, if permitted under federal law and the National Organic Program (Section 6517 of the federal Organic Foods Production Act of 1990 (7 U.S.C. Sec. 6501 et seq.)), and Article 7 (commencing with Section 110810) of Chapter 5 of Part 5 of Division 104 of the Health and Safety Code.
(b)The bureau may establish appellations of origin for marijuana grown in California.
(c)It is unlawful for medical marijuana to be marketed, labeled, or sold as grown in a California county when the medical marijuana was not grown in that county.
(d)It is unlawful to use the name of a California county in the labeling, marketing, or packaging of medical marijuana products unless the product was grown in that county.
19333.An employee engaged in commercial cannabis cultivation activity shall be subject to Wage Order 4-2001 of the Industrial Welfare Commission.
SEC. 14.Article 7.5 (commencing with Section 19335) is added to Chapter 3.5 of Division 8 of the Business and Professions Code, to read:7.5.Unique Identifier and Track and Trace Program19335.(a)The Department of Food and Agriculture, in consultation with the bureau, shall establish a track and trace program for reporting the movement of medical marijuana items throughout the distribution chain that utilizes a unique identifier pursuant to Section 11362.777 of the Health and Safety Code and secure packaging and is capable of providing information that captures, at a minimum, all of the following:
(1)The licensee receiving the product.
(2)The transaction date.
(3)The cultivator from which the product originates, including the associated unique identifier, pursuant to Section 11362.777 of the Health and Safety Code.
(b)(1)The Department of Food and Agriculture shall create an electronic database containing the electronic shipping manifests which shall include, but not be limited to, the following information:
(A)The quantity, or weight, and variety of products shipped.
(B)The estimated times of departure and arrival.
(C)The quantity, or weight, and variety of products received.
(D)The actual time of departure and arrival.
(E)A categorization of the product.
(F)The license number and the unique identifier pursuant to Section 11362.777 of the Health and Safety Code issued by the licensing authority for all licensees involved in the shipping process, including cultivators, transporters, distributors, and dispensaries.
(2)(A)The database shall be designed to flag irregularities for all licensing authorities in this chapter to investigate. All licensing authorities pursuant to this chapter may access the database and share information related to licensees under this chapter, including social security and individual taxpayer identifications notwithstanding Section 30.
(B)The Department of Food and Agriculture shall immediately inform the bureau upon the finding of an irregularity or suspicious finding related to a licensee, applicant, or commercial cannabis activity for investigatory purposes.
(3)Licensing authorities and state and local agencies may, at any time, inspect shipments and request documentation for current inventory.
(4)The bureau shall have 24-hour access to the electronic database administered by the Department of Food and Agriculture.
(5)The Department of Food and Agriculture shall be authorized to enter into memoranda of understandings with licensing authorities for data sharing purposes, as deemed necessary by the Department of Food and Agriculture.
(6)Information received and contained in records kept by the Department of Food and Agriculture or licensing authorities for the purposes of administering this section are confidential and shall not be disclosed pursuant to the California Public Records Act (Chapter 3.5 (commencing with Section 6250) of Division 7 of Title 1 of the Government Code), except as necessary for authorized employees of the State of California or any city, county, or city and county to perform official duties pursuant to this chapter or a local ordinance.
(7)Upon the request of a state or local law enforcement agency, licensing authorities shall allow access to or provide information contained within the database to assist law enforcement in their duties and responsibilities pursuant to this chapter.
19336.(a)Chapter 4 (commencing with Section 55121) of Part 30 of Division 2 of the Revenue and Taxation Code shall apply with respect to the bureaus collection of the fees, civil fines, and penalties imposed pursuant to this chapter.
(b)Chapter 8 (commencing with Section 55381) of Part 30 of Division 2 of the Revenue and Taxation Code shall apply with respect to the disclosure of information under this chapter.
SEC. 15.Article 8 (commencing with Section 19337) is added to Chapter 3.5 of Division 8 of the Business and Professions Code, to read:8.Licensed Transporters19337.(a)A licensee authorized to transport medical cannabis and medical cannabis products between licenses shall do so only as set forth in this chapter.
(b)Prior to transporting medical cannabis or medical cannabis products, a licensed transporter of medical cannabis or medical cannabis products shall do both of the following:
(1)Complete an electronic shipping manifest as prescribed by the licensing authority. The shipping manifest must include the unique identifier, pursuant to Section 11362.777 of the Health and Safety Code, issued by the Department of Food and Agriculture for the original cannabis product.
(2)Securely transmit the manifest to the bureau and the licensee that will receive the medical cannabis product. The bureau shall inform the Department of Food and Agriculture of information pertaining to commercial cannabis activity for the purpose of the track and trace program identified in Section 19335.
(c)During transportation, the licensed transporter shall maintain a physical copy of the shipping manifest and make it available upon request to agents of the Department of Consumer Affairs and law enforcement officers.
(d)The licensee receiving the shipment shall maintain each electronic shipping manifest and shall make it available upon request to the Department of Consumer Affairs and any law enforcement officers.
(e)Upon receipt of the transported shipment, the licensee receiving the shipment shall submit to the licensing agency a record verifying receipt of the shipment and the details of the shipment.
(f)Transporting, or arranging for or facilitating the transport of, medical cannabis or medical cannabis products in violation of this chapter is grounds for disciplinary action against the license.
19338.(a)This chapter shall not be construed to authorize or permit a licensee to transport or cause to be transported cannabis or cannabis products outside the state, unless authorized by federal law.
(b)A local jurisdiction shall not prevent transportation of medical cannabis or medical cannabis products on public roads by a licensee transporting medical cannabis or medical cannabis products in compliance with this chapter.
SEC. 16.Article 11 (commencing with Section 19348) is added to Chapter 3.5 of Division 8 of the Business and Professions Code, to read:11.Taxation19348.(a)(1)A county may impose a tax on the privilege of cultivating, dispensing, producing, processing, preparing, storing, providing, donating, selling, or distributing medical cannabis or medical cannabis products by a licensee operating pursuant to this chapter.
(2)The board of supervisors shall specify in the ordinance proposing the tax the activities subject to the tax, the applicable rate or rates, the method of apportionment, if necessary, and the manner of collection of the tax. The tax may be imposed for general governmental purposes or for purposes specified in the ordinance by the board of supervisors.
(3)In addition to any other method of collection authorized by law, the board of supervisors may provide for the collection of the tax imposed pursuant to this section in the same manner, and subject to the same penalties and priority of lien, as other charges and taxes fixed and collected by the county. A tax imposed pursuant to this section is a tax and not a fee or special assessment. The board of supervisors shall specify whether the tax applies throughout the entire county or within the unincorporated area of the county.
(4)The tax authorized by this section may be imposed upon any or all of the activities set forth in paragraph (1), as specified in the ordinance, regardless of whether the activity is undertaken individually, collectively, or cooperatively, and regardless of whether the activity is for compensation or gratuitous, as determined by the board of supervisors.
(b)A tax imposed pursuant to this section shall be subject to applicable voter approval requirements imposed by law.
(c)This section is declaratory of existing law and does not limit or prohibit the levy or collection of any other fee, charge, or tax, or a license or service fee or charge upon, or related to, the activities set forth in subdivision (a) as otherwise provided by law. This section shall not be construed as a limitation upon the taxing authority of a county as provided by law.
(d)This section shall not be construed to authorize a county to impose a sales or use tax in addition to the sales and use tax imposed under an ordinance conforming to the provisions of Sections 7202 and 7203 of the Revenue and Taxation Code.
SEC. 17.The provisions of this act are severable. If any provision of this act or its application is held invalid, that invalidity shall not affect other provisions or applications that can be given effect without the invalid provision or application.
SEC. 18.The Legislature finds and declares that Section 14 of this act, which adds Section 19335 to the Business and Professions Code, thereby imposes a limitation on the publics right of access to the meetings of public bodies or the writings of public officials and agencies within the meaning of Section 3 of Article I of the California Constitution. Pursuant to that constitutional provision, the Legislature makes the following findings to demonstrate the interest protected by this limitation and the need for protecting that interest:
The limitation imposed under this act is necessary for purposes of compliance with the federal Health Insurance Portability and Accountability Act of 1996 (42 U.S.C. Sec. 1320d et seq.), the Confidentiality of Medical Information Act (Part 2.6 (commencing with Section 56) of Division 1 of the Civil Code), and the Insurance Information and Privacy Protection Act (Article 6.6 (commencing with Section 791) of Part 2 of Division 1 of the Insurance Code).
SEC. 19.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution for certain costs that may be incurred by a local agency or school district because, in that regard, this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
However, if the Commission on State Mandates determines that this act contains other costs mandated by the state, reimbursement to local agencies and school districts for those costs shall be made pursuant to Part 7 (commencing with Section 17500) of Division 4 of Title 2 of the Government Code.
SEC. 20.This act shall become operative only if Assembly Bill 266 and Assembly Bill 243 of the 201516 Session are enacted and take effect on or before January 1, 2016.
(a)Notwithstanding any other provision of law, an agency designated in subdivision (b) shall require an applicant to furnish to the agency a full set of fingerprints for purposes of conducting criminal history record checks. Any agency designated in subdivision (b) may obtain and receive, at its discretion, criminal history information from the Department of Justice and the United States Federal Bureau of Investigation.
(b)Subdivision (a) applies to the following:
(1)California Board of Accountancy.
(2)State Athletic Commission.
(3)Board of Behavioral Sciences.
(4)Court Reporters Board of California.
(5)State Board of Guide Dogs for the Blind.
(6)California State Board of Pharmacy.
(7)Board of Registered Nursing.
(8)Veterinary Medical Board.
(9)Board of Vocational Nursing and Psychiatric Technicians.
(10)Respiratory Care Board of California.
(11)Physical Therapy Board of California.
(12)Physician Assistant Committee of the Medical Board of California.
(13)Speech-Language Pathology and Audiology and Hearing Aid Dispenser Board.
(14)Medical Board of California.
(15)State Board of Optometry.
(16)Acupuncture Board.
(17)Cemetery and Funeral Bureau.
(18)Bureau of Security and Investigative Services.
(19)Division of Investigation.
(20)Board of Psychology.
(21)California Board of Occupational Therapy.
(22)Structural Pest Control Board.
(23)Contractors State License Board.
(24)Naturopathic Medicine Committee.
(25)Professional Fiduciaries Bureau.
(26)Board for Professional Engineers, Land Surveyors, and Geologists.
(27)Bureau of Medical Marijuana Regulation.
(c)For purposes of paragraph (26) of subdivision (b), the term applicant shall be limited to an initial applicant who has never been registered or licensed by the board or to an applicant for a new licensure or registration category.
SECTION 1.SEC. 2.Section 2220.05 of the Business and Professions Code is amended to read:2220.05.(a)In order to ensure that its resources are maximized for the protection of the public, the Medical Board of California shall prioritize its investigative and prosecutorial resources to ensure that physicians and surgeons representing the greatest threat of harm are identified and disciplined expeditiously. Cases involving any of the following allegations shall be handled on a priority basis, as follows, with the highest priority being given to cases in the first paragraph:
(1)Gross negligence, incompetence, or repeated negligent acts that involve death or serious bodily injury to one or more patients, such that the physician and surgeon represents a danger to the public.
(2)Drug or alcohol abuse by a physician and surgeon involving death or serious bodily injury to a patient.
(3)Repeated acts of clearly excessive prescribing, furnishing, or administering of controlled substances, or repeated acts of prescribing, dispensing, or furnishing of controlled substances without a good faith prior examination of the patient and medical reason therefor. However, in no event shall a physician and surgeon prescribing, furnishing, or administering controlled substances for intractable pain consistent with lawful prescribing, including, but not limited to, Sections 725, 2241.5, and 2241.6 of this code and Sections 11159.2 and 124961 of the Health and Safety Code, be prosecuted for excessive prescribing and prompt review of the applicability of these provisions shall be made in any complaint that may implicate these provisions.
(4)Repeated acts of clearly excessive recommending of cannabis to patients for medical purposes, or repeated acts of recommending cannabis to patients for medical purposes without a good faith prior examination of the patient and a medical reason for the recommendation.
(5)Sexual misconduct with one or more patients during a course of treatment or an examination.
(6)Practicing medicine while under the influence of drugs or alcohol.
(b)The board may by regulation prioritize cases involving an allegation of conduct that is not described in subdivision (a). Those cases prioritized by regulation shall not be assigned a priority equal to or higher than the priorities established in subdivision (a).
(c)The Medical Board of California shall indicate in its annual report mandated by Section 2312 the number of temporary restraining orders, interim suspension orders, and disciplinary actions that are taken in each priority category specified in subdivisions (a) and (b).
SEC. 3.Section 2241.5 of the Business and Professions Code is amended to read:2241.5.(a)A physician and surgeon may prescribe for, or dispense or administer to, a person under his or her treatment for a medical condition dangerous drugs or prescription controlled substances for the treatment of pain or a condition causing pain, including, but not limited to, intractable pain.
(b)No physician and surgeon shall be subject to disciplinary action for prescribing, dispensing, or administering dangerous drugs or prescription controlled substances in accordance with this section.
(c)This section shall not affect the power of the board to take any action described in Section 2227 against a physician and surgeon who does any of the following:
(1)Violates subdivision (b), (c), or (d) of Section 2234 regarding gross negligence, repeated negligent acts, or incompetence.
(2)Violates Section 2241 regarding treatment of an addict.
(3)Violates Section 2242 or 2525.3 regarding performing an appropriate prior examination and the existence of a medical indication for prescribing, dispensing, or furnishing dangerous drugs. drugs or recommending medical cannabis.
(4)Violates Section 2242.1 regarding prescribing on the Internet.
(5)Fails to keep complete and accurate records of purchases and disposals of substances listed in the California Uniform Controlled Substances Act (Division 10 (commencing with Section 11000) of the Health and Safety Code) or controlled substances scheduled in the federal Comprehensive Drug Abuse Prevention and Control Act of 1970 (21 U.S.C. Sec. 801 et seq.), or pursuant to the federal Comprehensive Drug Abuse Prevention and Control Act of 1970. A physician and surgeon shall keep records of his or her purchases and disposals of these controlled substances or dangerous drugs, including the date of purchase, the date and records of the sale or disposal of the drugs by the physician and surgeon, the name and address of the person receiving the drugs, and the reason for the disposal or the dispensing of the drugs to the person, and shall otherwise comply with all state recordkeeping requirements for controlled substances.
(6)Writes false or fictitious prescriptions for controlled substances listed in the California Uniform Controlled Substances Act or scheduled in the federal Comprehensive Drug Abuse Prevention and Control Act of 1970.
(7)Prescribes, administers, or dispenses in violation of this chapter, or in violation of Chapter 4 (commencing with Section 11150) or Chapter 5 (commencing with Section 11210) of Division 10 of the Health and Safety Code.
(d)A physician and surgeon shall exercise reasonable care in determining whether a particular patient or condition, or the complexity of a patients treatment, including, but not limited to, a current or recent pattern of drug abuse, requires consultation with, or referral to, a more qualified specialist.
(e)Nothing in this section shall prohibit the governing body of a hospital from taking disciplinary actions against a physician and surgeon pursuant to Sections 809.05, 809.4, and 809.5.
SEC. 4.Section 2242.1 of the Business and Professions Code is amended to read:2242.1.(a)No person or entity may prescribe, dispense, or furnish, or cause to be prescribed, dispensed, or furnished, dangerous drugs or dangerous devices, as defined in Section 4022, on the Internet for delivery to any person in this state, without an appropriate prior examination and medical indication, except as authorized by Section 2242.
(b)Notwithstanding any other provision of law, a violation of this section may subject the person or entity that has committed the violation to either a fine of up to twenty-five thousand dollars ($25,000) per occurrence pursuant to a citation issued by the board or a civil penalty of twenty-five thousand dollars ($25,000) per occurrence.
(c)The Attorney General may bring an action to enforce this section and to collect the fines or civil penalties authorized by subdivision (b).
(d)For notifications made on and after January 1, 2002, the Franchise Tax Board, upon notification by the Attorney General or the board of a final judgment in an action brought under this section, shall subtract the amount of the fine or awarded civil penalties from any tax refunds or lottery winnings due to the person who is a defendant in the action using the offset authority under Section 12419.5 of the Government Code, as delegated by the Controller, and the processes as established by the Franchise Tax Board for this purpose. That amount shall be forwarded to the board for deposit in the Contingent Fund of the Medical Board of California.
(e)If the person or entity that is the subject of an action brought pursuant to this section is not a resident of this state, a violation of this section shall, if applicable, be reported to the persons or entitys appropriate professional licensing authority.
(f)Nothing in this section shall prohibit the board from commencing a disciplinary action against a physician and surgeon pursuant to Section 2242. 2242 or 2525.3.
SEC. 5.Article 25 (commencing with Section 2525) is added to Chapter 5 of Division 2 of the Business and Professions Code, to read:25.Recommending Medical Cannabis2525.(a)It is unlawful for a physician and surgeon who recommends cannabis to a patient for a medical purpose to accept, solicit, or offer any form of remuneration from or to a facility issued a state license pursuant to Chapter 3.5 (commencing with Section 19300) of Division 8, if the physician and surgeon or his or her immediate family have a financial interest in that facility.
(b)For the purposes of this section, financial interest shall have the same meaning as in Section 650.01.
(c)A violation of this section shall be a misdemeanor punishable by up to one year in county jail and a fine of up to five thousand dollars ($5,000) or by civil penalties of up to five thousand dollars ($5,000) and shall constitute unprofessional conduct.
2525.1.The Medical Board of California shall consult with the California Marijuana Research Program, known as the Center for Medicinal Cannabis Research, authorized pursuant to Section 11362.9 of the Health and Safety Code, on developing and adopting medical guidelines for the appropriate administration and use of medical cannabis.
2525.2.An individual who possesses a license in good standing to practice medicine or osteopathy issued by the Medical Board of California or the Osteopathic Medical Board of California shall not recommend medical cannabis to a patient, unless that person is the patients attending physician, as defined by subdivision (a) of Section 11362.7 of the Health and Safety Code.
2525.3.Recommending medical cannabis to a patient for a medical purpose without an appropriate prior examination and a medical indication constitutes unprofessional conduct.
2525.4.It is unprofessional conduct for any attending physician recommending medical cannabis to be employed by, or enter into any other agreement with, any person or entity dispensing medical cannabis.
2525.5.(a)A person shall not distribute any form of advertising for physician recommendations for medical cannabis in California unless the advertisement bears the following notice to consumers:
NOTICE TO CONSUMERS: The Compassionate Use Act of 1996 ensures that seriously ill Californians have the right to obtain and use cannabis for medical purposes where medical use is deemed appropriate and has been recommended by a physician who has determined that the persons health would benefit from the use of medical cannabis. Recommendations must come from an attending physician as defined in Section 11362.7 of the Health and Safety Code. Cannabis is a Schedule I drug according to the federal Controlled Substances Act. Activity related to cannabis use is subject to federal prosecution, regardless of the protections provided by state law.
(b)Advertising for attending physician recommendations for medical cannabis shall meet all of the requirements in Section 651. Price advertising shall not be fraudulent, deceitful, or misleading, including statements or advertisements of bait, discounts, premiums, gifts, or statements of a similar nature.
SEC. 6.Section 19302.1 is added to the Business and Professions Code, to read:19302.1.(a)The Governor shall appoint a chief of the bureau, subject to confirmation by the Senate, at a salary to be fixed and determined by the director with the approval of the Director of Finance. The chief shall serve under the direction and supervision of the director and at the pleasure of the Governor.
(b)Every power granted to or duty imposed upon the director under this chapter may be exercised or performed in the name of the director by a deputy or assistant director or by the chief, subject to conditions and limitations that the director may prescribe. In addition to every power granted or duty imposed with this chapter, the director shall have all other powers and duties generally applicable in relation to bureaus that are part of the Department of Consumer Affairs.
(c)The director may employ and appoint all employees necessary to properly administer the work of the bureau, in accordance with civil service laws and regulations.
(d)The Department of Consumer Affairs shall have the sole authority to create, issue, renew, discipline, suspend, or revoke licenses for the transportation, storage unrelated to manufacturing activities, distribution, and sale of medical marijuana within the state and to collect fees in connection with activities the bureau regulates. The bureau may create licenses in addition to those identified in this chapter that the bureau deems necessary to effectuate its duties under this chapter.
(e)The Department of Food and Agriculture shall administer the provisions of this chapter related to and associated with the cultivation of medical cannabis. The Department of Food and Agriculture shall have the authority to create, issue, and suspend or revoke cultivation licenses for violations of this chapter. The State Department of Public Health shall administer the provisions of this chapter related to and associated with the manufacturing and testing of medical cannabis.
SEC. 7.Section 19319 is added to the Business and Professions Code, to read:19319.(a)A qualified patient, as defined in Section 11362.7 of the Health and Safety Code, who cultivates, possesses, stores, manufactures, or transports cannabis exclusively for his or her personal medical use but who does not provide, donate, sell, or distribute cannabis to any other person is not thereby engaged in commercial cannabis activity and is therefore exempt from the licensure requirements of this chapter.
(b)A primary caregiver who cultivates, possesses, stores, manufactures, transports, donates, or provides cannabis exclusively for the personal medical purposes of no more than five specified qualified patients for whom he or she is the primary caregiver within the meaning of Section 11362.7 of the Health and Safety Code, but who does not receive remuneration for these activities except for compensation in full compliance with subdivision (c) of Section 11362.765 of the Health and Safety Code, is exempt from the licensure requirements of this chapter.
SEC. 8.Section 19320 is added to the Business and Professions Code, to read:19320.(a)Licensing authorities administering this chapter may issue state licenses only to qualified applicants engaging in commercial cannabis activity pursuant to this chapter. Upon the date of implementation of regulations by the licensing authority, no person shall engage in commercial cannabis activity without possessing both a state license and a local permit, license, or other authorization. A licensee shall not commence activity under the authority of a state license until the applicant has obtained, in addition to the state license, a license or permit from the local jurisdiction in which he or she proposes to operate, following the requirements of the applicable local ordinance.
(b)Revocation of a local license, permit, or other authorization shall terminate the ability of a medical cannabis business to operate within that local jurisdiction until the local jurisdiction reinstates or reissues the local license, permit, or other required authorization. Local authorities shall notify the bureau upon revocation of a local license. The bureau shall inform relevant licensing authorities.
(c)Revocation of a state license shall terminate the ability of a medical cannabis licensee to operate within California until the licensing authority reinstates or reissues the state license. Each licensee shall obtain a separate license for each location where it engages in commercial medical cannabis activity. However, transporters only need to obtain licenses for each physical location where the licensee conducts business while not in transport, or any equipment that is not currently transporting medical cannabis or medical cannabis products, permanently resides.
(d)In addition to the provisions of this chapter, local jurisdictions retain the power to assess fees and taxes, as applicable, on facilities that are licensed pursuant to this chapter and the business activities of those licensees.
(e)Nothing in this chapter shall be construed to supersede or limit state agencies, including the State Water Resources Control Board and Department of Fish and Wildlife, from establishing fees to support their medical cannabis regulatory programs.
SEC. 9.Section 19322 is added to the Business and Professions Code, to read:19322.(a)A person or entity shall not submit an application for a state license issued by the department pursuant to this chapter unless that person or entity has received a license, permit, or authorization by a local jurisdiction. An applicant for any type of state license issued pursuant to this chapter shall do all of the following:
(1)Electronically submit to the Department of Justice fingerprint images and related information required by the Department of Justice for the purpose of obtaining information as to the existence and content of a record of state or federal convictions and arrests, and information as to the existence and content of a record of state or federal convictions and arrests for which the Department of Justice establishes that the person is free on bail or on his or her own recognizance, pending trial or appeal.
(A)The Department of Justice shall provide a response to the licensing authority pursuant to paragraph (1) of subdivision (p) of Section 11105 of the Penal Code.
(B)The licensing authority shall request from the Department of Justice subsequent notification service, as provided pursuant to Section 11105.2 of the Penal Code, for applicants.
(C)The Department of Justice shall charge the applicant a fee sufficient to cover the reasonable cost of processing the requests described in this paragraph.
(2)Provide documentation issued by the local jurisdiction in which the proposed business is operating certifying that the applicant is or will be in compliance with all local ordinances and regulations.
(3)Provide evidence of the legal right to occupy and use the proposed location. For an applicant seeking a cultivator, distributor, manufacturing, or dispensary license, provide a statement from the owner of real property or their agent where the cultivation, distribution, manufacturing, or dispensing commercial medical cannabis activities will occur, as proof to demonstrate the landowner has acknowledged and consented to permit cultivation, distribution, manufacturing, or dispensary activities to be conducted on the property by the tenant applicant.
(4)If the application is for a cultivator or a dispensary, provide evidence that the proposed location is located beyond at least a 600 foot radius from a school, as required by Section 11362.768 of the Health and Safety Code.
(5)Provide a statement, signed by the applicant under penalty of perjury, that the information provided is complete, true, and accurate.
(6)(A)For an applicant with 20 or more employees, provide a statement that the applicant will enter into, or demonstrate that it has already entered into, and abide by the terms of a labor peace agreement.
(B)For the purposes of this paragraph, employee does not include a supervisor.
(C)For purposes of this paragraph, supervisor means an individual having authority, in the interest of the licensee, to hire, transfer, suspend, lay off, recall, promote, discharge, assign, reward, or discipline other employees, or responsibility to direct them or to adjust their grievances, or effectively to recommend such action, if, in connection with the foregoing, the exercise of that authority is not of a merely routine or clerical nature, but requires the use of independent judgment.
(7)Provide the applicants sellers permit number issued pursuant to Part 1 (commencing with Section 6001) of Division 2 of the Revenue and Taxation Code or indicate that the applicant is currently applying for a sellers permit.
(8)Provide any other information required by the licensing authority.
(9)For an applicant seeking a cultivation license, provide a statement declaring the applicant is an agricultural employer, as defined in the Alatorre-Zenovich-Dunlap-Berman Agricultural Labor Relations Act of 1975 (Part 3.5 (commencing with Section 1140) of Division 2 of the Labor Code), to the extent not prohibited by law.
(10)For an applicant seeking licensure as a testing laboratory, register with the State Department of Public Health and provide any information required by the State Department of Public Health.
(11)Pay all applicable fees required for licensure by the licensing authority.
(b)For applicants seeking licensure to cultivate, distribute, or manufacture medical cannabis, the application shall also include a detailed description of the applicants operating procedures for all of the following, as required by the licensing authority:
(1)Cultivation.
(2)Extraction and infusion methods.
(3)The transportation process.
(4)Inventory procedures.
(5)Quality control procedures.
SEC. 10.Section 19323 is added to the Business and Professions Code, to read:19323.(a)The licensing authority shall deny an application if either the applicant or the premises for which a state license is applied do not qualify for licensure under this chapter.
(b)The licensing authority may deny the application for licensure or renewal of a state license if any of the following conditions apply:
(1)Failure to comply with the provisions of this chapter or any rule or regulation adopted pursuant to this chapter, including but not limited to, any requirement imposed to protect natural resources, instream flow, and water quality pursuant to subdivision (a) of Section 19332.
(2)Conduct that constitutes grounds for denial of licensure pursuant to Chapter 2 (commencing with Section 480) of Division 1.5.
(3)A local agency has notified the licensing authority that a licensee or applicant within its jurisdiction is in violation of state rules and regulation relating to commercial cannabis activities, and the licensing authority, through an investigation, has determined that the violation is grounds for termination or revocation of the license. The licensing authority shall have the authority to collect reasonable costs, as determined by the licensing authority, for investigation from the licensee or applicant.
(4)The applicant has failed to provide information required by the licensing authority.
(5)The applicant or licensee has been convicted of an offense that is substantially related to the qualifications, functions, or duties of the business or profession for which the application is made, except that if the licensing authority determines that the applicant or licensee is otherwise suitable to be issued a license and granting the license would not compromise public safety, the licensing authority shall conduct a thorough review of the nature of the crime, conviction, circumstances, and evidence of rehabilitation of the applicant, and shall evaluate the suitability of the applicant or licensee to be issued a license based on the evidence found through the review. In determining which offenses are substantially related to the qualifications, functions, or duties of the business or profession for which the application is made, the licensing authority shall include, but not be limited to, the following:
(A)A felony conviction for the illegal possession for sale, sale, manufacture, transportation, or cultivation of a controlled substance.
(B)A violent felony conviction, as specified in subdivision (c) of Section 667.5 of the Penal Code.
(C)A serious felony conviction, as specified in subdivision (c) of Section 1192.7 of the Penal Code.
(D)A felony conviction involving fraud, deceit, or embezzlement.
(6)The applicant, or any of its officers, directors, or owners, is a licensed physician making patient recommendations for medical cannabis pursuant to Section 11362.7 of the Health and Safety Code.
(7)The applicant or any of its officers, directors, or owners has been subject to fines or penalties for cultivation or production of a controlled substance on public or private lands pursuant to Section 12025 or 12025.1 of the Fish and Game Code.
(8)The applicant, or any of its officers, directors, or owners, has been sanctioned by a licensing authority or a city, county, or city and county for unlicensed commercial medical cannabis activities or has had a license revoked under this chapter in the three years immediately preceding the date the application is filed with the licensing authority.
(9)Failure to obtain and maintain a valid sellers permit required pursuant to Part 1 (commencing with Section 6001) of Division 2 of the Revenue and Taxation Code.
SEC. 11.Section 19324 is added to the Business and Professions Code, to read:19324.Upon the denial of any application for a license, the licensing authority shall notify the applicant in writing. Within 30 days of service of the notice, the applicant may file a written petition for a license with the licensing authority. Upon receipt of a timely filed petition, the licensing authority shall set the petition for hearing. The hearing shall be conducted in accordance with Chapter 5 (commencing with Section 11500) of Part 1 of Division 3 of Title 2 of the Government Code, and the director of each licensing authority shall have all the powers granted therein.
SEC. 12.Section 19325 is added to the Business and Professions Code, to read:19325.An applicant shall not be denied a state license if the denial is based solely on any of the following:
(a)A conviction or act that is substantially related to the qualifications, functions, or duties of the business or profession for which the application is made for which the applicant or licensee has obtained a certificate of rehabilitation pursuant to Chapter 3.5 (commencing with Section 4852.01) of Title 6 of Part 3 of the Penal Code.
(b)A conviction that was subsequently dismissed pursuant to Section 1203.4, 1203.4a, or 1203.41 of the Penal Code.
SEC. 13.Article 6 (commencing with Section 19331) is added to Chapter 3.5 of Division 8 of the Business and Professions Code, to read:6.Licensed Cultivation Sites19331.The Legislature finds and declares all of the following:
(a)The United States Environmental Protection Agency has not established appropriate pesticide tolerances for, or permitted the registration and lawful use of, pesticides on cannabis crops intended for human consumption pursuant to the Federal Insecticide, Fungicide, and Rodenticide Act (7 U.S.C. 136 et seq.).
(b)The use of pesticides is not adequately regulated due to the omissions in federal law, and cannabis cultivated in California for California patients can and often does contain pesticide residues.
(c)Lawful California medical cannabis growers and caregivers urge the Department of Pesticide Regulation to provide guidance, in absence of federal guidance, on whether the pesticides currently used at most cannabis cultivation sites are actually safe for use on cannabis intended for human consumption.
19332.(a)The Department of Food and Agriculture shall promulgate regulations governing the licensing of indoor and outdoor cultivation sites.
(b)The Department of Pesticide Regulation, in consultation with the Department of Food and Agriculture, shall develop standards for the use of pesticides in cultivation, and maximum tolerances for pesticides and other foreign object residue in harvested cannabis.
(c)The State Department of Public Health shall develop standards for the production and labeling of all edible medical cannabis products.
(d)The Department of Food and Agriculture, in consultation with the Department of Fish and Wildlife and the State Water Resources Control Board, shall ensure that individual and cumulative effects of water diversion and discharge associated with cultivation do not affect the instream flows needed for fish spawning, migration, and rearing, and the flows needed to maintain natural flow variability.
(e)The Department of Food and Agriculture shall have the authority necessary for the implementation of the regulations it adopts pursuant to this chapter. The regulations shall do all of the following:
(1)Provide that weighing or measuring devices used in connection with the sale or distribution of medical cannabis are required to meet standards equivalent to Division 5 (commencing with Section 12001).
(2)Require that cannabis cultivation by licensees is conducted in accordance with state and local laws related to land conversion, grading, electricity usage, water usage, agricultural discharges, and similar matters. Nothing in this chapter, and no regulation adopted by the department, shall be construed to supersede or limit the authority of the State Water Resources Control Board, regional water quality control boards, or the Department of Fish and Wildlife to implement and enforce their statutory obligations or to adopt regulations to protect water quality, water supply, and natural resources.
(3)Establish procedures for the issuance and revocation of unique identifiers for activities associated with a cannabis cultivation license, pursuant to Article 8 (commencing with Section 19337). All cannabis shall be labeled with the unique identifier issued by the Department of Food and Agriculture.
(4)Prescribe standards, in consultation with the bureau, for the reporting of information as necessary related to unique identifiers, pursuant to Article 8 (commencing with Section 19337).
(f)The Department of Pesticide Regulation, in consultation with the State Water Resources Control Board, shall promulgate regulations that require that the application of pesticides or other pest control in connection with the indoor or outdoor cultivation of medical cannabis meets standards equivalent to Division 6 (commencing with Section 11401) of the Food and Agricultural Code and its implementing regulations.
(g)State cultivator license types issued by the Department of Food and Agriculture include:
(1)Type 1, or specialty outdoor, for outdoor cultivation using no artificial lighting of less than or equal to 5,000 square feet of total canopy size on one premises, or up to 50 mature plants on noncontiguous plots.
(2)Type 1A, or specialty indoor, for indoor cultivation using exclusively artificial lighting of less than or equal to 5,000 square feet of total canopy size on one premises.
(3)Type 1B, or specialty mixed-light, for cultivation using a combination of natural and supplemental artificial lighting at a maximum threshold to be determined by the licensing authority, of less than or equal to 5,000 square feet of total canopy size on one premises.
(4)Type 2, or small outdoor, for outdoor cultivation using no artificial lighting between 5,001 and 10,000 square feet, inclusive, of total canopy size on one premises.
(5)Type 2A, or small indoor, for indoor cultivation using exclusively artificial lighting between 5,001 and 10,000 square feet, inclusive, of total canopy size on one premises.
(6)Type 2B, or small mixed-light, for cultivation using a combination of natural and supplemental artificial lighting at a maximum threshold to be determined by the licensing authority, between 5,001 and 10,000 square feet, inclusive, of total canopy size on one premises.
(7)Type 3, or outdoor, for outdoor cultivation using no artificial lighting from 10,001 square feet to one acre, inclusive, of total canopy size on one premises. The Department of Food and Agriculture shall limit the number of licenses allowed of this type.
(8)Type 3A, or indoor, for indoor cultivation using exclusively artificial lighting between 10,001 and 22,000 square feet, inclusive, of total canopy size on one premises. The Department of Food and Agriculture shall limit the number of licenses allowed of this type.
(9)Type 3B, or mixed-light, for cultivation using a combination of natural and supplemental artificial lighting at a maximum threshold to be determined by the licensing authority, between 10,001 and 22,000 square feet, inclusive, of total canopy size on one premises. The Department of Food and Agriculture shall limit the number of licenses allowed of this type.
(10)Type 4, or nursery, for cultivation of medical cannabis solely as a nursery. Type 4 licensees may transport live plants.
19332.5.(a)Not later than January 1, 2020, the Department of Food and Agriculture in conjunction with the bureau, shall make available a certified organic designation and organic certification program for medical marijuana, if permitted under federal law and the National Organic Program (Section 6517 of the federal Organic Foods Production Act of 1990 (7 U.S.C. Sec. 6501 et seq.)), and Article 7 (commencing with Section 110810) of Chapter 5 of Part 5 of Division 104 of the Health and Safety Code.
(b)The bureau may establish appellations of origin for marijuana grown in California.
(c)It is unlawful for medical marijuana to be marketed, labeled, or sold as grown in a California county when the medical marijuana was not grown in that county.
(d)It is unlawful to use the name of a California county in the labeling, marketing, or packaging of medical marijuana products unless the product was grown in that county.
19333.An employee engaged in commercial cannabis cultivation activity shall be subject to Wage Order 4-2001 of the Industrial Welfare Commission.
SEC. 14.Article 7.5 (commencing with Section 19335) is added to Chapter 3.5 of Division 8 of the Business and Professions Code, to read:7.5.Unique Identifier and Track and Trace Program19335.(a)The Department of Food and Agriculture, in consultation with the bureau, shall establish a track and trace program for reporting the movement of medical marijuana items throughout the distribution chain that utilizes a unique identifier pursuant to Section 11362.777 of the Health and Safety Code and secure packaging and is capable of providing information that captures, at a minimum, all of the following:
(1)The licensee receiving the product.
(2)The transaction date.
(3)The cultivator from which the product originates, including the associated unique identifier, pursuant to Section 11362.777 of the Health and Safety Code.
(b)(1)The Department of Food and Agriculture shall create an electronic database containing the electronic shipping manifests which shall include, but not be limited to, the following information:
(A)The quantity, or weight, and variety of products shipped.
(B)The estimated times of departure and arrival.
(C)The quantity, or weight, and variety of products received.
(D)The actual time of departure and arrival.
(E)A categorization of the product.
(F)The license number and the unique identifier pursuant to Section 11362.777 of the Health and Safety Code issued by the licensing authority for all licensees involved in the shipping process, including cultivators, transporters, distributors, and dispensaries.
(2)(A)The database shall be designed to flag irregularities for all licensing authorities in this chapter to investigate. All licensing authorities pursuant to this chapter may access the database and share information related to licensees under this chapter, including social security and individual taxpayer identifications notwithstanding Section 30.
(B)The Department of Food and Agriculture shall immediately inform the bureau upon the finding of an irregularity or suspicious finding related to a licensee, applicant, or commercial cannabis activity for investigatory purposes.
(3)Licensing authorities and state and local agencies may, at any time, inspect shipments and request documentation for current inventory.
(4)The bureau shall have 24-hour access to the electronic database administered by the Department of Food and Agriculture.
(5)The Department of Food and Agriculture shall be authorized to enter into memoranda of understandings with licensing authorities for data sharing purposes, as deemed necessary by the Department of Food and Agriculture.
(6)Information received and contained in records kept by the Department of Food and Agriculture or licensing authorities for the purposes of administering this section are confidential and shall not be disclosed pursuant to the California Public Records Act (Chapter 3.5 (commencing with Section 6250) of Division 7 of Title 1 of the Government Code), except as necessary for authorized employees of the State of California or any city, county, or city and county to perform official duties pursuant to this chapter or a local ordinance.
(7)Upon the request of a state or local law enforcement agency, licensing authorities shall allow access to or provide information contained within the database to assist law enforcement in their duties and responsibilities pursuant to this chapter.
19336.(a)Chapter 4 (commencing with Section 55121) of Part 30 of Division 2 of the Revenue and Taxation Code shall apply with respect to the bureaus collection of the fees, civil fines, and penalties imposed pursuant to this chapter.
(b)Chapter 8 (commencing with Section 55381) of Part 30 of Division 2 of the Revenue and Taxation Code shall apply with respect to the disclosure of information under this chapter.
SEC. 15.Article 8 (commencing with Section 19337) is added to Chapter 3.5 of Division 8 of the Business and Professions Code, to read:8.Licensed Transporters19337.(a)A licensee authorized to transport medical cannabis and medical cannabis products between licenses shall do so only as set forth in this chapter.
(b)Prior to transporting medical cannabis or medical cannabis products, a licensed transporter of medical cannabis or medical cannabis products shall do both of the following:
(1)Complete an electronic shipping manifest as prescribed by the licensing authority. The shipping manifest must include the unique identifier, pursuant to Section 11362.777 of the Health and Safety Code, issued by the Department of Food and Agriculture for the original cannabis product.
(2)Securely transmit the manifest to the bureau and the licensee that will receive the medical cannabis product. The bureau shall inform the Department of Food and Agriculture of information pertaining to commercial cannabis activity for the purpose of the track and trace program identified in Section 19335.
(c)During transportation, the licensed transporter shall maintain a physical copy of the shipping manifest and make it available upon request to agents of the Department of Consumer Affairs and law enforcement officers.
(d)The licensee receiving the shipment shall maintain each electronic shipping manifest and shall make it available upon request to the Department of Consumer Affairs and any law enforcement officers.
(e)Upon receipt of the transported shipment, the licensee receiving the shipment shall submit to the licensing agency a record verifying receipt of the shipment and the details of the shipment.
(f)Transporting, or arranging for or facilitating the transport of, medical cannabis or medical cannabis products in violation of this chapter is grounds for disciplinary action against the license.
19338.(a)This chapter shall not be construed to authorize or permit a licensee to transport or cause to be transported cannabis or cannabis products outside the state, unless authorized by federal law.
(b)A local jurisdiction shall not prevent transportation of medical cannabis or medical cannabis products on public roads by a licensee transporting medical cannabis or medical cannabis products in compliance with this chapter.
SEC. 16.Article 11 (commencing with Section 19348) is added to Chapter 3.5 of Division 8 of the Business and Professions Code, to read:11.Taxation19348.(a)(1)A county may impose a tax on the privilege of cultivating, dispensing, producing, processing, preparing, storing, providing, donating, selling, or distributing medical cannabis or medical cannabis products by a licensee operating pursuant to this chapter.
(2)The board of supervisors shall specify in the ordinance proposing the tax the activities subject to the tax, the applicable rate or rates, the method of apportionment, if necessary, and the manner of collection of the tax. The tax may be imposed for general governmental purposes or for purposes specified in the ordinance by the board of supervisors.
(3)In addition to any other method of collection authorized by law, the board of supervisors may provide for the collection of the tax imposed pursuant to this section in the same manner, and subject to the same penalties and priority of lien, as other charges and taxes fixed and collected by the county. A tax imposed pursuant to this section is a tax and not a fee or special assessment. The board of supervisors shall specify whether the tax applies throughout the entire county or within the unincorporated area of the county.
(4)The tax authorized by this section may be imposed upon any or all of the activities set forth in paragraph (1), as specified in the ordinance, regardless of whether the activity is undertaken individually, collectively, or cooperatively, and regardless of whether the activity is for compensation or gratuitous, as determined by the board of supervisors.
(b)A tax imposed pursuant to this section shall be subject to applicable voter approval requirements imposed by law.
(c)This section is declaratory of existing law and does not limit or prohibit the levy or collection of any other fee, charge, or tax, or a license or service fee or charge upon, or related to, the activities set forth in subdivision (a) as otherwise provided by law. This section shall not be construed as a limitation upon the taxing authority of a county as provided by law.
(d)This section shall not be construed to authorize a county to impose a sales or use tax in addition to the sales and use tax imposed under an ordinance conforming to the provisions of Sections 7202 and 7203 of the Revenue and Taxation Code.
SEC. 17.The provisions of this act are severable. If any provision of this act or its application is held invalid, that invalidity shall not affect other provisions or applications that can be given effect without the invalid provision or application.
SEC. 18.The Legislature finds and declares that Section 14 of this act, which adds Section 19335 to the Business and Professions Code, thereby imposes a limitation on the publics right of access to the meetings of public bodies or the writings of public officials and agencies within the meaning of Section 3 of Article I of the California Constitution. Pursuant to that constitutional provision, the Legislature makes the following findings to demonstrate the interest protected by this limitation and the need for protecting that interest:
The limitation imposed under this act is necessary for purposes of compliance with the federal Health Insurance Portability and Accountability Act of 1996 (42 U.S.C. Sec. 1320d et seq.), the Confidentiality of Medical Information Act (Part 2.6 (commencing with Section 56) of Division 1 of the Civil Code), and the Insurance Information and Privacy Protection Act (Article 6.6 (commencing with Section 791) of Part 2 of Division 1 of the Insurance Code).
SEC. 19.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution for certain costs that may be incurred by a local agency or school district because, in that regard, this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
However, if the Commission on State Mandates determines that this act contains other costs mandated by the state, reimbursement to local agencies and school districts for those costs shall be made pursuant to Part 7 (commencing with Section 17500) of Division 4 of Title 2 of the Government Code.
SEC. 2.SEC. 20.This act shall become operative only if Assembly Bill 266 and Assembly Bill 243 of the 201516 Session is are enacted and takes take effect on or before January 1, 2016.
(a)In order to ensure that its resources are maximized for the protection of the public, the Medical Board of California shall prioritize its investigative and prosecutorial resources to ensure that physicians and surgeons representing the greatest threat of harm are identified and disciplined expeditiously. Cases involving any of the following allegations shall be handled on a priority basis, as follows, with the highest priority being given to cases in the first paragraph:
(1)Gross negligence, incompetence, or repeated negligent acts that involve death or serious bodily injury to one or more patients, such that the physician and surgeon represents a danger to the public.
(2)Drug or alcohol abuse by a physician and surgeon involving death or serious bodily injury to a patient.
(3)Repeated acts of clearly excessive prescribing, furnishing, or administering of controlled substances, or repeated acts of prescribing, dispensing, or furnishing of controlled substances without a good faith prior examination of the patient and medical reason therefor. However, in no event shall a physician and surgeon prescribing, furnishing, or administering controlled substances for intractable pain consistent with lawful prescribing, including, but not limited to, Sections 725, 2241.5, and 2241.6 of this code and Sections 11159.2 and 124961 of the Health and Safety Code, be prosecuted for excessive prescribing and prompt review of the applicability of these provisions shall be made in any complaint that may implicate these provisions.
(4)Repeated acts of clearly excessive recommending of cannabis to patients for medical purposes, or repeated acts of recommending cannabis to patients for medical purposes without a good faith prior examination of the patient and a medical reason for the recommendation.
(4)
(5)Sexual misconduct with one or more patients during a course of treatment or an examination.
(5)
(6)Practicing medicine while under the influence of drugs or alcohol.
(b)The board may by regulation prioritize cases involving an allegation of conduct that is not described in subdivision (a). Those cases prioritized by regulation shall not be assigned a priority equal to or higher than the priorities established in subdivision (a).
(c)The Medical Board of California shall indicate in its annual report mandated by Section 2312 the number of temporary restraining orders, interim suspension orders, and disciplinary actions that are taken in each priority category specified in subdivisions (a) and (b).
SECTION 1.It is the intent of the Legislature to enact a comprehensive regulatory framework for medical marijuana in the State of California.
SEC. 2.This act shall become operative only if Assembly Bill 266 of the 201516 Session is enacted and takes effect on or before January 1, 2016.
It is the intent of the Legislature to enact a comprehensive regulatory framework for medical marijuana in the State of California.
SEC. 2.This act shall become operative only if Assembly Bill 266 of the 201516 Session is enacted and takes effect on or before January 1, 2016.
SECTION 1.This act shall be known, and may be cited, as the Medical Marijuana Public Safety and Environmental Protection Act.
SEC. 2.The Legislature finds and declares all of the following:
(a)In 1996, the people of the State of California enacted the Compassionate Use Act of 1996, codified in Section 11362.5 of the Health and Safety Code. The people of the State of California declared that their purpose in enacting the measure was, among other things, to ensure that seriously ill Californians have the right to obtain and use marijuana for medical purposes where that medical use is deemed appropriate and has been recommended by a physician who has determined that the persons health would benefit from the use of marijuana in the treatment of cancer, anorexia, AIDS, chronic pain, spasticity, glaucoma, arthritis, migraine, or any other illness for which marijuana provides relief.
(b)The Compassionate Use Act of 1996 called on state government to implement a plan for the safe and affordable distribution of marijuana to all patients in medical need of marijuana, while ensuring that nothing in that act would be construed to condone the diversion of marijuana for nonmedical purposes.
(c)In 2003, the Legislature enacted the Medical Marijuana Program Act (MMPA), codified in Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10 of the Health and Safety Code.
(d)Greater certainty and minimum statewide standards are urgently needed regarding the obligations of medical marijuana facilities, and for the imposition and enforcement of regulations to prevent unlawful cultivation and the diversion of marijuana to nonmedical use.
(e)Despite the passage of the Compassionate Use Act of 1996 and the MMPA, because of the lack of an effective statewide system for regulating and controlling medical marijuana, cities, counties, and local law enforcement officials have been confronted with uncertainty about the legality of some medical marijuana cultivation and distribution activities. The current state of affairs makes law enforcement difficult and endangers patient safety because of an inability to monitor the supply of medical marijuana in the state and the lack of quality control, testing, and labeling requirements.
(f)The California Constitution grants cities and counties the authority to make and enforce, within their borders, all local police, sanitary, and other ordinances and regulations not in conflict with the general laws. This inherent local police power includes broad authority to determine, for purposes of public health, safety, and welfare, the appropriate uses of land within the local jurisdictions borders. The police power, therefore, allows each city and county to determine whether or not a medical marijuana dispensary or other facility that makes medical marijuana available may operate within its borders. Nothing in this act shall diminish, erode, or modify that authority.
(g)If a city or county determines that a dispensary or other facility that makes medical marijuana available may operate within its borders, then there is a need for the state and local governments to license these dispensaries and other facilities for the purpose of adopting and enforcing protocols for security standards at dispensaries and in the transportation of medical marijuana, as well as health and safety standards to ensure patient safety. This licensing requirement is not intended in any way nor shall it be construed to preempt local ordinances, regulations, or enforcement actions regarding the sale and use of medical marijuana, including, but not limited to, security, signage, lighting, and inspections.
(h)Greater oversight, uniformity, and enforcement are urgently needed regarding the obligations and rights of medical marijuana cultivators, transporters, and distribution facilities.
(i)Marijuana has widely accepted medical applications that make it inappropriate to be classified as a Schedule I controlled substance in the State of California.
(j)For the protection of Californians, the state must act to regulate and control commercial medical marijuana and not preempt local government ordinances. Counties should be allowed to impose local taxes and enact zoning regulations and other restrictions applicable to the cultivation, transportation, and distribution of medical marijuana based on local needs.
(k)For the protection of Californias environment and its natural resources, all efforts must be made to prevent and mitigate the harmful environmental impacts that can be associated with some marijuana cultivation.
(l)Illegal trespass grows on private and public property pose a threat to public safety and the environment.
(m)The North Coast Regional Water Quality Control Board is currently in the process of promulgating regulations that would create a 3-tiered system for cultivator wastewater discharge permits. A similar permitting system would assist the state in controlling damaging wastewater runoff from cultivation sites, while minimizing the burden on smaller cultivators.
(n)Nothing in this act shall have a diminishing effect on the rights and protections granted to a patient or primary caregiver pursuant to the Compassionate Use Act of 1996.
(o)Nothing in this act shall be construed to promote or facilitate the nonmedical, recreational possession, sale, or use of marijuana.
SEC. 3.Section 2220.05 of the Business and Professions Code is amended to read:2220.05.(a)In order to ensure that its resources are maximized for the protection of the public, the Medical Board of California shall prioritize its investigative and prosecutorial resources to ensure that physicians and surgeons representing the greatest threat of harm are identified and disciplined expeditiously. Cases involving any of the following allegations shall be handled on a priority basis, as follows, with the highest priority being given to cases in the first paragraph:
(1)Gross negligence, incompetence, or repeated negligent acts that involve death or serious bodily injury to one or more patients, such that the physician and surgeon represents a danger to the public.
(2)Drug or alcohol abuse by a physician and surgeon involving death or serious bodily injury to a patient.
(3)Repeated acts of clearly excessive prescribing, furnishing, or administering of controlled substances, or repeated acts of prescribing, dispensing, or furnishing of controlled substances, or recommending marijuana to patients for medical purposes, without a good faith prior examination of the patient and medical reason therefor. However, in no event shall a physician and surgeon prescribing, furnishing, or administering controlled substances for intractable pain consistent with lawful prescribing, including, but not limited to, Sections 725, 2241.5, and 2241.6 of this code and Sections 11159.2 and 124961 of the Health and Safety Code, be prosecuted for excessive prescribing and prompt review of the applicability of these provisions shall be made in any complaint that may implicate these provisions.
(4)Sexual misconduct with one or more patients during a course of treatment or an examination.
(5)Practicing medicine while under the influence of drugs or alcohol.
(b)The board may by regulation prioritize cases involving an allegation of conduct that is not described in subdivision (a). Those cases prioritized by regulation shall not be assigned a priority equal to or higher than the priorities established in subdivision (a).
(c)The Medical Board of California shall indicate in its annual report mandated by Section 2312 the number of temporary restraining orders, interim suspension orders, and disciplinary actions that are taken in each priority category specified in subdivisions (a) and (b).
SEC. 4.Article 25 (commencing with Section 2525) is added to Chapter 5 of Division 2 of the Business and Professions Code, to read:25.Recommending Medical Marijuana2525.(a)It is unlawful for a physician and surgeon who recommends marijuana to a patient for a medical purpose to accept, solicit, or offer any form of remuneration from or to a facility issued a license pursuant to Part 5 (commencing with Section 18100) of Division 7, if the physician and surgeon or his or her immediate family have a financial interest in that facility.
(b)For the purposes of this section, financial interest shall have the same meaning as in Section 650.01.
(c)A violation of this section shall be a misdemeanor.
2525.1.The Medical Board of California shall consult with the California Marijuana Research Program, known as the Center for Medicinal Cannabis Research, authorized pursuant to Section 11362.9 of the Health and Safety Code, on developing and adopting medical guidelines for the appropriate administration and use of medical marijuana.
2525.2.A physician and surgeon shall not recommend medical marijuana to a patient, unless that person is the patients attending physician, as defined by subdivision (a) of Section 11362.7 of the Health and Safety Code.
SEC. 5.Part 5 (commencing with Section 18100) is added to Division 7 of the Business and Professions Code, to read:5.Medical Marijuana1.General Provisions18100.For purposes of this part, the following definitions shall apply:
(a)Chief means the Chief of the Office of Medical Marijuana Regulation.
(b)Delivery means the commercial transfer of medical marijuana or medical marijuana products from a dispensary, up to an amount determined by the office, to a primary caregiver or qualified patient, as defined in Section 11362.7 of the Health and Safety Code, a testing laboratory, or to an event or location where it will be used solely for promotional purposes. Delivery also includes the use by a dispensary of a third party or any technology platform that enables qualified patients or primary caregivers to arrange for or facilitate the commercial transfer of medical marijuana or medical marijuana products.
(c)Dispensary means a distribution operation that provides medical marijuana or medical marijuana derived products to patients and caregivers.
(d)Distribution means procurement, sale, and transport of medical marijuana and medical marijuana products purchased and sold between licensed entities.
(e)Distributor means a person who is engaged in the business of purchasing medical marijuana from a licensed cultivator or medical marijuana products from a licensed manufacturer in order to distribute to other licensees.
(f)Fund means the Medical Marijuana Regulation Fund established pursuant to Section 18118.
(g)Labor peace agreement means an agreement between a licensee and a bona fide labor organization that, at a minimum, protects the states proprietary interests by prohibiting labor organizations and members from engaging in picketing, work stoppages, boycotts, and any other economic interference with the applicants business. This agreement means that the applicant has agreed not to disrupt efforts by the bona fide labor organization to communicate with, and attempt to organize and represent, the applicants employees. The agreement shall provide a bona fide labor organization access, at reasonable times, to areas in which the applicants employees work, for the purpose of meeting with employees to discuss their right to representation, employment rights under state law, and terms and conditions of employment. This type of agreement shall not mandate a particular method of election or certification of the bona fide labor organization.
(h)Licensed cultivation site means a facility that plants, grows, cultivates, harvests, dries, or processes medical marijuana and that is issued both a license pursuant to this part and a local license or permit.
(i)Licensed dispensing facility means a dispensary or other facility that provides medical marijuana, medical marijuana products, or devices for the use of medical marijuana or medical marijuana products that is issued both a license pursuant to this part and a local license or permit.
(j)Licensed manufacturer means a person who extracts, prepares, derives, produces, compounds, or repackages medical marijuana or medical marijuana products into consumable and nonconsumable forms and that is issued both a license pursuant to this part and a local license or permit.
(k)Licensed transporter means an individual or entity issued a license by the office to transport medical marijuana to and from facilities that have been issued both a license pursuant to this part and a local license or permit for medical marijuana products above a quantity limit established by the office.
(l)Marijuana or cannabis means all parts of the plant Cannabis sativa, Cannabis indica, or Cannabis ruderalis, whether growing or not; the seeds thereof; the resin, whether crude or purified, extracted from any part of the plant; and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds, or resin. Marijuana does not include the mature stalks of the plant, fiber produced from the stalks, oil or cake made from the seeds of the plant, any other compound, manufacture, salt, derivative, mixture, or preparation of the mature stalks (except the resin extracted therefrom), fiber, oil, or cake, or the sterilized seed of the plant which is incapable of germination. Marijuana also means marijuana, as defined by Section 11018 of the Health and Safety Code.
(m)Office means the Office of Medical Marijuana Regulation in the Business, Consumer Services, and Housing Agency.
18101.(a)There is hereby created in the Business, Consumer Affairs, and Housing Agency the Office of Medical Marijuana Regulation, under the supervision and control of the Chief of the Office of Medical Marijuana Regulation.
(b)Preservation of patients access to medical marijuana and the protection of the public shall be the highest priorities for the office in exercising its licensing, regulatory, and disciplinary functions. Whenever the protection of the public is inconsistent with other interests sought to be promoted, the protection of the public shall be paramount.
(c)The office shall have the authority to issue, suspend, or revoke conditional licenses for the cultivation, manufacture, transportation, storage, distribution, testing, and sale of medical marijuana within the state and to collect fees in connection with these actions. The office shall have the authority to create, issue, suspend, or revoke other licenses in order to protect patient health and the public and to facilitate the regulation of medical marijuana.
(d)(1)The Governor shall appoint the chief at a salary to be fixed and determined by the secretary with the approval of the Director of Finance.
(2)Appointment of the chief shall be subject to confirmation by the Senate Committee on Rules.
(e)The duty of enforcing and administering this part shall be vested in the chief. The chief may adopt and enforce those rules and regulations that he or she determines are reasonably necessary to carry out the purposes of this part and declaring the policy of the office, including a system for the issuance of citations for violations of this part, as specified in Section 18127.
(f)The chief, as necessary to carry out the provisions of this part, and in accordance with the State Civil Service Act (Part 2 (commencing with Section 18500) of Division 5 of Title 2 of the Government Code), may appoint and fix the compensation of personnel, including, but not limited to, clerical, inspection, investigation, and auditing personnel, as well as an assistant chief. These personnel shall perform their respective duties under the supervision and the direction of the chief.
(g)Every power granted to, or duty imposed upon, the chief under this part may be exercised or performed in the name of the chief by a deputy or assistant chief, subject to conditions and limitations that the chief prescribes.
(h)The office shall exercise its authority pursuant to this part consistent with Section 1 of the act that added this section and consistent with the provisions of this part.
18102.Funds for the establishment and support of the office shall be advanced as a loan from the General Fund and shall be repaid by the initial proceeds from fees collected pursuant to this part or any rule or regulation adopted pursuant to this part.
18103.The office shall have the authority necessary for the implementation of this part, including, but not limited to, all of the following:
(a)Establishing rules or regulations necessary to carry out the purposes and intent of this part and to enable the office to exercise the powers and perform the duties conferred upon it by this part and in accordance with Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code. These rules and regulations shall not limit any authority of a city, county, or city and county provided by law. For the performance of its duties, the office has the powers as set forth in Article 2 (commencing with Section 11180) of Chapter 2 of Part 1 of Division 3 of Title 2 of the Government Code.
(b)Issuing licenses to persons for the cultivation, manufacture, transportation, storage, distribution, testing, and sale of medical marijuana within the state.
(c)Setting application, licensing, and renewal fees for licenses issued pursuant to Section 18114.
(d)Establishing standards for the cultivation, manufacturing, transportation, storage, distribution, provision, testing, donation, and sale of medical marijuana and medical marijuana products.
(e)Establishing procedures for the issuance, renewal, suspension, denial, and revocation of licenses.
(f)Enforcing the licensing and regulatory requirement of this part, subject to the requirements of Section 18126.
(g)Imposing a penalty authorized by this part or any rule or regulation adopted pursuant to this part.
(h)Taking action with respect to an application for a license in accordance with procedures established pursuant to this part.
(i)Overseeing the operation of the Medical Marijuana Regulation Fund and the Special Account for Environmental Enforcement, established pursuant to Section 18115.
(j)Consulting with other state or local agencies, departments, representatives of the medical marijuana community, or public or private entities for the purposes of establishing statewide standards and regulations.
18104.(a)On or before January 1, 2018, the office shall promulgate regulations for implementation and enforcement of this part, including, but not limited to, all of the following:
(1)Procedures for the issuance, renewal, suspension, denial, and revocation of licenses.
(2)Procedures for appeal of fines and the appeal of denial, suspension, or revocation of licenses.
(3)Application, licensing, and renewal forms and fees.
(4)A time period in which the office shall approve or deny an application for a license pursuant to this part.
(5)Qualifications for licensees.
(b)The office, in consultation with the Division of Labor Standards Enforcement, shall adopt regulations establishing worker safety standards for entities licensed pursuant to this part.
(c)The office shall not issue a license unless the applicant has met all of the requirements of this part, including the requirements of subdivision (h) of Section 18110, and has demonstrated compliance with all applicable agricultural requirements, consumer protection requirements, food and product safety requirements, and environmental requirements, including, but not limited to, applicable water quality standards.
18104.5.(a)On or before April 1, 2016, the office shall convene an advisory committee to advise the office on the development of standards and regulations pursuant to this chapter. The advisory committee shall recommend to the office the appropriate roles of each state entity as it pertains to this chapter, and shall recommend guidelines on communication and information sharing between state entities, and with local agencies, for implementation of this chapter.
(b)The advisory committee shall be comprised of gubernatorial and legislative appointees, including, but not limited to, representatives of the medical marijuana industry, representatives of medical marijuana cultivators, appropriate local and state agencies, appropriate local and state law enforcement, physicians, environmental and public health experts, and medical marijuana patient advocates.
(c)(1)The advisory committee shall submit a report on these standards, determinations, and guidelines for implementation of this chapter to the Legislature and state entities affected by this chapter by August 1, 2016.
(2)The report submitted to the Legislature shall be submitted in compliance with Section 9795 of the Government Code.
(3)The requirement for submitting a report imposed pursuant to this subdivision is inoperative on January 1, 2020, pursuant to Section 10231.5 of the Government Code.
18105.(a)The chief shall keep a complete record of all facilities issued a license.
(b)This record shall be made available on the offices Internet Web site.
(c)The office shall not disclose information that the office determines is sensitive and should not be publicly disclosed, including, but not limited to, the address or location of cultivation sites.
(d)Upon request, the office shall provide summary information on all licensees, including, but not limited to, the name of the licensee, the date the license was issued, the status of the license, and the licensees mailing address.
18106.The office shall establish procedures to provide state and local law enforcement and state and local agencies, upon their request, with 24-hour access to information to verify a license, track transportation manifests, and track the inventories of facilities issued a license.
18107.Notwithstanding Section 18119, a licensed transporter may transport medical marijuana products to an unlicensed dispensing facility within the City of Los Angeles, provided the following requirements are met:
(a)The licensed transporter shall comply with subdivisions (b) and (c) of Section 18117, except that, in complying with paragraph (2) of subdivision (b), the licensed transporter shall securely transmit the manifest to the office and the unlicensed dispensing facility that will receive the medical marijuana products.
(b)The licensed transporter shall record and maintain, in both physical and electronic format, the following information with respect to the delivery of medical marijuana products to the unlicensed dispensing facility:
(1)The date of delivery.
(2)The address of delivery.
(3)The name of the individual who completed the delivery.
(4)The name of the individual at the facility who received the delivery.
(5)The name of the owner or operator of the facility.
(6)The name of the facility, as reflected on any signage.
(7)The quantity, or weight, and variety of all medical marijuana products delivered.
(8)The source of all medical marijuana delivered.
(9)The monetary amount charged and received for all medical marijuana products delivered.
(c)The recorded information specified in subdivision (b) shall be transmitted within five days to the City of Los Angeles, in a manner to be determined and specified by the City of Los Angeles.
(d)The records required by this section shall be maintained and made available in accordance with the regulations promulgated by the office pursuant to Section 18140.
18107.1.(a)The office shall develop a database containing the electronic shipping manifests, which shall include, but not be limited to, the following information:
(1)The quantity, or weight, and variety of products shipped.
(2)The estimated times of departure and arrival.
(3)The quantity, or weight, and variety of products received.
(4)The actual time of arrival.
(5)A categorization of the product.
(b)The database shall be designed to flag irregularities for the office to investigate. An authorized enforcement authority may, at any time, inspect shipments and request documentation for current inventory.
18107.2.(a)This part shall not be construed to authorize or permit a licensee to transport or deliver, or cause to be transported or delivered, marijuana or marijuana products outside the state, unless authorized by federal law.
(b)A local jurisdiction shall not prevent transportation of medical marijuana or medical marijuana products on public roads by a licensee transporting medical marijuana or medical marijuana products that acts in compliance with this part.
(c)A local jurisdiction shall not prevent delivery of medical marijuana or medical marijuana products on public roads by a licensee that acts in compliance with this part and applicable local ordinances.
2.Licenses18108.The following persons are exempt from the requirement of licensure under this part:
(a)A qualified patient who cultivates, possesses, stores, manufactures, or transports marijuana exclusively for his or her personal medical use but who does not provide, donate, sell, or distribute marijuana to any other person or entity is not, thereby, engaged in commercial marijuana activity and is, therefore, exempt from the licensure requirements of this part.
(b)A primary caregiver who cultivates, possesses, stores, manufactures, transports, donates, or provides marijuana exclusively for the personal medical purposes of no more than five specified qualified patients for whom he or she is the primary caregiver within the meaning of Section 11362.7 of the Health and Safety Code, but who does not receive remuneration for these activities except for compensation in full compliance with subdivision (c) of Section 11362.765 of the Health and Safety Code is not engaged in commercial marijuana activity and is, therefore, exempt from the licensure requirements of this part.
18109.(a)Except as provided in Section 11362.5 of, and Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10 of, the Health and Safety Code, a person shall not sell or provide medical marijuana to a patient or caregiver other than at a licensed dispensing facility or through delivery from a licensed dispensing facility.
(b)Except as provided in Section 11362.5 of, and Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10 of, the Health and Safety Code, a person shall not grow medical marijuana other than at a licensed cultivation site.
(c)Except as provided in Section 11362.5 of, and Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10 of, the Health and Safety Code, a person shall not manufacture medical marijuana or medical marijuana products other than a licensed manufacturer.
(d)A person other than a licensed transporter shall not transport medical marijuana from one facility issued a license to another.
(e)A licensed manufacturer may obtain medical marijuana from a licensed cultivator and may furnish medical marijuana products to a licensed dispensary.
18110.(a)The office may issue state licenses only to qualified applicants engaging in commercial marijuana activity pursuant to this chapter. Upon the date of implementation of regulations by the office, no person shall engage in commercial marijuana activity without possessing both a state license and a local permit, license, or other authorization.
(b)Local permits shall be determined by local ordinances. The office issuing state licenses shall have sole authority to revoke a state license. Local agencies issuing local permits shall have sole authority to revoke a local permit.
(c)Each applicant for a state license shall provide notice to every affected local jurisdiction at the same time the state application is filed. The office shall confirm with the applicant a list of affected local jurisdictions, including those jurisdictions affected by potential deliveries by the applicant.
(d)The issuance of a state license shall not, in and of itself, authorize the recipient to begin business operations. The state license shall certify, at a minimum, that the applicant has paid the state licensing fee, successfully passed a criminal background check, and is a resident of the state of California.
(e)Even if a state license has been granted pursuant to this chapter, a facility shall not operate in a local jurisdiction that prohibits the establishment of that type of business. A facility shall not commence activity under the authority of a state license until the applicant has obtained, in addition to the state license, a license or permit from the local jurisdiction in which he or she proposes to operate, following the requirements of the applicable local ordinances.
(f)If a local government agency notifies the office and provides evidence that a licensee or applicant within its jurisdiction is in violation of local ordinances relating to commercial marijuana activities, the office shall schedule a hearing within 20 days to determine whether the evidence is sufficient to constitute grounds for the revocation of the state license.
(g)Revocation of a state license or local license or permit shall terminate the ability of a medical marijuana business to operate within California until the office or local jurisdiction reinstates or reissues the state license or local license or permit.
(h)An applicant for a license shall do all of the following:
(1)Pay the fee or fees required by this part for each license being applied for.
(2)Register with the office on forms prescribed by the chief. The forms shall contain sufficient information to identify the licensee, including all of the following:
(A)Name of the owner or owners of a proposed facility, including all persons or entities having an ownership interest other than a security interest, lien, or encumbrance on property that will be used by the applicant.
(B)The name, address, and date of birth of each principal officer and board member.
(C)The address and telephone number of the proposed facility.
(D)In the case of a cultivation site, the GPS coordinates of the site.
(3)Describe, in writing, the scope of business of the proposed facility.
(4)Provide evidence that the applicant and owner have their primary residence in California.
(5)Provide detailed operating procedures, in writing, for the proposed facility, which shall include, but not be limited to, procedures for facility and operational security, prevention of diversion, employee screening, storage of medical marijuana, personnel policies, and recordkeeping procedures.
(6)Provide evidence that the applicant has received all required environmental permits, including compliance with the California Environmental Quality Act, and wastewater discharge permits.
(7)For an applicant seeking a cultivation license, provide a statement declaring the applicant is an agricultural employer, as defined in the Alatorre-Zenovich-Dunlap-Berman Agricultural Labor Relations Act of 1975 (Part 3.5 (commencing with Section 1140) of Division 2 of the Labor Code), to the extent not prohibited by law.
(8)Provide the applicants fingerprint images. For purposes of this paragraph, applicant means the owner or owners of a proposed facility, including all persons or entities having an ownership interest other than a security interest, lien, or encumbrance on property that will be used by the facility.
(A)The applicant shall electronically submit to the Department of Justice fingerprint images and related information required by the Department of Justice for the purpose of obtaining information as to the existence and content of a record of state or federal convictions and arrests, and information as to the existence and content of a record of state or federal convictions and arrests for which the Department of Justice establishes that the person is free on bail, or on his or her own recognizance, pending trial or appeal.
(B)The Department of Justice shall provide a response to the office pursuant to paragraph (1) of subdivision (p) of Section 11105 of the Penal Code.
(C)The office shall request from the Department of Justice subsequent notification service, as provided pursuant to Section 11105.2 of the Penal Code, for persons described in subparagraph (A).
(D)The Department of Justice shall charge the applicant a fee sufficient to cover the reasonable cost of processing the requests described in this paragraph.
(9)Provide a statement, signed by the applicant under penalty of perjury, that the information provided is true.
(10)Provide any other information required by the office.
(i)Each location and each discrete use of a single location shall require a license. Each application for a license is separate and distinct, and the office may charge a separate fee for each.
(j)A license issued pursuant to this section shall be valid for 12 months after the date of issuance. After the initial 12-month period, a license may be renewed for a period of 12 months. The office shall establish procedures for the renewal of a license.
(k)Notwithstanding any other law, the office shall not issue a license to an individual or entity, or for a premise, against whom there is a pending state or local administrative or judicial proceeding, against whom there are pending state or local administrative actions, judicial proceedings, or other actions initiated against the applicant, by a city, county, or city and county under an applicable local ordinance, or who has been determined through those proceedings to have violated a local ordinance related to commercial marijuana activity.
(l)A facility or entity that is operating in compliance with local zoning ordinances and other state and local requirements on January 1, 2016, may continue its operations until its application for licensure is approved or denied pursuant to this part.
(m)A licensee shall not be licensed as a retailer of alcoholic beverages pursuant to Division 9 (commencing with Section 23000).
18111.(a)Upon receipt of the application for licensure and the applicable fee, the office shall make a thorough investigation to determine whether the applicant and the premises for which a state license is applied qualify for the state license and whether this chapter has been complied with, and shall investigate all relevant matters that may affect the public welfare and morals.
(b)The office shall deny an application if either the applicant or the premises for which a state license is applied do not qualify for licensure under this part.
(c)The office shall deny the application for licensure or renewal, or suspend or revoke a state license, if any of the following conditions apply:
(1)Conduct involving dishonesty, fraud, or deceit, with the intent to substantially benefit himself, herself, or another, or substantially injure another.
(2)Failure to comply with the provisions of this part or any rule or regulation adopted pursuant to this part.
(3)Conduct that constitutes grounds for denial of licensure pursuant to Chapter 2 (commencing with Section 480) of Division 1.5.
(4)Local agencies have notified the office and provided evidence that a licensee or applicant within its jurisdiction is in violation of local ordinances relating to commercial marijuana activities.
(5)The applicant fails to meet the requirements of this part or any regulation adopted pursuant to this part or any applicable city, county, or city and county ordinance or regulation. If a local government adopts an ordinance or resolution authorizing medical marijuana to be cultivated, manufactured, stored, distributed, or sold within its jurisdiction, it may submit documentation to the office detailing its renewal requirements. Failure to submit an ordinance or resolution to the office shall not impair the enforceability of the ordinance or resolution. Ordinances or resolutions that are not submitted pursuant to this subdivision shall not be considered in denial of licensure pursuant to this part.
(6)Granting or continuation of a state license would be contrary to the publics safety.
(7)The applicant holding or seeking a state license has been convicted of a misdemeanor involving moral turpitude, excluding misdemeanors involving possession of a controlled substance.
(8)The application has failed to state with sufficient specificity the jurisdiction and location at which the applicant proposes to establish operations.
(9)The applicant, or any of its officers, directors, or owners, is under 21 years of age.
(10)The applicant fails to provide notarized written proof that the owner of real property or landlord has acknowledged and consented to its tenants proposed cultivation or dispensing of medical marijuana or medical marijuana products.
(11)The applicant has failed to provide information requested.
(12)Unless otherwise provided by this paragraph, the applicant or any of its officers, directors, or owners, have been convicted of a crime or act that is substantially related to the qualifications, functions, or duties of the business or profession for which the application is made or is convicted of a misdemeanor involving moral turpitude, excluding misdemeanors involving possession of a controlled substance. For purposes of this section, a conviction means a plea or verdict of guilty or a conviction following a plea of nolo contendere. An action that the office is permitted to take following the establishment of a conviction, including, but not limited to, the issuance, renewal, suspension, and revocation of a license for commercial marijuana activity pursuant to this part, shall be held in abeyance until after the time for appeal has elapsed, or the judgment of conviction has been affirmed on appeal. Action may be taken when an order granting probation is made suspending the imposition of sentence.
(A)An applicant shall not be denied a state license if the denial is based solely on any of the following:
(i)The applicant has been convicted of transporting a controlled substance pursuant to Section 11352 or 11379 of the Health and Safety Code prior to January 1, 2014, and the facts underlying the conviction establish that the applicant did not transport the controlled substance with the intent to sell or the intent to aid and abet the commission of, or conspiracy to commit, a crime of transportation of the controlled substance.
(ii)The applicant has been convicted of a felony that would not be subject to criminal prosecution pursuant to Section 11362.5 or 11362.775 of the Health and Safety Code.
(B)An applicant shall not be denied a state license under either of the following conditions:
(i)The applicant has obtained a certificate of rehabilitation pursuant to Chapter 3.5 (commencing with Section 4852.01) of Title 6 of Part 3 of the Penal Code, for a crime or act that is substantially related to the qualifications, functions, or duties of the business or profession for which the application is made.
(ii)The applicant has been convicted of a misdemeanor, and he or she has met all of the applicable requirements of the criteria for rehabilitation developed by the office to evaluate the rehabilitation of a person when considering the denial of license.
(C)In determining convictions that are substantially related to the qualifications, functions, or duties of the business or profession for which the application is made, the office shall include, but not be limited to, the following:
(i)A felony conviction for the possession for sale, sale, manufacture, transportation, or cultivation of a controlled substance.
(ii)A violent felony, as specified in subdivision (c) of Section 667.5 of the Penal Code.
(iii)A serious felony as specified in subdivision (c) of Section 1192.7 of the Penal Code.
(iv)A felony offense involving fraud, deceit, or embezzlement.
(13)The applicant, or any of its officers, directors, or owners, is a licensed physician making patient recommendations for medical marijuana.
(14)The applicant or any of its officers, directors, or owners has been subject to fines or penalties for cultivation or production of a controlled substance on public or private lands pursuant to Section 12025 of the Fish and Game Code.
(15)The applicant, or any of its officers, directors, or owners, have been sanctioned by the office, or a city, county, or a city and county for unlicensed commercial medical marijuana activities or has had a license revoked under this part in the previous three years.
(16)The proposed commercial marijuana activity will violate any applicable local law or ordinance.
(17)The applicant has had 20 employees or more in the past year and failed to enter into a labor peace agreement.
(18)The applicant or the owner is unable to show that he or she has established domicile within the state.
(19)Failure to obtain and maintain a valid sellers permit required pursuant to Part 1 (commencing with Section 6001) of the Revenue and Taxation Code.
(20)There are pending state or local administrative actions, judicial proceedings, or other actions initiated against the applicant, by a city, county, or city and county under an applicable local ordinance, or who has been determined through those proceedings to have violated a local ordinance related to commercial marijuana activity, or who knowingly provides false or fraudulent information on an application for licensure.
(d)Notwithstanding any other section of this part, the office may grant a license to an applicant who has been convicted of a crime if the office determines that the applicant is otherwise suitable to be issued a state license and granting a license would not compromise public safety. The office shall conduct a thorough investigation of the nature of the crime, conviction, circumstances, and evidence of rehabilitation of the applicant, and shall evaluate the suitability of the applicant to be issued a state license based on the evidence found through the investigation. In the evaluation, public protection shall take priority over rehabilitation and, where evidence of rehabilitation and public protection are in conflict, public protection shall take precedence.
(e)Applicants shall be notified of a denied application, and licensees of a suspended or revoked license shall be notified, in writing via personal service or mail addressed to the address of the applicant or licensee set forth in the application. The letter shall contain the detailed reasons for which the application was denied, the license was revoked, or the license was suspended. The applicant or licensee shall have the right to appeal the denial, suspension, or revocation and shall be given a hearing within 30 days of the appeal. On appeal, the decision shall be upheld unless the applicant or licensee demonstrates that he or she is in fact eligible for licensure and the application or licensee is in compliance with this part.
(f)The chief shall, by regulation, prescribe conditions upon which a person whose license has previously been denied, suspended, or revoked, may be issued a license.
(g)All proceedings to deny, suspend, or revoke a license shall be conducted pursuant to Chapter 5 (commencing with Section 11500) of Part 1 of Division 3 of Title 2 of the Government Code.
18112.(a)In addition to the provisions of this part, a license shall be subject to the restrictions of the local jurisdiction in which the facility operates or proposes to operate. Even if a license has been granted pursuant to this part, a facility shall not operate in a local jurisdiction that prohibits the establishment of that type of business.
(b)In addition to the provisions of this part, local jurisdictions retain the power to assess fees and taxes, as applicable, on facilities that are licensed pursuant to this part and the business activities of those licensees.
18113.The office may adopt regulations to limit the number of licenses issued pursuant to this part upon a finding that the otherwise unrestricted issuance of licenses is dangerous to the public health and safety.
3.Fees18114.(a)The licensing fee shall be established by the office at a level sufficient to fund the reasonable costs of all of the following:
(1)Administrative costs incurred by the office in overseeing the licensing program and establishing health and safety standards.
(2)Costs incurred by the office or the Department of Justice for enforcement of the provisions of this part.
(3)Costs incurred by law enforcement and other public safety entities for enforcing the provisions of this part in their jurisdiction.
(b)In addition to the licensing fee required pursuant to subdivision (a), a cultivation facility shall be assessed a fee in a sufficient amount to cover the reasonable regulatory costs of enforcing the environmental impact provisions relating to those cultivation facilities. This fee shall be distributed, as necessary and in proportion to its regulatory function, between the following agencies responsible for enforcing the regulations relating to the environmental impact of licensed cultivation sites:
(1)The State Water Resources Control Board.
(2)The Department of Fish and Wildlife.
(3)The Department of Forestry and Fire Protection.
(4)The Department of Pesticide Regulation.
(5)The Department of Food and Agriculture.
(6)Local law enforcement.
18115.(a)The Medical Marijuana Regulation Fund is hereby established within the State Treasury. Notwithstanding Section 16305.7 of the Government Code, the fund shall include any interest and dividends earned on the money in the fund.
(b)Except as provided in subdivision (c), all fees collected pursuant to this part shall be deposited into the Medical Marijuana Regulation Fund. All moneys within the fund are available, upon appropriation by the Legislature, to the office solely for the purposes of fully funding and administering this part, including, but not limited to, the costs incurred by the office for its administrative expenses.
(c)The Special Account for Environmental Enforcement is hereby established as an account within the Medical Marijuana Regulation Fund. Notwithstanding Section 16305.7 of the Government Code, the account shall include any interest and dividends earned on the money in the account. All fees collected pursuant to subdivision (b) of Section 18114 shall be deposited in this account. All moneys within the fund are available, upon appropriation by the Legislature, to the office for distribution to the entities listed in subdivision (b) of Section 18114 to be used to enforce the environmental regulation of licensed cultivation sites.
(d)All moneys collected as a result of penalties imposed under this part shall be deposited directly into the General Fund, to be available upon appropriation.
(e)The office may establish and administer a grant program to allocate moneys from the Medical Marijuana Regulation Fund to state and local entities for the purpose of assisting with medical marijuana regulation and the enforcement of this part.
18116.(a)A facility issued a license shall not acquire, cultivate, process, possess, store, manufacture, distribute, sell, deliver, transfer, transport, or dispense medical marijuana for any purpose other than those authorized by Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10 of the Health and Safety Code.
(b)A licensed dispensing facility shall not acquire, cultivate, process, possess, store, manufacture, distribute, sell, deliver, transfer, transport, or dispense medical marijuana plants or medical marijuana products except through a licensed cultivation site or a licensed manufacturer.
4.Transportation of Medical Marijuana18117.(a)A licensee authorized to transport, or transport and deliver, medical marijuana and medical marijuana products shall do so only as set forth in this chapter.
(b)Prior to transporting or delivering medical marijuana or medical marijuana products, a licensee authorized to transport or deliver medical marijuana or medical marijuana products shall do both of the following:
(1)Complete an electronic shipping manifest as prescribed by the office. All delivery shipping manifests shall not identify the qualified patient or primary caregiver by name or address.
(2)Securely transmit the manifest to the office and the licensee that will receive the medical marijuana product, as applicable, prior to transport.
(c)During transportation or delivery, the licensed transporter shall maintain a physical copy of the shipping manifest and shall make it available upon request to office, local law enforcement officers, or any other designated enforcement agency.
(d)The licensee receiving the shipment shall maintain each electronic shipping manifest and shall make it available upon request to agents of the office, local law enforcement officers, or any other locally designated enforcement agency.
(e)Upon receipt of the transported shipment, a licensee shall submit to the office a record verifying receipt of the shipment and the details of the shipment.
(f)Notwithstanding any other law or the wage orders of the Industrial Welfare Commission, a driver employed to transport medical marijuana or medical marijuana products shall be entitled to overtime pay pursuant to Section 510 of the Labor Code.
18118.An entity licensed pursuant to Sections 18109 to 18113, inclusive, may transport between licensees medical marijuana or medical marijuana products with a total retail value, weight of medical marijuana, and weight of medical marijuana products, below the statewide threshold, which shall be adopted by regulation by the office after review by the advisory committee and the office.
18119.(a)Transported and delivered medical marijuana or medical marijuana products shall be transported only in a storage compartment that is securely affixed to the interior of the transporting vehicle and that is not visible from outside the vehicle. This requirement shall only apply to licensees transporting medical marijuana or medical marijuana products with a total retail value of at least an amount equal to a statewide monetary threshold, which shall be adopted by regulation by the office after review by the advisory committee and the office.
(b)A vehicle transporting medical marijuana or medical marijuana products shall travel only directly between licensed facilities authorized to receive the shipment, unless otherwise authorized under its license. All transport and deliveries shall be conducted between 8:00 a.m. and 8:00 p.m. Transportation and delivery of shipments do not have to be completed in a single day.
(c)All transport or delivery vehicles shall be staffed with a minimum of two direct employees of the licensee. At least one employee shall remain with the vehicle at all times when the vehicle contains medical marijuana. This requirement shall only apply to licensees transporting medical marijuana or medical marijuana products with a total retail value of at least an amount equal to a statewide monetary threshold, which shall be adopted by regulation by the office after review by the advisory committee and the office.
(d)Each transport or delivery team member shall possess documentation of licensing and a government-issued identification card at all times when transporting or delivering medical marijuana and shall produce it upon the request of agents of the office or a law enforcement official.
(e)This section shall be enforced by the Department of the California Highway Patrol in collaboration with local agencies.
5.Enforcement18124.The office is not required by this section to enforce a city, county, city and county, or local law, ordinance, rule, or regulation regarding the site or operation of a facility issued a license.
18125.The office may assist state taxation authorities in the development of uniform policies for the state taxation of licensees.
18126.(a)The office may enforce all of the requirements of this part, including any regulations adopted pursuant to this part.
(b)The office shall delegate the authority to enforce the requirements of this part, including any regulations, to a city, county, or city and county, upon request of that entity.
(c)Nothing in this part shall be interpreted to supersede or limit existing local authority for law enforcement activity, enforcement of local zoning requirements, or enforcement of local licensing requirements.
(d)Nothing in this part shall be interpreted to require the office to undertake local law enforcement responsibilities, enforce local zoning requirements, or enforce local licensing requirements.
18127.(a)A willful violation of Section 18110, including an attempt to falsify information on an application or to otherwise defraud or mislead a state or local agency in the course of the application process, shall be punishable by a civil fine of up to thirty-five thousand dollars ($35,000) for each individual violation.
(b)A technical violation of Section 18110 shall, at the offices discretion, be punishable by a civil fine of up to ten thousand dollars ($10,000) for each individual violation.
18128.A district attorney, county counsel, city attorney, city prosecutor, the Attorney General, or the office may bring an action to enjoin a violation or the threatened violation of any provision of this part, including, but not limited to, a licensees failure to correct objectionable conditions following notice or as a result of a rule promulgated pursuant to this part. The action shall be brought in the county in which the violation occurred or is threatened to occur. A proceeding brought pursuant to this part shall conform to the requirements of Chapter 3 (commencing with Section 525) of Title 7 of Part 2 of the Code of Civil Procedure. Nothing in this section shall diminish the authority of a local government to take requisite enforcement actions pertaining to its own ordinances or regulations.
18129.Nothing in this part shall prevent a city or other local governing body from taking action as specified in Section 11362.83 of the Health and Safety Code.
18130.This part shall not be construed to limit a law enforcement agencys ability to investigate unlawful activity in relation to a facility issued a conditional license.
6.Tiered Licensing and Vertical Integration18131.(a)A licensee may only hold a state license in up to two separate license categories, as follows:
(1)Type 1, 1A, 1B, 2, 2A, and 2B licensees, or a combination thereof, may apply for a Type 6 or 7 state license, or a combination thereof.
(2)Type 6 and 7 licensees, or a combination thereof, may apply for a Type 1, 1A, 1B, 2, 2A, and 2B state license, or a combination thereof.
(3)Type 6 and 7 licensees, or a combination thereof, may apply for a Type 10A state license.
(4)Type 10A licensees may apply for a Type 6 and 7 state license, or a combination thereof.
(5)Type 1, 1A, 1B, 2, 2A, and 2B licensees, or a combination thereof, may apply for a Type 10A state license.
(6)Type 10A licensees, may apply for Type 1, 1A, 1B, 2, 2A, and 2B state license, or a combination thereof.
(7)Type 11 licensees may apply for a Type 12 state license.
(8)Type 12 licensees may apply for a Type 11 state license.
(b)State licenses to be issued by the office are as follows:
(1)Type 1, or specialty outdoor, for outdoor cultivation using no artificial lighting of 5,000 square feet or less of total canopy size on one premises, or up to 50 mature plants on noncontiguous plots.
(2)Type 1A, or specialty indoor, for indoor cultivation using exclusively artificial lighting of 5,000 square feet or less of total canopy size on one premises.
(3)Type 1B, or specialty mixed-light, for cultivation using a combination of natural and supplemental artificial lighting at a maximum threshold to be determined by the office, than 5,000 square feet or less of total canopy size on one premises.
(4)Type 2, or small outdoor, for outdoor cultivation using no artificial lighting between 5,001 and 10,000 square feet of total canopy size on one premises.
(5)Type 2A, or small indoor, for indoor cultivation using exclusively artificial lighting between 5,001 and 10,000 square feet of total canopy size on one premises.
(6)Type 2B, or small mixed-light, for cultivation using a combination of natural and supplemental artificial lighting at a maximum threshold to be determined by the office, between 5,001 and 10,000 square feet of total canopy size on one premises.
(7)Type 3, or outdoor, for outdoor cultivation using no artificial lighting between 10,001 and 44,000 square feet of total canopy size on one premises. The office shall limit the number of licenses allowed of this type.
(8)Type 3A, or indoor, for indoor cultivation using exclusively artificial lighting between 10,001 and 22,000 square feet of total canopy size on one premises. The office shall limit the number of licenses allowed of this type.
(9)Type 3B, or mixed-light, for cultivation using a combination of natural and supplemental artificial lighting at a maximum threshold to be determined by the office, between 10,001 and 22,000 square feet of total canopy size on one premises. The office shall limit the number of licenses allowed of this type.
(10)Type 4, or nursery, for cultivation of medical marijuana solely as a nursery. Type 4 licensees may transport live plants.
(c)The office shall promulgate regulations governing the licensing of marijuana manufacturers.
(d)Licenses to be issued by the office to marijuana manufacturers are as follows:
(1)Type 6, or manufacturing level 1, for manufacturing sites that produce medical marijuana products using nonvolatile solvents.
(2)Type 7, or manufacturing level 2, for manufacturing sites that produce medical marijuana products using volatile solvents. The office shall limit the number of licenses of this type.
(3)Type 8, or testing, for testing of medical marijuana and medical marijuana products. Type 8 licensees shall have their facilities certified licensed according to regulations set forth by the office. A Type 8 licensee shall not hold a license in another license category of this part and shall not own or have ownership interest in a facility licensed pursuant to this part.
(e)State licenses to be issued by the office for dispensing and distributing are as follows:
(1)Type 10, or dispensary, for the retail of medical marijuana and medical marijuana products. This license shall allow for delivery where expressly authorized by local ordinance.
(2)Type 10A or special dispensary status, for dispensers who have no more than three licensed dispensary facilities. This license shall allow for delivery where expressly authorized by local ordinance.
(3)Type 11, or distributor, for the certification of the content of all medical marijuana or medical marijuana products and distribution licensees. A Type 11 licensee shall hold a Type 12, or transporter, license and register each facility location where product is stored for the purposes of distribution. A Type 11 licensee shall not hold a license in a cultivation, manufacturing, dispensing, or testing license category and shall not own, or have an ownership interest in, a facility licensed in those categories other than a security interest, lien, or encumbrance on property that is used by a licensee. A Type 11 licensee shall be bonded and insured at a minimum level established by the office.
(4)Type 12, or transport, for transporters of medical marijuana or medical marijuana products. A Type 12 licensee shall be bonded and insured at a minimum level established by the office.
7.Cultivation Sites18132.(a)Not later than January 1, 2020, the Department of Food and Agriculture, in conjunction with the office, shall make available a certified organic designation and organic certification program for medical marijuana, if permitted under federal law.
(b)If the certified organic designation and organic certification program is not available to medical marijuana by January 1, 2020, the Department of Food and Agriculture, in conjunction with the office, shall develop an equivalent program with standards for designation and certification for medical marijuana by January 1, 2022.
(c)The office shall establish appellations of origin for marijuana grown in California.
(d)It is unlawful for medical marijuana to be marketed, labeled, or sold as grown in a California county when the medical marijuana was not grown in that county.
(e)It is unlawful to use the name of a California county in the labeling, marketing, or packaging of medical marijuana products unless the product was grown in that county.
18133.The office shall work with county agricultural commissioners to provide all the information and forms required for licensure as a cultivation site in a single location, including state licensure, local requirements in that jurisdiction, and environmental requirements.
8.Regulation of Medical Marijuana18134.This part and Article 2 (commencing with Section 11357) and Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10 of the Health and Safety Code shall not interfere with an employers rights and obligations to maintain a drug and alcohol free workplace or require an employer to permit or accommodate the use, consumption, possession, transfer, display, transportation, sale, or growth of marijuana in the workplace or affect the ability of employers to have policies prohibiting the use of marijuana by employees and prospective employees, or prevent employers from complying with state or federal law.
18135.(a)A person shall not distribute any form of advertising for physician recommendations for medical marijuana in California unless the advertisement bears the following notice to consumers:
NOTICE TO CONSUMERS: The Compassionate Use Act of 1996 ensures that seriously ill Californians have the right to obtain and use marijuana for medical purposes where medical use is deemed appropriate and has been recommended by a physician who has determined that the persons health would benefit from the use of medical marijuana. Physicians are licensed and regulated by the Medical Board of California and arrive at the decision to make this recommendation in accordance with accepted standards of medical responsibility. Marijuana is a Schedule I drug according to the federal Controlled Substances Act. Activity related to marijuana use is subject to federal prosecution, without protections provided by state law.
(b)Advertising for physician recommendations for medical marijuana shall meet all requirements of Section 651. Price advertising shall not be fraudulent, deceitful, or misleading, including statements or advertisements of bait, discounts, premiums, gifts, or statements of a similar nature.
18136.(a)A facility issued a license shall implement sufficient security measures to both deter and prevent unauthorized entrance into areas containing medical marijuana or medical marijuana products and theft of medical marijuana or medical marijuana products at those facilities. These security measures shall include, but not be limited to, all of the following:
(1)Preventing individuals from remaining on the premises of the facility if they are not engaging in activity expressly related to the operations of the facility.
(2)Establishing limited access areas accessible only to authorized facility personnel.
(3)Storing all finished medical marijuana and medical marijuana products in a secured and locked room, safe, or vault, and in a manner as to prevent diversion, theft, and loss, except for limited amounts of marijuana used for display purposes, samples, or immediate sale.
(b)A facility issued a license shall notify appropriate law enforcement authorities within 24 hours after discovering any of the following:
(1)Significant discrepancies identified during inventory. The level of significance shall be determined by the office.
(2)Diversion, theft, loss, or any criminal activity involving the facility or a facility agent.
(3)The loss or unauthorized alteration of records related to marijuana, registered qualifying patients, personal caregivers, or facility agents.
(4)Any other breach of security.
(c)A licensed cultivation site shall weigh, inventory, and account for on video, all medical marijuana to be transported prior to its leaving its origination location. Within eight hours after arrival at the destination, the licensed dispensing facility shall reweigh, reinventory, and account for on video, all transported marijuana.
18137.(a)A licensed cultivation site or licensed dispensing facility shall display the license in a manner so as to be available and easily read at the location.
(b)The office shall notify local law enforcement of all licenses issued for cultivation sites, manufacturers, and dispensaries in that jurisdiction.
18138.(a)Information identifying the names of patients, their medical conditions, or the names of their primary caregivers received and contained in records kept by the office for the purposes of administering this part shall be maintained in accordance with Chapter 1 (commencing with Section 123100) of Part 1 of Division 106 of the Health and Safety Code, Part 2.6 (commencing with Section 56) of Division 1 of the Civil Code, and other state and federal laws relating to confidential patient information.
(b)(1)Nothing in this section shall preclude any of the following:
(A)Office employees notifying state or local agencies about information submitted to the office that the employee suspects is falsified or fraudulent.
(B)Notifications from the office to state or local agencies of apparent violations of this part or an applicable local ordinance.
(C)Verification of requests by state or local agencies to confirm licenses and certificates issued by the office or other state agency.
(D)Providing information requested pursuant to a court order or subpoena issued by a court, an administrative agency, or local governing body authorized by law to issue subpoenas.
(2)Information shall not be disclosed beyond what is necessary to achieve the goals of a specific investigation or notification or the parameters of a specific court order or subpoena.
18139.(a)The actions of a licensee, its employees, and its agents, that are permitted pursuant to a license and that are conducted in accordance with the requirements of this part and regulations adopted pursuant to this part, are not unlawful under state law and shall not be an offense subject to arrest or prosecution.
(b)The actions of a person who, in good faith and upon investigation, allows his or her property to be used by a licensee, its employees, and its agents, as permitted pursuant to a license, are not unlawful under state law and shall not be an offense subject to arrest or prosecution.
(c)This section shall not be deemed to limit the authority or remedies of a city, county, or city and county under any law, including, without limitation, Section 7 of Article XI of the California Constitution.
18140.(a)A licensee shall not cultivate, process, store, manufacture, transport, test, or sell medical marijuana in the state unless accurate records are kept at the licensed premises of the growing, processing, storing, manufacturing, transporting, testing, or selling by the licensee in the state. These records shall include the name and address of the supplier of marijuana received or possessed by the licensee, the location at which the marijuana was cultivated, the amount of marijuana received, the form in which it is received, the name of the employee receiving it, and the date of receipt. These records shall also include receipts for all expenditures incurred by the licensee and banking records, if any, for all funds obtained or expended in the performance of any activity under the authority of the license. A licensee who has a license for more than one premises may keep all records at one of the licensed premises. Required records shall be kept for a period of seven years from the date of the transaction.
(b)The office or a local agency delegated the authority to enforce the licensing requirements of this part may examine the books and records of a licensee and may visit and inspect the premises of a licensee, as the office or local agency deems necessary to perform its duties under this part.
(c)Books or records requested by the office or a local agency delegated the authority to enforce licensing requirements of this part shall be provided by the licensee no later than five business days after the request is made.
(d)The office or a local agency delegated the authority to enforce the licensing requirements of this part may enter and inspect the premises of a facility issued a license between the hours of 8 a.m. and 8 p.m. on any day that the facility is open, or at any reasonable time, to ensure compliance and enforcement of the provisions of this part or a local ordinance.
(e)If a licensee or an employee of a licensee refuses, impedes, obstructs, or interferes with an inspection pursuant to subdivision (d), the license may be summarily suspended and the office shall directly commence proceedings for the revocation of the license.
(f)If a licensee fails to maintain or provide the books and records required pursuant to this section, the licensee shall be subject to a civil fine of fifteen thousand dollars ($15,000) per individual violation.
(g)The office or a local agency delegated the authority to enforce the licensing requirement of this part may, at its discretion, require a licensee to contract for an independent audit of the records required under this section. The licensee shall be liable for all costs associated with such an audit.
9.Apprenticeship Program18141.This chapter applies only to cultivation sites and dispensaries.
18142.The Division of Labor Standards Enforcement shall do all of the following:
(a)Maintain minimum standards for the competency and training of employees of a licensed cultivator or dispensary through a system of testing and certification.
(b)Maintain an advisory committee and panels as necessary to carry out its functions under this chapter. There shall be employer representation on the committee and panels.
(c)Adopt regulations as determined to be necessary to implement this chapter.
(d)Issue certification cards to employees certified pursuant to this chapter.
(e)Establish registration fees in an amount reasonably necessary to implement this chapter, not to exceed twenty-five dollars ($25) for the initial registration. There shall be no fee for annual renewal of registration. Fees collected for cultivation sites and dispensaries shall be placed into the Medical Marijuana Regulation Fund.
18143.(a)By January 1, 2017, the Division of Labor Standards Enforcement shall develop a certification program for marijuana employees. Commencing January 1, 2019, except as provided in subdivision (c), certification shall be required of all persons who perform work as marijuana employees.
(b)Individuals desiring to be certified shall submit an application for certification and examination.
(c)(1)Certification is not required for registered apprentices working as marijuana employees as part of a state-approved apprenticeship program. An apprentice who is within one year of completion of his or her term of apprenticeship shall be permitted to take the certification examination and, upon passing the examination, shall be certified immediately upon completion of the term of apprenticeship.
(2)Commencing January 1, 2019, an uncertified person may perform work for which certification is otherwise required in order to acquire the necessary on-the-job experience for certification provided that the person shall be under the direct supervision of a marijuana employee certified pursuant to this section who is responsible for supervising no more than one uncertified person.
(3)The Division of Labor Standards Enforcement may develop additional criteria governing this subdivision.
18144.(a)The following shall constitute additional grounds for disciplinary proceedings, including suspension or revocation of the license issued pursuant to this part:
(1)The licensee willfully employs one or more uncertified persons to perform work as marijuana employees in violation of this chapter.
(2)The licensee willfully fails to provide adequate supervision of uncertified workers.
(3)The licensee willfully fails to provide adequate supervision of apprentices.
(b)The Labor Commissioner shall maintain a process for referring cases to the office when it has been determined that a violation of this section has likely occurred. The Labor Commissioner shall have a memorandum of understanding with the regulatory authorities office in furtherance of this section.
(c)Upon receipt of a referral by the Labor Commissioner alleging a violation under this section, the office shall open an investigation. Disciplinary action against the licensee shall be initiated within 60 days of the receipt of the referral. The office may initiate disciplinary action against a licensee upon his or her own investigation, the filing of a complaint, or a finding that results from a referral from the Labor Commissioner alleging a violation under this section. Failure of the employer or employee to provide evidence of certification or apprentice status shall create a rebuttable presumption of violation of this section.
(d)This section shall become operative on January 1, 2019.
10.Tracking Program18145.On or before March 1, 2016, the chief shall submit a request for proposal to the public regarding a tracking program for medical marijuana and medical marijuana products as part of the antidiversion effort. The office shall choose a supplier and begin full implementation of the program prior to the issuance of state licenses pursuant to this part.
SEC. 6.Section 23028 is added to the Government Code, to read:23028.(a)(1)A county may impose a tax on the privilege of cultivating, dispensing, producing, processing, preparing, storing, providing, donating, selling, or distributing medical marijuana or medical marijuana products by a licensee operating pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code.
(2)The board of supervisors shall specify in the ordinance proposing the tax the activities subject to the tax, the applicable rate or rates, the method of apportionment, if necessary, and the manner of collection of the tax. The tax may be imposed for general governmental purposes or for purposes specified in the ordinance by the board of supervisors.
(3)In addition to any other method of collection authorized by law, the board of supervisors may provide for the collection of the tax imposed pursuant to this section in the same manner, and subject to the same penalties and priority of lien, as other charges and taxes fixed and collected by the county. A tax imposed pursuant to this section is a tax and not a fee or special assessment. The board of supervisors shall specify whether the tax applies throughout the entire county or within the unincorporated area of the county.
(4)The tax authorized by this section may be imposed upon any or all of the activities set forth in paragraph (1) specified in the ordinance, regardless of whether the activity is undertaken individually, collectively, or cooperatively, and regardless of whether the activity is for compensation or gratuitously, as determined by the board of supervisors or city council.
(b)A tax imposed pursuant to this section shall be subject to applicable voter approval requirements imposed by law.
(c)For purposes of this section, marijuana has the same meaning as the term marijuana product set forth in Section 111658 of the Health and Safety Code.
(d)This section is declaratory of existing law and does not limit or prohibit the levy or collection of any other fee, charge, or tax, or a license or service fee or charge upon, or related to, the activities set forth in subdivision (a) as otherwise provided by law. This section shall not be construed as a limitation upon the taxing authority of a county as provided by law.
(e)A tax imposed pursuant to this section is not a sales and use tax subject to Part 1.5 (commencing with Section 7200) of Division 2 of the Revenue and Taxation Code or a transactions and use tax subject to Chapter 2 (commencing with Section 7285) of Part 1.7 of Division 2 of the Revenue and Taxation Code. This subdivision shall not preclude imposition of any other tax authorized under this section upon the privilege of selling, storing, using, or consuming medical marijuana.
SEC. 7.Section 11362.775 of the Health and Safety Code is amended to read:11362.775.(a)Qualified patients, persons with valid identification cards, and the designated primary caregivers of qualified patients and persons with identification cards, who cultivate marijuana for medical purposes, shall not solely on the basis of that fact be subject to state criminal sanctions under Section 11357, 11358, 11359, 11360, 11366, 11366.5, or 11570.
(b)An individual employee, officer, or board member of a facility issued a license pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code shall not be subject to state criminal sanctions under Section 11357, 11358, 11359, 11360, 11366, 11366.5, or 11570 and any successor statutes, based solely on holding a license, for the possession, cultivation, processing, packaging, storage, transportation, testing, sale, or distribution of medical marijuana to a facility holding a license pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code or directly to a qualified patient, a person with a valid identification card, or the designated primary caregiver of a qualified patient or person with a valid identification card, within the state, unless the information contained on the licensing paperwork is false or falsified, the license has been obtained by means of fraud, or the person is otherwise in violation of Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code.
(c)This section shall not diminish the protections of Section 18139 of the Business and Professions Code.
SEC. 8.Article 8 (commencing with Section 111658) is added to Chapter 6 of Part 5 of Division 104 of the Health and Safety Code, to read:8.Medical Marijuana111658.For purposes of this article, the following definitions shall apply:
(a)Edible medical marijuana product means medical marijuana or a medical marijuana-derived product that is ingested or meant to be ingested through the mouth and into the digestive system.
(b)Marijuana means all parts of the plant Cannabis sativa L. sativa, Cannabis indica, or Cannabis ruderalis, whether growing or not; the seeds thereof; the resin, whether crude or purified, extracted from any part of the plant; and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds, or resin. Marijuana does not include the mature stalks of the plant, fiber produced from the stalks, oil or cake made from the seeds of the plant, any other compound, manufacture, salt, derivative, mixture, or preparation of the mature stalks (except the resin extracted therefrom), fiber, oil, or cake, or the sterilized seed of the plant which is incapable of germination. Marijuana also means marijuana, as defined by Section 11018.
(c)Office means the Office of Medical Marijuana Regulation in the Business, Consumer Services, and Housing Agency.
111659.(a)The office shall promulgate regulations for implementation and enforcement, including requirements to ensure that all licensees and certified testing laboratories conform with applicable standards equivalent to state statutory environmental, agricultural, consumer protection, and food and product safety requirements. These standards shall be in addition, and not limited, to any other state and local requirements.
(b)Medical marijuana and medical marijuana products shall be tested by a certified testing laboratory, prior to retail sale or dispensing, as follows:
(1)Medical marijuana from dried flower shall, at a minimum, be tested for potency, pesticides, mold, rodenticide, and other contaminants.
(2)Medical marijuana extracts shall, at a minimum, be tested for potency and purity of the product.
(3)This article shall not prohibit a licensee from performing onsite testing for the purposes of quality assurance of the product in conjunction with reasonable business operations. Onsite testing by the licensee shall not be certified by the office.
(c)The office shall promulgate standards for certification of testing laboratories to perform random sample testing of all medical marijuana and medical marijuana products, including standards for onsite testing.
(d)Certification of testing laboratories shall be consistent with general requirements for the competence of testing and calibration activities, including sampling, using standard methods established by the International Organization for Standardization, specifically ISO/IEC 17020 and ISO/IEC 17025.
(e)These requirements shall apply to all entities, including third-party laboratories, engaged in the testing of medical marijuana pursuant to this article.
(f)A laboratory certified by the office to perform random sample testing of medical marijuana or medical marijuana products shall not acquire or receive medical marijuana or medical marijuana products except from a licensed facility in accordance with this article, and shall not distribute, sell, deliver, transfer, transport, or dispense medical marijuana or medical marijuana products except to the licensed facility from which the medical marijuana or medical marijuana products were acquired or received. All transfer or transportation shall be performed pursuant to a specified chain of custody protocol.
(g)The office shall develop procedures to ensure that testing of marijuana occurs prior to delivery to dispensaries or any other business, and specify how often licensees shall test marijuana, that the cost of testing shall be borne by the licensed cultivators, and requiring destruction of harvested batches whose testing samples indicate noncompliance with health and safety standards promulgated by the office, unless remedial measures can bring the marijuana into compliance with quality assurance standards as promulgated by the office.
(h)The office shall establish a certification fee, and laboratories shall pay a fee to be certified. Certification fees shall not exceed the reasonable regulatory cost of the certification activities.
(i)All certification fees collected by the office pursuant to this chapter shall be deposited into the Medical Marijuana Regulation Fund. All moneys in the Medical Marijuana Regulation Fund that are attributable to this section shall be available to the office upon appropriation of the Legislature solely for the purpose of fully funding administration of this article, including, but not limited to, the costs incurred by the office for the administrative expenses and costs and the costs of regulation.
111660.(a)The office shall promulgate the following public health standards:
(1)Health and safety standards applicable to all medical marijuana and medical marijuana products, including maximum potency standards for medical marijuana products.
(2)Standards for licensed manufacturers of medical marijuana and medical marijuana products, including, but not limited to, edible products.
(b)At a minimum, the standards required by this section shall do all of the following:
(1)Prescribe sanitation standards equivalent to the California Retail Food Code (Part 7 (commencing with Section 113700)) for food preparation, storage, handling, and sale of edible medical marijuana products. For purposes of this article, edible medical marijuana products are deemed to be unadulterated food products.
(2)Require that edible medical marijuana products produced, distributed, provided, donated, or sold by licensees shall be limited to nonpotentially hazardous food, as established by the State Department of Public Health pursuant to Section 114365.5.
(3)Require that facilities in which edible medical marijuana products are prepared shall be constructed in accordance with applicable building standards, health and safety standards, and other state laws.
(4)Require that all edible medical marijuana products shall be packaged at the original point of preparation.
(c)No person shall engage in the manufacture, packing, or holding of processed food containing edible marijuana unless the person has a valid registration from the office pursuant to Sections 18109 to 18113, inclusive, of the Business and Professions Code. Health and safety standards prescribed by this section or promulgated through regulation may be enforced by local environmental health departments.
111661.(a)Prior to sale or distribution at a licensed dispensing facility or an unlicensed dispensing facility in the City of Los Angeles, medical marijuana products shall be labeled and shall be in a tamper evident package. Labels and packages of medical marijuana products shall meet the following requirements:
(1)Medical marijuana packages and labels shall not be made to be attractive to children.
(2)All medical marijuana product labels shall include the following information, shall be prominently displayed, and shall be in a clear and legible font:
(A)Manufacture date and source.
(B)The statement KEEP OUT OF REACH OF CHILDREN AND ANIMALS in bold print.
(C)The statement FOR MEDICAL USE ONLY.
(D)The statement THE INTOXICATING EFFECTS OF THIS PRODUCT MAY BE DELAYED BY UP TO TWO HOURS.
(E)The statement THIS PRODUCT MAY IMPAIR THE ABILITY TO DRIVE OR OPERATE MACHINERY. PLEASE USE EXTREME CAUTION.
(F)For packages containing only dried marijuana, the net weight of medical marijuana in the package.
(G)A warning if nuts or other known allergens are used.
(H)List of pharmacologically active ingredients, including, but not limited to, tetrahydrocannabinol (THC), cannabidiol (CBD), and other cannabinoid content, the THC and other cannabinoid amount in milligrams per serving, servings per package, and the THC and other cannabinoid amount in milligrams for the package total.
(I)Clear indication, in bold type, that the product contains medical marijuana.
(J)Identification of the source and date of cultivation and manufacture.
(K)The date of sale.
(L)Any other requirement set by the office.
(b)Only generic food names may be used to describe edible medical marijuana products.
111662.For purposes of this article, edible medical marijuana products are deemed to be unadulterated food products. In addition to the quality assurance standards provided in Section 111661, all edible medical marijuana products shall comply with the following requirements:
(a)Baked edible medical marijuana products, including, but not limited to, brownies, bars, cookies, and cakes, tinctures, and other edible medical marijuana products that do not require refrigeration or hot holding may be manufactured, sold, or otherwise distributed at facilities issued a license pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code.
(b)A facility issued a license pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code shall have an owner or employee who has successfully passed an approved and accredited food safety certification examination as specified in Sections 113947.1, 113947.2, and 113947.3 prior to selling, manufacturing, or distributing edible medical marijuana products requiring refrigeration or hot holding.
(c)Individuals manufacturing or selling edible medical marijuana products shall thoroughly wash their hands before commencing production and before handling finished edible medical marijuana products.
(d)All edible medical marijuana products sold for direct consumption and infused with marijuana concentrate shall be individually wrapped at the original point of preparation.
(e)Products containing tetrahydrocannabinol (THC) shall be prepared in compliance with maximum potency standards for THC and THC concentrates set forth in the offices regulations.
(f)Prior to sale or distribution at a licensed dispensing facility, edible medical marijuana products shall be labeled and in a tamper evident package. Labels and packages of edible medical marijuana products shall meet the following requirements:
(1)Edible medical marijuana packages and labels shall not be made to be attractive to children.
(2)In addition to the labeling requirements set forth in Section 111660, edible medical marijuana product labels shall include the following information, prominently displayed and in a clear and legible font:
(A)Manufacture date and source.
(B)Net weight of medical marijuana in package.
(C)A warning if nuts or other known allergens are used and shall include the total weight, in ounces or grams, of medical marijuana in the package.
(D)Any other requirement set by the office.
(g)Photos or images of food are not allowed on edible medical marijuana product packages or labels.
(h)Only generic food names may be used to describe edible medical marijuana products.
111663.All facilities issued a license pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code that conduct business related to food or food-based products shall be subject to requirements equivalent to those of the California Retail Food Code and other applicable laws, as determined by the office.
SEC. 9.Section 3094 is added to the Labor Code, to read:3094.The Division of Apprenticeship Standards shall investigate, approve, or reject applications for apprenticeship programs for employees of a licensee subject to Sections 18141 to 18144, inclusive, of the Business and Professions Code. The Division of Apprenticeship Standards shall adopt regulations necessary to implement and regulate the establishment of the apprenticeship programs described in this section.
SEC. 10.Section 2402.5 is added to the Vehicle Code, to read:2402.5.(a)The Department of the California Highway Patrol shall establish protocols to determine whether a driver is operating a vehicle under the influence of marijuana, and shall develop protocols setting forth best practices to assist law enforcement agencies. The costs to the Department of the California Highway Patrol of implementing this subdivision shall, upon appropriation by the Legislature, be paid for with appropriations from moneys in the Medical Marijuana Regulation Fund.
(b)(1)Department of Motor Vehicles, in consultation with the Department of the California Highway Patrol, shall prepare a report to the Office of Medical Marijuana Regulation, the Senate, and the Assembly that identifies best practices for the identification, detection, and apprehension of drivers operating a vehicle unsafely due to marijuana impairment.
(2)It is the intent of the Legislature that Department of Motor Vehicles use various resources, including, but not limited to, peer reviewed research and drug recognition experts to prepare the report.
(3)The report shall include, but not be limited to, an identification of roadside tests that enhance the ability of law enforcement officers to detect marijuana impairment and specific indicators that correlate performance on roadside testing with the inability of a driver to safely operate a motor vehicle.
(4)Publication of the report shall not occur until the Department of the California Highway Patrol concurs with its findings.
(5)The report shall be provided no later than September 1, 2016.
(6)The Department of Motor Vehicles and the Department of the California Highway Patrol are authorized to contract for consultation services necessary to complete the report and receive reimbursement for the costs of consultation services from the Medical Marijuana Regulation Fund.
SEC. 11.On or before July 1, 2016, the State Board of Equalization shall compile a report on the estimated tax collected on the sale of medical marijuana, using the most current data available. The report should also include expected tax revenues, under the existing tax structure, for the years 2016 to 2021, inclusive. This report shall be submitted to the Legislature and the Governors office pursuant to Section 9795 of the Government Code.
SEC. 12.The provisions of this act are severable. If any provision of this act or its application is held invalid, that invalidity shall not affect other provisions or applications that can be given effect without the invalid provision or application.
SEC. 13.The Legislature finds and declares that Section 5 of this act imposes a limitation on the publics right of access to the meetings of public bodies or the writings of public officials and agencies within the meaning of Section 3 of Article I of the California Constitution. Pursuant to that constitutional provision, the Legislature makes the following findings to demonstrate the interest protected by this limitation and the need for protecting that interest:
The limitation imposed under this act is necessary for purposes of compliance with the federal Health Insurance Portability and Accountability Act of 1996 (42 U.S.C. Sec. 1320d et seq.), the Confidentiality of Medical Information Act (Part 2.6 (commencing with Section 56) of Division 1 of the Civil Code), and the Insurance Information and Privacy Protection Act (Article 6.6 (commencing with Section 791) of Part 2 of Division 1 of the Insurance Code).
SEC. 14.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
SEC. 15.The amendments made to Section 11362.775 of the Health and Safety Code by this act shall become operative on July 1, 2018.
This act shall be known, and may be cited, as the Medical Marijuana Public Safety and Environmental Protection Act.
SEC. 2.The Legislature finds and declares all of the following:
(a)In 1996, the people of the State of California enacted the Compassionate Use Act of 1996, codified in Section 11362.5 of the Health and Safety Code. The people of the State of California declared that their purpose in enacting the measure was, among other things, to ensure that seriously ill Californians have the right to obtain and use marijuana for medical purposes where that medical use is deemed appropriate and has been recommended by a physician who has determined that the persons health would benefit from the use of marijuana in the treatment of cancer, anorexia, AIDS, chronic pain, spasticity, glaucoma, arthritis, migraine, or any other illness for which marijuana provides relief.
(b)The Compassionate Use Act of 1996 called on state government to implement a plan for the safe and affordable distribution of marijuana to all patients in medical need of marijuana, while ensuring that nothing in that act would be construed to condone the diversion of marijuana for nonmedical purposes.
(c)In 2003, the Legislature enacted the Medical Marijuana Program Act (MMPA), codified in Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10 of the Health and Safety Code.
(d)Greater certainty and minimum statewide standards are urgently needed regarding the obligations of medical marijuana facilities, and for the imposition and enforcement of regulations to prevent unlawful cultivation and the diversion of marijuana to nonmedical use.
(e)Despite the passage of the Compassionate Use Act of 1996 and the MMPA, because of the lack of an effective statewide system for regulating and controlling medical marijuana, cities, counties, and local law enforcement officials have been confronted with uncertainty about the legality of some medical marijuana cultivation and distribution activities. The current state of affairs makes law enforcement difficult and endangers patient safety because of an inability to monitor the supply of medical marijuana in the state and the lack of quality control, testing, and labeling requirements.
(f)The California Constitution grants cities and counties the authority to make and enforce, within their borders, all local police, sanitary, and other ordinances and regulations not in conflict with the general laws. This inherent local police power includes broad authority to determine, for purposes of public health, safety, and welfare, the appropriate uses of land within the local jurisdictions borders. The police power, therefore, allows each city and county to determine whether or not a medical marijuana dispensary or other facility that makes medical marijuana available may operate within its borders. This authority has been upheld by City of Riverside v. Inland Empire Patients Health and Wellness Center, Inc. (2013) 56 Cal.4th 729 and County of Los Angeles v. Hill (2011) 192 Cal.App.4th 861. Nothing in this act shall diminish, erode, or modify that authority.
(g)If a city or county determines that a dispensary or other facility that makes medical marijuana available may operate within its borders, then there is a need for the state and local governments to license these dispensaries and other facilities for the purpose of adopting and enforcing protocols for security standards at dispensaries and in the transportation of medical marijuana, as well as health and safety standards to ensure patient safety. This licensing requirement is not intended in any way nor shall it be construed to preempt local ordinances, regulations, or enforcement actions regarding the sale and use of medical marijuana, including, but not limited to, security, signage, lighting, and inspections.
(h)Greater oversight, uniformity, and enforcement are urgently needed regarding the obligations and rights of medical marijuana cultivators, transporters, and distribution facilities.
(i)Marijuana has widely accepted medical applications that make it inappropriate to be classified as a Schedule I controlled substance in the State of California.
(j)For the protection of Californians, the state must act to regulate and control commercial medical marijuana and not preempt local government ordinances. Counties should be allowed to impose local taxes and enact zoning regulations and other restrictions applicable to the cultivation, transportation, and distribution of medical marijuana based on local needs.
(k)For the protection of Californias environment and its natural resources, all efforts must be made to prevent and mitigate the harmful environmental impacts that can be associated with some marijuana cultivation.
(l)Illegal trespass grows on private and public property pose a threat to public safety and the environment.
(m)The North Coast Regional Water Quality Control Board is currently in the process of promulgating regulations that would create a 3-tiered system for cultivator wastewater discharge permits. A similar permitting system would assist the state in controlling damaging wastewater runoff from cultivation sites, while minimizing the burden on smaller cultivators.
(n)Nothing in this act shall have a diminishing effect on the rights and protections granted to a patient or primary caregiver pursuant to the Compassionate Use Act of 1996.
(o)Nothing in this act shall be construed to promote or facilitate the nonmedical, recreational possession, sale, or use of marijuana.
SEC. 3.Section 2220.05 of the Business and Professions Code is amended to read:2220.05.(a)In order to ensure that its resources are maximized for the protection of the public, the Medical Board of California shall prioritize its investigative and prosecutorial resources to ensure that physicians and surgeons representing the greatest threat of harm are identified and disciplined expeditiously. Cases involving any of the following allegations shall be handled on a priority basis, as follows, with the highest priority being given to cases in the first paragraph:
(1)Gross negligence, incompetence, or repeated negligent acts that involve death or serious bodily injury to one or more patients, such that the physician and surgeon represents a danger to the public.
(2)Drug or alcohol abuse by a physician and surgeon involving death or serious bodily injury to a patient.
(3)Repeated acts of clearly excessive prescribing, furnishing, or administering of controlled substances, or repeated acts of prescribing, dispensing, or furnishing of controlled substances, or recommending marijuana to patients for medical purposes, without a good faith prior examination of the patient and medical reason therefor. However, in no event shall a physician and surgeon prescribing, furnishing, or administering controlled substances for intractable pain consistent with lawful prescribing, including, but not limited to, Sections 725, 2241.5, and 2241.6 of this code and Sections 11159.2 and 124961 of the Health and Safety Code, be prosecuted for excessive prescribing and prompt review of the applicability of these provisions shall be made in any complaint that may implicate these provisions.
(4)Sexual misconduct with one or more patients during a course of treatment or an examination.
(5)Practicing medicine while under the influence of drugs or alcohol.
(b)The board may by regulation prioritize cases involving an allegation of conduct that is not described in subdivision (a). Those cases prioritized by regulation shall not be assigned a priority equal to or higher than the priorities established in subdivision (a).
(c)The Medical Board of California shall indicate in its annual report mandated by Section 2312 the number of temporary restraining orders, interim suspension orders, and disciplinary actions that are taken in each priority category specified in subdivisions (a) and (b).
SEC. 4.Article 25 (commencing with Section 2525) is added to Chapter 5 of Division 2 of the Business and Professions Code, to read:25.Recommending Medical Marijuana2525.(a)It is unlawful for a physician and surgeon who recommends marijuana to a patient for a medical purpose to accept, solicit, or offer any form of remuneration from or to a facility issued a conditional license pursuant to Part 5 (commencing with Section 18100) of Division 7, if the physician and surgeon or his or her immediate family have a financial interest in that facility.
(b)For the purposes of this section, financial interest shall have the same meaning as in Section 650.01.
(c)A violation of this section shall be a misdemeanor.
2525.1.The Medical Board of California shall consult with the California Marijuana Research Program, known as the Center for Medicinal Cannabis Research, authorized pursuant to Section 11362.9 of the Health and Safety Code, on developing and adopting medical guidelines for the appropriate administration and use of medical marijuana.
2525.2.A physician and surgeon shall not recommend medical marijuana to a patient, unless that person is the patients attending physician, as defined by subdivision (a) of Section 11362.7 of the Health and Safety Code.
SEC. 5.Part 5 (commencing with Section 18100) is added to Division 7 of the Business and Professions Code, to read:5.Medical Marijuana1.General Provisions18100.For purposes of this part, the following definitions shall apply:
(a)Chief means the Chief of the Office of Medical Marijuana Regulation.
(b)Delivery means the commercial transfer of medical marijuana or medical marijuana products from a dispensary, up to an amount determined by the office, to a primary caregiver or qualified patient, as defined in Section 11362.7 of the Health and Safety Code, a testing laboratory, or to an event or location where it will be used solely for promotional purposes. Delivery also includes the use by a dispensary of a third party or any technology platform that enables qualified patients or primary caregivers to arrange for or facilitate the commercial transfer of medical marijuana or medical marijuana products.
(b)
(c)Dispensary means a distribution operation that provides medical marijuana or medical marijuana derived products to patients and caregivers.
(d)Distribution means procurement, sale, and transport of medical marijuana and medical marijuana products purchased and sold between licensed entities.
(e)Distributor means a person who is engaged in the business of purchasing medical marijuana from a licensed cultivator or medical marijuana products from a licensed manufacturer in order to distribute to other licensees.
(c)
(f)Fund means the Medical Marijuana Regulation Fund established pursuant to Section 18118.
(g)Labor peace agreement means an agreement between a licensee and a bona fide labor organization that, at a minimum, protects the states proprietary interests by prohibiting labor organizations and members from engaging in picketing, work stoppages, boycotts, and any other economic interference with the applicants business. This agreement means that the applicant has agreed not to disrupt efforts by the bona fide labor organization to communicate with, and attempt to organize and represent, the applicants employees. The agreement shall provide a bona fide labor organization access, at reasonable times, to areas in which the applicants employees work, for the purpose of meeting with employees to discuss their right to representation, employment rights under state law, and terms and conditions of employment. This type of agreement shall not mandate a particular method of election or certification of the bona fide labor organization.
(d)
(h)Licensed cultivation site means a facility that plants, grows, cultivates, harvests, dries, or processes medical marijuana and that is issued both a conditional license pursuant to this part and a local license or permit.
(e)
(i)Licensed dispensing facility means a dispensary or other facility that provides medical marijuana, medical marijuana products, or devices for the use of medical marijuana or medical marijuana products that is issued both a conditional license pursuant to this part and a local license or permit.
(f)
(j)Licensed manufacturer means a person who extracts, prepares, derives, produces, compounds, or repackages medical marijuana or medical marijuana products into consumable and nonconsumable forms and that is issued both a conditional license pursuant to this part and a local license or permit.
(g)
(k)Licensed transporter means an individual or entity issued both a conditional a license by the office and a local license or permit to transport medical marijuana to and from facilities that have been issued conditional licenses both a license pursuant to this part or and a local license or permit for medical marijuana products above a quantity limit established by the office.
(h)
(l)Marijuana or cannabis means all parts of the plant Cannabis sativa, Cannabis indica, or Cannabis ruderalis, whether growing or not; the seeds thereof; the resin, whether crude or purified, extracted from any part of the plant; and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds, or resin. Marijuana does not include the mature stalks of the plant, fiber produced from the stalks, oil or cake made from the seeds of the plant, any other compound, manufacture, salt, derivative, mixture, or preparation of the mature stalks (except the resin extracted therefrom), fiber, oil, or cake, or the sterilized seed of the plant which is incapable of germination. Marijuana also means marijuana, as defined by Section 11018 of the Health and Safety Code.
(i)
(m)Office means the Office of Medical Marijuana Regulation in the Business, Consumer Affairs, Services, and Housing Agency.
18101.(a)There is hereby created in the Business, Consumer Affairs, and Housing Agency the Office of Medical Marijuana Regulation, under the supervision and control of the Chief of the Office of Medical Marijuana Regulation.
(b)Protection of the public shall be the highest priority Preservation of patients access to medical marijuana and the protection of the public shall be the highest priorities for the office in exercising its licensing, regulatory, and disciplinary functions. Whenever the protection of the public is inconsistent with other interests sought to be promoted, the protection of the public shall be paramount.
(c)The office shall have the authority to issue, suspend, or revoke conditional licenses for the cultivation, manufacture, transportation, storage, distribution, testing, and sale of medical marijuana within the state and to collect fees in connection with these actions. The office shall have the authority to create, issue, suspend, or revoke other licenses in order to protect patient health and the public and to facilitate the regulation of medical marijuana.
(d)(1)The Governor shall appoint the chief at a salary to be fixed and determined by the secretary with the approval of the Director of Finance.
(2)Appointment of the chief shall be subject to confirmation by the Senate Committee on Rules.
(e)The duty of enforcing and administering this part shall be vested in the chief. The chief may adopt and enforce those rules and regulations that he or she determines are reasonably necessary to carry out the purposes of this part and declaring the policy of the office, including a system for the issuance of citations for violations of this part, as specified in Section 18127.
(f)The chief, as necessary to carry out the provisions of this part, and in accordance with the State Civil Service Act (Part 2 (commencing with Section 18500) of Division 5 of Title 2 of the Government Code), may appoint and fix the compensation of personnel, including, but not limited to, clerical, inspection, investigation, and auditing personnel, as well as an assistant chief. These personnel shall perform their respective duties under the supervision and the direction of the chief.
(g)Every power granted to, or duty imposed upon, the chief under this part may be exercised or performed in the name of the chief by a deputy or assistant chief, subject to conditions and limitations that the chief prescribes.
(h)The office shall exercise its authority pursuant to this part consistent with Section 1 of the act that added this section and consistent with the provisions of this part.
18102.Funds for the establishment and support of the office shall be advanced as a loan from the General Fund and shall be repaid by the initial proceeds from fees collected pursuant to this part or any rule or regulation adopted pursuant to this part.
18103.The office shall have the authority necessary for the implementation of this part, including, but not limited to, all of the following:
(a)Establishing rules or regulations necessary to carry out the purposes and intent of this part and to enable the office to exercise the powers and perform the duties conferred upon it by this part and in accordance with Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code. These rules and regulations shall not limit any authority of a city, county, or city and county provided by law. For the performance of its duties, the office has the powers as set forth in Article 2 (commencing with Section 11180) of Chapter 2 of Part 1 of Division 3 of Title 2 of the Government Code.
(b)Issuing conditional licenses to persons for the cultivation, manufacture, transportation, storage, distribution, testing, and sale of medical marijuana within the state.
(c)Setting application, licensing, and renewal fees for conditional licenses issued pursuant to Section 18117. 18114.
(d)Establishing standards for the cultivation, manufacturing, transportation, storage, distribution, provision, testing, donation, and sale of medical marijuana and medical marijuana products.
(e)Establishing procedures for the issuance, renewal, suspension, denial, and revocation of conditional licenses.
(f)Enforcing the licensing and regulatory requirement of this part, subject to the requirements of Section 18126.
(g)Imposing a penalty authorized by this part or any rule or regulation adopted pursuant to this part.
(h)Taking action with respect to an application for a conditional license in accordance with procedures established pursuant to this part.
(i)Overseeing the operation of the Medical Marijuana Regulation Fund and the Special Account for Environmental Enforcement, established pursuant to Section 18118. 18115.
(j)Consulting with other state or local agencies, departments, representatives of the medical marijuana community, or public or private entities for the purposes of establishing statewide standards and regulations.
18104.(a)On or before January 1, 2018, the office shall promulgate regulations for implementation and enforcement of this part, including, but not limited to, all of the following:
(1)Procedures for the issuance, renewal, suspension, denial, and revocation of conditional licenses.
(2)Procedures for appeal of fines and the appeal of denial, suspension, or revocation of conditional licenses.
(3)Application, licensing, and renewal forms and fees.
(4)A time period in which the office shall approve or deny an application for a conditional license pursuant to this part.
(5)Qualifications for licensees.
(b)The office, in consultation with the Division of Labor Standards Enforcement, shall adopt regulations establishing worker safety standards for entities licensed pursuant to this part.
(c)The office shall not issue a conditional license unless the applicant has met all of the requirements of this part, including the requirements of subdivision (d) (h) of Section 18110, and has demonstrated compliance with all applicable agricultural requirements, consumer protection requirements, food and product safety requirements, and environmental requirements, including, but not limited to, applicable water quality standards.
18104.5.(a)On or before April 1, 2016, the office shall convene an advisory committee to advise the office on the development of standards and regulations pursuant to this chapter. The advisory committee shall recommend to the office the appropriate roles of each state entity as it pertains to this chapter, and shall recommend guidelines on communication and information sharing between state entities, and with local agencies, for implementation of this chapter.
(b)The advisory committee shall be comprised of gubernatorial and legislative appointees, including, but not limited to, representatives of the medical marijuana industry, representatives of medical marijuana cultivators, appropriate local and state agencies, appropriate local and state law enforcement, physicians, environmental and public health experts, and medical marijuana patient advocates.
(c)(1)The advisory committee shall submit a report on these standards, determinations, and guidelines for implementation of this chapter to the Legislature and state entities affected by this chapter by August 1, 2016.
(2)The report submitted to the Legislature shall be submitted in compliance with Section 9795 of the Government Code.
(3)The requirement for submitting a report imposed pursuant to this subdivision is inoperative on January 1, 2020, pursuant to Section 10231.5 of the Government Code.
18105.(a)The chief shall keep a complete record of all facilities issued a conditional license.
(b)This record shall be made available on the offices Internet Web site.
(c)The office shall not disclose information that the office determines is sensitive and should not be publicly disclosed, including, but not limited to, the address or location of cultivation sites.
(d)Upon request, the office shall provide summary information on all licensees, including, but not limited to, the name of the licensee, the date the license was issued, the status of the license, and the licensees mailing address.
18106.The office shall establish procedures to provide state and local law enforcement and state and local agencies, upon their request, with 24-hour access to information to verify a conditional license, track transportation manifests, and track the inventories of facilities issued a conditional license.
18107.This part shall in no way supersede the provisions of Measure D, approved by the voters of the City of Los Angeles on the May 21, 2013, ballot for the city, or any similar measure in other jurisdictions, which grants medical marijuana businesses and dispensaries qualified immunity consistent with the terms of the measure and local ordinances. Immunity granted by Measure D shall be sufficient to comply with the requirement of local approval for licensure pursuant to Section 18110.
18107.Notwithstanding Section 18119, a licensed transporter may transport medical marijuana products to an unlicensed dispensing facility within the City of Los Angeles, provided the following requirements are met:
(a)The licensed transporter shall comply with subdivisions (b) and (c) of Section 18117, except that, in complying with paragraph (2) of subdivision (b), the licensed transporter shall securely transmit the manifest to the office and the unlicensed dispensing facility that will receive the medical marijuana products.
(b)The licensed transporter shall record and maintain, in both physical and electronic format, the following information with respect to the delivery of medical marijuana products to the unlicensed dispensing facility:
(1)The date of delivery.
(2)The address of delivery.
(3)The name of the individual who completed the delivery.
(4)The name of the individual at the facility who received the delivery.
(5)The name of the owner or operator of the facility.
(6)The name of the facility, as reflected on any signage.
(7)The quantity, or weight, and variety of all medical marijuana products delivered.
(8)The source of all medical marijuana delivered.
(9)The monetary amount charged and received for all medical marijuana products delivered.
(c)The recorded information specified in subdivision (b) shall be transmitted within five days to the City of Los Angeles, in a manner to be determined and specified by the City of Los Angeles.
(d)The records required by this section shall be maintained and made available in accordance with the regulations promulgated by the office pursuant to Section 18140.
18107.1.(a)The office shall develop a database containing the electronic shipping manifests, which shall include, but not be limited to, the following information:
(1)The quantity, or weight, and variety of products shipped.
(2)The estimated times of departure and arrival.
(3)The quantity, or weight, and variety of products received.
(4)The actual time of arrival.
(5)A categorization of the product.
(b)The database shall be designed to flag irregularities for the office to investigate. An authorized enforcement authority may, at any time, inspect shipments and request documentation for current inventory.
18107.2.(a)This part shall not be construed to authorize or permit a licensee to transport or deliver, or cause to be transported or delivered, marijuana or marijuana products outside the state, unless authorized by federal law.
(b)A local jurisdiction shall not prevent transportation of medical marijuana or medical marijuana products on public roads by a licensee transporting medical marijuana or medical marijuana products that acts in compliance with this part.
(c)A local jurisdiction shall not prevent delivery of medical marijuana or medical marijuana products on public roads by a licensee that acts in compliance with this part and applicable local ordinances.
2.Conditional Licenses18108.The following persons are exempt from the requirement of licensure under this part:
(a)A patient who cultivates, possesses, stores, manufactures, or transports marijuana exclusively for his or her personal medical use and who does not sell, distribute, donate, or provide marijuana to any other person or entity.
(b)A primary caregiver who cultivates, possesses, stores, manufactures, transports, or provides marijuana exclusively for the personal medical purposes to no more than five specified qualified patients for whom he or she is the primary caregiver within the meaning of Section 11362.7 of the Health and Safety Code and who does not receive remuneration for these activities, except for compensation in full compliance with subdivision (c) of Section 11362.765 of the Health and Safety Code. Nothing in this section shall permit primary caregivers to organize themselves as cooperatives or collectives of caregivers.
(a)A qualified patient who cultivates, possesses, stores, manufactures, or transports marijuana exclusively for his or her personal medical use but who does not provide, donate, sell, or distribute marijuana to any other person or entity is not, thereby, engaged in commercial marijuana activity and is, therefore, exempt from the licensure requirements of this part.
(b)A primary caregiver who cultivates, possesses, stores, manufactures, transports, donates, or provides marijuana exclusively for the personal medical purposes of no more than five specified qualified patients for whom he or she is the primary caregiver within the meaning of Section 11362.7 of the Health and Safety Code, but who does not receive remuneration for these activities except for compensation in full compliance with subdivision (c) of Section 11362.765 of the Health and Safety Code is not engaged in commercial marijuana activity and is, therefore, exempt from the licensure requirements of this part.
18109.(a)Except as provided in Section 11362.5 of, and Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10 of, the Health and Safety Code, a person shall not sell or provide medical marijuana to a patient or caregiver other than at a licensed dispensing facility or through delivery from a licensed dispensing facility.
(b)Except as provided in Section 11362.5 of, and Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10 of, the Health and Safety Code, a person shall not grow medical marijuana other than at a licensed cultivation site.
(c)Except as provided in Section 11362.5 of, and Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10 of, the Health and Safety Code, a person shall not manufacture medical marijuana or medical marijuana products other than a licensed manufacturer.
(d)A person other than a licensed transporter shall not transport medical marijuana from one facility issued a conditional license to another.
(e)A licensed manufacturer may obtain medical marijuana from a licensed cultivator and may furnish medical marijuana products to a licensed dispensary.
18110.(a)Beginning no later than July 1, 2018, the office shall provide for and shall issue conditional licenses. Conditional licenses shall be required for all activity authorized under this chapter, including, but not limited to, cultivation, processing, storage, transportation, and dispensing of medical marijuana.
(b)The issuance of a conditional license shall not, in and of itself, authorize the recipient to begin business operations. The conditional license shall certify, at a minimum, that the applicant has paid the state conditional licensing fee, successfully passed a criminal background check, and met the state residency requirements.
(c)A conditionally licensed facility shall not commence activity under the authority of a conditional license until the applicant has also obtained a license or permit from the local jurisdiction in which he or she proposes to operate, following the requirements of local ordinances.
18110.(a)The office may issue state licenses only to qualified applicants engaging in commercial marijuana activity pursuant to this chapter. Upon the date of implementation of regulations by the office, no person shall engage in commercial marijuana activity without possessing both a state license and a local permit, license, or other authorization.
(b)Local permits shall be determined by local ordinances. The office issuing state licenses shall have sole authority to revoke a state license. Local agencies issuing local permits shall have sole authority to revoke a local permit.
(c)Each applicant for a state license shall provide notice to every affected local jurisdiction at the same time the state application is filed. The office shall confirm with the applicant a list of affected local jurisdictions, including those jurisdictions affected by potential deliveries by the applicant.
(d)The issuance of a state license shall not, in and of itself, authorize the recipient to begin business operations. The state license shall certify, at a minimum, that the applicant has paid the state licensing fee, successfully passed a criminal background check, and is a resident of the state of California.
(e)Even if a state license has been granted pursuant to this chapter, a facility shall not operate in a local jurisdiction that prohibits the establishment of that type of business. A facility shall not commence activity under the authority of a state license until the applicant has obtained, in addition to the state license, a license or permit from the local jurisdiction in which he or she proposes to operate, following the requirements of the applicable local ordinances.
(f)If a local government agency notifies the office and provides evidence that a licensee or applicant within its jurisdiction is in violation of local ordinances relating to commercial marijuana activities, the office shall schedule a hearing within 20 days to determine whether the evidence is sufficient to constitute grounds for the revocation of the state license.
(g)Revocation of a state license or local license or permit shall terminate the ability of a medical marijuana business to operate within California until the office or local jurisdiction reinstates or reissues the state license or local license or permit.
(d)
(h)An applicant for a conditional license shall do all of the following:
(1)Pay the fee or fees required by this part for each license being applied for.
(2)Register with the office on forms prescribed by the chief. The forms shall contain sufficient information to identify the licensee, including all of the following:
(A)Name of the owner or owners of a proposed facility, including all persons or entities having an ownership interest other than a security interest, lien, or encumbrance on property that will be used by the applicant.
(B)The name, address, and date of birth of each principal officer and board member.
(C)The address and telephone number of the proposed facility.
(D)In the case of a cultivation site, the GPS coordinates of the site.
(3)Describe, in writing, the scope of business of the proposed facility.
(4)Provide evidence that the applicant and owner have been legal full-time residents of the state for not less than 12 months. their primary residence in California.
(5)Provide detailed operating procedures, in writing, for the proposed facility, which shall include, but not be limited to, procedures for facility and operational security, prevention of diversion, employee screening, storage of medical marijuana, personnel policies, and recordkeeping procedures.
(6)Provide evidence that the applicant has received all required environmental permits, including compliance with the California Environmental Quality Act, and wastewater discharge permits.
(7)For an applicant seeking a cultivation license, provide a statement declaring the applicant is an agricultural employer, as defined in the Alatorre-Zenovich-Dunlap-Berman Agricultural Labor Relations Act of 1975 (Part 3.5 (commencing with Section 1140) of Division 2 of the Labor Code), to the extent not prohibited by law.
(7)
(8)Provide the applicants fingerprint images. For purposes of this paragraph, applicant means the owner or owners of a proposed facility, including all persons or entities having an ownership interest other than a security interest, lien, or encumbrance on property that will be used by the facility.
(A)The applicant shall electronically submit to the Department of Justice fingerprint images and related information required by the Department of Justice for the purpose of obtaining information as to the existence and content of a record of state or federal convictions and arrests, and information as to the existence and content of a record of state or federal convictions and arrests for which the Department of Justice establishes that the person is free on bail, or on his or her own recognizance, pending trial or appeal.
(B)The Department of Justice shall provide a response to the office pursuant to paragraph (1) of subdivision (p) of Section 11105 of the Penal Code.
(C)The office shall request from the Department of Justice subsequent notification service, as provided pursuant to Section 11105.2 of the Penal Code, for persons described in subparagraph (A).
(D)The Department of Justice shall charge the applicant a fee sufficient to cover the reasonable cost of processing the requests described in this paragraph.
(8)
(9)Provide a statement, signed by the applicant under penalty of perjury, that the information provided is true.
(9)
(10)Provide any other information required by the office.
(e)
(i)Each location and each discrete use of a single location shall require a conditional license. Each application for a conditional license is separate and distinct, and the office may charge a separate fee for each.
(f)
(j)A conditional license issued pursuant to this section shall be valid for 12 months after the date of issuance. After the initial 12-month period, a conditional license may be renewed for a period of 24 12 months. The office shall establish procedures for the renewal of a conditional license.
(g)
(k)Notwithstanding any other law, the office shall not issue a conditional license to an individual or entity, or for a premise, against whom there is a pending state or local administrative or judicial proceeding, against whom there is an action initiated by a city, county, or city and county under a local ordinance, or who has been determined to have violated an applicable local ordinance. are pending state or local administrative actions, judicial proceedings, or other actions initiated against the applicant, by a city, county, or city and county under an applicable local ordinance, or who has been determined through those proceedings to have violated a local ordinance related to commercial marijuana activity.
(h)
(l)A facility or entity that is operating in compliance with local zoning ordinances and other state and local requirements on January 1, 2016, may continue its operations until its application for conditional licensure is approved or denied pursuant to this part.
(m)A licensee shall not be licensed as a retailer of alcoholic beverages pursuant to Division 9 (commencing with Section 23000).
18111.(a)Upon receipt of the application materials and fee required in Section 18110, the office, provided the applicant has not committed an act or crime constituting grounds for the denial of licensure under Section 18112, may issue the conditional license and send a proof of issuance to the applicant. for licensure and the applicable fee, the office shall make a thorough investigation to determine whether the applicant and the premises for which a state license is applied qualify for the state license and whether this chapter has been complied with, and shall investigate all relevant matters that may affect the public welfare and morals.
(b)The office shall deny an application if either the applicant or the premises for which a state license is applied do not qualify for licensure under this part.
(c)The office shall deny the application for licensure or renewal, or suspend or revoke a state license, if any of the following conditions apply:
(1)Conduct involving dishonesty, fraud, or deceit, with the intent to substantially benefit himself, herself, or another, or substantially injure another.
(2)Failure to comply with the provisions of this part or any rule or regulation adopted pursuant to this part.
(3)Conduct that constitutes grounds for denial of licensure pursuant to Chapter 2 (commencing with Section 480) of Division 1.5.
(4)Local agencies have notified the office and provided evidence that a licensee or applicant within its jurisdiction is in violation of local ordinances relating to commercial marijuana activities.
(5)The applicant fails to meet the requirements of this part or any regulation adopted pursuant to this part or any applicable city, county, or city and county ordinance or regulation. If a local government adopts an ordinance or resolution authorizing medical marijuana to be cultivated, manufactured, stored, distributed, or sold within its jurisdiction, it may submit documentation to the office detailing its renewal requirements. Failure to submit an ordinance or resolution to the office shall not impair the enforceability of the ordinance or resolution. Ordinances or resolutions that are not submitted pursuant to this subdivision shall not be considered in denial of licensure pursuant to this part.
(6)Granting or continuation of a state license would be contrary to the publics safety.
(7)The applicant holding or seeking a state license has been convicted of a misdemeanor involving moral turpitude, excluding misdemeanors involving possession of a controlled substance.
(8)The application has failed to state with sufficient specificity the jurisdiction and location at which the applicant proposes to establish operations.
(9)The applicant, or any of its officers, directors, or owners, is under 21 years of age.
(10)The applicant fails to provide notarized written proof that the owner of real property or landlord has acknowledged and consented to its tenants proposed cultivation or dispensing of medical marijuana or medical marijuana products.
(11)The applicant has failed to provide information requested.
(12)Unless otherwise provided by this paragraph, the applicant or any of its officers, directors, or owners, have been convicted of a crime or act that is substantially related to the qualifications, functions, or duties of the business or profession for which the application is made or is convicted of a misdemeanor involving moral turpitude, excluding misdemeanors involving possession of a controlled substance. For purposes of this section, a conviction means a plea or verdict of guilty or a conviction following a plea of nolo contendere. An action that the office is permitted to take following the establishment of a conviction, including, but not limited to, the issuance, renewal, suspension, and revocation of a license for commercial marijuana activity pursuant to this part, shall be held in abeyance until after the time for appeal has elapsed, or the judgment of conviction has been affirmed on appeal. Action may be taken when an order granting probation is made suspending the imposition of sentence.
(A)An applicant shall not be denied a state license if the denial is based solely on any of the following:
(i)The applicant has been convicted of transporting a controlled substance pursuant to Section 11352 or 11379 of the Health and Safety Code prior to January 1, 2014, and the facts underlying the conviction establish that the applicant did not transport the controlled substance with the intent to sell or the intent to aid and abet the commission of, or conspiracy to commit, a crime of transportation of the controlled substance.
(ii)The applicant has been convicted of a felony that would not be subject to criminal prosecution pursuant to Section 11362.5 or 11362.775 of the Health and Safety Code.
(B)An applicant shall not be denied a state license under either of the following conditions:
(i)The applicant has obtained a certificate of rehabilitation pursuant to Chapter 3.5 (commencing with Section 4852.01) of Title 6 of Part 3 of the Penal Code, for a crime or act that is substantially related to the qualifications, functions, or duties of the business or profession for which the application is made.
(ii)The applicant has been convicted of a misdemeanor, and he or she has met all of the applicable requirements of the criteria for rehabilitation developed by the office to evaluate the rehabilitation of a person when considering the denial of license.
(C)In determining convictions that are substantially related to the qualifications, functions, or duties of the business or profession for which the application is made, the office shall include, but not be limited to, the following:
(i)A felony conviction for the possession for sale, sale, manufacture, transportation, or cultivation of a controlled substance.
(ii)A violent felony, as specified in subdivision (c) of Section 667.5 of the Penal Code.
(iii)A serious felony as specified in subdivision (c) of Section 1192.7 of the Penal Code.
(iv)A felony offense involving fraud, deceit, or embezzlement.
(13)The applicant, or any of its officers, directors, or owners, is a licensed physician making patient recommendations for medical marijuana.
(14)The applicant or any of its officers, directors, or owners has been subject to fines or penalties for cultivation or production of a controlled substance on public or private lands pursuant to Section 12025 of the Fish and Game Code.
(15)The applicant, or any of its officers, directors, or owners, have been sanctioned by the office, or a city, county, or a city and county for unlicensed commercial medical marijuana activities or has had a license revoked under this part in the previous three years.
(16)The proposed commercial marijuana activity will violate any applicable local law or ordinance.
(17)The applicant has had 20 employees or more in the past year and failed to enter into a labor peace agreement.
(18)The applicant or the owner is unable to show that he or she has established domicile within the state.
(19)Failure to obtain and maintain a valid sellers permit required pursuant to Part 1 (commencing with Section 6001) of the Revenue and Taxation Code.
(20)There are pending state or local administrative actions, judicial proceedings, or other actions initiated against the applicant, by a city, county, or city and county under an applicable local ordinance, or who has been determined through those proceedings to have violated a local ordinance related to commercial marijuana activity, or who knowingly provides false or fraudulent information on an application for licensure.
(d)Notwithstanding any other section of this part, the office may grant a license to an applicant who has been convicted of a crime if the office determines that the applicant is otherwise suitable to be issued a state license and granting a license would not compromise public safety. The office shall conduct a thorough investigation of the nature of the crime, conviction, circumstances, and evidence of rehabilitation of the applicant, and shall evaluate the suitability of the applicant to be issued a state license based on the evidence found through the investigation. In the evaluation, public protection shall take priority over rehabilitation and, where evidence of rehabilitation and public protection are in conflict, public protection shall take precedence.
(e)Applicants shall be notified of a denied application, and licensees of a suspended or revoked license shall be notified, in writing via personal service or mail addressed to the address of the applicant or licensee set forth in the application. The letter shall contain the detailed reasons for which the application was denied, the license was revoked, or the license was suspended. The applicant or licensee shall have the right to appeal the denial, suspension, or revocation and shall be given a hearing within 30 days of the appeal. On appeal, the decision shall be upheld unless the applicant or licensee demonstrates that he or she is in fact eligible for licensure and the application or licensee is in compliance with this part.
(b)
(f)The chief shall, by regulation, prescribe conditions upon which a person whose conditional license has previously been denied, suspended, or revoked, may be issued a conditional license.
(g)All proceedings to deny, suspend, or revoke a license shall be conducted pursuant to Chapter 5 (commencing with Section 11500) of Part 1 of Division 3 of Title 2 of the Government Code.
18112.(a)An application for a conditional license shall be denied and a conditional license shall be suspended or revoked for a past felony conviction for the possession for sale, sale, manufacture, transportation, or cultivation of a controlled substance, a felony criminal conviction for drug trafficking, a felony conviction for embezzlement, a felony conviction involving fraud or deceit, or any violent or serious felony conviction pursuant to subdivision (c) of Section 667.5 of, or subdivision (c) of Section 1192.7 of, the Penal Code. A conditional license shall not be denied solely on the basis of a prior conviction for a felony that was committed after the enactment of the Compassionate Use Act of 1996, but which would not be a felony after the enactment of the measure that added this part. The office, at its discretion, may issue a license to an applicant that would be otherwise denied pursuant to this subdivision, with the exception of the requirement of having been issued a conditional license, if the applicant has obtained a certificate of rehabilitation, pursuant to Section 4852.13 of the Penal Code.
(b)The chief, upon his or her determination, may deny, suspend, or revoke a conditional license when a conditional licensee, applicant, or employee, partner, officer, or member of an entity conditionally licensed does any of the following:
(1)Making or authorizing in any manner or by any means a written or oral statement that is untrue or misleading and that is known, or that by exercise of reasonable care should be known, to be untrue or misleading.
(2)Any other conduct that constitutes fraud.
(3)Conduct constituting gross negligence.
(4)Failure to comply with the provisions of this part, Article 8 (commencing with Section 111658) of Chapter 6 of Part 5 of Division 104 of the Health and Safety Code, or any rule or regulation adopted pursuant to this part.
(5)Conduct that constitutes grounds for denial of licensure pursuant to Chapter 2 (commencing with Section 480) of Division 1.5.
18113.(a)Upon denying, suspending, or revoking a conditional license, the chief shall notify the applicant or licensee, in writing, by personal service or mail addressed to the address of the applicant or licensee set forth in the application. The applicant or licensee shall be given a hearing within 30 days thereafter if he or she files with the office a written request for hearing. Otherwise, the denial, suspension, or revocation is deemed affirmed.
(b)All proceedings to deny, suspend, or revoke a conditional license shall be conducted pursuant to Chapter 5 (commencing with Section 11500) of Part 1 of Division 3 of Title 2 of the Government Code.
18114.An application for or renewal of a conditional license shall not be approved if the office determines any of the following:
(a)The applicant fails to meet the requirements of this part or has had an applicable permit or license revoked or denied by an applicable city, county, or city and county agency. If a local government adopts an ordinance or resolution authorizing medical marijuana to be cultivated, manufactured, stored, distributed, or sold within its jurisdiction, it shall submit to the office documentation detailing their renewal requirements.
(b)The applicant, or any of its officers, directors, owners, members, or shareholders, is a minor.
(c)The applicant has knowingly answered a question or request for information falsely on the application form or failed to provide information requested.
(d)The applicant, or any of its officers, directors, owners, members, or shareholders has been sanctioned by the office, a city, county, or city and county, for medical marijuana activities conducted in violation of this part or any applicable local ordinance or has had a license revoked in the previous five years.
(e)The proposed cultivation, processing, possession, storage, manufacturing, testing, transporting, distribution, provision, or sale of medical marijuana will violate any applicable local law or ordinance.
(f)The applicant or the owner is unable to establish that he or she has been a resident of the state for not less than 12 months.
18115.18112.(a)In addition to the provisions of this part, a conditional license shall be subject to the restrictions of the local jurisdiction in which the facility operates or proposes to operate. Even if a conditional license has been granted pursuant to this part, a facility shall not operate in a local jurisdiction that prohibits the establishment of that type of business.
(b)In addition to the provisions of this part, local jurisdictions retain the power to assess fees and taxes, as applicable, on facilities that are conditionally licensed pursuant to this part and the business activities of those licensees.
18116.18113.The office may adopt regulations to limit the number of conditional licenses issued pursuant to this part upon a finding that the otherwise unrestricted issuance of conditional licenses is dangerous to the public health and safety.
3.Fees18117.18114.(a)The conditional licensing fee shall be established by the office at a level sufficient to fund the reasonable costs of all of the following:
(1)Administrative costs incurred by the office in overseeing the conditional licensing program and establishing health and safety standards.
(2)Costs incurred by the office or the Department of Justice for enforcement of the provisions of this part.
(3)Costs incurred by law enforcement and other public safety entities for enforcing the provisions of this part in their jurisdiction.
(b)In addition to the conditional licensing fee required pursuant to subdivision (a), a cultivation facility shall be assessed a fee in a sufficient amount to cover the reasonable regulatory costs of enforcing the environmental impact provisions relating to those cultivation facilities. This fee shall be distributed, as necessary and in proportion to its regulatory function, between the following agencies responsible for enforcing the regulations relating to the environmental impact of licensed cultivation sites:
(1)The State Water Resources Control Board.
(2)The Department of Fish and Wildlife.
(3)The Department of Forestry and Fire Protection.
(4)The Department of Pesticide Regulation.
(5)The Department of Food and Agriculture.
(6)Local law enforcement.
18118.18115.(a)The Medical Marijuana Regulation Fund is hereby established within the State Treasury. Notwithstanding Section 16305.7 of the Government Code, the fund shall include any interest and dividends earned on the money in the fund.
(b)Except as provided in subdivision (c), all fees collected pursuant to this part shall be deposited into the Medical Marijuana Regulation Fund. All moneys within the fund are available, upon appropriation by the Legislature, to the office solely for the purposes of fully funding and administering this part, including, but not limited to, the costs incurred by the office for its administrative expenses.
(c)The Special Account for Environmental Enforcement is hereby established as an account within the Medical Marijuana Regulation Fund. Notwithstanding Section 16305.7 of the Government Code, the account shall include any interest and dividends earned on the money in the account. All fees collected pursuant to subdivision (b) of Section 18117 18114 shall be deposited in this account. All moneys within the fund are available, upon appropriation by the Legislature, to the office for distribution to the entities listed in subdivision (b) of Section 18117 18114 to be used to enforce the environmental regulation of licensed cultivation sites.
(d)All moneys collected as a result of penalties imposed under this part shall be deposited directly into the General Fund, to be available upon appropriation.
(e)The office may establish and administer a grant program to allocate moneys from the Medical Marijuana Regulation Fund to state and local entities for the purpose of assisting with medical marijuana regulation and the enforcement of this part.
18119.18116.(a)A facility issued a conditional license shall not acquire, cultivate, process, possess, store, manufacture, distribute, sell, deliver, transfer, transport, or dispense medical marijuana for any purpose other than those authorized by Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10 of the Health and Safety Code.
(b)A licensed dispensing facility shall not acquire, cultivate, process, possess, store, manufacture, distribute, sell, deliver, transfer, transport, or dispense medical marijuana plants or medical marijuana products except through a licensed cultivation site or a licensed manufacturer.
4.Transportation of Medical Marijuana18120.(a)A licensed transporter shall ship only to facilities issued a conditional license and only in response to a request for a specific quantity and variety from those facilities.
(b)Prior to transporting medical marijuana or medical marijuana products, a licensed transporter shall do both of the following:
(1)Complete a shipping manifest using a form prescribed by the office.
(2)Securely transmit a copy of the manifest to the licensee that will receive the medical marijuana or medical marijuana product, and to the office, prior to transport.
(c)The licensed transporter making the shipment and the licensee receiving the shipment shall maintain each shipping manifest and make it available to local code enforcement officers, any other locally designated enforcement entity, and the office upon request.
18121.(a)Transported medical marijuana and medical marijuana products shall:
(1)Be transported only in a locked, safe, and secure storage compartment that is securely affixed to the interior of the transporting vehicle.
(2)Not be visible from outside the vehicle.
(b)A vehicle transporting medical marijuana or medical marijuana products shall not have external markings or other indications that it is transporting medical marijuana.
(c)A vehicle transporting medical marijuana products shall travel directly from one licensed facility to another licensed facility authorized to receive the shipment.
(d)The provisions of this section only apply to a licensed transporter.
18122.(a)All transport vehicles carrying medical marijuana with a retail value greater than ten thousand dollars ($10,000) shall be staffed with a minimum of two employees. At least one transport team member shall remain with the vehicle at all times when the vehicle contains medical marijuana.
(b)Each transport team member shall have access to a secure form of communication by which each member can communicate with personnel at the licensed facility at all times when the vehicle contains medical marijuana.
(c)Each transport team member shall possess documentation of licensing and a government-issued identification card at all times when transporting or delivering medical marijuana and shall produce it to any representative of the office or law enforcement upon request.
(d)This part shall not be construed to authorize or permit a licensee to transport, or cause to be transported, medical marijuana or medical marijuana products outside the state.
(e)The requirements of this section shall only apply to a licensed transporter.
18123.A local jurisdiction shall not prevent transportation through or to a facility issued a conditional license, by a conditionally licensed transporter who acts in compliance with this part.
18117.(a)A licensee authorized to transport, or transport and deliver, medical marijuana and medical marijuana products shall do so only as set forth in this chapter.
(b)Prior to transporting or delivering medical marijuana or medical marijuana products, a licensee authorized to transport or deliver medical marijuana or medical marijuana products shall do both of the following:
(1)Complete an electronic shipping manifest as prescribed by the office. All delivery shipping manifests shall not identify the qualified patient or primary caregiver by name or address.
(2)Securely transmit the manifest to the office and the licensee that will receive the medical marijuana product, as applicable, prior to transport.
(c)During transportation or delivery, the licensed transporter shall maintain a physical copy of the shipping manifest and shall make it available upon request to office, local law enforcement officers, or any other designated enforcement agency.
(d)The licensee receiving the shipment shall maintain each electronic shipping manifest and shall make it available upon request to agents of the office, local law enforcement officers, or any other locally designated enforcement agency.
(e)Upon receipt of the transported shipment, a licensee shall submit to the office a record verifying receipt of the shipment and the details of the shipment.
(f)Notwithstanding any other law or the wage orders of the Industrial Welfare Commission, a driver employed to transport medical marijuana or medical marijuana products shall be entitled to overtime pay pursuant to Section 510 of the Labor Code.
18118.An entity licensed pursuant to Sections 18109 to 18113, inclusive, may transport between licensees medical marijuana or medical marijuana products with a total retail value, weight of medical marijuana, and weight of medical marijuana products, below the statewide threshold, which shall be adopted by regulation by the office after review by the advisory committee and the office.
18119.(a)Transported and delivered medical marijuana or medical marijuana products shall be transported only in a storage compartment that is securely affixed to the interior of the transporting vehicle and that is not visible from outside the vehicle. This requirement shall only apply to licensees transporting medical marijuana or medical marijuana products with a total retail value of at least an amount equal to a statewide monetary threshold, which shall be adopted by regulation by the office after review by the advisory committee and the office.
(b)A vehicle transporting medical marijuana or medical marijuana products shall travel only directly between licensed facilities authorized to receive the shipment, unless otherwise authorized under its license. All transport and deliveries shall be conducted between 8:00 a.m. and 8:00 p.m. Transportation and delivery of shipments do not have to be completed in a single day.
(c)All transport or delivery vehicles shall be staffed with a minimum of two direct employees of the licensee. At least one employee shall remain with the vehicle at all times when the vehicle contains medical marijuana. This requirement shall only apply to licensees transporting medical marijuana or medical marijuana products with a total retail value of at least an amount equal to a statewide monetary threshold, which shall be adopted by regulation by the office after review by the advisory committee and the office.
(d)Each transport or delivery team member shall possess documentation of licensing and a government-issued identification card at all times when transporting or delivering medical marijuana and shall produce it upon the request of agents of the office or a law enforcement official.
(e)This section shall be enforced by the Department of the California Highway Patrol in collaboration with local agencies.
5.Enforcement18124.A state agency The office is not required by this section to enforce a city, county, city and county, or local law, ordinance, rule, or regulation regarding the site or operation of a facility issued a conditional license.
18125.The office may assist state taxation authorities in the development of uniform policies for the state taxation of licensees.
18126.(a)The office may enforce all of the requirements of this part, including any regulations adopted pursuant to this part.
(b)The office shall delegate the authority to enforce the requirements of this part, including any regulations, to a city, county, or city and county, upon request of that entity.
(c)Nothing in this part shall be interpreted to supersede or limit existing local authority for law enforcement activity, enforcement of local zoning requirements, or enforcement of local licensing requirements.
(d)Nothing in this part shall be interpreted to require the office to undertake local law enforcement responsibilities, enforce local zoning requirements, or enforce local licensing requirements.
18127.(a)A willful violation of Section 18110, including an attempt to falsify information on an application or to otherwise defraud or mislead a state or local agency in the course of the application process, shall be punishable by a civil fine of up to thirty-five thousand dollars ($35,000) for each individual violation.
(b)A technical violation of Section 18110 shall, at the offices discretion, be punishable by a civil fine of up to ten thousand dollars ($10,000) for each individual violation.
18128.A district attorney, county counsel, city attorney, city prosecutor, the Attorney General, or the office may bring an action to enjoin a violation or the threatened violation of any provision of this part, including, but not limited to, a licensees failure to correct objectionable conditions following notice or as a result of a rule promulgated pursuant to this part. The action shall be brought in the county in which the violation occurred or is threatened to occur. A proceeding brought pursuant to this part shall conform to the requirements of Chapter 3 (commencing with Section 525) of Title 7 of Part 2 of the Code of Civil Procedure. Nothing in this section shall diminish the authority of a local government to take requisite enforcement actions pertaining to its own ordinances or regulations.
18129.Nothing in this part shall prevent a city or other local governing body from taking action as specified in Section 11362.83 of the Health and Safety Code.
18130.This part shall not be construed to limit a law enforcement agencys ability to investigate unlawful activity in relation to a facility issued a conditional license.
6.Tiered Licensing and Vertical Integration18131.(a)A licensee may only hold a state license in up to two separate license categories, as follows:
(1)Type 1, 1A, 1B, 2, 2A, and 2B licensees, or a combination thereof, may apply for a Type 6 or 7 state license, or a combination thereof.
(2)Type 6 and 7 licensees, or a combination thereof, may apply for a Type 1, 1A, 1B, 2, 2A, and 2B state license, or a combination thereof.
(3)Type 6 and 7 licensees, or a combination thereof, may apply for a Type 10A state license.
(4)Type 10A licensees may apply for a Type 6 and 7 state license, or a combination thereof.
(5)Type 1, 1A, 1B, 2, 2A, and 2B licensees, or a combination thereof, may apply for a Type 10A state license.
(6)Type 10A licensees, may apply for Type 1, 1A, 1B, 2, 2A, and 2B state license, or a combination thereof.
(7)Type 11 licensees may apply for a Type 12 state license.
(8)Type 12 licensees may apply for a Type 11 state license.
(b)State licenses to be issued by the office are as follows:
(1)Type 1, or specialty outdoor, for outdoor cultivation using no artificial lighting of 5,000 square feet or less of total canopy size on one premises, or up to 50 mature plants on noncontiguous plots.
(2)Type 1A, or specialty indoor, for indoor cultivation using exclusively artificial lighting of 5,000 square feet or less of total canopy size on one premises.
(3)Type 1B, or specialty mixed-light, for cultivation using a combination of natural and supplemental artificial lighting at a maximum threshold to be determined by the office, than 5,000 square feet or less of total canopy size on one premises.
(4)Type 2, or small outdoor, for outdoor cultivation using no artificial lighting between 5,001 and 10,000 square feet of total canopy size on one premises.
(5)Type 2A, or small indoor, for indoor cultivation using exclusively artificial lighting between 5,001 and 10,000 square feet of total canopy size on one premises.
(6)Type 2B, or small mixed-light, for cultivation using a combination of natural and supplemental artificial lighting at a maximum threshold to be determined by the office, between 5,001 and 10,000 square feet of total canopy size on one premises.
(7)Type 3, or outdoor, for outdoor cultivation using no artificial lighting between 10,001 and 44,000 square feet of total canopy size on one premises. The office shall limit the number of licenses allowed of this type.
(8)Type 3A, or indoor, for indoor cultivation using exclusively artificial lighting between 10,001 and 22,000 square feet of total canopy size on one premises. The office shall limit the number of licenses allowed of this type.
(9)Type 3B, or mixed-light, for cultivation using a combination of natural and supplemental artificial lighting at a maximum threshold to be determined by the office, between 10,001 and 22,000 square feet of total canopy size on one premises. The office shall limit the number of licenses allowed of this type.
(10)Type 4, or nursery, for cultivation of medical marijuana solely as a nursery. Type 4 licensees may transport live plants.
(c)The office shall promulgate regulations governing the licensing of marijuana manufacturers.
(d)Licenses to be issued by the office to marijuana manufacturers are as follows:
(1)Type 6, or manufacturing level 1, for manufacturing sites that produce medical marijuana products using nonvolatile solvents.
(2)Type 7, or manufacturing level 2, for manufacturing sites that produce medical marijuana products using volatile solvents. The office shall limit the number of licenses of this type.
(3)Type 8, or testing, for testing of medical marijuana and medical marijuana products. Type 8 licensees shall have their facilities certified licensed according to regulations set forth by the office. A Type 8 licensee shall not hold a license in another license category of this part and shall not own or have ownership interest in a facility licensed pursuant to this part.
(e)State licenses to be issued by the office for dispensing and distributing are as follows:
(1)Type 10, or dispensary, for the retail of medical marijuana and medical marijuana products. This license shall allow for delivery where expressly authorized by local ordinance.
(2)Type 10A or special dispensary status, for dispensers who have no more than three licensed dispensary facilities. This license shall allow for delivery where expressly authorized by local ordinance.
(3)Type 11, or distributor, for the certification of the content of all medical marijuana or medical marijuana products and distribution licensees. A Type 11 licensee shall hold a Type 12, or transporter, license and register each facility location where product is stored for the purposes of distribution. A Type 11 licensee shall not hold a license in a cultivation, manufacturing, dispensing, or testing license category and shall not own, or have an ownership interest in, a facility licensed in those categories other than a security interest, lien, or encumbrance on property that is used by a licensee. A Type 11 licensee shall be bonded and insured at a minimum level established by the office.
(4)Type 12, or transport, for transporters of medical marijuana or medical marijuana products. A Type 12 licensee shall be bonded and insured at a minimum level established by the office.
6. 7.Cultivation Sites18133.(a)No later than January 1, 2022, all medical marijuana grown, produced, distributed, and sold in the state shall meet standards equivalent to those for certified organic crops. Certification shall be by the office or an independent third party that contracts with the office for the purpose of certifying medical marijuana as organic.
(b)The office shall establish appellations of origin for marijuana grown in California.
18132.(a)Not later than January 1, 2020, the Department of Food and Agriculture, in conjunction with the office, shall make available a certified organic designation and organic certification program for medical marijuana, if permitted under federal law.
(b)If the certified organic designation and organic certification program is not available to medical marijuana by January 1, 2020, the Department of Food and Agriculture, in conjunction with the office, shall develop an equivalent program with standards for designation and certification for medical marijuana by January 1, 2022.
(c)The office shall establish appellations of origin for marijuana grown in California.
(d)It is unlawful for medical marijuana to be marketed, labeled, or sold as grown in a California county when the medical marijuana was not grown in that county.
(e)It is unlawful to use the name of a California county in the labeling, marketing, or packaging of medical marijuana products unless the product was grown in that county.
18134.18133.The office shall work with county agricultural commissioners to provide all the information and forms required for conditional licensure as a cultivation site in a single location, including state licensure, local requirements in that jurisdiction, and environmental requirements.
7. 8.Regulation of Medical Marijuana18134.This part and Article 2 (commencing with Section 11357) and Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10 of the Health and Safety Code shall not interfere with an employers rights and obligations to maintain a drug and alcohol free workplace or require an employer to permit or accommodate the use, consumption, possession, transfer, display, transportation, sale, or growth of marijuana in the workplace or affect the ability of employers to have policies prohibiting the use of marijuana by employees and prospective employees, or prevent employers from complying with state or federal law.
18136.18135.(a)A person shall not distribute any form of advertising for physician recommendations for medical marijuana in California unless the advertisement bears the following notice to consumers:
NOTICE TO CONSUMERS: The Compassionate Use Act of 1996 ensures that seriously ill Californians have the right to obtain and use marijuana for medical purposes where medical use is deemed appropriate and has been recommended by a physician who has determined that the persons health would benefit from the use of medical marijuana. Physicians are licensed and regulated by the Medical Board of California and arrive at the decision to make this recommendation in accordance with accepted standards of medical responsibility. Marijuana is a Schedule I drug according to the federal Controlled Substances Act. Activity related to marijuana use is subject to federal prosecution, without protections provided by state law.
(b)Advertising for physician recommendations for medical marijuana shall meet all requirements of Section 651. Price advertising shall not be fraudulent, deceitful, or misleading, including statements or advertisements of bait, discounts, premiums, gifts, or statements of a similar nature.
18137.18136.(a)A facility issued a conditional license shall implement sufficient security measures to both deter and prevent unauthorized entrance into areas containing medical marijuana or medical marijuana products and theft of medical marijuana or medical marijuana products at those facilities. These security measures shall include, but not be limited to, all of the following:
(1)Preventing individuals from remaining on the premises of the facility if they are not engaging in activity expressly related to the operations of the facility.
(2)Establishing limited access areas accessible only to authorized facility personnel.
(3)Storing all finished medical marijuana and medical marijuana products in a secured and locked room, safe, or vault, and in a manner as to prevent diversion, theft, and loss, except for limited amounts of marijuana used for display purposes, samples, or immediate sale.
(b)A facility issued a conditional license shall notify appropriate law enforcement authorities within 24 hours after discovering any of the following:
(1)Significant discrepancies identified during inventory. The level of significance shall be determined by the office.
(2)Diversion, theft, loss, or any criminal activity involving the facility or a facility agent.
(3)The loss or unauthorized alteration of records related to marijuana, registered qualifying patients, personal caregivers, or facility agents.
(4)Any other breach of security.
(c)A licensed cultivation site shall weigh, inventory, and account for on video, all medical marijuana to be transported prior to its leaving its origination location. Within eight hours after arrival at the destination, the licensed dispensing facility shall reweigh, reinventory, and account for on video, all transported marijuana.
18138.18137.(a)A licensed cultivation site or licensed dispensing facility shall display the conditional license in a manner so as to be available and easily read at the location.
(b)The office shall notify local law enforcement of all conditional licenses issued for cultivation sites, manufacturers, and dispensaries in that jurisdiction.
18140.18138.(a)Information identifying the names of patients, their medical conditions, or the names of their primary caregivers received and contained in records kept by the office for the purposes of administering this part shall be maintained in accordance with Chapter 1 (commencing with Section 123100) of Part 1 of Division 106 of the Health and Safety Code, Part 2.6 (commencing with Section 56) of Division 1 of the Civil Code, and other state and federal laws relating to confidential patient information.
(b)(1)Nothing in this section shall preclude any of the following:
(A)Office employees notifying state or local agencies about information submitted to the office that the employee suspects is falsified or fraudulent.
(B)Notifications from the office to state or local agencies of apparent violations of this part or an applicable local ordinance.
(C)Verification of requests by state or local agencies to confirm licenses and certificates issued by the office or other state agency.
(D)Providing information requested pursuant to a court order or subpoena issued by a court, an administrative agency, or local governing body authorized by law to issue subpoenas.
(2)Information shall not be disclosed beyond what is necessary to achieve the goals of a specific investigation or notification or the parameters of a specific court order or subpoena.
18141.18139.(a)The actions of a licensee, its employees, and its agents, that are permitted pursuant to a conditional license and that are conducted in accordance with the requirements of this part and regulations adopted pursuant to this part, are not unlawful under state law and shall not be an offense subject to arrest or prosecution.
(b)The actions of a person who, in good faith and upon investigation, allows his or her property to be used by a licensee, its employees, and its agents, as permitted pursuant to a conditional license, are not unlawful under state law and shall not be an offense subject to arrest or prosecution.
(c)This section shall not be deemed to limit the authority or remedies of a city, county, or city and county under any law, including, without limitation, Section 7 of Article XI of the California Constitution.
18142.18140.(a)A licensee shall not cultivate, process, store, manufacture, transport, test, or sell medical marijuana in the state unless accurate records are kept at the licensed premises of the growing, processing, storing, manufacturing, transporting, testing, or selling by the licensee in the state. These records shall include the name and address of the supplier of marijuana received or possessed by the licensee, the location at which the marijuana was cultivated, the amount of marijuana received, the form in which it is received, the name of the employee receiving it, and the date of receipt. These records shall also include receipts for all expenditures incurred by the licensee and banking records, if any, for all funds obtained or expended in the performance of any activity under the authority of the conditional license. A licensee who has a conditional license for more than one premises may keep all records at one of the conditionally licensed premises. Required records shall be kept for a period of seven years from the date of the transaction.
(b)The office or a local agency delegated the authority to enforce the licensing requirements of this part may examine the books and records of a conditional licensee and may visit and inspect the premises of a conditional licensee, as the office or local agency deems necessary to perform its duties under this part.
(c)Books or records requested by the office or a local agency delegated the authority to enforce licensing requirements of this part shall be provided by the conditional licensee no later than five business days after the request is made.
(d)The office or a local agency delegated the authority to enforce the licensing requirements of this part may enter and inspect the premises of a facility issued a conditional license between the hours of 8 a.m. and 8 p.m. on any day that the facility is open, or at any reasonable time, to ensure compliance and enforcement of the provisions of this part or a local ordinance.
(e)If a licensee or an employee of a licensee refuses, impedes, obstructs, or interferes with an inspection pursuant to subdivision (d), the conditional license may be summarily suspended and the office shall directly commence proceedings for the revocation of the conditional license.
(f)If a licensee fails to maintain or provide the books and records required pursuant to this section, the licensee shall be subject to a civil fine of fifteen thousand dollars ($15,000) per individual violation.
(g)The office or a local agency delegated the authority to enforce the licensing requirement of this part may, at its discretion, require a licensee to contract for an independent audit of the records required under this section. The licensee shall be liable for all costs associated with such an audit.
9.Apprenticeship Program18141.This chapter applies only to cultivation sites and dispensaries.
18142.The Division of Labor Standards Enforcement shall do all of the following:
(a)Maintain minimum standards for the competency and training of employees of a licensed cultivator or dispensary through a system of testing and certification.
(b)Maintain an advisory committee and panels as necessary to carry out its functions under this chapter. There shall be employer representation on the committee and panels.
(c)Adopt regulations as determined to be necessary to implement this chapter.
(d)Issue certification cards to employees certified pursuant to this chapter.
(e)Establish registration fees in an amount reasonably necessary to implement this chapter, not to exceed twenty-five dollars ($25) for the initial registration. There shall be no fee for annual renewal of registration. Fees collected for cultivation sites and dispensaries shall be placed into the Medical Marijuana Regulation Fund.
18143.(a)By January 1, 2017, the Division of Labor Standards Enforcement shall develop a certification program for marijuana employees. Commencing January 1, 2019, except as provided in subdivision (c), certification shall be required of all persons who perform work as marijuana employees.
(b)Individuals desiring to be certified shall submit an application for certification and examination.
(c)(1)Certification is not required for registered apprentices working as marijuana employees as part of a state-approved apprenticeship program. An apprentice who is within one year of completion of his or her term of apprenticeship shall be permitted to take the certification examination and, upon passing the examination, shall be certified immediately upon completion of the term of apprenticeship.
(2)Commencing January 1, 2019, an uncertified person may perform work for which certification is otherwise required in order to acquire the necessary on-the-job experience for certification provided that the person shall be under the direct supervision of a marijuana employee certified pursuant to this section who is responsible for supervising no more than one uncertified person.
(3)The Division of Labor Standards Enforcement may develop additional criteria governing this subdivision.
18144.(a)The following shall constitute additional grounds for disciplinary proceedings, including suspension or revocation of the license issued pursuant to this part:
(1)The licensee willfully employs one or more uncertified persons to perform work as marijuana employees in violation of this chapter.
(2)The licensee willfully fails to provide adequate supervision of uncertified workers.
(3)The licensee willfully fails to provide adequate supervision of apprentices.
(b)The Labor Commissioner shall maintain a process for referring cases to the office when it has been determined that a violation of this section has likely occurred. The Labor Commissioner shall have a memorandum of understanding with the regulatory authorities office in furtherance of this section.
(c)Upon receipt of a referral by the Labor Commissioner alleging a violation under this section, the office shall open an investigation. Disciplinary action against the licensee shall be initiated within 60 days of the receipt of the referral. The office may initiate disciplinary action against a licensee upon his or her own investigation, the filing of a complaint, or a finding that results from a referral from the Labor Commissioner alleging a violation under this section. Failure of the employer or employee to provide evidence of certification or apprentice status shall create a rebuttable presumption of violation of this section.
(d)This section shall become operative on January 1, 2019.
10.Tracking Program18145.On or before March 1, 2016, the chief shall submit a request for proposal to the public regarding a tracking program for medical marijuana and medical marijuana products as part of the antidiversion effort. The office shall choose a supplier and begin full implementation of the program prior to the issuance of state licenses pursuant to this part.
SEC. 6.Section 23028 is added to the Government Code, to read:23028.(a)(1)A county may impose a tax on the privilege of cultivating, dispensing, producing, processing, preparing, storing, providing, donating, selling, or distributing medical marijuana or medical marijuana products by a licensee operating pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code.
(2)The board of supervisors shall specify in the ordinance proposing the tax the activities subject to the tax, the applicable rate or rates, the method of apportionment, if necessary, and the manner of collection of the tax. The tax may be imposed for general governmental purposes or for purposes specified in the ordinance by the board of supervisors.
(3)In addition to any other method of collection authorized by law, the board of supervisors may provide for the collection of the tax imposed pursuant to this section in the same manner, and subject to the same penalties and priority of lien, as other charges and taxes fixed and collected by the county. A tax imposed pursuant to this section is a tax and not a fee or special assessment. The board of supervisors shall specify whether the tax applies throughout the entire county or within the unincorporated area of the county.
(4)The tax authorized by this section may be imposed upon any or all of the activities set forth in paragraph (1) specified in the ordinance, regardless of whether the activity is undertaken individually, collectively, or cooperatively, and regardless of whether the activity is for compensation or gratuitously, as determined by the board of supervisors or city council.
(b)A tax imposed pursuant to this section shall be subject to applicable voter approval requirements imposed by law.
(c)For purposes of this section, marijuana has the same meaning as the term marijuana product set forth in Section 111658 of the Health and Safety Code.
(d)This section is declaratory of existing law and does not limit or prohibit the levy or collection of any other fee, charge, or tax, or a license or service fee or charge upon, or related to, the activities set forth in subdivision (a) as otherwise provided by law. This section shall not be construed as a limitation upon the taxing authority of a county as provided by law.
(e)A tax imposed pursuant to this section is not a sales and use tax subject to Part 1.5 (commencing with Section 7200) of Division 2 of the Revenue and Taxation Code or a transactions and use tax subject to Chapter 2 (commencing with Section 7285) of Part 1.7 of Division 2 of the Revenue and Taxation Code. This subdivision shall not preclude imposition of any other tax authorized under this section upon the privilege of selling, storing, using, or consuming medical marijuana.
SEC. 7.Section 11362.775 of the Health and Safety Code is amended to read:11362.775.(a)Qualified patients, persons with valid identification cards, and the designated primary caregivers of qualified patients and persons with identification cards, who cultivate marijuana for medical purposes, shall not solely on the basis of that fact be subject to state criminal sanctions under Section 11357, 11358, 11359, 11360, 11366, 11366.5, or 11570.
(b)An individual employee, officer, or board member of a facility issued a conditional license pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code shall not be subject to state criminal sanctions under Section 11357, 11358, 11359, 11360, 11366, 11366.5, or 11570 and any successor statutes, based solely on holding a conditional license, for the possession, cultivation, processing, packaging, storage, transportation, testing, sale, or distribution of medical marijuana to a facility holding a conditional license pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code or directly to a qualified patient, a person with a valid identification card, or the designated primary caregiver of a qualified patient or person with a valid identification card, within the state, unless the information contained on the licensing paperwork is false or falsified, the license has been obtained by means of fraud, or the person is otherwise in violation of Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code.
(c)This section shall not diminish the protections of Section 18141 18139 of the Business and Professions Code.
SEC. 8.Article 8 (commencing with Section 111658) is added to Chapter 6 of Part 5 of Division 104 of the Health and Safety Code, to read:8.Medical Marijuana111658.For purposes of this article, the following definitions shall apply:
(a)Edible medical marijuana product means medical marijuana or a medical marijuana-derived product that is ingested or meant to be ingested through the mouth and into the digestive system.
(b)Marijuana means all parts of the plant Cannabis sativa L. sativa, Cannabis indica, or Cannabis ruderalis, whether growing or not; the seeds thereof; the resin, whether crude or purified, extracted from any part of the plant; and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds, or resin. Marijuana does not include the mature stalks of the plant, fiber produced from the stalks, oil or cake made from the seeds of the plant, any other compound, manufacture, salt, derivative, mixture, or preparation of the mature stalks (except the resin extracted therefrom), fiber, oil, or cake, or the sterilized seed of the plant which is incapable of germination. Marijuana also means marijuana, as defined by Section 11018.
(c)Office means the Office of Medical Marijuana Regulation in the Business, Consumer Affairs, Services, and Housing Agency.
111659.On or before July 1, 2017, the office shall report to the Legislature on the feasibility of developing a program to certify laboratories for the testing of medical marijuana and related products and the feasibility of developing a labeling requirement for edible marijuana products that incorporates information on the cannabinoid content.
111660.A facility issued a conditional license pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code shall bear the responsibility for both of the following:
(a)Maintaining supplier information in order for recall procedures to be implemented, if and when necessary.
(b)Labeling of all medical marijuana and medical marijuana products that shall, at a minimum, include the following:
(1)List of pharmacologically active ingredients, including, but not limited to, tetrahydrocannabinol (THC) and cannabidiol (CBD) content, the quantity of active ingredients per serving, and the total amount within the package. For purposes of this paragraph, the office shall determine the appropriate size of one serving.
(2)Clear indication, in bold font, that the product contains medical marijuana.
(3)The statement FOR MEDICAL USE ONLY. KEEP OUT OF REACH OF CHILDREN AND ANIMALS in bold print.
(4)Identification of the source and date of cultivation and manufacture.
(5)The name and location of the dispensary providing the product.
(6)The date of sale.
(7)Any other requirements set by the office.
111659.(a)The office shall promulgate regulations for implementation and enforcement, including requirements to ensure that all licensees and certified testing laboratories conform with applicable standards equivalent to state statutory environmental, agricultural, consumer protection, and food and product safety requirements. These standards shall be in addition, and not limited, to any other state and local requirements.
(b)Medical marijuana and medical marijuana products shall be tested by a certified testing laboratory, prior to retail sale or dispensing, as follows:
(1)Medical marijuana from dried flower shall, at a minimum, be tested for potency, pesticides, mold, rodenticide, and other contaminants.
(2)Medical marijuana extracts shall, at a minimum, be tested for potency and purity of the product.
(3)This article shall not prohibit a licensee from performing onsite testing for the purposes of quality assurance of the product in conjunction with reasonable business operations. Onsite testing by the licensee shall not be certified by the office.
(c)The office shall promulgate standards for certification of testing laboratories to perform random sample testing of all medical marijuana and medical marijuana products, including standards for onsite testing.
(d)Certification of testing laboratories shall be consistent with general requirements for the competence of testing and calibration activities, including sampling, using standard methods established by the International Organization for Standardization, specifically ISO/IEC 17020 and ISO/IEC 17025.
(e)These requirements shall apply to all entities, including third-party laboratories, engaged in the testing of medical marijuana pursuant to this article.
(f)A laboratory certified by the office to perform random sample testing of medical marijuana or medical marijuana products shall not acquire or receive medical marijuana or medical marijuana products except from a licensed facility in accordance with this article, and shall not distribute, sell, deliver, transfer, transport, or dispense medical marijuana or medical marijuana products except to the licensed facility from which the medical marijuana or medical marijuana products were acquired or received. All transfer or transportation shall be performed pursuant to a specified chain of custody protocol.
(g)The office shall develop procedures to ensure that testing of marijuana occurs prior to delivery to dispensaries or any other business, and specify how often licensees shall test marijuana, that the cost of testing shall be borne by the licensed cultivators, and requiring destruction of harvested batches whose testing samples indicate noncompliance with health and safety standards promulgated by the office, unless remedial measures can bring the marijuana into compliance with quality assurance standards as promulgated by the office.
(h)The office shall establish a certification fee, and laboratories shall pay a fee to be certified. Certification fees shall not exceed the reasonable regulatory cost of the certification activities.
(i)All certification fees collected by the office pursuant to this chapter shall be deposited into the Medical Marijuana Regulation Fund. All moneys in the Medical Marijuana Regulation Fund that are attributable to this section shall be available to the office upon appropriation of the Legislature solely for the purpose of fully funding administration of this article, including, but not limited to, the costs incurred by the office for the administrative expenses and costs and the costs of regulation.
111660.(a)The office shall promulgate the following public health standards:
(1)Health and safety standards applicable to all medical marijuana and medical marijuana products, including maximum potency standards for medical marijuana products.
(2)Standards for licensed manufacturers of medical marijuana and medical marijuana products, including, but not limited to, edible products.
(b)At a minimum, the standards required by this section shall do all of the following:
(1)Prescribe sanitation standards equivalent to the California Retail Food Code (Part 7 (commencing with Section 113700)) for food preparation, storage, handling, and sale of edible medical marijuana products. For purposes of this article, edible medical marijuana products are deemed to be unadulterated food products.
(2)Require that edible medical marijuana products produced, distributed, provided, donated, or sold by licensees shall be limited to nonpotentially hazardous food, as established by the State Department of Public Health pursuant to Section 114365.5.
(3)Require that facilities in which edible medical marijuana products are prepared shall be constructed in accordance with applicable building standards, health and safety standards, and other state laws.
(4)Require that all edible medical marijuana products shall be packaged at the original point of preparation.
(c)No person shall engage in the manufacture, packing, or holding of processed food containing edible marijuana unless the person has a valid registration from the office pursuant to Sections 18109 to 18113, inclusive, of the Business and Professions Code. Health and safety standards prescribed by this section or promulgated through regulation may be enforced by local environmental health departments.
111661.(a)Prior to sale or distribution at a licensed dispensing facility or an unlicensed dispensing facility in the City of Los Angeles, medical marijuana products shall be labeled and shall be in a tamper evident package. Labels and packages of medical marijuana products shall meet the following requirements:
(1)Medical marijuana packages and labels shall not be made to be attractive to children.
(2)All medical marijuana product labels shall include the following information, shall be prominently displayed, and shall be in a clear and legible font:
(A)Manufacture date and source.
(B)The statement KEEP OUT OF REACH OF CHILDREN AND ANIMALS in bold print.
(C)The statement FOR MEDICAL USE ONLY.
(D)The statement THE INTOXICATING EFFECTS OF THIS PRODUCT MAY BE DELAYED BY UP TO TWO HOURS.
(E)The statement THIS PRODUCT MAY IMPAIR THE ABILITY TO DRIVE OR OPERATE MACHINERY. PLEASE USE EXTREME CAUTION.
(F)For packages containing only dried marijuana, the net weight of medical marijuana in the package.
(G)A warning if nuts or other known allergens are used.
(H)List of pharmacologically active ingredients, including, but not limited to, tetrahydrocannabinol (THC), cannabidiol (CBD), and other cannabinoid content, the THC and other cannabinoid amount in milligrams per serving, servings per package, and the THC and other cannabinoid amount in milligrams for the package total.
(I)Clear indication, in bold type, that the product contains medical marijuana.
(J)Identification of the source and date of cultivation and manufacture.
(K)The date of sale.
(L)Any other requirement set by the office.
(b)Only generic food names may be used to describe edible medical marijuana products.
111662.For purposes of this article, edible medical marijuana products are deemed to be unadulterated food products. In addition to the quality assurance standards provided in Section 111661, all edible medical marijuana products shall comply with the following requirements:
(a)Baked edible medical marijuana products, including, but not limited to, brownies, bars, cookies, and cakes, tinctures, and other edible medical marijuana products that do not require refrigeration or hot holding may be manufactured, sold, or otherwise distributed at facilities issued a conditional license pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code.
(b)A facility issued a conditional license pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code shall have an owner or employee who has successfully passed an approved and accredited food safety certification examination as specified in Sections 113947.1, 113947.2, and 113947.3 prior to selling, manufacturing, or distributing edible medical marijuana products requiring refrigeration or hot holding.
(c)Individuals manufacturing or selling edible medical marijuana products shall thoroughly wash their hands before commencing production and before handling finished edible medical marijuana products.
(d)All edible medical marijuana products sold for direct consumption and infused with marijuana concentrate shall be individually wrapped at the original point of preparation.
(e)Products containing tetrahydrocannabinol (THC) shall be prepared in compliance with maximum potency standards for THC and THC concentrates set forth in the offices regulations.
(f)Prior to sale or distribution at a licensed dispensing facility, edible medical marijuana products shall be labeled and in a tamper evident package. Labels and packages of edible medical marijuana products shall meet the following requirements:
(1)Edible medical marijuana packages and labels shall not be made to be attractive to children.
(2)In addition to the labeling requirements set forth in Section 111660, edible medical marijuana product labels shall include the following information, prominently displayed and in a clear and legible font:
(A)Manufacture date and source.
(B)Net weight of medical marijuana in package.
(C)A warning if nuts or other known allergens are used and shall include the total weight, in ounces or grams, of medical marijuana in the package.
(D)Any other requirement set by the office.
(g)Photos or images of food are not allowed on edible medical marijuana product packages or labels.
(h)Only generic food names may be used to describe edible medical marijuana products.
111663.All facilities issued a conditional license pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code that conduct business related to food or food-based products shall be subject to requirements equivalent to those of the California Retail Food Code and other applicable laws, as determined by the office.
SEC. 9.Section 3094 is added to the Labor Code, to read:3094.The Division of Apprenticeship Standards shall investigate, approve, or reject applications for apprenticeship programs for employees of a licensee subject to Sections 18141 to 18144, inclusive, of the Business and Professions Code. The Division of Apprenticeship Standards shall adopt regulations necessary to implement and regulate the establishment of the apprenticeship programs described in this section.
SEC. 10.Section 2402.5 is added to the Vehicle Code, to read:2402.5.(a)The Department of the California Highway Patrol shall establish protocols to determine whether a driver is operating a vehicle under the influence of marijuana, and shall develop protocols setting forth best practices to assist law enforcement agencies. The costs to the Department of the California Highway Patrol of implementing this subdivision shall, upon appropriation by the Legislature, be paid for with appropriations from moneys in the Medical Marijuana Regulation Fund.
(b)(1)Department of Motor Vehicles, in consultation with the Department of the California Highway Patrol, shall prepare a report to the Office of Medical Marijuana Regulation, the Senate, and the Assembly that identifies best practices for the identification, detection, and apprehension of drivers operating a vehicle unsafely due to marijuana impairment.
(2)It is the intent of the Legislature that Department of Motor Vehicles use various resources, including, but not limited to, peer reviewed research and drug recognition experts to prepare the report.
(3)The report shall include, but not be limited to, an identification of roadside tests that enhance the ability of law enforcement officers to detect marijuana impairment and specific indicators that correlate performance on roadside testing with the inability of a driver to safely operate a motor vehicle.
(4)Publication of the report shall not occur until the Department of the California Highway Patrol concurs with its findings.
(5)The report shall be provided no later than September 1, 2016.
(6)The Department of Motor Vehicles and the Department of the California Highway Patrol are authorized to contract for consultation services necessary to complete the report and receive reimbursement for the costs of consultation services from the Medical Marijuana Regulation Fund.
SEC. 9.SEC. 11.On or before July 1, 2016, the State Board of Equalization shall compile a report on the estimated tax collected on the sale of medical marijuana, using the most current data available. The report should also include expected tax revenues, under the existing tax structure, for the years 2016 to 2021, inclusive. This report shall be submitted to the Legislature and the Governors office pursuant to Section 9795 of the Government Code.
SEC. 10.SEC. 12.The provisions of this act are severable. If any provision of this act or its application is held invalid, that invalidity shall not affect other provisions or applications that can be given effect without the invalid provision or application.
SEC. 11.SEC. 13.The Legislature finds and declares that Section 5 of this act imposes a limitation on the publics right of access to the meetings of public bodies or the writings of public officials and agencies within the meaning of Section 3 of Article I of the California Constitution. Pursuant to that constitutional provision, the Legislature makes the following findings to demonstrate the interest protected by this limitation and the need for protecting that interest:
The limitation imposed under this act is necessary for purposes of compliance with the federal Health Insurance Portability and Accountability Act of 1996 (42 U.S.C. Sec. 1320d et seq.), the Confidentiality of Medical Information Act (Part 2.6 (commencing with Section 56) of Division 1 of the Civil Code), and the Insurance Information and Privacy Protection Act (Article 6.6 (commencing with Section 791) of Part 2 of Division 1 of the Insurance Code).
SEC. 12.SEC. 14.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
SEC. 13.SEC. 15.The amendments made to Section 11362.775 of the Health and Safety Code by this act shall become operative on July 1, 2018.
This act shall be known, and may be cited, as the Medical Marijuana Public Safety and Environmental Protection Act.
SEC. 2.The Legislature finds and declares all of the following:
(a)In 1996, the people of the State of California enacted the Compassionate Use Act of 1996, codified in Section 11362.5 of the Health and Safety Code. The people of the State of California declared that their purpose in enacting the measure was, among other things, to ensure that seriously ill Californians have the right to obtain and use marijuana for medical purposes where that medical use is deemed appropriate and has been recommended by a physician who has determined that the persons health would benefit from the use of marijuana in the treatment of cancer, anorexia, AIDS, chronic pain, spasticity, glaucoma, arthritis, migraine, or any other illness for which marijuana provides relief.
(b)The Compassionate Use Act of 1996 called on state government to implement a plan for the safe and affordable distribution of marijuana to all patients in medical need of marijuana, while ensuring that nothing in that act would be construed to condone the diversion of marijuana for nonmedical purposes.
(c)In 2003, the Legislature enacted the Medical Marijuana Program Act (MMPA), codified in Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10 of the Health and Safety Code.
(d)Greater certainty and minimum statewide standards are urgently needed regarding the obligations of medical marijuana facilities, and for the imposition and enforcement of regulations to prevent unlawful cultivation and the diversion of marijuana to nonmedical use.
(e)Despite the passage of the Compassionate Use Act of 1996 and the MMPA, because of the lack of an effective statewide system for regulating and controlling medical marijuana, cities, counties, and local law enforcement officials have been confronted with uncertainty about the legality of some medical marijuana cultivation and distribution activities. The current state of affairs makes law enforcement difficult and endangers patient safety because of an inability to monitor the supply of medical marijuana in the state and the lack of quality control, testing, and labeling requirements.
(f)The California Constitution grants cities and counties the authority to make and enforce, within their borders, all local police, sanitary, and other ordinances and regulations not in conflict with the general laws. This inherent local police power includes broad authority to determine, for purposes of public health, safety, and welfare, the appropriate uses of land within the local jurisdictions borders. The police power, therefore, allows each city and county to determine whether or not a medical marijuana dispensary or other facility that makes medical marijuana available may operate within its borders. This authority has been upheld by City of Riverside v. Inland Empire Patients Health and Wellness Center, Inc. (2013) 56 Cal.4th 729 and County of Los Angeles v. Hill (2011) 192 Cal.App.4th 861. Nothing in this act shall diminish, erode, or modify that authority.
(g)If a city or county determines that a dispensary or other facility that makes medical marijuana available may operate within its borders, then there is a need for the state and local governments to license these dispensaries and other facilities for the purpose of adopting and enforcing protocols for security standards at dispensaries and in the transportation of medical marijuana, as well as health and safety standards to ensure patient safety. This licensing requirement is not intended in any way nor shall it be construed to preempt local ordinances, regulations, or enforcement actions regarding the sale and use of medical marijuana, including, but not limited to, security, signage, lighting, and inspections.
(h)Greater oversight, uniformity, and enforcement are urgently needed regarding the obligations and rights of medical marijuana cultivators, transporters, and distribution facilities.
(i)Marijuana has widely accepted medical applications that make it inappropriate to be classified as a Schedule I controlled substance in the State of California.
(j)For the protection of Californians, the state must act to regulate and control commercial medical marijuana and not preempt local government ordinances. Counties should be allowed to impose local taxes and enact zoning regulations and other restrictions applicable to the cultivation, transportation, and distribution of medical marijuana based on local needs.
(k)For the protection of Californias environment and its natural resources, all efforts must be made to prevent and mitigate the harmful environmental impacts that can be associated with some marijuana cultivation.
(l)Illegal trespass grows on private and public property pose a threat to public safety and the environment.
(m)The North Coast Regional Water Quality Control Board is currently in the process of promulgating regulations that would create a 3-tiered system for cultivator wastewater discharge permits. A similar permitting system would assist the state in controlling damaging wastewater runoff from cultivation sites, while minimizing the burden on smaller cultivators.
(n)Nothing in this act shall have a diminishing effect on the rights and protections granted to a patient or primary caregiver pursuant to the Compassionate Use Act of 1996.
(o)Nothing in this act shall be construed to promote or facilitate the nonmedical, recreational possession, sale, or use of marijuana.
SEC. 3.Section 2220.05 of the Business and Professions Code is amended to read:2220.05.(a)In order to ensure that its resources are maximized for the protection of the public, the Medical Board of California shall prioritize its investigative and prosecutorial resources to ensure that physicians and surgeons representing the greatest threat of harm are identified and disciplined expeditiously. Cases involving any of the following allegations shall be handled on a priority basis, as follows, with the highest priority being given to cases in the first paragraph:
(1)Gross negligence, incompetence, or repeated negligent acts that involve death or serious bodily injury to one or more patients, such that the physician and surgeon represents a danger to the public.
(2)Drug or alcohol abuse by a physician and surgeon involving death or serious bodily injury to a patient.
(3)Repeated acts of clearly excessive prescribing, furnishing, or administering of controlled substances, or repeated acts of prescribing, dispensing, or furnishing of controlled substances, or recommending marijuana to patients for medical purposes, without a good faith prior examination of the patient and medical reason therefor. However, in no event shall a physician and surgeon prescribing, furnishing, or administering controlled substances for intractable pain consistent with lawful prescribing, including, but not limited to, Sections 725, 2241.5, and 2241.6 of this code and Sections 11159.2 and 124961 of the Health and Safety Code, be prosecuted for excessive prescribing and prompt review of the applicability of these provisions shall be made in any complaint that may implicate these provisions.
(4)Sexual misconduct with one or more patients during a course of treatment or an examination.
(5)Practicing medicine while under the influence of drugs or alcohol.
(b)The board may by regulation prioritize cases involving an allegation of conduct that is not described in subdivision (a). Those cases prioritized by regulation shall not be assigned a priority equal to or higher than the priorities established in subdivision (a).
(c)The Medical Board of California shall indicate in its annual report mandated by Section 2312 the number of temporary restraining orders, interim suspension orders, and disciplinary actions that are taken in each priority category specified in subdivisions (a) and (b).
SEC. 4.Article 25 (commencing with Section 2525) is added to Chapter 5 of Division 2 of the Business and Professions Code, to read:25.Recommending Medical Marijuana2525.(a)It is unlawful for a physician and surgeon who recommends marijuana to a patient for a medical purpose to accept, solicit, or offer any form of remuneration from or to a facility issued a conditional license pursuant to Part 5 (commencing with Section 18100) of Division 7, if the physician and surgeon or his or her immediate family have a financial interest in that facility.
(b)For the purposes of this section, financial interest shall have the same meaning as in Section 650.01.
(c)A violation of this section shall be a misdemeanor.
2525.1.The Medical Board of California shall consult with the California Marijuana Research Program, known as the Center for Medicinal Cannabis Research, authorized pursuant to Section 11362.9 of the Health and Safety Code, on developing and adopting medical guidelines for the appropriate administration and use of medical marijuana.
2525.2.A physician and surgeon shall not recommend medical marijuana to a patient, unless that person is the patients attending physician, as defined by subdivision (a) of Section 11362.7 of the Health and Safety Code.
SEC. 5.Part 5 (commencing with Section 18100) is added to Division 7 of the Business and Professions Code, to read:5.Medical Marijuana1.General Provisions18100.For purposes of this part, the following definitions shall apply:
(a)Chief means the Chief of the Office of Medical Marijuana Regulation.
(b)Dispensary means a distribution operation that provides medical marijuana or medical marijuana derived products to patients and caregivers.
(c)Fund means the Medical Marijuana Regulation Fund established pursuant to Section 18118.
(d)Licensed cultivation site means a facility that plants, grows, cultivates, harvests, dries, or processes medical marijuana and that is issued both a conditional license pursuant to this part and a local license or permit.
(e)Licensed dispensing facility means a dispensary or other facility that provides medical marijuana, medical marijuana products, or devices for the use of medical marijuana or medical marijuana products that is issued both a conditional license pursuant to this part and a local license or permit.
(f)Licensed manufacturer means a person who extracts, prepares, derives, produces, compounds, or repackages medical marijuana or medical marijuana products into consumable and nonconsumable forms and that is issued both a conditional license pursuant to this part and a local license or permit.
(g)Licensed transporter means an individual or entity issued both a conditional license by the office and a local license or permit to transport medical marijuana to and from facilities that have been issued conditional licenses pursuant to this part or medical marijuana products above a quantity limit established by the office.
(h)Marijuana means all parts of the plant Cannabis sativa, Cannabis indica, or Cannabis ruderalis, whether growing or not; the seeds thereof; the resin, whether crude or purified, extracted from any part of the plant; and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds, or resin. Marijuana does not include the mature stalks of the plant, fiber produced from the stalks, oil or cake made from the seeds of the plant, any other compound, manufacture, salt, derivative, mixture, or preparation of the mature stalks (except the resin extracted therefrom), fiber, oil, or cake, or the sterilized seed of the plant which is incapable of germination. Marijuana also means marijuana, as defined by Section 11018 of the Health and Safety Code.
(i)Office means the Office of Medical Marijuana Regulation in the Business, Consumer Affairs, and Housing Agency.
18101.(a)There is hereby created in the Business, Consumer Affairs, and Housing Agency the Office of Medical Marijuana Regulation, under the supervision and control of the Chief of the Office of Medical Marijuana Regulation.
(b)Protection of the public shall be the highest priority for the office in exercising its licensing, regulatory, and disciplinary functions. Whenever the protection of the public is inconsistent with other interests sought to be promoted, the protection of the public shall be paramount.
(c)The office shall have the authority to issue, suspend, or revoke conditional licenses for the cultivation, manufacture, transportation, storage, distribution, and sale of medical marijuana within the state and to collect fees in connection with these actions. The office shall have the authority to create, issue, suspend, or revoke other licenses in order to protect patient health and the public and to facilitate the regulation of medical marijuana.
(d)(1)The Governor shall appoint the chief at a salary to be fixed and determined by the secretary with the approval of the Director of Finance. The chief shall serve in accordance with the State Civil Service Act (Part 2 (commencing with Section 18500) of Division 5 of Title 2 of the Government Code).
(2)Appointment of the chief shall be subject to confirmation by the Senate Committee on Rules.
(e)The duty of enforcing and administering this part shall be vested in the chief. The chief may adopt and enforce those rules and regulations that he or she determines are reasonably necessary to carry out the purposes of this part and declaring the policy of the office, including a system for the issuance of citations for violations of this part, as specified in Section 18127.
(f)The chief, as necessary to carry out the provisions of this part, and in accordance with the State Civil Service Act (Part 2 (commencing with Section 18500) of Division 5 of Title 2 of the Government Code), may appoint and fix the compensation of personnel, including, but not limited to, clerical, inspection, investigation, and auditing personnel, as well as an assistant chief. These personnel shall perform their respective duties under the supervision and the direction of the chief.
(g)Every power granted to, or duty imposed upon, the chief under this part may be exercised or performed in the name of the chief by a deputy or assistant chief, subject to conditions and limitations that the chief prescribes.
(h)The office shall exercise its authority pursuant to this part consistent with Section 1 of the act that added this section and consistent with the provisions of this part.
18102.Funds for the establishment and support of the office shall be advanced as a loan from the General Fund and shall be repaid by the initial proceeds from fees collected pursuant to this part or any rule or regulation adopted pursuant to this part.
18103.The office shall have the authority necessary for the implementation of this part, including, but not limited to, all of the following:
(a)Establishing rules or regulations necessary to carry out the purposes and intent of this part and to enable the office to exercise the powers and perform the duties conferred upon it by this part and in accordance with Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code. These rules and regulations shall not limit any authority of a city, county, or city and county provided by law. For the performance of its duties, the office has the powers as set forth in Article 2 (commencing with Section 11180) of Chapter 2 of Part 1 of Division 3 of Title 2 of the Government Code.
(b)Issuing conditional licenses to persons for the cultivation, manufacture, transportation, storage, distribution, and sale of medical marijuana within the state.
(c)Setting application, licensing, and renewal fees for conditional licenses issued pursuant to Section 18117.
(d)Establishing standards for the cultivation, manufacturing, transportation, storage, distribution, provision, testing, donation, and sale of medical marijuana and medical marijuana products.
(e)Establishing procedures for the issuance, renewal, suspension, denial, and revocation of conditional licenses.
(f)Enforcing the licensing and regulatory requirement of this part, subject to the requirements of Section 18126.
(g)Imposing a penalty authorized by this part or any rule or regulation adopted pursuant to this part.
(h)Taking action with respect to an application for a conditional license in accordance with procedures established pursuant to this part.
(i)Overseeing the operation of the Medical Marijuana Regulation Fund and the Special Account for Environmental Enforcement, established pursuant to Section 18118.
(j)Consulting with other state or local agencies, departments, representatives of the medical marijuana community, or public or private entities for the purposes of establishing statewide standards and regulations.
18104.(a)On or before January 1, 2018, the office shall promulgate regulations for implementation and enforcement of this part, including, but not limited to, all of the following:
(1)Procedures for the issuance, renewal, suspension, denial, and revocation of conditional licenses.
(2)Procedures for appeal of fines and the appeal of denial, suspension, or revocation of conditional licenses.
(3)Application, licensing, and renewal forms and fees.
(4)A time period in which the office shall approve or deny an application for a conditional license pursuant to this part.
(5)Qualifications for licensees.
(b)The office, in consultation with the Division of Labor Standards Enforcement, shall adopt regulations establishing worker safety standards for entities licensed pursuant to this part.
(c)The office shall not issue a conditional license unless the applicant has met all of the requirements of this part, including the requirements of subdivision (d) of Section 18110, and has demonstrated compliance with all applicable agricultural requirements, consumer protection requirements, food and product safety requirements, and environmental requirements, including, but not limited to, applicable water quality standards.
18104.5.(a)On or before April 1, 2016, the office shall convene an advisory committee to advise the office on the development of standards and regulations pursuant to this chapter. The advisory committee shall recommend to the office the appropriate roles of each state entity as it pertains to this chapter, and shall recommend guidelines on communication and information sharing between state entities, and with local agencies, for implementation of this chapter.
(b)The advisory committee shall be comprised of gubernatorial and legislative appointees, including, but not limited to, representatives of the medical marijuana industry, appropriate local and state agencies, appropriate local and state law enforcement, physicians, environmental and public health experts, and medical marijuana patient advocates.
(c)(1)The advisory committee shall submit a report on these standards, determinations, and guidelines for implementation of this chapter to the Legislature and state entities affected by this chapter by August 1, 2016.
(2)The report submitted to the Legislature shall be submitted in compliance with Section 9795 of the Government Code.
(3)The requirement for submitting a report imposed pursuant to this subdivision is inoperative on January 1, 2020, pursuant to Section 10231.5 of the Government Code.
18105.(a)The chief shall keep a complete record of all facilities issued a conditional license.
(b)This record shall be made available on the offices Internet Web site.
(c)The office shall not disclose information that the office determines is sensitive and should not be publicly disclosed, including, but not limited to, the address or location of cultivation sites.
(d)Upon request, the office shall provide summary information on all licensed, licensees, including, but not limited to, the name of the licensee, the date the license was issued, the status of the license, and the licensees mailing address.
18106.The office shall establish procedures to provide state and local law enforcement, enforcement and state and local agencies, upon their request, with 24-hour access to information to verify a conditional license, track transportation manifests, and track the inventories of facilities issued a conditional license.
18107.This part shall in no way supersede the provisions of Measure D, approved by the voters of the City of Los Angeles on the May 21, 2013, ballot for the city, or any similar measure in other jurisdictions, which grants medical marijuana businesses and dispensaries qualified immunity consistent with the terms of the measure and local ordinances. Notwithstanding the provisions of this part, marijuana businesses and dispensaries subject to the provisions of Measure D or other similar qualified immunity shall continue to be subject to the ordinances and regulations of the relevant local jurisdiction. Immunity granted by Measure D shall be sufficient to comply with the requirement of local approval for licensure pursuant to Section 18110.
2.Conditional Licenses18108.The following persons are exempt from the requirement of licensure under this part:
(a)A patient who cultivates, possesses, stores, manufactures, or transports marijuana exclusively for his or her personal medical use and who does not sell, distribute, donate, or provide marijuana to any other person or entity.
(b)A primary caregiver who cultivates, possesses, stores, manufactures, transports, or provides marijuana exclusively for the personal medical purposes to no more than five specified qualified patients for whom he or she is the primary caregiver within the meaning of Section 11362.7 of the Health and Safety Code and who does not receive remuneration for these activities, except for compensation in full compliance with subdivision (c) of Section 11362.765 of the Health and Safety Code. Nothing in this section shall permit primary caregivers to organize themselves as cooperatives or collectives of caregivers.
18109.(a)Except as provided in Section 11362.5 of, and Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10 of, the Health and Safety Code, a person shall not sell or provide medical marijuana to a patient or caregiver other than at a licensed dispensing facility or through delivery from a licensed dispensing facility.
(b)Except as provided in Section 11362.5 of, and Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10 of, the Health and Safety Code, a person shall not grow medical marijuana other than at a licensed cultivation site.
(c)Except as provided in Section 11362.5 of, and Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10 of, the Health and Safety Code, a person shall not manufacture medical marijuana or medical marijuana products other than a licensed manufacturer.
(d)A person other than a licensed transporter shall not transport medical marijuana from one facility issued a conditional license to another.
(e)A licensed manufacturer may obtain medical marijuana from a licensed cultivator and may furnish medical marijuana products to a licensed dispensary.
18110.(a)Beginning no later than July 1, 2018, the office shall provide for and shall issue conditional licenses. Conditional licenses shall be required for all activity authorized under this chapter, including, but not limited to, cultivation, processing, storage, transport, transportation, and dispensing of medical marijuana.
(b)The issuance of a conditional license shall not, in and of itself, authorize the recipient to begin business operations. The conditional license shall certify, at a minimum, that the applicant has paid the state conditional licensing fee, successfully passed a criminal background check, and met the state residency requirements.
(c)A conditionally licensed facility shall not commence activity under the authority of a conditional license until the applicant has also obtained a license or permit from the local jurisdiction in which he or she proposes to operate, following the requirements of local ordinances.
(d)An applicant for a conditional license shall do all of the following:
(1)Pay the fee or fees required by this part for each license being applied for.
(2)Register with the office on forms prescribed by the chief. The forms shall contain sufficient information to identify the licensee, including all of the following:
(A)Name of the owner or owners of a proposed facility, including all persons or entities having an ownership interest other than a security interest, lien, or encumbrance on property that will be used by the applicant.
(B)The name, address, and date of birth of each principal officer and board member.
(C)The address and telephone number of the proposed facility.
(D)In the case of a cultivation site, the GPS coordinates of the site.
(3)Describe, in writing, the scope of business of the proposed facility.
(4)Provide evidence that the applicant and owner have been legal full-time residents of the state for not less than 12 months.
(5)Provide detailed operating procedures, in writing, for the proposed facility, which shall include, but not be limited to, procedures for facility and operational security, prevention of diversion, employee screening, storage of medical marijuana, personnel policies, and recordkeeping procedures.
(6)Provide evidence that the applicant has received all required environmental permits, including compliance with the California Environmental Quality Act, and wastewater discharge permits.
(7)Provide the applicants fingerprint images. For purposes of this paragraph, applicant means the owner or owners of a proposed facility, including all persons or entities having an ownership interest other than a security interest, lien, or encumbrance on property that will be used by the facility.
(A)The applicant shall electronically submit to the Department of Justice fingerprint images and related information required by the Department of Justice for the purpose of obtaining information as to the existence and content of a record of state or federal convictions and arrests, and information as to the existence and content of a record of state or federal convictions and arrests for which the Department of Justice establishes that the person is free on bail, or on his or her own recognizance, pending trial or appeal.
(B)The Department of Justice shall provide a response to the office pursuant to paragraph (1) of subdivision (p) of Section 11105 of the Penal Code.
(C)The office shall request from the Department of Justice subsequent notification service, as provided pursuant to Section 11105.2 of the Penal Code, for persons described in subparagraph (A).
(D)The Department of Justice shall charge the applicant a fee sufficient to cover the reasonable cost of processing the requests described in this paragraph.
(8)Provide a statement, signed by the applicant under penalty of perjury, that the information provided is true.
(9)Provide any other information required by the office.
(e)Each location and each discrete use of a single location shall require a conditional license. Each application for a conditional license is separate and distinct, and the office may charge a separate fee for each.
(f)A conditional license issued pursuant to this section shall be valid for 12 months after the date of issuance. After the initial 12-month period, a conditional license may be renewed for a period of 36 24 months. The office shall establish procedures for the renewal of a conditional license.
(g)Notwithstanding any other law, the office shall not issue a conditional license to an individual or entity, or for a premise, against whom there is a pending state or local administrative or judicial proceeding, against whom there is an action initiated by a city, county, or city and county under a local ordinance, or who has been determined to have violated an applicable local ordinance.
(h)A facility or entity that is operating in conformance compliance with local zoning ordinances and other state and local requirements on January 1, 2016, may continue its operations until its application for conditional licensure is approved or denied pursuant to this part.
18111.(a)Upon receipt of the application materials and fee required in Section 18110, the office, provided the applicant has not committed an act or crime constituting grounds for the denial of licensure under Section 18112, may issue the conditional license and send a proof of issuance to the applicant.
(b)The chief shall, by regulation, prescribe conditions upon which a person whose conditional license has previously been denied, suspended, or revoked, may be issued a conditional license.
18112.(a)An application for a conditional license shall be denied and a conditional license shall be suspended or revoked for a past felony conviction for the possession for sale, sale, manufacture, transportation, or cultivation of a controlled substance, a felony criminal conviction for drug trafficking, a felony conviction for embezzlement, a felony conviction involving fraud or deceit, or any violent or serious felony conviction pursuant to subdivision (c) of Section 667.5 of, or subdivision (c) of Section 1192.7 of, the Penal Code. A conditional license shall not be denied solely on the basis of a prior conviction for a felony that was committed after the enactment of the Compassionate Use Act, Act of 1996, but which would not be a felony after the enactment of the measure that added this part. The office, at its discretion, may issue a license to an applicant that would be otherwise denied pursuant to this subdivision subdivision, with the exception of the requirement of having been issued a conditional license, if the applicant has obtained a certificate of rehabilitation, pursuant to Section 4852.13 of the Penal Code.
(b)The chief, upon his or her determination, may deny, suspend, or revoke a conditional license when a conditional licensee, applicant, or employee, partner, officer, or member of an entity conditionally licensed does any of the following:
(1)Making or authorizing in any manner or by any means a written or oral statement that is untrue or misleading and that is known, or that by exercise of reasonable care should be known, to be untrue or misleading.
(2)Any other conduct that constitutes fraud.
(3)Conduct constituting gross negligence.
(4)Failure to comply with the provisions of this part, Article 8 (commencing with Section 111658) of Chapter 6 of Part 5 of Division 104 of the Health and Safety Code, or any rule or regulation adopted pursuant to this part.
(5)Conduct that constitutes grounds for denial of licensure pursuant to Chapter 2 (commencing with Section 480) of Division 1.5.
18113.(a)Upon denying, suspending, or revoking a conditional license, the chief shall notify the applicant or licensee, in writing, by personal service or mail addressed to the address of the applicant or licensee set forth in the application. The applicant or licensee shall be given a hearing within 30 days thereafter if he or she files with the office a written request for hearing. Otherwise, the denial, suspension, or revocation is deemed affirmed.
(b)All proceedings to deny, suspend, or revoke a conditional license shall be conducted pursuant to Chapter 5 (commencing with Section 11500) of Part 1 of Division 3 of Title 2 of the Government Code.
18114.An application for or renewal of a conditional license shall not be approved if the office determines any of the following:
(a)The applicant fails to meet the requirements of this part or has had an applicable permit or license revoked or denied by an applicable city, county, or city and county agency. If a local government adopts an ordinance or resolution authorizing medical marijuana to be cultivated, manufactured, stored, distributed, or sold within its jurisdiction, it shall submit to the office documentation detailing their renewal requirements.
(b)The applicant, or any of its officers, directors, owners, members, or shareholders, is a minor.
(c)The applicant has knowingly answered a question or request for information falsely on the application form or failed to provide information requested.
(d)The applicant, or any of its officers, directors, owners, members, or shareholders has been sanctioned by the office, a city, county, or city and county, for medical marijuana activities conducted in violation of this part or any applicable local ordinance or has had a license revoked in the previous five years.
(e)The proposed cultivation, processing, possession, storage, manufacturing, testing, transporting, distribution, provision, or sale of medical marijuana will violate any applicable local law or ordinance.
(f)The applicant or the owner is unable to establish that he or she has been a resident of the state for not less than 12 months.
18115.(a)In addition to the provisions of this part, a conditional license shall be subject to the restrictions of the local jurisdiction in which the facility operates or proposes to operate. Even if a conditional license has been granted pursuant to this part, a facility shall not operate in a local jurisdiction that prohibits the establishment of that type of business.
(b)In addition to the provisions of this part, local jurisdictions retain the power to assess fees and taxes, as applicable, on facilities that are conditionally licensed pursuant to this part and the business activities of those licensees.
18116.The office may adopt regulations to limit the number of conditional licenses issued pursuant to this part upon a finding that the otherwise unrestricted issuance of conditional licenses is dangerous to the public health and safety.
3.Fees18117.(a)The conditional licensing fee shall be established by the office at a level sufficient to fund the reasonable costs of all of the following:
(1)Administrative costs incurred by the office in overseeing the conditional licensing program, program and establishing health and safety standards, and certifying the required testing laboratories. standards.
(2)Costs incurred by the office or the Department of Justice for enforcement of the provisions of this part.
(3)Costs incurred by law enforcement and other public safety entities for enforcing the provisions of this part in their jurisdiction.
(b)In addition to the conditional licensing fee required pursuant to subdivision (a), a cultivation facility shall be assessed a fee in a sufficient amount to cover the reasonable regulatory costs of enforcing the environmental impact provisions relating to those cultivation facilities. This fee shall be distributed, as necessary and in proportion to its regulatory function, between the following agencies responsible for enforcing the regulations relating to the environmental impact of licensed cultivation sites:
(1)The State Water Resources Control Board.
(2)The Department of Fish and Wildlife.
(3)The Department of Forestry and Fire Protection.
(4)The Department of Pesticide Regulation.
(5)The Department of Food and Agriculture.
(6)Local law enforcement.
18118.(a)The Medical Marijuana Regulation Fund is hereby established within the State Treasury. Notwithstanding Section 16305.7 of the Government Code, the fund shall include any interest and dividends earned on the money in the fund.
(b)Except as provided in subdivision (c), all fees collected pursuant to this part shall be deposited into the Medical Marijuana Regulation Fund. All moneys within the fund are available, upon appropriation by the Legislature, to the office solely for the purposes of fully funding and administering this part, including, but not limited to, the costs incurred by the office for its administrative expenses.
(c)The Special Account for Environmental Enforcement is hereby established as an account within the Medical Marijuana Regulation Fund. Notwithstanding Section 16305.7 of the Government Code, the account shall include any interest and dividends earned on the money in the account. All fees collected pursuant to subdivision (b) of Section 18117 shall be deposited in this account. All moneys within the fund are available, upon appropriation by the Legislature, to the office for distribution to the entities listed in subdivision (b) of Section 18117 to be used to enforce the environmental regulation of licensed cultivation sites.
(d)All moneys collected as a result of penalties imposed under this part shall be deposited directly into the General Fund, to be available upon appropriation.
(e)The office may establish and administer a grant program to allocate moneys from the Medical Marijuana Regulation Fund to state and local entities for the purpose of assisting with medical marijuana regulation and the enforcement of this part.
18119.(a)A facility issued a conditional license shall not acquire, cultivate, process, possess, store, manufacture, distribute, sell, deliver, transfer, transport, or dispense medical marijuana for any purpose other than those authorized by Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10 of the Health and Safety Code.
(b)A licensed dispensing facility shall not acquire, cultivate, process, possess, store, manufacture, distribute, sell, deliver, transfer, transport, or dispense medical marijuana plants or medical marijuana products except through a licensed cultivation site or a licensed manufacturer.
4.Transportation of Medical Marijuana18120.(a)A licensed transporter shall ship only to facilities issued a conditional license and only in response to a request for a specific quantity and variety from those facilities.
(b)Prior to transporting medical marijuana or medical marijuana products, a licensed transporter shall do both of the following:
(1)Complete a shipping manifest using a form prescribed by the office.
(2)Securely transmit a copy of the manifest to the licensee that will receive the medical marijuana or medical marijuana product, and to the office, prior to transport.
(c)The licensed transporter making the shipment and the licensee receiving the shipment shall maintain each shipping manifest and make it available to local code enforcement officers, any other locally designated enforcement entity, and the office upon request.
18121.(a)Transported medical marijuana and medical marijuana products shall:
(1)Be transported only in a locked, safe, and secure storage compartment that is securely affixed to the interior of the transporting vehicle.
(2)Not be visible from outside the vehicle.
(b)A vehicle transporting medical marijuana or medical marijuana products shall not have external markings or other indications that it is transporting medical marijuana.
(c)A vehicle transporting medical marijuana products shall travel directly from one licensed facility to another licensed facility authorized to receive the shipment.
(d)The provisions of this section only apply to a licensed transporter.
18122.(a)All transport vehicles carrying medical marijuana with a retail value greater than ten thousand dollars ($10,000) shall be staffed with a minimum of two employees. At least one transport team member shall remain with the vehicle at all times when the vehicle contains medical marijuana.
(b)Each transport team member shall have access to a secure form of communication by which each member can communicate with personnel at the licensed facility at all times when the vehicle contains medical marijuana.
(c)Each transport team member shall possess documentation of licensing and a government-issued identification card at all times when transporting or delivering medical marijuana and shall produce it to any representative of the office or law enforcement upon request.
(d)This part shall not be construed to authorize or permit a licensee to transport, or cause to be transported, medical marijuana or medical marijuana products outside the state.
(e)The requirements of this section shall only apply to a licensed transporter.
18123.A local jurisdiction shall not prevent transportation through or to a facility issued a conditional license, by a conditionally licensed transporter who acts in compliance with this part.
5.Enforcement18124.A state agency is not required by this section to enforce a city, county, city and county, or local law, ordinance, rule, or regulation regarding the site or operation of a facility issued a conditional license.
18125.The office may assist state taxation authorities in the development of uniform policies for the state taxation of licensees.
18126.(a)The office may enforce all of the requirements of this part, including any regulations adopted pursuant to this part.
(b)The office shall delegate the authority to enforce the requirements of this part, including any regulations, to a city, county, or city and county, upon request of that entity.
(c)Nothing in this part shall be interpreted to supersede or limit existing local authority for law enforcement activity, enforcement of local zoning requirements, or enforcement of local licensing requirements.
(d)Nothing in this part shall be interpreted to require the office to undertake local law enforcement responsibilities, enforce local zoning requirements, or enforce local licensing requirements.
18127.(a)A willful violation of Section 18110, including an attempt to falsify information on an application or to otherwise defraud or mislead a state or local agency in the course of the application process, shall be punishable by a civil fine of up to thirty-five thousand dollars ($35,000) for each individual violation.
(b)A technical violation of Section 18110 shall, at the offices discretion, be punishable by a civil fine of up to ten thousand dollars ($10,000) for each individual violation.
18128.A district attorney, county counsel, city attorney, or city prosecutor prosecutor, the Attorney General, or the office may bring an action to enjoin a violation or the threatened violation of any provision of this part, including, but not limited to, a licensees failure to correct objectionable conditions following notice or as a result of a rule promulgated pursuant to this part. The action shall be brought in the county in which the violation occurred or is threatened to occur. A proceeding brought pursuant to this part shall conform to the requirements of Chapter 3 (commencing with Section 525) of Title 7 of Part 2 of the Code of Civil Procedure. Nothing in this section shall diminish the authority of a local government to take requisite enforcement actions pertaining to its own ordinances or regulations.
18129.Nothing in this part shall prevent a city or other local governing body from taking action as specified in Section 11362.83 of the Health and Safety Code.
18130.This part shall not be construed to limit a law enforcement agencys ability to investigate unlawful activity in relation to a facility issued a conditional license.
6.Cultivation Sites18132.(a)The office shall notify local law enforcement of all conditional licenses issues for cultivation sites in that jurisdiction.
(b)A licensed cultivation site shall display the state license in a manner so as to be available and easily read at the location.
18133.(a)No later than January 1, 2022, all medical marijuana grown, produced, distributed, and sold in the state shall meet the certified organic standards. standards equivalent to those for certified organic crops. Certification shall be by the office or an independent third party that contracts with the office for the purpose of certifying medical marijuana as organic.
(b)The office shall establish appellations of origin for marijuana grown in California.
18134.The office shall work with county agricultural commissioners, offices commissioners to provide all the information and forms required for conditional licensure as a cultivation site in a single location, including state licensure, local requirements in that jurisdiction, and environmental requirements.
7.Regulation of Medical Marijuana18136.(a)A person shall not distribute any form of advertising for physician recommendations for medical marijuana in California unless the advertisement bears the following notice to consumers:
NOTICE TO CONSUMERS: The Compassionate Use Act of 1996 ensures that seriously ill Californians have the right to obtain and use marijuana for medical purposes where medical use is deemed appropriate and has been recommended by a physician who has determined that the persons health would benefit from the use of medical marijuana. Physicians are licensed and regulated by the Medical Board of California and arrive at the decision to make this recommendation in accordance with accepted standards of medical responsibility. Marijuana is a Schedule I drug according to the federal Controlled Substances Act. Activity related to marijuana use is subject to federal prosecution, without protections provided by state law.
(b)Advertising for physician recommendations for medical marijuana shall meet all requirements of Section 651. Price advertising shall not be fraudulent, deceitful, or misleading, including statements or advertisements of bait, discounts, premiums, gifts, or statements of a similar nature.
18137.(a)A facility issued a conditional license shall implement sufficient security measures to both deter and prevent unauthorized entrance into areas containing medical marijuana or medical marijuana products and theft of medical marijuana or medical marijuana products at those facilities. These security measures shall include, but not be limited to, all of the following:
(1)Preventing individuals from remaining on the premises of the facility if they are not engaging in activity expressly related to the operations of the facility.
(2)Establishing limited access areas accessible only to authorized facility personnel.
(3)Storing all finished medical marijuana and medical marijuana products in a secured and locked room, safe, or vault, and in a manner as to prevent diversion, theft, and loss, except for limited amounts of marijuana used for display purposes, samples, or immediate sale.
(b)A facility issued a conditional license shall notify appropriate law enforcement authorities within 24 hours after discovering any of the following:
(1)Significant discrepancies identified during inventory. The level of significance shall be determined by the office.
(2)Diversion, theft, loss, or any criminal activity involving the facility or a facility agent.
(3)The loss or unauthorized alteration of records related to marijuana, registered qualifying patients, personal caregivers, or facility agents.
(4)Any other breach of security.
(c)A licensed cultivation site shall weigh, inventory, and account for on video, all medical marijuana to be transported prior to its leaving its origination location. Within eight hours after arrival at the destination, the licensed dispensing facility shall reweigh, reinventory, and account for on video, all transported marijuana.
18138.(a)A licensed cultivation site or licensed dispensing facility shall display the conditional license in a manner so as to be available and easily read at the location.
(b)The office shall notify local law enforcement of all conditional licenses issued for cultivation sites, manufacturers, and dispensaries in that jurisdiction.
18140.(a)Information identifying the names of patients, their medical conditions, or the names of their primary caregivers received and contained in records kept by the office for the purposes of administering this part are confidential and exempt from the California Public Records Act (Chapter 3.5 (commencing with Section 6250) of Division 7 of Title 1 of the Government Code) and are not subject to disclosure to an individual or private entity, except as necessary for authorized employees of the state to perform official duties pursuant to this part. shall be maintained in accordance with Chapter 1 (commencing with Section 123100) of Part 1 of Division 106 of the Health and Safety Code, Part 2.6 (commencing with Section 56) of Division 1 of the Civil Code, and other state and federal laws relating to confidential patient information.
(b)(1)Nothing in this section shall preclude any of the following:
(A)Office employees notifying state or local agencies about information submitted to the office that the employee suspects is falsified or fraudulent.
(B)Notifications from the office to state or local agencies of apparent violations of this part or an applicable local ordinance.
(C)Verification of requests by state or local agencies to confirm licenses and certificates issued by the office or other state agency.
(D)Providing information requested pursuant to a court order or subpoena issued by a court, an administrative agency, or local governing body authorized by law to issue subpoenas.
(2)Information shall not be disclosed beyond what is necessary to achieve the goals of a specific investigation or notification or the parameters of a specific court order or subpoena.
18141.(a)The actions of a licensee, its employees, and its agents, that are permitted pursuant to a conditional license and that are conducted in accordance with the requirements of this part and regulations adopted pursuant to this part, are not unlawful under state law and shall not be an offense subject to arrest or prosecution.
(b)The actions of a person who, in good faith and upon investigation, allows his or her property to be used by a licensee, its employees, and its agents, as permitted pursuant to a conditional license, are not unlawful under state law and shall not be an offense subject to arrest or prosecution.
(c)This section shall not be deemed to limit the authority or remedies of a city, county, or city and county under any law, including, without limitation, Section 7 of Article XI of the California Constitution.
18142.(a)A licensee shall not cultivate, process, store, manufacture, transport, or sell medical marijuana in the state unless accurate records are kept at the licensed premises of the growing, processing, storing, manufacturing, transporting, or selling by the licensee in the state. These records shall include the name and address of the supplier of marijuana received or possessed by the licensee, the location at which the marijuana was cultivated, the amount of marijuana received, the form in which it is received, the name of the employee receiving it, and the date of receipt. These records shall also include receipts for all expenditures incurred by the licensee and banking records, if any, for all funds obtained or expended in the performance of any activity under the authority of the conditional license. A licensee who has a conditional license for more than one premises may keep all records at one of the conditionally licensed premises. Required records shall be kept for a period of seven years from the date of the transaction.
(b)The office or a local agency delegated the authority to enforce the licensing requirements of this part may examine the books and records of a conditional licensee and may visit and inspect the premises of a conditional licensee, as the office or local agency deems necessary to perform its duties under this part.
(c)Books or records requested by the office or a local agency delegated the authority to enforce licensing requirements of this part shall be provided by the conditional licensee no later than five business days after the request is made.
(d)The office or a local agency delegated the authority to enforce the licensing requirements of this part may enter and inspect the premises of a facility issued a conditional license between the hours of 8 a.m. and 8 p.m. on any day that the facility is open, or at any reasonable time, to ensure compliance and enforcement of the provisions of this part or a local ordinance.
(e)If a licensee or an employee of a licensee refuses, impedes, obstructs, or interferes with an inspection pursuant to subdivision (d), the conditional license may be summarily suspended and the office shall directly commence proceedings for the revocation of the conditional license.
(f)If a licensee fails to maintain or provide the books and records required pursuant to this section, the licensee shall be subject to a civil fine of fifteen thousand dollars ($15,000) per individual violation.
(g)The office or a local agency delegated the authority to enforce the licensing requirement of this part may, at its discretion, require a licensee to contract for an independent audit of the records required under this section. The licensee shall be liable for all costs associated with such an audit.
SEC. 6.Section 23028 is added to the Government Code, to read:23028.(a)(1)A city, county, or city and county, county may impose a tax on the privilege of cultivating, dispensing, producing, processing, preparing, storing, providing, donating, selling, or distributing medical marijuana or medical marijuana products by a licensee operating pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code.
(2)The board of supervisors or city council shall specify in the ordinance proposing the tax the activities subject to the tax, the applicable rate or rates, the method of apportionment, if necessary, and the manner of collection of the tax. The tax may be imposed for general governmental purposes or for purposes specified in the ordinance by the board of supervisors or city council. supervisors.
(3)In addition to any other method of collection authorized by law, the board of supervisors may provide for the collection of the tax imposed pursuant to this section in the same manner, and subject to the same penalties and priority of lien, as other charges and taxes fixed and collected by the county. A tax imposed pursuant to this section is a tax and not a fee or special assessment. The board of supervisors shall specify whether the tax applies throughout the entire county or within the unincorporated area of the county.
(3)
(4)The tax authorized by this section may be imposed upon any or all of the activities set forth in paragraph (1) specified in the ordinance, regardless of whether the activity is undertaken individually, collectively, or cooperatively, and regardless of whether the activity is for compensation or gratuitously, as determined by the board of supervisors or city council.
(b)A tax imposed pursuant to this section shall be subject to applicable voter approval requirements imposed by law.
(c)For purposes of this section, marijuana has the same meaning as the term marijuana product set forth in Section 111658 of the Health and Safety Code.
(d)This section is declaratory of existing law and does not limit or prohibit the levy or collection or of any other fee, charge, or tax, or a license or service fee or charge upon, or related to, the activities set forth in subdivision (a) as otherwise provided by law, including Section 37100.5. law. This section shall not be construed as a limitation upon the taxing authority of a city, county, or city and county as provided by law.
(e)A tax imposed pursuant to this section is not a sales and use tax subject to Part 1.5 (commencing with Section 7200) of Division 2 of the Revenue and Taxation Code or a transactions and use tax subject to Chapter 2 (commencing with Section 7285) of Part 1.7 of Division 2 of the Revenue and Taxation Code. This subdivision shall not preclude imposition of any other tax authorized under this section upon the privilege of selling, storing, using, or consuming medical marijuana.
SEC. 7.Section 11362.775 of the Health and Safety Code is amended to read:11362.775.(a)Qualified patients, persons with valid identification cards, and the designated primary caregivers of qualified patients and persons with identification cards, who cultivate marijuana for medical purposes, shall not solely on the basis of that fact be subject to state criminal sanctions under Section 11357, 11358, 11359, 11360, 11366, 11366.5, or 11570.
(b)An individual employee, officer, or board member of a facility issued a conditional license pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code shall not be subject to state criminal sanctions under Section 11357, 11358, 11359, 11360, 11366, 11366.5, or 11570 and any successor statutes, based solely on holding a conditional license, for the possession, cultivation, processing, packaging, storage, transportation, sale, or distribution of medical marijuana to a facility holding a conditional license pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code or directly to a qualified patient, a person with a valid identification card, or the designated primary caregiver of a qualified patient or person with a valid identification card, within the state, unless the information contained on the licensing paperwork is false or falsified, the license has been obtained by means of fraud, or the person is otherwise in violation of Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code.
(c)This section shall not diminish the protections of Section 18141 of the Business and Professions Code.
SEC. 8.Article 8 (commencing with Section 111658) is added to Chapter 6 of Part 5 of Division 104 of the Health and Safety Code, to read:8.Medical Marijuana111658.For purpose purposes of this article, the following definitions shall apply:
(a)Edible medical marijuana product means medical marijuana or a medical marijuana-derived product that is ingested or meant to be ingested through the mouth and into the digestive system.
(b)Labor peace agreement means an agreement between an entity and a bona fide labor organization that, at a minimum, protects the states proprietary interests by prohibiting labor organizations and members from engaging in picketing, work stoppages, boycotts, and any other economic interference with the applicants business. This agreement means that the applicant has agreed not to disrupt efforts by the bona fide labor organization to communicate with, and attempt to organize and represent, the applicants employees.
(c)
(b)Marijuana means all parts of the plant Cannabis sativa L. sativa, Cannabis indica, or Cannabis ruderalis, whether growing or not; the seeds thereof; the resin, whether crude or purified, extracted from any part of the plant; and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds, or resin. Marijuana does not include the mature stalks of the plant, fiber produced from the stalks, oil or cake made from the seeds of the plant, any other compound, manufacture, salt, derivative, mixture, or preparation of the mature stalks (except the resin extracted therefrom), fiber, oil, or cake, or the sterilized seed of the plant which is incapable of germination. Marijuana also means marijuana, as defined by Section 11018.
(d)
(c)Office means the Office of Medical Marijuana Regulation in the Business, Consumer Affairs, and Housing Agency.
(e)Representative samples means samples taken from each batch or shipment of medical marijuana received from a licensed cultivation site or any other source if intended for sale.
111659.On or before July 1, 2017, the office shall report to the Legislature on the feasability feasibility of developing a program to certify laboratories for the testing of medical marijuana and related products and the feasability feasibility of developing a labeling requirement for edible marijuana products that incorporates information on the cannabinoid content.
111660.(a)A facility issued a conditional license pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code shall bear the responsibility for both of the following:
(1)
(a)Maintaining supplier information in order for recall procedures to be implemented, if and when necessary.
(2)
(b)Labeling of all medical marijuana and medical marijuana products that shall, at a minimum, include the following:
(A)
(1)List of pharmacologically active ingredients, including, but not limited to, tetrahydrocannabinol (THC) and cannabidiol (CBD) content, clear recommended dosage, and the size or volume of the recommended dose. the quantity of active ingredients per serving, and the total amount within the package. For purposes of this paragraph, the office shall determine the appropriate size of one serving.
(B)
(2)Clear indication, in bold font, that the product contains medical marijuana.
(C)
(3)The statement FOR MEDICAL USE ONLY. KEEP OUT OF REACH OF CHILDREN AND ANIMALS in bold print.
(D)
(4)Identification of the source and date of cultivation and manufacture.
(E)
(5)The name and location of the dispensary providing the product.
(F)
(6)The date of sale.
(G)
(7)Any other requirements set by the office.
111662.For purposes of this article, edible medical marijuana products are deemed to be unadulterated food products. In addition to the quality assurance standards provided in Section 111661, all edible medical marijuana products shall comply with the following requirements:
(a)Baked edible medical marijuana products, including, but not limited to, brownies, bars, cookies, and cakes, tinctures, and other edible medical marijuana products that do not require refrigeration or hot holding may be manufactured, sold, or otherwise distributed at facilities issued a conditional license pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code.
(b)A facility issued a conditional license pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code shall have an owner or employee who has successfully passed an approved and accredited food safety certification examination as specified in Sections 113947.1, 113947.2, and 113947.3 prior to selling, manufacturing, or distributing edible medical marijuana products requiring refrigeration or hot holding.
(c)Individuals manufacturing or selling edible medical marijuana products shall thoroughly wash their hands before commencing production and before handling finished edible medical marijuana products.
(d)All edible medical marijuana products sold for direct consumption and infused with marijuana concentrate shall be individually wrapped at the original point of preparation.
(e)Products containing tetrahydrocannabinol (THC) shall be prepared in compliance with maximum potency standards for THC and THC concentrates set forth in the bureaus offices regulations.
(f)Prior to sale or distribution at a licensed dispensing facility, edible medical marijuana products shall be labeled and in an opaque and a tamper evident package. Labels and packages of edible medical marijuana products shall meet the following requirements:
(1)Edible medical marijuana packages and labels shall not be made to be attractive to children.
(2)All In addition to the labeling requirements set forth in Section 111660, edible medical marijuana product labels shall include the following information, prominently displayed and in a clear and legible font:
(A)Manufacture date and source.
(B)The statement KEEP OUT OF REACH OF CHILDREN AND ANIMALS in bold print.
(C)The statement FOR MEDICAL USE ONLY.
(D)
(B)Net weight of medical marijuana in package.
(E)
(C)A warning if nuts or other known allergens are used and shall include the total weight, in ounces or grams, of medical marijuana in the package.
(F)List of pharmacologically active ingredients, including, but not limited to, tetrahydrocannabinol (THC) and cannabidiol (CBD) content, clear recommended dosage, and the size or volume of recommended dose.
(G)
(D)Any other requirement set by the office.
(g)Photos or images of food are not allowed on edible medical marijuana product packages or labels.
(h)Only generic food names may be used to describe edible medical marijuana products.
111663.All facilities issued a conditional license pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code that conduct business related to food or food-based products shall be subject to requirements equivalent to those of the California Retail Food Code and other applicable laws, as determined by the office.
SEC. 9.On or before July 1, 2016, the State Board of Equalization shall compile a report on the estimated tax collected on the sale of medical marijuana, using the most current data available. The report should also include expected tax revenues, under the existing tax structure, for the years 2016 to 2021, inclusive. This report shall be submitted to the Legislature and the Governors office pursuant to Section 9795 of the Government Code.
SEC. 10.The provisions of this act are severable. If any provision of this act or its application is held invalid, that invalidity shall not affect other provisions or applications that can be given effect without the invalid provision or application.
SEC. 11.The Legislature finds and declares that Section 5 of this act imposes a limitation on the publics right of access to the meetings of public bodies or the writings of public officials and agencies within the meaning of Section 3 of Article I of the California Constitution. Pursuant to that constitutional provision, the Legislature makes the following findings to demonstrate the interest protected by this limitation and the need for protecting that interest:
The limitation imposed under this act is necessary for purposes of compliance with the federal Health Insurance Portability and Accountability Act of 1996 (42 U.S.C. Sec. 1320d et seq.), the Confidentiality of Medical Information Act (Part 2.6 (commencing with Section 56) of Division 1 of the Civil Code), and the Insurance Information and Privacy Protection Act (Article 6.6 (commencing with Section 791) of Part 2 of Division 1 of the Insurance Code).
SEC. 12.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
SEC. 13.The amendments made to Section 11362.775 of the Health and Safety Code by this act shall become operative on July 1, 2017. 2018.
This act shall be known, and may be cited, as the Medical Marijuana Public Safety and Environmental Protection Act.
SEC. 2.The Legislature finds and declares all of the following:
(a)In 1996, the people of the State of California enacted the Compassionate Use Act of 1996, codified in Section 11362.5 of the Health and Safety Code. The people of the State of California declared that their purpose in enacting the measure was, among other things, to ensure that seriously ill Californians have the right to obtain and use marijuana for medical purposes where that medical use is deemed appropriate and has been recommended by a physician who has determined that the persons health would benefit from the use of marijuana in the treatment of cancer, anorexia, AIDS, chronic pain, spasticity, glaucoma, arthritis, migraine, or any other illness for which marijuana provides relief.
(b)The Compassionate Use Act of 1996 called on state government to implement a plan for the safe and affordable distribution of marijuana to all patients in medical need of marijuana, while ensuring that nothing in that act would be construed to condone the diversion of marijuana for nonmedical purposes.
(c)In 2003, the Legislature enacted the Medical Marijuana Program Act (MMPA), codified in Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10 of the Health and Safety Code.
(d)Greater certainty and minimum statewide standards are urgently needed regarding the obligations of medical marijuana facilities, and for the imposition and enforcement of regulations to prevent unlawful cultivation and the diversion of marijuana to nonmedical use.
(e)Despite the passage of the Compassionate Use Act of 1996 and the MMPA, because of the lack of an effective statewide system for regulating and controlling medical marijuana, cities, counties, and local law enforcement officials have been confronted with uncertainty about the legality of some medical marijuana cultivation and distribution activities. The current state of affairs makes law enforcement difficult and endangers patient safety because of an inability to monitor the supply of medical marijuana in the state and the lack of quality control, testing, and labeling requirements.
(f)The California Constitution grants cities and counties the authority to make and enforce, within their borders, all local police, sanitary, and other ordinances and regulations not in conflict with the general laws. This inherent local police power includes broad authority to determine, for purposes of public health, safety, and welfare, the appropriate uses of land within the local jurisdictions borders. The police power, therefore, allows each city and county to determine whether or not a medical marijuana dispensary or other facility that makes medical marijuana available may operate within its borders. This authority has been upheld by City of Riverside v. Inland Empire Patients Health and Wellness Center, Inc. (2013) 56 Cal.4th 729 and County of Los Angeles v. Hill (2011) 192 Cal.App.4th 861. Nothing in this act shall diminish, erode, or modify that authority.
(g)If a city or county determines that a dispensary or other facility that makes medical marijuana available may operate within its borders, then there is a need for the state and local governments to license these dispensaries and other facilities for the purpose of adopting and enforcing protocols for security standards at dispensaries and in the transportation of medical marijuana, as well as health and safety standards to ensure patient safety. This licensing requirement is not intended in any way nor shall it be construed to preempt local ordinances, regulations, or enforcement actions regarding the sale and use of medical marijuana, including, but not limited to, security, signage, lighting, and inspections.
(h)Greater oversight, uniformity, and enforcement are urgently needed regarding the obligations and rights of medical marijuana cultivators, transporters, and distribution facilities.
(i)Marijuana has widely accepted medical applications that make it inappropriate to be classified as a Schedule I controlled substance in the State of California.
(j)For the protection of Californians, the state must act to regulate and control commercial medical marijuana and not preempt local government ordinances. Cities and counties Counties should be allowed to impose local taxes and enact zoning regulations and other restrictions applicable to the cultivation, transportation, and distribution of medical marijuana based on local needs.
(k)For the protection of Californias environment and its natural resources, all efforts must be made to prevent and mitigate the harmful environmental impacts that can be associated with some marijuana cultivation.
(l)Illegal trespass grows on private and public property pose a threat to public safety and the environment.
(l)
(m)The North Coast Regional Water Quality Control Board is currently in the process of promulgating regulations that would create a 3-tiered system for cultivator wastewater discharge permits. A similar permitting system would assist the state in controlling damaging wastewater runoff from cultivation sites, while minimizing the burden on smaller cultivators.
(m)
(n)Nothing in this act shall have a diminishing effect on the rights and protections granted to a patient or primary caregiver pursuant to the Compassionate Use Act of 1996.
(n)
(o)Nothing in this act shall be construed to promote or facilitate the nonmedical, recreational possession, sale, or use of marijuana.
SEC. 3.Section 2220.05 of the Business and Professions Code is amended to read:2220.05.(a)In order to ensure that its resources are maximized for the protection of the public, the Medical Board of California shall prioritize its investigative and prosecutorial resources to ensure that physicians and surgeons representing the greatest threat of harm are identified and disciplined expeditiously. Cases involving any of the following allegations shall be handled on a priority basis, as follows, with the highest priority being given to cases in the first paragraph:
(1)Gross negligence, incompetence, or repeated negligent acts that involve death or serious bodily injury to one or more patients, such that the physician and surgeon represents a danger to the public.
(2)Drug or alcohol abuse by a physician and surgeon involving death or serious bodily injury to a patient.
(3)Repeated acts of clearly excessive prescribing, furnishing, or administering of controlled substances, or repeated acts of prescribing, dispensing, or furnishing of controlled substances, or recommending marijuana to patients for medical purposes, without a good faith prior examination of the patient and medical reason therefor. However, in no event shall a physician and surgeon prescribing, furnishing, or administering controlled substances for intractable pain consistent with lawful prescribing, including, but not limited to, Sections 725, 2241.5, and 2241.6 of this code and Sections 11159.2 and 124961 of the Health and Safety Code, be prosecuted for excessive prescribing and prompt review of the applicability of these provisions shall be made in any complaint that may implicate these provisions.
(4)Sexual misconduct with one or more patients during a course of treatment or an examination.
(5)Practicing medicine while under the influence of drugs or alcohol.
(b)The board may by regulation prioritize cases involving an allegation of conduct that is not described in subdivision (a). Those cases prioritized by regulation shall not be assigned a priority equal to or higher than the priorities established in subdivision (a).
(c)The Medical Board of California shall indicate in its annual report mandated by Section 2312 the number of temporary restraining orders, interim suspension orders, and disciplinary actions that are taken in each priority category specified in subdivisions (a) and (b).
SEC. 4.Article 25 (commencing with Section 2525) is added to Chapter 5 of Division 2 of the Business and Professions Code, to read:25.Recommending Medical Marijuana2525.(a)It is unlawful for a physician and surgeon who recommends marijuana to a patient for a medical purpose to accept, solicit, or offer any form of remuneration from or to a facility issued a conditional license pursuant to Part 5 (commencing with Section 18100) of Division 7, if the physician and surgeon or his or her immediate family have a financial interest in that facility.
(b)For the purposes of this section, financial interest shall have the same meaning as in Section 650.01.
(c)A violation of this section shall be a misdemeanor.
2525.1.The Medical Board of California shall consult with the California Marijuana Research Program, known as the Center for Medicinal Cannabis Research, authorized pursuant to Section 11362.9 of the Health and Safety Code, on developing and adopting medical guidelines for the appropriate administration and use of medical marijuana.
2525.2.A physician and surgeon shall not recommend medical marijuana to a patient, unless that person is the patients attending physician, as defined by subdivision (a) of Section 11362.7 of the Health and Safety Code.
SEC. 5.Part 5 (commencing with Section 18100) is added to Division 7 of the Business and Professions Code, to read:5.Medical Marijuana1.General Provisions18100.For purposes of this part, the following definitions shall apply:
(a)Bureau means the Bureau of Medical Marijuana Regulation in the Department of Consumer Affairs.
(b)Certified testing laboratory means a laboratory that is certified by the bureau to perform random sample testing of medical marijuana pursuant to the certification standards for these facilities promulgated by the bureau.
(c)
(a)Chief means the Chief of the Bureau Office of Medical Marijuana Regulation.
(d)Department means the Department of Consumer Affairs.
(e)Director means the Director of Consumer Affairs.
(f)
(b)Dispensary means a distribution operation that provides medical marijuana or medical marijuana derived products to patients and caregivers.
(g)
(c)Fund means the Medical Marijuana Regulation Fund established pursuant to Section 18118.
(h)
(d)Licensed cultivation site means a facility that plants, grows, cultivates, harvests, dries, or processes medical marijuana and that is issued a conditional license pursuant to this part.
(i)
(e)Licensed dispensing facility means a dispensary or other facility that provides medical marijuana, medical marijuana products, or devices for the use of medical marijuana or medical marijuana products that is issued a conditional license pursuant to this part.
(j)
(f)Licensed manufacturer means a person who extracts, prepares, derives, produces, compounds, or repackages medical marijuana or medical marijuana products into consumable and nonconsumable forms and that is issued a conditional license pursuant to this part.
(k)
(g)Licensed transporter means an individual or entity issued a conditional license by the bureau office to transport medical marijuana to and from facilities that have been issued conditional licenses pursuant to this part or medical marijuana products above a quantity limit established by the office.
(l)
(h)Marijuana means all parts of the plant Cannabis sativa, Cannabis indica, or Cannabis ruderalis, whether growing or not; the seeds thereof; the resin, whether crude or purified, extracted from any part of the plant; and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds, or resin. Marijuana does not include the mature stalks of the plant, fiber produced from the stalks, oil or cake made from the seeds of the plant, any other compound, manufacture, salt, derivative, mixture, or preparation of the mature stalks (except the resin extracted therefrom), fiber, oil, or cake, or the sterilized seed of the plant which is incapable of germination. Marijuana also means marijuana, as defined by Section 11018 of the Health and Safety Code.
(m)Trespass grows means illicit marijuana cultivation on public or private land without the explicit permission of the landowner.
(i)Office means the Office of Medical Marijuana Regulation in the Business, Consumer Affairs, and Housing Agency.
18101.(a)There is hereby created in the Department of Consumer Affairs the Bureau Business, Consumer Affairs, and Housing Agency the Office of Medical Marijuana Regulation, under the supervision and control of the Chief of the Bureau Office of Medical Marijuana Regulation.
(b)Protection of the public shall be the highest priority for the bureau office in exercising its licensing, regulatory, and disciplinary functions. Whenever the protection of the public is inconsistent with other interests sought to be promoted, the protection of the public shall be paramount.
(c)The bureau office shall have the authority to issue, suspend, or revoke conditional licenses for the cultivation, manufacture, transportation, storage, distribution, and sale of medical marijuana within the state and to collect fees in connection with these actions. The bureau office shall have the authority to create, issue, suspend, or revoke other licenses in order to protect patient health and the public and to facilitate the regulation of medical marijuana.
(d)(1)The Governor shall appoint the chief at a salary to be fixed and determined by the director secretary with the approval of the Director of Finance. The chief shall serve in accordance with the State Civil Service Act (Part 2 (commencing with Section 18500) of Division 5 of Title 2 of the Government Code).
(2)Appointment of the chief shall be subject to confirmation by the Senate Committee on Rules.
(e)The duty of enforcing and administering this part shall be vested in the chief, who is responsible to the director. chief. The chief may adopt and enforce those rules and regulations that he or she determines are reasonably necessary to carry out the purposes of this part and declaring the policy of the bureau, office, including a system for the issuance of citations for violations of this part, as specified in Section 18127.
(f)The chief, as necessary to carry out the provisions of this part, and in accordance with the State Civil Service Act (Part 2 (commencing with Section 18500) of Division 5 of Title 2 of the Government Code), may appoint and fix the compensation of personnel, including, but not limited to, clerical, inspection, investigation, and auditing personnel, as well as an assistant chief. These personnel shall perform their respective duties under the supervision and the direction of the chief.
(g)Every power granted to, or duty imposed upon, the chief under this part may be exercised or performed in the name of the chief by a deputy or assistant chief, subject to conditions and limitations that the chief prescribes.
(h)The bureau office shall exercise its authority pursuant to this part consistent with Section 1 of the act that added this section and consistent with the provisions of this part.
18102.Funds for the establishment and support of the bureau office shall be advanced as a loan by the department from the General Fund and shall be repaid by the initial proceeds from fees collected pursuant to this part or any rule or regulation adopted pursuant to this part.
18103.The bureau office shall have the authority necessary for the implementation of this part, including, but not limited to, all of the following:
(a)Establishing rules or regulations necessary to carry out the purposes and intent of this part and to enable the bureau office to exercise the powers and perform the duties conferred upon it by this part and in accordance with Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code. These rules and regulations shall not limit any authority of a city, county, or city and county provided by law. For the performance of its duties, the bureau office has the powers as set forth in Article 2 (commencing with Section 11180) of Chapter 2 of Part 1 of Division 3 of Title 2 of the Government Code.
(b)Issuing conditional licenses to persons for the cultivation, manufacture, transportation, storage, distribution, and sale of medical marijuana within the state.
(c)Setting application, licensing, and renewal fees for conditional licenses issued pursuant to Section 18117.
(d)Establishing standards for the cultivation, manufacturing, transportation, storage, distribution, provision, donation, and sale of medical marijuana and medical marijuana products.
(e)Establishing procedures for the issuance, renewal, suspension, denial, and revocation of conditional licenses.
(f)Enforcing the licensing and regulatory requirement of this part, subject to the requirements of Section 18126.
(f)
(g)Imposing a penalty authorized by this part or any rule or regulation adopted pursuant to this part.
(g)
(h)Taking action with respect to an application for a conditional license in accordance with procedures established pursuant to this part.
(h)
(i)Overseeing the operation of the Medical Marijuana Regulation Fund and the Special Account for Environmental Enforcement, established pursuant to Section 18118.
(i)
(j)Consulting with other state or local agencies, departments, representatives of the medical marijuana community, or public or private entities for the purposes of establishing statewide standards and regulations.
(j)Certifying laboratories to perform testing of medical marijuana.
18104.(a)On or before January 1, 2018, the bureau office shall promulgate regulations for implementation and enforcement of this part, including, but not limited to, all of the following:
(1)Procedures for the issuance, renewal, suspension, denial, and revocation of conditional licenses.
(2)Procedures for appeal of fines and the appeal of denial, suspension, or revocation of conditional licenses.
(3)Application, licensing, and renewal forms and fees.
(4)A time period in which the bureau office shall approve or deny an application for a conditional license pursuant to this part.
(5)Qualifications for licensees.
(6)Standards for certification of testing laboratories to perform random sample testing of all medical marijuana products, including standards for onsite testing.
(A)Certification of testing laboratories shall be consistent with general requirements for the competence of testing and calibration activities, including sampling, using standard methods established by the International Organization for Standardization, specifically ISO/IEC 17025.
(B)These requirements shall apply to all entities, including third-party laboratories, engaged in the testing of medical marijuana pursuant to this part.
(7)Requirements to ensure conformance with standards analogous to state statutory environmental, agricultural, consumer protection, and food and product safety requirements. At a minimum, these standards shall do all of the following:
(A)Prescribe sanitation standards analogous to the California Retail Food Code (Part 7 (commencing with Section 113700) of Division 104 of the Health and Safety Code) for food preparation, storage, handling, and sale of edible medical marijuana products.
(B)Require that edible medical marijuana products produced, distributed, provided, donated, or sold by licensees shall be limited to nonpotentially hazardous food, as established by the State Department of Public Health pursuant to Section 114365.5.
(C)Require that facilities in which edible medical marijuana products are prepared shall be constructed in accordance with applicable building standards, health and safety standards, and other state laws.
(D)Provide that weighing or measuring devices used in connection with the sale or distribution of medical marijuana are required to meet standards analogous to Division 5 (commencing with Section 12001).
(E)Require that the application of pesticides or other pest control in connection with the indoor or outdoor cultivation of medical marijuana shall meet standards analogous to Division 6 (commencing with Section 11401) of the Food and Agricultural Code and its implementing regulations.
(b)On or before July 1, 2017, the bureau shall also promulgate regulations for minimum statewide health and safety standards and quality assurance standards associated with the cultivation, transport, storage, manufacture, and sale of all medical marijuana produced in this state. Consistent with Section 18126, local agencies shall have primary responsibility for enforcement of these standards in accordance with bureau regulations.
(c)
(b)The bureau, office, in consultation with the Division of Labor Standards Enforcement, shall adopt regulations establishing worker safety standards for entities licensed pursuant to this part.
(d)The bureau, in consultation with the State Water Resources Control Board, shall adopt regulations to ensure that commercial medical marijuana activity licensed pursuant to this part does not threaten the states environment and watersheds and is otherwise in conformance with the California Environmental Quality Act.
(e)
(c)The bureau office shall not issue a conditional license unless the applicant has met all of the requirements of this part, including the requirements of subdivision (d) of Section 18110, and has demonstrated compliance with all applicable agricultural requirements, consumer protection requirements, food and product safety requirements, and environmental requirements, including, but not limited to, applicable water quality standards.
18105.(a)The chief shall keep a complete record of all facilities issued a conditional license. This
(b)This record shall be made available on the bureaus offices Internet Web site.
(c)The office shall not disclose information that the office determines is sensitive and should not be publicly disclosed, including, but not limited to, the address or location of cultivation sites.
(d)Upon request, the office shall provide summary information on all licensed, including, but not limited to, the name of the licensee, the date the license was issued, the status of the license, and the licensees mailing address.
18106.The bureau office shall establish procedures to provide state and local law enforcement, upon their request, with 24-hour access to information to verify a conditional license, track transportation manifests, and track the inventories of facilities issued a conditional license.
18107.This part shall in no way supersede the provisions of Measure D, approved by the voters of the City of Los Angeles on the May 21, 2013, ballot for the city, or any similar measure in other jurisdictions, which grants medical marijuana businesses and dispensaries qualified immunity consistent with the terms of the measure and local ordinances. Notwithstanding the provisions of this part, marijuana businesses and dispensaries subject to the provisions of Measure D or other similar qualified immunity shall continue to be subject to the ordinances and regulations of the relevant local jurisdiction.
2.Conditional Licenses18108.The following persons are exempt from the requirement of licensure under this part:
(a)A patient who cultivates, possesses, stores, manufactures, or transports marijuana exclusively for his or her personal medical use and who does not sell, distribute, donate, or provide marijuana to any other person or entity.
(b)A primary caregiver who cultivates, possesses, stores, manufactures, transports, or provides marijuana exclusively for the personal medical purposes to no more than five specified qualified patients for whom he or she is the primary caregiver within the meaning of Section 11362.7 of the Health and Safety Code and who does not receive remuneration for these activities, except for compensation in full compliance with subdivision (c) of Section 11362.765 of the Health and Safety Code. Nothing in this section shall permit primary caregivers to organize themselves as cooperatives or collectives of caregivers.
18109.(a)Except as provided in Section 11362.5 of, and Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10 of, the Health and Safety Code, a person shall not sell or provide medical marijuana to a patient or caregiver other than at a licensed dispensing facility or through delivery from a licensed dispensing facility.
(b)Except as provided in Section 11362.5 of, and Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10 of, the Health and Safety Code, a person shall not grow medical marijuana other than at a licensed cultivation site.
(c)Except as provided in Section 11362.5 of, and Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10 of, the Health and Safety Code, a person shall not manufacture medical marijuana or medical marijuana products other than a licensed manufacturer.
(d)A person other than a licensed transporter shall not transport medical marijuana from one facility issued a conditional license to another, other than a licensed transporter. another.
(e)A licensed manufacturer may obtain medical marijuana from a licensed cultivator and may furnish medical marijuana products to a licensed dispensary.
(f)To meet the requirements of Article 8 (commencing with Section 111658) of Chapter 6 of Part 5 of Division 104 of the Health and Safety Code, medical marijuana and medical marijuana products shall be tested by a certified testing laboratory.
18110.(a)Beginning no later than July 1, 2018, the bureau office shall provide for and shall issue conditional licenses. Conditional licenses shall be issued required for all activity authorized under this chapter, including, but not limited to, cultivation, processing, storage, transport, and dispensing of medical marijuana.
(b)The issuance of a conditional license shall not, in and of itself, authorize the recipient to begin business operations. The conditional license shall certify, at a minimum, that the applicant has paid the state conditional licensing fee, successfully passed a criminal background check, and met the state residency requirements.
(c)In order to begin business operations pursuant to this chapter, an applicant shall, in addition to the conditional license, obtain a license or permit from the local jurisdiction in which he or she proposes to operate, following the requirements of the applicable local ordinances.
(c)A conditionally licensed facility shall not commence activity under the authority of a conditional license until the applicant has also obtained a license or permit from the local jurisdiction in which he or she proposes to operate, following the requirements of local ordinances.
(d)An applicant for a conditional license shall do all following:
(1)Pay the fee or fees required by this part for each license being applied for.
(2)Register with the bureau office on forms prescribed by the chief. The forms shall contain sufficient information to identify the licensee, including all of the following:
(A)Name of the owner or owners of a proposed facility, including all persons or entities having an ownership interest other than a security interest, lien, or encumbrance on property that will be used by the applicant.
(B)The name, address, and date of birth of each principal officer and board member.
(C)The address and telephone number of the proposed facility.
(D)In the case of a cultivation site, the GPS coordinates of the site.
(3)Describe, in writing, the scope of business of the proposed facility.
(4)Provide evidence that the applicant and owner have been legal full-time residents of the state for not less than 12 months.
(5)Provide detailed operating procedures, in writing, for the proposed facility, which shall include, but not be limited to, procedures for facility and operational security, prevention of diversion, employee screening, storage of medical marijuana, personnel policies, and recordkeeping procedures.
(6)Provide evidence that the applicant has received all required environmental permits, including compliance with the California Environmental Quality Act, and wastewater discharge permits.
(7)Provide the applicants fingerprint images. For purposes of this paragraph, applicant means the owner or owners of a proposed facility, including all persons or entities having an ownership interest other than a security interest, lien, or encumbrance on property that will be used by the facility.
(A)The applicant shall electronically submit to the Department of Justice fingerprint images and related information required by the Department of Justice for the purpose of obtaining information as to the existence and content of a record of state or federal convictions and arrests, and information as to the existence and content of a record of state or federal convictions and arrests for which the Department of Justice establishes that the person is free on bail, or on his or her own recognizance, pending trial or appeal.
(B)The Department of Justice shall provide a response to the bureau office pursuant to paragraph (1) of subdivision (p) of Section 11105 of the Penal Code.
(C)The bureau office shall request from the Department of Justice subsequent notification service, as provided pursuant to Section 11105.2 of the Penal Code, for persons described in subparagraph (A).
(D)The Department of Justice shall charge the applicant a fee sufficient to cover the reasonable cost of processing the requests described in this paragraph.
(8)Provide a statement, signed by the applicant under penalty of perjury, that the information provided is true.
(9)Provide any other information required by the bureau. office.
(e)Each location and each discrete use of a single location shall require a conditional license. Each application for a conditional license is separate and distinct, and the bureau office may charge a separate fee for each.
(f)A conditional license issued pursuant to this section shall be valid for 12 months after the date of issuance. After the initial 12-month period, a conditional license may be renewed for a period of 36 months. The bureau office shall establish procedures for the renewal of a conditional license.
(g)Notwithstanding any other law, the bureau office shall not issue a conditional license to an individual or entity, or for a premise, against whom there is a pending state or local administrative or judicial proceeding, against whom there is an action initiated by a city, county, or city and county under a local ordinance, or who has been determined to have violated an applicable local ordinance.
(h)A facility or entity that is operating in conformance with local zoning ordinances and other state and local requirements on January 1, 2016, may continue its operations until its application for conditional licensure is approved or denied pursuant to this part.
18111.(a)Upon receipt of the application materials and fee required in Section 18110, the bureau, office, provided the applicant has not committed an act or crime constituting grounds for the denial of licensure under Section 18112, may issue the conditional license and send a proof of issuance to the applicant.
(b)The chief shall, by regulation, prescribe conditions upon which a person whose conditional license has previously been denied, suspended, or revoked, may be issued a conditional license.
18112.(a)An application for a conditional license shall be denied and a conditional license shall be suspended or revoked for a past felony conviction for the possession for sale, sale, manufacture, transportation, or cultivation of a controlled substance, a felony criminal conviction for drug trafficking, a felony conviction for embezzlement, a felony conviction involving fraud or deceit, or any violent or serious felony conviction pursuant to subdivision (c) of Section 667.5 of, or subdivision (c) of Section 1192.7 of, the Penal Code. A conditional license shall not be denied solely on the basis of a prior conviction for a felony that was committed after the enactment of the Compassionate Use Act, but which would not be a felony after the enactment of the measure that added this part. The bureau, office, at its discretion, may issue a license to an applicant that would be otherwise denied pursuant to this subdivision if the applicant has obtained a certificate of rehabilitation, pursuant to Section 4852.13 of the Penal Code.
(b)The chief, upon his or her determination, may deny, suspend, or revoke a conditional license when a conditional licensee, applicant, or employee, partner, officer, or member of an entity conditionally licensed does any of the following:
(1)Making or authorizing in any manner or by any means a written or oral statement that is untrue or misleading and that is known, or that by exercise of reasonable care should be known, to be untrue or misleading.
(2)Any other conduct that constitutes fraud.
(3)Conduct constituting gross negligence.
(4)Failure to comply with the provisions of this part, Article 8 (commencing with Section 111658) of Chapter 6 of Part 5 of Division 104 of the Health and Safety Code, or any rule or regulation adopted pursuant to this part.
(5)Conduct that constitutes grounds for denial of licensure pursuant to Chapter 2 (commencing with Section 480) of Division 1.5.
18113.(a)Upon denying, suspending, or revoking a conditional license, the chief shall notify the applicant or licensee, in writing, by personal service or mail addressed to the address of the applicant or licensee set forth in the application. The applicant or licensee shall be given a hearing within 30 days thereafter if he or she files with the bureau office a written request for hearing. Otherwise, the denial, suspension, or revocation is deemed affirmed.
(b)All proceedings to deny, suspend, or revoke a conditional license shall be conducted pursuant to Chapter 5 (commencing with Section 11500) of Part 1 of Division 3 of Title 2 of the Government Code.
18114.An application for or renewal of a conditional license shall not be approved if the bureau office determines any of the following:
(a)The applicant fails to meet the requirements of this part or any regulation adopted pursuant to this part or any has had an applicable permit or license revoked or denied by an applicable city, county, or city and county ordinance or regulation. agency. If a local government adopts an ordinance or resolution authorizing medical marijuana to be cultivated, manufactured, stored, distributed, or sold within its jurisdiction, it shall submit to the bureau office documentation detailing their renewal requirements.
(b)The applicant, or any of its officers, directors, owners, members, or shareholders, is a minor.
(c)The applicant has knowingly answered a question or request for information falsely on the application form or failed to provide information requested.
(d)The applicant, or any of its officers, directors, owners, members, or shareholders has been sanctioned by the bureau, office, a city, county, or city and county, for medical marijuana activities conducted in violation of this part or any applicable local ordinance or has had a license revoked in the previous five years.
(e)The proposed cultivation, processing, possession, storage, manufacturing, testing, transporting, distribution, provision, or sale of medical marijuana will violate any applicable local law or ordinance.
(f)The applicant or the owner is unable to establish that he or she has been a resident of the state for not less than 12 months.
18115.(a)In addition to the provisions of this part, a conditional license shall be subject to the restrictions of the local jurisdiction in which the facility operates or proposes to operate. Even if a conditional license has been granted pursuant to this part, a facility shall not operate in a local jurisdiction that prohibits the establishment of that type of business.
(b)In addition to the provisions of this part, local jurisdictions retain the power to assess fees and taxes, as applicable, on facilities that are conditionally licensed pursuant to this part and the business activities of those licensees.
18116.The bureau office may adopt regulations to limit the number of conditional licenses issued pursuant to this part upon a finding that the otherwise unrestricted issuance of conditional licenses is dangerous to the public health and safety.
3.Fees18117.(a)The conditional licensing fee shall be established by the bureau office at a level sufficient to fund the reasonable costs of all of the following:
(1)Administrative costs incurred by the bureau office in overseeing the conditional licensing program, establishing health and safety standards, and certifying the required testing laboratories.
(2)Costs incurred by the bureau office or the Department of Justice for enforcement of the provisions of this part.
(3)Costs incurred by law enforcement and other public safety entities for enforcing the provisions of this part in their jurisdiction.
(b)In addition to the conditional licensing fee required pursuant to subdivision (a), a cultivation facility shall be assessed a fee in a sufficient amount to cover the reasonable regulatory costs of enforcing the environmental impact provisions relating to those cultivation facilities. This fee shall be distributed, as necessary and in proportion to its regulatory function, between the following agencies responsible for enforcing the regulations relating to the environmental impact of licensed cultivation sites:
(1)The State Water Resources Control Board.
(2)The Department of Fish and Wildlife.
(3)The Department of Forestry and Fire Protection.
(4)The Department of Pesticide Regulation.
(5)The Department of Food and Agriculture.
(6)Local law enforcement.
18118.(a)The Medical Marijuana Regulation Fund is hereby established within the State Treasury. Notwithstanding Section 16305.7 of the Government Code, the fund shall include any interest and dividends earned on the money in the fund.
(b)Except as provided in subdivision (c), all fees collected pursuant to this part shall be deposited into the Medical Marijuana Regulation Fund. Notwithstanding Section 13340 of the Government Code, all All moneys within the fund are hereby continuously appropriated, without regard to fiscal year, available, upon appropriation by the Legislature, to the bureau office solely for the purposes of fully funding and administering this part, including, but not limited to, the costs incurred by the bureau office for its administrative expenses.
(c)The Special Account for Environmental Enforcement is hereby established as an account within the Medical Marijuana Regulation Fund. Notwithstanding Section 16305.7 of the Government Code, the account shall include any interest and dividends earned on the money in the account. All fees collected pursuant to subdivision (b) of Section 18117 shall be deposited in this account. Notwithstanding Section 13340 of the Government Code, all All moneys within the fund are hereby continuously appropriated, without regard to fiscal year, available, upon appropriation by the Legislature, to the bureau office for distribution to the entities listed in subdivision (b) of Section 18117 to be used to enforce the environmental regulation of licensed cultivation sites.
(d)All moneys collected as a result of penalties imposed under this part shall be deposited directly into the General Fund, to be available upon appropriation.
(e)The bureau office may establish and administer a grant program to allocate moneys from the Medical Marijuana Regulation Fund to state and local entities for the purpose of assisting with medical marijuana regulation and the enforcement of this part and other state and local laws applicable to licensees. part.
18119.(a)A facility issued a conditional license shall not acquire, cultivate, process, possess, store, manufacture, distribute, sell, deliver, transfer, transport, or dispense medical marijuana for any purpose other than those authorized by Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10 of the Health and Safety Code.
(b)A licensed dispensing facility shall not acquire, cultivate, process, possess, store, manufacture, distribute, sell, deliver, transfer, transport, or dispense medical marijuana plants or medical marijuana products except through a licensed cultivation site or a licensed manufacturer.
4.Transportation of Medical Marijuana18120.(a)A licensed transporter shall ship only to facilities issued a conditional license and only in response to a request for a specific quantity and variety from those facilities.
(b)Prior to transporting medical marijuana products, a licensed transporter shall do both of the following:
(1)Complete a shipping manifest using a form prescribed by the bureau. office.
(2)Securely transmit a copy of the manifest to the licensee that will receive the medical marijuana product, and to the bureau, office, prior to transport.
(c)The licensed transporter making the shipment and the licensee receiving the shipment shall maintain each shipping manifest and make it available to local code enforcement officers, any other locally designated enforcement entity, and the bureau office upon request.
18121.(a)Transported medical marijuana products shall:
(1)Be transported only in a locked, safe, and secure storage compartment that is securely affixed to the interior of the transporting vehicle.
(2)Not be visible from outside the vehicle.
(b)A vehicle transporting medical marijuana shall not have external markings or other indications that it is transporting medical marijuana.
(b)
(c)A vehicle transporting medical marijuana products shall travel directly from one licensed facility to another licensed facility authorized to receive the shipment.
(d)The provisions of this section only apply to a licensed transporter.
18122.(a)All transport vehicles carrying medical marijuana with a retail value greater than ten thousand dollars ($10,000) shall be staffed with a minimum of two employees. At least one transport team member shall remain with the vehicle at all times when the vehicle contains medical marijuana.
(b)Each transport team member shall have access to a secure form of communication by which each member can communicate with personnel at the licensed facility at all times when the vehicle contains medical marijuana.
(c)Each transport team member shall possess documentation of licensing and a government-issued identification card at all times when transporting or delivering medical marijuana and shall produce it to any representative of the bureau office or law enforcement upon request.
(d)This part shall not be construed to authorize or permit a licensee to transport, or cause to be transported, medical marijuana or medical marijuana products outside the state.
(e)The requirements of this section shall only apply to a licensed transporter.
18123.A local jurisdiction shall not prevent transportation through or to a facility issued a conditional license, by a conditionally licensed transporter who acts in compliance with this part.
5.Enforcement18124.A state agency is not required by this section to enforce a city, county, city and county, or local law, ordinance, rule, or regulation regarding the site or operation of a facility issued a conditional license.
18125.The bureau office may assist state taxation authorities in the development of uniform policies for the state taxation of licensees.
18126.(a)For facilities issued a conditional license that are located within the incorporated area of a city, the city shall have full power and authority to enforce this part and Article 8 (commencing with Section 111658) of Chapter 6 of Part 5 of Division 104 of the Health and Safety Code and the rules, regulations, and standards promulgated by the bureau. The city shall further assume complete responsibility for any regulatory function relating to those licensees within the city limits that would otherwise be performed by the county or any county officer or employee, without liability, cost, or expense to the county.
(b)For licensed facilities located within the unincorporated area of a county, the county shall have full power and authority to enforce this part and Article 8 (commencing with Section 111658) of Chapter 6 of Part 5 of Division 104 of the Health and Safety Code and the rules, regulations, and standards promulgated by the bureau.
18126.(a)The office may enforce all of the requirements of this part, including any regulations adopted pursuant to this part.
(b)The office shall delegate the authority to enforce the requirements of this part, including any regulations, to a city, county, or city and county, upon request of that entity.
(c)Nothing in this part shall be interpreted to supersede or limit existing local authority for law enforcement activity, enforcement of local zoning requirements, or enforcement of local licensing requirements.
(d)Nothing in this part shall be interpreted to require the office to undertake local law enforcement responsibilities, enforce local zoning requirements, or enforce local licensing requirements.
18127.(a)A willful violation of Section 18110, including an attempt to falsify information on an application or to otherwise defraud or mislead a state or local agency in the course of the application process, shall be punishable by a civil fine of up to thirty-five thousand dollars ($35,000) for each individual violation.
(b)A technical violation of Section 18110 shall, at the bureaus offices discretion, be punishable by a civil fine of up to ten thousand dollars ($10,000) for each individual violation.
18128.A district attorney, county counsel, city attorney, or city prosecutor may bring an action to enjoin a violation or the threatened violation of any provision of this part, including, but not limited to, a licensees failure to correct objectionable conditions following notice or as a result of a rule promulgated pursuant to this part. The action shall be brought in the county in which the violation occurred or is threatened to occur. A proceeding brought pursuant to this part shall conform to the requirements of Chapter 3 (commencing with Section 525) of Title 7 of Part 2 of the Code of Civil Procedure. Nothing in this section shall diminish the authority of a local government to take requisite enforcement actions pertaining to its own ordinances or regulations.
18129.Nothing in this part shall prevent a city or other local governing body from taking action as specified in Section 11362.83 of the Health and Safety Code.
18130.This part shall not be construed to limit a law enforcement agencys ability to investigate unlawful activity in relation to a facility issued a conditional license.
6.Cultivation Sites18132.(a)The bureau office shall notify local law enforcement of all conditional licenses issues for cultivation sites in that jurisdiction.
(b)A licensed cultivation site shall display the state license in a manner so as to be available and easily read at the location.
(c)The bureau shall work with and assist state and local law enforcement to eliminate trespass grows in the state.
18133.(a)No later than January 1, 2022, all medical marijuana grown, produced, distributed, and sold in the state shall meet the certified organic standards.
(b)The bureau office shall establish appellations of origin for marijuana grown in California.
18134.The bureau office shall work with county agricultural commissioners, offices to provide all the information and forms required for conditional licensure as a cultivation site in a single location, including state licensure, local requirements in that jurisdiction, and environmental requirements.
7.Regulation of Medical Marijuana18136.(a)A person shall not distribute any form of advertising for physician recommendations for medical marijuana in California unless the advertisement bears the following notice to consumers:
NOTICE TO CONSUMERS: The Compassionate Use Act of 1996 ensures that seriously ill Californians have the right to obtain and use marijuana for medical purposes where medical use is deemed appropriate and has been recommended by a physician who has determined that the persons health would benefit from the use of medical marijuana. Physicians are licensed and regulated by the Medical Board of California and arrive at the decision to make this recommendation in accordance with accepted standards of medical responsibility.
(b)Advertising for physician recommendations for medical marijuana shall meet all requirements of Section 651. Price advertising shall not be fraudulent, deceitful, or misleading, including statements or advertisements of bait, discounts, premiums, gifts, or statements of a similar nature.
18137.(a)A facility issued a conditional license shall implement sufficient security measures to both deter and prevent unauthorized entrance into areas containing marijuana and theft of marijuana at those facilities. These security measures shall include, but not be limited to, all of the following:
(1)Preventing individuals from remaining on the premises of the facility if they are not engaging in activity expressly related to the operations of the facility.
(2)Establishing limited access areas accessible only to authorized facility personnel.
(3)Storing all finished marijuana in a secured and locked room, safe, or vault, and in a manner as to prevent diversion, theft, and loss, except for limited amounts of marijuana used for display purposes, samples, or immediate sale.
(b)A facility issued a conditional license shall notify appropriate law enforcement authorities within 24 hours after discovering any of the following:
(1)Discrepancies Significant discrepancies identified during inventory. The level of significance shall be determined by the office.
(2)Diversion, theft, loss, or any criminal activity involving the facility or a facility agent.
(3)The loss or unauthorized alteration of records related to marijuana, registered qualifying patients, personal caregivers, or facility agents.
(4)Any other breach of security.
(c)A licensed cultivation site shall weigh, inventory, and account for on video, all medical marijuana to be transported prior to its leaving its origination location. Within eight hours after arrival at the destination, the licensed dispensing facility shall reweigh, reinventory, and account for on video, all transported marijuana.
18138.(a)The bureau shall require an annual audit of all facilities issued a conditional license to cultivate, manufacture, process, transport, store, or sell medical marijuana. The reasonable costs of the audit shall be paid for by the licensee.
(b)Completed audit reports shall also be submitted by the licensee to local code enforcement offices, or the appropriate locally designated enforcement entity, within 30 days of the completion of the audit.
(c)It is the responsibility of each facility issued a conditional license to develop a robust quality assurance protocol that includes all of the provisions of this part.
18139.(a)A laboratory certified by the bureau to perform random sample testing of medical marijuana products shall not acquire, process, possess, store, transfer, transport, or dispense medical marijuana for any purpose other than those authorized by Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10 of the Health and Safety Code. All transfer or transportation shall be performed pursuant to a specified chain of custody protocol.
(b)A laboratory certified by the bureau to perform random sample testing of medical marijuana products shall not acquire, process, possess, store, transfer, transport, or dispense medical marijuana plants or medical marijuana products except through a patient, primary caregiver, or a facility issued a conditional license. All transfer or transportation shall be performed pursuant to a specified chain of custody protocol.
18140.(a)Information identifying the names of patients, their medical conditions, or the names of their primary caregivers received and contained in records kept by the bureau office for the purposes of administering this part are confidential and exempt from the California Public Records Act (Chapter 3.5 (commencing with Section 6250) of Division 7 of Title 1 of the Government Code) and are not subject to disclosure to an individual or private entity, except as necessary for authorized employees of the state to perform official duties pursuant to this part.
(b)(1)Nothing in this section shall preclude any of the following:
(A)Bureau Office employees notifying state or local agencies about information submitted to the bureau office that the employee suspects is falsified or fraudulent.
(B)Notifications from the bureau office to state or local agencies of apparent violations of this part or an applicable local ordinance.
(C)Verification of requests by state or local agencies to confirm licenses and certificates issued by the bureau office or other state agency.
(D)Providing information requested pursuant to a court order or subpoena issued by a court, an administrative agency, or local governing body authorized by law to issue subpoenas.
(2)Information shall not be disclosed beyond what is necessary to achieve the goals of a specific investigation or notification or the parameters of a specific court order or subpoena.
18141.(a)The actions of a licensee, its employees, and its agents, that are permitted pursuant to a conditional license and that are conducted in accordance with the requirements of this part and regulations adopted pursuant to this part, are not unlawful under state law and shall not be an offense subject to arrest or prosecution.
(b)The actions of a person who, in good faith and upon investigation, allows his or her property to be used by a licensee, its employees, and its agents, as permitted pursuant to a conditional license, are not unlawful under state law and shall not be an offense subject to arrest or prosecution.
(c)This section shall not be deemed to limit the authority or remedies of a city, county, or city and county under any provision of law, including, without limitation, Section 7 of Article XI of the California Constitution.
18142.(a)A licensee shall not cultivate, process, store, manufacture, transport, or sell medical marijuana in the state unless accurate records are kept at the licensed premises of the growing, processing, storing, manufacturing, transporting, or selling by the licensee in the state. These records shall include the name and address of the supplier of marijuana received or possessed by the licensee, the location at which the marijuana was cultivated, the amount of marijuana received, the form in which it is received, the name of the employee receiving it, and the date of receipt. These records shall also include receipts for all expenditures incurred by the licensee and banking records, if any, for all funds obtained or expended in the performance of any activity under the authority of the conditional license. A licensee who has a conditional license for more than one premises may keep all records at one of the conditionally licensed premises. Required records shall be kept for a period of seven years from the date of the transaction.
(b)The bureau and an appropriate state or local agency office or a local agency delegated the authority to enforce the licensing requirements of this part may examine the books and records of a conditional licensee and may visit and inspect the premises of a conditional licensee, as the bureau or state office or local agency deems necessary to perform its duties under this part.
(c)Books or records requested by the bureau or an appropriate state or local agency office or a local agency delegated the authority to enforce licensing requirements of this part shall be provided by the conditional licensee no later than five business days after the request is made.
(d)The bureau or a state or local agency office or a local agency delegated the authority to enforce the licensing requirements of this part may enter and inspect the premises of a facility issued a conditional license between the hours of 8 a.m. and 8 p.m. on any day that the facility is open, or at any reasonable time, to ensure compliance and enforcement of the provisions of this part or a local ordinance.
(e)If a licensee or an employee of a licensee refuses, impedes, obstructs, or interferes with an inspection pursuant to subdivision (d), the conditional license may be summarily suspended and the bureau office shall directly commence proceedings for the revocation of the conditional license.
(f)If a licensee or an employee of a licensee fails to maintain or provide the books and records required pursuant to this section, the licensee shall be subject to a civil fine of fifteen thousand dollars ($15,000) per individual violation.
(g)The office or a local agency delegated the authority to enforce the licensing requirement of this part may, at its discretion, require a licensee to contract for an independent audit of the records required under this section. The licensee shall be liable for all costs associated with such an audit.
SEC. 6.Section 23028 is added to the Government Code, to read:23028.(a)(1)A city, county, or city and county, may impose a tax on the privilege of cultivating, dispensing, producing, processing, preparing, storing, providing, donating, selling, or distributing marijuana by a licensee operating pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code.
(2)The board of supervisors or city council shall specify in the ordinance proposing the tax the activities subject to the tax, the applicable rate or rates, the method of apportionment, if necessary, and the manner of collection of the tax. The tax may be imposed for general governmental purposes or for purposes specified in the ordinance by the board of supervisors or city council.
(3)The tax authorized by this section may be imposed upon any or all of the activities set forth in paragraph (1) specified in the ordinance, regardless of whether the activity is undertaken individually, collectively, or cooperatively, and regardless of whether the activity is for compensation or gratuitously, as determined by the board of supervisors or city council.
(b)A tax imposed pursuant to this section shall be subject to applicable voter approval requirements imposed by law.
(c)For purposes of this section, marijuana has the same meaning as the term marijuana product set forth in Section 111658 of the Health and Safety Code.
(d)This section does not limit or prohibit the levy or collection or any other fee, charge, or tax, or a license or service fee or charge upon, or related to, the activities set forth in subdivision (a) as otherwise provided by law, including Section 37100.5. This section shall not be construed as a limitation upon the taxing authority of a city, county, or city and county as provided by law.
SEC. 7.Section 11362.775 of the Health and Safety Code is amended to read:11362.775.(a)Qualified patients, persons with valid identification cards, and the designated primary caregivers of qualified patients and persons with identification cards, who cultivate marijuana for medical purposes, shall not solely on the basis of that fact be subject to state criminal sanctions under Section 11357, 11358, 11359, 11360, 11366, 11366.5, or 11570.
(b)An individual employee, officer, or board member of a facility issued a conditional license pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code shall not be subject to state criminal sanctions under Section 11357, 11358, 11359, 11360, 11366, 11366.5, or 11570 and any successor statutes, based solely on holding a conditional license, for the possession, cultivation, processing, packaging, storage, transportation, sale, or distribution of medical marijuana to a facility holding a conditional license pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code or directly to a qualified patient, a person with a valid identification card, or the designated primary caregiver of a qualified patient or person with a valid identification card, within the state, unless the information contained on the licensing paperwork is false or falsified, the license has been obtained by means of fraud, or the person is otherwise in violation of Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code.
(c)This section shall not diminish the protections of Section 18141 of the Business and Professions Code.
SEC. 8.Article 8 (commencing with Section 111658) is added to Chapter 6 of Part 5 of Division 104 of the Health and Safety Code, to read:8.Medical Marijuana111658.For purpose of this article, the following definitions shall apply:
(a)Bureau means the Bureau of Medical Marijuana Regulations in the Department of Consumer Affairs.
(b)Certified testing laboratory means a laboratory that is certified by the bureau to perform random sample testing of medical marijuana for patients, primary caregivers, and facilities issued conditional licenses pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code, pursuant to the certification standards for those facilities promulgated by the bureau.
(c)
(a)Edible medical marijuana product means medical marijuana or a medical marijuana-derived product that is ingested or meant to be ingested through the mouth and into the digestive system.
(b)Labor peace agreement means an agreement between an entity and a bona fide labor organization that, at a minimum, protects the states proprietary interests by prohibiting labor organizations and members from engaging in picketing, work stoppages, boycotts, and any other economic interference with the applicants business. This agreement means that the applicant has agreed not to disrupt efforts by the bona fide labor organization to communicate with, and attempt to organize and represent, the applicants employees.
(d)
(c)Marijuana means all parts of the plant Cannabis sativa L. sativa, Cannabis indica, or Cannabis ruderalis, whether growing or not; the seeds thereof; the resin, whether crude or purified, extracted from any part of the plant; and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds, or resin. Marijuana does not include the mature stalks of the plant, fiber produced from the stalks, oil or cake made from the seeds of the plant, any other compound, manufacture, salt, derivative, mixture, or preparation of the mature stalks (except the resin extracted therefrom), fiber, oil, or cake, or the sterilized seed of the plant which is incapable of germination. Marijuana also means marijuana, as defined by Section 11018.
(e)Labor peace agreement means an agreement between an entity and a bona fide labor organization that, at a minimum, protects the states proprietary interests by prohibiting labor organizations and members from engaging in picketing, work stoppages, boycotts, and any other economic interference with the applicants business. This agreement means that the applicant has agreed not to disrupt efforts by the bona fide labor organization to communicate with, and attempt to organize and represent, the applicants employees.
(d)Office means the Office of Medical Marijuana Regulation in the Business, Consumer Affairs, and Housing Agency.
(f)
(e)Representative samples means samples taken from each batch or shipment of medical marijuana received from a licensed cultivation site or any other source if intended for sale.
111659.The bureau, by July 1, 2017, shall accomplish both of the following:
(a)Establish quality assurance protocols to ensure uniform testing standards for all medical marijuana sold via dispensaries or other facilities, or cultivated or manufactured by facilities, that are issued a conditional license pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code.
(b)In consultation with outside entities at its discretion, develop a list of certified testing laboratories that can perform uniform testing in compliance with this article, and post that list on its Internet Web site.
111659.On or before July 1, 2017, the office shall report to the Legislature on the feasability of developing a program to certify laboratories for the testing of medical marijuana and related products and the feasability of developing a labeling requirement for edible marijuana products that incorporates information on the cannabinoid content.
111660.(a)A facility issued a conditional license pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code shall bear the responsibility for contracting with certified testing laboratories for regular, systematic testing of representative samples of all medical marijuana cultivated or intended for sale or distribution, and shall bear the cost of that testing. both of the following:
(b)A facility issued a conditional license pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code shall maintain records of testing reports for seven years, either on site in a digital format or at a secure offsite location in either digital or paper format. These facilities shall provide results of test reports to local code enforcement officers, any other locally designated enforcement entity, and the bureau upon request.
(1)Maintaining supplier information in order for recall procedures to be implemented, if and when necessary.
(2)Labeling of all medical marijuana and medical marijuana products that shall, at a minimum, include the following:
(A)List of pharmacologically active ingredients, including, but not limited to, tetrahydrocannabinol (THC) and cannabidiol (CBD) content, clear recommended dosage, and the size or volume of the recommended dose.
(B)Clear indication, in bold font, that the product contains medical marijuana.
(C)The statement FOR MEDICAL USE ONLY. KEEP OUT OF REACH OF CHILDREN AND ANIMALS in bold print.
(D)Identification of the source and date of cultivation and manufacture.
(E)The name and location of the dispensary providing the product.
(F)The date of sale.
(G)Any other requirements set by the office.
111661.Quality assurance protocols shall be required between all licensed cultivation sites, licensed manufacturers, and licensed dispensing facilities to guarantee safe and reliable medicinal marijuana delivery to all patients. These quality assurance protocols shall include:
(a)Providing supplier information to dispensaries in order for recall procedures to be implemented, if and when necessary.
(b)Safety testing of all medical marijuana prior to packaging for sale and patient exposure to identify and eliminate microbiological contaminants and chemical residue.
(c)Labeling of all medical marijuana and medical marijuana products that shall, at a minimum, include the following:
(1)List of pharmacologically active ingredients, including, but not limited to, tetrahydrocannabinol (THC) and cannabidiol (CBD) content, clear recommended dosage, and the size or volume of the recommended dose.
(2)Clear indication, in bold font, that the product contains medical marijuana.
(3)The statement FOR MEDICAL USE ONLY. KEEP OUT OF REACH OF CHILDREN AND ANIMALS in bold print.
(4)Identification of the source and date of cultivation and manufacture.
(5)The name and location of the dispensary providing the product.
(6)The date of sale.
(7)Any other requirements set by the bureau.
111662.For purposes of this article, edible medical marijuana products are deemed to be unadulterated food products. In addition to the quality assurance standards provided in Section 111661, all edible medical marijuana products shall comply with the following requirements:
(a)Baked edible medical marijuana products, including, but not limited to, brownies, bars, cookies, and cakes, tinctures, and other edible medical marijuana products that do not require refrigeration or hot holding may be manufactured, sold, or otherwise distributed at facilities issued a conditional license pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code.
(b)A facility issued a conditional license pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code shall have an owner or employee who has successfully passed an approved and accredited food safety certification examination as specified in Sections 113947.1, 113947.2, and 113947.3 prior to selling, manufacturing, or distributing edible medical marijuana products requiring refrigeration or hot holding.
(c)Individuals manufacturing or selling edible medical marijuana products shall thoroughly wash their hands before commencing production and before handling finished edible medical marijuana products.
(d)All edible medical marijuana products sold for direct consumption and infused with marijuana concentrate shall be individually wrapped at the original point of preparation. The products shall be packaged in a fashion that does not exceed a single dosage for one individual.
(e)Products containing tetrahydrocannabinol (THC) shall be prepared in compliance with maximum potency standards for THC and THC concentrates set forth in the bureaus regulations.
(f)Prior to sale or distribution at a licensed dispensing facility, edible medical marijuana products shall be labeled and in an opaque and tamper evident package. Labels and packages of edible medical marijuana products shall meet the following requirements:
(1)Edible medical marijuana packages and labels shall not be made to be attractive to children.
(2)All edible medical marijuana product labels shall include the following information, prominently displayed and in a clear and legible font:
(A)Manufacture date and source.
(B)The statement KEEP OUT OF REACH OF CHILDREN AND ANIMALS in bold print.
(C)The statement FOR MEDICAL USE ONLY.
(D)Net weight of medical marijuana in package.
(E)A warning if nuts or other known allergens are used and shall include the total weight, in ounces or grams, of medical marijuana in the package.
(F)List of pharmacologically active ingredients, including, but not limited to, tetrahydrocannabinol (THC) and cannabidiol (CBD) content, clear recommended dosage, and the size or volume of recommended dose.
(G)Any other requirement set by the bureau. office.
(g)Photos or images of food are not allowed on edible medical marijuana product packages or labels.
(h)Only generic food names may be used to describe edible medical marijuana products.
SEC. 9.On or before July 1, 2016, the State Board of Equalization shall compile a report on the estimated tax collected on the sale of medical marijuana, using the most current data available. The report should also include expected tax revenues, under the existing tax structure, for the years 2016 to 2021, inclusive. This report shall be submitted to the Legislature and the Governors office pursuant to Section 9795 of the Government Code.
SEC. 10.The provisions of this act are severable. If any provision of this act or its application is held invalid, that invalidity shall not affect other provisions or applications that can be given effect without the invalid provision or application.
SEC. 11.The Legislature finds and declares that Section 5 of this act imposes a limitation on the publics right of access to the meetings of public bodies or the writings of public officials and agencies within the meaning of Section 3 of Article I of the California Constitution. Pursuant to that constitutional provision, the Legislature makes the following findings to demonstrate the interest protected by this limitation and the need for protecting that interest:
The limitation imposed under this act is necessary for purposes of compliance with the federal Health Insurance Portability and Accountability Act of 1996 (42 U.S.C. Sec. 1320d et seq.), the Confidentiality of Medical Information Act (Part 2.6 (commencing with Section 56) of Division 1 of the Civil Code), and the Insurance Information and Privacy Protection Act (Article 6.6 (commencing with Section 791) of Part 2 of Division 1 of the Insurance Code).
SEC. 12.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
SEC. 13.The amendments made to Section 11362.775 of the Health and Safety Code by this act shall become operative on July 1, 2017.
This act shall be known, and may be cited, as the Medical Marijuana Public Safety and Environmental Protection Act.
SEC. 2.The Legislature finds and declares all of the following:
(a)In 1996, the people of the State of California enacted the Compassionate Use Act of 1996, codified in Section 11362.5 of the Health and Safety Code. The people of the State of California declared that their purpose in enacting the measure was, among other things, to ensure that seriously ill Californians have the right to obtain and use marijuana for medical purposes where that medical use is deemed appropriate and has been recommended by a physician who has determined that the persons health would benefit from the use of marijuana in the treatment of cancer, anorexia, AIDS, chronic pain, spasticity, glaucoma, arthritis, migraine, or any other illness for which marijuana provides relief.
(b)The Compassionate Use Act of 1996 called on state government to implement a plan for the safe and affordable distribution of marijuana to all patients in medical need of marijuana, while ensuring that nothing in that act would be construed to condone the diversion of marijuana for nonmedical purposes.
(c)In 2003, the Legislature enacted the Medical Marijuana Program Act (MMPA), codified in Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10 of the Health and Safety Code.
(d)Greater certainty and minimum statewide standards are urgently needed regarding the obligations of medical marijuana facilities, and for the imposition and enforcement of regulations to prevent unlawful cultivation and the diversion of marijuana to nonmedical use.
(e)Despite the passage of the Compassionate Use Act of 1996 and the MMPA, because of the lack of an effective statewide system for regulating and controlling medical marijuana, cities, counties, and local law enforcement officials have been confronted with uncertainty about the legality of some medical marijuana cultivation and distribution activities. The current state of affairs makes law enforcement difficult and endangers patient safety because of an inability to monitor the supply of medical marijuana in the state and the lack of quality control, testing, and labeling requirements.
(f)The California Constitution grants cities and counties the authority to make and enforce, within their borders, all local police, sanitary, and other ordinances and regulations not in conflict with the general laws. This inherent local police power includes broad authority to determine, for purposes of public health, safety, and welfare, the appropriate uses of land within the local jurisdictions borders. The police power, therefore, allows each city and county to determine whether or not a medical marijuana dispensary or other facility that makes medical marijuana available may operate within its borders. This authority has been upheld by City of Riverside v. Inland Empire Patients Health and Wellness Center, Inc. (2013) 56 Cal.4th 729 and County of Los Angeles v. Hill (2011) 192 Cal.App.4th 861. Nothing in this act shall diminish, erode, or modify that authority.
(g)If a city or county determines that a dispensary or other facility that makes medical marijuana available may operate within its borders, then there is a need for the state to license these dispensaries and other facilities for the purpose of adopting and enforcing protocols for security standards at dispensaries and in the transportation of medical marijuana, as well as health and safety standards to ensure patient safety. This licensing requirement is not intended in any way nor shall it be construed to preempt local ordinances, regulations, or enforcement actions regarding the sale and use of medical marijuana, including, but not limited to, security, signage, lighting, and inspections.
(h)Greater oversight, uniformity, and enforcement are urgently needed regarding the obligations and rights of medical marijuana cultivators, transporters, and distribution facilities.
(i)Marijuana has widely accepted medical applications that make it inappropriate to be classified as a Schedule I controlled substance in the State of California.
(j)For the protection of Californians, the state must act to regulate and control medical marijuana and not preempt local government ordinances. Cities and counties should be allowed to impose local taxes and enact zoning regulations and other restrictions applicable to the cultivation, transportation, and distribution of medical marijuana based on local needs.
(k)For the protection of Californias environment and its natural resources, all efforts must be made to prevent and mitigate the harmful environmental impacts that can be associated with some marijuana cultivation.
(l)The North Coast Regional Water Quality Control Board is currently in the process of promulgating regulations that would create a 3-tiered system for cultivator wastewater discharge permits. A similar permitting system would assist the state in controlling damaging wastewater runoff from cultivation sites, while minimizing the burden on smaller cultivators.
(m)Nothing in this act shall have a diminishing effect on the rights and protections granted to a patient or primary caregiver pursuant to the Compassionate Use Act of 1996.
(n)Nothing in this act shall be construed to promote or facilitate the nonmedical, recreational possession, sale, or use of marijuana.
SEC. 3.Section 2220.05 of the Business and Professions Code is amended to read:2220.05.(a)In order to ensure that its resources are maximized for the protection of the public, the Medical Board of California shall prioritize its investigative and prosecutorial resources to ensure that physicians and surgeons representing the greatest threat of harm are identified and disciplined expeditiously. Cases involving any of the following allegations shall be handled on a priority basis, as follows, with the highest priority being given to cases in the first paragraph:
(1)Gross negligence, incompetence, or repeated negligent acts that involve death or serious bodily injury to one or more patients, such that the physician and surgeon represents a danger to the public.
(2)Drug or alcohol abuse by a physician and surgeon involving death or serious bodily injury to a patient.
(3)Repeated acts of clearly excessive prescribing, furnishing, or administering of controlled substances, or repeated acts of prescribing, dispensing, or furnishing of controlled substances, or recommending marijuana to patients for medical purposes, without a good faith prior examination of the patient and medical reason therefor. However, in no event shall a physician and surgeon prescribing, furnishing, or administering controlled substances for intractable pain consistent with lawful prescribing, including, but not limited to, Sections 725, 2241.5, and 2241.6 of this code and Sections 11159.2 and 124961 of the Health and Safety Code, be prosecuted for excessive prescribing and prompt review of the applicability of these provisions shall be made in any complaint that may implicate these provisions.
(4)Sexual misconduct with one or more patients during a course of treatment or an examination.
(5)Practicing medicine while under the influence of drugs or alcohol.
(b)The board may by regulation prioritize cases involving an allegation of conduct that is not described in subdivision (a). Those cases prioritized by regulation shall not be assigned a priority equal to or higher than the priorities established in subdivision (a).
(c)The Medical Board of California shall indicate in its annual report mandated by Section 2312 the number of temporary restraining orders, interim suspension orders, and disciplinary actions that are taken in each priority category specified in subdivisions (a) and (b).
SEC. 4.Article 25 (commencing with Section 2525) is added to Chapter 5 of Division 2 of the Business and Professions Code, to read:25.Recommending Medical Marijuana2525.(a)It is unlawful for a physician and surgeon who recommends marijuana to a patient for a medical purpose to accept, solicit, or offer any form of remuneration from or to a facility issued a conditional license pursuant to Part 5 (commencing with Section 18100) of Division 7, if the physician and surgeon or his or her immediate family have a financial interest in that facility.
(b)For the purposes of this section, financial interest shall have the same meaning as in Section 650.01.
(c)A violation of this section shall be a misdemeanor.
2525.1.The Medical Board of California shall consult with the California Marijuana Research Program, known as the Center for Medicinal Cannabis Research, authorized pursuant to Section 11362.9 of the Health and Safety Code, on developing and adopting medical guidelines for the appropriate administration and use of medical marijuana.
2525.2.A physician and surgeon shall not recommend medical marijuana to a patient, unless that person is the patients attending physician, as defined by subdivision (a) of Section 11362.7 of the Health and Safety Code.
SEC. 5.Part 5 (commencing with Section 18100) is added to Division 7 of the Business and Professions Code, to read:5.Medical Marijuana1.General Provisions18100.For purposes of this part, the following definitions shall apply:
(a)Bureau means the Bureau of Medical Marijuana Regulation in the Department of Consumer Affairs.
(b)Certified testing laboratory means a laboratory that is certified by the bureau to perform random sample testing of medical marijuana pursuant to the certification standards for these facilities promulgated by the bureau.
(c)Chief means the Chief of the Bureau of Medical Marijuana Regulation.
(d)Department means the Department of Consumer Affairs.
(e)Director means the Director of Consumer Affairs.
(f)Dispensary means a distribution operation that provides medical marijuana or medical marijuana derived products to patients and caregivers.
(g)Fund means the Medical Marijuana Regulation Fund established pursuant to Section 18118.
(h)Licensed cultivation site means a facility that plants, grows, cultivates, harvests, dries, or processes medical marijuana and that is issued a conditional license pursuant to this part.
(i)Licensed dispensing facility means a dispensary or other facility that provides medical marijuana, medical marijuana products, or devices for the use of medical marijuana or medical marijuana products that is issued a conditional license pursuant to this part.
(j)Licensed manufacturer means a person who extracts, prepares, derives, produces, compounds, or repackages medical marijuana or medical marijuana products into consumable and nonconsumable forms and that is issued a conditional license pursuant to this part.
(k)Licensed transporter means an individual or entity issued a conditional license by the bureau to transport medical marijuana to and from facilities that have been issued conditional licenses pursuant to this part.
(l)Marijuana means all parts of the plant Cannabis sativa, Cannabis indica, or Cannabis ruderalis, whether growing or not; the seeds thereof; the resin, whether crude or purified, extracted from any part of the plant; and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds, or resin. Marijuana does not include the mature stalks of the plant, fiber produced from the stalks, oil or cake made from the seeds of the plant, any other compound, manufacture, salt, derivative, mixture, or preparation of the mature stalks (except the resin extracted therefrom), fiber, oil, or cake, or the sterilized seed of the plant which is incapable of germination. Marijuana also means marijuana, as defined by Section 11018 of the Health and Safety Code.
(m)Trespass grows means illicit marijuana cultivation on public or private land without the explicit permission of the landowner.
18101.(a)There is hereby created in the Department of Consumer Affairs the Bureau of Medical Marijuana Regulation, under the supervision and control of the Chief of the Bureau of Medical Marijuana Regulation.
(b)Protection of the public shall be the highest priority for the bureau in exercising its licensing, regulatory, and disciplinary functions. Whenever the protection of the public is inconsistent with other interests sought to be promoted, the protection of the public shall be paramount.
(c)The bureau shall have the authority to issue, suspend, or revoke conditional licenses for the cultivation, manufacture, transportation, storage, distribution, and sale of medical marijuana within the state and to collect fees in connection with these actions. The bureau shall have the authority to create, issue, suspend, or revoke other licenses in order to protect patient health and the public and to facilitate the regulation of medical marijuana.
(d)The Governor shall appoint the chief at a salary to be fixed and determined by the director with the approval of the Director of Finance. The chief shall serve in accordance with the State Civil Service Act (Part 2 (commencing with Section 18500) of Division 5 of Title 2 of the Government Code).
(e)The duty of enforcing and administering this part shall be vested in the chief, who is responsible to the director. The chief may adopt and enforce those rules and regulations that he or she determines are reasonably necessary to carry out the purposes of this part and declaring the policy of the bureau, including a system for the issuance of citations for violations of this part, as specified in Section 18126. 18127.
(f)The chief, as necessary to carry out the provisions of this part, and in accordance with the State Civil Service Act (Part 2 (commencing with Section 18500) of Division 5 of Title 2 of the Government Code), may appoint and fix the compensation of personnel, including, but not limited to, clerical, inspection, investigation, and auditing personnel, as well as an assistant chief. These personnel shall perform their respective duties under the supervision and the direction of the chief.
(g)Every power granted to, or duty imposed upon, the chief under this part may be exercised or performed in the name of the chief by a deputy or assistant chief, subject to conditions and limitations that the chief prescribes.
(h)The bureau shall exercise its authority pursuant to this part consistent with Section 1 of the act that added this section and consistent with the provisions of this part.
18102.Funds for the establishment and support of the bureau shall be advanced as a loan by the department and shall be repaid by the initial proceeds from fees collected pursuant to this part or any rule or regulation adopted pursuant to this part.
18103.The bureau shall have the authority necessary for the implementation of this part, including, but not limited to, all of the following:
(a)Establishing rules or regulations necessary to carry out the purposes and intent of this part and to enable the bureau to exercise the powers and perform the duties conferred upon it by this part and in accordance with Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code. For the performance of its duties, the bureau has the powers as set forth in Article 2 (commencing with Section 11180) of Chapter 2 of Part 1 of Division 3 of Title 2 of the Government Code.
(b)Issuing conditional licenses to persons for the cultivation, manufacture, transportation, storage, distribution, and sale of medical marijuana within the state.
(c)Setting application, licensing, and renewal fees for conditional licenses issued pursuant to Section 18117.
(d)Establishing standards for the cultivation, manufacturing, transportation, storage, distribution, provision, donation, and sale of medical marijuana and medical marijuana products.
(e)Establishing procedures for the issuance, renewal, suspension, denial, and revocation of conditional licenses.
(f)Imposing a penalty authorized by this part or any rule or regulation adopted pursuant to this part.
(g)Taking action with respect to an application for a conditional license in accordance with procedures established pursuant to this part.
(h)Overseeing the operation of the Medical Marijuana Regulation Fund and the Special Account for Environmental Enforcement, established pursuant to Section 18118.
(i)Consulting with other state or local agencies, departments, representatives of the medical marijuana community, or public or private entities for the purposes of establishing statewide standards and regulations.
(j)Certifying laboratories to perform testing of medical marijuana.
18104.(a)On or before January 1, 2018, the bureau shall promulgate regulations for implementation and enforcement of this part, including, but not limited to, all of the following:
(1)Procedures for the issuance, renewal, suspension, denial, and revocation of conditional licenses.
(2)Procedures for appeal of fines and the appeal of denial, suspension, or revocation of conditional licenses.
(3)Application, licensing, and renewal forms and fees.
(4)A time period in which the bureau shall approve or deny an application for a conditional license pursuant to this part.
(5)Qualifications for licensees.
(6)Standards for certification of testing laboratories to perform random sample testing of all medical marijuana products, including standards for onsite testing.
(A)Certification of testing laboratories shall be consistent with general requirements for the competence of testing and calibration activities, including sampling, using standard methods established by the International Organization for Standardization, specifically ISO/IEC 17025.
(B)These requirements shall apply to all entities, including third-party laboratories, engaged in the testing of medical marijuana pursuant to this part.
(7)Requirements to ensure conformance with standards analogous to state statutory environmental, agricultural, consumer protection, and food and product safety requirements. At a minimum, these standards shall do all of the following:
(A)Prescribe sanitation standards analogous to the California Retail Food Code (Part 7 (commencing with Section 113700) of Division 104 of the Health and Safety Code) for food preparation, storage, handling, and sale of edible medical marijuana products.
(B)Require that edible medical marijuana products produced, distributed, provided, donated, or sold by licensees shall be limited to nonpotentially hazardous food, as established by the State Department of Public Health pursuant to Section 114365.5.
(C)Require that facilities in which edible medical marijuana products are prepared shall be constructed in accordance with applicable building standards, health and safety standards, and other state laws.
(D)Provide that weighing or measuring devices used in connection with the sale or distribution of medical marijuana are required to meet standards analogous to Division 5 (commencing with Section 12001).
(E)Require that the application of pesticides or other pest control in connection with the indoor or outdoor cultivation of medical marijuana shall meet standards analogous to Division 6 (commencing with Section 11401) of the Food and Agricultural Code and its implementing regulations.
(b)On or before July 1, 2017, the bureau shall also promulgate regulations for minimum statewide health and safety standards and quality assurance standards associated with the cultivation, transport, storage, manufacture, and sale of all medical marijuana produced in this state. Consistent with Section 18126, local agencies shall have primary responsibility for enforcement of these standards in accordance with bureau regulations.
(c)The bureau, in consultation with the Division of Labor Standards Enforcement, shall adopt regulations establishing worker safety standards for entities licensed pursuant to this part.
(d)The bureau, in consultation with the State Water Resources Control Board, shall adopt regulations to ensure that commercial medical marijuana activity licensed pursuant to this part does not threaten the states environment and watersheds and is otherwise in conformance with the California Environmental Quality Act.
(e)The bureau shall not issue a conditional license unless the applicant has met all of the requirements of this part, including the requirements of paragraph (4) of subdivision (d) of Section 18110.
18105.The chief shall keep a complete record of all facilities issued a conditional license. This record shall be made available on the bureaus Internet Web site.
18106.The bureau shall establish procedures to provide state and local law enforcement, upon their request, with 24-hour access to information to verify a conditional license, track transportation manifests, and track the inventories of facilities issued a conditional license.
18107.This part shall in no way supersede the provisions of Measure D, approved by the voters of the City of Los Angeles on the May 21, 2013, ballot for the city, or any similar measure in other jurisdictions, which grants medical marijuana businesses and dispensaries qualified immunity consistent with the terms of the measure and local ordinances. Notwithstanding the provisions of this part, marijuana businesses and dispensaries subject to the provisions of Measure D or other similar qualified immunity shall continue to be subject to the ordinances and regulations of the relevant local jurisdiction.
2.Conditional Licenses18108.The following persons are exempt from the requirement of licensure under this part:
(a)A patient who cultivates, possesses, stores, manufactures, or transports marijuana exclusively for his or her personal medical use and who does not sell, distribute, donate, or provide marijuana to any other person or entity.
(b)A primary caregiver who cultivates, possesses, stores, manufactures, transports, or provides marijuana exclusively for the personal medical purposes to no more than five specified qualified patients for whom he or she is the primary caregiver within the meaning of Section 11362.7 of the Health and Safety Code and who does not receive remuneration for these activities, except for compensation in full compliance with subdivision (c) of Section 11362.765 of the Health and Safety Code. Nothing in this section shall permit primary caregivers to organize themselves as cooperatives or collectives of caregivers.
18109.(a)Except as provided in Section 11362.5 of, and Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10 of, the Health and Safety Code, a person shall not sell or provide medical marijuana to a patient or caregiver other than at a licensed dispensing facility or through delivery from a licensed dispensing facility.
(b)Except as provided in Section 11362.5 of, and Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10 of, the Health and Safety Code, a person shall not grow medical marijuana other than at a licensed cultivation site.
(c)Except as provided in Section 11362.5 of, and Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10 of, the Health and Safety Code, a person shall not manufacture medical marijuana or medical marijuana products other than a licensed manufacturer.
(d)A person shall not transport medical marijuana from one facility issued a conditional license to another, other than a licensed transporter.
(e)A licensed manufacturer may obtain medical marijuana from a licensed cultivator and may furnish medical marijuana products to a licensed dispensary.
(f)To meet the requirements of Article 8 (commencing with Section 111658) of Chapter 6 of Part 5 of Division 104 of the Health and Safety Code, medical marijuana and medical marijuana products shall be tested by a certified testing laboratory.
18110.(a)Beginning no later than July 1, 2018, the bureau shall provide for and shall issue conditional licenses. Conditional licenses shall be issued for all activity authorized under this chapter, including, but not limited to, cultivation, processing, storage, transport, and dispensing of medical marijuana.
(b)The issuance of a conditional license shall not, in and of itself, authorize the recipient to begin business operations. The conditional license shall certify, at a minimum, that the applicant has paid the state conditional licensing fee, successfully passed a criminal background check, and met the state residency requirements.
(c)In order to begin business operations pursuant to this chapter, an applicant shall, in addition to the conditional license, obtain a license or permit from the local jurisdiction in which he or she proposes to operate, following the requirements of the applicable local ordinances.
(d)An applicant for a conditional license shall do all following:
(1)Pay the fee or fees required by this part for each license being applied for.
(2)Register with the bureau on forms prescribed by the chief. The forms shall contain sufficient information to identify the licensee, including all of the following:
(A)Name of the owner or owners of a proposed facility, including all persons or entities having an ownership interest other than a security interest, lien, or encumbrance on property that will be used by the applicant.
(B)The name, address, and date of birth of each principal officer and board member.
(C)The address and telephone number of the proposed facility.
(D)In the case of a cultivation site, the GPS coordinates of the site.
(3)Describe, in writing, the scope of business of the proposed facility.
(4)Provide evidence that the applicant and owner have been legal full-time residents of the state for not less than 12 months.
(5)Provide detailed operating procedures, in writing, for the proposed facility, which shall include, but not be limited to, procedures for facility and operational security, prevention of diversion, employee screening, storage of medical marijuana, personnel policies, and recordkeeping procedures.
(6)Provide evidence that the applicant has received all required environmental permits, including compliance with the California Environmental Quality Act, and wastewater discharge permits.
(7)Provide the applicants fingerprint images. For purposes of this paragraph, applicant means the owner or owners of a proposed facility, including all persons or entities having an ownership interest other than a security interest, lien, or encumbrance on property that will be used by the facility.
(A)The applicant shall electronically submit to the Department of Justice fingerprint images and related information required by the Department of Justice for the purpose of obtaining information as to the existence and content of a record of state or federal convictions and arrests, and information as to the existence and content of a record of state or federal convictions and arrests for which the Department of Justice establishes that the person is free on bail, or on his or her own recognizance, pending trial or appeal.
(B)The Department of Justice shall provide a response to the bureau pursuant to paragraph (1) of subdivision (p) of Section 11105 of the Penal Code.
(C)The bureau shall request from the Department of Justice subsequent notification service, as provided pursuant to Section 11105.2 of the Penal Code, for persons described in subparagraph (A).
(D)The Department of Justice shall charge the applicant a fee sufficient to cover the reasonable cost of processing the requests described in this paragraph.
(8)Provide a statement, signed by the applicant under penalty of perjury, that the information provided is true.
(9)Provide any other information required by the bureau.
(e)Each location and each discrete use of a single location shall require a conditional license. Each application for a conditional license is separate and distinct, and the bureau may charge a separate fee for each.
(f)A conditional license issued pursuant to this section shall be valid for 12 months after the date of issuance. After the initial 12-month period, a conditional license may be renewed for a period of 36 months. The bureau shall establish procedures for the renewal of a conditional license.
(g)Notwithstanding any other law, the bureau shall not issue a conditional license to an individual or entity, or for a premise, against whom there is a pending state or local administrative or judicial proceeding, against whom there is an action initiated by a city, county, or city and county under a local ordinance, or who has been determined to have violated an applicable local ordinance.
(h)A facility or entity that is operating in conformance with local zoning ordinances and other state and local requirements on January 1, 2016, may continue its operations until its application for conditional licensure is approved or denied pursuant to this part.
18111.(a)Upon receipt of the application materials and fee required in Section 18110, the bureau, provided the applicant has not committed an act or crime constituting grounds for the denial of licensure under Section 18112, may issue the conditional license and send a proof of issuance to the applicant.
(b)The chief shall, by regulation, prescribe conditions upon which a person whose conditional license has previously been denied, suspended, or revoked, may be issued a conditional license.
18112.(a)An application for a conditional license shall be denied and a conditional license shall be suspended or revoked for a past felony conviction for the possession for sale, sale, manufacture, transportation, or cultivation of a controlled substance, a felony criminal conviction for drug trafficking, a felony conviction for embezzlement, a felony conviction involving fraud or deceit, or any violent or serious felony conviction pursuant to subdivision (c) of Section 667.5 of, or subdivision (c) of Section 1192.7 of, the Penal Code. The bureau, at its discretion, may issue a license to an applicant that would be otherwise denied pursuant to this subdivision if the applicant has obtained a certificate of rehabilitation, pursuant to Section 4852.13 of the Penal Code.
(b)The chief, upon his or her determination, may deny, suspend, or revoke a conditional license when a conditional licensee, applicant, or employee, partner, officer, or member of an entity conditionally licensed does any of the following:
(1)Making or authorizing in any manner or by any means a written or oral statement that is untrue or misleading and that is known, or that by exercise of reasonable care should be known, to be untrue or misleading.
(2)Any other conduct that constitutes fraud.
(3)Conduct constituting gross negligence.
(4)Failure to comply with the provisions of this part, Article 8 (commencing with Section 111658) of Chapter 6 of Part 5 of Division 104 of the Health and Safety Code, or any rule or regulation adopted pursuant to this part.
(5)Conduct that constitutes grounds for denial of licensure pursuant to Chapter 2 (commencing with Section 480) of Division 1.5.
18113.(a)Upon denying, suspending, or revoking a conditional license, the chief shall notify the applicant or licensee, in writing, by personal service or mail addressed to the address of the applicant or licensee set forth in the application. The applicant or licensee shall be given a hearing within 30 days thereafter if he or she files with the bureau a written request for hearing. Otherwise, the denial, suspension, or revocation is deemed affirmed.
(b)All proceedings to deny, suspend, or revoke a conditional license shall be conducted pursuant to Chapter 5 (commencing with Section 11500) of Part 1 of Division 3 of Title 2 of the Government Code.
18114.An application for or renewal of a conditional license shall not be approved if the bureau determines any of the following:
(a)The applicant fails to meet the requirements of this part or any regulation adopted pursuant to this part or any applicable city, county, or city and county ordinance or regulation. If a local government adopts an ordinance or resolution authorizing medical marijuana to be cultivated, manufactured, stored, distributed, or sold within its jurisdiction, it shall submit to the bureau documentation detailing their renewal requirements.
(b)The applicant, or any of its officers, directors, owners, members, or shareholders, is a minor.
(c)The applicant has knowingly answered a question or request for information falsely on the application form or failed to provide information requested.
(d)The applicant, or any of its officers, directors, owners, members, or shareholders has been sanctioned by the bureau, a city, county, or city and county, for medical marijuana activities conducted in violation of this part or any applicable local ordinance or has had a license revoked in the previous five years.
(e)The proposed cultivation, processing, possession, storage, manufacturing, testing, transporting, distribution, provision, or sale of medical marijuana will violate any applicable local law or ordinance.
(f)The applicant or the owner is unable to establish that he or she has been a resident of the state for not less than 12 months.
18115.(a)In addition to the provisions of this part, a conditional license shall be subject to the restrictions of the local jurisdiction in which the facility operates or proposes to operate. Even if a conditional license has been granted pursuant to this part, a facility shall not operate in a local jurisdiction that prohibits the establishment of that type of business.
(b)In addition to the provisions of this part, local jurisdictions retain the power to assess fees and taxes, as applicable, on facilities that are conditionally licensed pursuant to this part and the business activities of those licensees.
18116.The bureau may adopt regulations to limit the number of conditional licenses issued pursuant to this part upon a finding that the otherwise unrestricted issuance of conditional licenses is dangerous to the public health and safety.
3.Fees18117.(a)The conditional licensing fee shall be established by the bureau at a level sufficient to fund the reasonable costs of all of the following:
(1)Administrative costs incurred by the bureau in overseeing the conditional licensing program, establishing health and safety standards, and certifying the required testing laboratories.
(2)Costs incurred by the bureau or the Department of Justice for enforcement of the provisions of this part.
(3)Costs incurred by law enforcement and other public safety entities for enforcing the provisions of this part in their jurisdiction.
(b)In addition to the conditional licensing fee required pursuant to subdivision (a), a cultivation facility shall be assessed a fee in a sufficient amount to cover the reasonable regulatory costs of enforcing the environmental impact provisions relating to those cultivation facilities. This fee shall be distributed, as necessary and in proportion to its regulatory function, between the following agencies responsible for enforcing the regulations relating to the environmental impact of licensed cultivation sites:
(1)The State Water Resources Control Board.
(2)The Department of Fish and Wildlife.
(3)The Department of Forestry and Fire Protection.
(4)The Department of Pesticide Regulation.
(5)The Department of Food and Agriculture.
(6)Local law enforcement.
18118.(a)The Medical Marijuana Regulation Fund is hereby established within the State Treasury. Notwithstanding Section 16305.7 of the Government Code, the fund shall include any interest and dividends earned on the money in the fund.
(b)Except as provided in subdivision (c), all fees collected pursuant to this part shall be deposited into the Medical Marijuana Regulation Fund. Notwithstanding Section 13340 of the Government Code, all moneys within the fund are hereby continuously appropriated, without regard to fiscal year, to the bureau solely for the purposes of fully funding and administering this part, including, but not limited to, the costs incurred by the bureau for its administrative expenses.
(c)The Special Account for Environmental Enforcement is hereby established as an account within the Medical Marijuana Regulation Fund. Notwithstanding Section 16305.7 of the Government Code, the account shall include any interest and dividends earned on the money in the account. All fees collected pursuant to subdivision (b) of Section 18112 18117 shall be deposited in this account. Notwithstanding Section 13340 of the Government Code, all moneys within the fund are hereby continuously appropriated, without regard to fiscal year, to the bureau for distribution to the entities listed in subdivision (b) of Section 18117 to be used to enforce the environmental regulation of licensed cultivation sites.
(d)All moneys collected as a result of penalties imposed under this part shall be deposited directly into the General Fund, to be available upon appropriation.
(e)The bureau may establish and administer a grant program to allocate moneys from the Medical Marijuana Regulation Fund to state and local entities for the purpose of assisting with medical marijuana regulation and the enforcement of this part and other state and local laws applicable to licensees.
18119.(a)A facility issued a conditional license shall not acquire, cultivate, process, possess, store, manufacture, distribute, sell, deliver, transfer, transport, or dispense medical marijuana for any purpose other than those authorized by Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10 of the Health and Safety Code.
(b)A licensed dispensing facility shall not acquire, cultivate, process, possess, store, manufacture, distribute, sell, deliver, transfer, transport, or dispense medical marijuana plants or medical marijuana products except through a licensed cultivation site or a licensed manufacturer.
4.Transportation of Medical Marijuana18120.(a)A licensed transporter shall ship only to facilities issued a conditional license and only in response to a request for a specific quantity and variety from those facilities.
(b)Prior to transporting medical marijuana products, a licensed transporter shall do both of the following:
(1)Complete a shipping manifest using a form prescribed by the bureau.
(2)Securely transmit a copy of the manifest to the licensee that will receive the medical marijuana product, and to the bureau, prior to transport.
(c)The licensed transporter making the shipment and the licensee receiving the shipment shall maintain each shipping manifest and make it available to local code enforcement officers, any other locally designated enforcement entity, and the bureau upon request.
18121.(a)Transported medical marijuana products shall:
(1)Be transported only in a locked, safe, and secure storage compartment that is securely affixed to the interior of the transporting vehicle.
(2)Not be visible from outside the vehicle.
(b)A vehicle transporting medical marijuana products shall travel directly from one licensed facility to another licensed facility authorized to receive the shipment.
18122.(a)All transport vehicles shall be staffed with a minimum of two employees. At least one transport team member shall remain with the vehicle at all times when the vehicle contains medical marijuana.
(b)Each transport team member shall have access to a secure form of communication by which each member can communicate with personnel at the licensed facility at all times when the vehicle contains medical marijuana.
(c)Each transport team member shall possess documentation of licensing and a government-issued identification card at all times when transporting or delivering medical marijuana and shall produce it to any representative of the bureau or law enforcement upon request.
(d)This part shall not be construed to authorize or permit a licensee to transport, or cause to be transported, medical marijuana or medical marijuana products outside the state.
18123.A local jurisdiction shall not prevent transportation through or to a facility issued a conditional license, by a conditionally licensed transporter who acts in compliance with this part.
5.Enforcement18124.A state agency is not required by this section to enforce a city, county, city and county, or local law, ordinance, rule, or regulation regarding the site or operation of a facility issued a conditional license.
18125.The bureau may assist state taxation authorities in the development of uniform policies for the state taxation of licensees.
18126.(a)For facilities issued a conditional license that are located within the incorporated area of a city, the city shall have full power and authority to enforce this part and Article 8 (commencing with Section 111658) of Chapter 6 of Part 5 of Division 104 of the Health and Safety Code and the rules, regulations, and standards promulgated by the bureau. The city shall further assume complete responsibility for any regulatory function relating to those licensees within the city limits that would otherwise be performed by the county or any county officer or employee, without liability, cost, or expense to the county.
(b)For licensed facilities located within the unincorporated area of a county, the county shall have full power and authority to enforce this part and Article 8 (commencing with Section 111658) of Chapter 6 of Part 5 of Division 104 of the Health and Safety Code and the rules, regulations, and standards promulgated by the bureau.
18127.(a)A willful violation of Section 18110, including an attempt to falsify information on an application or to otherwise defraud or mislead a state or local agency in the course of the application process, shall be punishable by a civil fine of up to thirty-five thousand dollars ($35,000) for each individual violation.
(b)A technical violation of Section 18110 shall, at the bureaus discretion, be punishable by a civil fine of up to ten thousand dollars ($10,000) for each individual violation.
18128.A district attorney, county counsel, city attorney, or city prosecutor may bring an action to enjoin a violation or the threatened violation of any provision of this part, including, but not limited to, a licensees failure to correct objectionable conditions following notice or as a result of a rule promulgated pursuant to this part. The action shall be brought in the county in which the violation occurred or is threatened to occur. A proceeding brought pursuant to this part shall conform to the requirements of Chapter 3 (commencing with Section 525) of Title 7 of Part 2 of the Code of Civil Procedure. Nothing in this section shall diminish the authority of a local government to take requisite enforcement actions pertaining to its own ordinances or regulations.
18129.Nothing in this part shall prevent a city or other local governing body from taking action as specified in Section 11362.83 of the Health and Safety Code.
18130.This part shall not be construed to limit a law enforcement agencys ability to investigate unlawful activity in relation to a facility issued a conditional license.
6.Cultivation Sites18131.A licensed cultivation site shall not be located in an area zoned residential.
18132.(a)The bureau shall notify local law enforcement of all conditional licenses issues for cultivation sites in that jurisdiction.
(b)A licensed cultivation site shall display the state license in a manner so as to be available and easily read at the location.
(c)The bureau shall work with and assist state and local law enforcement to eliminate trespass grows in the state.
18133.(a)No later than January 1, 2022, all medical marijuana grown, produced, distributed, and sold in the state shall meet the certified organic standards.
(b)The bureau shall establish appellations of origin for marijuana grown in California.
18134.The bureau shall work with county agricultural commissioners, offices to provide all the information and forms required for conditional licensure as a cultivation site in a single location, including state licensure, local requirements in that jurisdiction, and environmental requirements.
7.Regulation of Medical Marijuana18136.(a)A person shall not distribute any form of advertising for physician recommendations for medical marijuana in California unless the advertisement bears the following notice to consumers:
NOTICE TO CONSUMERS: The Compassionate Use Act of 1996 ensures that seriously ill Californians have the right to obtain and use marijuana for medical purposes where medical use is deemed appropriate and has been recommended by a physician who has determined that the persons health would benefit from the use of medical marijuana. Physicians are licensed and regulated by the Medical Board of California and arrive at the decision to make this recommendation in accordance with accepted standards of medical responsibility.
(b)Advertising for physician recommendations for medical marijuana shall meet all requirements of Section 651. Price advertising shall not be fraudulent, deceitful, or misleading, including statements or advertisements of bait, discounts, premiums, gifts, or statements of a similar nature.
18137.(a)A facility issued a conditional license shall implement sufficient security measures to both deter and prevent unauthorized entrance into areas containing marijuana and theft of marijuana at those facilities. These security measures shall include, but not be limited to, all of the following:
(1)Preventing individuals from remaining on the premises of the facility if they are not engaging in activity expressly related to the operations of the facility.
(2)Establishing limited access areas accessible only to authorized facility personnel.
(3)Storing all finished marijuana in a secured and locked room, safe, or vault, and in a manner as to prevent diversion, theft, and loss.
(b)A facility issued a conditional license shall notify appropriate law enforcement authorities within 24 hours after discovering any of the following:
(1)Discrepancies identified during inventory.
(2)Diversion, theft, loss, or any criminal activity involving the facility or a facility agent.
(3)The loss or unauthorized alteration of records related to marijuana, registered qualifying patients, personal caregivers, or facility agents.
(4)Any other breach of security.
(c)A licensed cultivation site shall weigh, inventory, and account for on video, all medical marijuana to be transported prior to its leaving its origination location. Within eight hours after arrival at the destination, the licensed dispensing facility shall reweigh, reinventory, and account for on video, all transported marijuana.
18138.(a)The bureau shall require an annual audit of all facilities issued a conditional license to cultivate, manufacture, process, transport, store, or sell medical marijuana. The reasonable costs of the audit shall be paid for by the licensee.
(b)Completed audit reports shall also be submitted by the licensee to local code enforcement offices, or the appropriate locally designated enforcement entity, within 30 days of the completion of the audit.
(c)It is the responsibility of each facility issued a conditional license to develop a robust quality assurance protocol that includes all of the provisions of this part.
18139.(a)A laboratory certified by the bureau to perform random sample testing of medical marijuana products shall not acquire, process, possess, store, transfer, transport, or dispense medical marijuana for any purpose other than those authorized by Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10 of the Health and Safety Code. All transfer or transportation shall be performed pursuant to a specified chain of custody protocol.
(b)A laboratory certified by the bureau to perform random sample testing of medical marijuana products shall not acquire, process, possess, store, transfer, transport, or dispense medical marijuana plants or medical marijuana products except through a patient, primary caregiver, or a facility issued a conditional license. All transfer or transportation shall be performed pursuant to a specified chain of custody protocol.
18140.(a)Information identifying the names of patients, their medical conditions, or the names of their primary caregivers received and contained in records kept by the bureau for the purposes of administering this part are confidential and exempt from the California Public Records Act (Chapter 3.5 (commencing with Section 6250) of Division 7 of Title 1 of the Government Code) and are not subject to disclosure to an individual or private entity, except as necessary for authorized employees of the state to perform official duties pursuant to this part.
(b)(1)Nothing in this section shall preclude any of the following:
(A)Bureau employees notifying state or local agencies about information submitted to the bureau that the employee suspects is falsified or fraudulent.
(B)Notifications from the bureau to state or local agencies of apparent violations of this part or an applicable local ordinance.
(C)Verification of requests by state or local agencies to confirm licenses and certificates issued by the bureau or other state agency.
(D)Providing information requested pursuant to a court order or subpoena issued by a court, an administrative agency, or local governing body authorized by law to issue subpoenas.
(2)Information shall not be disclosed beyond what is necessary to achieve the goals of a specific investigation or notification or the parameters of a specific court order or subpoena.
18141.(a)The actions of a licensee, its employees, and its agents, that are permitted pursuant to a conditional license and that are conducted in accordance with the requirements of this part and regulations adopted pursuant to this part, are not unlawful under state law and shall not be an offense subject to arrest or prosecution.
(b)The actions of a person who, in good faith and upon investigation, allows his or her property to be used by a licensee, its employees, and its agents, as permitted pursuant to a conditional license, are not unlawful under state law and shall not be an offense subject to arrest or prosecution.
(c)This section shall not be deemed to limit the authority or remedies of a city, county, or city and county under any provision of law, including, without limitation, Section 7 of Article XI of the California Constitution.
18142.(a)A licensee shall not cultivate, process, store, manufacture, transport, or sell medical marijuana in the state unless accurate records are kept at the licensed premises of the growing, processing, storing, manufacturing, transporting, or selling by the licensee in the state. These records shall include the name and address of the supplier of marijuana received or possessed by the licensee, the location at which the marijuana was cultivated, the amount of marijuana received, the form in which it is received, the name of the employee receiving it, and the date of receipt. These records shall also include receipts for all expenditures incurred by the licensee and banking records, if any, for all funds obtained or expended in the performance of any activity under the authority of the conditional license. A licensee who has a conditional license for more than one premises may keep all records at one of the conditionally licensed premises. Required records shall be kept for a period of seven years from the date of the transaction.
(b)The bureau and an appropriate state or local agency may examine the books and records of a conditional licensee and may visit and inspect the premises of a conditional licensee, as the bureau or state or local agency deems necessary to perform its duties under this part.
(c)Books or records requested by the bureau or an appropriate state or local agency shall be provided by the conditional licensee no later than five business days after the request is made.
(d)The bureau or a state or local agency may enter and inspect the premises of a facility issued a conditional license between the hours of 8 a.m. and 8 p.m. on any day that the facility is open, or at any reasonable time, to ensure compliance and enforcement of the provisions of this part or a local ordinance.
(e)If a licensee or an employee of a licensee refuses, impedes, obstructs, or interferes with an inspection pursuant to subdivision (d), the conditional license may be summarily suspended and the bureau shall directly commence proceedings for the revocation of the conditional license.
(f)If a licensee or an employee of a licensee fails to maintain or provide the books and records required pursuant to this section, the licensee shall be subject to a civil fine of fifteen thousand dollars ($15,000) per individual violation.
SEC. 6.Section 23028 is added to the Government Code, to read:23028.(a)(1)In addition to any authority otherwise provided by law, the board of supervisors of a county or the city council of a city may impose, by ordinance, a tax on the privilege of cultivating, dispensing, producing, processing, preparing, storing, providing, donating, selling, or distributing marijuana by a licensee operating pursuant to Chapter 18 (commencing with Section 26000) of Division 9 of the Business and Professions Code. The tax may be imposed for general governmental purposes or for purposes specified in the ordinance by the board of supervisors or city council.
(2)The board of supervisors or city council shall specify in the ordinance proposing the tax the activities subject to the tax, the applicable rate or rates, the method of apportionment, and the manner of collection of the tax. A tax imposed pursuant to this section is a tax and not a fee or special assessment, and the tax is not required to be apportioned on the basis of benefit to any person or property or be applied uniformly to all taxpayers or all real property.
(3)A tax imposed by a city or county pursuant to this section may include a transactions and use tax imposed solely for marijuana or marijuana products, which shall otherwise conform to Part 1.6 (commencing with Section 7251) of Division 2 of the Revenue and Taxation Code. Notwithstanding Section 7251.1 of the Revenue and Taxation Code, the tax may be imposed at any rate specified by the board of supervisors or city council, and the tax rate authorized by this section shall not be considered for purposes of the combined tax rate limitation established by that section.
(4)The tax authorized by this section may be imposed upon any or all of the activities set forth in paragraph (1), regardless of whether the activity is undertaken individually, collectively, or cooperatively, and regardless of whether the activity is for compensation or gratuitously, as determined by the board of supervisors or city council.
(5)The board of supervisors shall specify whether the tax applies throughout the entire county or within the unincorporated area of the county.
(b)In addition to any other method of collection authorized by law, the board of supervisors or city council may provide for the collection of the tax imposed pursuant to this section in the same manner, and subject to the same penalties and priority of lien, as other charges and taxes fixed and collected by the city or county.
(c)Any tax imposed pursuant to this section shall be subject to applicable voter approval requirements imposed by law.
(d)For purposes of this section, marijuana shall have the meanings set forth in Section 18100 of the Business and Professions Code.
(e)This section does not limit or prohibit the levy or collection or any other fee, charge, or tax, or any license or service fee or charge upon, or related to, the activities set forth in subdivision (a) as otherwise provided by law. This section shall not be construed as a limitation upon the taxing authority of a city or county as provided law.
SEC. 6.Section 23028 is added to the Government Code, to read:23028.(a)(1)A city, county, or city and county, may impose a tax on the privilege of cultivating, dispensing, producing, processing, preparing, storing, providing, donating, selling, or distributing marijuana by a licensee operating pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code.
(2)The board of supervisors or city council shall specify in the ordinance proposing the tax the activities subject to the tax, the applicable rate or rates, the method of apportionment, if necessary, and the manner of collection of the tax. The tax may be imposed for general governmental purposes or for purposes specified in the ordinance by the board of supervisors or city council.
(3)The tax authorized by this section may be imposed upon any or all of the activities set forth in paragraph (1) specified in the ordinance, regardless of whether the activity is undertaken individually, collectively, or cooperatively, and regardless of whether the activity is for compensation or gratuitously, as determined by the board of supervisors or city council.
(b)A tax imposed pursuant to this section shall be subject to applicable voter approval requirements imposed by law.
(c)For purposes of this section, marijuana has the same meaning as the term marijuana product set forth in Section 111658 of the Health and Safety Code.
(d)This section does not limit or prohibit the levy or collection or any other fee, charge, or tax, or a license or service fee or charge upon, or related to, the activities set forth in subdivision (a) as otherwise provided by law, including Section 37100.5. This section shall not be construed as a limitation upon the taxing authority of a city, county, or city and county as provided by law.
SEC. 7.Section 11362.775 of the Health and Safety Code is amended to read:11362.775.(a)Qualified patients, persons with valid identification cards, and the designated primary caregivers of qualified patients and persons with identification cards, who cultivate marijuana for medical purposes, shall not solely on the basis of that fact be subject to state criminal sanctions under Section 11357, 11358, 11359, 11360, 11366, 11366.5, or 11570.
(b)An individual employee, officer, or board member of a facility issued a conditional license pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code shall not be subject to state criminal sanctions under Section 11357, 11358, 11359, 11360, 11366, 11366.5, or 11570 and any successor statutes, based solely on holding a conditional license, for the possession, cultivation, processing, packaging, storage, transportation, sale, or distribution of medical marijuana to a facility holding a conditional license pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code or directly to a qualified patient, a person with a valid identification card, or the designated primary caregiver of a qualified patient or person with a valid identification card, within the state, unless the information contained on the licensing paperwork is false or falsified, the license has been obtained by means of fraud, or the person is otherwise in violation of Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code.
(c)This section shall not diminish the protections of Section 18141 of the Business and Professions Code.
SEC. 8.Article 8 (commencing with Section 111658) is added to Chapter 6 of Part 5 of Division 104 of the Health and Safety Code, to read:8.Medical Marijuana111658.For purpose of this article, the following definitions shall apply:
(a)Bureau means the Bureau of Medical Marijuana Regulations in the Department of Consumer Affairs.
(b)Certified testing laboratories laboratory means a laboratory that is certified by the bureau to perform random sample testing of medical marijuana for patients, primary caregivers, and facilities issued conditional licenses pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code, pursuant to the certification standards for those facilities promulgated by the bureau.
(c)Edible medical marijuana product means medical marijuana or a medical marijuana-derived product that is ingested or meant to be ingested through the mouth and into the digestive system.
(d)Marijuana means all parts of the plant Cannabis sativa L. sativa, Cannabis indica, or Cannabis ruderalis, whether growing or not; the seeds thereof; the resin, whether crude or purified, extracted from any part of the plant; and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds, or resin. Marijuana does not include the mature stalks of the plant, fiber produced from the stalks, oil or cake made from the seeds of the plant, any other compound, manufacture, salt, derivative, mixture, or preparation of the mature stalks (except the resin extracted therefrom), fiber, oil, or cake, or the sterilized seed of the plant which is incapable of germination. Marijuana also means marijuana, as defined by Section 11018.
(e)Labor peace agreement means an agreement between an entity and a bona fide labor organization that, at a minimum, protects the states proprietary interests by prohibiting labor organizations and members from engaging in picketing, work stoppages, boycotts, and any other economic interference with the applicants business. This agreement means that the applicant has agreed not to disrupt efforts by the bona fide labor organization to communicate with, and attempt to organize and represent, the applicants employees.
(f)Representative samples means samples taken from each batch or shipment of medical marijuana received from a licensed cultivation site or any other source if intended for sale.
111659.The bureau, by July 1, 2017, shall accomplish both of the following:
(a)Establish quality assurance protocols to ensure uniform testing standards for all medical marijuana sold via dispensaries or other facilities, or cultivated or manufactured by facilities, that are issued a conditional license pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code.
(b)In consultation with outside entities at its discretion, develop a list of certified testing laboratories that can perform uniform testing in compliance with this article, and post that list on its Internet Web site.
111660.(a)A facility issued a conditional license pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code shall bear the responsibility for contracting with certified testing laboratories for regular, systematic testing of representative samples of all medical marijuana cultivated or intended for sale or distribution, and shall bear the cost of that testing.
(b)A facility issued a conditional license pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code shall maintain records of testing reports for seven years, either on site in a digital format or at a secure offsite location in either digital or paper format. These facilities shall provide results of test reports to local code enforcement officers, any other locally designated enforcement entity, and the bureau upon request.
111661.Quality assurance protocols shall be required between all licensed cultivation sites, licensed manufacturers, and licensed dispensing facilities to guarantee safe and reliable medicinal marijuana delivery to all patients. These quality assurance protocols shall include:
(a)Providing supplier information to dispensaries in order for recall procedures to be implemented, if and when necessary.
(b)Safety testing of all medical marijuana prior to packaging for sale and patient exposure to identify and eliminate microbiological contaminants and chemical residue.
(c)Labeling of all medical marijuana and medical marijuana products that shall, at a minimum, include the following:
(1)List of pharmacologically active ingredients, including, but not limited to, tetrahydrocannabinol (THC) and cannabidiol (CBD) content, clear recommended dosage, and the size or volume of the recommended dose.
(2)Clear indication, in bold font, that the product contains medical marijuana.
(3)The statement FOR MEDICAL USE ONLY. KEEP OUT OF REACH OF CHILDREN AND ANIMALS in bold print.
(4)Identification of the source and date of cultivation and manufacture.
(5)The name and location of the dispensary providing the product.
(6)The date of sale.
(7)Any other requirements set by the bureau.
111662.For purposes of this article, edible medical marijuana products are deemed to be unadulterated food products. In addition to the quality assurance standards provided in Section 111661, all edible medical marijuana products shall comply with the following requirements:
(a)Baked edible medical marijuana products, including, but not limited to, brownies, bars, cookies, and cakes, tinctures, and other edible medical marijuana products that do not require refrigeration or hot holding may be manufactured, sold, or otherwise distributed at facilities issued a conditional license pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code.
(b)A facility issued a conditional license pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code shall have an owner or employee who has successfully passed an approved and accredited food safety certification examination as specified in Sections 113947.1, 113947.2, and 113947.3 prior to selling, manufacturing, or distributing edible medical marijuana products requiring refrigeration or hot holding.
(c)Individuals manufacturing or selling edible medical marijuana products shall thoroughly wash their hands before commencing production and before handling finished edible medical marijuana products.
(d)All edible medical marijuana products sold for direct consumption and infused with marijuana concentrate shall be individually wrapped at the original point of preparation. The products shall be packaged in a fashion that does not exceed a single dosage for one individual.
(e)Products containing tetrahydrocannabinol (THC) shall be prepared in compliance with maximum potency standards for THC and THC concentrates set forth in the bureaus regulations.
(f)Prior to sale or distribution at a licensed dispensing facility, edible medical marijuana products shall be labeled and in an opaque and tamper evident package. Labels and packages of edible medical marijuana products shall meet the following requirements:
(1)Edible medical marijuana packages and labels shall not be made to be attractive to children.
(2)All edible medical marijuana product labels shall include the following information, prominently displayed and in a clear and legible font:
(A)Manufacture date and source.
(B)The statement KEEP OUT OF REACH OF CHILDREN AND ANIMALS in bold print.
(C)The statement FOR MEDICAL USE ONLY.
(D)Net weight of medical marijuana in package.
(E)A warning if nuts or other known allergens are used and shall include the total weight, in ounces or grams, of medical marijuana in the package.
(F)List of pharmacologically active ingredients, including, but not limited to, tetrahydrocannabinol (THC) and cannabidiol (CBD) content, clear recommended dosage, and the size or volume of recommended dose.
(G)Any other requirement set by the bureau.
(g)Photos or images of food are not allowed on edible medical marijuana product packages or labels.
(h)Only generic food names may be used to describe edible medical marijuana products.
SEC. 9.On or before July 1, 2016, the State Board of Equalization shall compile a report on the actual estimated tax collected on the sale of medical marijuana, using the most current data available. The report should also include expected tax revenues, under the existing tax structure, for the years 2016 to 2021, inclusive. This report shall be submitted to the Legislature and the Governors office pursuant to Section 9795 of the Government Code.
SEC. 10.The provisions of this act are severable. If any provision of this act or its application is held invalid, that invalidity shall not affect other provisions or applications that can be given effect without the invalid provision or application.
SEC. 11.The Legislature finds and declares that Section 5 of this act imposes a limitation on the publics right of access to the meetings of public bodies or the writings of public officials and agencies within the meaning of Section 3 of Article I of the California Constitution. Pursuant to that constitutional provision, the Legislature makes the following findings to demonstrate the interest protected by this limitation and the need for protecting that interest:
The limitation imposed under this act is necessary for purposes of compliance with the federal Health Insurance Portability and Accountability Act of 1996 (42 U.S.C. Sec. 1320d et seq.), the Confidentiality of Medical Information Act (Part 2.6 (commencing with Section 56) of Division 1 of the Civil Code), and the Insurance Information and Privacy Protection Act (Article 6.6 (commencing with Section 791) of Part 2 of Division 1 of the Insurance Code).
SEC. 12.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
This act shall be known, and may be cited, as the Medical Marijuana Public Safety and Environmental Protection Act.
SEC. 2.The Legislature finds and declares all of the following:
(a)In 1996, the people of the State of California enacted the Compassionate Use Act of 1996, codified in Section 11362.5 of the Health and Safety Code. The people of the State of California declared that their purpose in enacting the measure was, among other things, to ensure that seriously ill Californians have the right to obtain and use marijuana for medical purposes where that medical use is deemed appropriate and has been recommended by a physician who has determined that the persons health would benefit from the use of marijuana in the treatment of cancer, anorexia, AIDS, chronic pain, spasticity, glaucoma, arthritis, migraine, or any other illness for which marijuana provides relief.
(b)The Compassionate Use Act of 1996 called on state government to implement a plan for the safe and affordable distribution of marijuana to all patients in medical need of marijuana, while ensuring that nothing in that act would be construed to condone the diversion of marijuana for nonmedical purposes.
(c)In 2003, the Legislature enacted the Medical Marijuana Program Act (MMPA), codified in Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10 of the Health and Safety Code.
(d)Greater certainty and minimum statewide standards are urgently needed regarding the obligations of medical marijuana facilities, and for the imposition and enforcement of regulations to prevent unlawful cultivation and the diversion of marijuana to nonmedical use.
(e)Despite the passage of the Compassionate Use Act of 1996 and the MMPA, because of the lack of an effective statewide system for regulating and controlling medical marijuana, cities, counties, and local law enforcement officials have been confronted with uncertainty about the legality of some medical marijuana cultivation and distribution activities. The current state of affairs makes law enforcement difficult and endangers patient safety because of an inability to monitor the supply of medical marijuana in the state and the lack of quality control, testing, and labeling requirements.
(f)The California Constitution grants cities and counties the authority to make and enforce, within their borders, all local police, sanitary, and other ordinances and regulations not in conflict with the general laws. This inherent local police power includes broad authority to determine, for purposes of public health, safety, and welfare, the appropriate uses of land within the local jurisdictions borders. The police power, therefore, allows each city and county to determine whether or not a medical marijuana dispensary or other facility that makes medical marijuana available may operate within its borders. This authority has been upheld by City of Riverside v. Inland Empire Patients Health and Wellness Center, Inc. (2013) 56 Cal.4th 729 and County of Los Angeles v. Hill (2011) 192 Cal.App.4th 861. Nothing in this act shall diminish, erode, or modify that authority.
(g)If a city or county determines that a dispensary or other facility that makes medical marijuana available may operate within its borders, then there is a need for the state to license these dispensaries and other facilities for the purpose of adopting and enforcing protocols for security standards at dispensaries and in the transportation of medical marijuana, as well as health and safety standards to ensure patient safety. This licensing requirement is not intended in any way nor shall it be construed to preempt local ordinances, regulations, or enforcement actions regarding the sale and use of medical marijuana, including, but not limited to, security, signage, lighting, and inspections.
(h)Greater oversight, uniformity, and enforcement are urgently needed regarding the obligations and rights of medical marijuana cultivators, transporters, and distribution facilities.
(i)Marijuana has widely accepted medical applications that make it inappropriate to be classified as a Schedule I controlled substance in the State of California.
(j)For the protection of Californians, the state must act to regulate and control medical marijuana and not preempt local government ordinances. Cities and counties should be allowed to impose local taxes and enact zoning regulations and other restrictions applicable to the cultivation, transportation, and distribution of medical marijuana based on local needs.
(k)For the protection of Californias environment and its natural resources, all efforts must be made to prevent and mitigate the harmful environmental impacts that can be associated with some marijuana cultivation.
(l)The North Coast Regional Water Quality Control Board is currently in the process of promulgating regulations that would create a 3-tiered system for cultivator wastewater discharge permits. A similar permitting system would assist the state in controlling damaging wastewater runoff from cultivation sites, while minimizing the burden on smaller cultivators.
(m)Nothing in this act shall have a diminishing effect on the rights and protections granted to a patient or primary caregiver pursuant to the Compassionate Use Act of 1996.
(n)Nothing in this act shall be construed to promote or facilitate the nonmedical, recreational possession, sale, or use of marijuana.
SEC. 3.Section 2220.05 of the Business and Professions Code is amended to read:2220.05.(a)In order to ensure that its resources are maximized for the protection of the public, the Medical Board of California shall prioritize its investigative and prosecutorial resources to ensure that physicians and surgeons representing the greatest threat of harm are identified and disciplined expeditiously. Cases involving any of the following allegations shall be handled on a priority basis, as follows, with the highest priority being given to cases in the first paragraph:
(1)Gross negligence, incompetence, or repeated negligent acts that involve death or serious bodily injury to one or more patients, such that the physician and surgeon represents a danger to the public.
(2)Drug or alcohol abuse by a physician and surgeon involving death or serious bodily injury to a patient.
(3)Repeated acts of clearly excessive prescribing, furnishing, or administering of controlled substances, or repeated acts of prescribing, dispensing, or furnishing of controlled substances substances, or recommending marijuana to patients for medical purposes, without a good faith prior examination of the patient and medical reason therefor. However, in no event shall a physician and surgeon prescribing, furnishing, or administering controlled substances for intractable pain consistent with lawful prescribing, including, but not limited to, Sections 725, 2241.5, and 2241.6 of this code and Sections 11159.2 and 124961 of the Health and Safety Code, be prosecuted for excessive prescribing and prompt review of the applicability of these provisions shall be made in any complaint that may implicate these provisions.
(4)Sexual misconduct with one or more patients during a course of treatment or an examination.
(5)Practicing medicine while under the influence of drugs or alcohol.
(b)The board may by regulation prioritize cases involving an allegation of conduct that is not described in subdivision (a). Those cases prioritized by regulation shall not be assigned a priority equal to or higher than the priorities established in subdivision (a).
(c)The Medical Board of California shall indicate in its annual report mandated by Section 2312 the number of temporary restraining orders, interim suspension orders, and disciplinary actions that are taken in each priority category specified in subdivisions (a) and (b).
SEC. 4.Article 25 (commencing with Section 2525) is added to Chapter 5 of Division 2 of the Business and Professions Code, to read:25.Recommending Medical Marijuana2525.(a)It is unlawful for a physician and surgeon who recommends marijuana to a patient for a medical purpose to accept, solicit, or offer any form of remuneration from or to a facility issued a conditional license pursuant to Part 5 (commencing with Section 18100) of Division 7, if the physician and surgeon or his or her immediate family have a financial interest in that facility.
(b)For the purposes of this section, financial interest shall have the same meaning as in Section 650.01.
(c)A violation of this section shall be a misdemeanor.
2525.1.The Medical Board of California shall consult with the California Marijuana Research Program, known as the Center for Medicinal Cannabis Research, authorized pursuant to Section 11362.9 of the Health and Safety Code, on developing and adopting medical guidelines for the appropriate administration and use of medical marijuana.
2525.2.A physician and surgeon shall not recommend medical marijuana to a patient, unless that person is the patients attending physician, as defined by subdivision (a) of Section 11362.7 of the Health and Safety Code.
SEC. 5.Part 5 (commencing with Section 18100) is added to Division 7 of the Business and Professions Code, to read:5.Medical Marijuana1.General Provisions18100.For purposes of this part, the following definitions shall apply:
(a)Bureau means the Bureau of Medical Marijuana Regulation in the Department of Consumer Affairs.
(b)Certified testing laboratory means a laboratory that is certified by the bureau to perform random sample testing of medical marijuana pursuant to the certification standards for these facilities promulgated by the bureau.
(c)Chief means the Chief of the Bureau of Medical Marijuana Regulation.
(d)Department means the Department of Consumer Affairs.
(e)Director means the Director of Consumer Affairs.
(f)Dispensary means a distribution operation that provides medical marijuana or medical marijuana derived products to patients and caregivers.
(g)Fund means the Medical Marijuana Regulation Fund established pursuant to Section 18118.
(h)Licensed cultivation site means a facility that plants, grows, cultivates, harvests, dries, or processes medical marijuana and that is issued a conditional license pursuant to this part.
(i)Licensed dispensing facility means a dispensary or other facility that provides medical marijuana, medical marijuana products, or devices for the use of medical marijuana or medical marijuana products that is issued a conditional license pursuant to this part.
(j)Licensed manufacturer means a person who extracts, prepares, derives, produces, compounds, or repackages medical marijuana or medical marijuana products into consumable and nonconsumable forms and that is issued a conditional license pursuant to this part.
(k)Licensed transporter means an individual or entity issued a conditional license by the bureau to transport medical marijuana to and from facilities that have been issued conditional licenses pursuant to this part.
(l)Marijuana means all parts of the plant Cannabis sativa, cannabis indica, or cannabis ruderalis, whether growing or not; the seeds thereof; the resin, whether crude or purified, extracted from any part of the plant; and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds, or resin. Marijuana does not include the mature stalks of the plant, fiber produced from the stalks, oil or cake made from the seeds of the plant, any other compound, manufacture, salt, derivative, mixture, or preparation of the mature stalks (except the resin extracted therefrom), fiber, oil, or cake, or the sterilized seed of the plant which is incapable of germination. Marijuana also means marijuana, as defined by Section 11018 of the Health and Safety Code.
(m)Trespass grows means illicit marijuana cultivation on public or private land without the explicit permission of the land owner.
18101.(a)There is hereby created in the Department of Consumer Affairs the Bureau of Medical Marijuana Regulation, under the supervision and control of the Chief of the Bureau of Medical Marijuana Regulation.
(b)Protection of the public shall be the highest priority for the bureau in exercising its licensing, regulatory, and disciplinary functions. Whenever the protection of the public is inconsistent with other interests sought to be promoted, the protection of the public shall be paramount.
(c)The bureau shall have the authority to issue, suspend, or revoke conditional licenses for the cultivation, manufacture, transportation, storage, distribution, and sale of medical marijuana within the state and to collect fees in connection with these actions. The bureau shall have the authority to create, issue, suspend, or revoke other licenses in order to protect patient health and the public and to facilitate the regulation of medical marijuana.
(d)The Governor shall appoint the chief at a salary to be fixed and determined by the director with the approval of the Director of Finance. The chief shall serve in accordance with the State Civil Service Act (Part 2 (commencing with Section 18500) of Division 5 of Title 2 of the Government Code).
(e)The duty of enforcing and administering this part shall be vested in the chief, who is responsible to the director. The chief may adopt and enforce those rules and regulations that he or she determines are reasonably necessary to carry out the purposes of this part and declaring the policy of the bureau, including a system for the issuance of citations for violations of this part, as specified in Section 18126.
(f)The chief, as necessary to carry out the provisions of this part, and in accordance with the State Civil Service Act (Part 2 (commencing with Section 18500) of Division 5 of Title 2 of the Government Code), may appoint and fix the compensation of personnel, including, but not limited to, clerical, inspection, investigation, and auditing personnel, as well as an assistant chief. These personnel shall perform their respective duties under the supervision and the direction of the chief.
(g)Every power granted to, or duty imposed upon, the chief under this part may be exercised or performed in the name of the chief by a deputy or assistant chief, subject to conditions and limitations that the chief prescribes.
(h)The bureau shall exercise its authority pursuant to this part consistent with Section 1 of the act that added this section and consistent with the provisions of this part.
18102.Funds for the establishment and support of the bureau shall be advanced as a loan by the department and shall be repaid by the initial proceeds from fees collected pursuant to this part or any rule or regulation adopted pursuant to this part.
18103.The bureau shall have the authority necessary for the implementation of this part, including, but not limited to, all of the following:
(a)Establishing rules or regulations necessary to carry out the purposes and intent of this part and to enable the bureau to exercise the powers and perform the duties conferred upon it by this part and in accordance with Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code. For the performance of its duties, the bureau has the powers as set forth in Article 2 (commencing with Section 11180) of Chapter 2 of Part 1 of Division 3 of Title 2 of the Government Code.
(b)Issuing conditional licenses to persons for the cultivation, manufacture, transportation, storage, distribution, and sale of medical marijuana within the state.
(c)Setting application, licensing, and renewal fees for conditional licenses issued pursuant to Section 18117.
(d)Establishing standards for the cultivation, manufacturing, transportation, storage, distribution, provision, donation, and sale of medical marijuana and medical marijuana products.
(e)Establishing procedures for the issuance, renewal, suspension, denial, and revocation of conditional licenses.
(f)Imposing a penalty authorized by this part or any rule or regulation adopted pursuant to this part.
(g)Taking action with respect to an application for a conditional license in accordance with procedures established pursuant to this part.
(h)Overseeing the operation of the Medical Marijuana Regulation Fund and the Special Account for Environmental Enforcement, established pursuant to Section 18118.
(i)Consulting with other state or local agencies, departments, representatives of the medical marijuana community, or public or private entities for the purposes of establishing statewide standards and regulations.
(j)Certifying laboratories to perform testing of medical marijuana.
18104.(a)On or before January 1, 2018, the bureau shall promulgate regulations for implementation and enforcement of this part, including, but not limited to, all of the following:
(1)Procedures for the issuance, renewal, suspension, denial, and revocation of conditional licenses.
(2)Procedures for appeal of fines and the appeal of denial, suspension, or revocation of conditional licenses.
(3)Application, licensing, and renewal forms and fees.
(4)A time period in which the bureau shall approve or deny an application for a conditional license pursuant to this part.
(5)Qualifications for licensees.
(6)Standards for certification of testing laboratories to perform random sample testing of all medical marijuana products, including standards for onsite testing.
(A)Certification of testing laboratories shall be consistent with general requirements for the competence of testing and calibration activities, including sampling, using standard methods established by the International Organization for Standardization, specifically ISO/IEC 17025.
(B)These requirements shall apply to all entities, including third-party laboratories, engaged in the testing of medical marijuana pursuant to this part.
(7)Requirements to ensure conformance with standards analogous to state statutory environmental, agricultural, consumer protection, and food and product safety requirements. At a minimum, these standards shall do all of the following:
(A)Prescribe sanitation standards analogous to the California Retail Food Code (Part 7 (commencing with Section 113700) of Division 104 of the Health and Safety Code) for food preparation, storage, handling, and sale of edible medical marijuana products.
(B)Require that edible medical marijuana products produced, distributed, provided, donated, or sold by licensees shall be limited to nonpotentially hazardous food, as established by the State Department of Public Health pursuant to Section 114365.5.
(C)Require that facilities in which edible medical marijuana products are prepared shall be constructed in accordance with applicable building standards, health and safety standards, and other state laws.
(D)Provide that weighing or measuring devices used in connection with the sale or distribution of medical marijuana are required to meet standards analogous to Division 5 (commencing with Section 12001).
(E)Require that the application of pesticides or other pest control in connection with the indoor or outdoor cultivation of medical marijuana shall meet standards analogous to Division 6 (commencing with Section 11401) of the Food and Agricultural Code and its implementing regulations.
(b)On or before July 1, 2017, the bureau shall also promulgate regulations for minimum statewide health and safety standards and quality assurance standards associated with the cultivation, transport, storage, manufacture, and sale of all medical marijuana produced in this state. Consistent with Section 18126, local agencies shall have primary responsibility for enforcement of these standards in accordance with bureau regulations.
(c)The bureau, in consultation with the Division of Labor Standards Enforcement, shall adopt regulations establishing worker safety standards for entities licensed pursuant to this part.
(d)The bureau, in consultation with the State Water Resources Control Board, shall adopt regulations to ensure that commercial medical marijuana activity licensed pursuant to this part does not threaten the states environment and watersheds and is otherwise in conformance with the California Environmental Quality Act.
(e)The bureau shall not issue a conditional license unless the applicant has met all of the requirements of this part, including the requirements of paragraph (4) of subdivision (d) of Section 18110.
18105.The chief shall keep a complete record of all facilities issued a conditional license. This record shall be made available on the bureaus Internet Web site.
18106.The bureau shall establish procedures to provide state and local law enforcement, upon their request, with 24-hour access to information to verify a conditional license, track transportation manifests, and track the inventories of facilities issued a conditional license.
18107.This part shall in no way supersede the provisions of Measure D, approved by the voters of the City of Los Angeles on the May 21, 2013, ballot for the city, or any similar measure in other jurisdictions, which grants medical marijuana businesses and dispensaries qualified immunity consistent with the terms of the measure and local ordinances. Notwithstanding the provisions of this part, marijuana businesses and dispensaries subject to the provisions of Measure D or other similar qualified immunity shall continue to be subject to the ordinances and regulations of the relevant local jurisdiction.
2.Conditional Licenses18108.The following persons are exempt from the requirement of licensure under this part:
(a)A patient who cultivates, possesses, stores, manufactures, or transports marijuana exclusively for his or her personal medical use and who does not sell, distribute, donate, or provide marijuana to any other person or entity.
(b)A primary caregiver who cultivates, possesses, stores, manufactures, transports, or provides marijuana exclusively for the personal medical purposes to no more than five specified qualified patients for whom he or she is the primary caregiver within the meaning of Section 11362.7 of the Health and Safety Code and who does not receive remuneration for these activities, except for compensation in full compliance with subdivision (c) of Section 11362.765 of the Health and Safety Code. Nothing in this section shall permit primary caregivers to organize themselves as cooperatives or collectives of caregivers.
18109.(a)Except as provided in Section 11362.5 of, and Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10 of, the Health and Safety Code, a person shall not sell or provide medical marijuana to a patient or caregiver other than at a licensed dispensing facility or through delivery from a licensed dispensing facility.
(b)Except as provided in Section 11362.5 of, and Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10 of, the Health and Safety Code, a person shall not grow medical marijuana other than at a licensed cultivation site.
(c)Except as provided in Section 11362.5 of, and Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10 of, the Health and Safety Code, a person shall not manufacture medical marijuana or medical marijuana products other than a licensed manufacturer.
(d)A person shall not transport medical marijuana from one facility issued a conditional license to another, other than a licensed transporter.
(e)A licensed manufacturer may obtain medical marijuana from a licensed cultivator and may furnish medical marijuana products to a licensed dispensary.
(f)To meet the requirements of Article 8 (commencing with Section 111658) of Chapter 6 of Part 5 of Division 104 of the Health and Safety Code, medical marijuana and medical marijuana products shall be tested by a certified testing laboratory.
18110.(a)Beginning no later than July 1, 2018, the bureau shall provide for and shall issue conditional licenses. Conditional licenses shall be issued for all activity authorized under this chapter, including, but not limited to, cultivation, processing, storage, transport, and dispensing of medical marijuana.
(b)The issuance of a conditional license shall not, in and of itself, authorize the recipient to begin business operations. The conditional license shall certify, at a minimum, that the applicant has paid the state conditional licensing fee, successfully passed a criminal background check, and met the state residency requirements.
(c)In order to begin business operations pursuant to this chapter, an applicant shall, in addition to the conditional license, obtain a license or permit from the local jurisdiction in which he or she proposes to operate, following the requirements of the applicable local ordinances.
(d)An applicant for a conditional license shall do all following:
(1)Pay the fee or fees required by this part for each license being applied for.
(2)Register with the bureau on forms prescribed by the chief. The forms shall contain sufficient information to identify the licensee, including all of the following:
(A)Name of the owner or owners of a proposed facility, including all persons or entities having an ownership interest other than a security interest, lien, or encumbrance on property that will be used by the applicant.
(B)The name, address, and date of birth of each principal officer and board member.
(C)The address and telephone number of the proposed facility.
(D)In the case of a cultivation site, the GPS coordinates of the site.
(3)Describe, in writing, the scope of business of the proposed facility.
(4)Provide evidence that the applicant and owner have been legal full-time residents of the state for not less than 12 months.
(5)Provide detailed operating procedures, in writing, for the proposed facility, which shall include, but not be limited to, procedures for facility and operational security, prevention of diversion, employee screening, storage of medical marijuana, personnel policies, and recordkeeping procedures.
(6)Provide evidence that the applicant has received all required environmental permits, including compliance with the California Environmental Quality Act, and wastewater discharge permits.
(7)Provide the applicants fingerprint images. For purposes of this paragraph, applicant means the owner or owners of a proposed facility, including all persons or entities having an ownership interest other than a security interest, lien, or encumbrance on property that will be used by the facility.
(A)The applicant shall electronically submit to the Department of Justice fingerprint images and related information required by the Department of Justice for the purpose of obtaining information as to the existence and content of a record of state or federal convictions and arrests, and information as to the existence and content of a record of state or federal convictions and arrests for which the Department of Justice establishes that the person is free on bail, or on his or her own recognizance, pending trial or appeal.
(B)The Department of Justice shall provide a response to the bureau pursuant to paragraph (1) of subdivision (p) of Section 11105 of the Penal Code.
(C)The bureau shall request from the Department of Justice subsequent notification service, as provided pursuant to Section 11105.2 of the Penal Code, for persons described in subparagraph (A).
(D)The Department of Justice shall charge the applicant a fee sufficient to cover the reasonable cost of processing the requests described in this paragraph.
(8)Provide a statement, signed by the applicant under penalty of perjury, that the information provided is true.
(9)Provide any other information required by the bureau.
(e)Each location and each discrete use of a single location shall require a conditional license. Each application for a conditional license is separate and distinct, and the bureau may charge a separate fee for each.
(f)A conditional license issued pursuant to this section shall be valid for 12 months after the date of issuance. After the initial 12-month period, a conditional license may be renewed for a period of 36 months. The bureau shall establish procedures for the renewal of a conditional license.
(g)Notwithstanding any other law, the bureau shall not issue a conditional license to an individual or entity, or for a premise, against whom there is a pending state or local administrative or judicial proceeding, against whom there is an action initiated by a city, county, or city and county under a local ordinance, or who has been determined to have violated an applicable local ordinance.
(h)A facility or entity that is operating in conformance with local zoning ordinances and other state and local requirements on January 1, 2016, may continue its operations until its application for conditional licensure is approved or denied pursuant to this part.
18111.(a)Upon receipt of the application materials and fee required in Section 18110, the bureau, provided the applicant has not committed an act or crime constituting grounds for the denial of licensure under Section 18112, may issue the conditional license and send a proof of issuance to the applicant.
(b)The chief shall, by regulation, prescribe conditions upon which a person whose conditional license has previously been denied, suspended, or revoked, may be issued a conditional license.
18112.(a)An application for a conditional license shall be denied and a conditional license shall be suspended or revoked for a past felony conviction for the possession for sale, sale, manufacture, transportation, or cultivation of a controlled substance, a felony criminal conviction for drug trafficking, a felony conviction for embezzlement, a felony conviction involving fraud or deceit, or any violent or serious felony conviction pursuant to subdivision (c) of Section 667.5 of, or subdivision (c) of Section 1192.7 of, the Penal Code. The bureau, at its discretion, may issue a license to an applicant that would be otherwise denied pursuant to this subdivision if the applicant has obtained a certificate of rehabilitation, pursuant to Section 4852.13 of the Penal Code.
(b)The chief, upon his or her determination, may deny, suspend, or revoke a conditional license when a conditional licensee, applicant, or employee, partner, officer, or member of an entity conditionally licensed does any of the following:
(1)Making or authorizing in any manner or by any means a written or oral statement that is untrue or misleading and that is known, or that by exercise of reasonable care should be known, to be untrue or misleading.
(2)Any other conduct that constitutes fraud.
(3)Conduct constituting gross negligence.
(4)Failure to comply with the provisions of this part, Article 8 (commencing with Section 111658) of Chapter 6 of Part 5 of Division 104 of the Health and Safety Code, or any rule or regulation adopted pursuant to this part.
(5)Conduct that constitutes grounds for denial of licensure pursuant to Chapter 2 (commencing with Section 480) of Division 1.5.
18113.(a)Upon denying, suspending, or revoking a conditional license, the chief shall notify the applicant or licensee, in writing, by personal service or mail addressed to the address of the applicant or licensee set forth in the application. The applicant or licensee shall be given a hearing within 30 days thereafter if he or she files with the bureau a written request for hearing. Otherwise, the denial, suspension, or revocation is deemed affirmed.
(b)All proceedings to deny, suspend, or revoke a conditional license shall be conducted pursuant to Chapter 5 (commencing with Section 11500) of Part 1 of Division 3 of Title 2 of the Government Code.
18114.An application for or renewal of a conditional license shall not be approved if the bureau determines any of the following:
(a)The applicant fails to meet the requirements of this part or any regulation adopted pursuant to this part or any applicable city, county, or city and county ordinance or regulation. If a local government adopts an ordinance or resolution authorizing medical marijuana to be cultivated, manufactured, stored, distributed, or sold within its jurisdiction, it shall submit to the bureau documentation detailing their renewal requirements.
(b)The applicant, or any of its officers, directors, owners, members, or shareholders, is a minor.
(c)The applicant has knowingly answered a question or request for information falsely on the application form or failed to provide information requested.
(d)The applicant, or any of its officers, directors, owners, members, or shareholders has been sanctioned by the bureau, a city, county, or city and county, for medical marijuana activities conducted in violation of this part or any applicable local ordinance or has had a license revoked in the previous five years.
(e)The proposed cultivation, processing, possession, storage, manufacturing, testing, transporting, distribution, provision, or sale of medical marijuana will violate any applicable local law or ordinance.
(f)The applicant or the owner is unable to establish that he or she has been a resident of the state for not less than 12 months.
18115.(a)In addition to the provisions of this part, a conditional license shall be subject to the restrictions of the local jurisdiction in which the facility operates or proposes to operate. Even if a conditional license has been granted pursuant to this part, a facility shall not operate in a local jurisdiction that prohibits the establishment of that type of business.
(b)In addition to the provisions of this part, local jurisdictions retain the power to assess fees and taxes, as applicable, on facilities that are conditionally licensed pursuant to this part and the business activities of those licensees.
18116.The bureau may adopt regulations to limit the number of conditional licenses issued pursuant to this part upon a finding that the otherwise unrestricted issuance of conditional licenses is dangerous to the public health and safety.
3.Fees18117.(a)The conditional licensing fee shall be established by the bureau at a level sufficient to fund the reasonable costs of all of the following:
(1)Administrative costs incurred by the bureau in overseeing the conditional licensing program, establishing health and safety standards, and certifying the required testing laboratories.
(2)Costs incurred by the bureau or the Department of Justice for enforcement of the provisions of this part.
(3)Costs incurred by law enforcement and other public safety entities for enforcing the provisions of this part in their jurisdiction.
(b)In addition to the conditional licensing fee required pursuant to subdivision (a), a cultivation facility shall be assessed a fee in a sufficient amount to cover the reasonable regulatory costs of enforcing the environmental impact provisions relating to those cultivation facilities. This fee shall be distributed, as necessary and in proportion to its regulatory function, between the following agencies responsible for enforcing the regulations relating to the environmental impact of licensed cultivation sites:
(1)The State Water Board.
(2)The Department of Fish and Wildlife.
(3)The Department of Forestry and Fire Protection.
(4)The Department of Pesticide Regulation.
(5)The Department of Food and Agriculture.
(6)Local law enforcement.
18118.(a)The Medical Marijuana Regulation Fund is hereby established within the State Treasury. Notwithstanding Section 16305.7 of the Government Code, the fund shall include any interest and dividends earned on the money in the fund.
(b)Except as provided in subdivision (c), all fees collected pursuant to this part shall be deposited into the Medical Marijuana Regulation Fund. Notwithstanding Section 13340 of the Government Code, all moneys within the fund are hereby continuously appropriated, without regard to fiscal year, to the bureau solely for the purposes of fully funding and administering this part, including, but not limited to, the costs incurred by the bureau for its administrative expenses.
(c)The Special Account for Environmental Enforcement is hereby established as an account within the Medical Marijuana Regulation Fund. Notwithstanding Section 16305.7 of the Government Code, the account shall include any interest and dividends earned on the money in the account. All fees collected pursuant to subdivision (b) of Section 18112 shall be deposited in this account. Notwithstanding Section 13340 of the Government Code, all moneys within the fund are hereby continuously appropriated, without regard to fiscal year, to the bureau for distribution to the entities listed in subdivision (b) of Section 18117 to be used to enforce the environmental regulation of licensed cultivation sites.
(d)All moneys collected as a result of penalties imposed under this part shall be deposited directly into the General Fund, to be available upon appropriation.
(e)The bureau may establish and administer a grant program to allocate moneys from the Medical Marijuana Regulation Fund to state and local entities for the purpose of assisting with medical marijuana regulation and the enforcement of this part and other state and local laws applicable to licensees.
18119.(a)A facility issued a conditional license shall not acquire, cultivate, process, possess, store, manufacture, distribute, sell, deliver, transfer, transport, or dispense medical marijuana for any purpose other than those authorized by Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10 of the Health and Safety Code.
(b)A licensed dispensing facility shall not acquire, cultivate, process, possess, store, manufacture, distribute, sell, deliver, transfer, transport, or dispense medical marijuana plants or medical marijuana products except through a licensed cultivation site or a licensed manufacturer.
4.Transportation of Medical Marijuana18120.(a)A licensed transporter shall ship only to facilities issued a conditional license and only in response to a request for a specific quantity and variety from those facilities.
(b)Prior to transporting medical marijuana products, a licensed transporter shall do both of the following:
(1)Complete a shipping manifest using a form prescribed by the bureau.
(2)Securely transmit a copy of the manifest to the licensee that will receive the medical marijuana product, and to the bureau, prior to transport.
(c)The licensed transporter making the shipment and the licensee receiving the shipment shall maintain each shipping manifest and make it available to local code enforcement officers, any other locally designated enforcement entity, and the bureau upon request.
18121.(a)Transported medical marijuana products shall:
(1)Be transported only in a locked, safe, and secure storage compartment that is securely affixed to the interior of the transporting vehicle.
(2)Not be visible from outside the vehicle.
(b)A vehicle transporting medical marijuana products shall travel directly from one licensed facility to another licensed facility authorized to receive the shipment.
18122.(a)All transport vehicles shall be staffed with a minimum of two employees. At least one transport team member shall remain with the vehicle at all times when the vehicle contains medical marijuana.
(b)Each transport team member shall have access to a secure form of communication by which each member can communicate with personnel at the licensed facility at all times when the vehicle contains medical marijuana.
(c)Each transport team member shall possess documentation of licensing and a government-issued identification card at all times when transporting or delivering medical marijuana and shall produce it to any representative of the bureau or law enforcement upon request.
(d)This part shall not be construed to authorize or permit a licensee to transport, or cause to be transported, medical marijuana or medical marijuana products outside the state.
18123.A local jurisdiction shall not prevent transportation through or to a facility issued a conditional license, by a conditionally licensed transporter who acts in compliance with this part.
5.Enforcement18124.A state agency is not required by this section to enforce a city, county, city and county, or local law, ordinance, rule, or regulation regarding the site or operation of a facility issued a conditional license.
18125.The bureau may assist state taxation authorities in the development of uniform policies for the state taxation of licensees.
18126.(a)For facilities issued a conditional license that are located within the incorporated area of a city, the city shall have full power and authority to enforce this part and Article 8 (commencing with Section 111658) of Chapter 6 of Part 5 of Division 104 of the Health and Safety Code and the rules, regulations, and standards promulgated by the bureau. The city shall further assume complete responsibility for any regulatory function relating to those licensees within the city limits that would otherwise be performed by the county or any county officer or employee, without liability, cost, or expense to the county.
(b)For licensed facilities located within the unincorporated area of a county, the county shall have full power and authority to enforce this part and Article 8 (commencing with Section 111658) of Chapter 6 of Part 5 of Division 104 of the Health and Safety Code and the rules, regulations, and standards promulgated by the bureau.
18127.(a)A willful violation of Section 18110, including an attempt to falsify information on an application or to otherwise defraud or mislead a state or local agency in the course of the application process, shall be punishable by a civil fine of up to thirty-five thousand dollars ($35,000) for each individual violation.
(b)A technical violation of Section 18110 shall, at the bureaus discretion, be punishable by a civil fine of up to ten thousand dollars ($10,000) for each individual violation.
18128.A district attorney, county counsel, city attorney, or city prosecutor may bring an action to enjoin a violation or the threatened violation of any provision of this part, including, but not limited to, a licensees failure to correct objectionable conditions following notice or as a result of a rule promulgated pursuant to this part. The action shall be brought in the county in which the violation occurred or is threatened to occur. A proceeding brought pursuant to this part shall conform to the requirements of Chapter 3 (commencing with Section 525) of Title 7 of Part 2 of the Code of Civil Procedure. Nothing in this section shall diminish the authority of a local government to take requisite enforcement actions pertaining to its own ordinances or regulations.
18129.Nothing in this part shall prevent a city or other local governing body from taking action as specified in Section 11362.83 of the Health and Safety Code.
18130.This part shall not be construed to limit a law enforcement agencys ability to investigate unlawful activity in relation to a facility issued a conditional license.
6.Cultivation Sites18131.A licensed cultivation site shall not be located in an area zoned residential.
18132.(a)The bureau shall notify local law enforcement of all conditional licenses issues for cultivation sites in that jurisdiction.
(b)A licensed cultivation site shall display the state license in a manner so as to be available and easily read at the location.
(c)The bureau shall work with and assist state and local law enforcement to eliminate trespass grows in the state.
18133.(a)No later than January 1, 2022, all medical marijuana grown, produced, distributed, and sold in the state shall meet the certified organic standards.
(b)The bureau shall establish appellations of origin for marijuana grown in California.
18134.The bureau shall work with county agricultural commissioners, offices to provide all the information and forms required for conditional licensure as a cultivation site in a single location, including state licensure, local requirements in that jurisdiction, and environmental requirements.
7.Regulation of Medical Marijuana18136.(a)A person shall not distribute any form of advertising for physician recommendations for medical marijuana in California unless the advertisement bears the following notice to consumers:
NOTICE TO CONSUMERS: The Compassionate Use Act of 1996 ensures that seriously ill Californians have the right to obtain and use marijuana for medical purposes where medical use is deemed appropriate and has been recommended by a physician who has determined that the persons health would benefit from the use of medical marijuana. Physicians are licensed and regulated by the Medical Board of California and arrive at the decision to make this recommendation in accordance with accepted standards of medical responsibility.
(b)Advertising for physician recommendations for medical marijuana shall meet all requirements of Section 651. Price advertising shall not be fraudulent, deceitful, or misleading, including statements or advertisements of bait, discounts, premiums, gifts, or statements of a similar nature.
18137.(a)A facility issued a conditional license shall implement sufficient security measures to both deter and prevent unauthorized entrance into areas containing marijuana and theft of marijuana at those facilities. These security measures shall include, but not be limited to, all of the following:
(1)Preventing individuals from remaining on the premises of the facility if they are not engaging in activity expressly related to the operations of the facility.
(2)Establishing limited access areas accessible only to authorized facility personnel.
(3)Storing all finished marijuana in a secured and locked room, safe, or vault, and in a manner as to prevent diversion, theft, and loss.
(b)A facility issued a conditional license shall notify appropriate law enforcement authorities within 24 hours after discovering any of the following:
(1)Discrepancies identified during inventory.
(2)Diversion, theft, loss, or any criminal activity involving the facility or a facility agent.
(3)The loss or unauthorized alteration of records related to marijuana, registered qualifying patients, personal caregivers, or facility agents.
(4)Any other breach of security.
(c)A licensed cultivation site shall weigh, inventory, and account for on video, all medical marijuana to be transported prior to its leaving its origination location. Within eight hours after arrival at the destination, the licensed dispensing facility shall reweigh, reinventory, and account for on video, all transported marijuana.
18138.(a)The bureau shall require an annual audit of all facilities issued a conditional license to cultivate, manufacture, process, transport, store, or sell medical marijuana. The reasonable costs of the audit shall be paid for by the licensee.
(b)Completed audit reports shall also be submitted by the licensee to local code enforcement offices, or the appropriate locally designated enforcement entity, within 30 days of the completion of the audit.
(c)It is the responsibility of each facility issued a conditional license to develop a robust quality assurance protocol that includes all of the provisions of this part.
18139.(a)A laboratory certified by the bureau to perform random sample testing of medical marijuana products shall not acquire, process, possess, store, transfer, transport, or dispense medical marijuana for any purpose other than those authorized by Article 2.5 (commencing with Section 11362.7) of Chapter 6 of Division 10 of the Health and Safety Code. All transfer or transportation shall be performed pursuant to a specified chain of custody protocol.
(b)A laboratory certified by the bureau to perform random sample testing of medical marijuana products shall not acquire, process, possess, store, transfer, transport, or dispense medical marijuana plants or medical marijuana products except through a patient, primary caregiver, or a facility issued a conditional license. All transfer or transportation shall be performed pursuant to a specified chain of custody protocol.
18140.(a)Information identifying the names of patients, their medical conditions, or the names of their primary caregivers received and contained in records kept by the bureau for the purposes of administering this part are confidential and exempt from the California Public Records Act (Chapter 3.5 (commencing with Section 6250) of Division 7 of Title 1 of the Government Code) and are not subject to disclosure to an individual or private entity, except as necessary for authorized employees of the state to perform official duties pursuant to this part.
(b)(1)Nothing in this section shall preclude any of the following:
(A)Bureau employees notifying state or local agencies about information submitted to the bureau that the employee suspects is falsified or fraudulent.
(B)Notifications from the bureau to state or local agencies of apparent violations of this part or an applicable local ordinance.
(C)Verification of requests by state or local agencies to confirm licenses and certificates issued by the bureau or other state agency.
(D)Providing information requested pursuant to a court order or subpoena issued by a court, an administrative agency, or local governing body authorized by law to issue subpoenas.
(2)Information shall not be disclosed beyond what is necessary to achieve the goals of a specific investigation or notification or the parameters of a specific court order or subpoena.
18141.(a)The actions of a licensee, its employees, and its agents, that are permitted pursuant to a conditional license and that are conducted in accordance with the requirements of this part and regulations adopted pursuant to this part, are not unlawful under state law and shall not be an offense subject to arrest or prosecution.
(b)The actions of a person who, in good faith and upon investigation, allows his or her property to be used by a licensee, its employees, and its agents, as permitted pursuant to a conditional license, are not unlawful under state law and shall not be an offense subject to arrest or prosecution.
(c)This section shall not be deemed to limit the authority or remedies of a city, county, or city and county under any provision of law, including, without limitation, Section 7 of Article XI of the California Constitution.
18142.(a)A licensee shall not cultivate, process, store, manufacture, transport, or sell medical marijuana in the state unless accurate records are kept at the licensed premises of the growing, processing, storing, manufacturing, transporting, or selling by the licensee in the state. These records shall include the name and address of the supplier of marijuana received or possessed by the licensee, the location at which the marijuana was cultivated, the amount of marijuana received, the form in which it is received, the name of the employee receiving it, and the date of receipt. These records shall also include receipts for all expenditures incurred by the licensee and banking records, if any, for all funds obtained or expended in the performance of any activity under the authority of the conditional license. A licensee who has a conditional license for more than one premises may keep all records at one of the conditionally licensed premises. Required records shall be kept for a period of seven years from the date of the transaction.
(b)The bureau and an appropriate state or local agency may examine the books and records of a conditional licensee and may visit and inspect the premises of a conditional licensee, as the bureau or state or local agency deems necessary to perform its duties under this part.
(c)Books or records requested by the bureau or an appropriate state or local agency shall be provided by the conditional licensee no later than five business days after the request is made.
(d)The bureau or a state or local agency may enter and inspect the premises of a facility issued a conditional license between the hours of 8 a.m. and 8 p.m. on any day that the facility is open, or at any reasonable time, to ensure compliance and enforcement of the provisions of this part or a local ordinance.
(e)If a licensee or an employee of a licensee refuses, impedes, obstructs, or interferes with an inspection pursuant to subdivision (d), the conditional license may be summarily suspended and the bureau shall directly commence proceedings for the revocation of the conditional license.
(f)If a licensee or an employee of a licensee fails to maintain or provide the books and records required pursuant to this section, the licensee shall be subject to a civil fine of fifteen thousand dollars ($15,000) per individual violation.
SEC. 6.Section 23028 is added to the Government Code, to read:23028.(a)(1)In addition to any authority otherwise provided by law, the board of supervisors of a county or the city council of a city may impose, by ordinance, a tax on the privilege of cultivating, dispensing, producing, processing, preparing, storing, providing, donating, selling, or distributing marijuana by a licensee operating pursuant to Chapter 18 (commencing with Section 26000) of Division 9 of the Business and Professions Code. The tax may be imposed for general governmental purposes or for purposes specified in the ordinance by the board of supervisors or city council.
(2)The board of supervisors or city council shall specify in the ordinance proposing the tax the activities subject to the tax, the applicable rate or rates, the method of apportionment, and the manner of collection of the tax. A tax imposed pursuant to this section is a tax and not a fee or special assessment, and the tax is not required to be apportioned on the basis of benefit to any person or property or be applied uniformly to all taxpayers or all real property.
(3)A tax imposed by a city or county pursuant to this section may include a transactions and use tax imposed solely for marijuana or marijuana products, which shall otherwise conform to Part 1.6 (commencing with Section 7251) of Division 2 of the Revenue and Taxation Code. Notwithstanding Section 7251.1 of the Revenue and Taxation Code, the tax may be imposed at any rate specified by the board of supervisors or city council, and the tax rate authorized by this section shall not be considered for purposes of the combined tax rate limitation established by that section.
(4)The tax authorized by this section may be imposed upon any or all of the activities set forth in paragraph (1), regardless of whether the activity is undertaken individually, collectively, or cooperatively, and regardless of whether the activity is for compensation or gratuitously, as determined by the board of supervisors or city council.
(5)The board of supervisors shall specify whether the tax applies throughout the entire county or within the unincorporated area of the county.
(b)In addition to any other method of collection authorized by law, the board of supervisors or city council may provide for the collection of the tax imposed pursuant to this section in the same manner, and subject to the same penalties and priority of lien, as other charges and taxes fixed and collected by the city or county.
(c)Any tax imposed pursuant to this section shall be subject to applicable voter approval requirements imposed by law.
(d)For purposes of this section, marijuana shall have the meanings set forth in Section 18100 of the Business and Professions Code.
(e)This section does not limit or prohibit the levy or collection or any other fee, charge, or tax, or any license or service fee or charge upon, or related to, the activities set forth in subdivision (a) as otherwise provided by law. This section shall not be construed as a limitation upon the taxing authority of a city or county as provided law.
SEC. 7.Section 11362.775 of the Health and Safety Code is amended to read:11362.775.(a)Qualified patients, persons with valid identification cards, and the designated primary caregivers of qualified patients and persons with identification cards, who associate within the State of California in order collectively or cooperatively to cultivate marijuana for medical purposes, shall not solely on the basis of that fact be subject to state criminal sanctions under Section 11357, 11358, 11359, 11360, 11366, 11366.5, or 11570.
(b)An individual employee, officer, or board member of a facility issued a conditional license pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code shall not be subject to state criminal sanctions under Section 11357, 11358, 11359, 11360, 11366, 11366.5, or 11570 and any successor statutes, based solely on holding a conditional license, for the possession, cultivation, processing, packaging, storage, transportation, sale, or distribution of medical marijuana to a facility holding a conditional license pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code or directly to a qualified patient, a person with a valid identification card, or the designated primary caregiver of a qualified patient or person with a valid identification card, within the state, unless the information contained on the licensing paperwork is false or falsified, the license has been obtained by means of fraud, or the person is otherwise in violation of Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code.
(c)This section shall not diminish the protections of Section 18141 of the Business and Professions Code.
SEC. 8.Article 8 (commencing with Section 111658) is added to Chapter 6 of Part 5 of Division 104 of the Health and Safety Code, to read:8.Medical Marijuana111658.For purpose of this article, the following definitions shall apply:
(a)Bureau means the Bureau of Medical Marijuana Regulations in the Department of Consumer Affairs.
(b)Certified testing laboratories means a laboratory that is certified by the bureau to perform random sample testing of medical marijuana for patients, primary caregivers, and facilities issued conditional licenses pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code, pursuant to the certification standards for those facilities promulgated by the bureau.
(c)Edible medical marijuana product means medical marijuana or a medical marijuana-derived product that is ingested or meant to be ingested through the mouth and into the digestive system.
(d)Marijuana means all parts of the plant Cannabis sativa L. sativa, cannabis indica, or cannabis ruderalis, whether growing or not; the seeds thereof; the resin, whether crude or purified, extracted from any part of the plant; and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds, or resin. Marijuana does not include the mature stalks of the plant, fiber produced from the stalks, oil or cake made from the seeds of the plant, any other compound, manufacture, salt, derivative, mixture, or preparation of the mature stalks (except the resin extracted therefrom), fiber, oil, or cake, or the sterilized seed of the plant which is incapable of germination. Marijuana also means marijuana, as defined by Section 11018.
(e)Labor peace agreement means an agreement between an entity and a bona fide labor organization that, at a minimum, protects the states proprietary interests by prohibiting labor organizations and members from engaging in picketing, work stoppages, boycotts, and any other economic interference with the applicants business. This agreement means that the applicant has agreed not to disrupt efforts by the bona fide labor organization to communicate with, and attempt to organize and represent, the applicants employees.
(f)Representative samples means samples taken from each batch or shipment of medical marijuana received from a licensed cultivation site or any other source if intended for sale.
111659.The bureau, by July 1, 2017, shall accomplish both of the following:
(a)Establish quality assurance protocols to ensure uniform testing standards for all medical marijuana sold via dispensaries or other facilities, or cultivated or manufactured by facilities, that are issued a conditional license pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code.
(b)In consultation with outside entities at its discretion, develop a list of certified testing laboratories that can perform uniform testing in compliance with this article, and post that list on its Internet Web site.
111660.(a)A facility issued a conditional license pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code shall bear the responsibility for contracting with certified testing laboratories for regular, systematic testing of representative samples of all medical marijuana cultivated or intended for sale or distribution, and shall bear the cost of that testing.
(b)A facility issued a conditional license pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code shall maintain records of testing reports for seven years, either on site in a digital format or at a secure off-site location in either digital or paper format. These facilities shall provide results of test reports to local code enforcement officers, any other locally designated enforcement entity, and the bureau upon request.
111661.Quality assurance protocols shall be required between all licensed cultivation sites, licensed manufacturers, and licensed dispensing facilities to guarantee safe and reliable medicinal marijuana delivery to all patients. These quality assurance protocols shall include:
(a)Providing supplier information to dispensaries in order for recall procedures to be implemented, if and when necessary.
(b)Safety testing of all medical marijuana prior to packaging for sale and patient exposure to identify and eliminate microbiological contaminants and chemical residue.
(c)Labeling of all medical marijuana and medical marijuana products that shall, at a minimum, include the following:
(1)List of pharmacologically active ingredients, including, but not limited to, tetrahydrocannabinol (THC) and cannabidiol (CBD) content, clear recommended dosage, and the size or volume of the recommended dose.
(2)Clear indication, in bold font, that the product contains medical marijuana.
(3)The statement FOR MEDICAL USE ONLY. KEEP OUT OF REACH OF CHILDREN AND ANIMALS in bold print.
(4)Identification of the source and date of cultivation and manufacture.
(5)The name and location of the dispensary providing the product.
(6)The date of sale.
(7)Any other requirements set by the bureau.
111662.For purposes of this article, edible medical marijuana products are deemed to be unadulterated food products. In addition to the quality assurance standards provided in Section 111661, all edible medical marijuana products shall comply with the following requirements:
(a)Baked edible medical marijuana products, including, but not limited to, brownies, bars, cookies, and cakes, tinctures, and other edible medical marijuana products that do not require refrigeration or hot holding may be manufactured, sold, or otherwise distributed at facilities issued a conditional license pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code.
(b)A facility issued a conditional license pursuant to Part 5 (commencing with Section 18100) of Division 7 of the Business and Professions Code shall have an owner or employee who has successfully passed an approved and accredited food safety certification examination as specified in Sections 113947.1, 113947.2, and 113947.3 prior to selling, manufacturing, or distributing edible medical marijuana products requiring refrigeration or hot holding.
(c)Individuals manufacturing or selling edible medical marijuana products shall thoroughly wash their hands before commencing production and before handling finished edible medical marijuana products.
(d)All edible medical marijuana products sold for direct consumption and infused with marijuana concentrate shall be individually wrapped at the original point of preparation. The products shall be packaged in a fashion that does not exceed a single dosage for one individual.
(e)Products containing tetrahydrocannabinol (THC) shall be prepared in compliance with maximum potency standards for THC and THC concentrates set forth in the bureaus regulations.
(f)Prior to sale or distribution at a licensed dispensing facility, edible medical marijuana products shall be labeled and in an opaque and tamper evident package. Labels and packages of edible medical marijuana products shall meet the following requirements:
(1)Edible medical marijuana packages and labels shall not be made to be attractive to children.
(2)All edible medical marijuana product labels shall include the following information, prominently displayed and in a clear and legible font:
(A)Manufacture date and source.
(B)The statement KEEP OUT OF REACH OF CHILDREN AND ANIMALS in bold print.
(C)The statement FOR MEDICAL USE ONLY.
(D)Net weight of medical marijuana in package.
(E)A warning if nuts or other known allergens are used and shall include the total weight, in ounces or grams, of medical marijuana in the package.
(F)List of pharmacologically active ingredients, including, but not limited to, tetrahydrocannabinol (THC) and cannabidiol (CBD) content, clear recommended dosage, and the size or volume of recommended dose.
(G)Any other requirement set by the bureau.
(g)Photos or images of food are not allowed on edible medical marijuana product packages or labels.
(h)Only generic food names may be used to describe edible medical marijuana products.
SEC. 9.On or before July 1, 2016, the State Board of Equalization shall compile a report on the actual tax collected on the sale of medical marijuana, using the most current data available. The report should also include expected tax revenues, under the existing tax structure, for the years 2016 to 2021, inclusive. This report shall be submitted to the Legislature and the Governors Office pursuant to Section 9795 of the Government Code.
SEC. 10.The provisions of this act are severable. If any provision of this act or its application is held invalid, that invalidity shall not affect other provisions or applications that can be given effect without the invalid provision or application.
SEC. 11.The Legislature finds and declares that Section 5 of this act imposes a limitation on the publics right of access to the meetings of public bodies or the writings of public officials and agencies within the meaning of Section 3 of Article I of the California Constitution. Pursuant to that constitutional provision, the Legislature makes the following findings to demonstrate the interest protected by this limitation and the need for protecting that interest:
The limitation imposed under this act is necessary for purposes of compliance with the federal Health Insurance Portability and Accountability Act of 1996 (42 U.S.C. Sec. 1320d et seq.), the Confidentiality of Medical Information Act (Part 2.6 (commencing with Section 56) of Division 1 of the Civil Code), and the Insurance Information and Privacy Protection Act (Article 6.6 (commencing with Section 791) of Part 2 of Division 1 of the Insurance Code).
SEC. 12.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
SECTION 1.It is the intent of the Legislature to enact legislation that would do all of the following:
(1)Protect the residents of California, private property, public lands, and waterways from trespass cultivation of medical marijuana.
(2)Reaffirm and clarify aspects of the Medical Marijuana Program Act.
(3)Regulate the cultivation of medical marijuana and authorize the collection of fees.
(4)Authorize and appropriate adequate funding for the Board of Equalization to undertake a study of the results of legislation recently passed in Colorado and the State of Washington in order to make recommendations on the best way to levy and collect fees to regulate the cultivation and sale of medical marijuana.
(5)Authorize the creation of appellations of origin for medical marijuana cultivated in California.
It is the intent of the Legislature to enact legislation that would do all of the following:
(1)Protect the residents of California, private property, public lands, and waterways from trespass cultivation of medical marijuana.
(2)Reaffirm and clarify aspects of the Medical Marijuana Program Act.
(3)Regulate the cultivation of medical marijuana and authorize the collection of fees.
(4)Authorize and appropriate adequate funding for the Board of Equalization to undertake a study of the results of legislation recently passed in Colorado and the State of Washington in order to make recommendations on the best way to levy and collect fees to regulate the cultivation and sale of medical marijuana.
(5)Authorize the creation of appellations of origin for medical marijuana cultivated in California.
|
Date
|
Status
|
|---|---|
| Sep 11, 2015 | Assembly amendments concurred in. (Ayes 30. Noes 9. Page 2781.) Ordered to engrossing and enrolling. |
| Aug 17, 2015 | Read second time and amended. Re-referred to Com. on APPR. |
| Aug 18, 2015 | From committee with author's amendments. Read second time and amended. Re-referred to Com. on APPR. |
| Aug 26, 2015 | August 26 set for first hearing. Placed on APPR. suspense file. |
| Aug 27, 2015 | Joint Rule 62(a) suspended. |
| Aug 31, 2015 | From committee: Do pass as amended. (Ayes 11. Noes 0.) (August 27). |
| Sep 1, 2015 | Read second time and amended. Ordered to second reading. |
| Sep 2, 2015 | Read second time. Ordered to third reading. |
| Sep 4, 2015 | Assembly Rule 69 suspended. |
| Sep 4, 2015 | Ordered to third reading. |
| Sep 4, 2015 | Re-referred to Com. on B. & P. pursuant to Assembly Rule 77.2. |
| Sep 4, 2015 | Read third time and amended. |
| Jul 16, 2015 | From committee: Do pass as amended and re-refer to Com. on APPR. (Ayes 11. Noes 2.) (July 14). |
| Sep 11, 2015 | Assembly amendments concurred in. (Ayes 30. Noes 9.) Ordered to engrossing and enrolling. |
| Sep 11, 2015 | Assembly Rule 63 suspended. |
| Sep 11, 2015 | From committee: Do pass as amended. (Ayes 8. Noes 1.) (September 11). |
| Sep 11, 2015 | In Senate. Concurrence in Assembly amendments pending. |
| Sep 11, 2015 | Joint Rule 62(a) suspended. |
| Sep 11, 2015 | Read second time and amended. Ordered to third reading. |
| Sep 11, 2015 | Read third time. Passed. Ordered to the Senate. |
| Sep 11, 2015 | Read third time. Passed. (Ayes 58. Noes 13. Page 3191.) Ordered to the Senate. |
| Sep 17, 2015 | Enrolled and presented to the Governor at 4:45 p.m. |
| Oct 9, 2015 | Approved by the Governor. |
| Oct 9, 2015 | Chaptered by Secretary of State. Chapter 719, Statutes of 2015. |
| May 6, 2015 | Read second time and amended. Re-referred to Com. on APPR. |
| Mar 2, 2015 | From printer. May be acted upon on or after April 1. |
| Mar 2, 2015 | Read first time. |
| Mar 12, 2015 | Referred to Com. on RLS. |
| Apr 6, 2015 | From committee with author's amendments. Read second time and amended. Re-referred to Com. on RLS. |
| Apr 9, 2015 | Re-referred to Coms. on B., P. & E.D. and RLS. |
| Apr 10, 2015 | Set for hearing April 20. |
| Apr 21, 2015 | From committee: Do pass and re-refer to Com. on RLS. (Ayes 7. Noes 0. Page 699.) (April 20). Re-referred to Com. on RLS. |
| Apr 22, 2015 | Re-referred to Com. on GOV. & F. |
| Apr 24, 2015 | Set for hearing April 29. |
| May 5, 2015 | From committee: Do pass as amended and re-refer to Com. on APPR. (Ayes 5. Noes 1. Page 816.) (April 29). |
| May 5, 2015 | From committee: Do pass as amended and re-refer to Com. on APPR. (Ayes 5. Noes 1.) (April 29). |
| Feb 27, 2015 | Introduced. To Com. on RLS. for assignment. To print. |
| May 8, 2015 | Set for hearing May 18. |
| May 18, 2015 | May 18 hearing: Placed on APPR. suspense file. |
| May 23, 2015 | Set for hearing May 28. |
| Jun 2, 2015 | From committee: Do pass as amended. (Ayes 5. Noes 1. Page 1157.) (May 28). |
| Jun 2, 2015 | From committee: Do pass as amended. (Ayes 5. Noes 1.) (May 28). |
| Jun 3, 2015 | Read second time and amended. Ordered to third reading. |
| Jun 4, 2015 | In Assembly. Read first time. Held at Desk. |
| Jun 4, 2015 | Read third time. Passed. (Ayes 26. Noes 13. Page 1328.) Ordered to the Assembly. |
| Jun 4, 2015 | Read third time. Passed. (Ayes 26. Noes 13.) Ordered to the Assembly. |
| Jun 19, 2015 | Referred to Coms. on B. & P. and HEALTH. |
| Jul 7, 2015 | From committee: Do pass and re-refer to Com. on HEALTH. (Ayes 8. Noes 2.) (July 7). Re-referred to Com. on HEALTH. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| Sep 11, 2015 | Unfinished Business (Supplemental File 6) SB643 McGuire Concurrence | Senate Floor |
Passed |
|
| Sep 11, 2015 | SB 643 McGuire Senate Third Reading By BONTA | Assembly Floor |
Passed |
|
| Sep 11, 2015 | Do pass as amended. | Assembly Standing Committee on Business and Professions |
Passed |
|
| Aug 27, 2015 | Do pass as amended. | Assembly Standing Committee on Appropriations |
Passed |
|
| Jul 14, 2015 | Do pass as amended and be re-referred to the Committee on [Appropriations] | Assembly Standing Committee on Health |
Passed |
|
| Jul 7, 2015 | Do pass and be re-referred to the Committee on [Health] | Assembly Standing Committee on Business and Professions |
Passed |
|
| Jun 4, 2015 | Senate 3rd Reading SB643 McGuire | Senate Floor |
Passed |
|
| May 28, 2015 | Do pass as amended | Senate Standing Committee on Appropriations |
Passed |
|
| May 18, 2015 | Placed on suspense file | Senate Standing Committee on Appropriations |
Passed |
|
| Apr 29, 2015 | Do pass as amended, but first amend, and re-refer to the Committee on [Appropriations] | Senate Standing Committee on Governance and Finance |
Passed |
|
| Apr 20, 2015 | Do pass, but first be re-referred to the Committee on [Rules] | Senate Standing Committee on Business, Professions and Economic Development |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
|
Organization
|
Position
|
Date
|
|---|---|---|
| Breast Cancer Fund, The | * Indeterminate | Jul 7, 2015 |
| Brownie Mary Democratic Club of Sacramento County | * Indeterminate | Jul 7, 2015 |
| California Cannabis Coalition | * Against | Jul 14, 2015 |
| California Cannabis Industry Association | * Support | Jul 14, 2015 |
| California Director for Americans for Safe Access | * Support | Jul 14, 2015 |
| California NORML | * Support | Apr 20, 2015 |
| California State Association Of Counties | * Support | Apr 20, 2015 |
| California Teamsters Public Affairs Council | * Support | Jul 14, 2015 |
| California Trout | * Support | Jul 14, 2015 |
| Cannabis Community | * Indeterminate | Jul 7, 2015 |
| Crusaders for Patients' Rights | * Against | Jul 14, 2015 |
| Emerald Grower's Association | * Support | Jul 14, 2015 |
| Etagen Inc. | * Indeterminate | May 18, 2015 |
| Fresno Cannabis Association | * Against | Jul 14, 2015 |
| Fresno Cannabis Associations | * Against Unless Amend | Jul 14, 2015 |
| Health and Education for Legal Patients Rights | * Against Unless Amend | Jul 14, 2015 |
| Health Education and Legal Patient's Rights | * Indeterminate | Jul 7, 2015 |
| League Of California Cities | * Support | Jul 14, 2015 |
| Rural Counties | * Support | Apr 20, 2015 |
| Statewide Association of Medical Cannabis Farmers | * Support | Apr 20, 2015 |
| Therapeutic Alternative | * Against Unless Amend | Apr 20, 2015 |
| United Food And Commercial Workers (Ufcw) | * Support | Jul 14, 2015 |
SB 643
Page 6
(Without Reference to File)
SENATE THIRD READING
SB 643
(McGuire)
As Amended September 11, 2015
Majority vote
SENATE VOTE: 26-13
Committee |
Votes |
Ayes |
Noes |
Business & Professions |
8-2 |
Bonilla, Bloom, Dodd, Eggman, Mullin, Ting, Wilk, Wood |
Jones, Gatto |
Health |
11-2 |
Bonta, Maienschein, Bonilla, Burke, Chiu, Gomez, Lackey, Santiago, Steinorth, Thurmond, Wood |
Chávez, Patterson |
Appropriations |
11-0 |
Gomez, Bloom, Bonta, Nazarian, Eggman, Eduardo Garcia, Holden, Quirk, Rendon, Weber, Wood |
|
Business & Professions |
8-1 |
Bonilla, Baker, Dodd, Eggman, Mullin, Ting, Wilk, Wood |
Gatto |
SUMMARY: Establishes a comprehensive licensing and regulatory framework for the cultivation, manufacture, transportation, storage, distribution, and sale of medical cannabis to be administered by the Department of Consumer Affairs (DCA), Department of Food and Agriculture (CDFA), and Department of Public Health (CDPH), as specified. Specifically, this bill:
Requires the Medical Board of California (MBC) to prioritize cases for repeated acts of clearly excessive recommending of cannabis to patients without a good faith prior examination of the patient and medical reason therefor, and specifies that it is unprofessional conduct to recommend medical cannabis to a patient without an appropriate prior examination and medical indication.
Makes it a misdemeanor for a physician and surgeon who recommends cannabis to a patient for a medical purpose to accept, solicit, or offer any form of remuneration from or to a licensed facility if the physician and surgeon or his or her immediate family has a financial stake in that facility.
Requires the Governor to appoint a Chief of the Bureau of Medical Marijuana Regulation (Bureau), within the DCA and authorizes the Chief of the Bureau or a deputy to exercise every power or duty given to the Director.
Vests in the DCA the sole authority to create, issue, renew, discipline, suspend, or revoke licenses for medical marijuana activities within the state and to collect related fees, and authorizes the DCA to create additional licenses.
Requires the CDFA to administer the provisions of the Act related to the cultivation of medical cannabis, and to create, issue, and suspend or revoke cultivation licenses for violations of the Act.
Requires the CDPH to administer the provisions of the Act related to the manufacturing and testing of medical cannabis.
Exempts from the licensure requirements of the Act qualified patients who do not provide, donate, sell, or distribute cannabis to any other person, and primary caregivers who provide cannabis exclusively for medical purposes to no more than five specified qualified patients, as specified.
Upon the date of implementation of regulations by the licensing authority, prohibits any person from engaging in commercial cannabis activity without possessing both a state license and local authorization, and prohibits a licensee from commencing activity under the authority of a state license until the applicant has obtained a local license or permit, as specified.
Provides that revocation of a local license terminates the ability of a medical cannabis business to operate within that local jurisdiction, and that revocation of a state license terminates the ability of a licensee to operate within the state.
Requires an applicant for state license to, among other things, submit fingerprints to the Department of Justice, and provide documentation, issued by the local jurisdiction, certifying that the applicant is in compliance with all local ordinances and regulations; evidence of the legal right to occupy the proposed location; for applicants with 20 or more employees, provide a statement that the applicant will enter into, or already has entered into, a labor peace agreement; a seller's permit number; and other specified information.
Requires applicants seeking licensure as a testing laboratory to register with the CDPH, and requires applicants seeking licensure to cultivate, distribute, or manufacture medical cannabis to include in their application a detailed description of their operating procedures.
Requires a licensing authority to deny an application if the applicant or the premises do not qualify for licensure under the Act, and authorizes a licensing authority to deny a license or license renewal for specified acts.
Requires the CDFA to promulgate regulations governing the licensing of indoor and outdoor cultivation sites.
Requires the Department of Pesticide Regulation (DPR), in consultation with the CDFA, to develop standards for the use of pesticides in cultivation, and maximum tolerances for pesticides and other foreign object residue in harvested cannabis.
Requires the CDPH to develop standards for the production and labeling of all edible medical cannabis products.
Requires the CDFA, in consultation with the Department of Fish and Wildlife and the State Water Resources Control Board, to ensure that individual and cumulative effects of water diversion and discharge associated with cultivation do not affect the in stream flows needed for fish spawning, migration, and rearing, and the flows needed to maintain natural flow variability.
Provides the CDFA with the authority necessary for the implementation of regulations it adopts pursuant to the Act, and requires those regulations: to regulate weighing or measuring devices; require that cannabis cultivation is conducted in accordance with state and local laws; establish procedures for the issuance and revocation of unique identifiers for cannabis cultivation activities; and prescribe standards, in consultation with the Bureau, for the reporting of necessary information relating to unique identifiers.
Requires the DPR, in consultation with the State Water Resources Control Board, to promulgate regulations that require that the application of pesticides or other pest control in connection with the cultivation of medical cannabis to meet standards equivalent to existing law.
Specifies various license types for state cultivator licenses issued by the CDFA, including licenses for special outdoor, specialty indoor, specialty mixed-light, small outdoor, small indoor, small mixed-light, outdoor, indoor, and mixed-light cultivation, and nursery licenses, and requires the CDFA to limit the number of outdoor, indoor, and mixed-light licenses, as specified.
By January 1, 2020, requires the CDFA, in conjunction with the Bureau, to make available a certified organic designation and organic certification program for medical marijuana, if permitted under federal and state law, as specified, and authorizes the Bureau to establish appellations of origin for marijuana grown in California.
Requires the CDFA, in consultation with the Bureau, to establish a track and trace program for reporting the movement of medical marijuana items throughout the distribution chain that use a unique identifier and secure packaging, and is capable of providing specified information, including the licensee receiving the product, the transaction date, and the cultivator from which the product originates.
Requires the CDFA to create an electronic database containing the electronic shipping manifests which shall include the quantity, or weight, and variety of products shipped and received; estimated and actual times of departure and arrival; and license number and unique identifiers issued by the licensing authority for all licensees involved in the shipping process.
Prior to transporting medical cannabis or medical cannabis products, requires a licensed transporter to complete an electronic shipping manifest and to transmit that manifest to the Bureau and the licensee that will receive the medical cannabis product, and requires licensees receiving the shipment to submit to the licensing agency a record verifying receipt of the shipment and details of the shipment.
Authorizes a county to impose a tax on the privilege of cultivating, dispensing, producing, processing, preparing, storing, providing, donating, selling, or distributing medical cannabis or medical cannabis products by a licensee operating pursuant to the Act, as specified.
Provides that the provisions of this Act are severable if any provision or its application is invalid.
Makes this bill operative only if AB 266 (Bonta, et al.) and AB 243 (Wood) of the current legislative session is enacted and takes effect on or before January 1, 2016.
Makes other technical and conforming changes.
FISCAL EFFECT: Unknown. This bill is keyed fiscal by the Legislative Counsel.
COMMENTS:
Purpose. This bill is author sponsored. According to the author, "SB 643 seeks to resolve many of the issues created by the enactment of the Compassionate Use Act and subsequent legislation….California voters made it clear that they wanted medical marijuana to be legalized, but issues and concerns for growers, doctors, dispensaries, law enforcement, district attorneys, cities, counties and others have only become more complicated…Since the voters of California passed Proposition 215 in 1996, it has become clear that there needs to be a comprehensive regulation bill from the Legislature that oversees the cultivating, processing, manufacturing, transportation, prescribing and sale of medical marijuana…."
The Compassionate Use Act (CUA) and SB 420. In 1996, voters approved the CUA, which allowed patients and primary caregivers to obtain and use medical marijuana, as recommended by a physician, and prohibited physicians from being punished or denied any right or privilege for making a medical marijuana recommendation to a patient. In 2003, SB 420 (Vasconcellos), Chapter 875, established the Medical Marijuana Program (MMP), which allowed patients and primary caregivers to collectively and cooperatively cultivate medical marijuana, and established a medical marijuana card program for patients to use on a voluntary basis. However, since the passage of Proposition 215 and SB 420, the state has not adopted a framework to provide for appropriate licensure and regulation of medical marijuana. As a result, in the nearly 20 years since the passage of Proposition 215, there has been an explosion of medical marijuana collectives and cooperatives that are largely left to the enforcement of local governments, resulting in the creation of a patchwork of local regulations for these industries and with little statewide involvement.
The California Attorney General's Compassionate Use Guidelines. SB 420 required the California Attorney General to "…develop and adopt appropriate guidelines to ensure the security and non-diversion of marijuana grown for medical use by patients qualified under the Compassionate Use Act of 1996." In 2008, the Attorney General issued guidelines to: 1) ensure that marijuana grown for medical purposes remains secure and does not find its way to non-patients or illicit markets, 2) help law enforcement agencies perform their duties effectively and in accordance with California law, and 3) help patients and primary caregivers understand how they may cultivate, transport, possess, and use medical marijuana under California law. According to a 2011 letter, after a series of meeting with stakeholders to assess whether to clarify the 2008 guidelines to stop the exploitation of California's medical marijuana laws by gangs, criminal enterprises, and others, the Attorney General decided to postpone the issuance of new guidelines because of pending litigation and to urge the Legislature to amend the law to establish clear rules governing access to medical marijuana.
California Supreme Court Affirms Local Control Over Medical Marijuana. By exempting qualified patients and caregivers from prosecution for using or from collectively or cooperatively cultivating medical marijuana, the CUA and the MPP essentially authorized the cultivation and use of medical marijuana. These laws have triggered the growth of medical marijuana dispensaries in many localities, and in response, local governments have sought to exercise their police powers to regulate or ban activities relating to medical marijuana. After numerous court cases and years of uncertainty relating to the ability of local governments to control medical marijuana activities, particularly relating to the ability to control the zoning, operation, and existence of medical marijuana dispensaries, the California Supreme Court, in City of Riverside v. Inland Empire Patients (2013) 56 Cal. 4th 729, held that California's medical marijuana statutes do not preempt a local ban on facilities that distribute medical marijuana. The court held that nothing in the CUA or the MMP expressly or impliedly limited the inherent authority of a local jurisdiction, by its own ordinances, to regulate the use of its land, including the authority to provide that facilities for the distribution of medical marijuana will not be permitted to operate within its borders.
Federal Controlled Substances Act. Despite the CUA and SB 420, marijuana is still illegal under state and federal law. Under California law, marijuana is listed as a hallucinogenic substance in Schedule I of the California Uniform Controlled Substances Act. Yet, the CUA prohibits prosecution for obtaining, distributing, or using marijuana for medical purposes. However, under the federal Controlled Substances Act, it is unlawful for any person to manufacture, distribute, dispense or possess a controlled substance, including marijuana, whether or not it is for a medical purpose. As a result, patients, caregivers, and dispensary operators, who engage in activities relating to medical marijuana, may still vulnerable to federal arrest and prosecution. According to the California Attorney General's guidelines, the difference between state and federal law gives rise to confusion. However, California has tried to avoid this conflict by deciding not to use the state's powers to punish certain marijuana offenses under state law when a physician has recommended its use to treat a serious medical condition.
United States Department of Justice (USDOJ) Guidance Regarding Marijuana Enforcement. On August 29, 2013, the USDOJ issued a memorandum that updated its guidance to all United States Attorneys in light of state ballot initiatives to legalize under state law the possession of small amounts of marijuana and provide for the regulation of marijuana production, processing, and sale. While the memorandum noted that illegal distribution and sale of marijuana is a serious crime that provides a significant source of revenue to large-scale criminal enterprises, gangs, and cartels, it also noted that USDOJ is committed to using its limited investigative and prosecutorial resources to address the most significant threats. According to the USDOJ, "In jurisdictions that have enacted laws legalizing marijuana in some form and that have also implemented strong and effective regulatory and enforcement systems to control the cultivation, distribution, sale, and possession of marijuana, conduct in compliance with those laws and regulations is less likely to threaten the federal priorities set forth above…In those circumstances, consistent with the traditional allocation of federal-state efforts in this area, enforcement of state law by state and local law enforcement and regulatory bodies should remain the primary means of addressing marijuana-related activity."
Medical Marijuana Industry in California. According to the author's Sunrise Questionnaire, submitted to the Committee pursuant to Government Code Section 9148 et seq., by law enforcement estimates, over 60% of all marijuana in the country is grown in the Emerald Triangle counties of Humboldt, Mendocino and Trinity, all of which are in the author's district, and once the industry is regulated, and the medical marijuana products are certified as safe, the market is expected to open up substantially. In addition, once the industry is regulated, the author believes that physicians who do not recommend or even discuss medical marijuana due to its quasi-legal nature and outright ban from the federal government may be more willing to discuss and recommend medical marijuana to their patients.
The author asserts that the harm starts at the environmental side of things, and simply expands from there. The regional and State Water Boards, along with California Department of Fish and Wildlife, are doing what they can, but without legislation, their hands are largely tied. This leads to streams and rivers literally running dry (even before the current drought) and to huge loads of sediments and toxic wastes being dumped into the watersheds. According to the author, the lack of regulation complicates water supply for millions of legal residential and commercial water users throughout the state-- entire tracts of forests are being mowed down by rogue growers and planted with marijuana with no permits, oversight, or regard for the environment.
The author also believes that the lack of regulation on the processing, manufacturing, testing, transportation and resale needs to be fixed as well, and that without statewide standards produced by specific health and safety testing, ingredient lists, and dosage listings on all marijuana products, people are put at risk.
According to the author, cities and counties that have medical marijuana ordinances take the first step in protecting consumers and the public, but without a strong state-wide regulatory body overseeing all aspects of the product chain, consumers have very little control over the risk unless they have personal knowledge of the product. The author believes that clear guidelines from the state and or the local jurisdiction, backed up by the state, is the only way to ensure protection of consumers and the public.
Analysis Prepared by: Eunie Linden / B. & P. / (916) 319-3301 FN: 0002442
SB 643
Page 8
Date of Hearing: September 11, 2015
ASSEMBLY COMMITTEE ON BUSINESS AND PROFESSIONS
Susan Bonilla, Chair
SB 643
(McGuire) –Amended September 4, 2015
(As Proposed to be Amended)
SENATE VOTE: 26-13
SUBJECT: Medical marijuana.
SUMMARY: Establishes a comprehensive licensing and regulatory framework for the cultivation, manufacture, transportation, storage, distribution, and sale of medical cannabis to be administered by the Department of Consumer Affairs (DCA), Department of Food and Agriculture (CDFA), and Department of Public Health (CDPH), as specified. Specifically, this bill:
Requires the Medical Board of California (MBC) to prioritize cases for repeated acts of clearly excessive recommending of cannabis to patients without a good faith prior examination of the patient and medical reason therefor, and specifies that it is unprofessional conduct to recommend medical cannabis to a patient without an appropriate prior examination and medical indication.
Makes it a misdemeanor for a physician and surgeon who recommends cannabis to a patient for a medical purpose to accept, solicit, or offer any form of remuneration from or to a licensed facility if the physician and surgeon or his or her immediate family has a financial stake in that facility.
Requires the MBC to consult with the California Marijuana Research Program on developing and adopting guidelines for the appropriate administration and use of medical cannabis.
Prohibits an individual who possesses a license in good standing to practice medicine or osteopathy from recommending medical cannabis to a patient unless that person is the patient's attending physician, as specified.
Requires advertisements for physician recommendations for medical cannabis to include a specified notice.
Requires the Governor to appoint a Chief of the Bureau of Medical Marijuana Regulation (Bureau), within the DCA and authorizes the Chief of the Bureau or a deputy to exercise every power or duty given to the Director.
Vests in the DCA the sole authority to create, issue, renew, discipline, suspend, or revoke licenses for medical marijuana activities within the state and to collect related fees, and authorizes the DCA to create additional licenses.
Requires the CDFA to administer the provisions of the Act related to the cultivation of medical cannabis, and to create, issue, and suspend or revoke cultivation licenses for violations of the Act.
Requires the CDPH to administer the provisions of the Act related to the manufacturing and testing of medical cannabis.
Exempts from the licensure requirements of the Act qualified patients who do not provide, donate, sell, or distribute cannabis to any other person, and primary caregivers who provide cannabis exclusively for medical purposes to no more than five specified qualified patients, as specified.
Upon the date of implementation of regulations by the licensing authority, prohibits any person from engaging in commercial cannabis activity without possessing both a state license and local authorization, and prohibits a licensee from commencing activity under the authority of a state license until the applicant has obtained a local license or permit, as specified.
Provides that revocation of a local license terminates the ability of a medical cannabis business to operate within that local jurisdiction, and that revocation of a state license terminates the ability of a licensee to operate within the state.
Prohibits a person from submitting an application for a state license issued by the DCA unless that person has received local authorization.
Requires an applicant for state license to, among other things, submit fingerprints to the Department of Justice, and provide documentation, issued by the local jurisdiction, certifying that the applicant is in compliance with all local ordinances and regulations; evidence of the legal right to occupy the proposed location; for applicants with 20 or more employees, provide a statement that the applicant will enter into, or already has entered into, a labor peace agreement; a seller's permit number; and other specified information.
Requires applicants seeking licensure as a testing laboratory to register with the CDPH, and requires applicants seeking licensure to cultivate, distribute, or manufacture medical cannabis to include in their application a detailed description of their operating procedures.
Requires a licensing authority to deny an application if the applicant or the premises do not qualify for licensure under the Act, and authorizes a licensing authority to deny a license or license renewal for specified acts.
Requires the CDFA to promulgate regulations governing the licensing of indoor and outdoor cultivation sites.
Requires the Department of Pesticide Regulation (DPR), in consultation with the CDFA, to develop standards for the use of pesticides in cultivation, and maximum tolerances for pesticides and other foreign object residue in harvested cannabis.
Requires the CDPH to develop standards for the production and labeling of all edible medical cannabis products.
Requires the CDFA, in consultation with the Department of Fish and Wildlife and the State Water Resources Control Board, to ensure that individual and cumulative effects of water diversion and discharge associated with cultivation do not affect the in stream flows needed for fish spawning, migration, and rearing, and the flows needed to maintain natural flow variability.
Provides the CDFA with the authority necessary for the implementation of regulations it adopts pursuant to the Act, and requires those regulations: to regulate weighing or measuring devices; require that cannabis cultivation is conducted in accordance with state and local laws; establish procedures for the issuance and revocation of unique identifiers for cannabis cultivation activities; and prescribe standards, in consultation with the Bureau, for the reporting of necessary information relating to unique identifiers.
Requires the DPR, in consultation with the State Water Resources Control Board, to promulgate regulations that require that the application of pesticides or other pest control in connection with the cultivation of medical cannabis to meet standards equivalent to existing law.
Specifies various license types for state cultivator licenses issued by the CDFA, including licenses for special outdoor, specialty indoor, specialty mixed-light, small outdoor, small indoor, small mixed-light, outdoor, indoor, and mixed-light cultivation, and nursery licenses, and requires the CDFA to limit the number of outdoor, indoor, and mixed-light licenses, as specified.
By January 1, 2020, requires the CDFA, in conjunction with the Bureau, to make available a certified organic designation and organic certification program for medical marijuana, if permitted under federal and state law, as specified.
Authorizes the Bureau to establish appellations of origin for marijuana grown in California.
Requires an employee engaged in commercial cannabis activity to be subject to Wage Order 4-2001 of the Industrial Welfare Commission.
Requires the CDFA, in consultation with the Bureau, to establish a track and trace program for reporting the movement of medical marijuana items throughout the distribution chain that use a unique identifier and secure packaging, and is capable of providing specified information, including the licensee receiving the product, the transaction date, and the cultivator from which the product originates.
Requires the CDFA to create an electronic database containing the electronic shipping manifests which shall include the quantity, or weight, and variety of products shipped and received; estimated and actual times of departure and arrival; and license number and unique identifiers issued by the licensing authority for all licensees involved in the shipping process.
Requires the database to be designed to flag irregularities for all licensing authorities to investigate, and authorizes all licensing authorities to access the database and share information related to licensees.
Requires the CDFA to immediately notify the Bureau of any irregularity or suspicious finding relating to a licensee or applicant, and requires the Bureau to have 24 hour access to the database.
Authorizes licensing authorities and state and local agencies to inspect shipments and request documentation for current inventory.
Requires licensing authorities, upon request of a state or local law enforcement agency, to allow access to information contained within the database to assist law enforcement, as specified.
Provides that licensed transporters authorized to transport medical cannabis and medical cannabis products between licensees shall only do so as set forth in the Act.
Prior to transporting medical cannabis or medical cannabis products, requires a licensed transporter to complete an electronic shipping manifest and to transmit that manifest to the Bureau and the licensee that will receive the medical cannabis product.
Requires licensees receiving the shipment to submit to the licensing agency a record verifying receipt of the shipment and details of the shipment.
Prohibits a local jurisdiction from preventing transportation of medical cannabis or medical cannabis products on public roads by a licensee transporting medical cannabis or medical cannabis products in compliance with the Act.
Authorizes a county to impose a tax on the privilege of cultivating, dispensing, producing, processing, preparing, storing, providing, donating, selling, or distributing medical cannabis or medical cannabis products by a licensee operating pursuant to the Act, as specified.
Provides that the provisions of this Act are severable if any provision or its application is invalid.
Makes this bill operative only if AB 266 (Bonta, Cooley, Jones-Sawyer, Lackey, and Wood) and AB 243 (Wood) of the current legislative session is enacted and takes effect on or before January 1, 2016.
Makes other technical and conforming changes.
EXISTING LAW:
Recognizes the authority of cities and counties to make and enforce, within their borders, all local, police, sanitary, and other ordinances and regulations not in conflict with general interest laws. (Cal. Const. Article XI sec. 7)
Prohibits the possession, possession with intent to sell, cultivation, sale, transportation, importation, or furnishing of marijuana, except as otherwise provided by law. (Health and Safety Code (HSC) Sections 11357, 11358, 11359, and 11360)
Prohibits prosecution of a patient or a patient’s primary caregiver, under the Compassionate Use Act of 1996 (CUA), an initiative measure, for possessing or cultivating marijuana for personal medical purposes of the patient upon the written or oral recommendation or approval of a physician. (HSC Section 11362.5)
Licenses and regulates physicians and surgeons, including osteopathic physicians, under the Medical Practice Act (Act) by the MBC within the DCA. (Business and Professions Code (BPC) Section 2000 et seq.)
Defines "attending physician" as an individual who possesses a license in good standing to practice medicine or osteopathy issued by the MBC or the Osteopathic Medical Board of California (OMB) and who has taken responsibility for an aspect of the medical care, treatment, diagnosis, counseling, or referral of a patient and who has conducted a medical examination of that patient before recording in the patient’s medical record the physician’s assessment of whether the patient has a serious medical condition and whether the medical use of marijuana is appropriate. (HSC Section 11362.7(a))
Defines "primary caregiver," for purposes of the CUA, as the individual designated by a patient who has consistently assumed responsibility for the housing, health, or safety of that person. (HSC Section 11362.7(d))
Requires the CDPH to establish and maintain a voluntary Medical Marijuana Program (MMP) for qualified patients to apply for identification cards, and county health departments to issue identification cards to qualified patients and their caregivers. (HSC Section 11362.7 et seq.)
Provides that qualified patients, persons with valid identification cards, and their designated primary caregivers who associate in order to collectively or cooperatively to cultivate marijuana, are not subject to criminal liability solely on that basis. (HSC Section 11362.775)
FISCAL EFFECT: Unknown. This bill is keyed fiscal by the Legislative Counsel.
COMMENTS:
Purpose. This bill is author sponsored. According to the author, "SB 643 seeks to resolve many of the issues created by the enactment of the Compassionate Use Act and subsequent legislation….California voters made it clear that they wanted medical marijuana to be legalized, but issues and concerns for growers, doctors, dispensaries, law enforcement, district attorneys, cities, counties and others have only become more complicated…Since the voters of California passed Proposition 215 in 1996, it has become clear that there needs to be a comprehensive regulation bill from the Legislature that oversees the cultivating, processing, manufacturing, transportation, prescribing and sale of medical marijuana…."
This bill is drafted to work in conjunction with AB 266 (Bonta, Cooley, Jones-Sawyer, and Lackey) and AB 243 (Wood) of the current legislative session, and is contingent upon the enactment of both of those bills.
The Compassionate Use Act (CUA) and SB 420. In 1996, voters approved the CUA, which allowed patients and primary caregivers to obtain and use medical marijuana, as recommended by a physician, and prohibited physicians from being punished or denied any right or privilege for making a medical marijuana recommendation to a patient. Senate Bill 420 (Vasconcellos, Statutes of 2003, Chapter 875), established the MMP, which allowed patients and primary caregivers to collectively and cooperatively cultivate medical marijuana, and established a medical marijuana card program for patients to use on a voluntary basis. However, since the passage of Proposition 215 and SB 420, the state has not adopted a framework to provide for appropriate licensure and regulation of medical marijuana. As a result, in the nearly 20 years since the passage of Proposition 215, there has been an explosion of medical marijuana collectives and cooperatives that are largely left to the enforcement of local governments, resulting in the creation of a patchwork of local regulations for these industries and with little statewide involvement.
The California Attorney General's Compassionate Use Guidelines. SB 420 required the California Attorney General to "…develop and adopt appropriate guidelines to ensure the security and non-diversion of marijuana grown for medical use by patients qualified under the Compassionate Use Act of 1996." In 2008, the Attorney General issued guidelines to: 1) ensure that marijuana grown for medical purposes remains secure and does not find its way to non-patients or illicit markets, 2) help law enforcement agencies perform their duties effectively and in accordance with California law, and 3) help patients and primary caregivers understand how they may cultivate, transport, possess, and use medical marijuana under California law. According to a 2011 letter, after a series of meeting with stakeholders to assess whether to clarify the 2008 guidelines to stop the exploitation of California's medical marijuana laws by gangs, criminal enterprises, and others, the Attorney General decided to postpone the issuance of new guidelines because of pending litigation and to urge the Legislature to amend the law to establish clear rules governing access to medical marijuana.
California Supreme Court Affirms Local Control Over Medical Marijuana. By exempting qualified patients and caregivers from prosecution for using or from collectively or cooperatively cultivating medical marijuana, the CUA and the MPP essentially authorized the cultivation and use of medical marijuana. These laws have triggered the growth of medical marijuana dispensaries in many localities, and in response, local governments have sought to exercise their police powers to regulate or ban activities relating to medical marijuana. After numerous court cases and years of uncertainty relating to the ability of local governments to control medical marijuana activities, particularly relating to the ability to control the zoning, operation, and existence of medical marijuana dispensaries, the California Supreme Court, in City of Riverside v. Inland Empire Patients (2013) 56 Cal. 4th 729, held that California's medical marijuana statutes do not preempt a local ban on facilities that distribute medical marijuana. The court held that nothing in the CUA or the MMP expressly or impliedly limited the inherent authority of a local jurisdiction, by its own ordinances, to regulate the use of its land, including the authority to provide that facilities for the distribution of medical marijuana will not be permitted to operate within its borders.
Federal Controlled Substances Act. Despite the CUA and SB 420, marijuana is still illegal under state and federal law. Under California law, marijuana is listed as a hallucinogenic substance in Schedule I of the California Uniform Controlled Substances Act. Yet, the CUA prohibits prosecution for obtaining, distributing, or using marijuana for medical purposes. However, under the federal Controlled Substances Act, it is unlawful for any person to manufacture, distribute, dispense or possess a controlled substance, including marijuana, whether or not it is for a medical purpose. As a result, patients, caregivers, and dispensary operators, who engage in activities relating to medical marijuana, may still vulnerable to federal arrest and prosecution. According to the California Attorney General's guidelines, the difference between state and federal law gives rise to confusion. However, California has tried to avoid this conflict by deciding not to use the state's powers to punish certain marijuana offenses under state law when a physician has recommended its use to treat a serious medical condition.
United States Department of Justice (USDOJ) Guidance Regarding Marijuana Enforcement. On August 29, 2013, the USDOJ issued a memorandum that updated its guidance to all United States Attorneys in light of state ballot initiatives to legalize under state law the possession of small amounts of marijuana and provide for the regulation of marijuana production, processing, and sale. While the memorandum noted that illegal distribution and sale of marijuana is a serious crime that provides a significant source of revenue to large-scale criminal enterprises, gangs, and cartels, it also noted that USDOJ is committed to using its limited investigative and prosecutorial resources to address the most significant threats. According to the USDOJ, "In jurisdictions that have enacted laws legalizing marijuana in some form and that have also implemented strong and effective regulatory and enforcement systems to control the cultivation, distribution, sale, and possession of marijuana, conduct in compliance with those laws and regulations is less likely to threaten the federal priorities set forth above…In those circumstances, consistent with the traditional allocation of federal-state efforts in this area, enforcement of state law by state and local law enforcement and regulatory bodies should remain the primary means of addressing marijuana-related activity."
Marijuana Frameworks Established in Other States. There are currently 23 states, plus the District of Columbia, that allow for medical marijuana and have some level of regulation. California is the only state that permits medical marijuana in the absence of a robust state-wide regulatory system. The following states have statewide medical marijuana regulatory systems: Alaska, Arizona, Colorado, Connecticut, Washington DC, Delaware, Hawaii, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, Oregon, Rhode Island, Vermont and Washington. In addition, Alaska, Colorado, Oregon, Washington, and the District of Columbia have legalized the use of recreational marijuana.
According to the Brookings Institute, since the early 1990s, U.S. public opinion has trended in favor of marijuana legalization. Currently, a majority of Americans support legalization by a margin of seven points—52 percent to 45 percent, according to findings from a Pew Research Center survey in March 2013. Support for marijuana legalization has risen sharply since 2010, by 11 percentage points.
This increasing support for marijuana legalization is present in California as well, with recent polls showing that a majority of Californians support marijuana legalization. Currently, there are multiple marijuana initiatives attempting to qualify for the 2016 ballot. In order for any marijuana scheme to be effective, it should address all parts of the industry, including establishing a robust licensing and regulatory scheme, a taxation scheme, and incorporate health and safety standards, in addition to ensuring that the public is protected; however, if the measure is too prescriptive, it may hamper the ability to address any unintended consequences or fill in any policy gaps without having to go back to the ballot. As a result, if the State is able to create a comprehensive framework for medical cannabis, it may also serve a dual role by serving as a basis for a recreational marijuana scheme.
Medical Marijuana Industry in California. According to the author's Sunrise Questionnaire, submitted to the Committee pursuant to Government Code Section 9148 et seq., by law enforcement estimates, over 60% of all marijuana in the country is grown in the Emerald Triangle counties of Humboldt, Mendocino and Trinity, all of which are in the author's district, and once the industry is regulated, and the medical marijuana products are certified as safe, the market is expected to open up substantially. In addition, once the industry is regulated, the author believes that physicians who do not recommend or even discuss medical marijuana due to its quasi-legal nature and outright ban from the federal government may be more willing to discuss and recommend medical marijuana to their patients.
The author asserts that the harm starts at the environmental side of things, and simply expands from there. The regional and State Water Boards, along with California Department of Fish and Wildlife, are doing what they can, but without legislation, their hands are largely tied. This leads to streams and rivers literally running dry (even before the current drought) and to huge loads of sediments and toxic wastes being dumped into the watersheds. According to the author, the lack of regulation complicates water supply for millions of legal residential and commercial water users throughout the state-- entire tracts of forests are being mowed down by rogue growers and planted with marijuana with no permits, oversight, or regard for the environment.
The author also believes that the lack of regulation on the processing, manufacturing, testing, transportation and resale needs to be fixed as well, and that without statewide standards produced by specific health and safety testing, ingredient lists, and dosage listings on all marijuana products, people are put at risk.
According to the author, cities and counties that have medical marijuana ordinances take the first step in protecting consumers and the public, but without a strong state-wide regulatory body overseeing all aspects of the product chain, consumers have very little control over the risk unless they have personal knowledge of the product. The author believes that clear guidelines from the state and or the local jurisdiction, backed up by the state, is the only way to ensure protection of consumers and the public.
REGISTERED SUPPORT / OPPOSITION:
Support
None on file.
Opposition
None on file.
Analysis Prepared by: Eunie Linden / B. & P. / (916) 319-3301
SB 643
Page 23
|
Office of Senate Floor Analyses (916) 651-1520 Fax: (916) 327-4478 |
UNFINISHED BUSINESS
Bill No: SB 643
Amended: 9/11/15
SENATE BUS, PROF. & ECON. DEV. COMMITTEE: 7-0, 4/20/15
AYES: Hill, Block, Galgiani, Hernandez, Jackson, Mendoza, Wieckowski
NO VOTE RECORDED: Bates, Berryhill
SENATE GOVERNANCE & FIN. COMMITTEE: 5-1, 4/29/15
AYES: Hertzberg, Beall, Hernandez, Lara, Pavley
NOES: Nguyen
NO VOTE RECORDED: Moorlach
SENATE APPROPRIATIONS COMMITTEE: 5-1, 5/28/15
AYES: Lara, Beall, Hill, Leyva, Mendoza
NOES: Nielsen
NO VOTE RECORDED: Bates
SENATE FLOOR: 26-13, 6/4/15
AYES: Allen, Beall, Block, Cannella, De León, Glazer, Hall, Hancock, Hernandez, Hertzberg, Hill, Hueso, Jackson, Lara, Leno, Leyva, Liu, McGuire, Mendoza, Mitchell, Monning, Moorlach, Pan, Pavley, Wieckowski, Wolk
NOES: Anderson, Bates, Berryhill, Fuller, Gaines, Huff, Morrell, Nguyen, Nielsen, Roth, Runner, Stone, Vidak
NO VOTE RECORDED: Galgiani
ASSEMBLY FLOOR: Not available
DIGEST: This bill establishes a regulatory framework for the cultivation, sale, and transport of medical cannabis by the Bureau of Medical Marijuana Regulation (Bureau), the Department of Food and Agriculture (DFA), and other state entities.
Assembly Amendments add substantial amendments relating to licensure and regulation of medical cannabis.
Existing law:
Declares that the entities under the Department of Consumer Affairs (DCA) are established for the purpose of ensuring that those private businesses and professions deemed to engage in activities which have potential impact upon the public health, safety, and welfare are adequately regulated in order to protect the people of California. (Business and Professions Code (BPC) § 101.6)
Licenses and regulates physicians and surgeons under the Medical Practice Act (Act) by the Medical Board of California (MBC) within the DCA.
(BPC §§ 2000 et seq.)
Provides that the MBC shall take action against a physician who is charged with unprofessional conduct, as specified. (BPC § 2234)
Requires the MBC to prioritize its investigative and prosecutorial resources to ensure that physicians representing the greatest threat of harm are identified and disciplined expeditiously and includes in that prioritization list: “Repeated acts of clearly excessive prescribing, furnishing, or administering of controlled substances, or repeated acts of prescribing, dispensing, or furnishing of controlled substances without a good faith prior examination of the patient and medical reason therefor.” (BPC § 2220.05)
The Compassionate Use Act of 1996 (CUA), an initiative measure, prohibits prosecution for the possession or cultivation of marijuana of a patient or a patient's primary caregiver who possesses or cultivates marijuana for the personal medical purposes of the patient upon the written or oral recommendation or approval of a physician. (Health and Safety Code (HSC) § 11362.5)
Declares that the purposes of the CUA are:
To ensure that seriously ill Californians have the right to obtain and use marijuana for medical purposes where that medical use is deemed appropriate and has been recommended by a physician who has determined that the person's health would benefit from the use of marijuana in the treatment of cancer, anorexia, AIDS, chronic pain, spasticity, glaucoma, arthritis, migraine, or any other illness for which marijuana provides relief.
To ensure that patients and their primary caregivers who obtain and use marijuana for medical purposes upon the recommendation of a physician are not subject to criminal prosecution or sanction.
To encourage the federal and state governments to implement a plan to provide for the safe and affordable distribution of marijuana to all patients in medical need of marijuana. (HSC § 11362.5 (b)(1)(A) to (C))
States that nothing in the CUA shall be construed to supersede legislation prohibiting persons from engaging in conduct that endangers others, or to condone the diversion of marijuana for non-medical purposes.
(HSC § 11362.5 (b)(2))
Prohibits, notwithstanding any other provision of law, a physician in California from being punished or denied any right or privilege for having recommended marijuana to a patient for medical purposes. (HSC § 11362.5 (c))
States that existing law, relating to the possession and the cultivation of marijuana, shall not apply to a patient, or to a patient's primary caregiver, who possesses or cultivates marijuana for the personal medical purposes of the patient upon the written or oral recommendation or approval of a physician. (HSC § 11362.5 (d))
Defines “primary caregiver” for purposes of the CUA as the individual designated by a patient who has consistently assumed responsibility for the housing, health, or safety of that person. (HSC § 11362.5 (e))
States legislative intent to commission objective scientific research by the University of California (UC) regarding the efficacy and safety of administering marijuana as part of medical treatment. Requires UC, if it accepts by appropriate resolution the responsibility to create a California Marijuana Research Program (Program) that it will develop and conduct studies intended to ascertain the general medical safety and efficacy of marijuana, and if found valuable, to develop medical guidelines for the appropriate administration and use of marijuana. (HSC § 11362.9)
Establishes the Medical Marijuana Program Act (MMPA), which exempts qualified patients who hold an identification card issued pursuant to the Medical Marijuana Program (MMP) and the caregivers of those persons, from certain state criminal sanctions related to the possession, cultivation, transportation, processing, or use of limited amounts of marijuana, as specified. (HSC §§ 11362.7 et seq.)
Requires a person who seeks a MMP identification card to pay a fee and provide to the county health department the person's name, proof of residency, written doctor's recommendation, doctor's name and contact information, caregiver's name and duties, and patient's and caregiver's government issued photo identification card. (HSC § 11362.715 (a))
Requires the California Department of Public Health (CDPH) to establish and maintain a voluntary program for qualified patients to apply for identification cards, and county health departments to issue identification cards to qualified patients and their caregivers. (HSC § 11362.71 (a) & (b))
Provides that persons with valid identification cards shall not be subject to arrest for possession, transportation, delivery, or cultivation of marijuana, absent evidence of fraud. (HSC § 11362.71 (e))
Requires county health departments to issue serially numbered identification cards to patients and caregivers containing the following: a unique user identification number, an expiration date, the county health department's name and telephone number, photo identification of the cardholder, and a toll-free CDPH telephone number enabling state and local law enforcement officers to immediately verify the card's validity. (HSC § 11362.735 (a))
Prohibits medical marijuana dispensaries that possess, cultivate, or distribute medical marijuana from being located within a 600 foot radius of a school, and authorizes cities and counties to further restrict the locations of medical marijuana collectives. (HSC § 11362.768)
Provides that qualified patients, persons with valid MMP identification cards, and the designated primary caregivers of qualified patients and persons with MMP identification cards who associate within California in order to cultivate marijuana for medical purposes, collectively or cooperatively, shall not, solely on that basis, be subject to state criminal sanctions for the possession, sale, transport, or other proscribed acts relating to marijuana. (HSC § 11362.775)
Prohibits state or local law enforcement officers from refusing to accept an MMP identification card unless the officer has reasonable cause to believe that the card is being used fraudulently or its information is false or fraudulent. (HSC § 11362.78)
Makes it a misdemeanor offense to, among other things, fraudulently represent a medical condition or provide any material misinformation to a physician, health department designee, or to law enforcement, for the purpose or falsely obtaining an identification card; fraudulently use any person's identification card in order to acquire, possess, cultivate, transport, use, produce, or distribute marijuana; counterfeit, tamper with, or fraudulently produce an identification card; breach any confidentiality requirements pertaining to an identification card program. (HSC § 11362.81)
Lists marijuana as a hallucinogenic substance in Schedule I of the California Uniform Controlled Substances Act. (HSC § 11054 (d))
This bill:
Provisions related to Bureau administration:
Requires the Governor to appoint a chief of the Bureau, subject to confirmation by the Senate, at a salary to be fixed and determined by the DCA Director (Director) with the approval of the Director of Finance. Requires the chief to serve under the direction and supervision of the Director and at the pleasure of the Governor.
States that every power granted to or duty imposed upon the Director by this bill may be exercised or performed in the name of the Director by a deputy or assistant director or by the chief, subject to conditions and limitations that the Director may prescribe. In addition to every power granted or duty imposed with this chapter, the Director shall have all other powers and duties generally applicable in relation to bureaus that are part of the DCA.
Authorizes the Director to employ and appoint all employees necessary to properly administer the work of the Bureau, in accordance with civil service laws and regulations.
Authorizes the DCA as the sole authority to create, issue, renew, discipline, suspend, or revoke licenses for the transportation, storage unrelated to manufacturing activities, distribution, and sale of medical marijuana within the state and to collect fees in connection with activities the Bureau regulates.
Authorizes the Bureau to create licenses in addition to those in this bill if the Bureau deems it necessary to effectuate its duties.
Authorizes the Bureau to bring any legal action that is necessary to collect any deficiency in the fee required to be paid, and upon the Bureau’s request, the Attorney General shall bring the action.
Provisions related to licensing:
Requires the Bureau to mandate that applicants provide a full set of fingerprints for purposes of conducting criminal history record checks. States that the Bureau may obtain and receive, at its discretion, criminal history information from the Department of Justice (DOJ) and the United States Federal Bureau of Investigation (FBI).
Authorizes licensing authorities administering this bill to issue state licenses only to qualified applicants engaging in commercial cannabis activity pursuant to this bill. Prohibits anyone from engaging in commercial cannabis activity without a state license and a local permit, license, or other authorization after regulations are implemented.
Prohibits a licensee from commencing activity under the authority of a state license until the applicant has obtained a license or permit from the local jurisdiction in which he or she proposes to operate, following the requirements of the applicable local ordinance.
States that revocation of a local license, permit, or other authorization shall terminate the ability of a medical cannabis business to operate within that local jurisdiction until the local jurisdiction reinstates or reissues the local license.
Requires a person to get a local license prior to applying for a state license.
Requires an applicant for state licensure to do the following:
Electronically submit fingerprints and any other required information to the DOJ for purposes of obtaining state and federal convictions and arrests.
Requires the DOJ to report the following to the Bureau:
Every conviction rendered against the applicant, except a conviction for which relief has been granted as specified;
Every arrest for an offense for which the applicant is presently awaiting trial, whether the applicant is incarcerated or has been released on bail or on his or her own recognizance pending trial; and,
Sex offender registration status of the applicant;
Requires the licensing authority to request subsequent notifications on applicants from the DOJ; and,
Requires the DOJ to charge applicants a fee sufficient to cover reasonable costs;
Provide documentation issued by the local jurisdiction in which the proposed business is operating certifying that the applicant is or will be in compliance with all local requirements;
Provide evidence of the legal right to occupy and use the proposed location;
For an applicant seeking a cultivator, distributor, manufacturing, or dispensary license, provide a statement from the owner of real property or their agent where the activity will occur to prove that the landowner has acknowledged and consented to the activity to be conducted on the property by the applicant;
If the application is for a cultivator or dispensary, provide evidence that the proposed location is located beyond at least a 600 foot radius from a school;
Provide a statement, signed under penalty of perjury, that the information provided by the applicant is complete, true, and accurate;
For an applicant with 20 or more employees (not counting supervisors), provide a statement that the applicant will enter into, or demonstrate that it has already entered into, and abide by the terms of a labor peace agreement;
Provide the applicant’s seller’s permit number, as specified, or indicate that the applicant is currently applying for a seller’s permit;
Provide any other information required by the licensing authority;
For an applicant seeking a cultivation license, provide a statement declaring the applicant is an “agricultural employer,” as specified, to the extent not prohibited by law;
For an applicant seeking licensure as a testing laboratory, register with the DPH and provide any information required by DPH; and,
Pay all required fees.
Provides that for applicants seeking licensure to cultivate, distribute, or manufacture medical cannabis, the application shall also include a detailed description of the applicant’s operating procedures for all the following, as required by the licensing authority:
Cultivation;
Extraction and infusion methods;
Transportation process;
Inventory procedures; and,
Quality control procedures.
Requires the licensing authority to deny an application if either the applicant or the premises for which a state license is applied do not qualify for licensure under this bill.
Authorizes the licensing authority to deny the application for licensure or renewal of a state license if any of the following apply:
Failure to comply with the provisions of this bill, or any rules or regulations adopted pursuant to this bill;
Conduct that constitutes ground for denial of licensure under existing law, as specified;
A local agency has notified the licensing authority that a license or applicant within its jurisdiction is in violation of state rules and regulations relating to commercial cannabis activities, and the licensing authority, through an investigation, has determined that the violation is grounds for termination or revocation of the license. The licensing authority shall have the authority to collect reasonable costs, as determined by the licensing authority, for investigation from the licensee or applicant.
The applicant has failed to provide information required by the licensing authority.
The applicant or licensee has been convicted of an offense that is substantially related to the qualifications, functions, or duties of the business or profession for which the application is made, except that if the licensing authority determines that the applicant or licensee is otherwise suitable to be issued a license and granting the license would not compromise public safety, the licensing authority shall conduct a thorough review of the nature of the crime, conviction, circumstances, and evidence of rehabilitation of the applicant, and shall evaluate the suitability of the applicant or licensee to be issued a license based on the evidence found through the review.
States that the following include offenses that are substantially related:
A felony conviction for the illegal possession for sale, illegal sale, manufacture, transportation, or cultivation of a controlled substance;
A violent felony conviction, as specified;
A serious felony conviction, as specified; and,
A felony conviction involving fraud, deceit, or embezzlement.
The applicant, or any of its officers, directors, or owners:
Is a licensed physician making patient recommendations for medical cannabis;
Has been subject to fines or penalties for cultivation or production of a controlled substance on public or private lands; or,
Has been sanctioned by a licensing authority or a city, county, or city and county for unlicensed commercial medical cannabis activities or has had a license revoked according to this bill in the three years immediately preceding the date the application is filed with the licensing authority.
Failure to obtain and maintain a valid seller’s permit.
Requires the licensing authority to notify the applicant in writing upon denial of any application. Within 30 days of service of the notice, the applicant may file a written petition for a license, and upon receipt, the licensing authority shall set the petition for hearing, as specified.
Prohibits the denial of a state license if the denial is based solely on any of the following:
A conviction or act that is substantially related to the qualifications, functions, or duties of the business or profession for which the application is made for which the applicant or licensee has obtained a certificate of rehabilitation, as specified.
A conviction that was subsequently dismissed.
Requires local authorities to notify the Bureau upon revocation of a local license, and requires the Bureau to inform relevant licensing authorities upon the revocation of a license.
States that revocation of the state license shall terminate the ability of a medical cannabis license to operate within California until the licensing authority reinstates or reissues the state license.
Requires each license to obtain a separate license for each location where it engages in commercial medical cannabis activity, except that transporters only need to obtain licenses for each physical location where the licensee conducts business while not in transport, or any equipment that is not currently transporting medical cannabis or medical cannabis products permanently resides.
Exempts a qualified patient from the requirements of this bill who cultivates, possesses, stores, manufactures, or transports cannabis exclusively for his or her personal medical use but who does not provide, donate, sell, or distribute cannabis to any other person and is thereby not engaged in commercial cannabis activity.
Exempts a primary caregiver from the provisions of this bill who cultivates, possesses, stores, manufactures, transports, donates, or provides cannabis exclusively for the personal medical purposes of no more than five specified qualified patients for whom her or she is the primary caregiver, as specified, but who does not receive remuneration for those activities except for specified compensation.
Provisions related to administration by the Department of Food and Agriculture:
Authorizes the Department of Food and Agriculture (DFA) to administer the provisions of this bill related to and associated with the cultivation of medical cannabis. Authorizes the DFA to create, issue, and suspend or revoke cultivation licenses for violations of this bill.
Requires DFA to promulgate regulations governing the licensing of indoor and outdoor cultivation sites.
Requires DFA, in consultation with the Department of Fish and Wildlife and the State Water Resources Control Board, to ensure that individual and cumulative effects of water diversion and discharge associated with cultivation do not affect the instream flows needed for fish spawning, migration, and rearing, and the flows needed to maintain natural flow variability.
Deems the DFA to have the authority necessary to implement regulations necessary for this bill. The regulations shall do all the following:
Require that weighing and measuring devices used in the sale or distribution of medical cannabis meet specified standards;
Require that licensees’ cannabis cultivation is conducted in accordance with state and local laws related to land conversion, grading, electricity usage, water usage, agricultural discharges, and similar matters. Specifies that nothing in this bill or in subsequent regulations shall be construed to supersede or limit the authority of the State Water Resources Control Board, regional water quality control boards, or DFW to implement and enforce their statutory obligations or to adopt regulations to protect water quality, water supply, and natural resources;
Establish procedures for the issuance and revocation of unique identifiers for activities associated with a cannabis cultivation license, which shall be included on all cannabis labels; and,
Prescribe standards, in consultation with the Bureau, for the reporting of information as necessary related to unique identifiers.
Describes state cultivator license types issued by the DFA.
Provisions related to DFA’s track and trace program:
Requires the DFA, in consultation with the Bureau, to establish a track and trace program for reporting the movement of medical marijuana items throughout the distribution chain that utilizes a unique identifier and secure packaging and is capable of providing information that captures, at a minimum, all of the following:
The licensee receiving the product;
The transaction date; and,
The cultivator from which the product originates, including the unique identifier.
Requires the DFA to create an electronic database containing the electronic shipping manifests which shall include, but not be limited to, specified information.
Requires the database to be designed to flag irregularities for all licensing authorities in this bill to investigate. All licensing authorities in this bill may access the database and share information related to licensees under this bill, including the social security and individual taxpayer identification, as specified.
Requires the DFA to inform the Bureau upon the finding of an irregularity or suspicious finding related to a licensee, applicant, or commercial cannabis activity for investigatory purposes.
Authorizes licensing authorities and state and local agencies to inspect shipments and request documentation for current inventory at any time.
Requires the Bureau to have 24-hour access to the electronic database administered by the DFA.
Authorizes the DFA to enter into memoranda of understandings with licensing authorities for data sharing purposes, as deemed necessary by the DFA.
Deems confidential information received and contained in records kept by the DFA or licensing authorities for purposes of administering this bill, and shall not be disclosed pursuant to the California Public Records Act, except as necessary for authorized state or local employees to perform official duties pursuant to this bill or a local ordinance.
Requires licensing authorities, upon request of a state or local law enforcement agency, to allow access to or provide information contained within the database to assist law enforcement in their duties and responsibilities required by this bill.
Subjects information disclosure to specified current laws.
Provisions related to fees and taxation:
States that nothing in this bill shall be construed to superseded or limit state agencies, including the State Water Resources Control Board and the Department of Fish and Wildlife, from establishing fees to support their medical cannabis regulatory programs.
States that local jurisdictions retain the power to assess fees and taxes, as applicable, on facilities that are licensed pursuant to this bill and the business activities of those licensees.
Authorizes a county to impose a tax on the privilege of cultivating, dispensing, producing, processing, preparing, storing, providing, donating, selling, or distributing medical cannabis or medical cannabis products by a licensee operating in accordance with this bill.
Requires a board of supervisors to specify in the ordinance proposing the tax the activities subject to the tax, the applicable tax rate or rates, the method of apportionment, if necessary, and the manner of tax collection. States that the tax may be imposed for general governmental purposes or for purposes specified in the ordinance.
Authorizes the board of supervisors to provide for the collection of the tax and any penalties and lien priorities in the same manner as other charges and taxes fixed and collected by the county.
States that a tax imposed by this bill is a tax and not a fee or special assessment.
Requires the board of supervisors to specify whether the tax applies throughout the entire county or within the unincorporated areas.
Authorizes the tax to be imposed upon any or all of the activities specified in # 40, above, as specified in the ordinance, regardless of whether the activity is undertaken individually, collectively, or cooperatively, and regardless of whether the activity is for compensation or gratuitous, as determined by the board of supervisors.
Requires that a tax imposed pursuant to this bill be subject to applicable voter approval requirements imposed by law.
States that specified provisions are declaratory of existing law and do not limit or prohibit the levy or collection of any other fee, charge, or tax, or a license or service fee or charge upon, or related to, the activities described as otherwise provided by law. States that this bill shall not be construed as a limitation upon the taxing authority of a county as provided by law.
States that provisions of this bill shall not be construed to authorize a county to impose a sales or use tax in addition to the sales and use taxes imposed under an ordinance conforming with specified existing state law.
Provisions related to pesticides:
Makes the following Legislative findings and declarations:
The United States Environmental Protection Agency has not established appropriate pesticide tolerances for, or permitted the registration and lawful use of, pesticides on cannabis crops intended for human consumption pursuant to the Federal Insecticide, Fungicide, and Rodenticide Act;
The use of pesticides is not adequately regulated due to the omissions in federal law, and cannabis cultivated in California for California patients can and often does contain pesticide residues; and,
Lawful California medical cannabis growers and caregivers urge the Department of Pesticide Regulation (DPR) to provide guidance, in absence of federal guidance, on whether the pesticides currently used at most cannabis cultivation sites are actually safe for use on cannabis intended for human consumption.
Requires DPR, in consultation with DFA, to develop standards for the use of pesticides in cultivation and maximum tolerances for pesticides and other foreign object residue in harvested cannabis.
Requires DPR, in consultation with the State Water Resources Control Board, to promulgate regulations that require that the application of pesticides or other pest control in connection with the indoor or outdoor cultivation of medical cannabis meets specified standards.
Provisions related to labeling:
Requires the Department of Public Health (DPH) to develop standards for the production and labeling of all edible medical cannabis products.
Authorizes the Bureau to establish appelations of origin for marijuana grown in California.
States that it is unlawful for medical marijuana to be marketed, labeled, or sold as grown in a California county if it was not.
States that it is unlawful to use the name of a California county in the labeling, marketing, or packaging of medical marijuana products unless the product was grown in that county.
Requires the DFA, in conjunction with the Bureau, to make available a certified organic designation and organic certification program for medical marijuana by January 1, 2020, if permitted under state and federal law and the National Organic Program.
Provisions related to transportation:
Requires a licensee authorized to transport medical cannabis and medical cannabis products between licensees to do so only as permitted in this bill.
Requires a licensed transporter to do both of the following prior to transporting cannabis or cannabis products:
Complete an electronic shipping manifest, as specified; and,
Securely transmit the manifest to the Bureau and the licensee that will receive the medical cannabis product. The Bureau must inform the DFA of information pertaining to commercial cannabis activity for purpose of the track and trace program.
Requires a transporter to maintain a physical copy of the shipping manifest during transportation and make it available upon request to agents of the DCA and law enforcement officers.
Requires the licensee receiving the shipment to maintain each electronic shipping manifest and make it available upon request to the DCA and any law enforcement officers.
Requires the licensee receiving the shipment to submit to the licensing agency a record verifying receipt and details of the shipment upon receipt of the shipment.
States that transporting, arranging for, or facilitating the transport of medical cannabis or medical cannabis products in violation of this bill is grounds for disciplinary action against the license.
States that this bill shall not be construed to authorize or permit a licensee to transport or cause to be transported cannabis or cannabis products outside the state, unless authorized by federal law.
Prohibits a local jurisdiction from preventing transportation of medical cannabis or medical cannabis products on public roads by a licensee in compliance with this bill.
Provisions related to prescribing by a physician and surgeon:
Declares that repeated acts of clearly excessive recommending of cannabis to patients for medical purposes, or repeated acts of recommending cannabis to patients for medical purposes without a good faith prior examination of the patient and a medical reason for the recommendation is number four on the list of priorities for MBC’s investigative and prosecutorial resources.
Authorizes a physician to prescribe for, or dispense or administer to, a person under his or her treatment dangerous drugs or prescription controlled substances for the treatment of pain, but states that a physician shall still be subject to MBC discipline if he or she violates laws related to performing an appropriate prior examination and determining the existence of a medical indication prior to recommending medical cannabis.
States that it is unlawful for a physician who recommends cannabis to a patient for a medical purpose to accept, solicit, or offer any form of remuneration from or to a licensed cannabis facility, as specified, if the physician or his or her immediate family have a financial interest in the facility. A violation is misdemeanor punishable by up to one year in county jail and a fine of up to $5,000, or by civil penalties of up to $5,000 and shall constitute unprofessional conduct.
Requires the MBC to consult with the Program on developing and adopting medical guidelines for the appropriate administration and use of medical cannabis.
Prohibits the recommendation of medical cannabis to a patient unless the physician is the patient’s attending physician, as specified.
Declares that recommending medical cannabis to a patient for a medical purpose without an appropriate prior examination and a medical indication constitutes unprofessional conduct.
Declares that it is unprofessional conduct for an attending physician recommending medical cannabis to be employed by, or enter into any other agreement with, any person or entity dispensing medical cannabis.
Requires any distribution of any form of advertising for physician recommendation for medical cannabis in California to include a consumer notice, as specified.
Requires advertising for attending physician recommendations for medical cannabis to meet all the requirements of existing law related to medical advertising, and states that price advertising shall not be fraudulent, deceitful, or misleading, including statements or advertisements of bait, discounts, premiums, gifts, or statements of a similar nature.
Other provisions:
Authorizes the DPH to administer the provisions of this bill related to and associated with the manufacturing and testing of medical cannabis.
Requires that an employee engaged in commercial cannabis cultivation be subject to Wage Order 4-1001 of the Industrial Welfare Commission.
States that provisions of this bill are severable, and if any provision of this bill or its application is held invalid, that invalidity shall not affect other provisions or applications that can be given effect without the invalid provision or application.
States that this bill shall become operative only if AB 266 and AB 243 of the 2015–16 Session are enacted and take effect on or before January 1, 2016.
Background
Compassionate
Use Act of 1996 (CUA). The Compassionate Use Act, enacted in
1996 by Proposition 215, established the right of patients to obtain
and use marijuana to treat specified illnesses for which marijuana
provides relief. CUA protects physicians who recommend the use of
marijuana for medical purposes and exempts qualified patients and
their primary caregivers from California drug laws prohibiting
possession and cultivation of marijuana.
Although CUA
encouraged the development of a comprehensive regulatory framework by
the state and federal government, resulting guidelines have been
established by a patchwork of uncoordinated bills and legal
advisories.
Medical Marijuana Program. The Medical Marijuana Program (MMP) was established by SB 420 (Vasconcellos, Chapter 875, Statutes of 2003) in an effort to clarify and expand on CUA. The MMP created a voluntary state medical marijuana identification card (MMP Card) and a registry database. Under the MMP, a patient or qualified caregiver with a recommendation for medical marijuana from a licensed California physician can apply for MMP Card through a local county public health department. The MMP web-based registry allows law enforcement and the public to verify the validity of a qualified patient or primary caregiver's MMP Card as authorization to possess, grow, transport, and/or use medical marijuana within California.
California Attorney General’s Compassionate Use Guidelines. SB 420 additionally required the California Attorney General to adopt “guidelines to ensure the security and non-diversion of marijuana grown for medical use.” To fulfill this mandate, the Attorney General published Guidelines for the Security and Non-Diversion of Marijuana Grown for Medical Use in August of 2008. The Guidelines were intended to:
Ensure that marijuana grown for medical purposes remains secure and does not find its way to non-patients or illicit markets;
Help law enforcement agencies perform their duties effectively and in accordance with California law; and,
Help patients and primary caregivers understand how they may cultivate, transport, possess, and use medical marijuana under California law.
Federal concerns. Despite CUA and MMP, possession of marijuana under federal law, even by medical users, continues to be a crime. In August of 2013, the U.S. Department of Justice (USDOJ) issued a memorandum titled “Guidance Regarding Marijuana Enforcement” to all U.S. Attorneys. While affirming that marijuana is still considered a dangerous drug and that the illegal distribution and sale of marijuana is a serious crime, the memorandum outlines the following enforcement priorities:
Preventing distribution to minors;
Preventing revenue from marijuana from going to criminal enterprises;
Preventing diversion to other states where marijuana is not legal under state law;
Preventing state-authorized marijuana from being a cover for trafficking in other illegal drugs or illegal activity;
Preventing violence in cultivating and distributing marijuana;
Preventing drugged driving and other public health problems from marijuana use; and,
Preventing growing, possessing or using marijuana on public lands or on federal property.
The document lays out the federal expectation for states with legalized marijuana laws that the states develop a robust system of regulation and enforcement so as to reduce the likelihood of federal enforcement activity.
Medical Marijuana Regulation in Other States. Currently, 23 states and the District of Columbia currently have laws allowing the use of medical marijuana. 12 additional states have laws providing for limited access to medical marijuana products strictly for medical purposes, and four states authorize the recreational use of marijuana.
The experiences of other states have helped to inform the current conversation in California. Notably, this bill establishes standards for cultivation, transport, testing, and labeling of edible medical marijuana products.
Trespass Grows and Environmental Concerns. California land, watersheds and some species, particularly Northern California, have been significantly damaged as a result of certain marijuana cultivation efforts. “Trespass grows”, cultivating marijuana without permission on public, tribal or privately owned land, have been associated with wildlife poisoning, use and dumping of fertilizers and pesticides, illegal water diversions and water pollution, logging and land disturbance, and severe problems with garbage and human waste. These industrial-size marijuana grows, taking place in the national forests and on private timberland in some of the state’s most remote and ecologically sensitive areas, are the subject of a recent study by the California Department of Fish and Wildlife, Impacts of Surface Water Diversions for Marijuana Cultivation on Aquatic Habitat in Four Northwestern California Watershed. This report showed that during drought conditions, water demand for marijuana cultivation is likely to have extraordinarily detrimental effects on state and federally listed salmon and steelhead trout and will cause further decline of sensitive amphibian species.
This bill requires that multiple state agencies guard against illegal marijuana growing and requires the development of standards for cultivation, fertilization, and impacts on surrounding lands.
Related Legislation
AB 243 (Wood) and AB 266 (Bonta) are joint bills with this bill. (Status: These bills are currently pending Senate Rules Committee.)
Prior Legislation
SB 1262 (Correa, 2014) is also very similar to this bill and would have created a Bureau of Medical Marijuana Regulation within DCA. (Status: The bill was held under submission in the Assembly Committee on Appropriations.)
AB 1894 (Ammiano, 2014), AB 473 (Ammiano, 2013) and AB 604 (Ammiano, 2013) would have established an Act to license and regulate the cultivation, manufacture, testing, transportation, storage, distribution, and sale of medical cannabis within the Department of Alcoholic Beverage Control. (Status: AB 1894 and AB 473 both failed passage on the Assembly Floor. AB 604 was referred to the Senate Committee on Public Safety but was not set for hearing in enough time for consideration before the Legislature adjourned.)
AB
2312 (Ammiano, 2012) established a nine-member Board of Medical
Marijuana Enforcement within the DCA to regulate the medical
marijuana industry and to collect fees from medical marijuana
businesses to be deposited into a new Medical Marijuana Fund. The
bill would have authorized local taxes on medical marijuana up to 5%.
(Status: The bill failed passage in this Committee.)
AB
1300 (Blumenfield, Chapter, 196, Statutes of 2011) provided that a
local government may enact an ordinance regulating the location,
operation or establishment of a medical marijuana cooperative or
collective. The bill also authorized a local government to enforce
such ordinances through civil or criminal remedies and actions and
authorized the local government to enact any ordinance that is
consistent with the MMP, which is intended to implement the CUA.
SB
420 (Vasconcellos, Chapter 875, Statutes of 2003) established the
Medical Marijuana Program Act, a statewide, voluntary program for the
issuance of identification cards to identify persons authorized to
engage in the medical use of marijuana under the CUA.
FISCAL EFFECT: Appropriation: No Fiscal Com.: Yes Local: No
California Association of Code Enforcement Officers
California College & University Police Chiefs Association
California League of Conservation Voters
California Native Plant Society
California Police Chiefs Association
California State Association of Counties
California State Parks Foundation
California Teamsters Public Affairs Council
California Trout
California Urban Streams Partnership
Clean Water Action
Defenders of Wildlife
League of California Cities
Pacific Forest Trust
Rural County Representatives of California
Trout Unlimited
The Nature Conservancy
The Trust for Public Land
UFCW Western States Council
Urban Counties Caucus
OPPOSITION: (Verified 9/11/15)
None received
ARGUMENTS IN SUPPORT: Supporters of the bill write that as the scale and volume of individual grow sites has enlarged, an appropriate statewide licensing and regulatory framework is necessary to address the wide range of environmental, land-use, and health and safety issues that many counties are currently experiencing. Supporters also write that this piece of legislation will provide the necessary framework for protecting the environment from medical marijuana production and clean up the impact of past illegal operations.
Prepared by: Sarah Huchel / B., P. & E.D. / (916) 651-4104
9/11/15 21:22:50
**** END ****
SB 643
Page 3
SENATE THIRD READING
SB 643
(McGuire)
As Amended September 1, 2015
Majority vote
SENATE VOTE: 26-13
Committee |
Votes |
Ayes |
Noes |
Business & Professions |
8-2 |
Bonilla, Bloom, Dodd, Eggman, Mullin, Ting, Wilk, Wood |
Jones, Gatto |
Health |
11-2 |
Bonta, Maienschein, Bonilla, Burke, Chiu, Gomez, Lackey, Santiago, Steinorth, Thurmond, Wood |
Chávez, Patterson |
Appropriations |
11-0 |
Gomez, Bloom, Bonta, Nazarian, Eggman, Eduardo Garcia, Holden, Quirk, Rendon, Weber, Wood |
|
SUMMARY: Declares the intent of the Legislature to enact a comprehensive regulatory framework for medical marijuana, and makes this bill operative only if AB 266 (Bonta) of the current legislative session is enacted and takes effect on or before January 1, 2016.
FISCAL EFFECT: None. This bill is keyed non-fiscal by the Legislative Counsel.
COMMENTS:
Purpose. This bill is author sponsored. According to the author, "SB 643 seeks to resolve many of the issues created by the enactment of the Compassionate Use Act and subsequent legislation….California voters made it clear that they wanted medical marijuana to be legalized, but issues and concerns for growers, doctors, dispensaries, law enforcement, district attorneys, cities, counties and others have only become more complicated…Since the voters of California passed Proposition 215 in 1996, it has become clear that there needs to be a comprehensive regulation bill from the Legislature that oversees the cultivating, processing, manufacturing, transportation, prescribing and sale of medical marijuana…."
The Compassionate Use Act (CUA) and SB 420. In 1996, voters approved the CUA, which allowed patients and primary caregivers to obtain and use medical marijuana, as recommended by a physician, and prohibited physicians from being punished or denied any right or privilege for making a medical marijuana recommendation to a patient. In 2003, SB 420 (Vasconcellos), Chapter 875, established the Medical Marijuana Program (MMP), which allowed patients and primary caregivers to collectively and cooperatively cultivate medical marijuana, and established a medical marijuana card program for patients to use on a voluntary basis. However, since the passage of Proposition 215 and SB 420, the state has not adopted a framework to provide for appropriate licensure and regulation of medical marijuana. As a result, in the nearly 20 years since the passage of Proposition 215, there has been an explosion of medical marijuana collectives and cooperatives that are largely left to the enforcement of local governments, resulting in the creation of a patchwork of local regulations for these industries and with little statewide involvement.
The California Attorney General's Compassionate Use Guidelines. SB 420 required the California Attorney General to "…develop and adopt appropriate guidelines to ensure the security and non-diversion of marijuana grown for medical use by patients qualified under the Compassionate Use Act of 1996." In 2008, the Attorney General issued guidelines to: 1) ensure that marijuana grown for medical purposes remains secure and does not find its way to non-patients or illicit markets, 2) help law enforcement agencies perform their duties effectively and in accordance with California law, and 3) help patients and primary caregivers understand how they may cultivate, transport, possess, and use medical marijuana under California law. According to a 2011 letter, after a series of meeting with stakeholders to assess whether to clarify the 2008 guidelines to stop the exploitation of California's medical marijuana laws by gangs, criminal enterprises, and others, the Attorney General decided to postpone the issuance of new guidelines because of pending litigation and to urge the Legislature to amend the law to establish clear rules governing access to medical marijuana.
California Supreme Court Affirms Local Control Over Medical Marijuana. By exempting qualified patients and caregivers from prosecution for using or from collectively or cooperatively cultivating medical marijuana, the CUA and the MPP essentially authorized the cultivation and use of medical marijuana. These laws have triggered the growth of medical marijuana dispensaries in many localities, and in response, local governments have sought to exercise their police powers to regulate or ban activities relating to medical marijuana. After numerous court cases and years of uncertainty relating to the ability of local governments to control medical marijuana activities, particularly relating to the ability to control the zoning, operation, and existence of medical marijuana dispensaries, the California Supreme Court, in City of Riverside v. Inland Empire Patients (2013) 56 Cal. 4th 729, held that California's medical marijuana statutes do not preempt a local ban on facilities that distribute medical marijuana. The court held that nothing in the CUA or the MMP expressly or impliedly limited the inherent authority of a local jurisdiction, by its own ordinances, to regulate the use of its land, including the authority to provide that facilities for the distribution of medical marijuana will not be permitted to operate within its borders.
Federal Controlled Substances Act. Despite the CUA and SB 420, marijuana is still illegal under state and federal law. Under California law, marijuana is listed as a hallucinogenic substance in Schedule I of the California Uniform Controlled Substances Act. Yet, the CUA prohibits prosecution for obtaining, distributing, or using marijuana for medical purposes. However, under the federal Controlled Substances Act, it is unlawful for any person to manufacture, distribute, dispense or possess a controlled substance, including marijuana, whether or not it is for a medical purpose. As a result, patients, caregivers, and dispensary operators, who engage in activities relating to medical marijuana, may still vulnerable to federal arrest and prosecution. According to the California Attorney General's guidelines, the difference between state and federal law gives rise to confusion. However, California has tried to avoid this conflict by deciding not to use the state's powers to punish certain marijuana offenses under state law when a physician has recommended its use to treat a serious medical condition.
United States Department of Justice (USDOJ) Guidance Regarding Marijuana Enforcement. On August 29, 2013, the USDOJ issued a memorandum that updated its guidance to all United States Attorneys in light of state ballot initiatives to legalize under state law the possession of small amounts of marijuana and provide for the regulation of marijuana production, processing, and sale. While the memorandum noted that illegal distribution and sale of marijuana is a serious crime that provides a significant source of revenue to large-scale criminal enterprises, gangs, and cartels, it also noted that USDOJ is committed to using its limited investigative and prosecutorial resources to address the most significant threats. According to the USDOJ, "In jurisdictions that have enacted laws legalizing marijuana in some form and that have also implemented strong and effective regulatory and enforcement systems to control the cultivation, distribution, sale, and possession of marijuana, conduct in compliance with those laws and regulations is less likely to threaten the federal priorities set forth above…In those circumstances, consistent with the traditional allocation of federal-state efforts in this area, enforcement of state law by state and local law enforcement and regulatory bodies should remain the primary means of addressing marijuana-related activity."
Medical Marijuana Industry in California. According to the author's Sunrise Questionnaire, submitted to the Committee pursuant to Government Code Section 9148 et seq., by law enforcement estimates, over 60% of all marijuana in the country is grown in the Emerald Triangle counties of Humboldt, Mendocino and Trinity, all of which are in the author's district, and once the industry is regulated, and the medical marijuana products are certified as safe, the market is expected to open up substantially. In addition, once the industry is regulated, the author believes that physicians who do not recommend or even discuss medical marijuana due to its quasi-legal nature and outright ban from the federal government may be more willing to discuss and recommend medical marijuana to their patients.
The author asserts that the harm starts at the environmental side of things, and simply expands from there. The regional and State Water Boards, along with California Department of Fish and Wildlife, are doing what they can, but without legislation, their hands are largely tied. This leads to streams and rivers literally running dry (even before the current drought) and to huge loads of sediments and toxic wastes being dumped into the watersheds. According to the author, the lack of regulation complicates water supply for millions of legal residential and commercial water users throughout the state-- entire tracts of forests are being mowed down by rogue growers and planted with marijuana with no permits, oversight, or regard for the environment.
The author also believes that the lack of regulation on the processing, manufacturing, testing, transportation and resale needs to be fixed as well, and that without statewide standards produced by specific health and safety testing, ingredient lists, and dosage listings on all marijuana products, people are put at risk.
According to the author, cities and counties that have medical marijuana ordinances take the first step in protecting consumers and the public, but without a strong state-wide regulatory body overseeing all aspects of the product chain, consumers have very little control over the risk unless they have personal knowledge of the product. The author believes that clear guidelines from the state and or the local jurisdiction, backed up by the state, is the only way to ensure protection of consumers and the public.
Analysis Prepared by: Eunie Linden / B. & P. / (916) 319-3301 FN: 0002013
Date of Hearing: August 26, 2015
ASSEMBLY COMMITTEE ON APPROPRIATIONS
Jimmy Gomez, Chair
SB 643
(McGuire) – As Amended August 18, 2015
Policy Committee: |
Business and Professions |
Vote: |
8 - 2 |
|
Health |
|
11 - 2 |
|
|
|
|
Urgency: No State Mandated Local Program: Yes Reimbursable: No
SUMMARY:
This bill creates a state licensing and regulatory framework for medical marijuana. The bill includes provisions related to licensure; health and safety standards, which include testing and labeling; record-keeping; security; transportation; taxation; certification of employees; and physician recommendation and advertising. Specifically, this bill:
Establishes parameters related to medical recommendation of marijuana, requiring the Medical Board to prioritize for investigation repeated acts of recommending marijuana for medical reasons and adopt medical guidelines for its administration and use, and prohibiting a physician from recommending marijuana unless the person is a patient's "attending physician," as defined by the Compassionate Use Act.
Exempts from licensure a patient who cultivates or possesses marijuana for personal medical use, or a primary caregiver who cultivates, possesses or provides marijuana to no more than five patients, as specified.
Establishes the Office of Medical Marijuana Regulation Office within the Business, Consumer Affairs, and Housing Agency, to enforce its provisions. Requires the Office, by January 1, 2018, to promulgate regulations for implementation and enforcement, as specified.
Requires the Office to convene an advisory committee, as specified, to advise on the development of standards and regulations.
Specifies protection of the public and preserving patient access to medical marijuana are the highest priorities.
Requires various licensee records to be kept in a database, and made available with 24-hour access to information upon request.
Creates the fee-based Medical Marijuana Regulation Fund and the Special Account for Environmental Enforcement; specifies all penalties are deposited into the GF; and authorizes the Office to administer a grant program to allocate funds to state and local entities to assist with administration and enforcement.
Authorizes the Office to issue, suspend, and revoke licenses for marijuana cultivation, manufacture, transportation, storage, distribution, testing, and sale of medical marijuana within the state, and to collect related licensing fees.
Establishes a tiered licensing scheme, depending on size, complexity, and type of license, for cultivation, manufacturers, dispensing facilities, distributors, and testing entities.
Requires the California Department of Food and Agriculture (CDFA) to develop an organic designation or its equivalent, and to establish appellations of origin for marijuana grown in California.
Prohibits unlicensed activity. Makes licensees subject to local jurisdiction restrictions, including prohibitions on operation. Requires local permits and state licenses in order for a business to operate. Specifies existing businesses can operate until a license is approved or denied.
Specifies medical marijuana transportation requirements, including secure vehicles and minimum staffing.
References, but does not explicitly allow, unlicensed activity in the City of Los Angeles.
Requires licensed facilities to implement specified security measures, including access, storage, and inventory controls.
Authorizes boards of supervisors to impose a tax on the privilege of cultivating, dispensing, producing, processing, preparing, storing, providing, donating, selling, or distributing medical marijuana or medical marijuana products by a licensee, and provides it is declaratory of existing law.
Requires a tracking program be in place prior to commencement of licensure.
Establishes food safety, potency, and labeling standards for edible marijuana products.
Requires the Office to promulgate standards for certification of testing laboratories to perform random sample testing of all medical marijuana products, and to certify testing laboratories.
Requires the Division of Labor Standards Enforcement in the Department of Industrial Relations (DIR) to develop competency and training certification standards for cultivation and dispensing employees.
Makes willful violations of this act punishable by a civil fine of up to $35,000. Technical violations are punishable by fines of up to $10,000.
Requires the California Highway Patrol (CHP) to conduct research to determine whether a driver is operating a vehicle under the influence of cannabis, and to assist law enforcement agencies to establish best practices. Funds this activity through the fines and penalties account.
Specifies funds for the establishment and support of the Office shall be advanced as a loan from the General Fund, and shall be repaid by the initial proceeds from fees.
FISCAL EFFECT:
Costs/Fees:
Significant one-time costs in the range of $25 million (GF loan) to establish the Office, basic structure, information technology infrastructure, and regulations. The bill specifies startup costs for establishment of the bureau are to be advanced as a loan from the General Fund.
Annual costs, conservatively around $20 million and potentially exceeding $50 million (Medical Marijuana Regulation Fund), to maintain the Office within the Agency to regulate the medical marijuana industry.
As a comparison, the budget of the Department of Alcoholic Beverage Control (ABC) is approximately $60 million and 450 positions. The ABC is charged with licensing and regulating persons and businesses engaged in the manufacture, importation and distribution of alcoholic beverages, and administering the provisions of the ABC Act to protect the health, safety, welfare and economic well-being of the state. In addition, the ABC Appeals Board has a $1 million budget.
Based on funding and staffing levels of the ABC, and considering the complexities of the undertaking and the significant start-up costs of any new entity (adoption of regulations and fee schedules, office equipment and expenses, etc.), it appears reasonable to assume the costs of providing statewide regulation for cultivation, manufacture, testing, transportation, distribution, and sale of medical marijuana, along with associated hearings, appeals, litigation and enforcement, would conservatively be in the range of 35% of the ABC budget.
This bill establishes unspecified registration fees. The costs of creating and maintaining the Office, as specified, would require significant application fees. For purpose of illustration, the average fee to cover the cost of a $20 million entity, if there were 5,000 annual applications, would be $4,000 per application.
Unspecified revenues related to marijuana cultivation based on an additional fee assessment, distributed to the Account to State Water Resources Control Board, the Department of Fish and Wildlife, the Department of Forestry and Fire Protection, the Department of Pesticide Regulation, and the Department of Food and Agriculture to support enforcement of environmental regulation.
One-time costs potentially exceeding $100,000 (Contingent Fund of the Medical Board of California) to issue medical guidelines related to marijuana. Ongoing costs to the California Medical Board for investigating physicians who overprescribe marijuana should be minor and absorbable.
Minor ongoing costs to DOJ for background checks, covered by applicant fees.
Litigation costs to DOJ to defend the office, estimated in the range of $10 million. Costs would be reimbursed by DCA, presumably with applicant fee revenue, if sufficient.
One-time costs to DIR to certify cultivation and dispensing employees in the range of $1 million (GF), and $900,000 annually ongoing (Medical Marijuana Regulation Fund).
One-time costs to the Office, likely in the range of millions, as well as costs in a similar range ongoing, to certify laboratories for testing of marijuana (Medical Marijuana Regulation Fund).
Unknown, potentially significant non-reimbursable local law costs for enforcement of medical marijuana regulation.
Tax and penalty revenue:
Unknown moderate local revenue increase, potentially in the millions of dollars, from a permissive and unspecified local tax.
Unknown GF revenue from fines of up to $35,000 for willful violations and up to $10,000 for technical violations of the act.
COMMENTS:
Purpose. According to the author, this bill seeks to resolve many of the issues created by the enactment of Proposition 215, or the Compassionate Use Act, and subsequent legislation. The author states California voters clarified their desire to legalize medical marijuana; however, there are growing issues and concerns for many stakeholders. For instance, he notes trespass grows have become an environmental disaster, illegally diverting millions of gallons of water from rivers and streams, creating a clearance ground for pesticides, insecticides, rodenticides, and fertilizers, and depositing large amounts of sediment into waterways from crop runoff. The author concludes this bill contains provisions necessary to recognize the voters’ mandate of Proposition 215 and streamlines the ability of the medical marijuana industry to grow and sell a legal product.
Current Medical Marijuana Law. Possession and sale of marijuana is a crime under federal law, and federal law preempts state law. California patients who obtain a physician's recommendation are protected from prosecution for possessing or cultivating an amount of cannabis reasonably related to their current medical needs, as are patients' caregivers. Patients and caregivers who obtain a state Medical Marijuana Program (MMP) identification card from their county health department are protected from arrest and prosecution for possessing, delivering, or cultivating cannabis. Patients and caregivers who engage in these activities, however, remain liable to federal arrest and prosecution, and those who operate dispensaries face frequent federal enforcement actions. A brief history of relevant law is below:
In 1996, California voters passed Prop 215, the Compassionate Use Act (CUA), which prohibits prosecution for growing or using marijuana if a person has an oral or written recommendation of a physician.
In 2003, SB 420 (Vasconcellos, Statutes of 2003), the Medical Marijuana Program Act, created a voluntary identification card that patients and caregivers could obtain to protect them from arrest, and limited the amount of marijuana that could be legally grown and possessed.
In 2005, the U.S. Supreme Court ruled in Gonzales v. Raich (2005) that the federal government can enforce marijuana prohibitions despite state medical marijuana law.
In 2010, the CA Supreme Court ruled in People v. Kelly that the MMP section limiting quantities of cannabis is unconstitutional because it amends a voter initiative.
In 2013, the CA Supreme Court held medical marijuana statutes do not preempt a local ban on facilities that distribute medical marijuana, and that municipalities may prohibit such conduct as a public nuisance (City of Riverside v. Inland Empire Patient's Health & Wellness Center).
Also in 2013, the U.S. Department of Justice (USDOJ) issued guidance that stated, "In jurisdictions that have enacted laws legalizing marijuana in some form and that have also implemented strong and effective regulatory and enforcement systems to control the cultivation, distribution, sale, and possession of marijuana, conduct in compliance with those laws and regulations" is less likely to threaten federal priorities which include the most significant public threats, including disrupting gang and cartel activities, preventing revenue diversion, etc. DOJ states where strong state and local regulatory systems exist, "enforcement of state law by state and local law enforcement and regulatory bodies should remain the primary means of addressing marijuana-related activity." California is the only state that permits medical marijuana in the absence of a robust statewide regulatory system; half of all states have some such system.
Comments.
Organizational Structure. This bill places significant authority in a newly created Office within an existing state agency. The duties of the office will include promulgating regulations, contracting for a significant information technology project that will meet the bill's requirements, developing licensure programs and processes, conducting licensure and enforcement activities. The licensed entities are disparate, from farms to laboratories to retail outlets. While there is value in centralizing control and accountability, such a structure may fail to leverage existing state expertise and lead to a misalignment of duties by placing only those specific to marijuana in a stand-alone entity. For example, California Department of Public Health (CDPH) would be in the business of licensing all laboratories in the state, except for those dealing with marijuana testing, even though presumably they may have existing regulatory relationships with same laboratories for other non-marijuana activities. CDPH has existing infrastructure for doing this activity, including regulatory expertise, technical field staff, fee collection infrastructure, and other assets that could be leveraged.
An alternative approach would be to combine a central entity with the ability to leverage existing expertise. For example, a bill could assign duties to appropriate existing agencies but play a coordinating role. Or, a bill could require a central coordinating Office to issue all regulations, but allow the Office to contract via interagency agreement with CDPH and CDFA or other appropriate entities for actual licensure and enforcement activities. Staff could work within CDPH but under an interagency agreement with the Office, in order to maintain a higher level of accountability for the overall regulatory structure and prevention of diversion to the black market. There are a number of organizational options, but more flexibility may offer some benefits.
In addition or alternatively, a centralized Office could be set up
initially, in order to ensure consistency in the promulgation of
regulations and operations, with the intent that program activities
could be spun off from the centralized office once start-up
activities are complete and regulatory programs are robust.
Inserting a sunset date on the operation of the office would provide a natural opportunity for the Legislature and administration to reconsider whether the chosen approach is still the right one after start-up activities are completed.
Fiscal comments. The bill should specify that licensure fees can be scaled based on size and regulatory complexity. In addition, the fee revenue for different license types is not differentiated. This may result in cross-subsidization between licensure categories. Regulatory fees that are out of proportion to the cost of regulation may confer legal risks that fees are impermissible, and as a matter of principle they should be scaled according to regulatory costs. Staff suggests greater differentiation between categories to ensure licensees are fairly charged.
Analysis Prepared by: Lisa Murawski / APPR. / (916) 319-2081
SB 643
Page 27
Date of Hearing: July 14, 2015
ASSEMBLY COMMITTEE ON HEALTH
Rob Bonta, Chair
SB 643
(McGuire) – As Amended June 3, 2015
SENATE VOTE: 26-13
SUBJECT: Medical marijuana
SUMMARY:
Establishes the Medical Marijuana Public Safety and Environmental
Protection Act (Act) for the regulation and issuance of state
licenses, termed conditional licenses in this bill, for medical
marijuana (MM) activity. Specifically, this bill:
Medical Marijuana Recommendations
Requires the Medical Board of California (MBC) to prioritize, investigate, and prosecute cases under which a physician excessively recommends marijuana to patients for medical purposes without a good faith prior examination of the patient and medical reason.
Makes it a misdemeanor for a physician and surgeon who recommends marijuana for a patient for a medical purpose to accept, solicit, or offer any form of payment from or to a facility issued a conditional license pursuant to the Act, if the physician and surgeon or his or her immediate family have a financial interest in that facility.
Requires the MBC to consult with the California Marijuana Research Program, under the direction of the University of California, in the development and adoption of medical guidelines for the appropriate administration and use of MM.
Prohibits a physician and surgeon from recommending MM to a patient unless that person is a patient’s attending physician, as defined.
Definitions
Defines “dispensary” as a distribution operation that provides MM or MM-derived products to patients and caregivers.
Defines a “licensed cultivation site” as a facility that plants, grows, cultivates, harvests, dries, or processes MM and that is issued a conditional license.
Defines “licensed dispensing facility” as a dispensary or other facility that provides MM, MM products, or devices for the use of MM products that is issued a conditional license.
Defines “licensed manufacturer” as a person who extracts, prepares, derives, produces, compounds, or repackages MM or MM products into consumable and nonconsumable forms and that is issued a conditional license.
Establishes the Office of Medical Marijuana Regulation (Office) under the Business, Consumer Affairs, and Housing Agency, and requires the protection of the public to be the highest priority for the Office in exercising its licensing, regulatory and disciplinary functions.
Defines "Chief" as the Chief of the Office of Medical Marijuana Regulation.
Defines “licensed transporter” as an individual or entity issued a conditional license by the Office to transport MM to and from facilities that have been issued conditional licenses in limited quantities.
Defines “edible MM product” as an MM or an MM-derived product that is ingested or meant to be ingested through the mouth and into the digestive system.
Administrative
Provisions
Provides that the Office has the authority to issue, suspend, or revoke conditional licenses for the cultivation, manufacture, transportation, storage, distribution, and sale of MM within California and collect fees in association with those activities.
Authorizes the Office to adopt and enforce rules and regulations that he or she determines are reasonably necessary to carry out the Act, and to appoint and compensate personnel to assist in carrying out those rules and regulations.
Requires the funds for the establishment and support of the Office to be advanced as a loan from the General Fund (GF), to be repaid by the initial proceeds from fees collected as part of any rule or regulation of the Act.
Provides the Office with the authority to implement the Act, including:
Establishing rules or regulations necessary to carry out the Act;
Issuing conditional licenses to individuals; setting specified fees for conditional licenses;
Establishing standards for the cultivation, manufacturing, transportation, storage, distribution, provision, donation, and sale of MM and MM products;
Establishing procedures for the issuance, renewal, suspension, and revocation of conditional licenses; and,
Enforcing the licensing and regulatory requirements of the Act, including the imposition of penalties.
On or before January 1, 2018, requires the Office to promulgate regulations for implementation and enforcement of the Act related to conditional licensure.
Requires the Chief to keep a complete record of all facilities issued a conditional license to be made available on the Office’s Internet Website, and to provide information upon request.
Requires the Office to establish procedures to provide state and local law enforcement, upon request, with 24-hour access to information regarding conditional licenses, transportation manifests, and facility inventories for enforcement purposes.
Provides that the Act does not supersede the provisions of Measure D, approved by the voters of the City of Los Angeles on the May 21, 2013, ballot for the city, which grants MM businesses and dispensaries qualified immunity consistent with the terms of the measure and local ordinances, or any similar measure in other jurisdictions.
Conditional
Licensing Provisions
Exempts qualified patients and primary caregivers who care for no more than five specified patients, who engage in MM activity, from the requirement for conditional licensure.
Except as allowed under the Compassionate Use Act (CUA), prohibits the following:
An individual from selling or providing MM to a patient or caregiver other than at a licensed dispensing facility or through delivery from a licensed dispensing facility;
An individual from growing MM other than at a licensed cultivation site;
An individual, other than a licensed manufacturer, from manufacturing MM or MM products; and,
An individual, other than a licensed transporter, from transporting MM from on facility issued a conditional license to another.
Allows a licensed manufacturer to obtain MM from a licensed cultivator and to furnish MM products to a licensed dispensary.
Requires the Office to provide for and issue conditional licenses, no later than July 1, 2018, for all activity authorized under the Act, including, but not limited to, cultivation, processing, storage, transport, and dispensing of MM. Requires the conditional license to certify, at a minimum, that the applicant has paid the state conditional licensing fee, successfully passed a criminal background check, and met state residency requirements.
Clarifies that the issuance of a conditional license does not, in and of itself, authorize a recipient to begin MM business operations. Prohibits a conditionally licensed facility from beginning activity under the conditional license until the applicant has also obtained a license or permit from the local jurisdiction in which he or she proposed to operate, in accordance with the requirements of the local ordinance.
Requires applicants for conditional licenses to meet specified conditions, and prohibits the Office from issuing a conditional license to individuals, entities, or for premises under specified circumstances. Requires each conditional license to be valid for 12 months after the date of issuance, and requires the Office to establish procedures for the renewal of conditional licenses.
Authorizes a facility or entity that is operating in accordance with local zoning ordinances and other state and local requirements on January 1, 2016, to continue its operations until its application for conditional licensure is approved or denied.
Requires the Office, via regulation, to establish conditions upon which a person whose conditional license has previously been revoked, denied, or suspended to be issued a conditional license.
Requires an application for a conditional license to be denied and a conditional license to be suspended or revoked for past felony convictions for any of the following:
The possession for sale, sale, manufacture, transportation, or cultivation of a controlled substance;
Drug trafficking;
Embezzlement;
Fraud or deceit; and,
Violent or serious felonies, as defined.
Prohibits a conditional license from being denied solely on the basis of a prior conviction for a felony committed after the enactment of the CUA, but which would not be a felony after the enactment of the Act. Authorizes the Office, at its discretion, to issue a conditional license to an applicant that has obtained a certificate of rehabilitation, as defined.
Authorizes the Office to deny, suspend, or revoke a conditional license under specified conditions, and requires the Office to notify the applicant or licensee, in writing of the denial, suspension or revocation of the conditional license.
Requires an application for or renewal of a conditional license to be denied under any of the following conditions:
The applicant fails to meet the requirements of the Act or has had an applicable permit or license revoked or denied by an applicable local agency;
The applicant, or any of its officers, directors, owners, members, or shareholders, is a minor, has been sanctioned by the Office, a city, county, or city and county, for MM activities conducted in violation of the Act or any applicable local ordinance, or has had a license revoked in the previous five years;
The applicant has knowingly answered a question or request for information falsely on the application form or failed to provide information requested;
The proposed cultivation, processing, possession, storage, manufacturing, testing, transporting, distribution, provision, or sale of MM will violate any applicable law or ordinance; or,
The applicant or owner is unable to establish that he or she has been a resident of California for not less than 12 months.
Requires a conditional license to be subject to the restrictions of the local jurisdiction in which the facility operates or proposes to operate. Prohibits a facility from operating in a local jurisdiction that prohibits the establishment of that type of business, and provides that local jurisdictions retain the power to assess fees and taxes, as applicable, on facilities that are conditionally licensed.
Authorizes the Office to adopt regulations to limit the number of conditional license issued after finding that the otherwise unrestricted issuance of conditional licenses is dangerous to the health and safety of the public.
Fee
Provisions
Requires the Office to establish conditional licensing fees at a level sufficient enough to fund the reasonable administrative and enforcement costs of the Act.
Requires a cultivation facility, in addition to the conditional licensing fee, to be assessed a fee sufficient to cover the reasonable regulatory costs of enforcing the environmental impact provisions relating to cultivation facilities, and to be distributed to state and local agencies and law enforcement.
Establishes the Medical Marijuana Regulation Fund (Fund), and the Special Account for Environment Enforcement within the Fund, under the direction of the Office. Provides that the Special Account for Environment Enforcement is established to enforce the environmental regulation of licensed cultivation sites.
Requires all fees collected in accordance to the Act to be deposited into the Fund, and for all moneys within the Fund to be made available for the sole purposes of fully funding and administering the Act, subject to an appropriation by the Legislature.
Requires all moneys collected as a result of penalties in the Act to be deposited directly into the GF.
Authorizes the Office to establish and administer a grant program to state and local entities for the purpose of assisting with MM regulation and enforcement, subject to appropriation by the Legislature.
Prohibits a facility with a conditional license from acquiring, cultivating, processing, possessing, storing, manufacturing, distributing, selling, delivering, transferring, transporting, or dispensing MM for any other purpose other than those authorized under the Act.
Prohibits a licensed dispensing facility from acquiring, cultivating, processing, possessing, storing, manufacturing, distributing, selling, delivering, transferring, transporting, or dispensing MM plants or MM products except through a licensed cultivation site or a licensed manufacturer.
Transportation
Provisions
Requires a licensed transporter to ship only to facilities issued a conditional license, and in response to a request for a specific quantity and variety from those facilities.
Requires a licensed transporter, prior to transporting MM products, to complete a shipping manifest, using a form prescribed by the Office, and securely transmit a copy of the manifest to the licensee that will receive the MM product, and the Office upon request.
Requires both the licensed transporter making the shipment and the licensee receiving the shipment to maintain each shipping manifest and make it available to local code enforcement officers, the Office, and any other locally designated enforcement entity, upon request.
Applies the following requirements to only licensed transporters:
Transported MM products is required to be transported only in a locked, safe, and secure storage compartment that is securely affixed to the interior of the transporting vehicle, and not be visible from the outside of the vehicle;
Vehicles transporting MM are prohibited from having external markings or other indications that it is transporting MM;
All transport vehicles carrying MM with a retail value greater than $10,000 are required be staffed with a minimum of two employees, and requires at least one transport team member to remain with the vehicle at all times when the vehicle contains MM;
Each transport team member is required to have access to a secure form of communication by which each member can communicate with personnel at the licensed facility at all times when the vehicle contains MM; and,
Each transport team member is required to possess documentation of licensing and a government-issued identification card at all times when transporting or delivering MM and to produce it upon request by any representative of the Office or law enforcement.
Provides that specified transport provisions cannot be construed to authorize or permit a licensee to transport, or cause to be transported, MM or MM products outside California.
Prohibits a local jurisdiction from preventing transportation through or to a facility issued a conditional license, by a conditionally licensed transporter who acts in compliance with the Act.
Enforcement
Provisions
Provides that a state agency is not required to enforce a city, county, city and county, or local law, ordinance, rule, or regulation regarding the site or operation of a facility issued a conditional license.
Authorizes the Office to assist state taxation authorities in the development of uniform policies for the state taxation of licensees.
Authorizes the Office to enforce all of the requirements of the Act, including any regulations adopted.
Requires the Office to delegate the authority to enforce the requirements of the Act, including any regulations, to a city, county, or city and county, upon request of that entity.
Provides that nothing in this bill’s provisions shall be interpreted to supersede or limit existing local authority for law enforcement activity, enforcement of local zoning requirements, or enforcement of local licensing requirements, or to require the Office to undertake responsibilities for those activities.
Requires that a willful violation of the requirements for a conditional license, including an attempt to falsify information on an application or to otherwise defraud or mislead a state or local agency in the course of the application process, shall be punishable by a civil fine of up to $35,000 for each individual violation.
Requires, at the Office’s discretion, a technical violation of the requirements for a conditional license to be punishable by a civil fine of up to $10,000 for each individual violation.
Authorizes a district attorney, county counsel, city attorney, or city prosecutor, to bring an action to enjoin a violation or the threatened violation of any provision of the Act. Requires the action to be brought in the county in which the violation occurred or is threatened to occur. Requires a proceeding brought forward to conform to requirements of existing law. Provides that the authority of a local government to take required enforcement actions pertaining to its own ordinances or regulations is not to be diminished.
Prohibits anything within the Act to prevent a city or other local from taking action in the Medical Marijuana Program (MMP), in accordance with existing law.
Provides that nothing within the Act is to be construed to limit a law enforcement agency’s ability to investigate unlawful activity in relation to a facility issued a conditional license.
Requires the Office to notify local law enforcement of all conditional licenses issued for cultivation sites in that jurisdiction.
Requires a licensed cultivation site to display the state license in a manner so as to be available and easily read at the location.
No later than January 1, 2022, requires all MM grown, produced, distributed, and sold in the state to meet certified organic standards.
Requires the Office to establish appellations of origin for marijuana grown in California.
Requires the Office to work with specified entities to provide all the information and forms required for conditional licensure as a cultivation site in a single location, including state licensure, local requirements in that jurisdiction, and environmental requirements.
Advertising,
Security, and Recordkeeping Provisions
Prohibits a person from distributing any form of advertising for physician recommendations for MM in California unless the advertisement bears a notice to consumers, that reads:
NOTICE TO CONSUMERS: The
Compassionate Use Act of 1996 ensures that seriously ill Californians
have the right to obtain and use marijuana for medical purposes where
medical use is deemed appropriate and has been recommended by a
physician who has determined that the person’s health would benefit
from the use of medical marijuana. Physicians are licensed and
regulated by the Medical Board of California and arrive at the
decision to make this recommendation in accordance with accepted
standards of medical responsibility.
Requires advertisements for physician recommendations for MM to meet advertising requirements in existing law.
Requires a facility issued a conditional license to implement sufficient security measures to both deter and prevent unauthorized entrance into areas containing marijuana and theft of marijuana at those facilities.
Requires a facility issued a conditional license to notify appropriate law enforcement authorities within 24 hours after discovery of inventory discrepancies, diversion, theft, loss, criminal activity, the loss of records, or any other security breach.
Requires a licensed cultivation site to weigh, inventory, and account for on video, all MM to be transported prior to its leaving its origination location. Requires the licensed dispensing facility, within eight hours upon arrival at the destination, to reweigh, reinventory, and account for on video, all transported marijuana.
Requires information identifying the names of patients, their medical conditions, or the names of their primary caregivers received and contained in the records kept by the Office for administration purposes to be kept confidential and exempt from the California Public Records Act.
Provides that nothing shall prevent any of the following:
Office employees from notifying state or local agencies about information submitted to the Office that the employee suspects is falsified or fraudulent;
Notification from the Office to state or local agencies of apparent violations of the Act or an applicable local ordinance;
Verification of requests by state or local agencies to confirm licenses and certificates issued by the office or other state agency; or,
Providing information requests in accordance with a court order or subpoena issued by a court, an administrative agency, or local governing body authorized by law to issue subpoenas.
Prohibits information from being disclosed by the Office beyond what is necessary to achieve the goals of a specific investigation or notification or the parameters of a specific court order or subpoena.
Proclaims that the actions of a licensee, its employees, and its agents, that are permitted pursuant to a conditional license and that are conducted in accordance with the requirements of, and adopted regulations from, the Act are not unlawful under state law and are not an offense subject to arrest or prosecution.
Proclaims the actions of a person who, in good faith and upon investigation, allows his or her property to be used by a licensee, its employees, and its agents, as permits pursuant to a conditional license, are not unlawful under state law and are not an offense subject to arrest or prosecution.
Prohibits a licensee from cultivating, processing, storing, manufacturing, transporting, or selling MM in California unless accurate records are kept at the licensed premises of those activities by the licensee. Allows a licensee who has a conditional license for more than one premises to keep all records at one of the conditionally licensed premises. Requires records to be kept for seven years from the date of the transaction.
Authorizes the Office or a local agency delegated the authority to enforce the licensing requirements of the Act to examine the books and records of a conditional licensee and to visit and inspect the premises of a conditional licensee, as deemed necessary by that entity to perform its duties. Requires books or records requested by the enforcement entity to be provided by the conditional licensee no later than five business days after the request is made. Provides that a licensee shall be subject to a civil fine of $15,000 for each individual violation of failure to maintain or provide books and records.
Authorizes the Office or a local agency to enter and inspect the premises of a facility issued a conditional license between the hours of 8 a.m. and 8 p.m. on any day the facility is open, or any reasonable time, to ensure compliance and enforcement of the Act.
Authorizes the office to suspend a conditional license and commence proceedings for the revocation of a conditional license, if a licensee or an employee of a licensee refuses, impedes, obstructs, or interferes with an inspection of the licensed facility.
Tax
Provisions
Authorizes a city, county, or city and county, to impose a tax on the privilege of cultivating, dispensing, producing, processing, preparing, storing, providing, donating, selling, or distributing marijuana by a licensee, regardless of whether the activity is undertaken individually, collectively, or cooperatively, and regardless of whether the activity is for compensation or gratuitously, as determined by the board of supervisors or city council.
Requires the board of supervisors or city council to specify in the ordinance proposing the tax, the activities subject to the tax, the applicable rate or rates, the method of apportionment, if necessary, and the manner of collection of the tax. Authorizes the tax to be imposed for general governmental purposes or for purposes specified in the local ordinance.
Requires the tax imposed by local ordinances to be subject to applicable approval requirements imposed by existing law.
Provides that the imposition of a tax does not limit or prohibit the levy or collection of any other fee, charge, or tax, or a license or service fee or charge upon, or related to, activities related to the activities of a conditional license, as otherwise provided by law.
On or before July 1, 2016, requires the State Board of Equalization to compile a report on the estimated tax collected of the sale of MM, using the most current data available. Requires the report to include the expected tax revenues, under the existing tax structure, for the years 2016 to 2010, inclusive, and for the report to be submitted to the Legislature and the Governor’s office.
Collective
Model Provisions
Eliminates protections from prosecution for qualified patients, persons with valid identification cards, and designated primary caregivers who specifically cultivate marijuana for medical purposes through a collective or cooperative model.
Provides an individual employee, officer, or board member of a facility issued a conditional license pursuant to the Act will not be subject to state criminal sanctions in existing law, based solely on holding a conditional license for the possession, cultivation, processing, packaging, storage, transportation, sale, or distribution of MM to a facility also holding a conditional license, or directly to a qualified patient, a person with a valid identification card, or a designated primary caregiver, unless the license and related paperwork is falsified.
Labeling,
Testing and Edible MM Provisions
On or before July 1, 2017, requires the Office to report to the Legislature on the feasibility of developing a program to certify laboratories for the testing of MM and related products, and the feasibility of developing a labeling requirement for edible marijuana products that incorporates information on the cannabinoid content.
Requires a facility issued a conditional license to maintain supplier information in the event of recall procedures, and for labeling of all MM and MM products.
Declares edible MM products to be unadulterated food products.
Requires all edible MM products to comply with quality assurance standards in existing law, in addition to the following:
Allowance for baked edible MM products, that do not require refrigeration or hot holding, to be manufactured, sold, or otherwise distributed at facilities issued a conditional license;
A requirement that a facility issued a conditional license has an owner or employee who has successfully passed an approved and accredited food safety certification examination, as specified in existing law, prior to selling, manufacturing, or distributing edible MM products requiring refrigeration or hot holding;
A requirement that individuals manufacturing or selling edible MM products to thoroughly wash their hands before commencing production and handling finished edible MM products;
A requirement that all edible MM products sold for direct consumption and infused with marijuana concentrate to be individually wrapped at the original point of preparation;
A requirement that products containing tetrahydrocannabinol (THC) to be prepared in compliance with maximum potency standards for THC and THC concentrates;
A requirement that, prior to sale or distribution at a licensed dispensing facility, edible MM products are labeled and in an opaque and tamper evident package. Requires labels and packages of edible MM products to meet specified requirements;
A prohibition of photos or images of food on the packages or labels of edible MM products; and,
A requirement that only generic food names may be used to describe edible MM products.
EXISTING LAW:
Authorizes a county or city, with its jurisdiction, to make and enforce all local, policy, sanitary, and other ordinances and regulations not in conflict with general laws.
Licenses and regulates physicians and surgeons, including osteopathic physicians, under the Medical Practice Act by the MBC within the Department of Consumer Affairs.
Establishes the Sherman Food, Drug, and Cosmetic Law to regulate the packaging, labeling, and advertising of drugs and devices, under the direction of the Department of Public Health (DPH).
Prohibits the sale, possession, possession for sale, cultivation, transport, import, furnishing, donation, processing, administering, dispensing, and distribution of marijuana, punishable by imprisonment and/or fines, unless otherwise allowed by existing law.
Establishes the CUA of 1996 under Proposition 215 in law, which does the following:
Protects physicians from punishment, or denial of any right or privilege, for the recommending marijuana to a patient for medical purposes; and,
Provides that a qualified patient or primary caregiver, as defined, who possesses or cultivates marijuana for his or her own personal medical purpose with the written or oral recommendation or approval of a physician, shall not be punished.
Encourages the University of California to create the California Marijuana Research Program to commission objective scientific research concerning the efficacy and safety of administering marijuana as part of medical treatment.
Establishes the MMP under the direction of the DPH.
Defines an “attending physician” as an individual who possesses a license in good standing to practice medicine or osteopathy issued by the MBC or the Osteopathic Medical Board of California and who has taken the responsibility for an aspect of the medical care, treatment, diagnosis, counseling, or referral of patient and who has conducted a medical examination of that patient prior to recording in the patient’s medical card the physician’s assessment of whether the patient has a serious medical condition and whether the medical use of marijuana is appropriate.
Defines “primary caregiver” as an individual, designated by a qualified patient or by a person with an identification card, who has consistently assumed responsibility for the housing, health, or safety of that patient or person.
Defines a “qualified patient” as an individual who is entitled to the protections of the CUA, but who does not have an identification card pursuant to the MMP established in existing law.
Requires DPH to establish and maintain a voluntary program to issue identification cards to qualified patients of MM and voluntarily apply to the identification card program, and requires county health departments to issue identification cards to qualified patients and their caregivers.
Provides that qualified patients, persons with valid identification cards, and primary caregivers, who associate in order to collectively or cooperatively cultivate marijuana, are not subject to criminal liability solely on that basis.
Provides that individuals shall not be accommodated for the use of MM on the property or premises of any place of employment or during the hours of employment, or on the property or premises of any jail, correctional facility, or other type of penal institution in which prisoners reside or persons under arrest are detained.
Prohibits anything within the MMP from preventing a city or local governing body from adopting a local ordinance that regulates the location, operation, or establishment of a medical marijuana cooperative or collective, enforcing local ordinances for civil or criminal purposes, or enacting other laws consistent with the MMP.
FISCAL EFFECT:
According to the Senate Appropriations Committee, ongoing costs,
likely over $20 million per year to license MM cultivators,
transporters, and dispensaries by the new Bureau of Medical Marijuana
Regulation (special fund). For comparison, the California State
Board of Pharmacy, which licenses and regulates pharmacists and
pharmacies in the state has an annual budget of about $20 million per
year.
This bill would
create a new Bureau dedicated to licensing and enforcing licensing
requirements on the MM industry. The annual costs to operate the new
Bureau are highly uncertain. For example, the number of MM
cultivators, transporters, and dispensaries that would apply for
licensure under this bill is not known, in part because it is
difficult to know how the licensing and regulatory requirements in
this bill will change current practices in the MM industry.
Unknown costs for
enforcement of this bill’s requirements by local governments (local
funds and special funds). This bill requires both the new Bureau and
local governments to take responsibility for enforcement activity.
How those responsibilities will be divided between levels of
government and how much funding the state will make available to
local governments for enforcement activity is unknown at this time.
Because local governments have the legal authority under this bill to
prohibit the operation of MM facilities in their jurisdictions, local
governments can essentially opt out of the enforcement
responsibilities required under this bill. Thus the state is not
likely to be required to reimburse local governments for enforcement
costs.
Unknown costs for
the Department of Justice (DOJ) to conduct criminal background checks
of licensees (special fund). Under current practice, applicants for
a criminal background check are required to pay the $65 cost to
conduct a criminal background check using fingerprint databases.
Unknown fee revenues
to offset the costs to implement this bill (special fund). This bill
gives the new Bureau broad authority to set licensing fees sufficient
to pay for the Bureau’s costs to operate the licensing program,
costs incurred by the Bureau or the DOJ to enforce this bill, costs
incurred by local law enforcement agencies to enforce this bill, and
costs incurred by state and local environmental agencies for
enforcement costs relating to cultivation facilities. The fee
revenues generated under this bill would depend both on the allowed
costs that are incurred at the state and local level as well as the
feasibility of collecting sufficient fees from the MM industry. This
bill would continuously appropriate the fee revenues deposited in a
new special fund to implement this bill.
COMMENTS:
PURPOSE OF THIS BILL. According to the author, this bill seeks to resolve many of the issues created by the enactment of Proposition 215, or the Compassionate Use Act, and subsequent legislation. The author states California voters clarified their desire to legalize MM; however, there are growing issues and concerns for all MM stakeholders. The author explains how he represents the remote areas of Mendocino, Humboldt, and Trinity Counties, which are a primary growing region for MM in the country, responsible for up to 70% of the marijuana grown in the western United States. The author contends much of these local areas have become dependent on the economic benefits of marijuana cultivation, but also suffer from the negative environmental, public safety, and public health effects that arise from rogue cultivators and the lack of regulation of MM. The author maintains that trespass grows have become an environmental disaster, illegally diverting millions of gallons of water from rivers and streams, creating a clearance ground for pesticides, insecticides, rodenticides, and fertilizers, and depositing large amounts of sediment into waterways from crop runoff.
The author contends that since the passage of Proposition 215 in 1996, it has become clear that the state is in need of comprehensive regulation under the direction of the Legislature for the oversight of the cultivating, processing, manufacturing, transportation, prescribing, and safe of MM. The author maintains that existing law virtually contains no rules and regulations on the cultivation of MM and that it is important to bring this legal crop into the regulatory framework expected of other commodities. The author states the severe drought California is now experience has only made the need for this bill more urgent. The author concludes this bill contains provisions necessary to recognize the voters’ mandate of Proposition 215 and streamlines the ability of the MM industry to grow and sell a legal product.
BACKGROUND.
Medical use and research of marijuana. The marijuana, or cannabis, plant produces a resin containing compounds called cannabinoids, which are the active ingredients within the plant. Cannabinoids directly affect the central nervous system and immune system within the human body. Some cannabinoids are psychoactive, or act on the brain and have the potential to alter mood or consciousness. Two of the primary active cannabinoids within the marijuana plant are THC and cannabidiol (CBD).
Clinical trials on the medical effectiveness of marijuana are extremely limited due to the fact the federal government considers the marijuana plant to be dangerous and to have no medical benefits. As such, researchers must meet a myriad of requirements prior to gaining approval to conduct clinical research. Federal regulations currently require investigators seeking to conduct clinical trials with marijuana to gain approval from the U.S. Food and Drug Administration, the U.S. Drug Enforcement Administration, and the U.S. National Institute on Drug Abuse. In addition, approved protocols may only utilize marijuana supplied by the University of Mississippi, the sole provider of cannabis for federally approved research. An additional regulatory requirement mandating that the U.S. Public Health Service review all clinical protocols was eliminated in June 2015.
Results
from the limited research on the medicinal properties and adverse
effects of marijuana suggests that cannabinoids, the active
ingredient in the marijuana plant, are associated with improved
symptoms of patients with a variety of clinical indications, though
not all associations have yielded statistically significant results.
For example, some studies provide limited evidence that cannabinoids
may be beneficial for conditions such as spasticity due to multiple
sclerosis, and chronic neuropathic and cancer pain.
CUA and MMP. On November 5, 1996, the voters of California approved Proposition 215, a landmark initiative that allowed for the statewide medical use of marijuana for the first time in the history of the nation. Proposition 215, also referred to as the CUA, protects California physicians from prosecution for recommending marijuana to a patient for medical purposes, and protects qualified patients and primary caregivers from prosecution related to the possession or cultivation of marijuana. The CUA also makes findings and declarations on: the right of seriously ill Californians to obtain and use marijuana for medical purposes when appropriate and recommended by a physician; ensuring that qualified patients and primary caregivers are not subject to criminal prosecution or sanction; and, encouraging the federal and state government to implement a plan to provide for the safe and affordable distribution of marijuana to all in-need patients. Although allowed by law, the CUA does not explicitly grant the California State Legislature the authority to amend or repeal any provisions within the CUA without submitting the change to voters; thus any amendments to the CUA by the Legislature without approval of the voters would be deemed unconstitutional.
In
an effort to increase access to MM by qualified patients and primary
caregivers, and to provide protections to qualified patients and
primary caregivers from prosecution for the possession and
cultivation of MM, California enacted SB 420 (Vasconcellos), Chapter
85, Statutes of 2003, which established the MMP. The MMP, among
other things, provides for the creation of a voluntary program for
the issuance of MM identification cards to qualified patients. The
MM identification cards are intended to help law enforcement officers
identify and verify that cardholders are able to cultivate, possess,
and transport certain amounts of marijuana without being subject to
arrest. The MMP also creates protections for qualified patients and
primary caregivers from prosecution for the formation of collectives
and cooperatives for MM cultivation. The MMP sets a cap on the
maximum amount of MM a qualified patient or primary caregiver can
possess and the maximum number of plants each can grow; and,
authorized the California Attorney General to adopt guidelines to
ensure the security and non-diversion of MM. In 2008, Attorney
General Brown released guidelines that affirm
the legality of MM collectives and cooperatives, but make clear that
such entities cannot be operated for profit, may not purchase
marijuana from unlawful sources, and must have a defined
organizational structure that includes detailed records proving that
users are legitimate patients.
Although
the MMP expanded upon the CUA and provided California with some of
its first guidelines regarding MM activity, it did not explicitly
provide for robust state regulations or sanctions related to MM
activity. As a result, MM activity through collectives and
cooperatives has expanded nearly uncontrollably throughout
California, regulated only by local agencies and governments, and
leaving the state with a plethora of patchwork standards for MM
activity.
Federal Controlled Substances Act (CSA). At the federal level, marijuana remains classified as a Schedule I substance under the CSA, making distribution of marijuana a federal offense. Adopted in 1970, the CSA established a federal regulatory system designed to combat recreational drug abuse by making it unlawful to manufacture, distribute, dispense, or possess any controlled substance. Federal law defines a Schedule I substance as any drug or substance having a high potential for abuse, no accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision. Other Schedule I substances include specific types of opiates, opium derivatives (e.g. heroin), and hallucinogenic substances (e.g. lysergic acid diethylamide, commonly referred to as LSD).
The
guidelines published by the California Attorney General, as a result
of compliance with the MMP, state the incongruity between federal and
state law has given rise to confusion, but no legal conflict exists
merely because state law and federal law treat marijuana differently.
Although California’s MM laws have been challenged in court on the
basis that they are preempted by the CSA, these cases have been
unsuccessful. The California Attorney General’s guidelines clarify
that neither Proposition 215, nor the MMP, conflict with the CSA
because, in adopting these laws, California did not legalize MM, but
instead exercised the state’s reserved powers to not punish certain
marijuana offenses under state law when a physician has recommended
its use to treat a serious medical condition. In light of the fact
that the state has decided to remove the use and cultivation of
physician-recommended marijuana from the scope of the state’s drug
laws, the California Attorney General’s guidelines recommend that
state and local law enforcement officers not arrest individuals or
seize marijuana under federal law when the officer determines from
the facts available that the cultivation, possession, or
transportation is permitted under California’s MM laws.
Case law surrounding California’s marijuana laws. The Legislature enacted SB 420 in part to clarify the CUA. As part of its provisions, SB 420 limited the amounts of MM that were allowed to be possessed and cultivated legally to eight ounces of dried marijuana and either six mature or 12 immature marijuana plants, respectively. However in People v. Kelly (2010) 47 Cal.4th 1008, the California Supreme Court ruled that the state government is no longer allowed to impose any legal limits on the amount of marijuana that MM users can grow or possess, on the grounds that SB 420 amended Proposition 215, and the California Constitution prohibits legislative tampering with ballot initiatives approved by voters, unless explicitly allowed by the initiative.
The
California Supreme Court also granted review in several cases related
to the rights of qualified patients and dispensaries, specifically on
the legality of local rules regarding the operation and location of
dispensaries and cultivation sites. In 2013, in City of Riverside
v. Inland Empire Patients Health and Wellness Center, Inc. (2013)
Ct.App. 4/2 E052400, the Supreme Court of California ruled that the
state’s MM statutes do not preempt a local ban on facilities that
distribute MM. Later that year, in Maral
v. Live Oak
(2013) Ct.App. 3 C071822,
an appellate court decision ruled that cities and counties are
permitted to prevent patients from growing their own medicine,
despite the fact that it is allowed under state law. The results of
these cases inevitably have a significant impact on the degree of
local control that would be granted by the state in any statewide
regulatory framework for MM activity.
MBC guidelines. In its most recent guidelines, updated in October 2014, the MBC clarifies that physicians who recommend MM to their patients will not be subject to investigation or disciplinary action by the MBC, as long as they arrive to the recommendation in accordance with accepted standards of medical responsibility. The accepted standards include having a history and performing an appropriate prior examination of the patient; developing a treatment plan with objectives; providing appropriate consent to the patient; providing periodic review of the treatment’s efficacy; providing consultation, as necessary; and, maintaining proper medical records. The guidelines further clarify that although making a recommendation to a patient in writing may trigger federal action against a physician, it does not instigate any action by the MBC.
Guidance from the United States Department of Justice (USDOJ). Federal guidance on the issue of enforcement of the marijuana industry has vacillated to a certain extent in recent history. In October of 2009, the USDOJ sent a memo, known as the Ogden Memo, to federal prosecutors encouraging them to make efficient and rational use of its limited investigative and prosecutorial resources when pursuing prosecution of individuals who engage in MM activity. The 2009 memo stated that although prosecution of significant traffickers of illegal drugs, including marijuana, remains a core priority for the USDOJ, it encouraged them to not focus federal resources on individuals whose actions are in clear and unambiguous compliance with existing state laws providing for the medical use of marijuana, such as those individuals with cancer or other serious illnesses who use marijuana as part of a recommended treatment regimen consistent with applicable state law.
Two
years following the Ogden Memo, the USDOJ published the 2011 Cole
Memo to provide clarification to the previous memo. This second memo
reasserted the federal government’s authority and intent to
prosecute marijuana-related activity. The 2011 Cole Memo
acknowledged the increase in scope of commercial cultivation, sale,
distribution, and use of marijuana for purported medical purposes,
stating the Ogden Memo was never intended to shield such activities
from federal enforcement action and prosecution, even where those
activities assert to comply with state law. It further clarified
that any persons who are in the business of cultivating, selling, or
distributing marijuana are in violation of the CSA, regardless of
state law, clearing stating federal officials’ position that MM
dispensaries should not be given legal shelter.
In
August of 2013, the USDOJ announced its
most recent update to their marijuana enforcement policy, the 2013
Cole Memo, with a much more progressive shift in attitude towards
marijuana-related activity. The 2013 Cole Memo asserts that while
marijuana remains illegal federally, the federal government is less
likely to enforce marijuana-related activity in states that have
enacted laws legalizing marijuana in some form, and have also
implemented strong and effective regulatory and enforcement systems
to control the cultivation, distribution, sale, and possession of
marijuana. However the USDOJ still reserves the right to challenge
state policies at any time it feels it is appropriate and necessary.
In
an effort to provide guidance to states in their creation of robust
systems that affirmatively address the federal government’s primary
concerns related to MM, the 2013 USDOJ memo outlined the following
eight priorities for enforcement related to marijuana:
Preventing the distribution of marijuana to minors;
Preventing revenue from the sale of marijuana from going to criminal enterprises, gangs, and cartels;
Preventing the diversion of marijuana from states where it is legal under state law in some form to other states;
Preventing state-authorized marijuana activity from being used as a cover or pretext for the trafficking of other illegal drugs or other illegal activity;
Preventing violence and the use of firearms in the cultivation and distribution of marijuana;
Preventing drugged driving and the exacerbation of other adverse public health consequences associated with marijuana use;
Preventing the growing of marijuana on public lands and the attendant public safety and environmental dangers posed by marijuana production on public lands; and,
Preventing marijuana possession or use on federal property.
The
2013 Cole memo further suggested that the existence of a strong and
effective state regulatory system and a marijuana operation’s
compliance with such a system may allay the threat that an
operation’s size poses to federal enforcement interests, and
encouraged federal prosecutors to review marijuana cases on a
case-by-case basis, and consider whether or not the operation is in
compliance with a strong and effective state regulatory system prior
to prosecution.
To
date, existing law in California does not provide for a robust and
effective state regulatory system for MM; it merely provides limited
protections to qualified patients and primary caregivers from
prosecution. Because existing state law does not prohibit local
jurisdictions from enacting ordinances related to MM activity,
several local jurisdictions have established their own policies
regarding MM activity, which are not all fully consistent or
compliant with the priorities outlined in the 2013 Cole Memo.
Marijuana policies in other states. As of 2015, 23 states, the District of Columbia, and Guam allow for MM programs. Although California was the first to allow for the medical use of marijuana, it remains the only state that allows its use without a robust state regulatory framework. States with MM laws generally have some form of patient registry, which may provide some protection against arrest for possession up to a certain amount of marijuana for personal medicinal use. A limited number of states restrict MM usage to products with low to zero THC and high CBD concentrations, in an effort to more strictly limit the use of THC, known for its psychoactive effects.
Medical vs. recreational use. To date, only Alaska, Colorado, Oregon, Washington, and the District of Columbia have legalized the use of recreational marijuana. According to the Brookings Institute, since the early 1990s, U.S. public opinion has trended in favor of marijuana legalization. Since 2010, support for marijuana legalization has risen by 11 percentage points. A March 2013 survey conducted by the Pew Research Center found that the majority of Americans support legalization by a seven point margin – 52% to 45%.
The national trend to support marijuana legalization is consistent with recent polls in California, which also demonstrate a majority of residents support the concept. As of the date of publishing of this analysis, there are five recreational marijuana initiatives cleared for circulation by the Secretary of State; one measure relating to marijuana is pending title and summary with the California Attorney General. It is unclear whether or not the initiatives will be combined or will qualify for the ballot, however there is clearly an interest by Californians to submit a framework for recreational marijuana use for the approval of voters in 2016.
In
order for any marijuana scheme – whether for recreational or
medical purposes – to be effective, it should address all parts of
the industry, including establishing a robust licensing and
regulatory scheme, a taxation scheme, and incorporate health and
safety standards, in addition to ensuring that the public is
protected; however, if the measure is too prescriptive, it may hamper
the ability to address any unintended consequences or fill in any
policy gaps without having to go back to the ballot. As a result, if
the State is able to create a comprehensive framework for medical
marijuana, it may also serve a dual role by serving as a basis for a
recreational marijuana scheme.
OPPOSITION. The Fresno Cannabis Association has an oppose unless amended position on this bill, stating this bill would institutionalize and potentially expand the existing patchwork of local jurisdictions that allow and prohibit medical cannabis cultivation and dispensing. The opposition states this bill, as currently written, will leave patients in Fresno County and the Central Valley, who are currently covered by the CUA, with no safe access to cannabis gardens, collectives, or dispensaries. The opposition further asserts that allowing cities and counties to opt out of any and all state regulations that are developed would be bad public policy from a health perspective. The Fresno Cannabis Association states it will oppose this bill unless it is amended to prohibit local bans on medical cannabis dispensaries and/or cultivation.
RELATED LEGISLATION.
AB 26 (Jones-Sawyer) establishes the Medical Cannabis Regulation and Control Act to regulate the cultivation, testing, transportation, distribution, and sale of medical cannabis. AB 26 is currently pending in the Assembly Business and Professions Committee.
AB 34 (Cooley) would have created a comprehensive state licensing and regulatory framework for the cultivation, processing, distribution, testing, and sale of medical cannabis. AB 34 was held in the Assembly Appropriations Committee.
AB 243 (Wood) establishes a new regulatory framework for MM cultivation, authorizing cities and counties to issue or deny a conditional permit for the cultivation of MM. Requires the State Water Resources Control Board to implement an identification program for the monitoring, tracking, and inspection of each MM plant. Imposes a tax on each MM plant to be deposited in the Marijuana Production and Environment Mitigation Fund to be allocated as specified. AB 243 is currently pending in the Senate Committee on Environmental Quality.
AB 258 (Levine), Chapter 51, Statutes of 2015, prohibits the eligibility determination of a patient on the organ transplant waiting list from being based solely on his or her status as a qualified patient for MM, or based solely on a positive test for the use of MM by a qualified patient.
AB 266 (Bonta) establishes a licensing and regulatory framework for medical cannabis under the Medical Cannabis Regulation and Control Act, and establishes the Office of Medical Cannabis Regulation within the Office of the Governor, the Division of Medical Cannabis Regulation within the BOE, the Division of Medical Cannabis Manufacturing and Testing within the DPH, and the Division of Medical Cannabis Cultivation within the CDFA, and would set forth the duties of the respective regulatory authorities. AB 266 is currently pending in the Senate Governance and Finance Committee.
AB 730 (Quirk) provides that a conviction for transportation of marijuana, psilocybin mushrooms or phencyclidine requires proof of intent to sell, as is currently the case for cocaine, heroin and numerous other drugs. AB 730 is currently enrolled and pending review by the Governor.
AB 821 (Gipson) exempts from sales and use taxes the gross receipts from the sale, storage, use, or other consumption of MM for consumption by a terminally ill patient, and requires the purchaser to provide an exemption certificate as provided. AB 821 is currently pending in the Assembly Revenue and Taxation Committee.
AB 849 (Bonilla) makes it a felony for any person to extract THC or any other cannabinoids, by means of solvent extraction, from marijuana and cause an explosion resulting in great bodily injury, or damage to structures, property, or forest land. AB 849 is currently pending in the Senate Public Safety Committee.
AJR 25 (Lackey) memorializes the President and Congress of the United States to support legislation that will provide a comprehensive solution to allow banks and credit unions to perform financial services for marijuana businesses. AJR 25 is currently pending in the Assembly Banking and Finance Committee.
SB 165 (Monning) adds additional crimes or violations to an existing Fish and Game Code statute which authorizes civil fines for certain natural resource-related violations in connection with the production or cultivation of a controlled substance. SB 165 is currently pending in the Assembly Appropriations Committee.
SB 303 (Hueso) permits the destruction of excess seized marijuana by law enforcement agencies, subject to specified evidentiary and preservation requirements. SB 303 is currently pending in the Assembly Public Safety Committee.
PREVIOUS LEGISLATION.
AB 1894 (Ammiano) of 2014 would have established the Medical Cannabis Regulation and Control Act to regulate the cultivation, testing, transportation, distribution, and sale of medical cannabis. AB 1894 would have created the Division of Medical Cannabis Regulation in the Department of Alcoholic Beverage Control (ABC) and would have given ABC authority to register persons for specified activities relating to medical cannabis and to collect registration fees. AB 1894 was held on the Assembly Floor.
SB 1262 (Correa) of 2014 would have created a licensing and regulatory framework for the cultivation, transportation, testing, and sale of MM, administered by the Bureau of Medical Marijuana Regulation in the Department of Consumer Affairs. SB 1262 was held in the Assembly Appropriations Committee.
AB 473 (Ammiano) of 2013 would have created the Division of Medical Marijuana Regulation and Enforcement in order to regulate the cultivation, manufacture, testing, transportation, distribution, and sale of MM. AB 473 was held on the Assembly Floor.
AB 604 (Ammiano) of 2013 was gutted and amended from a different subject matter and would have enacted the Medical Cannabis Regulation and Control Act. AB 604 was never heard by the Senate Public Safety Committee.
AB 2312 (Ammiano) of 2012 would have established the Medical Marijuana Regulation and Control Act, authorizing local taxes on medical cannabis and creating a board to regulate the medical cannabis industry. AB 2312 was never heard by the Senate Committee on Business, Professions and Economic Development.
AB 1300 (Blumenfield), Chapter 196, Statutes of 2011, provides that a local government entity may enact an ordinance regulating the location, operation or establishment of a MM cooperative or collective; authorizes local government entity to enforce such ordinances through civil or criminal remedies and actions; and authorizes a local government entity to enact any ordinance that is consistent with the MMP. AB 1300 did not directly regulate MM facilities.
SB 626 (Calderon) of 2011 would have required the Board of Equalization (BOE) to establish a nine-member task force to conduct a study to determine ways to enhance collections of sales and use taxes on retail sales of marijuana and ensure proper regulation of the cultivation, transportation, and distribution of marijuana and marijuana products. SB 626 was held in the Senate Appropriations Committee.
AB 390 (Ammiano) of 2009 would have legalized the possession, sale, cultivation, and other conduct relating to marijuana and required ABC and enforce the terms of legalized marijuana. AB 390 was never heard by the Assembly Health Committee.
SB 1098 (Migden) of 2007 would have required the BOE to administer a tax amnesty program, for MM dispensaries, as defined. SB 1098 was never voted on by the Senate Revenue and Taxation Committee.
SB 420 (Vasconcellos) Chapter 875, Statutes of 2003, establishes the Medical Marijuana Program Act, a statewide, voluntary program for the issuance of identification cards to identify persons authorized to engage in the medical use of marijuana under the CUA.
Proposition 215, of the November 1996 General Election, prohibits prosecution for the possession and cultivation of cannabis by a patient or a patient's primary caregiver with a physician's written or oral recommendation.
CHAPTERING OUT. As currently written, this bill and AB 266, currently pending in the Senate Governance and Finance Committee, amend the same code sections. Amendments should be taken to avoid chaptering out conflicts, should both bills be enacted.
AUTHOR’S AMENDMENTS. The author is proposing a number of amendments to this bill. A portion of the amendments are technical cleanup language. Another part of the author’s proposed amendments are in an effort to address some of the concerns brought up by the Assembly Business and Professions Committee, including clarifications to labeling and packaging requirements, an extension to the immunity provided to collectives and cooperatives prior to the issuance of conditional licenses, and the establishment of testing standards by the Office. The author’s remaining proposed amendments eliminate references to city taxing authority, limit the length of time for which a conditional license may be renewed, and specify in the definitions that a licensed entity is one that is both conditionally licensed by the state and maintains a local license or permit. These changes are reflected in the mock-up associated with this analysis.
TECHNICAL AMENDMENTS. This bill establishes a statewide framework for the MM industry. However there are a number of instances in which this bill’s provisions refer to marijuana rather than MM. The Committee may suggest amending this bill to ensure consistency throughout the language and uphold the intent of the author to address the MM industry, rather than influence recreational activity. This bill also regulates both MM and MM products, however the language does not consistently regulate both types of commodities. The Committee may suggest amending this bill to regulate MM and MMP, as relevant, consistently throughout the language. In addition, this bill’s provisions contain references to definitions, such as “labor peace agreement,” which are not used at all in the rest of the language. The Committee may suggest amending this bill to delete unnecessary definitions and clauses.
RECOMMENDED AMENDMENTS. This bill establishes a statewide regulatory structure for the MM industry from the ground up. In order to ensure this bill meets the original intent of the author, the Committee may suggest a number of amendments the author may want to consider to strengthen current provisions within the language.
Appointments by the Governor vs. civil service employees. This bill requires the Governor to appoint the Chief, subject to confirmation by the Senate Committee on Rules. The Chief is then required to serve in accordance with State Civil Service Act. Under existing law, civil service employees cannot be subject to confirmation by the Legislature. This bill grants the Chief with the great authority to enforce and administer the Act, and adopt and enforce all rules and regulations necessary to implement the Act. As such, the Committee may suggest amending this bill to strike provisions requiring the Chief to be a civil service employee and maintain provisions requiring the Governor to appoint the position, subject to confirmation by the Senate, as is customary with similar positions appointed by the Governor.
Availability of records. This bill requires records of all facilities issued conditional licenses and authorizes access to those records by state and local law enforcement. However, state and local agencies, other than law enforcement, may need to access these records in order to properly perform their duties to enforce the chapter. The Committee may suggest amending this bill to allow state and local agencies equal access to the records of all facilities issued conditional licenses.
Organic marijuana. This bill requires, no later than January 1, 2022, for all MM grown, produced, distributed, and sold in the state to meet certified organic standards. Organic is a labeling term that indicates that the food or other agricultural product has been produced through approved methods. In order to sell, label, or represent their products as organic, operations must follow all of the specifications set out by the USDA organic regulations. As marijuana is currently listed as a Schedule I drug under federal law, the USDA does not recognize marijuana has a legal crop, and therefore cannot certify marijuana as organic. The Committee may suggest amending this bill to require all MM under this Act to meet standards equivalent to those for certified organic products, as certified by the Office or an independent third party.
Exemption for the City of Los Angeles. The author indicates the intent of this bill is to provide comprehensive regulations for the MM industry throughout the state, yet this bill currently leaves a large loophole within the framework of the regulatory structure. This bill exempts all marijuana businesses and dispensaries subject to Measure D, approved by the voters of the City of Los Angeles on the May 21, 2013 ballot for the city, from the regulations and provisions of this bill. Measure D grandfathered existing medical marijuana businesses and dispensaries but does not allow the City to license the businesses or allow new businesses.
In addition, as currently written, this bill does not provide any means for the state to track MM and MM products to ensure that they are not being illegally diverted into or out of the City of Los Angeles. This bill also limits entities holding a license from the state to engaging in MM activity only with entities that also hold a license from the state. Accordingly, any entity that holds a license from the state that engages in MM activity with an entity within the City limits is thereby participating in illegal activity.
Measure D prevents the City of Los Angeles from issuing licenses to
MM businesses; however nothing prohibits the state from issuing its
own licenses to qualifying applicants from the City. The Committee
may suggest amending this bill to allow the Office to issue licenses
to those MM businesses that are legally allowed to operate within the
City of Los Angeles, and make appropriate changes to ensure these
businesses are required to follow all requirements of the Act, in
order to close gaps in protections currently created by the
language.
Suitability for licensure. This bill provides for a conditional license to be denied, suspended, or revoked for a past felony conviction for the possession for sale, manufacture, transportation, or cultivation of a controlled substance, or a felony criminal conviction for drug trafficking, among others. However, this bill exempts, as a reason for denial of licensure, a prior conviction for a felony that was committed after the enactment of the CUA, but which would not be a felony after the enactment of this bill. This bill does not change any existing felonies or constitute resentencing, but instead provides that the actions of a licensee, in compliance with the law and its regulations, are not in and of themselves unlawful. The Committee may wish to consider that it would not be possible for the actions committed by individuals prior to the existence of a licensing scheme to be in full compliance with the Act, as full compliance requires licensure, and suggests amending this bill to clarify the intent.
Talking straight with consumers. This bill requires advertisements for physician recommendations to bear a notice to consumers that educate consumers on the intent of the CUA and physician credentials. The requirement of a consumer notice implies there is a need to warn them about issues related to MM recommendations. Yet the notice is silent on the fact that marijuana is currently listed as a Schedule I drug in the CSA, and federal officials still have the authority to prosecute against individuals, with the authority to charge felonies, for engaging in marijuana-related activities. The Committee may suggest amending this bill to clarify to consumers that they are still subject to prosecution by the federal government for marijuana-related activities, even if recommended marijuana by a physician.
Tax provisions. This bill authorizes counties to impose specified taxes on MM licensees within their jurisdictions. As currently written, the language does not specify the types of taxes that may or may not be imposed, and provides limited flexibility in methods for the collection of taxes. Additional clarity is also needed as to the location of which the tax applies. The Committee may suggest amending this bill to appropriately clarify these provisions.
Enforcement by the Office. The bill authorizes civil penalties but does not allow them to be levied administratively. Allowing the office to levy penalties after an administrative proceeding should make carrying out enforcement actions considerably easier. The Committee may suggest amending this bill to explicitly allow the office to conduct administrative enforcement actions.
Medical records. This bill requires the Office to ensure the confidentiality of patient information that it keeps for administrative purposes. Existing law provides extensive protections to patient medical records. In order to ensure full safeguards are guaranteed to MM patients, the Committee may suggest amending this bill to require all patient records to be held and protected by the Office in accordance with existing state and federal law.
Equal mandates for licensees. This bill requires a licensed cultivation site to display the state license in a manner so as to be available and easily read at the location; this signage requirement is not mandatory for other licensees. The Committee may suggest amending this bill to have signage, and all other relevant, mandates applied consistently to all licensees.
Edible MM facilities. This bill provides some requirements for licensed facilities that manufacture edible MM products, yet does not require these facilities to follow any statutory requirements of other food facilities. Existing law requires food facilities to abide by laws within the California Retail Food Code, which was established to safeguard public health and provide to consumers food that is safe, unadulterated, and honestly presented through adoption of science-based standards. Licensure as a MM facility that conducts business with food should not exempt these facilities from standards required for non-MM food facilities. The Committee may suggest amending this bill to clarify MM facilities are not exempt from relevant health and safety standards, and require all licensed food-related MM facilities to abide by standards and regulations equivalent to those in the California Retail Food Code.
POLICY COMMENTS. This bill establishes a licensing and regulatory scheme for MM, from cultivation to retail. This bill creates a new state agency, directing it to promulgate, implement, and enforce all necessary rules, regulations, and standards for the Act. As this bill creates a structure for an entirely new industry, there are a number of outstanding issues that the Committee should consider addressing in order to ensure the success of the regulatory scheme, should this bill be enacted into law.
Hazy definitions. This bill requires individuals who intend to engage in MM activity within the state to apply to the Office for a license from the state. This bill’s provisions refer to the license acquired from the state as a conditional license. However, the term “conditional” is a misnomer. All licenses issued by the state are conditional by nature; the privilege of holding any license from the state is conditioned upon following the laws relevant to that license. For example, individuals who hold a driver’s license only maintain their license if they follow the state’s rules of the road. Thus the Committee may wish to consider if the language should be amended to clarify references to licenses.
This bill also establishes requirements for all applicants for
licensure by the state. However it is unclear whether a licensee can
be either a person or a facility; the requirements for an applicant
appear to refer to a person, yet other bill provisions refer to both
licensed individuals and licensed facilities. The Committee may wish
to consider clarifying this bill’s provisions to explicitly define
what entities or persons can qualify for licensure under the Act.
One agency vs. multiple agencies. This bill builds a new state office from the ground up, and tasks it with establishing, implementing, and enforcing standards and regulations for an entirely new industry within the state; thus this bill creates a regulatory structure unlike any other for a single agricultural product. The establishment of a brand new state office is highly resource-intensive in terms of time, labor, and cost. The state currently regulates and enforces non-MM industries using multiple agencies that specialize in specific parts of each industry. The Committee may wish to consider whether it is appropriate to task one office with all of the responsibilities set forth in this bill or if it would be more appropriate to spread out the responsibilities among existing agencies that already have expertise in promulgating, implementing, and enforcing similar regulations as those required by this bill.
Getting advice from experts. This bill requires the Office to promulgate a myriad of regulations and standards to implement this Act. Given the breadth of experience and the significant resources that will inevitably be necessary to promulgate and enforce the rules, standards, and regulations required by this bill – from standards for health and safety to best practices for environmentally-friendly cultivation – the Committee may suggest amending this bill to require the Office to convene an advisory committee to provide the Office with necessary expertise from stakeholders in the MM industry, assist with the promulgation of regulations, and provide technical assistance regarding implementation and enforcement of the Act. The Committee may suggest the advisory committee be comprised of gubernatorial and Legislative appointments including, but not limited to, representatives from local and state agencies, public health and environmental experts, patient advocates, physicians, MM industry experts, and law enforcement.
The Office: Good cop and bad cop. This bill requires the Office to promote the MM industry by upholding the CUA and recognizing marijuana as a medicine to patients. Simultaneously, the Office is charged with establishing protections, collecting fees, and otherwise enforcing the provisions of the Act. The responsibilities of both promoting and enforcing the MM industry are inherently contradictory; it is unlikely that any single entity would be able to meet the obligations of both at equal standards or with equal efficiency. The Committee may wish to consider the ability of the Office to perform both sets of responsibilities equally as well, and the potential consequences of it meeting the duties of one more than the other.
Implementation challenges. This bill leaves nearly all of the administration of the Act to the rulemaking process by requiring the Office to promulgate a multitude of regulations rather than providing a clear, statutory framework. In general, the role of state agencies is to implement policies that are enacted by the Legislature, rather than determine what those policies should be. The process of promulgating regulations by a state agency can be time-consuming depending on the complexity of the issue, and given requirements for notification, public comment, and additional delays that arise when amendments to proposed regulations are made. Furthermore, the regulatory process has been criticized heavily for lacking the transparency and robust stakeholder input that the legislature process allows for. As such, the Committee may wish to consider whether or not it is in the best interest of the state to delegate all rulemaking to the Office, or to instead provide basic fundamental standards and guidelines, which the Legislature can have a voice in crafting, within this bill’s provisions.
Protections against poorly-performing locals. As currently written, this bill does not provide protections against local jurisdictions that do not have proper standards within their local ordinances or fail to adequately enforce local and state standards. For example, if locally licensed cultivation site is polluting the areas, should not the Office be able to act? The Committee may wish to consider if the provisions of this bill provide adequate protections against local ordinances or enforcement actions that do not meet the principles intended by the Office or this bill.
Protections for existing MM businesses. This bill does not provide any protections for existing MM businesses from January 1, 2016, the date this bill would become enacted, through June 30, 2018, the date before the Office is required to begin issuing licenses. As such, state and local agencies could potentially take civil and criminal actions against MM businesses during this timeframe. It is an unusual circumstance to subject an entity to civil and criminal penalties for an activity that will be legal in three years. The Committee may wish to consider amending this bill to address this concern.
Sufficient environmental protection? This bill establishes the Medical Marijuana Public Safety and Environmental Protection Act, and declares that all efforts must be made to prevent and mitigate the harmful environmental impacts that can be associated with some marijuana cultivation. Furthermore, the author points to the negative effects that the lack of regulations on the MM industry has had on the environment, particularly in California’s northern counties. Yet this bill is silent on specific standards that conditional licensees must meet and abide by to ensure environmental protections with regard to MM cultivation. The Committee may wish to consider whether or not this bill provides sufficient guidelines and standards to ensure adequate environmental protections regarding MM activity to meet the bill’s original intent.
Adequate consumer protection? This bill currently lacks guidelines on consumer protections. Of particular concern is the absence of guidelines for strict testing standards and regulations, which could potentially threaten the health of patients if not thoroughly articulated by the Office. This bill also does not expressly prohibit an individual from obtaining a license for both testing and any other license type. Without an explicit prohibition on the ability for an individual to hold a testing license in conjunction with any other license type, the language provides a loophole to the regulatory structure which could negatively impact health and safety protections for patients. The Committee may wish to consider, given the severity of the negative impacts the lack of regulation has had on the state, whether it is appropriate to provide no guidance to the Office and other responsible entities in this bill on the standards required by this bill.
The one notable exception to the lack of guidance by this bill’s provisions is in the area of edible MM products; this raises the question of why minimum standards have been provided in the language for these commodities, but have not been established for other commodities, such as those developed by extraction methods, which contribute to one of the fastest growing sectors within the MM market.
Whistle blowing or just indiscrete? This bill declares that nothing prevents an Office employee from disclosing information, including that related to fraud or violations of the Act, to state or local agencies. Oftentimes investigations of illicit activity require certain confidentiality so as to not compromise the entire operation. The Committee may wish to consider the appropriateness of granting Office employees the right to release information that could be confidential and relevant to an investigation, particularly to other state and local agencies that are not related to law enforcement.
Furthermore, although this bill allows for Office employees to act as
whistle blowers, it currently offers no protections to those who do.
If this ability to disclose is important, the Committee may wish to
consider amending the bill to provide sufficient protections to
individuals who provide more transparency or information to
authorities in specified circumstances.
Limited state revenues. This bill currently only provides revenue to the state by depositing penalties imposed upon non-compliant individuals into the GF. Although the language allows the Office to assist state taxation authorities to develop policies for state taxation, it does not explicitly provide for a state tax. The MM industry currently generates millions of dollars, with some industry supporters estimating it has the potential to produce billions of dollars in the future. The Legislature is granting local governments the first crack at taxing this revenue base. The Committee may wish to consider amending this bill to impose a state tax in the regulatory structure to provide the state with much needed monies to the GF.
Geographic branding for marijuana. This bill requires the Office to establish appellations of origin for marijuana grown in California. An appellation of origin is a geographic indication, generally consisting of a geographical name or a traditional designation, used on products which have a specific quality or characteristics that are from the geographic environment in which they are produced. Consumers are familiar with these products and often request them using their geographical name. Common examples include food and beverages such as Gruyère cheese, Champagne, and Tequila, all of which are products named for their origin, and they enjoy legal protection for their names and reputations. Geographic branding is rarely used for medical products, if at all. In addition, appellation systems are used throughout the world and require laborious standards and enforcement. The Committee may wish to consider the feasibility and need for the Office to create and enforce a system to brand a medical product based on its geographic origin.
REGISTERED SUPPORT / OPPOSITION:
Support
None on file.
Opposition
Fresno Cannabis Association
Analysis Prepared by: An-Chi Tsou / HEALTH / (916) 319-2097
SB 643
Page 26
Date of Hearing: July 7, 2015
ASSEMBLY COMMITTEE ON BUSINESS AND PROFESSIONS
Susan Bonilla, Chair
SB 643
(McGuire) – As Amended June 3, 2015
SENATE VOTE: 26-13
SUBJECT: Medical marijuana
SUMMARY: Establishes a comprehensive licensing and regulatory framework for the cultivation, manufacture, transportation, storage, distribution, and sale of medical marijuana to be administered by the Office of Medical Marijuana Regulation within the Business, Consumer Services, and Housing Agency.
EXISTING LAW:
Recognizes the authority of cities and counties to make and enforce, within their borders, all local, police, sanitary, and other ordinances and regulations not in conflict with general interest laws. (Cal. Const. Article XI sec. 7)
Prohibits the possession, possession with intent to sell, cultivation, sale, transportation, importation, or furnishing of marijuana, except as otherwise provided by law. (Health and Safety Code (HSC) Sections 11357, 11358, 11359, and 11360)
Prohibits prosecution of a patient or a patient’s primary caregiver, under the Compassionate Use Act of 1996 (CUA), an initiative measure, for possessing or cultivating marijuana for personal medical purposes of the patient upon the written or oral recommendation or approval of a physician. (HSC Section 11362.5)
Licenses and regulates physicians and surgeons, including osteopathic physicians, under the Medical Practice Act (Act) by the Medical Board of California (MBC) within the DCA. (Business and Professions Code (BPC) Section 2000 et seq.)
Defines "attending physician" as an individual who possesses a license in good standing to practice medicine or osteopathy issued by the Medical Board of California (MBC) or the Osteopathic Medical Board of California (OMB) and who has taken responsibility for an aspect of the medical care, treatment, diagnosis, counseling, or referral of a patient and who has conducted a medical examination of that patient before recording in the patient’s medical record the physician’s assessment of whether the patient has a serious medical condition and whether the medical use of marijuana is appropriate. (HSC Section 11362.7(a))
Defines "primary caregiver," for purposes of the CUA, as the individual designated by a patient who has consistently assumed responsibility for the housing, health, or safety of that person. (HSC Section 11362.7(d))
Requires the California Department of Public Health to establish and maintain a voluntary Medical Marijuana Program for qualified patients to apply for identification cards, and county health departments to issue identification cards to qualified patients and their caregivers. (HSC Section 11362.7 et seq.)
Provides that qualified patients, persons with valid identification cards, and their designated primary caregivers who associate in order to collectively or cooperatively to cultivate marijuana, are not subject to criminal liability solely on that basis. (HSC Section 11362.775)
THIS BILL:
Administrative Provisions
Defines the following terms:
"Licensed cultivation site" as a facility that plants, grows, cultivates, harvests, dries, or processes medical marijuana and that is issued a conditional license.
"Licensed dispensing facility" as a dispensary or other facility that provides MM, MM products, or devices for the use of medical marijuana or medical marijuana products that is issued a conditional license.
"Licensed manufacturer" as a person who extracts, prepares, derives, products, compounds, or repackages medical marijuana or medical marijuana products into consumable and nonconsumable forms and that is issued a conditional license.
"Licensed transporter" as an individual or entity issued a conditional license to transport medical marijuana to and from facilities that have been issued conditional licenses or medical marijuana products above a quantity limit, as specified.
Establishes the Office of Medical Marijuana Regulation (Office) in the Business, Consumer Affairs, and Housing Agency, under the supervision and control of the Chief of the Office.
Provides the Office with the authority to issue, suspend, or revoke conditional licenses for the cultivation, manufacture, transportation, storage, distribution, and sale of medical marijuana in the state and to collect fees in connection with these actions, and to create, issue, suspend, or revoke other licenses in order to protect patient health and the public and to facilitate the regulation of medical marijuana.
Requires the Chief to be appointed by the Governor, subject to Senate confirmation.
Requires funds for the establishment and support of the Office to be advanced as a loan from the General Fund, to be repaid by the initial proceeds from fees collected pursuant to this bill or any regulations adopted by this bill.
Provides the Office with the authority to implement this bill, including the authority to:
Establish necessary rules and regulations, in accordance with the Administrative Procedure Act, and subject to local control, as specified.
Set application, licensing, and renewal fees for conditional license.
Establish standards for the cultivation, manufacturing, transportation, storage, distribution, provision, donation, and sale of medical marijuana and medical marijuana products.
Establish procedures for the issuance, renewal, suspension, denial, and revocation of conditional licenses.
Enforcing the licensing and regulatory requirements of this bill, subject to provisions of the bill specifying enforcement.
Imposing a penalty authorized by these provisions or any regulations adopted pursuant to these provisions.
Taking action with respect to an application for a commercial license, as specified.
Overseeing the operation of the Medical Marijuana Regulation Fund and the Special Account for Environmental Enforcement, as specified.
Consulting with other state or local agencies, departments, representatives of the medical marijuana community, or public or private entities for the purposes of establishing statewide standards and regulations.
Requires the Office, on or before January 1, 2018, to promulgate regulations for implementation and enforcement, including:
Procedures for the issuance, renewal, suspension, denial, and revocation of conditional licenses.
Procedures for the appeal of fines and the appeal of denial, suspension, or revocation of conditional licenses.
Application, licensing, and renewal forms and fees.
A time period in which the Office shall approve or deny an application for a conditional license.
Qualifications for licensees.
Requires the Office, in consultation with the Division of Labor Standards Enforcement, to adopt regulations establishing worker safety standards for licensed entities.
Prohibits the Office from issuing a conditional license unless the applicant meets all application requirements, as specified, and has demonstrated compliance with all applicable agricultural, consumer protection, food and product safety, and environmental requirements, including applicable water quality standards.
Requires the Chief to keep a complete record of all facilities issued a conditional license, which shall be made available on the Office's website.
Prohibits the Office from disclosing sensitive information, including the address or location of cultivation sites.
Requires the Office to provide summary information on all licensees including the name, the date the license was issued, the status of the license, and the licensee's mailing address.
Requires the Office to establish procedures to provide state and local law enforcement, upon their request, with 24-hour access to information to verify a conditional license, track transportation manifests, and track the inventories of facilities issued a conditional license.
Immunity and Exemptions
Provides that these provisions do not supersede the provisions of Measure D, approved by the voters of the City of Los Angeles on the May, 21, 2013, ballot for the city, or any similar measure in other jurisdictions, which grants medical marijuana businesses and dispensaries qualified immunity consistent with the terms of the measure and local ordinances, as specified.
Exempts from these provisions:
Patients who cultivate, possess, store, manufacture, or transport marijuana exclusively for his or her personal medical use and who do not sell, distribute, donate, or provide marijuana to another person or entity.
Primary caregivers who cultivate, possess, store, manufacture, or transport marijuana exclusively for the personal medical use of no more than five qualified patients and who do not receive renumeration for these activities, except as specified.
After July 1, 2017, no longer exempts patients and primary caregivers who engage in medical marijuana activities collectively or cooperatively from criminal prosecution, and instead extends that criminal immunity to an individual employee, officer, or board member of a facility issued a conditional license, as specified.
Conditional Licensing Provisions
Prohibits the sale or provision of medical marijuana to a patient or caregiver other than through a licensed dispensing facility or delivery from a licensed dispensing facility; the growth of medical marijuana other than at a licensed cultivation site; the manufacturing of medical marijuana or medical marijuana products other than by a licensed manufacturer; and the transportation of medical marijuana other than from one licensed facility to another. Authorizes a licensed manufacturer to obtain medical marijuana from a licensed cultivator, and to furnish medical marijuana to a licensed dispensary.
Requires the Office, no later than July 1, 2018, to provide for and issue conditional licenses, which are required for all activities, including cultivation, processing, storage, transport, and dispensing of medical marijuana.
Provides that the issuance of a conditional license does not authorize a recipient to begin business operations, and instead only certifies that the applicant has paid the state license fee, successfully passed a criminal background check, and met the state residency requirements.
Prohibits a conditionally licensed facility from commencing activities until the applicant also obtained a license or permit from a local jurisdiction in which he or she proposed to operate, following the requirements of local ordinances.
Requires an applicant to do the following:
Pay the fee and register on forms prescribed by the Chief, and provide the following information:
Name of all persons or entities having an ownership interest, as specified, and the name, address, and date of birth of each principal officer and board member.
Address and telephone number of the facility, and for cultivation sites, the GPS coordinates.
Describe the scope of business.
Provide evidence that the applicant and the owner have been legal full-time residents of the state for not less than 12 months.
Provide detailed operating procedures, including procedures for facility and operational security; prevention of diversion; employee screening; storage of MM; personnel policies; and recordkeeping procedures.
Provide evidence that the applicant has received all required environmental permits, including compliance with the California Environmental Quality Act and wastewater discharge permits.
Provide the applicant's fingerprint images, as specified.
Provide a statement signed under penalty of perjury that the information provided is true.
Requires each location and discrete use of a single location to obtain a conditional license, and provides that each application for a conditional license is separate and distinct.
Provides that a conditional license is valid for 12 months, and after the initial 12-month period, may be renewed for a period of 36 months.
Prohibits the Office from issuing a conditional license to a person or entity against whom there is a pending enforcement case under a local ordinance, or who has been determined to have violated an applicable local ordinance, as specified.
Authorizes a facility or entity that is operating in conformance with local zoning ordinances and other requirements on the effective date of this bill to continue its operations until its application for conditional licensure is approved or denied.
Authorizes the Office to issue a conditional license and send proof of issuance to an applicant, provided the applicant has not committed an act or crime constituting grounds for the denial of licensure. Requires the Chief, by regulation, to prescribe conditions upon which a person, whose conditional license has previously been denied, suspended, or revoked, may be issued a conditional license.
Requires an application for a conditional license to be denied, and a conditional license suspended or revoked, for a past felony conviction for the possession for sale, sale, manufacture, transportation, or cultivation of a controlled substance, a felony criminal conviction for drug trafficking, a felony conviction for embezzlement, a felony conviction involving fraud or deceit, or any violent or serious felony conviction, as specified.
Provides that a conditional license shall not be denied solely on the basis of a prior conviction for a felony that was committed after the CUA, but which would not be a felony after the enactment of this bill.
Authorizes the Chief to deny, suspend, or revoke a conditional license when a conditional licensee, applicant, or employee, partner, officer, or member of an entity conditionally licensed for specified reasons such as: making untrue or misleading statements; engaging in conduct that constitutes fraud or gross negligence; failing to comply with these provisions or any rule or regulations adopted pursuant to these provisions; or conduct that constitutes grounds for denial of a license pursuant to the Business and Professions Code, as specified.
Sets the following as reasons a conditional license shall not be approved:
The applicant fails to meet requirements of this bill or has had an applicable permit or license revoked or denied by an applicable city, county, or city and county agency. States that if a local government adopts an ordinance or resolution authorizing MM to be cultivated, manufactured, stored, distributed, or sold within its jurisdiction, it shall submit to the Office documentation detailing their renewal requirements.
The applicant, or any of its officers, directors, owners, members, or shareholders, is a minor.
The applicant has knowingly answered a question or request for information falsely on the application form or failed to provide information requested.
The applicant, or any of its officers, directors, owners, members, or shareholders has been sanctioned by the Office, a city, county, or city and county, for MM activities conducted in violation of this part or any applicable local ordinance or has had a license revoked in the previous five years.
The proposed cultivation, processing, possession, storage, manufacturing, testing, transporting, distribution, provision, or sale of medical marijuana will violate any applicable local law or ordinance.
The applicant or the owner is unable to establish that he or she has been a resident of the state for at least 12 months.
Specifies that a conditional license is subject to the restrictions of the local jurisdiction in which the facility operates or proposes to operate. Clarifies that even if a conditional license has been granted pursuant to this part, a facility shall not operate in a local jurisdiction that prohibits the establishment of that type of business. Specifies that local jurisdictions retain the power to assess fees and taxes, as applicable, on facilities that are conditionally licensed and the business activities of those licensees.
Authorizes the Office to adopt regulations to limit the number of conditional licenses issued upon a finding that the otherwise unrestricted issuance of conditional licenses is dangerous to the public health and safety.
Fee Provisions
Sets the conditional licensing fee at a level sufficient to fund the Office's administrative costs (in overseeing the licensing program, in establishing health and safety standards and in certifying testing laboratories), costs incurred by the Office, the Department of Justice, law enforcement, and other public safety entities for enforcing these provisions.
Requires a cultivation facility fee to be assessed, in addition to a conditional licensing fee, set at an amount sufficient to cover the reasonable regulatory costs of enforcing environmental impact provisions of cultivation facilities. Requires this fee to be distributed between the State Water Resources Control Board, Department of Fish and Wildlife, Department of Forestry and Fire Protection, Department of Pesticide Regulation, Department of Food and Agriculture, and local law enforcement, as specified.
Establishes the Medical Marijuana Regulation Fund (Fund) in the State Treasury and states that all fees collected pursuant to the Act shall be deposited into the Fund. Provides that all moneys in the fund are available, upon appropriation, to the Office solely for the purposes of fully funding and administering the Act.
Creates the Special Account for Environmental Enforcement as an account within the Fund and provides that the moneys in the account are available, upon appropriation, to the Office to distribute monies to the entities listed above to be used to enforce the environmental regulation of licensed cultivation sites.
Requires all penalties collected to be deposited directly into the General Fund, to be available upon appropriation.
Authorizes the Office to establish and administer a grant program to allocate monies from the Fund to state and local entities for the purpose of assisting with medical marijuana regulation and enforcement of this part.
Transportation Provisions
Specifies requirements for a licensed transporter to include requirements that it: ship only to facilities issued a conditional license and only in response to a request for a specific quantity and variety; complete a shipping manifest form prescribed by the Office prior to transporting medical marijuana products; securely transmit a copy of the manifest to the licensee that will receive the medical marijuana product as well as to the Office prior to transport; and that both transporters and licensed facilities maintain each shipping manifest and make it available to local code enforcement officers, any other locally designated enforcement entity as well as the Office upon request.
Specifies transported medical marijuana products be transported only in a locked, safe and secure storage compartment that is securely affixed to the interior of the transporting vehicle and not visible from outside the vehicle. Prohibits the vehicle from having external markings that it is transporting medical marijuana. Requires the vehicle travel directly from one licensed facility to another licensed facility authorized to receive the shipment.
Requires transport vehicles carrying more than $10,000 retail value of medical marijuana to be staffed with a minimum of two employees, one of whom must remain with the vehicle at all times when the vehicle contains medical marijuana. Requires each transport team member to have access to a secure form of communication by which to communicate with personnel at the licensed facility at all times when the vehicle contains medical marijuana. Requires each transport team member to possess documentation of licensing and a government-issued identification card at all times when transporting or delivering medical marijuana, and to produce it to the Office or law enforcement upon request. Clarifies that these provisions do not authorize or permit a licensee to transport medical marijuana or medical marijuana products outside the state.
Provides that these transportation provisions only apply to licensed transporters.
Prohibits a local jurisdiction from preventing transportation through or to a facility issued a conditional license by a conditionally licensed transporter acting in compliance with the Act.
Enforcement Provisions
Clarifies that a state agency is not required to enforce local laws regarding the site or operation of a facility issued a conditional license.
Authorizes the Office to assist state taxation authorities in the development of uniform policies for the state taxation of licensees.
Authorizes the Office to enforce all of the requirements of this part, including any regulations adopted pursuant to this part.
Requires the Office to delegate the authority to enforce the requirements of this part, including any regulations, to a local government upon request of that entity.
Provides that nothing in this part shall be interpreted to supersede or limit local authority, or interpreted to require the Office to undertake local enforcement.
Establishes a fine of up to $35,000 for each willful violation of conditional license application provisions of the Act, and a fine of up to $10,000 for each technical violation, as specified.
Authorizes a District Attorney, County Counsel, City Attorney or City Prosecutor to bring an action to enjoin a violation or the threatened violation of the Act. Provides that the action be brought in the county in which the violation occurred or is threatened to occur and that a local government’s authority to take requisite enforcement actions pertaining to its own ordinances or regulations is not diminished. Clarifies that an action under the MMPA may still be taken. Clarifies that the Act shall not be construed to limit a law enforcement agency’s ability to investigate unlawful activity in relation to a facility issued a conditional license.
Cultivation Provisions
Requires the Office to notify local law enforcement of all conditional licenses issued for cultivation sites in that jurisdiction.
Requires a licensed cultivation site to display the state license in an available and easy to read manner at the location.
Requires that no later than January 1, 2022, all medical marijuana grown, produced, distributed and sold in the state meet the certified organic standards. Requires the Office to establish appellations of origin for marijuana grown in California and work with county agricultural commissioners to provide all the information and forms required for conditional licensure as a cultivation site in a single location, including state licensure, local requirements in that jurisdiction, and environmental requirements.
Security, Recordkeeping, and Other Regulatory Provisions
Requires conditionally licensed facilities to implement safety security measures to both deter and prevent unauthorized entrance into areas containing marijuana and theft of marijuana at those facilities to be implemented by a facility issued a conditional license. Requires security measures to include: preventing individuals from remaining on the premises of the facility if they are not engaging in activity expressly related to the operations of the facility; establishing limited access areas accessible only to authorized facility personnel: and storing all finished marijuana in a secured and locked room, safe, or vault, and in a manner as to prevent diversion, theft, and loss, except small amounts used for display, samples, or immediate sale.
Requires a facility issued a conditional license to notify appropriate law enforcement authorities within 24 hours after discovering significant discrepancies identified during inventory, as determined by the Office; diversion, theft, loss, or any criminal activity involving the facility or a facility agent; the loss or unauthorized alteration of records related to marijuana, registered qualifying patients, personal caregivers, or facility agents; and any other breach of security.
Requires a licensed cultivation site to weigh, inventory, and account for on video, all medical marijuana to be transported prior to its leaving its origination location. Requires that, within eight hours after arrival at the destination, the licensed dispensing facility shall reweigh, reinventory, and account for on video, all transported marijuana.
Requires the Office to maintain confidentiality for information identifying the names of patients, their medical conditions, or the names of their primary caregivers received and contained in records kept by the Office for the purposes of administering the Act and exempts this information from the California Public Records Act. States that this information is not subject to disclosure to an individual or private entity, except as necessary for authorized employees of the state to perform official duties pursuant to the Act.
Specifies that these provisions do not preclude the Office from notifying state or local agencies about information submitted to the Office that the employee suspects is falsified or fraudulent; notifications from the Office to state or local agencies of apparent violations of this Act or an applicable local ordinance; verification of requests by state or local agencies to confirm licenses and certificates issued by the Office or another state agency; or providing information requested pursuant to a court order or subpoena issued by a court, an administrative agency, or local governing body authorized by law to issue subpoenas.
Specifies that information shall not be disclosed beyond what is necessary to achieve the goals of a specific investigation or notification or the parameters of a specific court order or subpoena.
Provides that the actions of a licensee, its employees, and its agents, that are permitted pursuant to a conditional license and that are conducted in accordance with the requirements of the Act and regulations adopted pursuant to the Act, are not unlawful under state law and shall not be an offense subject to arrest or prosecution.
Provides that the actions of a person who, in good faith and upon investigation, allows his or her property to be used by a licensee, its employees, and its agents, as permitted pursuant to a conditional license, are not unlawful under state law and shall not be an offense subject to arrest or prosecution.
Sets forth requirements for record keeping by a licensee, specifically that a licensee shall not cultivate, process, store, manufacture, transport, or sell medical marijuana in the state unless accurate records are kept at the licensed premises of the growing, processing, storing, manufacturing, transporting, or selling by the licensee in the state.
States that the records shall include the name and address of the supplier of marijuana received or possessed by the licensee, the location at which the marijuana was cultivated, the amount of marijuana received, the form in which it is received, the name of the employee receiving it, and the date of receipt. States that these records shall also include receipts for all expenditures incurred by the licensee and banking records, if any, for all funds obtained or expended in the performance of any activity under the authority of the conditional license.
Authorizes a licensee who has a conditional license for more than one premises to keep all records at one of the conditionally licensed premises, and requires records to be kept for a period of seven years from the date of the transaction.
Authorizes the Office or a local agency delegated the authority to enforce the licensing requirements of this Act to examine the books and records of a conditional licensee and visit and inspect the premises. Requires books or records requested by the Office or that local agency to be provided by the conditional licensee no later than five business days after the request is made.
Authorizes the Office or a local agency delegated the authority to enforce the licensing requirements of this Act to enter and inspect the premises of a facility issued a conditional license between the hours of 8 a.m. and 8 p.m. on any day that the facility is open, or at any reasonable time, to ensure compliance and enforcement of the provisions of the Act or a local ordinance. Provides that if a licensee or an employee of a licensee refuses, impedes, obstructs, or interferes with an inspection, the conditional license may be summarily suspended and the Office shall directly commence proceedings for the revocation of the conditional license.
Provides that if a licensee fails to maintain or provide the books and records required, the licensee shall be subject to a civil fine of $15,000 per individual violation.
Authorizes the Office or a local agency delegated the authority to enforce the licensing requirements of this Act to require a licensee to contract for an independent audit of the records required under these provisions, and that the licensee shall be liable for all costs associated with the audit.
Taxation Provisions
Authorizes a city, county, or city and county to impose a tax on the privilege of cultivating, dispensing, producing, processing, preparing, storing, providing, donating, selling, or distributing marijuana by a licensee operating under the Act.
Requires the Board of Supervisors or City Council to specify in the ordinance the activities subject to the tax, the applicable rate or rates, the method of apportionment, and the manner of collection of the tax. Provides that the tax may be imposed for general governmental purposes or for purposes specified in the ordinance.
Specifies that the tax authorized may be imposed upon any or all of the activities outlined above, regardless of whether the activity is undertaken individually, collectively, or cooperatively, and regardless of whether the activity is for compensation or gratuitously, as determined by the Board of Supervisors or City Council. Specifies that a tax for these purposes is applicable voter approval requirements imposed by law.
Specifies that these provisions do not limit or prohibit the levy or collection or any other fee, charge, or tax, or a license or service fee or charge upon, or related to, the activities outlined above, and shall not be construed as limiting the tax authority of a city, county, or city and county as provided by law.
Requires, on or before July 1, 2016, the State Board of Equalization (BOE) to complete a report and submit it to the Legislature and Governor’s Office on the estimated tax collected on the sale of medical marijuana, using the most current data available. States that the report should also include expected tax revenues, under the existing tax structure, for the years 2016 to 2021, inclusive.
Health, Safety, and Labeling Provisions
Defines the following terms in the Sherman Food, Drug and Cosmetics Law:\
“Edible medical marijuana product” as medical marijuana or a medical marijuana-derived product that is ingested or meant to be ingested through the mouth and into the digestive system.
“Labor peace agreement” means an agreement between an entity and a bona fide labor organization that, at a minimum, protects the state’s proprietary interests by prohibiting labor organizations and members from engaging in picketing, work stoppages, boycotts, and any other economic interference with the applicant’s business. This agreement means that the applicant has agreed not to disrupt efforts by the bona fide labor organization to communicate with, and attempt to organize and represent, the applicant’s employees.
“Representative samples” as samples taken from each batch or shipment of medical marijuana received from a licensed cultivation site or any other source if intended for sale.
Requires the Office, by July 1, 2017, to report to the Legislature on the feasibility of developing a program to certify laboratories for the testing of medical marijuana and related products and the feasibility of a labeling requirement for edible marijuana products that incorporates information on the cannabinoid content.
Requires a facility issued a conditional license to bear the responsibility for:
Maintaining supplier information in order for recall procedures to be implemented, if and when necessary; and
Labeling of all medical marijuana and medical marijuana products that shall, at a minimum, include the following:
A list of pharmacologically active ingredients, including, but not limited to, tetrahydrocannabinol (THC) and cannabidiol (CBD) content, clear recommended dosage, and the size or volume of the recommended dose.
Clear indication, in bold font, that the product contains medical marijuana.
The statement “FOR MEDICAL USE ONLY. KEEP OUT OF REACH OF CHILDREN AND ANIMALS” in bold print.
Identification of the source and date of cultivation and manufacture.
The name and location of the dispensary providing the product, and the date of sale.
Any other requirements set by the Office.
Provides that for purposes of these provisions, edible medical marijuana products are deemed to be unadulterated food products. Authorizes baked edible medical marijuana products, including but not limited to, brownies, bars, cookies and cakes, tinctures and other edible medical marijuana products that do not require refrigeration or hot holding to be manufactured, sold or otherwise distributed at facilities issued a conditional license under the Act.
Requires a facility issued a conditional license to have an owner or employee who has successfully passed an approved and accredited food safety certification examination prior to selling, manufacturing or distributing edible medical marijuana products requiring refrigeration or hot holding. Requires individuals manufacturing or selling edible medical marijuana products to thoroughly wash their hands before commencing production and before handling finished edible medical marijuana products.
States that all edible medical marijuana products sold for direct consumption and infused with marijuana concentrate shall be individual wrapped at the original point of preparation.
Requires products containing THC to be prepared in compliance with maximum potency standards for THC and THC concentrates set forth in the Office's regulations.
Sets forth requirements for labeling of edible medical marijuana products. Requires, prior to sale or distribution at a licensed dispensing facility, edible medical marijuana products shall be labeled and in an opaque and tamper evident package. Labels and packages of edible medical marijuana products shall not be made to be attractive to children. Prohibits the use of photos or images of food on products or labels, and only authorizes the use of generic food names to describe the products.
All edible medical marijuana product labels shall include the information listed above, prominently displayed and in a clear and legible font, and also the net weight of medical marijuana in package and a warning if nuts or other known allergens are used and shall include the total weight, in ounces or grams, of medical marijuana in the package.
Physician Provisions
Requires the MBC to prioritize cases involving physicians who recommend marijuana to patients for medical purposes without a good faith prior examination of the patient and medical reason therefor.
Makes it a misdemeanor for a physician and surgeon who recommends medical marijuana to a patient to accept, solicit, or offer any form of remuneration from or to a facility issued a conditional license to engage in medical marijuana activities if the physician and surgeon or his or her immediately family have a financial interest in that facility.
Requires the MBC to consult with the California Marijuana Research Program, known as the Center for Medicinal Cannabis Research, on developing and adopting medical guidelines for the appropriate administration and use of medical marijuana.
Prohibits a physician and surgeon from recommending medical marijuana to a patient unless that person is the patient's attending physician, as defined under existing law.
Requires advertising for physician recommendations for medical marijuana to meet all requirements to bear a prescribed notice for consumers and comply with false advertising prohibitions for healing arts practitioners, as specified, and prohibits price advertising that is fraudulent, deceitful, or misleading.
FISCAL EFFECT: According to the Senate Appropriations Committee analysis dated May 28, 2015:
Ongoing costs, likely over $20 million per year to license medical marijuana cultivators, transporters, and dispensaries by the new Office of Medical Marijuana Regulation (special fund). For comparison, the California State Board of Pharmacy, which licenses and regulates pharmacists and pharmacies, has an annual budget of about $20 million per year.
The bill would create a new Office dedicated to licensing and enforcing licensing requirements on the medical marijuana industry. The annual costs to operate the new Office are highly uncertain. For example, the number of medical marijuana cultivators, transporters, and dispensaries that would apply for licensure under the bill is not known, in part because it is difficult to know how the licensing and regulatory requirements in the bill will change current practices in the medical marijuana industry.
Unknown costs for enforcement of the bill’s requirements by local governments (local funds and special funds). The bill requires the Office to enforce its provisions, but requires the Office to delegate enforcement authority to requesting local agencies. How those responsibilities will be divided between levels of government and how much funding the state will make available to local governments for enforcement activity is unknown at this time.
Unknown fee revenues to offset the costs to implement the bill (special fund). The bill gives the new Office broad authority to set licensing fees sufficient to pay for the Office’s costs to operate the licensing program, costs incurred by the Office or the Department of Justice to enforce the bill, costs incurred by local law enforcement agencies to enforce the bill, and costs incurred by state and local environmental agencies for enforcement costs relating to cultivation facilities. The fee revenues generated under the bill would depend both on the allowed costs that are incurred at the state and local level as well as the feasibility of collecting sufficient fees from the medical marijuana industry.
Unknown costs for the Department of Justice to conduct criminal background checks of licensees (special fund). Under current practice, applicants for a criminal background check are required to pay the $65 cost to conduct a criminal background check using fingerprint databases.
Ongoing costs of about $1 million per year for enforcement of food and drug safety requirements on medical marijuana products by the Department of Public Health (General Fund or fee revenues from licensees).
COMMENTS:
Purpose. This bill is author sponsored. According to the author, "SB 643 seeks to resolve many of the issues created by the enactment of the Compassionate Use Act and subsequent legislation. Our bill creates a statewide comprehensive program overseeing the medical marijuana industry, from planting to consumption, and all the steps in between. California voters made it clear that they wanted medical marijuana to be legalized, but issues and concerns for growers, doctors, dispensaries, law enforcement, district attorneys, cities, counties and others have only become more complicated.
I represent the primary growing region for medical marijuana in the western United States, specifically remote expanses of Mendocino, Humboldt and Trinity counties, which are responsible for up to 70% of the marijuana grown in the west. Much of this area of the state has come to rely on the economic benefits of marijuana cultivation, but also suffers from the negative environmental, public safety and public health effects that can arise from rogue cultivators and lack of regulation. Trespass grows have become an environmental disaster in this region, illegally diverting millions of gallons of water from rivers and streams, creating a dumping ground for pesticides, insecticides, rodenticides and fertilizers, and depositing huge amounts of sediment into our waterways from crop runoff.
Since the voters of California passed Proposition 215 in 1996, it has become clear that there needs to be a comprehensive regulation bill from the Legislature that oversees the cultivating, processing, manufacturing, transportation, prescribing and sale of medical marijuana. The Legislature has worked hard over the last couple of years to enact a regulatory program that will recognize the voter’s mandate, streamline the ability of the industry to grow and sell a legal product and that this bill contains much of that hard work as well as reflects the efforts of many groups, individuals who have spent years working in this industry.
Currently, there are virtually no rules and regulations on the cultivation side of the medical marijuana industry, and it is important that we bring this legal crop into the regulatory framework expected for other commodities. The severe drought California is now experiencing has only made the need for this legislation all the more urgent."
The
Compassionate Use Act (CUA) and SB 420. In 1996, voters approved
the CUA, which allowed patients and primary caregivers to obtain and
use medical marijuana, as recommended by a physician, and prohibited
physicians from being punished or denied any right or privilege for
making a medical marijuana recommendation to a patient. In 2003, SB
420 (Vasconcellos), Chapter 875, Statutes of 2003, established the
Medical Marijuana Program (MMP), which allowed patients and primary
caregivers to collectively and cooperatively cultivate medical
marijuana, and established a medical marijuana card program for
patients to use on a voluntary basis. The card can be used to verify
that a patient has authorization to possess, grow, transport, or use
medical marijuana in California, and that a caregiver has
authorization to possess, grow, and transport medical marijuana in
California. The MMP facilitates the registration of qualified
patients and their caregivers through a statewide identification
system, and qualified patients and their caregivers may apply for and
be issued an identification card through their county of residence.
Upon issuance of the card, it is registered with an online database
which law enforcement can use to verify whether a card is
valid.
Under the MPP, a person is required to get a
recommendation for medical marijuana from an attending physician,
which is defined to mean someone who, “ …has taken responsibility
for an aspect of the medical care, treatment, diagnosis, counseling,
or referral of a patient and who has conducted a medical examination
of that patient before recording in the patient’s medical record
the physician’s assessment of whether the patient has a serious
medical condition and whether the medical use of marijuana is
appropriate.” Written documentation of this recommendation is
required to be submitted to the county in order to receive a medical
marijuana card. However, since the passage of Proposition 215 and SB
420, the state has not adopted a framework to provide for appropriate
licensure and regulation of medical marijuana. As a result, in the
nearly 20 years since the passage of Proposition 215, there has been
an explosion of medical marijuana collectives and cooperatives that
are largely left to the enforcement of local governments, resulting
in the creation of a patchwork of local regulations for these
industries and with little statewide involvement.
The
California Attorney General's Compassionate Use Guidelines. SB
420 required the California Attorney General to "…develop and
adopt appropriate guidelines to ensure the security and non-diversion
of marijuana grown for medical use by patients qualified under the
Compassionate Use Act of 1996.” In 2008, the Attorney General
issued guidelines to: 1) ensure that marijuana grown for medical
purposes remains secure and does not find its way to non-patients or
illicit markets, 2) help law enforcement agencies perform their
duties effectively and in accordance with California law, and 3) help
patients and primary caregivers understand how they may cultivate,
transport, possess, and use medical marijuana under California law.
According to a 2011 letter, after a series of meeting with
stakeholders to assess whether to clarify the 2008 guidelines to stop
the exploitation of California's medical marijuana laws by gangs,
criminal enterprises, and others, the Attorney General decided to
postpone the issuance of new guidelines because of pending litigation
and to urge the Legislature to amend the law to establish clear rules
governing access to medical marijuana.
California
Supreme Court Affirms Local Control Over Medical Marijuana. By
exempting qualified patients and caregivers from prosecution for
using or from collectively or cooperatively cultivating medical
marijuana, the CUA and the MPP essentially authorized the cultivation
and use of medical marijuana. These laws have triggered the growth
of medical marijuana dispensaries in many localities, and in
response, local governments have sought to exercise their police
powers to regulate or ban activities relating to medical marijuana.
After numerous court cases and years of uncertainty relating to the
ability of local governments to control medical marijuana activities,
particularly relating to the ability to control the zoning,
operation, and existence of medical marijuana dispensaries, the
California Supreme Court, in City of Riverside v. Inland Empire
Patients (2013) 56 Cal. 4th 729, held that
California's medical marijuana statutes do not preempt a local ban on
facilities that distribute medical marijuana. The court held that
nothing in the CUA or the MMP expressly or impliedly limited the
inherent authority of a local jurisdiction, by its own ordinances, to
regulate the use of its land, including the authority to provide that
facilities for the distribution of medical marijuana will not be
permitted to operate within its borders.
Federal
Controlled Substances Act. Despite the CUA and SB 420, marijuana
is still illegal under state and federal law. Under California law,
marijuana is listed as a hallucinogenic substance in Schedule I of
the California Uniform Controlled Substances Act. Yet, the CUA
prohibits prosecution for obtaining, distributing, or using marijuana
for medical purposes. However, under the federal Controlled
Substances Act, it is unlawful for any person to manufacture,
distribute, dispense or possess a controlled substance, including
marijuana, whether or not it is for a medical purpose. As a result,
patients, caregivers, and dispensary operators, who engage in
activities relating to medical marijuana, may still vulnerable to
federal arrest and prosecution. According to the California Attorney
General's guidelines, the difference between state and federal law
gives rise to confusion. However, California has tried to avoid this
conflict by deciding not to use the state's powers to punish certain
marijuana offenses under state law when a physician has recommended
its use to treat a serious medical condition.
U.S.
Department of Justice (USDOJ) Guidance Regarding Marijuana
Enforcement. On August 29, 2013, the USDOJ issued a memorandum
that updated its guidance to all U.S. Attorneys in light of state
ballot initiatives to legalize under state law the possession of
small amounts of marijuana and provide for the regulation of
marijuana production, processing, and sale. While the memorandum
noted that illegal distribution and sale of marijuana is a serious
crime that provides a significant source of revenue to large-scale
criminal enterprises, gangs, and cartels, it also noted that USDOJ is
committed to using its limited investigative and prosecutorial
resources to address the most significant threats, which include:
preventing distribution to minors; preventing revenue from marijuana
from going to criminal enterprises; preventing diversion to other
states where marijuana is not legal under state law; preventing
state-authorized marijuana from being a cover for trafficking in
other illegal drugs or illegal activity; preventing violence in
cultivating and distributing marijuana; preventing drugged driving
and other public health problems from marijuana use; and preventing
growing, possessing or using marijuana on public lands or on federal
property.
According to the USDOJ, "In jurisdictions
that have enacted laws legalizing marijuana in some form and that
have also implemented strong and effective regulatory and enforcement
systems to control the cultivation, distribution, sale, and
possession of marijuana, conduct in compliance with those laws and
regulations is less likely to threaten the federal priorities set
forth above…In those circumstances, consistent with the traditional
allocation of federal-state efforts in this area, enforcement of
state law by state and local law enforcement and regulatory bodies
should remain the primary means of addressing marijuana-related
activity."
Marijuana Frameworks Established in Other States. There are currently 23 states, plus the District of Columbia, that allow for medical marijuana and have some level of regulation. California is the only state that permits medical marijuana in the absence of a robust state-wide regulatory system. The following states have statewide medical marijuana regulatory systems: Alaska, Arizona, Colorado, Connecticut, Washington DC, Delaware, Hawaii, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, Oregon, Rhode Island, Vermont and Washington. In addition, Alaska, Colorado, Oregon, Washington, and the District of Columbia have legalized the use of recreational marijuana.
According to the Brookings Institute, since the early 1990s, U.S. public opinion has trended in favor of marijuana legalization. Currently, a majority of Americans support legalization by a margin of seven points—52 percent to 45 percent, according to findings from a Pew Research Center survey in March 2013. Support for marijuana legalization has risen sharply since 2010, by 11 percentage points.
This increasing support for marijuana legalization is present in California as well, with recent polls showing that a majority of Californians support marijuana legalization. Currently, there are an estimated four different marijuana initiatives attempting to qualify for the 2016 ballot. In order for any marijuana scheme to be effective, it should address all parts of the industry, including establishing a robust licensing and regulatory scheme, a taxation scheme, and incorporate health and safety standards, in addition to ensuring that the public is protected; however, if the measure is too prescriptive, it may hamper the ability to address any unintended consequences or fill in any policy gaps without having to go back to the ballot. As a result, if the State is able to create a comprehensive framework for medical marijuana, it may also serve a dual role by serving as a basis for a recreational marijuana scheme.
Medical Marijuana Industry in California. According to the author's Sunrise Questionnaire, submitted to the Committee pursuant to Government Code Section 9148 et seq., by law enforcement estimates, over 60% of all marijuana in the country is grown in the Emerald Triangle counties of Humboldt, Mendocino and Trinity, all of which are in the author's district, and once the industry is regulated, and the medical marijuana products are certified as safe, the market is expected to open up substantially. In addition, once the industry is regulated, the author believes that physicians who do not recommend or even discuss medical marijuana due to its quasi-legal nature and outright ban from the federal government may be more willing to discuss and recommend medical marijuana to their patients.
Since 1996 when the Compassionate Use Act (CUA) was passed, individuals, patients and organizations from all sides have been asking the Legislature to enact a regulatory framework that will settle many of the open ended questions and legal status of the medical marijuana. According to the author, the Legislature has enacted several bills over the years clarifying CUA, but nearly everyone agrees that a complete regulatory framework needs to be enacted as soon as possible. The author asserts that the harm starts at the environmental side of things, and simply expands from there. Right now, with virtually no standards for cultivation, the state is seeing the worst damage to watersheds, forests and rivers than ever before on the North Coast. The regional and State Water Boards, along with California Department of Fish and Wildlife, are doing what they can, but without legislation, their hands are largely tied. This leads to streams and rivers literally running dry (even before the current drought) and to huge loads of sediments and toxic wastes being dumped into the watersheds. The lack of regulation complicates water supply for millions of legal residential and commercial water users throughout the state-- entire tracts of forests are being mowed down by rogue growers and planted with marijuana with no permits, oversight, or regard for the environment.
The author believes that the lack of regulation on the processing, manufacturing, testing, transportation and resale needs to be fixed as well. Without statewide standards produced by specific health and safety testing, ingredient lists, and dosage listings on all marijuana products, people are put at risk. Of significant concern is the “edibles” and “oils” market, which are relatively new to consumers and have the potential to expand beyond the typical cigarette style that most people are used to. And with no standards for dosages or active ingredient lists, for example, the danger is very real. According to the author, it is well past time we treat this product like a real medication and give it the same scrutiny and oversight that all other legal drugs have.
Cities and counties that have medical marijuana ordinances take the first step in protecting consumers and the public, but without a strong state-wide regulatory body overseeing all aspects of the product chain, consumers have very little control over the risk unless they have personal knowledge of the product. There simply is no cohesive strategy for protecting consumers in the industry, and as a very loose and only quasi-legal, it is very difficult for the industry to self-police. Clear guidelines from the state and or the local jurisdiction, backed up by the state, is the only way to ensure protection of consumers and the public.
According to the author, nearly every provision of the SB 643 is designed to preclude consumer injury, from the cultivation standards all the way to the resale of the final product, and by taking a multi-billion dollar industry with virtually no regulations and placing the entire product chain into a regulated environment. All aspects of the product chain need to be regulated, from “Seed to Sale”. This would include creating licensures and regulatory framework for all aspects of the industry, including cultivation, processing, manufacturing, prescribing, testing, transporting, and selling. The health and safety of the product must be of top concern for the state and other jurisdictions, and making sure no diversions occur for non-medical marijuana purposes.
Every aspect of this current quasi-legal product includes dangers at this time, from law enforcement to cultivator neighbors, to transportation, manufacturing and beyond. Creating a uniform policy toward all aspects of medical marijuana will be a giant step in protecting consumers, but the public at large, as well as our water and environment. However, according to the author, the one danger in this process is making it so onerous and laborious to become legitimate that people simply refuse to participate and stay in the black/grey market. The author asserts this bill is designed to limit that as much as possible, while accepting that some in the industry simply will not be able to participate.
SB 643 Licensing and Regulatory Framework. According to the author, this bill will address many of these concerns by doing all of the following:
Creates the Office of Medical Marijuana Regulation, under the Secretary of Business, Consumer Services and Housing. According to the author, the Secretary oversees the ABC and the Dept. of Consumer Services and can draw on the expertise of both agencies to help the Office get set up and running.
Requires that all medical marijuana grown, produced, distributed, prescribed, and sold in the state meet the California certified organic standards by January 1, 2022. According to the author, this is in effort to guard against consumption of harmful and damaging products, and to help protect the cultivating watersheds and environment from toxics.
Creates “Appellations of Origin” for medical marijuana. According to the author, similar to the wine grapes grown in the southern part of his district, this will help establish and perpetuate authenticity in the industry.
Allows local governments to impose a tax or fee on cultivation, above the ultimate sales tax, to help defray the expense of regulating the cultivation and processing of the commodity in their jurisdiction. This is designed to make sure local authorities can afford to pay for the implementation of the regulations allowed under this legislation or any other. Local authorities would have to abide by Prop. 218 regulations.
Licenses would only be valid if both the state and the local jurisdiction approved the applications. The author's goal is to allow as much local control as possible.
All licensed location and license information would be given to local law enforcement. In an effort to prevent wasted resources and limit dangerous circumstances, the author believes that local law enforcement should know when and where all licensees are operating.
A conditional license issued pursuant to this section shall be valid for 12 months after the date of issuance, after which it may be renewed for a period of 36 months. This is a departure from previous bills that only give 12-month renewals. Once licensees have established themselves, the author does not believe they should have to go through the process of renewal every year.
Current
Related Legislation. AB 26 (Jones-Sawyer) of the current
legislative session, would enact the Medical Cannabis Regulation and
Control Act to license and regulate medical cannabis, and would
create the Division of Medical Cannabis Regulation and Enforcement
within the Department of Alcoholic Beverage Control to administer the
act. STATUS: This bill is in the Assembly Business and
Professions Committee.
AB 34 (Bonta) of the current
legislation, session would enact the Medical Cannabis Regulation and
Control Act to license and regulate medical cannabis, and would
establish the Division of Medical Cannabis Regulation and Enforcement
within the Department of Alcoholic Beverage Control to administer the
act. STATUS: This bill was held in the Assembly
Appropriations Committee.
AB 243 (Wood) of the current legislation session, would require all medical marijuana cultivation (MMC) to be conducted in accordance with state and local laws and best practices, as specified, and would require state agencies to address environmental impacts of MMC and coordinate with local governments in enforcement efforts, and establishes a MMC permitting system. STATUS: This bill is scheduled to be heard in the Senate Governance and Finance Committee.
AB 266 (Bonta, Cooley, Jones-Sawyer, and Lackey), establishes a licensing and regulatory framework for medical cannabis under the Medical Cannabis Regulation and Control Act (Act), and would establish the Office of Medical Cannabis Regulation within the Office of the Governor, the Division of Medical Cannabis Regulation within the State Board of Equalization, the Division of Medical Cannabis Manufacturing and Testing within the California Department of Public Health, and the Division of Medical Cannabis Cultivation within the California Department of Food and Agriculture, and would set forth the duties of the respective regulatory authorities. STATUS: This bill is scheduled to be heard in the Senate Health Committee.
Prior Related
Legislation. AB 1262 (Correa) of 2014, would have established a
licensing and regulatory framework for the cultivation, processing,
transportation, testing, recommendation and sale of medical marijuana
to be administered by the Department of Consumer Affairs (DCA) and
enforced primarily at the local level. NOTE: This bill was
held in the Assembly Appropriations Committee.
AB 1894
(Ammiano) of 2014, would have enacted the Medical Cannabis Regulation
and Control Act to license and regulate the cultivation, manufacture,
testing, transportation, storage, distribution, and sale of medical
cannabis, and would create the Division of Medical Cannabis
Regulation and Enforcement within the Department of Alcoholic
Beverage Control. NOTE: This bill was held on the Assembly Floor.
AB 473 (Ammiano) of 2013, would have enacted the Medical
Marijuana Regulation and Control Act to license and regulate the
cultivation, manufacturing, testing, transportation, distribution,
and sales of medical marijuana and medical marijuana products, and
would create the Division of Medical Marijuana Regulation and
Enforcement within the Department of Alcoholic Beverage Control.
NOTE: This bill was held on the Assembly Floor.
AB 604 (Ammiano)
of 2013, would have enacted the Medical Cannabis Regulation and
Control Act to license and regulate the cultivation, manufacture,
testing, transportation, storage, distribution, and sale of medical
cannabis, and would create the Division of Medical Cannabis
Regulation and Enforcement within ABC. NOTE: This bill was held
in the Senate Public Safety Committee.
AB 2312
(Ammiano) of 2012, would have established the Medical Marijuana
Regulation and Control Act, authorizing local taxes on medical
cannabis and creating a board to regulate the medical cannabis
industry. NOTE: This bill was held in the Senate Committee on
Business, Professions and Economic Development.
SB 1182 (Leno) of
2012, would have provided that a cooperative or collective that
operates within the Attorney General's (AG) guidelines shall not be
subject to prosecution for marijuana possession or commerce, as
specified. NOTE: This bill was held on the Senate Floor.
AB 1300 (Blumenfield), Chapter 196, Statutes of 2011,
provided that a local government entity may enact an ordinance
regulating the location, operation or establishment of a medical
marijuana cooperative or collective; authorizes local government
entities to enforce such ordinances through civil or criminal
remedies and actions; and authorizes a local government entity to
enact any ordinance that is consistent with the Medical Marijuana
Program.
SB 626 (Calderon) of 2011, would have
required the Board of Equalization (BOE) to establish a nine-member
task force to conduct a study to determine ways to enhance
collections of sales and use taxes on retail sales of marijuana and
ensure proper regulation of the cultivation, transportation, and
distribution of marijuana and marijuana products. NOTE: This bill
was held in the Senate Appropriations Committee.
AB
390 (Ammiano) of 2009, would have legalized the possession, sale,
cultivation and other conduct relating to marijuana and required the
Department of Alcoholic Beverage Control to administer and enforce
the terms of legalized marijuana. NOTE: This bill was held in the
Assembly Health Committee.
SB 420 (Vasconcellos),
Chapter 875, Statutes of 2003, established the Medical Marijuana
Program Act, a statewide, voluntary program for the issuance of
identification cards to identify persons authorized to engage in the
medical use of marijuana under the Compassionate Use
Act.
Proposition 215, of the November 1996 General
Election, prohibits prosecution for the possession and cultivation of
cannabis by a patient or a patient's primary caregiver with a
physician's written or oral recommendation.
POLICY ISSUE(S):
This bill would establish a novel licensing and regulatory scheme for medical marijuana, which covers every aspect of the medical marijuana industry, from seed to sale. In addition to tasking the newly-created Office with myriad duties involved in this new scheme, the bill also places enforcement responsibilities primarily on the State, as well as establish a dual licensure scheme, which would require a close partnership between the Office and local governments. In addition, the bill seeks to establish a comprehensive regulatory scheme for medical marijuana, and would require the establishment of a comprehensive set of health and safety standards for medical marijuana and medical marijuana products. As would be expected for any new regulatory program of this scale and scope, a number of outstanding issues and questions will need to be addressed in order to ensure that the program has the greatest chance of success.
Establishing a new Office within the Business, Consumer Services, Housing Agency (BCSH). The BSCH oversees various departments, boards and commissions, including: 1) California Housing Finance Agency, 2) Department of Alcoholic Beverage Control; 3) Department of Business Oversight; 4) Department of Consumer Affairs; 5) Department of Fair Employment and Housing; 6) Department of Housing and Community Development; 7) Seismic Safety Commission; 8) Alcoholic Beverage Control Appeals Board; and 9) Horse Racing Board. As a result of its varied jursidiction, the BCSH's mission is to: license and regulate professionals and businesses in California, so as to protect consumers; to preserve, expand and fund safe and affordable housing opportunities; to investigate and research earthquake related issues to advise on ways to reduce earthquake risk; and to protect the civil rights of all Californians from acts of hate violence and unlawful discrimination in employment, housing and public accommodations.
While many of the entities within BCSH may adopt complex regulations relating to their specified areas, the type of expertise required to establish and implement, at wholesale, such a comprehensive program that covers all aspects of medical marijuana activities, will pose great challenge to any state entity, especially one that is completely new. Not only will a newly-established Office of Medical Marijuana Regulation have to deal with overcoming all of the administrative obstacles that exist to establishing a brand new government entity, such as establishing a budget, hiring new staff, developing business practices, and establishing an information technology system that will meet all of these needs under the bill, it will also have to take on an issue that is novel, complex, and requires much expertise. Successful implementation of any medical marijuana program will require strong leadership and involvement from the Administration to prioritize implementation so that it meets federal guidance and prevents the potential for illegitimate activities, to determine whether it is appropriate to coordinate efforts among all affected entities that will play a role in establishing a robust and effective licensing and regulatory framework, all of which the Office's success will rely heavily on, in addition to having sufficient resources to ensure that all staffing and other needs will be met.
Office's Ability to Absorb New Responsibilities. This bill would require the Office to adopt regulations for implementation and enforcement, including specific procedures for the issuance and revocation of licenses, the application forms and fees, by January 1, 2018. This bill also requires the Office to adopt regulations that establish standards for cultivation, manufacturing, transportation, storage, distribution, provision, donation, and sale of medical marijuana and medical marijuana products, as specified. These regulations are thereby required to cover everything from licensure, to comprehensive health and safety standards for medical marijuana, including establishing the maximum potency standards for THC. This bill would delay implementation, thereby giving the Office 24 months to adopt regulations. In addition, the bill authorizes the Office to consult with other state and local agencies, industry, and public and private entities to establish these regulations.
Due to the extensive number and type of regulations required to be adopted, in addition to the level of outside expertise the Office will need to rely on, the author may wish to consider whether 24 months will be enough time to establish all of these standards, or if the Office should be given more time to adopt these standards, or be authorized to adopt temporary emergency regulations.
The author may also wish to consider the benefits of spreading out duties among existing agencies that already have expertise in issues like adopting, implementing, and enforcing cultivation and health and safety standards, such as the Department of Food and Agriculture and the Department of Public Health. At a minimum, the author should strongly consider requiring the Office to consult with other agencies, instead of merely authorizing such consultation, and requiring the Office to establish an advisory taskforce with the requisite expertise to assist the newly-established Office during this rulemaking process and to clarify the appropriate roles of each state entity that is, or would be, affected by medical marijuana activities. Such an advisory taskforce should include representatives from the Department of Public Health, California Department of Food and Agriculture, State Water Resources Control Board and other environmental departments, such as the Department of Fish and Wildlife, the Attorney General's Office (especially critical to help navigate the federal and changing legal landscape), local governments, medical marijuana experts, and industry representatives.
In addition, while the bill authorizes the Office to assist state taxation authorities in the development of uniform policies for the state taxation of licensees and requires the State Board of Equalization (BOE) to complete a report on the estimated tax collected on the sale of medical marijuana and expected tax revenues, the author should consider requiring the Offie to work with the BOE on establishing clear policies for the state taxation of licensees, and include the BOE in any taskforce activities.
The author should also consider working with the BSCH to determine the feasibility, timeline, and cost to establish a database system that would meet these new requirements to assist in tracking licensees’, shipments, and other information to help and product, i.e."seed to sale" tracking, based on the State's troubled history with implementing new information technology projects.
Implementation of the Act through Rulemaking. The bill leaves much of the administration of the Act to the rulemaking process by requiring the Office to promulgate myriad regulations, instead of providing a clear, statutory framework. This process can take years, given requirements for notification, public comment and additional delays that arise whenever amendments to proposed regulations are made, and the regulatory process in general has been criticized for lacking transparency and robust stakeholder input that the Legislative process allows for.
For
example, this bill was recently amended to remove provisions
directing the Office to certify laboratories for the testing of
medical marijuana, and deleted language specifying health and safety
requirements for medical marijuana and medical marijuana products.
Now, the bill merely requires the Office to "establish standards
for the cultivation, manufacturing, transportation, storage,
distribution, provision, donation, and sale" of medical
marijuana," and requires applicants to demonstrate compliance
with "all applicable agricultural, consumer protection, food
product and safety, and environmental requirements," with little
other guidance. In addition, the bill requires the Office to report
to the Legislature on the "feasibility" of developing a
program to certify laboratories, by July 1, 2017, and only specifies
limited health and safety standards.
While the author has
indicated that the bill is designed to limit a regulatory process
that is not too onerous and laborious for market participants, the
author may wish to consider whether it is appropriate to delegate too
much discretion to the Office and other regulatory agencies, which
would leave policy decisions to be made at the agency level, rather
than through the legislative process. In addition, the role for many
agencies is to implement policies, rather than determine what those
policies should be; as a result, it might be beneficial to provide
greater guidance to the Office to help the Office understand the
intent of the Legislature and narrow the scope of the Office's
rulemaking authority.
Clarifying Licensure Provisions. The bill requires a dual licensure framework, thereby requiring both a conditional state license and a local license or permit in order to operate. The author may wish to clarify that such licensed facilities must be dually licensed in order to conduct business with one another by amending the definitions for licensees to specify that licensees must hold both a conditional license and a local license or permit. In addition, the author may wish to specify that the application process clearly require a licensee to verify that they are not located near schools, which would be a violation of existing law, in order to quickly weed out ineligible licensees.
Tiered Licensing Schemes. Washington and Colorado have both created comprehensive systems of legal production and sale, subject to licensing, regulation and taxation. However, the laws require different industry structures and build on their existing medical systems in different ways. Colorado allows entrepreneurs to produce cannabis and sell it at retail, and such businesses were, at least initially, required to produce the majority of the marijuana they sell (vertical integration), while Washington state maintains clear separation between marijuana growers, processors and retailers (horizontal integration or "tiered" licensing). Both models seek to, however, reduce diversion and increase accountability. In addition, the commercial market in Washington is supervised by the Washington State Liquor Control Board, while Colorado’s law vests authority to regulate the commercial market in the newly created Marijuana Enforcement Division of the Department of Revenue. Colorado's medical marijuana program is also under that Division – prior to the recreational initiative, the Medical Marijuana Enforcement Division was regulating that part of the market.
According to proponents of a tier licensing system, a horizontal or tiered system of licensing (requiring separate licenses for cultivators, manufacturers/wholesalers, and retailers, and limiting a licensee from holding more than one license type) is modeled after alcohol distribution, and acts to prevent the ability for large firms to dominate local markets by keeping the categories separate and distinct, which prevents one group from controlling too much of the market. Proponents also believe that a tiered licensing system based on the alcohol distribution system, which requires distributors to be responsible for collecting and remitting taxes, would make it easier for the state to keep track of industry transactions and to collect taxes, and would provide checks and balances that would make it harder to allow for diversion, contraband, or "cooking the books."
However, some believe that requiring licensees to be involved in all phases of medical marijuana activities would serve to keep these licensees smaller, as it would take more capital to engage in all parts of the industry. In addition, some believe that larger businesses are not problematic because those larger businesses may be better positioned to have the resources available to ensure that they are following all regulatory requirements, for example, by hiring compliance managers. In addition, some believe that requiring a horizontal licensure scheme would pose undue hardship on many existing businesses who may engaged in multiple aspects of the industry, some at the request of the localities in which they operate that require vertical licensure.
This bill adopts an open approach by allow licensees to hold more than one type of license type, but provides no additional clarification. However, the author may wish to consider the benefits of the different licensing schemes, including the ability of each scheme to prevent diversion and prevent just a few players from dominating the market. If multiple license types are able to be held by a single licensee, the author may also consider whether it may be appropriate to limit multiple license types based on the size of the operation, for example, by only allowing retailers to engage in cultivation if they are cultivating a small amount. The author may also wish to consider establishing different levels of license types to accommodate businesses of various sizes, and to clearly establish a sliding scale for fees to preserve the small businesses that are currently engaged in medical marijuana activities, for example, small farmers.
Dual Licensure and Enforcement. The bill requires facilities, manufacturers, cultivation sites, and transporters to be licensed by the Office, and requires enforcement of these provisions and health, safety, and other standards to be carried out by the State, unless a local entity has requested the authority to enforce these provisions at the local level. In addition, this bill enacts a dual licensure scheme that requires a licensee to obtain both a state conditional license and a local license or permit prior to engaging in any medical marijuana activities. As a result, there may be some inevitable confusion between the Office and local governments in their enforcement roles, which may be further complicated by the fact that licensure depends on having both approvals, and that an enforcement action taken by a state or local government will inevitably affect their equivalent state or local license, and trigger enforcement. The author may wish to require the Office to consult with local governments and develop a framework that clarifies enforcement roles, regardless of whether a local entity specifically requests to be delegated enforcement authority or not, and require the Office to ensure open communication and collaboration with local governments.
Patient Access to Care. This bill delays implementation of many of these provisions, including promulgating regulations for licensing and enforcement until January 1, 2018, and for issuing and requiring conditional licenses until July 1, 2018. However, the bill would delete the provisions authorizing patients and caregivers to be exempt from state criminal sanctions for "collectively or cooperatively" cultivating medical marijuana on July 1, 2017. As a result, the author may consider similarly delaying the implementation of that provision until the Office begins issuing conditional licenses, or until July 1, 2018, or longer, in order to provide time for applicants to go through the licensure process.
The bill also limits exemptions for patients who do not sell, distribute, donate, or provide marijuana to any other person or entity, and limits the exemption for patient caregivers who serve five or less qualified patients for whom he or she is a caregiver. The author may wish to consider whether patients should be exempt for distributing marijuana without compensation, and whether limiting the number of patients a primary caregiver may serve might limit access to care for certain patients, for example, those in rural areas. The author may wish to consider specifically authorizing a facility that is operating in accordance with local regulations, and who submits an application for state conditional licensure, to continue to operate until its application is approved or denied by the Office.
In addition, the bill currently authorizes the Office to adopt regulations to limit the number of conditional licenses issued upon a finding that the otherwise unrestricted issuance of conditional licenses is dangerous to the public health and safety. Because this licensure scheme relies upon dual license, the author may wish to consider whether it is necessary to empower the Office to restrict the number of licenses issued when the local government would have the last say on whether a business would receive necessary local approval to operate or not.
Labeling of Edible Marijuana Products. The bill would require, among other things, that medical marijuana products, including edibles, be labeled and include specified information, such as a list of THC and CBD content and clear recommended dosage. Because medicinal marijuana varies in terms of the levels and types of active ingredient, THC or CBD, for example, and what it is used for varies among patients, it may be difficult to develop a standard "dosage" for products. As a result, the author may wish to consider clarifying labeling standards in regards to medical marijuana products and requiring products to instead state the amount of THC per milligrams in each serving, and the total amount of THC in a package. In addition, the author should consider striking provisions that requires edible products to be in opaque packaging and prohibit any packaging from containing photos or images of food, which may cause confusion for consumers and employees. The author should also include a warning to let consumers know that the intoxicating effects of edible medical marijuana products may be delayed to prevent consumers from consuming more than is necessary to alleviate symptoms.
REGISTERED SUPPORT:
None on file.
REGISTERED OPPOSITION:
None on file.
Analysis Prepared by: Eunie Linden / B. & P. / (916) 319-3301
SB 643
Page 10
|
Office of Senate Floor Analyses (916) 651-1520 Fax: (916) 327-4478 |
THIRD READING
Bill No: SB 643
Amended: 6/3/15
SENATE BUS, PROF. & ECON. DEV. COMMITTEE: 7-0, 4/20/15
AYES: Hill, Block, Galgiani, Hernandez, Jackson, Mendoza, Wieckowski
NO VOTE RECORDED: Bates, Berryhill
SENATE GOVERNANCE & FIN. COMMITTEE: 5-1, 4/29/15
AYES: Hertzberg, Beall, Hernandez, Lara, Pavley
NOES: Nguyen
NO VOTE RECORDED: Moorlach
SENATE APPROPRIATIONS COMMITTEE: 5-1, 5/28/15
AYES: Lara, Beall, Hill, Leyva, Mendoza
NOES: Nielsen
NO VOTE RECORDED: Bates
DIGEST: This bill enacts the Medical Marijuana Public Safety and Environmental Protection Act. This bill establishes a licensing and regulatory framework for the cultivation, manufacture, transportation, storage, distribution and sale of medical marijuana to be administered by an Office of Medical Marijuana Regulation in the Business, Consumer Services Housing Agency and enforced primarily at the local level.
Existing law:
Prohibits, under the Compassionate Use Act of 1996 (CUA), an initiative measure, prosecution for the possession or cultivation of marijuana of a patient or a patient’s primary caregiver who possesses or cultivates marijuana for the personal medical purposes of the patient upon the written or oral recommendation or approval of a physician. (Health and Safety Code (HSC) § 11362.5)
Declares that the purposes of the CUA are to ensure that seriously ill Californians have the right to obtain and use marijuana for medical purposes where that medical use is deemed appropriate and has been recommended by a physician who has determined that the person’s health would benefit from the use of marijuana in the treatment of cancer, anorexia, AIDS, chronic pain, spasticity, glaucoma, arthritis, migraine, or any other illness for which marijuana provides relief; to ensure that patients and their primary caregivers who obtain and use marijuana for medical purposes upon the recommendation of a physician, are not subject to criminal prosecution or sanction; and to encourage the federal and state governments to implement a plan to provide for the safe and affordable distribution of marijuana to all patients in medical need of marijuana. (HSC § 11362.5 (b)(1)(A) to (C))
Does not apply, relating to the possession and the cultivation of marijuana, to a patient, or to a patient’s primary caregiver, who possesses or cultivates marijuana for the personal medical purposes of the patient upon the written or oral recommendation or approval of a physician. (HSC § 11362.5 (d))
Establishes the Medical Marijuana Program Act (MMPA), which exempts qualified patients who hold an identification card issued pursuant to the Medical Marijuana Program (MMP) and the caregivers of those persons, from certain state criminal sanctions related to the possession, cultivation, transportation, processing, or use of limited amounts of marijuana, as specified. (HSC § 11362.7 et seq.)
Requires the California Department of Public Health (CDPH) to establish and maintain a voluntary program for qualified patients to apply for identification cards, and county health departments to issue identification cards to qualified patients and their caregivers. (HSC § 11362.71 (a) & (b))
Provides that persons with valid identification cards shall not be subject to arrest for possession, transportation, delivery, or cultivation of marijuana, absent evidence of fraud. (HSC § 11362.71 (e))
Requires county health departments to issue serially numbered identification cards to patients and caregivers containing the following: a unique user identification number, an expiration date, the county health department’s name and telephone number, photo identification of the cardholder, and a toll-free CDPH telephone number enabling state and local law enforcement officers to immediately verify the card’s validity. (HSC Section 11362.735 (a))
Prohibits medical marijuana dispensaries that possess, cultivate, or distribute medical marijuana from being located within a 600 foot radius of a school, and authorizes cities and counties to further restrict the locations of medical marijuana collectives. (HSC § 11362.768)
Provides that qualified patients, persons with valid identification cards, and the designated primary caregivers of qualified patients and persons with identification cards who associate within the State of California in order to cultivate marijuana for medical purposes, collectively or cooperatively, shall not, solely on that basis, be subject to state criminal sanctions for the possession, sale, transport, or other proscribed acts relating to marijuana. (HSC § 11362.775)
Lists marijuana as a hallucinogenic substance in Schedule I of the California Uniform Controlled Substances Act. (HSC § 11054 (d))
This bill:
Enacts the Medical Marijuana Public Safety and Environmental Protection Act (Act) and makes findings and declarations about the need for greater statewide standards and an effective statewide system for regulating and controlling medical marijuana while clarifying that the Act shall not have a diminishing effect on the rights and protections granted to a patient or primary caregiver pursuant to the CUA nor shall be construed to promote or facilitate the nonmedical, recreational possession, sale, or use of marijuana.
Establishes the Office of Medical Marijuana Regulation (Office) in the Business, Consumer Services Housing Agency under the supervision and control of the Chief appointed by the Governor, subject to confirmation by the Senate Committee on Rules. Provides the Office with the authority to issue, suspend, or revoke conditional licenses related to medical marijuana in the state and collect fees in connection with cultivation, manufacture, transportation, storage, distribution and sale. Provides the Office the authority to create, issue, suspend, or revoke other licenses in order to protect patient health and the public and to facilitate the regulation of medical marijuana.
Provides the Office the authority to implement the Act, including, but not limited to, establishing rules or regulations necessary to carry out the purposes and intent of the Act so long as they shall not limit any authority of a city, county, or city and county provided by law. Provides the Office the authority for issuing conditional licenses to persons for the cultivation, manufacture, transportation, storage, distribution, and sale of medical marijuana within the state; setting application, licensing, and renewal fees for conditional licenses; establishing standards for the cultivation, manufacturing, transportation, storage, distribution, provision, donation, and sale of medical marijuana and medical marijuana products; establishing procedures for the issuance, renewal, suspension, denial, and revocation of conditional licenses; imposing a penalty; enforcing the licensing and regulatory requirements of the Act; overseeing the operation of the Medical Marijuana Regulation Fund and the Special Account for Environmental Enforcement and; consulting with other state or local agencies, departments, representatives of the medical marijuana community, or public or private entities for the purposes of establishing statewide standards and regulations.
Provides that a person shall not sell or provide medical marijuana to a patient or caregiver other than at a licensed dispensing facility or through delivery from a licensed dispensing facility unless otherwise authorized under the CUA and MMPA. Provides that a person shall not grow medical marijuana other than at a licensed cultivation site unless otherwise authorized under the CUA and MMPA. Provides that a person shall not manufacture medical marijuana or medical marijuana products other than a licensed manufacturer unless otherwise authorized under the CUA and MMPA. Provides that a person other than a licensed transporter shall transport medical marijuana from one facility issued a conditional license to another.
Requires the Office, beginning no later than July 1, 2018, to provide for and issue conditional licenses for all activity authorized under the Act, including, but not limited to the cultivation, processing, storage, transport and dispensing of medical marijuana. Clarifies that the issuance of a conditional license shall not, in and of itself, authorize the recipient to begin business operations, but it does certify, at a minimum, that the applicant has paid the state conditional licensing fee, successfully passed a criminal background check, and met the state residency requirements. Prohibits a conditionally licensed facility from commencing activity under the authority of that license until the applicant has also obtained a license or permit from the local jurisdiction in which he or she proposes to operate, following the requirements of local ordinances.
Specifies that a conditional license is subject to the restrictions of the local jurisdiction in which the facility operates or proposes to operate. Clarifies that even if a conditional license has been granted pursuant to the Act, a facility shall not operate in a local jurisdiction that prohibits the establishment of that type of business. Authorizes local jurisdictions retain the power to assess fees and taxes, as applicable, on facilities that are conditionally licensed and the business activities of those licensees.
Outlines requirements for a licensed transporter, including that it ship only to facilities issued a conditional license and only in response to a request for a specific quantity and variety; it complete a shipping manifest form prescribed by the Office prior to transporting medical marijuana products and that; it securely transmit a copy of the manifest to the licensee that will receive the medical marijuana product as well as to the Office prior to transport and that both transporters and licensed facilities maintain each shipping manifest and make it available to local code enforcement officers, any other locally designated enforcement entity as well as the Office upon request. Prohibits a local jurisdiction from preventing transportation through or to a facility issued a conditional license by a conditionally licensed transporter acting in compliance with the Act.
Authorizes the Office to enforce the Act and requires the Office to delegate the authority to enforce the Act, including any regulations, to a city, county, or city and county, upon request of that entity. Clarifies that nothing in the Act shall be interpreted to supersede or limit existing local authority for law enforcement activity, enforcement of local zoning requirements, or enforcement of local licensing and clarified that nothing in the Act shall be interpreted to require the Office to undertake local law enforcement responsibilities, enforce local zoning requirements, or enforce local licensing requirements.
Specifies requirements for cultivation sites, prohibiting them from being located in an area zoned residential and requires the Office to notify local law enforcement of all conditional licenses issued for cultivation sites in that jurisdiction. Provides that no later than January 1, 2022, all medical marijuana grown, produced, distributed and sold in the state shall meet the certified organic standards. Requires the Office to establish appellations of origin for marijuana grown in California and work with county agricultural commissioners to provide all the information and forms required for conditional licensure as a cultivation site in a single location.
Authorizes the board of supervisors of a county or the city council of a city to impose, by ordinance, a tax on the privilege of cultivating, dispensing, producing, processing, preparing, storing, providing, donating, selling, or distributing marijuana by a licensee operating under the Act. Authorizes the tax to be imposed for general governmental purposes or for purposes specified in the ordinance. Subjects a tax for these purposes to applicable voter approval requirements imposed by law.
Requires the Office, on or before July 1, 2017, to report to the Legislature on the feasibility of developing a program to certify laboratories for the testing of medical marijuana and related products and the feasibility of developing a labeling requirement for edible marijuana products that incorporates information on the cannabinoid content. Requires conditionally licensed facilities to maintain supplier information in order for recall procedures to be implemented, if and when necessary and label all medical marijuana and medical marijuana products according to certain requirements. Sets forth certain health and safety requirements for products sold in a conditionally licensed facility.
Requires, on or before July 1, 2016, the State Board of Equalization to complete a report and submit it to the Legislature and Governor’s Office on the actual tax collected actual tax collected on the sale of medical marijuana, using the most current data available. States that the report should also include expected tax revenues, under the existing tax structure, for the years 2016 to 2021, inclusive.
Background
According to the author, since the voters of California passed Proposition 215 in 1996, it has become clear that there needs to be a comprehensive regulation bill from the Legislature that oversees the cultivating, processing, manufacturing, transportation, prescribing and sale of medical marijuana. The author adds that the Legislature has worked hard over the last couple of years to enact a regulatory program that will recognize the voter’s mandate, streamline the ability of the industry to grow and sell a legal product and that this bill contains much of that hard work as well as reflects the efforts of many groups, individuals who have spent years working in this industry.
The author notes that currently, there are virtually no rules and regulations on the cultivation side of the medical marijuana industry, and it is important to bring this legal crop into the regulatory framework expected for other commodities. The author adds that the severe drought California is experiencing has only made the need for his legislation all the more urgent.
This bill focuses on a number of key aspects of medical marijuana cultivation and proposes regulatory changes for those items.
Compassionate
Use Act of 1996. Since the approval of the CUA, Proposition 215,
by voters in 1996, state law has allowed Californians access to
marijuana for medical purposes, and prohibits punitive action against
physicians for making medical marijuana recommendations. The CUA
established the right of patients to obtain and use marijuana to
treat specified illnesses and any other illness for which marijuana
provides relief. The CUA prohibits prosecution for growing or using
marijuana for Californians who have the oral or written
recommendation of their doctors and for these patients’ caregivers.
Additionally, the CUA specifically protects physicians who recommend
the use of marijuana to patients for medical purposes and exempts
qualified patients and their primary caregivers from California drug
laws prohibiting possession and cultivation of marijuana.
The
CUA is a very general law. While it establishes the right of a
patient to obtain medical marijuana pursuant to a physician’s
recommendation, the initiative then simply encourages the state and
federal governments to “implement a plan for safe and affordable
distribution of marijuana [to qualified patients].” It has been
argued that very little has been done to implement the initiative.
Instead of a comprehensive implementation plan, numerous
uncoordinated bills have been introduced in the Legislature.
Further, the courts have only provided a small measure of clarity and
certainty in this area.
Medical Marijuana Program. Established by SB 420 (Vasconcellos, Chapter 875, Statutes of 2003) and administered by CDPH when the Legislature sought to clarify Prop 215 and the CUA, the MMP created a state-authorized medical marijuana identification card (MMP Card), along with a registry database for verification of qualified patients and their primary caregivers. Participation by patients and primary caregivers in this identification card program is voluntary. The MMP Web-based registry allows law enforcement and the public to verify the validity of a qualified patient or primary caregiver’s MMP Card as authorization to possess, grow, transport, and/or use medical marijuana within California.
Federal regulation. Even though California voters enacted the CUA to permit the use of marijuana for medical purposes by persons deemed qualified by their physicians, marijuana still is an illegal drug both under federal and state law, and its use, possession, distribution, cultivation, or sale carries criminal penalties. In August of 2013, the U.S. Department of Justice (USDOJ) issued a memorandum titled “Guidance Regarding Marijuana Enforcement” to all U.S. Attorneys. The memorandum updated the prior guidance given by USDOJ regarding marijuana enforcement under the federal Controlled Substances Act, in light of state ballot initiatives that legalize marijuana under state laws and that provide for the possession and use of small amounts of marijuana. While affirming that marijuana is still, at the federal level, considered a dangerous drug and that the illegal distribution and sale of marijuana is a serious crime, the memorandum outlines enforcement priorities that are particularly important to the federal government, including: preventing distribution to minors; preventing revenue from marijuana from going to criminal enterprises; preventing diversion to other states where marijuana is not legal under state law; preventing state-authorized marijuana from being a cover for trafficking in other illegal drugs or illegal activity; preventing violence in cultivating and distributing marijuana; preventing drugged driving and other public health problems from marijuana use; and preventing growing, possessing or using marijuana on public lands or on federal property. The document clearly lays out the federal expectation for the states that have legalized marijuana, even if only for medical purposes, that they will develop a robust system of regulation and enforcement, and that such a system will reduce the likelihood of federal enforcement activity.
Environmental concerns. California land, watersheds and some species, particularly in the author’s district, have been significantly damaged as a result of certain marijuana cultivation efforts. “Trespass grows”, cultivating marijuana without permission on public, tribal or privately owned land, have been associated with wildlife poisoning, use and dumping of fertilizers and pesticides, illegal water diversions and water pollution, logging and land disturbance, and severe problems with garbage and human waste. These industrial-size marijuana grows, taking place in the National Forests and on private timberland in some of the state’s most remote and ecologically sensitive areas, are the subject of a recent study by the California Department of Fish and Wildlife, “Impacts of Surface Water Diversions for Marijuana Cultivation on Aquatic Habitat in Four Northwestern California Watershed,” which showed that during drought conditions, water demand for marijuana cultivation exceeded stream flow in three of four study watersheds and that diminished stream flow from this water-intensive activity is likely to have lethal to sub-lethal effects on state and federally listed salmon and steelhead trout and will cause further decline of sensitive amphibian species.
Other states. Currently, 23 States and the District of Columbia have laws related to medical marijuana or create a cannabis program or legal provisions to allow for the medical use of marijuana. The experiences of other states have helped to inform the current conversation in California. Notably, this bill establishes standards for transport of medical marijuana products and security surrounding transport, proper preparation and labeling of edible medical marijuana products and requirements for testing of products. Other states have attempted to ensure safety for the transit of these products, particularly given the high value of products and tendency toward cash transactions in the industry.
FISCAL EFFECT: Appropriation: No Fiscal Com.: Yes Local: Yes
According to the Senate Appropriations Committee:
Ongoing costs, likely over $20 million per year to license medical marijuana cultivators, transporters, and dispensaries by the Office (special fund). For comparison, the California State Board of Pharmacy, which licenses and regulates pharmacists and pharmacies in the state has an annual budget of about $20 million per year.
This bill creates the Office dedicated to licensing and enforcing licensing requirements on the medical marijuana industry. The annual costs to operate the Office are highly uncertain. For example, the number of medical marijuana cultivators, transporters, and dispensaries that would apply for licensure under this bill is not known, in part because it is difficult to know how the licensing and regulatory requirements in this bill will change current practices in the medical marijuana industry.
Unknown costs for enforcement of this bill’s requirements by local governments (local funds and special funds). This bill requires the Office to enforce its provisions, but requires the Office to delegate enforcement authority to requesting local agencies. How those responsibilities will be divided between levels of government and how much funding the state will make available to local governments for enforcement activity is unknown at this time.
Unknown fee revenues to offset the costs to implement this bill (special fund). This bill gives the Office broad authority to set licensing fees sufficient to pay for the Office’s costs to operate the licensing program, costs incurred by the Office or the Department of Justice to enforce this bill, costs incurred by local law enforcement agencies to enforce this bill, and costs incurred by state and local environmental agencies for enforcement costs relating to cultivation facilities. The fee revenues generated under this bill will depend both on the allowed costs that are incurred at the state and local level as well as the feasibility of collecting sufficient fees from the medical marijuana industry.
Unknown costs for the Department of Justice to conduct criminal background checks of licensees (special fund). Under current practice, applicants for a criminal background check are required to pay the $65 cost to conduct a criminal background check using fingerprint databases.
Ongoing costs of about $1 million per year for enforcement of food and drug safety requirements on medical marijuana products by CDPH (General Fund or fee revenues from licensees).
None received
None received
Prepared by: Sarah Mason / B., P. & E.D. / (916) 651-4104
6/3/15 16:48:21
**** END ****
SB 643 (McGuire) Page 4 of 4
SENATE COMMITTEE ON APPROPRIATIONS
Senator Ricardo Lara, Chair
2015 - 2016 Regular Session
SB 643 (McGuire) - Medical marijuana
|
|
Version: May 6, 2015 |
Policy Vote: B., P. & E.D. 7 - 0, GOV. & F. 5 - 1 |
Urgency: No |
Mandate: Yes |
Hearing Date: May 28, 2015 |
Consultant: Brendan McCarthy |
SUSPENSE FILE. AS AMENDED.
Bill Summary:
SB 643 would establish a licensing and regulatory framework for medical marijuana, to be administered by a new bureau within the Department of Consumer Affairs and enforced primarily by local governments.
Fiscal Impact (as approved on May 28, 2015):
Ongoing costs, likely over $20 million per year to license medical marijuana cultivators, transporters, and dispensaries by the new Office of Medical Marijuana Regulation (special fund). For comparison, the California State Board of Pharmacy, which licenses and regulates pharmacists and pharmacies in the state has an annual budget of about $20 million per year.
The bill would create a new Office dedicated to licensing and enforcing licensing requirements on the medical marijuana industry. The annual costs to operate the new Office are highly uncertain. For example, the number of medical marijuana cultivators, transporters, and dispensaries that would apply for licensure under the bill is not known, in part because it is difficult to know how the licensing and regulatory requirements in the bill will change current practices in the medical marijuana industry.
Unknown costs for enforcement of the bill’s requirements by local governments (local funds and special funds). The bill requires the Office to enforce its provisions, but requires the Office to delegate enforcement authority to requesting local agencies. How those responsibilities will be divided between levels of government and how much funding the state will make available to local governments for enforcement activity is unknown at this time.
Unknown fee revenues to offset the costs to implement the bill (special fund). The bill gives the new Office broad authority to set licensing fees sufficient to pay for the Office’s costs to operate the licensing program, costs incurred by the Office or the Department of Justice to enforce the bill, costs incurred by local law enforcement agencies to enforce the bill, and costs incurred by state and local environmental agencies for enforcement costs relating to cultivation facilities. The fee revenues generated under the bill would depend both on the allowed costs that are incurred at the state and local level as well as the feasibility of collecting sufficient fees from the medical marijuana industry.
Unknown costs for the Department of Justice to conduct criminal background checks of licensees (special fund). Under current practice, applicants for a criminal background check are required to pay the $65 cost to conduct a criminal background check using fingerprint databases.
Ongoing costs of about $1 million per year for enforcement of food and drug safety requirements on medical marijuana products by the Department of Public Health (General Fund or fee revenues from licensees).
Background:
Under the Compassionate Use Act of 1996 (a voter approved initiative measure), state law prohibits the criminal prosecution of a patient with specified illnesses or a caregiver for possession or cultivation of marijuana upon the recommendation of a physician.
Under current law, the Department of Public Health operates a program under which individuals can apply for an identification card for the use of medical marijuana.
Proposed Law:
SB 643 would establish a licensing and regulatory framework for medical marijuana, to be administered by a new bureau within the Department of Consumer Affairs and enforced primarily by local governments.
Specific provisions of the bill would:
Prohibit physicians who prescribe medical marijuana from receiving compensation from licensed medical marijuana facilities;
Prohibit a physician from prescribing medical marijuana, unless the physician is the patient’s attending physician;
Create a new Bureau of Medical Marijuana Regulation within the Department of Consumer Affairs;
Authorize the new Bureau to issue and revoke licenses for marijuana cultivation, manufacture, transportation, storage, distribution and sale;
Require the Department of Consumer Affairs to provide an initial loan to cover startup costs of the new Bureau, to be paid back with subsequent fee revenues;
Authorize the new Bureau to adopt regulations, issue licenses, set fees for application, licensing and renewal, and certify laboratories for testing marijuana;
Require the new Bureau to develop standards for licensing, protection of environmental, agricultural, consumer protection, and food and safety requirements;
Provide that the bill does not supersede local ordinances or regulations;
Require medical marijuana to be grown, transported, and sold only under license;
Specify the requirements for licensure;
Require a criminal background check of an applicant as part of the licensure process;
Prohibit the issuance of a license if the applicant has one of a specified list of convictions;
Prohibit a licensed facility from operating in a jurisdiction that prohibits the establishment of that type of business;
Require the new Bureau to establish licensing fees sufficient to pay for the costs of the licensing program, costs incurred by the state for enforcement, costs incurred by local law enforcement for enforcement, and costs for several state agencies and local agencies to enforce regulations relating to the environmental impact of licensed cultivation sites;
Create a new special fund for deposit of licensing fee revenues and continuously appropriate those funds;
Require deposit of penalty revenues in the General Fund;
Specify the standards for transportation of medical marijuana;
Require local governments to enforce the statutory and regulatory requirements of the bill;
Specify the standards for cultivation of medical marijuana;
Specify the licensing requirements for licensed facilities;
Require annual audits of all licensed facilities;
Specifically authorize a local government to impose a tax measure relating to medical marijuana (local governments would still need to receive voter approval for such tax measures);
Specify regulatory requirements for edible marijuana products;
Require the Board of Equalization to report on tax revenues relating to medical marijuana.
Related Legislation:
SB 1262 (Correa, 2014) was similar to this bill. That bill was held in the Assembly Appropriations Committee.
AB 604 (Ammiano) would have required the Department of Alcohol Beverage Control to regulate the cultivation and sale of medical marijuana. That bill was held in the Senate Public Safety Committee.
AB 1894 (Ammiano) is substantially similar to AB 604. Failed passage on the Assembly Floor.
Staff Comments:
Prop 26 limits the imposition of fees by legislative action. Under Proposition 26, state agencies may impose fees on regulated entities to perform licensing activities and enforce licensing requirements.
As noted above, the bill requires that the duty of enforcing and administering the bill be vested in the chief of the new Bureau of Medical Marijuana Regulation. However, the bill also requires that cities and counties shall have the full power and authority to enforce the provisions of the bill. How the new Bureau and local governments share responsibility for enforcement activities and the level of grant funding that the Bureau makes available to local governments for enforcement activity will have a significant impact on how the bill’s provisions will be enforced.
The bill mandates that local governments enforce the requirements of the bill (both explicit statutory requirements and requirements in regulations adopted by the new Bureau of Medical Marijuana Regulation). The bill also explicitly allows local governments to prohibit medical marijuana establishments in their jurisdiction. Because local governments can opt out of the enforcement requirements of the bill by prohibiting medical marijuana facilities in their jurisdiction, the bill does not impose a reimbursable mandate on the state. (Note, however, that the bill does authorize the new Bureau to establish licensing fees sufficient to cover both the Bureau’s licensing and enforcement costs and local enforcement costs.) The only other costs that may be incurred by a local agency relate to crimes and infractions. Such costs are not reimbursable by the state under the California Constitution.
Committee amendments (as adopted May 28, 2015): change the new entity from a bureau into an office and place the office within the Business, Consumer Services and Housing Agency. The amendments authorize the Office to enforce the provisions of the bill but also require the Office to delegate enforcement responsibilities to local governments, upon request. The amendments delete the requirement for certification of testing laboratories, delete the continuous appropriations of funds, and make a variety of clarifying changes to the licensing requirements.
-- END --
SB 643 (McGuire) Page 4 of 4
SENATE COMMITTEE ON APPROPRIATIONS
Senator Ricardo Lara, Chair
2015 - 2016 Regular Session
SB 643 (McGuire) - Medical marijuana
|
|
Version: May 6, 2015 |
Policy Vote: B., P. & E.D. 7 - 0, GOV. & F. 5 - 1 |
Urgency: No |
Mandate: Yes |
Hearing Date: May 18, 2015 |
Consultant: Brendan McCarthy |
This bill meets the criteria for referral to the Suspense File.
Bill Summary:
SB 643 would establish a licensing and regulatory framework for medical marijuana, to be administered by a new bureau within the Department of Consumer Affairs and enforced primarily by local governments.
Fiscal Impact:
Ongoing costs, likely over $20 million per year to license medical marijuana cultivators, transporters, and dispensaries by the new Bureau of Medical Marijuana Regulation (special fund). For comparison, the California State Board of Pharmacy, which licenses and regulates pharmacists and pharmacies in the state has an annual budget of about $20 million per year.
The bill would create a new Bureau dedicated to licensing and enforcing licensing requirements on the medical marijuana industry. The annual costs to operate the new Bureau are highly uncertain. For example, the number of medical marijuana cultivators, transporters, and dispensaries that would apply for licensure under the bill is not known, in part because it is difficult to know how the licensing and regulatory requirements in the bill will change current practices in the medical marijuana industry.
Unknown costs for enforcement of the bill’s requirements by local governments (local funds and special funds). The bill requires both the new Bureau and local governments to take responsibility for enforcement activity. How those responsibilities will be divided between levels of government and how much funding the state will make available to local governments for enforcement activity is unknown at this time. Because local governments have the legal authority under the bill to prohibit the operation of medical marijuana facilities in their jurisdictions, local governments can essentially opt out of the enforcement responsibilities required under the bill. Thus the state is not likely to be required to reimburse local governments for enforcement costs.
Unknown costs for the Department of Justice to conduct criminal background checks of licensees (special fund). Under current practice, applicants for a criminal background check are required to pay the $65 cost to conduct a criminal background check using fingerprint databases.
Unknown fee revenues to offset the costs to implement the bill (special fund). The bill gives the new Bureau broad authority to set licensing fees sufficient to pay for the Bureau’s costs to operate the licensing program, costs incurred by the Bureau or the Department of Justice to enforce the bill, costs incurred by local law enforcement agencies to enforce the bill, and costs incurred by state and local environmental agencies for enforcement costs relating to cultivation facilities. The fee revenues generated under the bill would depend both on the allowed costs that are incurred at the state and local level as well as the feasibility of collecting sufficient fees from the medical marijuana industry. The bill would continuously appropriate the fee revenues deposited in a new special fund to implement the bill.
Background:
Under the Compassionate Use Act of 1996 (a voter approved initiative measure), state law prohibits the criminal prosecution of a patient with specified illnesses or a caregiver for possession or cultivation of marijuana upon the recommendation of a physician.
Under current law, the Department of Public Health operates a program under which individuals can apply for an identification card for the use of medical marijuana.
Proposed Law:
SB 643 would establish a licensing and regulatory framework for medical marijuana, to be administered by a new bureau within the Department of Consumer Affairs and enforced primarily by local governments.
Specific provisions of the bill would:
Prohibit physicians who prescribe medical marijuana from receiving compensation from licensed medical marijuana facilities;
Prohibit a physician from prescribing medical marijuana, unless the physician is the patient’s attending physician;
Create a new Bureau of Medical Marijuana Regulation within the Department of Consumer Affairs;
Authorize the new Bureau to issue and revoke licenses for marijuana cultivation, manufacture, transportation, storage, distribution and sale;
Require the Department of Consumer Affairs to provide an initial loan to cover startup costs of the new Bureau, to be paid back with subsequent fee revenues;
Authorize the new Bureau to adopt regulations, issue licenses, set fees for application, licensing and renewal, and certify laboratories for testing marijuana;
Require the new Bureau to develop standards for licensing, protection of environmental, agricultural, consumer protection, and food and safety requirements;
Provide that the bill does not supersede local ordinances or regulations;
Require medical marijuana to be grown, transported, and sold only under license;
Specify the requirements for licensure;
Require a criminal background check of an applicant as part of the licensure process;
Prohibit the issuance of a license if the applicant has one of a specified list of convictions;
Prohibit a licensed facility from operating in a jurisdiction that prohibits the establishment of that type of business;
Require the new Bureau to establish licensing fees sufficient to pay for the costs of the licensing program, costs incurred by the state for enforcement, costs incurred by local law enforcement for enforcement, and costs for several state agencies and local agencies to enforce regulations relating to the environmental impact of licensed cultivation sites;
Create a new special fund for deposit of licensing fee revenues and continuously appropriate those funds;
Require deposit of penalty revenues in the General Fund;
Specify the standards for transportation of medical marijuana;
Require local governments to enforce the statutory and regulatory requirements of the bill;
Specify the standards for cultivation of medical marijuana;
Specify the licensing requirements for licensed facilities;
Require annual audits of all licensed facilities;
Specifically authorize a local government to impose a tax measure relating to medical marijuana (local governments would still need to receive voter approval for such tax measures);
Specify regulatory requirements for edible marijuana products;
Require the Board of Equalization to report on tax revenues relating to medical marijuana.
Related Legislation:
SB 1262 (Correa, 2014) was similar to this bill. That bill was held in the Assembly Appropriations Committee.
AB 604 (Ammiano) would have required the Department of Alcohol Beverage Control to regulate the cultivation and sale of medical marijuana. That bill was held in the Senate Public Safety Committee.
AB 1894 (Ammiano) is substantially similar to AB 604. Failed passage on the Assembly Floor.
Staff Comments:
Prop 26 limits the imposition of fees by legislative action. Under Proposition 26, state agencies may impose fees on regulated entities to perform licensing activities and enforce licensing requirements.
As noted above, the bill requires that the duty of enforcing and administering the bill be vested in the chief of the new Bureau of Medical Marijuana Regulation. However, the bill also requires that cities and counties shall have the full power and authority to enforce the provisions of the bill. How the new Bureau and local governments share responsibility for enforcement activities and the level of grant funding that the Bureau makes available to local governments for enforcement activity will have a significant impact on how the bill’s provisions will be enforced.
The bill mandates that local governments enforce the requirements of the bill (both explicit statutory requirements and requirements in regulations adopted by the new Bureau of Medical Marijuana Regulation). The bill also explicitly allows local governments to prohibit medical marijuana establishments in their jurisdiction. Because local governments can opt out of the enforcement requirements of the bill by prohibiting medical marijuana facilities in their jurisdiction, the bill does not impose a reimbursable mandate on the state. (Note, however, that the bill does authorize the new Bureau to establish licensing fees sufficient to cover both the Bureau’s licensing and enforcement costs and local enforcement costs.) The only other costs that may be incurred by a local agency relate to crimes and infractions. Such costs are not reimbursable by the state under the California Constitution.
-- END --
SB 643 (McGuire) 4/6/15 Page 5 of 5
SENATE COMMITTEE ON GOVERNANCE AND FINANCE
Senator Robert M. Hertzberg, Chair
2015 - 2016 Regular
Bill No: |
SB 643 |
Hearing Date: |
4/29/15 |
Author: |
McGuire |
Tax Levy: |
No |
Version: |
4/6/15 |
Fiscal: |
Yes |
Consultant: |
Grinnell & Weinberger |
||
MEDICAL MARIJUANA
Enacts a new regulatory framework for medical marijuana, authorizes local agencies to tax marijuana products, and prohibits marijuana cultivation in areas zoned residential.
Background and Existing Law
I. Local Taxes. Section Five of Article XI of the California Constitution allows charter cities to levy taxes which haven’t been preempted by state or federal governments. The Government Code also allows general law cities, but not counties, to levy any tax that a charter city can unless state law limits or prohibits such a tax. Article XIIIA of the California Constitution requires 2/3 voter approval when a local agency wants to impose or increase a special tax, or majority vote for general taxes.
In 1933, California enacted its sales tax, followed by the use tax two years later. Charter cities began applying their own sales taxes soon after, commencing with the City of San Bernardino in 1945. The Legislature also first authorized general law cities to levy their own sales and use taxes in 1949. While BOE administered the state tax, each city imposed, collected, and audited its own sales and use tax, which could be set at any rate the city chose, and could apply to different products than the state or other city sales taxes.
In 1955, the Legislature enacted the Bradley Burns Local Sales and Use Tax Law to provide uniformity for local sales and use taxes. The uniform act allowed local agencies to levy its own tax of one percent, and centralized administration, collection, and audit with the Board of Equalization (BOE), replacing the previous system where each city implemented its own tax on whatever products it chose. The Act required local agencies to be perfectly uniform with each other and the state, charge the same rate, and adopt the state’s base for the sales tax, which is “tangible personal property.” This tax rate currently is fixed at 1% of the sales price of tangible personal property sold at retail in the local jurisdiction, or purchased outside the jurisdiction for use within the jurisdiction. Of this 1%, cities and counties use 0.75% to support general operations, and the remaining 0.25% is designated by statute for county transportation purposes. In California, all cities and counties impose Bradley-Burns local taxes at the uniform rate of 1%.
Subsequently, the Legislature allowed cities, counties, and special districts to impose their own Transactions and Use tax within its jurisdiction subject to voter approval, known as “local add-ons” or “district taxes,” so long as they relied on the same base and procedures as the sales and use tax. Beginning April 1, 2015, 202 local jurisdictions (city, county, and special districts) will impose a district tax for general or specific purposes. Of the 202 jurisdictions, 48 are county-imposed taxes 154 are levied by cities, and of the 48 county-imposed taxes, 29 are imposed for transportation purposes. Cities and Counties may increase the sales and use tax rate, but state law caps the total rate for any county at 2%, with some exceptions. Cities and counties must contract with BOE to collect and remit both taxes, and BOE retains its administration costs before sending tax revenue to the appropriate local agency.
II. Licensing and Regulation of Medical Marijuana. Current law directs the Department of Consumer Affairs to regulate many businesses and professions to ensure public health, safety, and welfare, including the Medical Board, which licenses and regulates physicians and surgeons.
In 1996, voters enacted the Compassionate Use Act, which prohibits prosecution for the possession and cultivation of marijuana of a patient or their caregiver upon written or oral recommendation of a physician. The Act provided that it shouldn’t be construed to supersede legislation prohibiting conduct that endangers others, or to condone diversion of marijuana for non-medical purposes. However, no comprehensive statewide regulatory system currently applies to medical marijuana.
III. Zoning. The police power is the inherent authority of governments to regulate private behavior to protect the public safety, health, and welfare. The California Constitution allows counties and cities to adopt and enforce local ordinances, provided that they don't conflict with general state laws. When counties and cities adopt local zoning ordinances, they are using their police powers. The Planning and Zoning Law spells out the procedures that county supervisors and city councils must follow when they adopt zoning ordinances.
Proposed Law
Senate Bill 643 enacts the Medical Marijuana Public Safety and Environmental Protection Act, which creates a regulatory structure for medical marijuana in California, allows local agencies to levy taxes on licensees under the Act, and preempts local zoning ordinances.
I. Local Taxes. SB 643 allows a board of supervisors or a city council to enact an ordinance imposing a tax on the privilege of cultivating, dispensing, producing, processing, preparing, storing, providing, donating, selling or distributing marijuana, as defined by the bill. The board of supervisors or city council:
Must specify the activities subject to the tax, the applicable rate or rates, the method of apportionment, and the manner of collection of the tax in the ordinance.
May impose a general or special tax, so long as voters approve the measure under the appropriate Constitutional vote threshold.
May impose a transactions and use tax administered by BOE only on marijuana or marijuana products, as defined, and any rate imposed isn’t subject to the 2% cap on local transactions and use taxes.
Provide for the collection of the tax in the same manner, and subject to the same penalties as other local taxes.
A county board of supervisors must specify whether the tax applies throughout the entire county or within the unincorporated area of the county.
The tax can be imposed on activities undertaken individually, collectively, or cooperatively, and regardless of whether the activity is for compensation or gratuitously. The tax need not be apportioned based on the benefit to any person or property, or be applied uniformly to all taxpayers or real property. Additionally, SB 643 provides that its tax doesn’t limit or prohibit any other lawfully imposed fee.
II. Medical Marijuana Regulation. SB 643 creates the Bureau of Medical Marijuana Regulation within DCA, empowering it to license and regulate many aspects of medical marijuana cultivation, manufacturing, transportation, storage, distribution, and sale, and charge fees to pay for its licensing and enforcement duties. The measure provides direction to DCA and the Medical Board regarding regulating and sanctioning physicians who violate the bill’s terms, including creating misdemeanor crimes for specified acts. Additionally, the measure:
Regulates advertising physician recommendations.
Directs local agencies to have primary responsibility for enforcement of the act’s requirements.
Authorizes regulations to establish worker safety standards.
Ensures commercial marijuana activity licensed by the Act doesn’t threaten the environment and watersheds.
Requires medical marijuana to meet certified organic standards by January 1, 2022.
Provides that it does not supersede provisions of Measure D, as approved by the voters of the City of Los Angeles, or other similar measures.
Additionally, the measure provides that licensees must abide with any restrictions imposed by the local agency in which the facility operates, and must not operate in any jurisdiction that prohibits the establishment of that kind of business. For a more thorough analysis of the measure’s regulatory program, please refer to the Committee on Business and Professions analysis.
III. Local Zoning. SB 643 prohibits a licensed cultivation site from being located in an area zoned residential.
IV. State Tax/BOE Report. The measure allows the Bureau to assist state taxation authorities in the development of uniform policies for the state taxation of licensees. Additionally, the measure directs BOE to report to the Legislature to compile the actual tax collected on the sale of medical marijuana using the most current data available for years between 2016 and 2021.
The measure makes legislative findings supporting its purposes, defines many of its term, and includes a severability clause. The measure also makes specific findings regarding restricting the right of public access to information due to federal medical information laws.
State Revenue Impact
No estimate.
Comments
1. Purpose of the bill. According to the author, “SB 643 seeks to resolve many of the issues created by the enactment of the Compassionate Use Act and subsequent legislation. SB 643 creates a statewide comprehensive program overseeing the medical marijuana industry, from planting to consumption, and all the steps in between. California voters made it clear that they wanted medical marijuana to be legalized, but issues and concerns for growers, doctors, dispensaries, law enforcement, district attorneys, cities, counties and others have only become more complicated. The Author, who represents the primary growing region for medical marijuana in the western United States, specifically remote expanses of Mendocino, Humboldt and Trinity counties, which are responsible for up to 70% of the marijuana grown in the west, notes that much of this area of the state has come to rely on the economic benefits of marijuana cultivation, but also suffers from the negative environmental, public safety and public health effects that can arise from rogue cultivators and lack of regulation. The bill focuses on a number of key aspects of medical marijuana cultivation and proposes regulatory changes for those items, including banning commercial cultivation sites in areas zoned residential. According to the Author, this has been a big issue for neighborhoods and residences around the state. Commercial and industrial uses do not belong in residential areas, and medical marijuana grows create special problems that neighbors shouldn’t have to deal with. The measure also allows local governments to impose a tax or fee on cultivation, above the ultimate sales tax, to help defray the expense of regulating the cultivation and processing of the commodity in their jurisdiction. The Author states that this is designed to make sure local authorities can afford to pay for the implementation of the regulations allowed under this legislation or any other.”
2. Pay to play. SB 643 allows local agencies to impose transactions and use taxes specifically on marijuana products using higher rates than the current uniform rate on sales of all other tangible personal property. However, a local agency doing so may not receive any revenue because state law requires local agencies to contract with BOE to collect and remit the tax, and deduct its costs to do so from any revenue it remits to the local agency. BOE’s costs to administer the Bradley-Burns and Transactions and Use taxes can be spread over the hundreds of local agencies administering them, but a new tax only on one product requires BOE to create a new infrastructure to educate retailers, create returns, and procure information technology necessary to collect and remit revenue. The Committee may wish to consider deleting the measure’s transactions and use tax authority and make conforming changes, thereby ensuring that local agencies can tailor local taxes to their needs without incurring prohibitive costs.
3. Inputs and outputs. The bill requires BOE to report to the Legislature to compile the actual tax collected on the sale of medical marijuana using the most current data available for years between 2016 and 2021. However, retailers report one lump sum to BOE totaling all its sales of property, which isn’t divided into individual products. Instead of directing BOE to report information that it doesn’t receive, the measure should instead request BOE to estimate tax revenues.
4. Local control and state preemption. The California Constitution and state statutes delegate police power control over land use to locally elected officials. The Legislature has taken back these controls only in unusual instances involving important statewide objectives. SB 643 imposes a statewide ban on locating licensed cultivations sites within areas that are zoned for residential use. It is not clear why this state intrusion into local control over land use is warranted. While nothing prevents local officials from adopting zoning ordinances to prohibit cultivation sites in residential areas, why shouldn’t they have the discretion to decide, based on local conditions and priorities, that some cultivation sites are compatible with residential uses?
Additionally, charter cities have the constitutional authority to regulate their own municipal affairs, free of legislative interference. Their local regulations must give way only when statutes address issues of statewide concern. Because SB 643 does not assert that a cultivation site’s location is an issue of statewide concern, the bill may not apply to California's 121 charter cities. To avoid imposing on local officials’ land use discretion in some, but not all, local jurisdictions, the Committee may wish to consider amending SB 643 to delete the prohibition on locating cultivation sites in residential areas.
5. Incoming! The Senate Committee on Business and Professions approved SB 643 by a 7-0 vote on April 20th. This Committee is hearing the measure because of its local tax and zoning changes.
Support and Opposition
(4/23/15)
Support: Unknown.
Opposition: Unknown.
-- END --
SB 643 (McGuire) Page 33 of 33
SENATE COMMITTEE ON
BUSINESS, PROFESSIONS AND ECONOMIC DEVELOPMENT
Senator Jerry Hill, Chair
2015 - 2016 Regular
Bill No: SB 643 Hearing Date: April 20, 2015
Author: |
McGuire |
||
Version: |
April 6, 2015 |
||
Urgency: |
No |
Fiscal: |
Yes |
Consultant: |
Sarah Mason |
||
Subject: Medical marijuana
SUMMARY: Enacts the Medical Marijuana Public Safety and Environmental Protection Act. Establishes a licensing and regulatory framework for the cultivation, manufacture, transportation, storage, distribution and sale of medical marijuana to be administered by a Bureau of Medical Marijuana Regulation within the Department of Consumer Affairs and enforced primarily at the local level.
Existing law:
Specifies that the entities under the Department of Consumer Affairs (DCA) are established for the purpose of ensuring that those private businesses and professions deemed to engage in activities which have potential impact upon the public health, safety, and welfare are adequately regulated in order to protect the people of California. (Business and Professions Code (BPC) § 101.6)
Licenses and regulates physicians and surgeons under the Medical Practice Act (Act) by the Medical Board of California (MBC) within the DCA. (BPC § 2000 et seq.)
Provides that the MBC shall take action against a physician who is charged with unprofessional conduct, as specified. (BPC § 2234)
Requires the MBC to prioritize its investigative and prosecutorial resources to ensure that physicians representing the greatest threat of harm are identified and disciplined expeditiously and includes in that prioritization list: “Repeated acts of clearly excessive prescribing, furnishing, or administering of controlled substances, or repeated acts of prescribing, dispensing, or furnishing of controlled substances without a good faith prior examination of the patient and medical reason therefor.” (BPC § 2220.05)
The Compassionate Use Act of 1996 (CUA), an initiative measure, prohibits prosecution for the possession or cultivation of marijuana of a patient or a patient's primary caregiver who possesses or cultivates marijuana for the personal medical purposes of the patient upon the written or oral recommendation or approval of a physician. (Health and Safety Code (HSC) § 11362.5)
Declares that the purposes of the CUA are:
To ensure that seriously ill Californians have the right to obtain and use marijuana for medical purposes where that medical use is deemed appropriate and has been recommended by a physician who has determined that the person's health would benefit from the use of marijuana in the treatment of cancer, anorexia, AIDS, chronic pain, spasticity, glaucoma, arthritis, migraine, or any other illness for which marijuana provides relief.
To ensure that patients and their primary caregivers who obtain and use marijuana for medical purposes upon the recommendation of a physician, are not subject to criminal prosecution or sanction.
To encourage the Federal and State governments to implement a plan to provide for the safe and affordable distribution of marijuana to all patients in medical need of marijuana. (HSC § 11362.5 (b)(1)(A) to (C))
States that nothing in the CUA shall be construed to supersede legislation prohibiting persons from engaging in conduct that endangers others, or to condone the diversion of marijuana for non-medical purposes. (HSC § 11362.5 (b)(2))
Provides that, notwithstanding any other provision of law, no physician in California shall be punished, or denied any right or privilege, for having recommended marijuana to a patient for medical purposes. (HSC § 11362.5 (c))
States existing law, relating to the possession and the cultivation of marijuana, shall not apply to a patient, or to a patient's primary caregiver, who possesses or cultivates marijuana for the personal medical purposes of the patient upon the written or oral recommendation or approval of a physician. (HSC § 11362.5 (d))
Defines “primary caregiver” for purposes of the CUA as the individual designated by a patient who has consistently assumed responsibility for the housing, health, or safety of that person. (HSC § 11362.5 (e))
States legislative intent to commission objective scientific research by the premier research institute of the world, the University of California (UC), regarding the efficacy and safety of administering marijuana as part of medical treatment. Requires UC, if it accepts by appropriate resolution the responsibility to create a marijuana research program (California Marijuana Research Program) that it will develop and conduct studies intended to ascertain the general medical safety and efficacy of marijuana, and if found valuable, to develop medical guidelines for the appropriate administration and use of marijuana. (HSC § 11362.9)
Establishes the Medical Marijuana Program Act (MMPA), which exempts qualified patients who hold an identification card issued pursuant to the Medical Marijuana Program (MMP) and the caregivers of those persons, from certain state criminal sanctions related to the possession, cultivation, transportation, processing, or use of limited amounts of marijuana, as specified. (HSC § 11362.7 et seq.)
Requires a person who seeks an identification card to pay a fee and provide to the county health department the person's name, proof of residency, written doctor's recommendation, doctor's name and contact information, caregiver's name and duties, and patient's and caregiver's government issued photo identification card. (HSC § 11362.715 (a))
Requires the California Department of Public Health (CDPH) to establish and maintain a voluntary program for qualified patients to apply for identification cards, and county health departments to issue identification cards to qualified patients and their caregivers. (HSC § 11362.71 (a) & (b))
Provides that persons with valid identification cards shall not be subject to arrest for possession, transportation, delivery, or cultivation of marijuana, absent evidence of fraud. (HSC § 11362.71 (e))
Requires county health departments to issue serially numbered identification cards to patients and caregivers containing the following: a unique user identification number, an expiration date, the county health department's name and telephone number, photo identification of the cardholder, and a toll-free Department of Public Health telephone number enabling state and local law enforcement officers to immediately verify the card's validity. (HSC Section 11362.735 (a))
Prohibits medical marijuana dispensaries that possess, cultivate, or distribute medical marijuana from being located within a 600 foot radius of a school, and authorizes cities and counties to further restrict the locations of medical marijuana collectives. (HSC § 11362.768)
Provides that qualified patients, persons with valid identification cards, and the designated primary caregivers of qualified patients and persons with identification cards who associate within the State of California in order to cultivate marijuana for medical purposes, collectively or cooperatively, shall not, solely on that basis, be subject to state criminal sanctions for the possession, sale, transport, or other proscribed acts relating to marijuana. (HSC § 11362.775)
Prohibits state or local law enforcement officers from refusing to accept an identification card unless the officer has reasonable cause to believe that the card is being used fraudulently or its information is false or fraudulent. (HSC § 11362.78)
Makes it a misdemeanor offense to, among other things, fraudulently represent a medical condition or provide any material misinformation to a physician, health department designee, or to law enforcement, for the purpose or falsely obtaining an identification card; fraudulently use any person's identification card in order to acquire, possess, cultivate, transport, use, produce, or distribute marijuana; counterfeit, tamper with, or fraudulently produce an identification card; breach any confidentiality requirements pertaining to an identification card program.
(HSC § 11362.81)
Lists marijuana as a hallucinogenic substance in Schedule I of the California Uniform Controlled Substances Act. (HSC § 11054 (d))
This bill:
Enacts the Medical Marijuana Public Safety and Environmental Protection Act (Act).
Finds and declares the following:
In 1996, the people of the State of California enacted the CUA. The people of the State of California declared that their purpose in enacting the measure was, among other things, “to ensure that seriously ill Californians have the right to obtain and use marijuana for medical purposes where that medical use is deemed appropriate and has been recommended by a physician who has determined that the person’s health would benefit from the use of marijuana in the treatment of cancer, anorexia, AIDS, chronic pain, spasticity, glaucoma, arthritis, migraine, or any other illness for which marijuana provides relief.”
CUA called on state government to implement a plan for the safe and affordable distribution of marijuana to all patients in medical need of marijuana, while ensuring that nothing in that act would be construed to condone the diversion of marijuana for nonmedical purposes.
In 2003, the Legislature enacted the MMPA.
Greater certainty and minimum statewide standards are urgently needed regarding the obligations of medical marijuana facilities, and for the imposition and enforcement of regulations to prevent unlawful cultivation and the diversion of marijuana to nonmedical use.
Despite the passage of the CUA and the MMPA, because of the lack of an effective statewide system for regulating and controlling medical marijuana, cities, counties, and local law enforcement officials have been confronted with uncertainty about the legality of some medical marijuana cultivation and distribution activities. The current state of affairs makes law enforcement difficult and endangers patient safety because of an inability to monitor the supply of medical marijuana in the state and the lack of quality control, testing, and labeling requirements.
The California Constitution grants cities and counties the authority to make and enforce, within their borders, “all local police, sanitary, and other ordinances and regulations not in conflict with the general laws.” This inherent local police power includes broad authority to determine, for purposes of public health, safety, and welfare, the appropriate uses of land within the local jurisdiction’s borders. The police power, therefore, allows each city and county to determine whether or not a medical marijuana dispensary or other facility that makes medical marijuana available may operate within its borders. This authority has been upheld by City of Riverside v. Inland Empire Patients Health and Wellness Center, Inc. (2013) 56 Cal.4th 729 and County of Los Angeles v. Hill (2011) (192 Cal.App.4th 861). Nothing in this act shall diminish, erode, or modify that authority.
If a city or county determines that a dispensary or other facility that makes medical marijuana available may operate within its borders, then there is a need for the state to license these dispensaries and other facilities for the purpose of adopting and enforcing protocols for security standards at dispensaries and in the transportation of medical marijuana, as well as health and safety standards to ensure patient safety. This licensing requirement is not intended in any way nor shall it be construed to preempt local ordinances, regulations, or enforcement actions regarding the sale and use of medical marijuana, including, but not limited to, security, signage, lighting, and inspections.
Greater oversight, uniformity, and enforcement are urgently needed regarding the obligations and rights of medical marijuana cultivators, transporters, and distribution facilities.
Marijuana has widely accepted medical applications that make it inappropriate to be classified as a Schedule I controlled substance in the State of California.
For the protection of Californians, the state must act to regulate and control medical marijuana and not preempt local government ordinances. Cities and counties should be allowed to impose local taxes and enact zoning regulations and other restrictions applicable to the cultivation, transportation, and distribution of medical marijuana based on local needs.
For the protection of California’s environment and its natural resources, all efforts must be made to prevent and mitigate the harmful environmental impacts that can be associated with some marijuana cultivation.
The North Coast Regional Water Quality Control Board (NCRWQCB) is currently in the process of promulgating regulations that would create a 3-tiered system for cultivator wastewater discharge permits. A similar permitting system would assist the state in controlling damaging wastewater runoff from cultivation sites, while minimizing the burden on smaller cultivators.
Nothing in the Act shall have a diminishing effect on the rights and protections granted to a patient or primary caregiver pursuant to the CUA.
Nothing in the Act shall be construed to promote or facilitate the nonmedical, recreational possession, sale, or use of marijuana.
Provisions Related to Physicians/Surgeons and the MBC
Adds repeated acts of clearly excessive recommending of marijuana to patients for medical purposes without a good faith prior examination of the patient and medical reason to the list of types of cases the MBC shall prioritize its investigative and prosecutorial resources for in order to ensure that physicians and surgeons representing the greatest threat of harm are identified and disciplined expeditiously.
Makes it a crime (misdemeanor) for a physician and surgeon who recommends marijuana to a patient for a medical purpose to accept, solicit or offer any form of renumeration from or to a facility that has been granted a conditional license under the Act if the physician or his or her immediate family have a financial interest in that facility.
Requires MBC to consult with the California Marijuana Research Program on developing and adopting medical guidelines for the appropriate administration and use of medical marijuana.
Prohibits a physician and surgeon from recommending medical marijuana to a patient, unless that person is the patient’s attending physician as defined in the MMPA.
Prohibits a person from distributing any form of advertising for physician recommendations for medical marijuana in California unless the advertisement bears the following notice to consumers: “NOTICE TO CONSUMERS: The Compassionate Use Act of 1996 ensures that seriously ill Californians have the right to obtain and use marijuana for medical purposes where medical use is deemed appropriate and has been recommended by a physician who has determined that the person’s health would benefit from the use of medical marijuana. Physicians are licensed and regulated by the Medical Board of California and arrive at the decision to make this recommendation in accordance with accepted standards of medical responsibility. Requires advertising for physician recommendations for medical marijuana to meet requirements set forth in the BPC related to false and misleading information concerning professional services. Provides that price advertising shall not be fraudulent, deceitful, or misleading, including statements or advertisements of bait, discounts, premiums, gifts, or statements of a similar nature.
Establishment of the Bureau of Medical Marijuana Regulation
And Bureau Authority
Defines the following terms within the Act in the BPC:
“Bureau” means the Bureau of Medical Marijuana Regulation (Bureau) within DCA.
“Certified testing laboratory” means a laboratory that is certified by the Bureau to perform random sample testing of medical marijuana pursuant to the certification standards for these facilities promulgated by the Bureau.
“Chief” means the Chief of the Bureau.
“Department” means DCA.
“Director” means the Director of DCA.
“Dispensary” means a distribution operation that provides medical marijuana or medical marijuana derived products to patients and caregivers.
“Fund” means the Medical Marijuana Regulation Fund.
“Licensed cultivation site” means a facility that plants, grows, cultivates, harvests, dries, or processes medical marijuana and that is issued a conditional license.
“Licensed dispensing facility” means a dispensary or other facility that provides medical marijuana, medical marijuana products, or devices for the use of medical marijuana or medical marijuana products that is issued a conditional license.
“Licensed manufacturer” means a person who extracts, prepares, derives, produces, compounds, or repackages medical marijuana or medical marijuana products into consumable and nonconsumable forms and who is issued a conditional license.
“Licensed transporter” means an individual or entity issued a conditional license by the Bureau to transport medical marijuana to and from facilities that have been issued conditional licenses.
“Marijuana” means all parts of the plant Cannabis sativa, cannabis indica, or cannabis ruderalis, whether growing or not; the seeds thereof; the resin, whether crude or purified, extracted from any part of the plant; and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds, or resin. “Marijuana” does not include the mature stalks of the plant, fiber produced from the stalks, oil or cake made from the seeds of the plant, any other compound, manufacture, salt, derivative, mixture, or preparation of the mature stalks (except the resin extracted therefrom), fiber, oil, or cake, or the sterilized seed of the plant which is incapable of germination. “Marijuana” also means marijuana, as defined by Section 11018 of the Health and Safety Code.
“Trespass grows” means illicit marijuana cultivation on public or private land without the explicit permission of the land owner.
Establishes the Bureau within DCA under the supervision and control of the Chief. States that protection of the public shall be the highest priority for the Bureau in exercising its licensing, regulatory, and disciplinary functions; whenever the protection of the public is inconsistent with other interests sought to be promoted, the protection of the public shall be paramount. Requires the Governor to appoint the Chief at a salary to be fixed and determined by the Director with the approval of the Director of Finance. States that the duty of enforcing and administering the Act shall be vested in the Chief, who is responsible to the Director. Authorizes the Chief to adopt and enforce rules and regulations that he or she determines are reasonably necessary to carry out the purposes of the Act and for declaring the policy of the Bureau, including a system for the issuance of citations for violations of the Act. Authorizes the Chief to appoint and fix the compensation of personnel, including, but not limited to, clerical, inspection, investigation, and auditing personnel, as well as an Assistant Chief. States that these personnel shall perform their respective duties under the supervision and the direction of the Chief.
Provides that funds for the establishment and support of the Bureau shall be advanced as a loan by the Department and shall be repaid by the initial proceeds from fees collected pursuant to the Act.
Provides the Bureau with the authority to issue, suspend, or revoke conditional licenses related to medical marijuana in the state and collect fees in connection with cultivation, manufacture, transportation, storage, distribution and sale.
Provides the Bureau the authority to create, issue, suspend, or revoke other licenses in order to protect patient health and the public and to facilitate the regulation of medical marijuana.
Provides the Bureau the authority to implement the Act, including, but not limited to, all of the following:
Establishing rules or regulations necessary to carry out the purposes and intent of the Act.
Issuing conditional licenses to persons for the cultivation, manufacture, transportation, storage, distribution, and sale of medical marijuana within the state.
Setting application, licensing, and renewal fees for conditional licenses.
Establishing standards for the cultivation, manufacturing, transportation, storage, distribution, provision, donation, and sale of medical marijuana and medical marijuana products.
Establishing procedures for the issuance, renewal, suspension, denial, and revocation of conditional licenses.
Imposing a penalty.
Taking action with respect to an application for a conditional license.
Overseeing the operation of the Medical Marijuana Regulation Fund and the Special Account for Environmental Enforcement.
Consulting with other state or local agencies, departments, representatives of the medical marijuana community, or public or private entities for the purposes of establishing statewide standards and regulations.
Certifying laboratories to perform testing of medical marijuana.
Requires the Bureau, on or before January 1, 2018, to promulgate regulations for implementation of the Act, including, but not limited to, all of the following:
Procedures for the issuance, renewal, suspension, denial, and revocation of conditional licenses.
Procedures for appeal of fines and the appeal of denial, suspension, or revocation of conditional licenses.
Application, licensing, and renewal forms and fees.
A time period in which the Bureau shall approve or deny an application for a conditional license pursuant to this part.
Qualifications for licensees.
Standards for certification of testing laboratories to perform random sample testing of all medical marijuana products, including standards for onsite testing.
Certification of testing laboratories shall be consistent with general requirements for the competence of testing and calibration activities, including sampling, using standard methods established by the International Organization for Standardization, specifically ISO/IEC 17025. States that these requirements shall apply to all entities, including third-party laboratories, engaged in the testing of medical marijuana pursuant to the Act.
Requirements to ensure conformance with standards analogous to state statutory environmental, agricultural, consumer protection, and food and product safety requirements. States that these requirements, at a minimum, must:
Prescribe sanitation standards analogous to those in the California Retail Food Code for food preparation, storage, handling, and sale of edible medical marijuana products.
Require that edible medical marijuana products produced, distributed, provided, donated, or sold by licensees shall be limited to nonpotentially hazardous food, as established by CDPH.
Require that facilities in which edible medical marijuana products are prepared shall be constructed in accordance with applicable building standards, health and safety standards, and other state laws.
Provide that weighing or measuring devices used in connection with the sale or distribution of medical marijuana are required to meet existing weighing and measuring standards.
Require that the application of pesticides or other pest control in connection with the indoor or outdoor cultivation of medical marijuana shall meet Food and Agricultural Code standards and implementing regulations.
Requires the Bureau, on or before July 1, 2017, to also promulgate regulations for minimum statewide health and safety standards and quality assurance standards associated with the cultivation, transport, storage, manufacture, and sale of all medical marijuana produced in this state.
Provides that local agencies shall have primary responsibility for enforcement of the minimum statewide health and safety standards outlined above in accordance with Bureau regulations.
Requires the Bureau, in consultation with the Division of Labor Standards Enforcement, to adopt regulations establishing worker safety standards for entities licensed pursuant to the Act.
Requires the Bureau, in consultation with the State Water Resources Control Board, to adopt regulations to ensure that commercial medical marijuana activity licensed pursuant to the Act does not threaten the state’s environment and watersheds and is otherwise in conformance with the California Environmental Quality Act (CEQA).
Requires the Chief to keep a complete record of all facilities issued a conditional license which shall be made available on the Bureau’s website.
Requires the Bureau to establish procedures to provide state and local law enforcement, upon their request, with 24-hour access to information to verify a conditional license, track transportation manifests, and track the inventories of facilities issued a conditional license.
States that the Act shall in no way supersede the provisions of Measure D, approved by the voters of the City of Los Angeles on the May 21, 2013, ballot for the city, or any similar measure in other jurisdictions, which grants medical marijuana businesses and dispensaries qualified immunity consistent with the terms of the measure and local ordinances. Notwithstanding the provisions of the Act, marijuana businesses and dispensaries subject to the provisions of Measure D or other similar qualified immunity shall continue to be subject to the ordinances and regulations of the relevant local jurisdiction.
Provisions Related to Licensure by the Bureau
States that the Bureau shall not issue a conditional license unless the applicant has met all of the requirements of the Act.
Exempts a patient who cultivates, possesses, stores, manufactures, or transports marijuana exclusively for his or her personal medical use and who does not sell, distribute, donate, or provide marijuana to any other person or entity and a caregiver who cultivates, possesses, stores, manufactures, transports, or provides marijuana exclusively for the personal medical purposes to no more than five specified qualified patients for whom he or she is the primary caregiver and who does not receive remuneration for these activities from licensure under the Act. States that nothing in this section shall permit primary caregivers to organize themselves as cooperatives or collectives of caregivers.
Provides that a person shall not sell or provide medical marijuana to a patient or caregiver other than at a licensed dispensing facility or through delivery from a licensed dispensing facility unless otherwise authorized under the CUA and MMPA.
Provides that a person shall not grow medical marijuana other than at a licensed cultivation site unless otherwise authorized under the CUA and MMPA.
Provides that a person shall not manufacture medical marijuana or medical marijuana products other than a licensed manufacturer unless otherwise authorized under the CUA and MMPA.
Provides that a person shall not transport medical marijuana from one facility issued a conditional license to another, other than a licensed transporter.
Authorizes a licensed manufacturer to obtain medical marijuana from a licensed cultivator and furnish medical marijuana products to a licensed dispensary.
To meet the requirements under the Act for testing, provides that medical marijuana and medical marijuana products shall be tested by a certified testing laboratory.
Requires the Bureau, beginning no later than July 1, 2018, to provide for and issue conditional licenses for all activity authorized under the Act, including, but not limited to the cultivation, processing, storage, transport and dispensing of medical marijuana.
Clarifies that the issuance of a conditional license shall not, in and of itself, authorize the recipient to begin business operations, but it does certify, at a minimum, that the applicant has paid the state conditional licensing fee, successfully passed a criminal background check, and met the state residency requirements.
Requires an applicant, in order to begin business operations, to obtain a license or permit from the local jurisdiction in which he or she proposes to operate, following the requirements of the applicable local ordinances, in addition to the conditional license.
Requires an applicant for a conditional license to do all of the following:
Pay the fee or fees required for each license being applied for.
Register with the Bureau on forms prescribed by the Chief which must contain sufficient information to identify the licensee, including all of the following:
Name of the owner or owners of a proposed facility, including all persons or entities having an ownership interest other than a security interest, lien, or encumbrance on property that will be used by the applicant.
The name, address, and date of birth of each principal officer and board member.
The address and telephone number of the proposed facility.
In the case of a cultivation site, the GPS coordinates of the site.
Describe, in writing, the scope of business of the proposed facility.
Provide evidence that the applicant and owner have been legal full-time residents of the state for not less than 12 months.
Provide detailed operating procedures, in writing, for the proposed facility, which shall include, but not be limited to, procedures for facility and operational security, prevention of diversion, employee screening, storage of medical marijuana, personnel policies, and recordkeeping procedures.
Provide evidence that the applicant has received all required environmental permits, including compliance with CEQA and wastewater discharge permits.
Provide the applicant’s fingerprint images.
Provide a statement, signed by the applicant under penalty of perjury, that the information provided is true.
Provide any other information required by the Bureau.
Provides that each application for a conditional license is separate and distinct, and authorizes the Bureau to charge a separate fee for each.
States that the Bureau shall not issue a conditional license to an individual or entity, or for a premise, against whom there is a pending state or local administrative or judicial proceeding, against whom there is an action initiated by a city, county, or city and county under a local ordinance, or who has been determined to have violated an applicable local ordinance.
Authorizes a facility or entity that is operating in conformance with local zoning ordinances and other state and local requirements on January 1, 2016, to continue its operations until its application for conditional licensure is approved or denied.
Authorizes the Bureau to issue a conditional license and send proof of issuance to an applicant, provided the applicant has not committed an act or crime constituting grounds for the denial of licensure. Requires the Chief, by regulation, to prescribe conditions upon which a person, whose conditional license has previously been denied, suspended, or revoked, may be issued a conditional license.
Requires an application for a conditional license to be denied and a conditional license suspended or revoked for a past felony conviction for the possession for sale, sale, manufacture, transportation, or cultivation of a controlled substance, a felony criminal conviction for drug trafficking, a felony conviction for embezzlement, a felony conviction involving fraud or deceit, or any violent or serious felony conviction pursuant to subdivision (c) of Section 667.5 of, or subdivision (c) of Section 1192.7 of, the Penal Code. Authorizes the Bureau, at its discretion, to issue a license to an applicant that would be otherwise denied if the applicant has obtained a certificate of rehabilitation. Authorizes the Chief to also deny, suspend, or revoke a conditional license when a conditional licensee, applicant, or employee, partner, officer, or member of an entity conditionally licensed for specified reasons such as: making untrue or misleading statements; engaging in conduct that constitutes fraud or gross negligence; failing to comply with testing provisions of the Act or any rule or regulations adopted pursuant to the Act.
Requires the Chief to notify an applicant or licensee in writing, by personal service or mail addressed to the applicant or licensee provided in the application, when a conditional license is denied, suspended or revoked. Requires the Bureau to provide the applicant or licensee a hearing within 30 days thereafter if he or she files a written request for hearing with the Bureau. Provides that otherwise, the denial, suspension, or revocation is deemed affirmed. Subjects all proceedings to deny, suspend, or revoke a conditional license to due process requirements under the law.
Sets the following as reasons a conditional license shall not be approved:
The applicant fails to meet requirements of the Act or requirements of any regulation adopted pursuant to the Act or any applicable city, county, or city and county ordinance or regulation. States that if a local government adopts an ordinance or resolution authorizing medical marijuana to be cultivated, manufactured, stored, distributed, or sold within its jurisdiction, it shall submit to the Bureau documentation detailing their renewal requirements.
The applicant, or any of its officers, directors, owners, members, or shareholders, is a minor.
The applicant has knowingly answered a question or request for information falsely on the application form or failed to provide information requested.
The applicant, or any of its officers, directors, owners, members, or shareholders has been sanctioned by the bureau, a city, county, or city and county, for medical marijuana activities conducted in violation of this part or any applicable local ordinance or has had a license revoked in the previous five years.
The testing, transporting, distribution, provision, or sale of medical marijuana will violate any applicable local law or ordinance.
The applicant or the owner is unable to establish that he or she has been a resident of the state for not less than 12 months.
Specifies that a conditional license is subject to the restrictions of the local jurisdiction in which the facility operates or proposes to operate. Clarifies that even if a conditional license has been granted pursuant to the Act, a facility shall not operate in a local jurisdiction that prohibits the establishment of that type of business. Authorizes local jurisdictions retain the power to assess fees and taxes, as applicable, on facilities that are conditionally licensed and the business activities of those licensees.
Authorizes the Bureau to adopt regulations to limit the number of conditional licenses issued pursuant to this part upon a finding that the otherwise unrestricted issuance of conditional licenses is dangerous to the public health and safety.
States that the Bureau shall require an annual audit of all facilities issued a conditional license to cultivate, manufacture, process, transport, store, or sell medical marijuana, the reasonable costs for which shall be paid for by the licensee. Requires completed audit reports to also be submitted by the licensee to local code enforcement offices, or the appropriate locally designated enforcement entity, within 30 days of the completion of the audit. States that it is the responsibility of each facility issued a conditional license to develop a robust quality assurance protocol that includes all of the provisions of the Act.
Requires the Bureau to maintain confidentiality for information identifying the names of patients, their medical conditions, or the names of their primary caregivers received and contained in records kept by the Bureau for the purposes of administering the Act and exempts this information from the California Public Records Act. States that this information is not subject to disclosure to an individual or private entity, except as necessary for authorized employees of the state to perform official duties pursuant to the Act. Specifies that information shall not be disclosed beyond what is necessary to achieve the goals of a specific investigation or notification or the parameters of a specific court order or subpoena.
Provides that the actions of a licensee, its employees, and its agents, that are permitted pursuant to a conditional license and that are conducted in accordance with the requirements of the Act and regulations adopted pursuant to the Act, are not unlawful under state law and shall not be an offense subject to arrest or prosecution.
Provides that the actions of a person who, in good faith and upon investigation, allows his or her property to be used by a licensee, its employees, and its agents, as permitted pursuant to a conditional license, are not unlawful under state law and shall not be an offense subject to arrest or prosecution.
Sets forth requirements for record keeping by a licensee, specifically that a licensee shall not cultivate, process, store, manufacture, transport, or sell medical marijuana in the state unless accurate records are kept at the licensed premises of the growing, processing, storing, manufacturing, transporting, or selling by the licensee in the state. States that the records shall include the name and address of the supplier of marijuana received or possessed by the licensee, the location at which the marijuana was cultivated, the amount of marijuana received, the form in which it is received, the name of the employee receiving it, and the date of receipt. States that these records shall also include receipts for all expenditures incurred by the licensee and banking records, if any, for all funds obtained or expended in the performance of any activity under the authority of the conditional license. Authorizes a licensee who has a conditional license for more than one premises to keep all records at one of the conditionally licensed premises. Requires records to be kept for a period of seven years from the date of the transaction. Authorizes the Bureau and an appropriate state or local agency to examine the books and records of a conditional licensee and visit and inspect the premises of a conditional licensee. Requires books or records requested by the Bureau or an appropriate state or local agency to be provided by the conditional licensee no later than five business days after the request is made.
Authorizes the Bureau or a state or local agency to enter and inspect the premises of a facility issued a conditional license between the hours of 8 a.m. and 8 p.m. on any day that the facility is open, or at any reasonable time, to ensure compliance and enforcement of the provisions of the Act or a local ordinance. Provides that if a licensee or an employee of a licensee refuses, impedes, obstructs, or interferes with an inspection, the conditional license may be summarily suspended and the Bureau shall directly commence proceedings for the revocation of the conditional license.
Provides that if a licensee or an employee of a licensee fails to maintain or provide the books and records required, the licensee shall be subject to a civil fine of $15,000 per individual violation.
Provisions Related to Fees and Funding for Implementation of the Act
Sets the conditional licensing fee at a level sufficient to fund the Bureau’s administrative costs (in overseeing the licensing program, in establishing health and safety standards and in certifying testing laboratories), costs incurred by the Bureau or DOJ and costs incurred by law enforcement and other public safety entities.
Requires a cultivation facility fee to be assessed, in addition to a conditional licensing fee, set at an amount sufficient to cover the reasonable regulatory costs of enforcing environmental impact provisions of those facilities. Requires this fee to be distributed between the State Water Board, Department of Fish and Wildlife, Department of Forestry and Fire Protection, Department of Pesticide Regulation, Department of Food and Agriculture and local law enforcement.
Establishes the Medical Marijuana Regulation Fund (Fund) in the State Treasury and states that all fees collected pursuant to the Act shall be deposited into the Fund. Provides a continuous appropriation to the Bureau for the purposes of fully funding and administering the Act.
Creates the Special Account for Environmental Enforcement as an account within the Fund and provides a continuous appropriation to the Bureau to distribute monies to the entities listed above to be used to enforce the environmental regulation of licensed cultivation sites.
Requires all penalties collected to be deposited directly into the General Fund.
Authorizes the Bureau to establish and administer a grant program to allocate monies from the Fund to state and local entities for the purpose of assisting with medical marijuana regulation and enforcement of the Act.
Provisions Related to the Transport of Medical Marijuana
States that a facility issued a conditional license shall not acquire, cultivate, process, possess, store, manufacture, distribute, sell, deliver, transfer, transport or dispense medical marijuana for any other reason than those authorized under the MMPA and by any other means other than through a licensed cultivation site or licensed manufacturer.
Specifies requirements for a licensed transporter to include requirements that it ship only to facilities issued a conditional license and only in response to a request for a specific quantity and variety, it complete a shipping manifest form prescribed by the Bureau prior to transporting medical marijuana products, it securely transmit a copy of the manifest to the licensee that will receive the medical marijuana product as well as to the Bureau prior to transport and that both transporters and licensed facilities maintain each shipping manifest and make it available to local code enforcement officers, any other locally designated enforcement entity as well as the Bureau upon request.
Specifies that transported medical marijuana products be transported only in a locked, safe and secure storage compartment that is securely affixed to the interior of the transporting vehicle, not be visible from outside the vehicle and that the vehicle travel directly from one licensed facility to another licensed facility authorized to receive the shipment. Requires all transport vehicles to be staffed with a minimum of two employees, one of whom must remain with the vehicle at all times when the vehicle contains medical marijuana. Requires each transport team member to have access to a secure form of communication by which to communicate with personnel at the licensed facility at all times when the vehicle contains medical marijuana. Requires each transport team member to possess documentation of licensing and a government-issued identification card at all times when transporting or delivering medical marijuana. Clarifies that the provisions do not authorize or permit a licensee to transport medical marijuana or medical marijuana products outside the state.
Prohibits a local jurisdiction from preventing transportation through or to a facility issued a conditional license by a conditionally licensed transporter acting in compliance with the Act.
Provisions Related to Enforcement of the Act
Clarifies that a state agency is not required to enforce laws regarding the site or operation of a facility issued a conditional license.
Authorizes the Bureau to assist state taxation authorities in the development of uniform policies for the state taxation of licensees.
States that for facilities issued a conditional license that are located within the incorporated area of a city, the city shall have full power and authority to enforce the Act. States that for licensed facilities located within the unincorporated area of a county, the county shall have full power and authority to enforce the Act.
Establishes a fine of up to $35,000 for each willful violation of conditional license provisions of the Act. Establishes a fine of up to $10,000 for each technical violation of conditional license provisions in the Act.
Authorizes a District Attorney, County Counsel, City Attorney or City Prosecutor to bring an action to enjoin a violation or the threatened violation of the Act. Provides that the action be brought in the county in which the violation occurred or is threatened to occur and that a local government’s authority to take requisite enforcement actions pertaining to its own ordinances or regulations is not diminished. Clarifies that an action under the MMPA may still be taken. Clarifies that the Act shall not be construed to limit a law enforcement agency’s ability to investigate unlawful activity in relation to a facility issued a conditional license.
Updates the MMPA so that an individual employee, officer, or board member of a facility issued a conditional license is not subject to criminal sanctions based solely on holding a conditional license for the possession, cultivation, processing, packaging, storage, transportation, sale, or distribution of medical marijuana to a facility holding a conditional license or directly to a qualified patient, a person with a valid identification card, or the designated primary caregiver of a qualified patient or person with a valid identification card, within the state, unless the information contained on the licensing paperwork is false or falsified, the license has been obtained by means of fraud, or the person is otherwise in violation of the Act.
Provisions Related to Cultivation Sites Licensed Under the Act
Specifies requirements for cultivation sites, specifically:
A site shall not be located in an area zoned residential.
The Bureau shall notify local law enforcement of all conditional licenses issued for cultivation sites in that jurisdiction.
A licensed cultivation site shall display the state license in an available and easy to read manner at the location.
The Bureau shall work with and assist state and local law enforcement to eliminate trespass grows in the state.
Provides that no later than January 1, 2022, all medical marijuana grown, produced, distributed and sold in the state shall meet the certified organic standards. Requires the Bureau to establish appellations of origin for marijuana grown in California and work with county agricultural commissioners to provide all the information and forms required for conditional licensure as a cultivation site in a single location.
Provisions Related to Safety and Security of Facilities
Requires safety security measures to both deter and prevent unauthorized entrance into areas containing marijuana and theft of marijuana at those facilities to be implemented by a facility issued a conditional license. Requires security measures to include, but not be limited to, preventing individuals from remaining on the premises of the facility if they are not engaging in activity expressly related to the operations of the facility, establishing limited access areas accessible only to authorized facility personnel and storing all finished marijuana in a secured and locked room, safe, or vault, and in a manner as to prevent diversion, theft, and loss.
Requires a facility issued a conditional license to notify appropriate law enforcement authorities within 24 hours after discovering discrepancies identified during inventory, diversion, theft, loss, or any criminal activity involving the facility or a facility agent, the loss or unauthorized alteration of records related to marijuana, registered qualifying patients, personal caregivers, or facility agents and any other breach of security.
Requires a licensed cultivation site to weigh, inventory, and account for on video, all medical marijuana to be transported prior to its leaving its origination location. Requires that, within eight hours after arrival at the destination, the licensed dispensing facility shall reweigh, reinventory, and account for on video, all transported marijuana.
Provisions Related to Certified Laboratories and Testing
Sets forth requirements related to a laboratory certified by the Bureau to perform random sample testing of medical marijuana products. Prohibits a laboratory from acquiring, processing, possessing, storing, transferring, transporting, or dispensing medical marijuana for any purpose other than those authorized by the MMPA. Provides that all transfer or transportation shall be performed pursuant to a specified chain of custody protocol. Provides that a laboratory certified by the Bureau to perform random sample testing of medical marijuana products shall not acquire, process, possess, store, transfer, transport, or dispense medical marijuana plants or medical marijuana products except through a patient, primary caregiver, or a facility issued a conditional license. Provides that all transfer or transportation shall be performed pursuant to a specified chain of custody protocol.
Provisions Related to Taxation
Authorizes the Board of Supervisors of a county or the City Council of a city to impose, by ordinance, a tax on the privilege of cultivating, dispensing, producing, processing, preparing, storing, providing, donating, selling, or distributing marijuana by a licensee operating under the Act. Authorizes the tax to be imposed for general governmental purposes or for purposes specified in the ordinance. Requires the Board of Supervisors or City Council to specify in the ordinance the activities subject to the tax, the applicable rate or rates, the method of apportionment, and the manner of collection of the tax. Clarifies that a tax imposed pursuant to this section is a tax and not a fee or special assessment, and the tax is not required to be apportioned on the basis of benefit to any person or property or be applied uniformly to all taxpayers or all real property. Provides that a tax imposed by a city or county may include a transactions and use tax imposed solely for marijuana or marijuana products and that the tax may be imposed at any rate specified by the Board of Supervisors or City Council, and the tax rate authorized by this section shall not be considered for purposes of the combined tax rate limitation. Specifies that the tax authorized may be imposed upon any or all of the activities outlined above, regardless of whether the activity is undertaken individually, collectively, or cooperatively, and regardless of whether the activity is for compensation or gratuitously, as determined by the Board of Supervisors or City Council. Requires the Board of Supervisors to specify whether the tax applies throughout the entire county or within the unincorporated area of the county. Subjects a tax for these purposes to applicable voter approval requirements imposed by law.
Provisions Related to Quality, Standards, Testing and Labeling of Medical Marijuana Products and Guidelines for Edible Medical Marijuana Products
Defines the following terms in the Sherman Food, Drug and Cosmetics Law:
“Bureau” means the Bureau of Medical Marijuana Regulations in the DCA.
“Certified testing laboratories” means a laboratory that is certified by the Bureau to perform random sample testing of medical marijuana for patients, primary caregivers, and facilities issued conditional licenses under the Act, pursuant to the certification standards for those facilities promulgated by the Bureau.
“Edible medical marijuana product” means medical marijuana or a medical marijuana-derived product that is ingested or meant to be ingested through the mouth and into the digestive system.
“Marijuana” means all parts of the plant Cannabis sativa L. sativa, cannabis indica, or cannabis ruderalis, whether growing or not; the seeds thereof; the resin, whether crude or purified, extracted from any part of the plant; and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds, or resin. “Marijuana” does not include the mature stalks of the plant, fiber produced from the stalks, oil or cake made from the seeds of the plant, any other compound, manufacture, salt, derivative, mixture, or preparation of the mature stalks (except the resin extracted therefrom), fiber, oil, or cake, or the sterilized seed of the plant which is incapable of germination. “Marijuana” also means marijuana, as defined by Section 11018.
“Labor peace agreement” means an agreement between an entity and a bona fide labor organization that, at a minimum, protects the state’s proprietary interests by prohibiting labor organizations and members from engaging in picketing, work stoppages, boycotts, and any other economic interference with the applicant’s business. This agreement means that the applicant has agreed not to disrupt efforts by the bona fide labor organization to communicate with, and attempt to organize and represent, the applicant’s employees.
“Representative samples” means samples taken from each batch or shipment of medical marijuana received from a licensed cultivation site or any other source if intended for sale.
Requires the Bureau to establish quality assurance protocols to ensure uniform testing standards for all medical marijuana sold via dispensaries or other facilities, or cultivated or manufactured by facilities that are issued a conditional license. Requires the Bureau, in consultation with outside entities at its discretion, to develop a list of certified testing laboratories that can perform uniform testing in compliance with this article, and post that list on its website.
Requires a facility issued a conditional license to bear the responsibility for contracting with certified testing laboratories for regular, systematic testing of representative samples of all medical marijuana cultivated or intended for sale or distribution, and shall bear the cost of that testing. Requires a facility issued a conditional license to maintain records of testing reports for seven years, either on site in a digital format or at a secure off-site location in either digital or paper format. Requires facilities to provide results of test reports to local code enforcement officers, any other locally designated enforcement entity, and the Bureau upon request.
States that quality assurance protocols shall be required between all licensed cultivation sites, licensed manufacturers, and licensed dispensing facilities to guarantee safe and reliable medicinal marijuana delivery to all patients. Outlines these quality assurance protocols to include:
Providing supplier information to dispensaries in order for recall procedures to be implemented, if and when necessary.
Safety testing of all medical marijuana prior to packaging for sale and patient exposure to identify and eliminate microbiological contaminants and chemical residue.
Labeling of all medical marijuana and medical marijuana products that shall, at a minimum, include:
A list of pharmacologically active ingredients, including, but not limited to, tetrahydrocannabinol (THC) and cannabidiol (CBD) content, clear recommended dosage, and the size or volume of the recommended dose.
Clear indication, in bold font, that the product contains medical marijuana.
The statement “FOR MEDICAL USE ONLY. KEEP OUT OF REACH OF CHILDREN AND ANIMALS” in bold print.
Identification of the source and date of cultivation and manufacture.
The name and location of the dispensary providing the product.
The date of sale.
Any other requirements set by the Bureau.
Provides that for purposes of these provisions, edible medical marijuana products are deemed to be unadulterated food products. Authorizes baked edible medical marijuana products, including but not limited to, brownies, bars, cookies and cakes, tinctures and other edible medical marijuana products that do not require refrigeration or hot holding to be manufactured, sold or otherwise distributed at facilities issued a conditional license under the Act.
Requires a facility issued a conditional license to have an owner or employee who has successfully passed an approved and accredited food safety certification examination prior to selling, manufacturing or distributing edible medical marijuana products requiring refrigeration or hot holding. Requires individuals manufacturing or selling edible medical marijuana products to thoroughly wash their hands before commencing production and before handling finished edible medical marijuana products.
States that all edible medical marijuana products sold for direct consumption and infused with marijuana concentrate shall be individual wrapped at the original point of preparation and in a fashion that does not exceed a single dose for one individual.
Requires products containing THC to be prepared in compliance with maximum potency standards for THC and THC concentrates set forth in the Bureau’s regulations.
Sets forth requirements for labeling of edible medical marijuana products. Requires, prior to sale or distribution at a licensed dispensing facility, edible medical marijuana products shall be labeled and in an opaque and tamper evident package. Labels and packages of edible medical marijuana products shall not be made to be attractive to children. All edible medical marijuana product labels shall include the following information, prominently displayed and in a clear and legible font:
Manufacture date and source.
The statement “KEEP OUT OF REACH OF CHILDREN AND ANIMALS” in bold print.
The statement “FOR MEDICAL USE ONLY.”
Net weight of medical marijuana in package.
A warning if nuts or other known allergens are used and shall include the total weight, in ounces or grams, of medical marijuana in the package.
List of pharmacologically active ingredients, including, but not limited to, THC and CBD content, clear recommended dosage, and the size or volume of recommended dose.
Any other requirement set by the Bureau.
Provides that photos or images of food are not allowed on edible medical marijuana product packages or labels and only generic food names may be used to describe edible medical marijuana products.
General Provisions and Reporting Requirements
Requires, on or before July 1, 2016, the State Board of Equalization (BOE) to complete a report and submit it to the Legislature and Governor’s Office on the actual tax collected actual tax collected on the sale of medical marijuana, using the most current data available. States that the report should also include expected tax revenues, under the existing tax structure, for the years 2016 to 2021, inclusive.
Provides that that the provisions of the Act are severable. Outlines rationale for a limitation on the public’s right of access to the meetings of public bodies or the writings of public officials and agencies within the meaning of Section 3 of Article I of the California Constitution as necessary for purposes of compliance with the federal Health Insurance Portability and Accountability Act of 1996 (42 U.S.C. Sec. 1320d et seq.), the Confidentiality of Medical Information Act (Part 2.6 (commencing with Section 56) of Division 1 of the Civil Code), and the Insurance Information and Privacy Protection Act (Article 6.6 (commencing with Section 791) of Part 2 of Division 1 of the Insurance Code).
FISCAL EFFECT: Unknown. This bill has been keyed “fiscal” by Legislative Counsel.
COMMENTS:
Purpose. The Author is the Sponsor of this measure. According to the Author, “SB 643 seeks to resolve many of the issues created by the enactment of the Compassionate Use Act and subsequent legislation. SB 643 creates a statewide comprehensive program overseeing the medical marijuana industry, from planting to consumption, and all the steps in between. California voters made it clear that they wanted medical marijuana to be legalized, but issues and concerns for growers, doctors, dispensaries, law enforcement, district attorneys, cities, counties and others have only become more complicated.”
The Author, who represents the primary growing region for medical marijuana in the western United States, specifically remote expanses of Mendocino, Humboldt and Trinity counties, which are responsible for up to 70% of the marijuana grown in the west, notes that much of this area of the state has come to rely on the economic benefits of marijuana cultivation, but also suffers from the negative environmental, public safety and public health effects that can arise from rogue cultivators and lack of regulation. According to the Author, “trespass grows have become an environmental disaster in this region, illegally diverting millions of gallons of water from rivers and streams, creating a dumping ground for pesticides, insecticides, rodenticides and fertilizers, and depositing huge amounts of sediment into our waterways from crop runoff.” The Author notes that it is imperative that the Legislature pass the best comprehensive measure possible this year.
According to the Author, since the voters of California passed Proposition 215 in 1996, it has become clear that there needs to be a comprehensive regulation bill from the Legislature that oversees the cultivating, processing, manufacturing, transportation, prescribing and sale of medical marijuana. The Author adds that the Legislature has worked hard over the last couple of years to enact a regulatory program that will recognize the voter’s mandate, streamline the ability of the industry to grow and sell a legal product and that this bill contains much of that hard work as well as reflects the efforts of many groups, individuals who have spent years working in this industry.
The Author notes that currently, there are virtually no rules and regulations on the cultivation side of the medical marijuana industry, and it is important that to bring this legal crop into the regulatory framework expected for other commodities. The Author adds that the severe drought California is experiencing has only made the need for his legislation all the more urgent.
The bill focuses on a number of key aspects of medical marijuana cultivation and proposes regulatory changes for those items. According to the Author, the bill:
Bans commercial cultivation sites in areas zoned residential. According to the Author, this has been a big issue for neighborhoods and residences around the state. Commercial and industrial uses do not belong in residential areas, and medical marijuana grows create special problems that neighbors shouldn’t have to deal with.
Requires that all medical marijuana grown, produced, distributed, recommended for use, and sold in the state meet the California certified organic standards set forth in the bill by January 1, 2022. According to the Author, this is an effort to guard against consumption of harmful and damaging products, and to help protect the cultivating watersheds and environment from toxics.
Creates “Appellations of Origin” for medical marijuana. The Author notes that, similar to wine grapes, this will help establish and perpetuate authenticity in the industry.
Allows local governments to impose a tax or fee on cultivation, above the ultimate sales tax, to help defray the expense of regulating the cultivation and processing of the commodity in their jurisdiction. The Author states that this is designed to make sure local authorities can afford to pay for the implementation of the regulations allowed under this legislation or any other.
Does not supersede provisions of Measure D, as approved by the voters of the City of Los Angeles, or other similar measures. According to the Author, this provision is important to reflect decisions made by residents of L.A. and is the same language referenced in most of the other similar legislative efforts to regulate medical marijuana over the past number of years.
Establishes licenses as valid if both the state and the local jurisdiction approved the applications. The Author states his goal of allowing as much local control as possible.
Requires all licensed location and license information to be given to local law enforcement. According to the Author, in an effort to prevent wasted resources and limit dangerous circumstances, local law enforcement should know when and where all licensees are operating.
Recognizes regulations being promulgated by the North Coast Regional Water Quality Control Board to create a new three-tiered system for cultivator/grower wastewater discharge permits. According to the Author, the new Bureau would be required to create a similar permitting system for the entire state which would strongly enhance waterway and environmental regulations and oversight of marijuana grows.
Authorizes longer terms of licensure. According to the Author, under the bill, a conditional license issued will be valid for 12 months after the date of issuance and then after the initial 12-month period, a conditional license may be renewed for a period of 36 months. The Author states that this is a departure from previous bills that only give 12-month renewals and once licensees have established themselves, the Author does not believe they should have to go through the process of renewal every year.
Requires the Bureau to work with county agricultural commissioners to provide all information and forms required for conditional licensure as a cultivation site in a single location, including state licensure, local requirements in that jurisdiction, and environmental requirements. The Author notes that this “one stop shop” concept is designed to help potential licensees through the many levels of regulations. The Author’s goal is to make it as easy as possible for applicants to comply with local, regional and state regulations.
Compassionate Use Act of 1996. Since the approval of the CUA, Proposition 215, by voters in 1996, state law has allowed Californians access to marijuana for medical purposes, and prohibits punitive action against physicians for making medical marijuana recommendations. The CUA established the right of patients to obtain and use marijuana to treat specified illnesses and any other illness for which marijuana provides relief. The CUA prohibits prosecution for growing or using marijuana for Californians who have the oral or written recommendation of their doctors and for these patients' caregivers.
Additionally, the CUA specifically protects physicians who recommend the use of marijuana to patients for medical purposes and exempts qualified patients and their primary caregivers from California drug laws prohibiting possession and cultivation of marijuana.
The CUA is a very general law. While it establishes the right of a patient to obtain medical marijuana pursuant to a physician's recommendation, the initiative then simply encourages the state and federal governments to “implement a plan for safe and affordable distribution of marijuana [to qualified patients].” It has been argued that very little has been done to implement the initiative. Instead of a comprehensive implementation plan, numerous uncoordinated bills have been introduced in the Legislature. Further, the courts have only provided a small measure of clarity and certainty in this area.
Medical Marijuana Program (MMP). Established by SB 420 (Vasconcellos, Chapter 875, Statutes of 2003) and administered by the California Department of Public Health (CDPH) when the Legislature sought to clarify Prop 215 and the CUA, the MMP created a State-authorized medical marijuana identification card (MMP Card), along with a registry database for verification of qualified patients and their primary caregivers. Participation by patients and primary caregivers in this identification card program is voluntary. The MMP web-based registry allows law enforcement and the public to verify the validity of a qualified patient or primary caregiver's MMP Card as authorization to possess, grow, transport, and/or use medical marijuana within California. A qualified patient or primary caregiver may possess no more than 8 ounces of dried marijuana per qualified patient (HSC § 11362.77). Under the MMP, a patient or qualified caregiver with a recommendation for medical marijuana from a licensed California physician can apply for MMP Card through a local county public health department. Fees for the card registration vary from county to county and the card is valid for one year, after which the card must be renewed. A primary caregiver card will expire when the patient's card expires.
In order to apply for a MMP Card, a patient or qualified caregiver must reside in the county where they apply, present the physician recommendation for medical marijuana, and pay the fee required by the county. Upon issuance of the MMP Card, the card is registered into the online database.
A patient or a qualified caregiver is not required to obtain a MMP Card or to participate in the MMP in order to use medical marijuana upon the recommendation of a physician under the CUA.
California patients who obtain a physician's oral or written recommendation are protected from prosecution in California for possessing or cultivating an amount of marijuana reasonably related to their current medical needs, as are their caregivers. Patients and caregivers who obtain a MMP Card from their county health department are protected from arrest and prosecution for possessing, transporting, delivering, or cultivating marijuana.
Recent Court Cases and Rulings. In 2010, the California Supreme Court ruled in People v. Kelly supra that the MMPA section limiting quantities of marijuana is unconstitutional because it amends a voter initiative. Additionally, the U.S. Supreme Court ruled in Gonzales v. Raich (2005) 545 U.S. 1 that the Federal Government can enforce marijuana prohibition despite state medical marijuana laws. Meanwhile, many city and county officials have expressed confusion about the scope of state medical marijuana law, and some have passed ordinances that have been overturned by the courts.
The California Supreme Court recently granted review in several cases related to the rights of medical marijuana patients and dispensaries, specifically the legality of local rules regarding the operation and location of dispensaries and cultivation sites. Pack v. City of Long Beach (review granted Jan. 18, 2012, S197169) was dismissed as being moot because the issue the Court was considering resolved itself. The original ordinance at issue was repealed and replaced by Ordinance No. 12-0004, which bans medical marijuana in the county. In 2013, the Court, in City of Riverside v. Inland Empire Patient’s Health and Wellness Center, upheld that local governments have inherent zoning power. The issue in this case was whether California‘s medical marijuana statutes preempt a local ban on facilities that distribute medical marijuana. The Court concluded they do not and upheld the City of Riverside’s implementation of a ban on medical marijuana dispensaries and on any facility that is prohibited by federal or state law. People v. G3 Holistic (review granted Jan. 18, 2012, S198395) was dismissed and remanded based on the Riverside case.
California Attorney General’s Compassionate Use Guidelines. In 2003, SB 420 additionally required the California Attorney General to adopt “guidelines to ensure the security and non-diversion of marijuana grown for medical use” (HSC § 11362.81 (d)). To fulfill this mandate, in August of 2008, the Attorney General published Guidelines for the Security and Non-Diversion of Marijuana Grown for Medical Use (California Attorney General. August 2008) (Guidelines). The Guidelines are intended to: (1) ensure that marijuana grown for medical purposes remains secure and does not find its way to non-patients or illicit markets, (2) help law enforcement agencies perform their duties effectively and in accordance with California law, and (3) help patients and primary caregivers understand how they may cultivate, transport, possess, and use medical marijuana under California law.
Marijuana – A Schedule I Drug. Even though California voters enacted the CUA to permit the use of marijuana for medical purposes by persons deemed qualified by their physicians, marijuana still is an illegal drug both under federal and state law, and its use, possession, distribution, cultivation, or sale carries criminal penalties. Under California law, marijuana is listed as a hallucinogenic substance in Schedule I of the California Uniform Controlled Substances Act (HSC § 11054 (d)). Under federal law, possession of marijuana, even by medical users, continues to be a crime. The federal Controlled Substances Act specifies that, except as provided, it is unlawful for any person knowingly or intentionally to manufacture, distribute, or dispense, or possess with intent to manufacture, distribute, or dispense a controlled substance. (21 U.S.C. Sec. 841(a)) The only exception provided in the Controlled Substances Act for marijuana, a Schedule I drug, is for its use in government-controlled research projects.
U. S. Department of Justice Guidance Regarding Marijuana Enforcement. In August of 2013, the U.S. Department of Justice (USDOJ) issued a memorandum titled “Guidance Regarding Marijuana Enforcement” to all U.S. Attorneys. The memorandum updated the prior guidance given by USDOJ regarding marijuana enforcement under the federal Controlled Substances Act, in light of state ballot initiatives that legalize marijuana under state laws and that provide for the possession and use of small amounts of marijuana.
While affirming that marijuana is still, at the federal level, considered a dangerous drug and that the illegal distribution and sale of marijuana is a serious crime, the memorandum outlines enforcement priorities that are particularly important to the federal government, including: preventing distribution to minors; preventing revenue from marijuana from going to criminal enterprises; preventing diversion to other states where marijuana is not legal under state law; preventing state-authorized marijuana from being a cover for trafficking in other illegal drugs or illegal activity; preventing violence in cultivating and distributing marijuana; preventing drugged driving and other public health problems from marijuana use; and preventing growing, possessing or using marijuana on public lands or on federal property
The document clearly lays out the federal expectation for the states that have legalized marijuana, even if only for medical purposes, that they will develop a robust system of regulation and enforcement, and that such a system will reduce the likelihood of federal enforcement activity.
Medical Marijuana Regulation in Other States. Currently, 23 States and the District of Columbia currently have laws related to medical marijuana or create a cannabis program or legal provisions to allow for the medical use of marijuana. These states also typically have a patient registry to provide for some protection against arrest for possession of medical marijuana, up to a certain amount. 12 additional states have laws providing for limited access to medical marijuana products strictly for medical purposes. In these states, a focus is on authorizing access to accommodate clinical research and clinical research trials, such as experimental treatments of seizure disorders or epilepsy.
Four states authorize the recreational use of marijuana. In Alaska, adults age 21 and older can now transport, buy or possess up to an ounce of marijuana and six plants. Oregon voters approved a similar measure allowing adults to possess up to an ounce of marijuana in public and 8 ounces in their homes, set to take effect July 1. Most recently, a measure approved by voters went into effect in the District of Columbia that legalizes possession of small amounts of marijuana. Colorado and Washington previously passed similar ballot measures legalizing marijuana in 2012.
The experiences of other states have helped to inform the current conversation in California. Notably, this bill establishes standards for transport of medical marijuana products and security surrounding transport, proper preparation and labeling of edible medical marijuana products and requirements for testing of products. Other states have attempted to ensure safety for the transit of these products, particularly given the high value of products and tendency toward cash transactions in the industry. However in Washington and Oregon, third-party carriers are not permitted, creating challenges for transport of products. Colorado authorizes third-party carriers with proper documentation to transport these products and private transport companies, often employing armed personnel, are being utilized in states that authorize both medical marijuana use and regulate marijuana for recreational purposes. Efforts to create a regulatory environment specifically for the transport of products could also result in an increase in the use of private security firms here. With regards to edible medical marijuana products, concerns have been raised over the lack of proper labeling and dosage in other states and efforts aimed at preventing accidental ingestion (such as labeling requirements) are taking shape. Edible products often produce delayed and longer-lasting results than other methods of delivery and consumers may be harmed by a lack of accuracy in information about the potency of edible medical marijuana products and a lack of awareness by patients of the amount of THC they may be ingesting. This bill also sets standards for testing medical marijuana products and the certification of testing laboratories. A report to the Oregon Legislature noted that, in the absence of any guidance from the United States Department of Agriculture and the Food and Drug Administration, many state regulatory agencies have determined that some safety testing of medical marijuana products is better than no safety-testing whatsoever, but that assumption creates other challenges when testing is done at unregulated or potentially substandard facilities and products potentially end up being sold with certificates of safety that may not be true or authentic and could in fact be misleading. Health risks have been cited for medical marijuana products that are treated with pesticides or other contaminants and proper testing by certified laboratories, as this bill establishes, is seen as an important measure to ensure product quality.
Trespass Grows and Environmental Concerns. California land, watersheds and some species, particularly in the Author’s district, have been significantly damaged as a result of certain marijuana cultivation efforts. “Trespass grows”, cultivating marijuana without permission on public, tribal or privately owned land, have been associated with wildlife poisoning, use and dumping of fertilizers and pesticides, illegal water diversions and water pollution, logging and land disturbance, and severe problems with garbage and human waste. These industrial-size marijuana grows, taking place in the National Forests and on private timberland in some of the state’s most remote and ecologically sensitive areas, are the subject of a recent study by the California Department of Fish and Wildlife (CDFW), Impacts of Surface Water Diversions for Marijuana Cultivation on Aquatic Habitat in Four Northwestern California Watershed, which showed that during drought conditions, water demand for marijuana cultivation exceeded stream flow in three of four study watersheds and that diminished stream flow from this water-intensive activity is likely to have lethal to sub-lethal effects on state and federally listed salmon and steelhead trout and will cause further decline of sensitive amphibian species. By using online tools to count marijuana plants and measure greenhouses, and conducting inspections of marijuana cultivation sites with state wildlife officers and local law enforcement, CDFW scientists quantified plant numbers and water use. Utilizing stream flow data provided by staff at the National Oceanic and Atmospheric Administration (NOAA), CDFW determined water demand for cultivation could use more than 100 percent of stream flow during the summer dry season in three of four study watersheds. All the streams monitored in watersheds with large scale marijuana cultivation went dry and the only stream monitored that didn’t go dry contained no observed marijuana cultivation.
Related Legislation This Year. AB 26 (Jones-Sawyer) and AB 34 (Bonta) are substantively similar to previous legislative efforts and aim to enact the Medical Cannabis Regulation and Control Act and would create the Division of Medical Cannabis Regulation and Enforcement within the Department of Alcoholic Beverage Control. (Status: Both bills are currently pending in the Assembly Committee on Business and Professions.)
AB 226 (Cooley) is very similar to this bill and also would create a Bureau of Medical Marijuana Regulation within DCA. (Status: The bill is also currently pending in the Assembly Committee on Business and Professions.)
AB 243 (Wood) would require all medical marijuana cultivation to be conducted in accordance with state and local laws and best practices, as specified, and would require state agencies to address environmental impacts of medical marijuana cultivation and coordinate with local governments in enforcement efforts. (Status: The bill is currently pending in the Assembly Committee on Agriculture.)
Prior Related Legislation. SB 1262 (Correa) of 2014 is also very similar to this bill and AB 266 and would have created a Bureau of Medical Marijuana Regulation within DCA. (Status: The bill was held under submission in the Assembly Committee on Appropriations.)
AB 1894 (Ammiano) of 2014, AB 473 (Ammiano) of 2013 and AB 604 (Ammiano) of 2013 would have established an Act to license and regulate the cultivation, manufacture, testing, transportation, storage, distribution, and sale of medical cannabis within the Department of Alcoholic Beverage Control. (Status: AB 1894 and AB 473 both failed passage on the Assembly Floor; AB 604 was referred to the Senate Committee on Public Safety but was not set for hearing in enough time for consideration before the Legislature adjourned.)
SB 439 (Steinberg) of 2013 would have exempted
medical-marijuana collectives and cooperatives from criminal
liability for possession, cultivation, possession for sale, sale,
transport, importation, and furnishing marijuana. The bill also
would have clarified MBC enforcement of medical marijuana
recommendations, what constitutes unprofessional conduct, and the ban
on the corporate practice of medicine. (Status: The bill
was amended to deal with an entirely different issue.)
SB
1182 (Leno) of 2012 provided that a cooperative or collective
that operates within the Attorney General's (AG) guidelines shall not
be subject to prosecution for marijuana possession or commerce, as
specified; and provided that where such an entity operates within the
AG's guidelines, the entity and its employees, officers and members
shall not be subject to prosecution for marijuana commerce because
the entity or its employees, officers, or members received
compensation for actual expenses incurred in carrying out activities
in compliance with the guidelines. (Status: This bill
died on the Senate Floor.)
SB 129 (Leno) of
2012 prohibited employment discrimination on the basis of a person's
status as a qualified patient (medical marijuana user) or on the
basis of the person's positive drug test for marijuana, provided the
person is a qualified patient and the medical use of marijuana does
not occur at the place of employment or during hours of employment.
(Status: The bill died on Senate Inactive File.)
AB
2312 (Ammiano) of 2012 established a nine-member Board of Medical
Marijuana Enforcement within the DCA to regulate the medical
marijuana industry and to collect fees from medical marijuana
businesses to be deposited into a new Medical Marijuana Fund. The
bill would have authorized local taxes on medical marijuana up to 5%.
(Status: The bill failed passage in this Committee.)
AB
2465 (Campos) of 2012 would have made medical marijuana patient
and caregiver identification cards mandatory, and required medical
marijuana collectives to keep copies of members' identification
cards. (Status: The bill was never heard in a policy
committee of the Legislature.)
SB 626 (Calderon) of 2011 would have required the Board of
Equalization (BOE) to establish a nine-member task force to conduct a
study to determine ways to enhance collections of sales and use taxes
on retail sales of marijuana and ensure proper regulation of the
cultivation, transportation, and distribution of marijuana and
marijuana products. (Status: This bill was held in the
Senate Committee on Appropriations.)
SB 847
(Correa) of 2011 would have prohibited any medical marijuana entity
that possesses, cultivates, or distributes medical marijuana from
locating within 600 feet of a residential area unless a local
ordinance has been adopted to specifically regulate the location of
these entities in relation to residential use. (Status: This
bill was vetoed by Governor Brown.)
AB 1300 (Blumenfield, Chapter, 196, Statutes of 2011) provided
that a local government may enact an ordinance regulating the
location, operation or establishment of a medical marijuana
cooperative or collective. The bill also authorized a local
government to enforce such ordinances through civil or criminal
remedies and actions and authorized the local government to enact any
ordinance that is consistent with the MMP, which is intended to
implement the CUA.
AB 1017 (Ammiano) of 2011 would
have made the cultivation of marijuana alternatively punishable as a
misdemeanor with a penalty of imprisonment in a county jail for a
period of not more than one year. (Status: This bill
failed passage on the Assembly Floor.)
AB 223
(Ammiano) of 2011 provided that the CUA does not authorize a
qualified patient or person with an identification card to engage in
the smoking of medical marijuana within 600 feet of the grounds of a
school, recreation center, or youth center, unless the medical use
occurs within a residence or within a medical marijuana cooperative,
collective, or dispensary. (Status: This bill failed
passage in the Assembly Committee on Public Safety.)
AB
2650 (Buchanan, Chapter 603, Stats. 2010) prohibited the
operation or establishment of a medical marijuana cooperative,
collective, dispensary or provider within 600 feet of a school;
provided that ordinances adopted prior to January 1, 2011 regulating
the location or establishment of such a medical marijuana entity
shall not be preempted by the bill; authorized a local entity to only
adopt an ordinance that restricts the location or establishment of a
medical marijuana entity at a further distance than is restricted by
the bill.
SB 1098 (Migden, 2008) would have
required the State Board of Equalization to administer a tax amnesty
program, as specified, for medical marijuana dispensaries, as
defined. (Status: This bill failed passage in the Senate
Committee on Revenue and Taxation.)
SB 529
(Migden, 2007) would have required the Board of Equalization to
administer a tax amnesty program, as specified, for medical marijuana
dispensaries. (Status: This bill was amended to deal with
an entirely different subject.)
SB 420
(Vasconcellos, Chapter 875, Statutes of 2003) established the Medical
Marijuana Program Act, a statewide, voluntary program for the
issuance of identification cards to identify persons authorized to
engage in the medical use of marijuana under the CUA.
Policy Issues:
Sunrise Review. The Legislature uses a “Sunrise Model” for the purpose of assessing requests for new or increased occupational regulation, including the creation of any new licensing scheme or licensing entity within the DCA. Government Code Sections 9148 et seq. require that “Prior to consideration by the Legislature of legislation . . . creating a new category of licensed professional, a plan for the establishment and operation of the proposed . . . new category of licensed professional shall be developed by the author or sponsor of the legislation.” The Code further states: “The necessary data and other information required by this section shall be provided to the Legislature with the initial legislation and forwarded to the policy committees in which the bill will be heard.”
Correspondingly, the Committee Rules of this Committee require: “Prior to hearing any bill or other measure that proposes to create a new state licensing agency or a new category of licensed or regulated professional, the Author or sponsor of the legislation shall develop a plan for the establishment and operation of the agency or creation of the new licensed category in accordance with the requirements of Government Code Section 9148 et seq. The plan shall include the completion of a regulation proposal review worksheet titled the “Sunrise Questionnaire” by the Author or sponsor of the legislation.”
This questionnaire is designed to assist proponents of new regulatory programs to collect and organize information that is necessary for an objective evaluation of the need and justification for the proposal. If a new program is to be established within the DCA or any other agency under this Committee’s jurisdiction, the Committee is better informed based on responses in the questionnaire and in a better position to properly evaluate and respond to the proposal. Typically the completion of the Sunrise process is a multi-year effort, with meetings and hearings being convened during the fall Interim Recess in order for the Committee to hear testimony from the stakeholders in a legislative proposal, including both the proponents and the opponents. This enables the Committee to ascertain the level of need for regulation, the type of regulation that is needed, any impediments to adopting the proposed regulatory scheme, and whether the proposed regulation is adequate to address the identified level of consumer harm, and is the least onerous way to efficiently regulate in that area.
The Author has not submitted a plan to this Committee for the establishment and operation of this new agency pursuant to Section 9148 of the Government Code and the Rules of the Committee, and therefore there is no corresponding Sunrise Questionnaire completed which would provide some detail to some of the more important aspects of regulating medical marijuana and medical marijuana products in California by a Bureau under the DCA.
Implementation of the Act through rulemaking, rather than establishing a clear statutory framework. The bill leaves the administration of the Act to the rulemaking process by requiring the Bureau to promulgate myriad regulations. This process can take years, given requirements for notification, public comment and additional delays that arise whenever amendments to proposed regulations are made. It is unlikely that the Bureau would be able to meet the deadlines for regulations set forth in this bill, and the regulatory process in general has been criticized for lacking transparency and robust stakeholder input that the Legislative process allows for.
A Bureau within the Department of Consumer Affairs (DCA) may not be the most appropriate agency to administer such an extensive regulatory program as envisioned in this measure, given a possible lack of expertise at the DCA on issues surrounding medical marijuana. This bill proposes to establish a Bureau tasked with enormous administrative responsibility within the DCA to implement a complex regulatory structure with implications for multiple levels of government that relies on expertise and an understanding of often confusing legal frameworks within multiple federal, state and local jurisdictions. Among other responsibilities, the Bureau would have to promulgate considerably dense and challenging regulations to administer the Act and create a robust licensing program as well as advance regulations establishing standards for worker safety, standards for environmental quality and impacts on CEQA, health and safety standards and quality assurance standards for medical marijuana and medical marijuana products and standards for laboratories and testing. The Bureau would also be required to share fees among multiple state agencies, administer a grant program for local law enforcement to access additional resources for enforcement of the Act, establish appellations of origin for marijuana grown in California and ensure that it meets organic standards.
While this bill appears to be modeled on certain aspects of multiple regulatory programs within state government (including those for products used by consumers and patients in California for treatment of illness or disease, programs regarding agricultural commodities and programs that regulate businesses subject to state and local taxation, to name a few), a Bureau within the DCA may not be able to achieve the extensive, complex requirements set forth in this bill unless there are requirements for staff to have, or for staff to rely on, expertise of persons and organizations with experience related to medical marijuana.
The DCA, in the State and Consumer Services Agency oversees about 40 programs, boards and bureaus that oversee almost 250 license categories, including doctors, nurses, dentists, engineers, architects, contractors, cosmetologists and automotive repair facilities, among others. These regulatory entities license, register, or certify more than 2.5 million professionals and health care practitioners, investigate complaints, and discipline violators. They also administer licensing laws which establish the minimum qualifications and levels of competency for licensure, establish education and experience requirements, including professional licensing examinations that assess skills, knowledge and abilities of candidates for professional licenses. The licensing laws which they oversee are largely administrative licensing and regulatory acts.
One recent example of significant challenges faced by the DCA in the implementation of broad laws by a Bureau under its purview is the efforts by the Bureau of Private Postsecondary Education (BPPE) to administer the Private Postsecondary Education Act. Similar to this bill, legislation in 2009 (AB 48, Portantino, Chapter 310, Statutes of 2009) created a new act and new Bureau to regulate an important segment of the economy, specifically private postsecondary institutions, and sought to establish quality standards and consumer protections for Californians attending these institutions. The law provided BPPE a wide array of enforcement tools to ensure schools comply with the law and relied on the promulgation of regulations to specifically implement the Act. However, BPPE has struggled since its inception to perform all of the required functions outlined in the Act and accompanying regulations. From staffing, to establishing policies and procedures, to data systems, to timelines, to processing complaints, BPPE has faced difficulties in implementing a broad law that, like this bill, exists in a complex regulatory framework of federal law and other state agencies and relies on expertise and understanding of multiple issues related to the sector that the DCA may not have.
NOTE: Double-referral to Senate Committee on Rules.
SUPPORT AND OPPOSITION:
Support: None on file as of April 14, 2015.
Opposition: None on file as of April 14, 2015.
-- END --
Discussed in Hearing
Assembly Floor
Senate Floor
Assembly Floor
Assembly Standing Committee on Health
Assembly Standing Committee on Business and Professions
Senate Floor
Senate Standing Committee on Appropriations
Senate Standing Committee on Business, Professions and Economic Development
Bill Author
Bill Co-Author(s):